Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AATF "BFR2, CHE-1, CHE1, DED" ENSG00000275700 "Apoptosis antagonizing transcription factor" Q9NY61 17 36948925-37056871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 163.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004940, HPA075963" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli Nucleoplasm "HPA004940: AB_1078075, HPA075963: " "unprognostic (1.10e-1)" "unprognostic (5.46e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-3)" "unprognostic (5.54e-2)" "unprognostic (1.94e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (3.06e-2)" "unprognostic (4.10e-2)" "unprognostic (2.84e-1)" "unprognostic (2.48e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.14e-5)" "unprognostic (2.18e-2)" "unprognostic (1.51e-1)" "unprognostic (7.53e-3)" "unprognostic (3.21e-3)" 29.8 24.4 22.2 26.3 25.6 34.7 26.6 23.6 24.9 24.6 19.8 28.3 18.5 25.6 17.5 24.4 24.7 15.4 26.1 21.0 23.2 22.1 22.5 23.4 34.1 24.0 23.4 29.5 37.5 20.3 15.9 23.2 24.5 20.3 24.0 17.3 21.0 24.1 40.8 37.1 24.2 24.5 22.8 27.1 30.0 22.9 23.5 35.3 20.4 14.2 39.2 31.2 23.4 26.8 107.2 174.2 37.0 73.8 49.3 57.0 67.3 61.2 50.4 76.0 67.3 120.3 74.3 178.2 79.5 60.5 123.4 89.9 141.8 80.0 102.6 83.4 97.3 77.1 65.6 85.8 59.4 121.9 73.4 49.5 138.7 98.4 88.4 68.2 56.6 92.3 114.4 51.7 68.6 81.6 162.4 105.0 46.0 62.8 63.3 104.0 96.7 105.6 62.6 93.7 79.0 33.8 90.9 40.8 95.5 79.6 69.6 72.3 50.4 58.1 96.2 122.5 211.9 61.3 83.1 124.2 72.2 101.9 107.1 48.9 55.2 90.2 60.0 74.0 59.6 46.8 53.9 64.0 51.0 51.0 48.1 47.7 67.5 58.1 77.7 45.5 75.7 57.2 22.2 25.6 23.6 24.9 21.0 23.2 24.0 23.4 24.5 22.8 23.5 26.8 24.5 22.4 34.6 25.1 41.2 43.7 46.3 39.7 29.6 13.4 14.7 13.1 17.8 32.9 37.8 25.8 22.9 72.9 48.5 26.4 9.8 41.6 32.0 23.4 22.9 30.1 16.1 33.7 28.5 48.1 59.8 30.3 23.0 22.0 47.5 37.4 14.6 16.9 46.8 18.5 24.6 26.4 6.1 33.9 30.3 62.0 23.6 33.4 28.4 30.0 54.9 34.3 53.5 29.1 57.7 51.1 26.3 23.3 38.4 52.1 48.8 52.0 31.1 24.0 32.9 32.3 39.0 52.5 40.8 28.2 43.9 163.9 44.3 27.4 31.9 43.6 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins, Transporters" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 16.1 56.1 10.9 13.3 10.9 16.8 15.8 11.8 13.4 18.2 9.6 15.5 15.7 15.5 12.3 20.0 17.0 12.7 28.5 10.9 12.7 19.2 22.7 14.4 17.0 13.9 12.3 20.0 23.6 43.5 21.0 16.4 12.8 16.2 13.6 14.2 26.9 19.6 46.8 19.6 16.3 12.4 9.2 17.8 17.5 16.5 12.4 14.6 17.9 41.3 16.1 17.1 17.6 11.6 49.9 30.2 16.9 32.8 48.1 26.9 33.3 35.2 39.1 46.7 36.5 52.0 19.3 29.8 69.5 38.1 54.9 46.4 26.5 37.1 24.1 38.4 25.5 25.7 26.6 30.8 40.4 29.2 25.2 39.7 33.5 33.1 32.7 27.4 33.8 25.7 24.1 34.9 33.5 60.0 28.7 18.8 25.7 51.1 41.2 28.5 28.1 50.4 25.4 29.6 29.1 16.9 36.5 69.1 33.8 18.3 93.7 25.3 33.5 24.9 27.1 39.5 53.1 39.2 40.5 38.2 38.8 28.7 31.3 8.1 29.1 22.7 32.9 30.4 34.7 23.6 29.0 27.5 25.6 23.8 36.0 29.5 14.6 24.0 32.4 15.8 27.2 37.2 10.9 10.9 11.8 13.4 10.9 12.7 13.9 12.3 12.8 9.2 12.4 11.6 10.2 9.6 2.0 6.2 17.4 14.5 10.0 29.8 9.6 16.7 10.8 6.7 11.6 17.2 19.7 14.7 14.6 36.9 16.2 19.8 29.4 22.5 9.5 11.2 12.0 11.6 11.4 8.6 7.1 22.4 25.5 12.5 13.3 12.0 9.5 16.0 16.8 20.0 21.6 20.2 9.9 13.4 30.5 9.4 6.9 10.2 12.5 12.9 16.0 3.7 22.8 14.7 17.5 6.6 7.3 20.5 9.8 11.7 19.4 9.0 28.6 37.3 14.4 22.3 6.6 11.9 9.5 12.8 17.1 14.5 10.2 43.8 16.6 18.1 14.7 11.7 ABTB1 "BPOZ, Btb3, BTBD21, EF1ABP" ENSG00000114626 "Ankyrin repeat and BTB domain containing 1" Q969K4 3 127672935-127680926 "Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 822.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 822.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035022, HPA035023" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoli "HPA035022: AB_10669998, HPA035023: AB_10602104" "unprognostic (6.76e-2)" "unprognostic (9.18e-3)" "unprognostic (2.11e-2)" "unprognostic (6.34e-2)" "unprognostic (6.51e-2)" "unprognostic (2.00e-3)" "unprognostic (4.43e-2)" "unprognostic (2.12e-2)" "unprognostic (9.81e-2)" "unprognostic (4.48e-3)" "unprognostic (4.55e-3)" "unprognostic (2.86e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.88e-1)" "unprognostic (1.81e-2)" "unprognostic (3.98e-2)" "unprognostic (7.92e-3)" 38.4 18.7 30.6 18.8 35.8 51.1 33.4 38.0 42.4 42.0 28.9 38.9 12.3 29.7 5.3 13.4 37.2 18.1 40.5 32.7 25.9 25.5 17.3 32.0 22.0 28.7 27.2 30.3 17.7 9.0 31.4 12.2 27.1 31.0 4.6 8.7 24.5 13.6 44.7 24.9 31.8 7.6 24.7 89.7 27.5 8.1 29.1 21.5 21.8 26.2 7.4 32.9 31.2 30.7 4.3 10.7 0.9 2.0 10.0 8.7 7.8 6.8 12.2 4.5 6.5 0.3 8.9 1.9 11.9 5.1 6.0 2.2 0.2 5.1 1.0 20.7 2.5 3.1 19.4 2.5 7.5 0.5 9.5 12.0 5.6 4.5 1.5 15.2 4.8 8.3 0.1 13.5 4.9 6.6 4.9 13.4 0.9 4.9 11.7 3.0 5.6 13.8 6.7 3.3 9.5 6.0 4.8 6.6 25.0 2.6 1.4 3.7 9.1 4.8 4.0 8.5 2.3 11.5 3.8 0.6 11.1 4.0 7.8 40.7 64.5 161.8 17.0 48.2 16.6 17.8 19.0 17.1 28.6 21.1 16.6 14.3 822.3 25.2 44.5 18.1 46.3 46.2 30.6 35.8 38.0 42.4 32.7 25.9 28.7 27.2 27.1 24.7 29.1 30.7 45.3 19.2 13.0 10.7 31.7 11.7 15.6 14.2 7.4 10.4 9.9 15.6 8.1 22.8 5.3 7.3 18.8 8.1 34.2 11.3 15.6 15.1 0.5 9.9 11.1 20.8 23.9 58.7 26.1 16.8 22.3 21.0 23.0 10.1 14.7 10.1 27.5 8.9 21.3 3.3 12.2 15.0 12.2 64.7 16.4 1.7 33.8 37.4 10.6 18.7 74.3 18.0 35.0 6.6 12.8 25.9 21.4 22.6 25.2 12.8 26.3 23.0 6.9 31.1 65.7 16.1 36.8 1.0 8.6 4.2 9.2 15.9 38.6 10.6 10.3 11.8 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979177 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 191.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 199.8;Hepatocytes: 287.4;Proximal enterocytes: 238.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 77.2;neutrophil: 113.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 113.7" "Cell line enhanced" "Detected in all" "BEWO: 96.9;RT4: 129.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes NA NA 96000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 15: RT4 - Unknown function" "Cluster 45: Enterocytes - Digestion" Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favorable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 37.8 18.1 16.1 10.6 18.2 8.8 17.1 17.4 15.1 11.0 21.3 40.9 62.5 9.3 9.8 30.4 9.9 14.9 23.0 14.3 17.5 40.3 191.5 13.6 6.2 16.6 17.9 9.5 39.7 18.8 12.6 17.3 15.9 18.4 27.1 16.1 15.4 11.8 30.1 24.8 51.4 11.1 17.5 10.5 27.4 9.3 20.6 8.3 17.0 29.2 12.1 19.5 12.7 18.9 16.3 24.5 7.2 9.9 34.0 14.4 96.9 11.8 11.3 12.9 14.8 16.4 24.0 9.1 14.0 17.9 12.5 9.9 28.7 12.4 19.2 10.0 9.5 10.9 13.1 47.2 19.4 9.7 7.8 24.0 9.4 15.7 9.2 13.1 32.3 13.6 12.3 8.9 14.0 45.3 26.3 7.0 4.9 36.8 19.8 13.4 21.3 10.2 20.7 129.1 8.7 12.6 30.6 46.5 11.4 21.2 32.6 11.3 20.9 18.2 13.4 15.2 11.5 14.4 11.0 4.0 10.0 9.7 11.4 77.2 18.3 5.2 6.9 14.2 8.2 5.4 6.6 8.8 10.3 4.5 7.2 7.1 113.7 7.2 9.4 9.4 9.3 8.0 16.1 18.2 17.4 15.1 14.3 17.5 16.6 17.9 15.9 17.5 20.6 18.9 28.0 28.9 25.0 25.1 10.8 13.5 15.9 26.1 21.1 27.4 19.4 13.5 47.4 51.5 23.4 23.9 22.9 37.7 12.1 199.8 21.5 22.9 11.6 18.1 16.7 18.8 34.4 21.5 17.8 40.6 46.5 19.8 88.7 24.1 17.1 21.4 21.8 287.4 25.4 18.5 18.8 44.5 24.4 35.4 14.1 7.1 29.8 23.7 14.2 15.0 36.3 61.9 9.2 22.1 18.2 34.2 100.0 47.0 18.3 24.0 238.7 107.8 17.4 28.4 0.0 18.4 17.2 5.5 11.0 28.5 30.3 43.2 13.2 17.1 41.9 31.7 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732539-111120610 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lung: 9.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 41.9" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 12.1;RPMI-8226: 22.0;RT4: 29.3;U-266/70: 18.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 1.1 0.6 0.4 0.5 0.7 1.5 0.1 0.2 0.4 0.4 0.0 0.5 0.5 0.5 7.2 0.4 0.3 0.6 1.2 0.3 0.1 0.5 0.3 9.3 0.9 0.4 0.4 0.2 1.0 2.9 0.3 0.7 0.3 3.2 0.3 0.7 0.6 0.0 1.3 0.7 0.6 0.1 0.0 0.6 0.5 3.2 0.2 0.3 0.8 0.0 1.2 4.6 0.1 0.5 12.1 0.2 0.3 0.2 0.1 0.0 0.8 0.1 0.0 0.0 0.0 0.9 0.7 0.3 0.5 0.1 0.3 1.3 0.0 0.1 0.0 0.3 3.5 0.2 0.5 0.5 0.0 0.0 0.3 0.1 1.2 0.0 0.1 0.3 0.0 0.6 1.8 1.8 0.1 4.4 0.9 0.4 4.2 0.0 0.3 0.6 0.2 22.0 0.0 29.3 2.5 1.0 0.3 0.5 0.1 0.6 0.4 1.2 0.3 0.2 1.0 0.2 0.1 18.7 4.8 0.7 0.0 0.1 0.1 0.7 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.0 0.9 0.2 0.2 0.2 0.1 0.1 0.4 0.7 0.2 0.4 0.3 0.1 0.4 0.4 0.3 0.0 0.2 0.5 0.3 0.0 41.9 0.0 1.0 0.3 0.3 0.0 0.0 0.6 0.1 0.3 0.5 0.0 0.7 0.0 0.0 0.0 0.1 1.3 0.0 0.2 5.4 0.2 0.1 0.2 1.2 0.0 2.2 0.0 0.0 0.4 0.0 0.8 0.0 5.9 0.0 0.0 0.1 0.0 2.0 0.3 0.0 0.0 0.8 8.1 0.0 0.2 0.0 0.0 0.0 0.1 1.0 1.0 1.3 0.1 2.3 0.0 7.5 0.8 0.0 0.1 0.1 0.3 0.0 0.2 0.3 1.6 2.7 0.0 0.3 0.0 1.1 0.0 0.2 0.8 ACVR1 "ACVR1A, ACVRLK2, ALK2, SKR1" ENSG00000115170 "Activin A receptor type 1" Q04771 2 157736444-157876330 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 6.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007505, HPA046514" Approved Uncertain Nucleoli,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA007505: AB_1844752, HPA046514: AB_2732526" "unprognostic (6.99e-2)" "unprognostic (3.32e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-2)" "unprognostic (2.73e-1)" "unprognostic (6.09e-2)" "unprognostic (3.66e-3)" "unprognostic (1.08e-1)" "unprognostic (3.99e-1)" "unprognostic (3.20e-1)" "unprognostic (2.65e-2)" "unprognostic (4.29e-2)" "unprognostic (2.42e-1)" "unprognostic (3.43e-3)" "unprognostic (3.17e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.17e-4)" 20.8 10.4 17.3 12.9 12.7 1.8 18.8 14.0 15.4 28.1 17.4 16.5 10.9 24.4 32.7 11.3 17.0 24.2 19.7 26.3 12.8 26.4 22.7 17.5 8.8 13.7 12.9 21.2 10.0 8.5 10.9 17.6 13.7 15.1 12.6 6.3 18.8 15.3 21.5 13.9 10.5 34.5 12.6 8.3 14.7 5.2 16.3 7.5 40.5 13.3 8.2 20.9 15.5 11.8 6.1 13.1 14.4 18.5 65.0 70.6 18.9 43.4 71.3 33.7 36.1 10.1 13.4 0.2 18.2 45.6 32.3 16.9 10.5 22.5 36.8 43.0 8.7 25.7 7.2 14.4 54.7 2.0 28.5 89.5 41.4 69.8 84.2 42.8 38.7 6.7 9.5 6.7 45.2 11.1 0.4 0.4 21.4 8.7 21.7 4.1 19.6 5.7 45.4 24.5 12.4 14.9 17.0 9.7 64.5 22.2 5.3 7.0 54.0 50.9 16.8 25.3 17.1 4.7 3.5 0.3 52.2 1.6 58.1 2.9 1.7 0.1 0.5 1.0 0.7 0.8 4.9 1.3 1.3 0.2 1.6 0.7 0.2 1.2 1.4 1.4 6.6 1.1 17.3 12.7 14.0 15.4 26.3 12.8 13.7 12.9 13.7 12.6 16.3 11.8 9.6 9.6 9.0 22.9 1.8 9.8 7.7 12.6 12.5 10.4 8.0 9.8 12.7 11.5 12.4 7.3 0.0 8.4 1.1 4.8 5.9 9.9 1.0 5.9 12.9 17.3 4.2 1.7 34.0 17.8 5.3 20.3 8.2 6.5 5.1 4.2 18.2 13.3 7.0 3.3 34.2 4.5 24.4 13.0 8.7 2.0 20.2 7.6 3.6 106.8 5.5 6.6 2.1 42.3 22.9 17.2 4.1 15.8 6.4 13.0 3.7 15.5 13.6 2.1 13.1 16.3 19.3 0.4 2.7 4.0 7.5 10.5 4.3 3.5 4.3 8.8 ADAMTS12 ENSG00000151388 "ADAM metallopeptidase with thrombospondin type 1 motif 12" P58397 5 33523535-33892019 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 25.2;Fibroblasts: 22.9;Leydig cells: 22.1;Microglial cells: 73.1;Sertoli cells: 52.6;Theca cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 47.4;hTERT-RPE1: 88.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035973, HPA075079" Uncertain Approved Nucleoli,Mitochondria "Secreted to extracellular matrix" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 52: Non-specific - Transcription" Nucleoli Mitochondria "HPA035973: AB_10669663, HPA075079: AB_2732278" "unprognostic (6.18e-3)" "unprognostic (3.12e-4)" "unprognostic (1.05e-1)" "unprognostic (8.37e-2)" "unprognostic (1.65e-1)" "unprognostic (3.52e-1)" "unprognostic (2.60e-2)" "unprognostic (3.49e-3)" "unprognostic (3.78e-3)" "unprognostic (3.39e-2)" "unprognostic (5.63e-3)" "unprognostic (1.45e-1)" "unprognostic (4.27e-7)" "unprognostic (4.45e-3)" "unprognostic (1.47e-1)" "unprognostic (5.85e-2)" "prognostic unfavorable (6.78e-4)" 9.0 5.2 0.9 1.6 0.7 0.0 7.8 0.5 0.4 2.7 1.7 2.5 0.5 3.8 0.5 0.9 3.2 4.0 1.6 0.2 0.4 1.3 1.4 5.6 0.9 1.2 0.9 2.7 0.6 0.5 0.6 3.9 1.0 1.3 1.0 0.7 0.9 1.4 0.8 1.5 1.1 6.5 1.5 0.5 1.2 2.0 1.3 0.3 1.9 0.7 0.6 2.2 2.0 3.3 28.7 0.9 25.5 0.0 35.9 17.2 0.0 13.3 33.1 16.8 19.5 0.0 0.0 0.0 0.0 9.0 29.1 0.8 0.7 16.7 24.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 13.8 0.0 47.4 12.2 88.0 0.0 0.0 0.0 0.1 26.6 0.0 0.0 0.0 5.0 0.0 0.0 0.0 29.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 36.9 0.0 0.0 0.0 28.0 36.2 0.3 7.9 4.4 3.5 0.0 23.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.5 0.4 0.2 0.4 1.2 0.9 1.0 1.5 1.3 3.3 6.4 0.0 0.0 1.3 0.5 0.8 0.0 0.0 0.0 0.1 1.5 2.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 4.9 1.2 25.2 2.1 0.0 0.0 3.0 0.2 0.4 22.9 0.0 0.6 0.0 3.3 11.4 0.2 0.6 0.0 6.2 0.0 0.0 0.3 2.1 3.0 22.1 0.2 7.2 73.1 0.0 5.3 0.0 0.5 7.8 0.1 0.0 17.7 0.0 0.1 0.0 2.4 0.7 0.2 52.6 1.7 19.1 0.4 4.7 0.1 0.9 0.8 0.3 55.4 0.0 0.1 ADAR "ADAR1, G1P1, IFI4" ENSG00000160710 "Adenosine deaminase RNA specific" P55265 1 154581695-154628013 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing" "DNA-binding, Hydrolase, RNA-binding" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003890, HPA051519, CAB056157" Enhanced Enhanced Nucleoplasm,Nucleoli No No "Cluster 52: Eosinophils - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520" "unprognostic (3.46e-1)" "unprognostic (8.11e-2)" "unprognostic (1.42e-1)" "unprognostic (1.83e-2)" "unprognostic (2.38e-1)" "unprognostic (9.37e-2)" "unprognostic (2.07e-2)" "unprognostic (6.97e-2)" "unprognostic (2.03e-1)" "unprognostic (2.90e-1)" "unprognostic (4.13e-2)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.30e-5)" "unprognostic (3.44e-1)" "unprognostic (1.49e-1)" "unprognostic (9.00e-2)" "unprognostic (3.94e-2)" 41.9 44.7 30.4 57.2 29.9 47.1 41.1 18.0 35.1 49.4 16.3 42.9 46.4 50.2 26.3 37.9 50.3 45.6 36.1 31.5 40.0 51.7 56.1 54.6 66.1 32.1 33.8 54.9 40.6 62.8 53.9 46.5 34.8 42.8 44.4 47.9 59.4 43.0 18.8 39.9 52.8 56.6 39.2 73.5 40.3 34.4 37.8 85.2 47.1 27.6 65.0 50.5 40.0 25.5 93.2 103.1 84.4 104.8 87.4 88.5 97.8 59.5 132.7 209.8 183.4 87.8 85.3 162.6 97.7 98.7 112.4 85.4 111.9 115.5 109.8 159.1 52.3 84.9 66.2 48.4 96.7 122.8 83.8 86.2 84.7 100.4 104.1 81.2 104.5 112.4 82.4 111.6 72.0 107.8 165.0 43.3 139.7 125.5 74.6 140.1 74.2 131.2 67.6 106.1 84.8 100.2 104.4 167.9 126.2 128.1 113.4 148.2 94.3 67.5 68.5 58.8 71.5 132.9 179.0 177.6 70.2 78.4 81.0 7.8 8.1 15.0 10.8 9.9 10.2 9.0 10.6 11.2 7.8 5.8 9.8 10.0 29.1 8.6 9.4 6.3 9.1 7.4 30.4 29.9 18.0 35.1 31.5 40.0 32.1 33.8 34.8 39.2 37.8 25.5 73.3 83.3 51.2 37.5 80.5 33.3 39.4 39.9 32.5 94.5 43.6 36.6 22.1 45.8 44.0 47.8 95.9 41.2 103.0 73.3 9.8 49.2 4.2 48.9 61.0 86.7 63.1 45.2 44.8 66.9 57.8 49.1 56.6 52.4 62.1 88.6 84.9 93.8 53.5 168.2 53.2 53.9 34.6 104.1 43.9 13.1 73.7 78.0 19.6 32.8 110.2 37.9 126.7 38.2 39.7 69.6 62.7 59.0 87.5 61.1 86.7 42.5 50.0 80.2 52.6 40.1 45.2 11.4 35.0 37.9 40.3 31.5 85.6 66.5 56.2 53.8 AGTPBP1 "CCP1, KIAA1035, Nna1" ENSG00000135049 "ATP/GTP binding protein 1" Q9UPW5 9 85546539-85742029 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 60.1;brain: 73.4;retina: 46.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 176.7;Inhibitory neurons: 163.0;Oligodendrocytes: 463.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057208, HPA071094" Approved Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli, Vesicles" "HPA057208: AB_2683370, HPA071094: " "unprognostic (2.15e-1)" "unprognostic (3.78e-2)" "unprognostic (4.93e-3)" "unprognostic (6.12e-2)" "unprognostic (1.42e-1)" "unprognostic (8.95e-3)" "unprognostic (1.86e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-1)" "unprognostic (8.26e-3)" "unprognostic (5.69e-3)" "unprognostic (6.31e-2)" "unprognostic (3.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.39e-1)" "unprognostic (9.60e-3)" "unprognostic (1.25e-1)" 8.4 5.5 31.1 9.5 44.3 60.1 6.2 23.2 36.3 4.7 0.0 5.1 3.7 4.9 3.9 5.3 4.6 5.3 12.2 20.1 30.3 6.9 4.6 14.4 9.4 30.5 28.6 3.6 6.7 7.5 5.3 6.1 31.5 4.7 5.8 46.5 4.1 3.0 16.5 6.2 5.1 6.5 32.0 14.8 5.5 14.1 34.3 12.4 5.8 20.5 8.4 5.7 4.3 73.4 5.1 9.6 27.9 11.1 5.6 6.0 10.6 7.4 6.4 7.4 8.4 5.2 8.6 31.3 6.2 7.7 13.2 2.9 13.0 9.4 6.9 33.6 11.8 5.3 11.5 9.3 11.8 24.5 6.2 5.8 10.8 7.0 23.5 4.8 11.9 15.9 6.7 24.5 3.3 8.0 19.3 14.5 19.3 18.1 6.8 17.3 10.2 9.8 12.8 5.4 33.5 23.7 8.4 9.1 15.4 26.1 3.5 7.8 12.0 4.8 8.5 30.4 8.9 16.7 14.8 14.3 10.1 23.5 9.8 37.4 14.4 12.7 9.0 8.4 8.8 2.3 4.4 7.0 15.6 1.7 3.7 7.0 21.2 6.8 6.7 2.5 5.1 9.6 31.1 44.3 23.2 36.3 20.1 30.3 30.5 28.6 31.5 32.0 34.3 73.4 22.3 64.1 12.8 46.0 14.3 7.9 2.6 2.9 8.0 38.0 4.7 4.8 48.3 0.0 13.8 3.7 102.2 4.1 41.8 4.3 7.9 5.7 52.5 29.3 8.6 12.0 7.7 16.8 176.7 4.0 4.3 6.9 9.2 22.0 27.1 9.2 8.2 3.7 8.1 35.3 163.0 5.6 6.1 35.4 24.1 53.9 1.8 42.8 3.6 61.8 46.6 16.7 47.4 82.9 463.5 5.1 1.2 2.6 26.2 3.8 3.2 9.8 14.7 59.1 13.1 9.3 10.4 46.6 29.2 9.2 10.7 2.9 26.3 6.4 4.7 2.3 AL121900.1 ENSG00000284776 "Novel protein" 20 18567453-18744216 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Nucleoli, Cytosol" "HPA040981: AB_10673268" 11.6 14.9 16.3 13.1 15.8 15.3 17.0 15.4 18.3 10.5 13.3 13.1 10.4 12.7 12.8 13.2 11.2 7.9 11.1 16.2 20.1 19.7 8.1 12.4 13.0 16.7 16.0 15.3 19.0 22.9 11.1 17.4 9.9 14.5 28.2 9.7 10.4 21.9 9.9 8.5 11.8 17.6 12.4 12.5 14.7 17.7 8.5 21.6 17.9 17.0 14.7 19.4 58.0 57.7 65.1 58.3 23.6 55.4 27.8 50.7 50.0 43.6 35.0 39.8 46.0 0.9 33.2 50.6 53.1 32.6 49.7 119.3 68.9 26.6 25.9 65.1 15.8 57.9 72.3 57.9 37.8 32.9 89.5 44.8 154.1 33.8 72.2 10.2 34.6 70.7 59.4 66.0 12.8 55.3 53.3 40.1 93.8 0.6 87.1 51.6 57.1 33.8 82.0 57.5 25.4 69.0 120.5 32.8 42.9 33.6 61.1 55.3 26.1 63.7 69.7 54.8 69.5 31.1 37.8 51.4 45.6 57.6 20.5 15.8 29.8 30.5 30.5 30.5 29.9 29.6 40.1 26.1 20.7 21.9 24.3 25.6 31.3 9.0 24.5 19.2 16.3 15.8 15.4 18.3 16.2 20.1 16.7 16.0 17.4 17.6 17.7 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALG14 MGC19780 ENSG00000172339 "ALG14 UDP-N-acetylglucosaminyltransferase subunit" Q96F25 1 94974405-95072951 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031829 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA031829: AB_2674062" "unprognostic (7.79e-2)" "unprognostic (3.59e-2)" "unprognostic (1.51e-3)" "unprognostic (1.75e-3)" "unprognostic (1.36e-1)" "unprognostic (6.56e-2)" "unprognostic (4.00e-1)" "unprognostic (2.17e-2)" "unprognostic (3.18e-1)" "unprognostic (2.01e-1)" "unprognostic (7.79e-2)" "unprognostic (1.15e-1)" "unprognostic (1.24e-1)" "unprognostic (9.55e-2)" "unprognostic (6.01e-2)" "unprognostic (4.99e-2)" "unprognostic (1.93e-1)" 1.2 2.5 1.5 0.8 1.7 0.9 1.3 2.2 1.9 1.0 1.7 1.6 1.8 0.8 2.3 1.0 0.8 1.2 0.9 1.6 1.4 1.5 2.1 0.7 0.8 1.7 1.4 0.9 1.8 1.6 1.0 0.8 1.5 0.9 1.7 1.4 1.8 0.8 1.5 0.9 1.3 0.8 1.2 0.8 1.1 1.1 1.7 0.7 1.7 0.5 0.8 0.9 0.7 2.2 2.5 1.6 1.3 1.2 1.0 1.7 1.1 1.8 1.9 1.8 1.5 1.8 0.8 1.3 1.8 2.2 2.2 1.7 1.5 1.7 2.2 2.8 2.5 0.7 1.6 2.9 1.6 1.7 0.4 1.9 1.7 1.4 1.3 1.4 1.6 1.7 1.4 1.6 1.8 1.2 1.9 1.1 0.8 2.5 2.2 1.2 2.6 1.4 2.1 1.4 1.1 1.5 1.0 3.4 3.2 0.9 1.5 1.5 1.2 1.1 1.3 2.0 3.9 1.0 1.0 1.1 0.8 0.8 0.9 1.3 1.0 0.3 0.8 1.3 0.7 1.6 0.9 1.0 1.5 1.4 0.8 0.9 0.8 0.9 0.6 1.9 1.3 0.6 1.5 1.7 2.2 1.9 1.6 1.4 1.7 1.4 1.5 1.2 1.7 2.2 11.8 0.0 12.2 14.0 13.1 11.7 11.4 30.5 19.4 16.9 13.8 15.2 7.7 10.0 20.3 16.5 6.2 34.6 10.5 25.7 19.6 24.9 10.0 12.2 19.6 10.1 4.2 13.0 24.6 53.7 25.9 18.9 11.2 13.3 1.3 14.7 11.7 32.4 18.9 8.4 22.4 12.9 18.3 8.4 8.9 8.4 14.3 8.6 32.0 14.0 10.3 30.9 3.1 14.6 35.4 23.6 22.6 10.1 41.6 8.9 22.1 40.0 12.7 14.4 32.9 17.1 15.2 36.1 23.0 19.0 8.7 25.2 5.6 39.9 26.9 12.9 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 64.1;Hofbauer cells: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 14.7 20.2 2.7 5.6 3.4 5.5 13.7 2.4 4.8 12.9 2.8 12.6 9.1 12.2 0.7 10.6 10.8 4.3 7.0 3.3 2.0 18.7 13.8 12.2 7.9 3.4 3.1 9.3 8.2 3.1 8.5 4.5 2.8 10.8 0.8 0.4 13.7 3.2 8.8 15.4 17.3 1.4 2.4 26.1 9.9 37.0 4.2 3.7 12.1 1.3 1.9 10.9 9.8 4.3 9.6 11.7 3.1 6.7 3.5 2.5 15.4 9.0 3.4 7.4 9.0 8.7 16.9 4.4 4.4 1.7 14.0 9.3 1.7 2.5 0.2 6.0 7.8 6.6 13.8 12.7 12.9 4.6 16.8 6.6 2.5 4.9 0.8 1.8 4.0 12.5 14.3 9.3 3.1 19.0 7.8 11.7 6.7 0.8 10.1 29.6 4.4 14.0 2.4 5.4 10.3 9.9 5.7 13.1 21.4 0.5 13.1 1.5 6.9 7.4 11.3 14.3 4.7 15.7 14.1 8.9 8.1 9.5 7.4 9.5 3.3 9.6 4.8 7.5 3.8 6.4 3.5 2.9 1.2 4.1 2.7 2.4 8.4 3.1 9.9 9.9 3.8 2.9 2.7 3.4 2.4 4.8 3.3 2.0 3.4 3.1 2.8 2.4 4.2 4.3 8.0 3.2 11.6 1.3 16.7 8.9 5.2 3.2 4.0 10.3 13.6 11.6 2.5 10.0 5.2 5.5 6.2 16.7 16.4 16.2 5.9 30.3 64.1 6.0 4.1 8.3 12.6 11.0 1.6 17.0 27.1 9.9 7.1 5.2 7.0 13.1 18.2 11.9 127.0 23.5 1.1 12.8 6.1 47.6 12.1 27.4 10.5 28.9 19.6 1.9 26.9 11.0 20.6 0.5 0.8 14.5 26.4 6.4 11.5 4.1 59.4 48.9 9.1 13.0 0.0 7.8 8.4 52.9 16.3 5.1 8.9 27.9 13.2 7.6 10.4 4.2 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1161.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 112.1 120.5 104.8 52.1 108.6 109.3 103.4 110.9 149.5 85.9 100.7 126.0 61.0 86.4 39.0 125.8 80.3 58.0 231.3 106.4 106.8 127.3 185.7 89.3 73.0 110.0 105.1 76.4 108.1 59.0 92.0 54.8 105.0 105.7 27.3 19.3 117.6 42.0 272.8 99.7 83.4 36.5 110.4 86.7 117.9 189.7 113.0 50.1 90.6 126.5 34.0 95.9 94.7 118.1 262.4 605.0 139.0 209.7 118.7 132.8 164.3 123.4 100.6 111.4 127.1 248.6 226.9 82.1 133.3 114.4 121.8 148.9 58.1 166.4 40.5 122.5 437.1 126.8 257.9 379.0 131.3 95.3 103.6 145.6 151.8 120.4 98.2 73.4 184.9 111.9 173.7 233.8 120.8 474.1 225.5 150.6 131.2 259.2 448.7 92.3 136.2 168.0 104.9 229.3 175.8 282.6 133.5 205.7 253.8 96.7 254.1 222.7 108.4 215.0 169.5 229.4 234.1 110.5 52.1 107.0 228.7 144.5 177.7 495.1 419.8 418.8 229.7 359.9 218.7 309.0 232.0 252.9 348.0 296.2 223.0 212.3 212.1 258.5 345.4 581.1 297.9 506.0 104.8 108.6 110.9 149.5 106.4 106.8 110.0 105.1 105.0 110.4 113.0 118.1 137.2 128.2 157.2 11.4 110.5 148.6 215.0 406.1 145.7 59.5 272.5 332.7 360.2 201.6 272.3 198.6 20.9 467.8 119.5 239.6 522.3 260.6 451.9 157.0 151.3 152.9 190.3 201.6 9.8 337.7 524.6 182.9 124.4 169.5 108.3 158.3 159.2 496.4 448.2 33.7 10.2 272.6 319.4 174.6 194.3 1161.0 181.7 170.1 261.5 13.1 251.4 227.7 176.1 7.1 17.0 324.3 274.0 164.7 226.8 334.2 290.7 548.0 199.8 78.9 105.2 115.9 245.0 435.8 252.5 257.4 186.7 508.7 117.3 156.0 271.4 307.0 AP002495.1 ENSG00000254469 "XRCC1 N-terminal domain containing 1-like" Q6ZNB5 11 71865504-71928665 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 1.1;Cytotrophoblasts: 6.0;Extravillous trophoblasts: 2.2;Hofbauer cells: 2.0;Respiratory ciliated cells: 1.5;Syncytiotrophoblasts: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051121, HPA051124" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes NA "Cluster 20: T-cells - T-cell receptor" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoli "Mitotic chromosome" "HPA051121: AB_2681349, HPA051124: " "unprognostic (1.66e-1)" "unprognostic (1.19e-2)" "unprognostic (2.23e-1)" "unprognostic (1.73e-2)" "unprognostic (2.39e-1)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (9.79e-4)" "unprognostic (5.91e-3)" "unprognostic (5.04e-3)" "unprognostic (7.21e-2)" "unprognostic (2.23e-1)" "unprognostic (1.92e-2)" "unprognostic (1.33e-2)" "unprognostic (2.07e-1)" "unprognostic (3.60e-1)" "unprognostic (3.12e-3)" 1.9 2.1 1.9 2.2 2.8 4.7 3.2 4.3 2.6 2.8 2.8 2.2 2.6 3.7 5.3 2.6 2.4 2.1 2.1 1.7 2.2 2.9 2.2 1.8 4.2 2.5 1.5 4.6 3.1 2.9 2.5 2.0 2.4 3.1 3.5 7.3 2.2 2.8 1.6 4.2 2.6 2.4 0.6 2.9 2.4 3.3 2.8 3.2 3.2 1.5 3.4 2.3 2.2 5.0 2.6 6.2 4.7 4.5 1.8 1.6 3.1 2.9 2.3 3.1 3.0 6.5 6.4 5.8 2.6 2.0 3.9 8.4 4.9 3.3 3.2 8.4 4.5 9.4 7.7 4.2 1.1 4.2 3.1 2.2 1.6 5.2 3.6 2.6 4.9 8.0 6.3 7.6 3.0 4.9 4.8 3.5 4.9 9.6 4.5 3.6 16.3 4.0 3.5 3.1 6.9 6.6 4.6 4.1 9.2 3.3 5.1 2.3 4.6 2.5 4.1 4.9 1.9 5.5 8.4 7.0 4.0 4.6 3.7 2.7 1.9 1.7 2.9 3.0 1.7 2.5 5.1 3.8 2.2 3.3 4.8 4.1 2.0 1.2 1.9 4.8 4.9 1.9 1.9 2.8 4.3 2.6 1.7 2.2 2.5 1.5 2.4 0.6 2.8 5.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 0.0 0.0 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32886601-33025130 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 9.7 14.8 14.6 7.0 14.8 11.0 10.4 14.8 20.2 9.1 13.9 10.2 8.6 8.6 7.6 14.7 8.9 4.9 9.9 14.8 15.0 13.6 15.6 9.3 8.1 14.7 14.6 8.5 9.6 12.1 7.6 7.8 15.0 9.6 11.2 8.0 9.0 6.6 9.8 15.3 8.3 8.6 14.2 8.9 9.7 14.7 15.2 9.3 7.0 6.9 11.0 10.4 9.6 15.0 36.2 26.1 18.4 17.1 19.0 17.4 25.6 24.8 26.0 28.7 31.5 35.1 12.7 27.8 14.6 21.1 18.4 19.4 33.7 32.8 35.1 39.2 11.2 17.9 32.5 37.8 24.4 29.4 15.1 23.8 36.3 32.5 37.9 16.9 26.8 20.2 27.0 24.2 26.0 15.6 24.4 43.2 33.5 24.4 29.0 21.2 14.4 21.5 25.2 21.2 15.6 11.1 21.4 18.0 15.5 17.9 23.0 11.4 17.7 16.2 21.1 29.9 25.0 11.1 21.2 27.5 23.4 23.8 13.2 3.3 14.7 13.4 12.2 15.6 15.2 16.3 12.8 14.6 17.6 16.1 16.0 12.1 5.9 23.1 21.7 15.2 17.3 16.1 14.6 14.8 14.8 20.2 14.8 15.0 14.7 14.6 15.0 14.2 15.2 15.0 14.8 19.2 29.0 31.3 16.9 16.7 23.1 32.9 22.2 15.2 17.9 17.0 14.9 21.5 23.1 9.2 10.4 27.7 15.1 12.6 29.4 25.3 55.6 19.7 18.3 13.3 16.8 20.0 27.3 28.2 27.7 15.6 19.4 18.1 16.5 17.8 8.9 21.4 18.8 13.5 29.0 15.3 34.6 14.7 9.9 48.7 13.4 15.0 14.2 15.9 19.3 18.3 15.5 23.6 43.0 31.9 6.8 10.5 28.3 24.0 13.9 31.7 25.4 16.6 13.1 13.5 20.2 42.2 26.9 25.8 21.2 27.9 15.9 20.5 16.3 23.1 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639941 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.7 0.9 2.0 7.9 2.5 24.2 1.7 2.1 2.1 1.5 1.2 7.5 6.1 1.5 1.0 5.3 0.8 1.7 0.7 1.7 1.9 0.6 1.3 1.7 13.5 2.6 3.0 0.6 2.6 1.2 0.7 4.3 2.6 0.6 8.8 0.5 1.2 0.5 0.9 4.4 7.6 4.8 2.5 2.8 3.6 8.6 2.2 26.1 1.3 0.4 14.3 2.8 1.9 3.0 80.8 69.4 73.1 46.2 5.0 13.0 39.6 78.5 50.2 80.0 63.3 52.2 41.5 43.5 23.7 49.9 91.3 56.9 55.3 43.8 110.9 83.5 27.4 132.6 68.9 33.5 2.0 103.8 55.5 4.3 5.5 61.6 50.9 15.2 61.5 94.4 101.0 112.7 95.3 31.7 58.6 39.7 44.6 71.6 44.5 67.8 141.7 38.2 28.4 41.6 64.7 44.5 72.9 46.2 17.6 37.6 63.6 115.8 35.3 102.5 74.1 42.0 87.2 38.3 63.7 123.7 44.4 129.1 91.8 0.1 0.3 0.8 0.5 0.5 0.2 0.3 1.0 0.9 0.4 0.2 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 2.0 2.5 2.1 2.1 1.7 1.9 2.6 3.0 2.6 2.5 2.2 3.0 0.7 0.0 2.3 0.3 4.6 4.8 1.1 2.4 2.2 0.2 1.3 1.7 0.9 4.3 1.9 1.8 0.0 9.8 2.9 6.2 0.0 0.8 4.7 3.8 2.6 2.0 0.0 38.7 1.0 0.8 23.7 3.5 8.6 2.8 0.0 21.1 1.8 2.1 9.5 0.0 0.6 7.8 0.0 6.5 4.2 5.0 0.6 3.5 0.0 1.0 3.9 0.1 2.1 0.5 1.4 0.5 2.9 0.4 18.6 1.4 1.1 0.4 1.4 1.0 6.6 1.4 3.3 24.7 22.6 10.5 2.3 3.1 5.4 2.0 14.1 2.1 ARID5A "MRF-1, RP11-363D14" ENSG00000196843 "AT-rich interaction domain 5A" Q03989 2 96536743-96552634 "Predicted intracellular proteins, Transcription factors" "Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HDLM-2: 295.3;RPMI-8226: 117.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002860, HPA023879" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Nucleoli "HPA002860: , HPA023879: AB_1845014" "prognostic favorable (2.05e-6)" "unprognostic (1.08e-3)" "unprognostic (1.69e-2)" "unprognostic (3.89e-3)" "unprognostic (1.90e-2)" "unprognostic (3.38e-2)" "unprognostic (3.03e-1)" "unprognostic (1.17e-1)" "unprognostic (1.24e-3)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.24e-8)" "unprognostic (2.74e-2)" "unprognostic (9.79e-2)" "unprognostic (1.06e-1)" "unprognostic (5.13e-2)" 32.6 4.5 8.1 19.5 8.9 11.8 38.8 8.7 11.1 18.5 7.7 25.9 5.0 25.2 2.0 7.8 24.1 12.3 28.8 7.8 8.7 12.3 8.5 48.1 19.0 14.3 10.8 10.8 6.9 2.2 9.3 9.6 11.5 23.2 2.3 2.2 10.2 2.6 23.5 11.3 19.8 7.3 10.6 22.8 14.6 5.6 10.2 10.3 13.0 2.3 9.9 19.9 15.4 9.6 3.4 1.9 1.6 5.4 2.7 3.0 7.5 5.1 17.2 6.1 5.3 3.1 0.9 1.1 3.8 2.9 9.1 4.6 1.4 0.3 2.1 295.3 4.1 6.9 1.1 5.8 3.4 4.7 4.9 2.1 5.7 5.0 0.9 5.3 5.4 8.1 5.4 38.5 2.4 2.9 8.7 16.1 3.3 1.5 0.2 12.2 11.3 117.5 0.7 2.5 2.2 1.1 0.5 0.6 4.3 1.3 0.2 10.0 6.0 5.4 6.7 6.2 4.6 24.7 21.5 3.1 3.0 11.1 4.9 10.5 7.9 32.8 15.3 6.9 14.9 5.9 13.1 14.6 10.3 6.5 14.1 14.4 21.5 27.5 5.5 18.4 16.0 14.9 8.1 8.9 8.7 11.1 7.8 8.7 14.3 10.8 11.5 10.6 10.2 9.6 97.1 3.2 18.3 3.9 59.9 52.4 46.5 17.0 5.7 24.8 80.3 44.7 14.7 8.6 14.7 3.7 31.3 4.9 121.1 10.8 3.9 33.7 14.2 16.7 26.8 82.2 0.0 3.4 1.5 30.9 9.0 41.2 11.2 32.4 61.9 2.1 38.6 28.7 72.6 0.0 1.6 10.7 20.3 41.5 137.1 36.7 3.7 61.6 58.7 15.9 66.6 6.5 123.6 3.5 1.3 29.1 23.9 6.4 54.5 28.2 0.6 10.6 8.3 25.7 46.0 49.1 120.1 3.2 17.9 1.1 32.5 4.0 98.2 2.1 7.8 26.9 ARL9 ENSG00000196503 "ADP ribosylation factor like GTPase 9" Q6T311 4 56505209-56524959 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.9" "Group enriched" "Detected in many" 17 "Early spermatids: 100.7;Late spermatids: 292.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HSkMC: 2.8;REH: 7.5;SCLC-21H: 7.0" "Region enhanced" "Detected in single" "cerebellum: 1.4" "Low region specificity" "Detected in all" HPA072942 Enhanced Approved Nucleoli,Mitochondria NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria Nucleoli "HPA072942: AB_2686561" "unprognostic (9.91e-2)" "unprognostic (2.19e-1)" "unprognostic (2.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.24e-3)" "unprognostic (6.86e-3)" "unprognostic (3.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.93e-2)" "unprognostic (4.46e-2)" "unprognostic (1.51e-1)" "unprognostic (1.71e-1)" "unprognostic (6.79e-6)" "unprognostic (1.47e-2)" "unprognostic (1.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.29e-2)" 0.2 1.1 1.2 0.2 1.3 2.2 0.8 1.4 1.6 1.5 4.2 1.2 0.3 1.4 0.4 0.5 0.5 1.0 0.2 1.1 1.4 0.2 0.1 0.2 0.2 2.2 1.4 1.4 0.1 0.1 1.2 0.0 1.3 1.0 0.2 0.4 0.8 1.6 0.2 2.1 0.5 1.7 1.0 0.1 0.4 12.9 1.5 0.4 0.4 0.0 0.2 0.6 1.9 1.3 0.0 0.1 0.3 0.2 0.6 1.7 0.0 0.6 0.3 1.3 1.2 0.1 0.5 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.1 0.0 0.0 1.7 0.0 0.3 2.8 0.4 1.2 0.1 0.4 1.3 0.0 0.0 0.3 1.1 0.0 0.1 0.0 1.6 0.0 0.8 7.5 0.0 0.0 0.0 0.0 7.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.0 1.2 1.3 1.4 1.6 1.1 1.4 2.2 1.4 1.3 1.0 1.5 1.3 0.4 0.0 1.1 0.3 0.0 6.0 1.3 3.6 1.8 0.1 2.6 2.5 0.1 1.5 0.3 1.8 0.0 0.1 0.1 0.0 0.0 0.6 100.7 2.5 2.0 0.7 0.0 0.0 3.3 0.2 0.1 3.0 0.0 2.9 0.0 2.0 0.4 0.0 0.1 0.0 2.4 0.8 0.0 0.8 0.3 292.4 1.5 0.2 5.4 0.0 0.0 0.9 0.0 3.0 1.7 0.8 0.1 1.2 0.0 1.6 0.1 0.7 0.4 0.1 0.0 1.3 0.9 11.5 1.2 0.0 1.6 0.0 0.2 1.6 0.6 0.3 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.1;lymphoid tissue: 22.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 45.6;Excitatory neurons: 78.8;Pancreatic endocrine cells: 86.9;Prostatic glandular cells: 109.0;Urothelial cells: 128.2" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 6.4" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 121.9;U-2197: 159.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Cluster 17: Basophils - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 18: U-2197 - ECM organization" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.0 1.0 1.3 10.0 6.4 2.3 2.1 0.0 3.6 5.8 0.0 2.5 2.8 1.2 0.2 28.1 0.9 3.6 0.8 2.8 1.6 1.1 4.7 2.3 5.2 0.0 0.5 0.2 1.3 1.5 0.8 2.8 0.0 1.1 3.2 0.4 7.2 0.6 0.2 7.6 2.6 4.6 0.0 1.0 10.9 2.7 0.6 4.4 0.6 0.8 22.2 14.7 11.9 2.2 76.0 19.2 4.2 1.6 3.6 11.0 58.3 26.3 34.5 16.8 26.2 18.2 57.4 0.6 14.4 12.6 51.9 30.6 12.3 92.1 42.7 121.9 15.7 14.6 11.7 15.2 4.8 29.6 6.1 4.0 8.1 58.8 45.6 28.9 80.0 17.7 7.5 29.8 19.6 9.2 16.2 16.2 32.1 25.7 65.8 29.8 68.2 4.7 14.1 42.8 13.6 2.2 13.5 2.1 0.4 10.0 2.9 9.7 54.6 54.2 31.4 159.5 110.0 4.4 8.4 0.1 46.5 23.5 10.9 1.3 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.5 0.0 1.3 6.4 0.0 3.6 2.8 1.6 0.0 0.5 0.0 0.0 0.6 2.2 2.1 3.2 1.3 1.3 0.4 0.8 45.6 8.6 1.2 0.9 1.6 0.8 0.9 11.5 7.5 9.2 0.0 1.9 0.3 1.5 0.0 22.1 3.8 7.9 0.7 6.9 1.2 3.4 78.8 27.4 4.0 3.2 28.1 11.8 0.0 5.3 2.5 3.5 1.4 0.0 24.8 3.3 2.0 2.5 5.4 4.4 0.0 2.9 1.8 7.5 15.7 0.0 0.0 8.5 2.3 86.9 1.4 0.0 3.4 109.0 1.7 0.6 2.7 0.1 0.0 1.7 3.6 3.1 4.7 6.6 2.3 4.2 1.3 0.2 2.1 128.2 ARPP21 "ARPP-21, R3HDM3, TARPP" ENSG00000172995 "CAMP regulated phosphoprotein 21" Q9UBL0 3 35638945-35794496 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 260.8;lymphoid tissue: 170.1;skeletal muscle: 85.6" "Group enriched" "Detected in some" 6 "Excitatory neurons: 861.9;Oligodendrocyte precursor cells: 624.8" "Cancer enriched" "Detected in single" 5 "glioma: 1.3" "Region enhanced" "Detected in many" "basal ganglia: 260.8" "Immune cell enriched" "Detected in single" 30 "plasmacytoid DC: 10.1" "Lineage enriched" "Detected in single" 30 "dendritic cells: 10.1" "Cell line enhanced" "Detected in some" "JURKAT: 111.4;MOLT-4: 68.4;REH: 37.3;RH-30: 20.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 254.3" HPA017303 Enhanced Supported Approved Nucleoli,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 10: Brain - Neuronal signaling" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoli Cytosol "HPA017303: AB_1845049" "unprognostic (1.72e-4)" "unprognostic (2.35e-1)" "unprognostic (1.10e-2)" "unprognostic (6.61e-2)" "unprognostic (6.30e-3)" "unprognostic (8.90e-2)" "unprognostic (2.42e-3)" "unprognostic (1.27e-1)" "unprognostic (7.42e-4)" "unprognostic (1.32e-1)" "unprognostic (2.35e-1)" "unprognostic (1.52e-1)" 0.2 0.2 34.8 0.4 260.8 4.5 0.1 85.2 69.9 0.0 0.0 0.4 0.2 0.0 0.0 2.6 0.0 0.0 0.2 48.5 15.7 1.1 2.3 0.1 0.1 14.3 7.8 0.0 0.1 0.0 12.6 0.0 15.6 1.1 0.4 2.9 2.1 0.2 85.6 0.2 0.3 0.0 0.0 0.2 0.2 0.0 9.1 170.1 0.5 48.6 0.4 0.0 0.0 44.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.6 0.0 5.2 0.0 0.0 0.0 0.6 0.0 111.4 0.0 0.2 2.6 0.0 68.4 0.0 0.1 0.0 2.7 37.3 20.6 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.1 0.0 0.0 34.8 260.8 85.2 69.9 48.5 15.7 14.3 7.8 15.6 0.0 9.1 44.5 0.0 0.0 0.0 24.8 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 1.8 0.0 0.2 0.2 0.0 0.0 861.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.1 0.0 108.2 0.0 0.0 0.0 0.0 3.5 0.3 0.1 0.0 21.5 0.1 0.0 0.0 624.8 85.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.5 0.0 21.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ASB18 ENSG00000182177 "Ankyrin repeat and SOCS box containing 18" Q6ZVZ8 2 236194872-236264409 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 4.8;heart muscle: 7.4;skeletal muscle: 11.3" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 6.5;Excitatory neurons: 2.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA068447 Approved Nucleoli,Mitochondria NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Nucleoli "HPA068447: AB_2685991" "unprognostic (1.12e-1)" "unprognostic (7.33e-3)" "unprognostic (3.07e-1)" "unprognostic (1.78e-6)" "unprognostic (4.75e-2)" "unprognostic (3.22e-1)" 0.0 0.0 0.6 0.0 4.8 0.0 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 1.0 0.6 0.0 0.0 0.0 0.0 2.3 2.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 1.5 0.0 0.0 0.5 3.3 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.8 1.0 1.0 1.0 0.6 2.3 2.0 1.4 1.5 3.3 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ASXL1 KIAA0978 ENSG00000171456 "ASXL transcriptional regulator 1" Q8IXJ9 20 32358330-32439319 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Repressor" "Cancer-related genes, Craniosynostosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064156 Approved Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA064156: AB_2685200" "unprognostic (1.49e-1)" "unprognostic (5.97e-2)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.86e-4)" "unprognostic (6.69e-2)" "prognostic favorable (9.16e-4)" "unprognostic (2.01e-3)" "unprognostic (2.89e-1)" "unprognostic (1.49e-1)" "unprognostic (1.38e-1)" "unprognostic (4.32e-2)" "unprognostic (3.21e-2)" "unprognostic (1.84e-3)" "unprognostic (5.47e-2)" "unprognostic (1.90e-1)" "unprognostic (4.82e-2)" "unprognostic (1.06e-1)" 31.6 24.6 13.4 18.1 14.4 36.9 30.5 15.0 14.4 30.6 20.2 31.6 12.2 26.8 15.6 17.2 28.6 13.7 21.8 14.1 15.6 28.7 32.8 36.0 24.0 15.8 14.2 32.3 32.9 13.1 19.2 17.3 13.8 24.8 13.2 19.7 21.0 13.3 30.1 23.2 27.8 18.4 13.8 35.0 24.7 37.2 15.1 27.4 32.0 16.4 25.0 26.4 24.2 17.1 59.2 33.6 52.7 28.2 23.6 28.6 45.6 35.4 33.0 64.1 48.6 99.8 35.2 54.4 24.5 47.3 62.2 39.5 45.3 37.8 53.2 70.6 24.1 88.9 53.6 55.7 21.6 38.5 36.1 32.4 25.1 46.1 35.6 33.3 37.4 45.3 45.2 29.1 31.9 18.4 51.7 30.3 12.9 27.7 38.9 30.8 62.1 24.8 27.1 28.4 23.7 38.2 68.9 23.5 31.7 27.9 32.7 27.0 39.9 69.1 59.4 32.3 43.2 33.9 38.6 39.3 34.0 100.2 27.8 0.1 0.6 1.0 2.6 0.5 2.5 4.8 3.6 3.9 0.8 3.3 3.5 4.0 0.5 1.5 0.6 2.7 9.0 1.5 13.4 14.4 15.0 14.4 14.1 15.6 15.8 14.2 13.8 13.8 15.1 17.1 92.3 51.3 35.5 54.9 63.3 40.0 51.8 8.6 50.7 21.4 52.9 48.6 19.8 15.7 17.9 27.6 52.1 18.0 55.2 18.8 25.4 13.5 97.8 59.4 80.1 65.6 7.2 40.8 61.4 12.6 16.5 49.8 30.5 86.2 18.3 57.7 41.0 34.7 21.3 18.5 80.3 14.1 16.2 21.2 42.2 84.9 25.4 33.5 78.2 75.9 16.7 11.6 20.6 78.4 125.9 15.6 13.7 14.7 94.6 49.6 29.9 31.7 20.8 30.7 6.6 96.7 62.7 31.0 16.1 34.6 30.5 5.9 67.2 36.4 17.5 40.5 ATF3 ENSG00000162772 "Activating transcription factor 3" P18847 1 212565334-212620777 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 1462.0;Endometrial ciliated cells: 1049.4;Glandular and luminal cells: 1429.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 6.4;intermediate monocyte: 4.0;myeloid DC: 1.6;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 15 "dendritic cells: 1.6;granulocytes: 6.4;monocytes: 6.3" "Cell line enhanced" "Detected in many" "BEWO: 131.5;HDLM-2: 100.4;SuSa: 155.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 9.3" HPA001562 Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 7: Monocytes - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA001562: AB_1078233" "unprognostic (2.66e-2)" "unprognostic (1.52e-2)" "unprognostic (2.80e-1)" "unprognostic (4.27e-3)" "unprognostic (3.29e-1)" "unprognostic (1.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.73e-1)" "unprognostic (9.31e-2)" "unprognostic (8.65e-3)" "unprognostic (8.75e-2)" "unprognostic (1.52e-1)" "unprognostic (6.97e-2)" "unprognostic (3.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-2)" "unprognostic (2.08e-2)" 176.1 82.8 14.2 63.3 17.7 45.3 97.6 16.5 18.7 106.2 17.1 66.6 21.0 108.6 9.3 128.4 122.6 135.0 113.7 14.4 20.2 98.1 139.9 116.0 20.8 21.1 16.7 40.2 67.2 48.8 45.0 66.3 17.2 116.3 60.0 16.2 33.1 24.1 30.7 154.9 45.6 313.0 15.4 24.4 104.8 3.9 18.8 84.5 181.1 30.0 3.1 281.2 55.2 25.0 21.1 1.2 40.7 8.7 3.9 10.4 131.5 14.7 11.9 12.5 29.8 27.7 15.5 0.4 6.5 0.9 68.0 11.6 24.6 4.0 20.5 100.4 24.6 1.6 11.6 10.0 72.9 9.0 22.7 18.3 65.3 34.9 80.4 2.4 2.6 23.9 10.0 77.0 1.9 2.8 27.5 5.9 29.2 11.5 9.2 8.1 27.1 18.4 1.8 3.0 18.3 18.4 19.1 34.2 59.0 155.0 19.9 6.5 2.4 3.6 19.5 12.3 6.7 60.4 27.9 7.4 11.9 4.8 10.8 6.4 0.7 0.0 0.3 4.0 0.3 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.2 0.0 6.3 0.8 0.0 0.7 14.2 17.7 16.5 18.7 14.4 20.2 21.1 16.7 17.2 15.4 18.8 25.0 568.2 423.1 146.5 1.6 55.3 202.8 866.2 236.1 1462.0 4.4 753.9 510.9 689.3 92.9 136.0 55.2 0.0 178.9 100.3 611.7 1.9 186.2 3.7 1049.4 318.2 176.2 889.6 2.7 2.6 122.7 330.8 452.6 966.9 1429.3 78.6 5.6 30.7 25.8 103.7 1.7 2.4 758.4 114.0 29.8 282.8 2.8 17.4 351.8 174.3 3.7 32.3 39.9 0.0 1.5 10.8 185.7 484.8 1.2 161.0 457.5 421.3 3.3 133.2 5.3 98.6 279.4 573.7 2.2 3.1 474.6 202.7 420.6 97.1 5.8 349.6 263.6 ATF6B "CREBL1, G13" ENSG00000213676 "Activating transcription factor 6 beta" Q99941 6 32115264-32128253 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046871 Uncertain Approved Nucleoplasm,Nucleoli NA NA 46000000 "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Nucleoli "HPA046871: AB_10963542" "unprognostic (2.93e-3)" "unprognostic (1.56e-1)" "unprognostic (5.50e-2)" "unprognostic (1.82e-2)" "unprognostic (1.13e-1)" "unprognostic (4.37e-2)" "unprognostic (9.80e-3)" "unprognostic (1.55e-1)" "unprognostic (3.15e-1)" "unprognostic (3.68e-2)" "unprognostic (9.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.04e-3)" "unprognostic (1.75e-2)" "unprognostic (1.76e-1)" "unprognostic (3.86e-1)" "unprognostic (1.10e-2)" 35.0 40.8 7.3 7.4 7.4 29.4 40.3 6.6 9.9 50.2 3.9 46.3 11.9 46.0 16.7 56.6 45.6 11.5 31.2 7.9 9.1 36.7 35.1 35.6 14.2 7.7 7.7 57.1 43.4 14.1 43.0 8.8 7.6 43.7 14.0 8.1 44.9 6.3 22.4 53.3 46.9 8.9 7.1 60.0 45.4 29.3 7.4 16.7 51.1 5.0 17.0 44.3 47.0 7.1 2.5 6.3 18.1 29.7 17.8 18.9 11.5 9.8 13.3 13.7 20.8 25.2 20.9 30.4 26.8 60.1 14.5 17.0 23.5 37.2 8.1 18.3 34.5 11.2 36.1 24.7 28.9 2.9 40.0 17.2 16.1 5.4 31.4 25.5 44.0 47.9 38.0 32.9 39.9 18.3 25.5 17.4 5.1 20.8 5.4 7.5 7.6 20.7 17.5 6.3 1.8 6.4 35.2 13.9 40.5 5.0 39.5 12.5 17.1 3.6 13.0 13.7 15.6 33.8 20.4 17.0 15.5 18.5 21.9 4.2 1.1 0.7 1.9 1.7 1.5 1.6 1.0 0.9 2.3 1.1 0.6 1.4 0.9 2.5 1.5 1.4 1.7 2.2 7.3 7.4 6.6 9.9 7.9 9.1 7.7 7.7 7.6 7.1 7.4 7.1 39.1 12.8 15.2 31.6 72.7 24.9 37.6 83.0 33.6 89.3 31.8 26.0 2.0 50.1 53.1 55.2 95.9 88.4 64.9 52.9 5.9 48.1 3.3 22.0 24.5 40.3 53.5 39.8 29.5 42.8 50.2 29.8 39.8 27.8 16.5 148.5 43.5 18.5 52.8 43.7 29.9 53.9 79.3 55.4 40.5 8.9 70.8 42.0 32.0 28.1 65.4 35.0 124.6 21.6 24.1 37.2 58.6 51.9 40.3 30.6 64.3 14.6 43.5 98.0 59.2 30.5 29.8 64.3 58.6 36.1 25.3 89.2 58.6 49.5 55.7 39.8 ATG10 "APG10L, DKFZP586I0418, FLJ13954" ENSG00000152348 "Autophagy related 10" Q9H0Y0 5 81972023-82276857 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044163 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli Nucleoplasm "HPA044163: AB_2678842" "unprognostic (1.20e-1)" "unprognostic (7.96e-2)" "unprognostic (1.07e-2)" "unprognostic (2.51e-2)" "unprognostic (3.18e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (3.22e-5)" "unprognostic (5.60e-3)" "unprognostic (2.96e-2)" "unprognostic (1.92e-2)" "unprognostic (2.48e-1)" "unprognostic (1.21e-1)" "unprognostic (9.62e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-3)" "unprognostic (4.43e-1)" 4.0 5.4 4.8 4.1 4.9 5.6 7.0 8.3 5.7 3.5 7.9 5.5 3.3 4.6 7.8 4.9 4.2 4.3 4.6 5.0 4.7 5.7 6.5 3.7 3.5 5.0 4.5 3.2 4.4 11.6 4.0 4.7 5.0 5.6 6.1 3.5 3.7 5.6 7.2 6.6 3.3 5.5 4.6 4.1 4.4 10.4 5.0 7.8 7.1 3.1 4.3 4.0 3.9 8.0 4.7 12.6 7.9 23.0 5.3 10.0 20.1 5.4 4.4 3.9 6.0 3.7 16.7 8.4 4.4 8.8 29.7 2.5 5.9 12.2 5.1 14.4 4.2 9.2 11.4 4.0 5.0 4.8 7.3 9.3 8.2 5.7 4.7 6.0 7.4 17.7 11.3 6.8 14.4 9.5 11.0 5.2 11.0 3.5 8.2 8.0 11.5 20.1 10.0 6.7 11.8 16.9 8.8 4.9 10.0 13.6 9.4 8.9 6.0 7.0 6.6 3.8 11.5 9.4 17.0 11.5 9.8 11.4 11.7 2.7 5.7 8.5 5.1 5.8 4.8 3.6 4.5 4.8 7.5 4.5 4.2 5.2 7.4 6.5 4.3 5.6 5.0 4.1 4.8 4.9 8.3 5.7 5.0 4.7 5.0 4.5 5.0 4.6 5.0 8.0 8.1 16.0 15.6 69.2 9.3 24.9 17.4 16.3 14.2 16.3 15.6 14.4 9.3 12.8 16.7 12.9 10.4 25.5 9.7 8.2 15.6 15.7 67.6 7.7 11.4 13.0 9.6 14.5 56.4 18.4 46.3 15.1 6.6 9.7 11.4 22.1 10.0 12.8 18.3 18.5 52.2 7.8 4.1 14.1 28.4 96.6 6.8 12.3 32.0 57.1 17.2 12.5 15.5 67.8 76.5 15.2 9.9 10.1 10.1 12.0 8.5 18.8 8.8 15.2 0.0 18.2 13.6 54.1 22.9 13.8 32.0 21.1 14.3 15.6 11.5 14.0 ATP6V1G1 "ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10" ENSG00000136888 "ATPase H+ transporting V1 subunit G1" O75348 9 114587706-114598915 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004615, HPA042898" Supported Approved Nucleoplasm,Nucleoli NA NA 96000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli Nucleoplasm "CAB004615: AB_2258908, HPA042898: AB_2678217" "unprognostic (3.85e-1)" "unprognostic (1.71e-1)" "unprognostic (2.03e-1)" "unprognostic (1.24e-1)" "unprognostic (2.23e-1)" "unprognostic (1.84e-3)" "unprognostic (2.49e-1)" "unprognostic (1.51e-1)" "unprognostic (2.28e-1)" "unprognostic (3.47e-3)" "unprognostic (9.40e-3)" "unprognostic (4.13e-2)" "prognostic favorable (1.73e-7)" "unprognostic (2.44e-2)" "unprognostic (1.50e-1)" "unprognostic (9.11e-2)" "unprognostic (3.92e-2)" 79.5 140.2 70.5 80.5 71.1 131.4 108.4 74.0 101.1 85.0 85.0 70.5 59.4 92.4 177.3 132.5 71.3 64.6 93.0 72.1 79.4 138.1 125.9 84.9 115.4 75.4 79.1 106.2 72.5 172.9 135.1 91.2 80.2 132.7 65.5 91.2 111.9 55.1 124.0 98.1 69.2 60.6 71.5 93.9 121.1 75.4 75.6 104.2 99.2 113.0 100.8 106.8 94.0 75.4 83.6 71.0 153.2 38.8 111.0 84.5 148.3 125.2 86.6 88.5 63.4 92.3 94.8 74.2 106.8 80.0 183.2 179.0 105.6 84.6 79.3 63.2 73.8 72.3 84.4 143.4 156.8 173.1 135.1 105.2 227.9 72.7 87.3 104.1 91.0 123.1 136.0 164.4 131.6 159.0 164.6 113.6 187.0 222.2 126.8 159.0 95.0 126.7 195.2 128.4 113.8 156.3 159.7 284.0 487.6 143.9 235.0 202.5 118.9 80.1 68.9 132.3 142.0 213.6 474.5 139.6 106.8 97.2 112.0 490.1 327.8 495.0 212.6 331.2 264.9 549.6 288.8 255.8 255.0 501.7 374.7 305.5 405.4 255.4 348.4 401.5 398.9 756.7 70.5 71.1 74.0 101.1 72.1 79.4 75.4 79.1 80.2 71.5 75.6 75.4 230.6 160.3 176.6 19.6 353.9 519.0 492.9 1068.9 277.7 170.5 470.4 494.1 151.6 163.0 629.7 331.1 41.7 346.1 268.2 198.5 970.5 374.1 85.7 381.6 223.8 227.7 360.7 157.6 35.0 263.6 336.5 247.0 231.4 594.9 267.4 156.8 219.2 337.1 548.1 164.9 37.4 346.8 1133.2 350.1 517.8 60.3 306.0 382.4 494.5 20.6 699.7 360.9 261.6 20.1 22.9 430.5 218.1 250.9 255.0 686.5 176.7 1021.5 426.3 158.6 236.7 155.6 393.0 400.6 326.7 361.4 576.7 757.4 304.0 280.3 201.6 852.2 AXIN1 PPP1R49 ENSG00000103126 "Axin 1" O15169 16 287440-352723 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012987 Approved Supported Nucleoli,Vesicles NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoli, Vesicles" "CAB012987: AB_2533178" "unprognostic (3.81e-2)" "unprognostic (1.56e-1)" "unprognostic (1.90e-1)" "unprognostic (7.64e-2)" "unprognostic (1.90e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (1.56e-1)" "unprognostic (4.58e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (4.41e-2)" "unprognostic (1.94e-1)" "unprognostic (1.23e-2)" "unprognostic (1.03e-1)" 11.9 9.3 10.5 9.2 10.8 23.0 11.5 14.8 12.5 12.9 9.1 17.1 12.3 13.2 3.1 16.3 11.8 6.2 11.6 10.0 9.2 11.6 11.2 13.7 10.5 10.2 10.2 13.8 13.0 7.2 12.6 5.8 9.8 12.9 6.9 2.6 11.5 6.0 21.1 20.1 15.0 5.4 9.2 15.0 12.9 11.8 10.1 12.5 11.9 7.0 6.6 14.5 13.1 11.9 18.1 25.6 13.4 23.7 9.8 9.0 28.0 11.9 10.8 16.1 13.8 37.9 20.4 27.7 18.0 12.3 19.4 25.4 21.1 18.5 7.2 27.5 34.6 18.0 21.9 27.6 16.6 20.9 19.3 9.0 31.7 16.6 20.3 14.1 10.7 19.8 45.6 14.8 7.4 48.1 22.7 14.5 30.6 21.6 15.4 42.4 12.2 38.8 12.2 10.5 30.4 18.6 22.6 24.9 38.3 10.0 16.5 26.1 12.4 15.9 17.0 18.5 17.5 17.3 18.1 34.2 7.5 13.7 15.9 1.2 0.9 5.0 8.3 0.8 7.6 1.5 2.4 5.8 0.7 1.2 2.4 3.4 2.7 3.5 0.6 1.2 2.6 2.3 10.5 10.8 14.8 12.5 10.0 9.2 10.2 10.2 9.8 9.2 10.1 11.9 7.9 3.2 8.6 4.9 5.7 18.4 7.6 8.5 5.7 4.3 11.2 9.5 4.9 5.7 7.2 3.7 0.0 3.5 30.1 27.4 0.0 7.2 1.4 10.2 7.0 6.3 10.8 8.6 18.5 6.9 27.5 6.7 15.3 14.4 10.8 10.5 5.7 5.1 7.5 5.0 12.7 15.1 6.1 6.2 9.0 2.1 5.3 6.7 10.6 1.0 5.7 4.5 28.8 8.5 8.9 11.0 12.2 4.9 7.0 13.4 11.1 2.4 7.7 5.7 13.1 8.7 7.6 5.5 8.8 7.2 15.2 3.7 12.4 5.0 15.7 10.5 B3GNT4 "B3GN-T4, beta3Gn-T4" ENSG00000176383 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4" Q9C0J1 12 122203681-122208952 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.9;skin 1: 3.1" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 3.3;Excitatory neurons: 3.2;Proximal tubular cells: 9.7;Spermatogonia: 2.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.1;hTCEpi: 4.0;T-47d: 4.2;U-266/84: 3.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055261 Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Nucleoli "HPA055261: AB_2682765" "unprognostic (1.67e-1)" "unprognostic (1.66e-1)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.60e-2)" "unprognostic (1.32e-3)" "unprognostic (1.98e-1)" "unprognostic (3.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.82e-2)" "unprognostic (3.69e-1)" "prognostic unfavorable (3.52e-6)" "unprognostic (1.24e-1)" "unprognostic (2.79e-1)" "unprognostic (8.97e-2)" "unprognostic (9.47e-2)" 0.2 0.7 2.3 0.1 2.6 1.5 0.2 4.9 3.1 0.3 0.0 0.3 0.2 0.1 0.0 1.3 0.6 0.2 0.1 3.8 0.5 2.7 0.4 0.3 0.1 0.0 0.0 0.2 0.3 0.3 1.4 0.1 0.0 0.4 0.0 0.5 0.5 0.0 0.2 3.1 0.3 0.0 0.0 0.5 0.3 1.6 0.9 0.0 0.4 0.0 0.1 0.1 0.5 1.2 3.4 0.6 0.2 1.4 0.1 0.1 0.6 0.1 0.0 0.2 0.3 2.2 0.3 0.3 0.5 0.0 0.2 1.3 1.7 1.2 0.1 5.1 1.9 0.1 1.3 0.2 0.4 0.5 0.7 0.3 4.0 0.1 0.2 0.5 0.0 1.3 1.0 0.4 0.0 3.2 0.0 0.5 0.4 0.1 1.4 0.2 0.4 0.7 0.5 0.4 0.8 1.1 0.9 0.7 0.4 0.5 4.2 0.1 0.1 0.3 1.7 0.4 0.2 0.4 3.6 0.8 0.3 0.5 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.3 2.6 4.9 3.1 3.8 0.5 0.0 0.0 0.0 0.0 0.9 1.2 0.4 0.0 1.8 0.7 0.3 1.3 0.7 3.3 0.6 0.2 0.7 0.8 0.5 0.0 1.1 0.0 0.0 0.5 0.5 0.6 1.9 1.0 0.4 0.6 0.3 0.3 0.0 0.0 3.2 0.2 1.1 0.3 0.0 0.8 0.0 0.1 0.4 0.0 0.2 0.0 1.4 0.0 2.0 0.6 0.6 0.1 0.3 0.3 0.0 1.9 0.0 0.2 0.0 0.5 0.6 0.4 1.3 0.0 0.4 0.3 0.1 9.7 1.1 0.2 0.0 0.5 0.2 0.8 2.9 0.8 1.4 0.5 0.4 0.1 0.3 0.4 BNIP2 "BNIP-2, Nip2" ENSG00000140299 "BCL2 interacting protein 2" Q12982 15 59659146-59689534 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 131.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026843 Approved Supported Nucleoli,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoli "HPA026843: AB_1845403" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "prognostic favorable (8.42e-4)" "unprognostic (6.70e-2)" "unprognostic (4.81e-2)" "unprognostic (2.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.44e-2)" "unprognostic (1.26e-1)" "unprognostic (4.72e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.68e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" 49.6 22.4 14.2 41.0 15.8 131.6 30.7 14.7 13.5 28.7 10.6 20.8 16.4 36.9 19.2 30.5 20.5 27.8 47.7 11.9 16.8 19.3 46.5 41.4 48.6 17.2 15.9 31.2 13.9 17.5 10.3 42.7 17.2 26.6 23.2 27.3 20.5 29.4 32.6 20.9 20.3 41.4 16.7 46.5 18.0 22.8 16.2 43.4 18.9 48.8 48.1 41.2 21.2 18.1 39.4 35.9 45.9 37.8 70.8 57.9 40.2 60.3 85.0 54.3 61.9 29.0 18.2 67.9 39.5 87.9 74.4 72.7 48.9 70.1 73.4 49.3 31.1 83.0 52.6 30.8 77.6 107.3 91.7 68.6 71.9 49.4 85.0 51.2 91.1 78.9 48.3 70.8 88.5 22.6 50.5 44.6 41.2 7.7 25.8 55.3 57.5 87.7 56.9 87.3 36.9 50.2 39.5 52.7 104.4 66.4 43.7 112.9 72.2 58.3 71.0 38.0 60.2 52.6 112.7 90.0 46.5 98.1 60.5 50.6 46.6 72.2 29.6 46.9 35.1 31.9 31.1 31.8 43.1 28.9 31.8 32.1 81.5 34.8 40.1 34.5 36.3 43.8 14.2 15.8 14.7 13.5 11.9 16.8 17.2 15.9 17.2 16.7 16.2 18.1 116.7 73.7 44.0 20.2 87.9 86.7 98.8 56.0 70.6 32.5 35.3 29.6 81.9 28.6 43.0 14.7 47.9 64.0 82.6 31.3 37.2 31.5 9.0 41.8 44.5 105.6 15.5 57.7 15.4 26.8 76.8 68.0 46.9 65.8 96.4 31.0 87.8 49.6 91.7 50.5 17.5 24.3 32.6 115.6 106.7 6.1 43.5 125.6 51.6 25.3 120.8 55.3 64.9 20.6 28.2 36.9 22.1 57.2 63.1 75.1 20.0 16.6 45.4 50.2 78.9 56.2 68.1 28.8 32.2 64.4 92.5 193.9 73.5 42.3 19.4 136.8 BRIX1 "BRIX, BXDC2, FLJ11100" ENSG00000113460 "Biogenesis of ribosomes BRX1" Q8TDN6 5 34915677-34925996 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039614 Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Mitotic chromosome" "HPA039614: AB_10963698" "prognostic unfavorable (2.18e-4)" "unprognostic (2.60e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.10e-5)" "unprognostic (1.82e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (4.11e-8)" "unprognostic (3.37e-2)" "unprognostic (3.84e-3)" "prognostic favorable (6.34e-4)" "unprognostic (1.24e-1)" "unprognostic (2.54e-2)" "prognostic unfavorable (3.07e-9)" "unprognostic (1.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (2.09e-2)" 18.6 17.1 13.3 17.6 13.8 37.1 24.7 15.2 18.7 15.1 12.8 15.6 12.9 17.4 17.8 17.7 16.1 12.2 14.7 13.2 14.1 15.1 18.5 13.0 26.4 13.7 13.6 18.5 13.7 18.2 9.5 25.7 13.8 15.7 17.1 11.6 12.9 14.5 10.4 14.6 12.8 16.1 13.9 14.3 13.1 13.9 13.5 20.7 15.8 12.2 25.8 30.1 12.3 15.2 66.1 57.0 64.2 87.1 26.0 37.8 121.6 74.9 52.7 100.0 63.5 74.5 81.0 138.8 38.7 45.5 113.5 52.1 108.5 79.8 117.3 75.1 101.3 93.9 125.7 71.9 67.4 150.8 63.8 44.4 49.8 93.3 85.9 31.0 48.5 72.9 158.4 43.8 66.2 63.6 108.3 163.9 101.0 75.2 86.8 94.6 112.5 60.5 59.3 70.7 75.1 68.8 157.6 109.7 76.1 50.0 66.4 92.7 28.4 78.7 87.5 58.1 151.0 39.3 87.7 177.6 66.3 171.3 100.3 15.0 21.4 10.0 34.5 21.0 50.1 63.7 43.2 44.3 27.8 49.9 53.3 46.6 1.2 43.7 30.6 37.5 43.5 44.6 13.3 13.8 15.2 18.7 13.2 14.1 13.7 13.6 13.8 13.9 13.5 15.2 35.5 28.9 30.7 8.5 40.0 108.7 114.3 110.2 55.2 20.8 27.3 41.3 23.2 25.8 63.0 23.9 12.5 127.1 37.0 13.5 49.0 52.5 24.8 29.9 45.1 40.6 21.0 45.2 11.9 42.7 100.6 44.4 19.4 31.6 20.2 30.0 20.0 11.9 42.7 21.9 13.4 19.0 63.1 10.7 20.1 8.4 39.4 18.4 32.0 4.7 31.1 22.3 21.6 10.6 13.6 44.7 13.1 29.0 21.4 70.9 9.9 37.9 45.8 37.2 6.6 54.3 55.7 59.9 77.6 46.0 95.8 126.1 37.1 31.7 31.9 85.1 BTBD16 "C10orf87, Em:AC061711.1, FLJ25359" ENSG00000138152 "BTB domain containing 16" Q32M84 10 122271296-122338159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 8.3;testis: 7.8;urinary bladder: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 123.2;Late spermatids: 69.9" "Cancer enriched" "Detected in many" 14 "urothelial cancer: 18.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "RT4: 33.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA040529, HPA057638" Uncertain Uncertain Nucleoli,Cytosol Yes NA "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" Nucleoli Cytosol "HPA040529: AB_2677022, HPA057638: " "unprognostic (1.41e-4)" "unprognostic (1.33e-1)" "unprognostic (5.97e-2)" "unprognostic (5.98e-3)" "unprognostic (2.08e-1)" "unprognostic (2.09e-3)" "unprognostic (2.88e-1)" "unprognostic (4.54e-2)" "unprognostic (1.76e-1)" "unprognostic (6.85e-2)" "unprognostic (2.48e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.08e-1)" "unprognostic (1.60e-1)" "unprognostic (9.12e-2)" "unprognostic (9.44e-3)" 0.1 0.0 1.0 0.0 1.4 0.0 0.5 1.2 2.3 0.3 0.7 0.5 0.0 0.1 0.3 0.1 0.4 0.2 0.0 1.1 1.2 0.3 4.0 0.2 0.0 1.4 1.4 0.0 0.1 0.0 0.4 0.1 1.4 0.8 0.0 0.0 0.4 0.0 0.3 8.3 0.1 0.1 1.3 0.0 0.1 7.8 1.2 0.0 0.4 0.0 0.1 20.2 0.5 2.1 0.0 0.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 1.5 33.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.0 1.4 1.2 2.3 1.1 1.2 1.4 1.4 1.4 1.3 1.2 2.1 0.0 0.0 0.0 0.0 0.0 2.8 0.4 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 1.4 123.2 0.6 0.0 0.2 0.0 0.0 0.9 0.7 0.1 0.0 0.0 0.4 0.0 0.0 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.0 0.4 69.9 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.5 9.8 1.1 3.8 0.4 0.0 0.1 0.2 1.0 3.1 0.0 0.0 0.4 0.2 10.0 0.8 0.0 3.1 0.1 0.4 0.0 0.0 2.9 BUD23 "MERM1, MGC19709, MGC2022, MGC5140, PP3381, WBMT, WBSCR22" ENSG00000071462 "BUD23 rRNA methyltransferase and ribosome maturation factor" O43709 7 73683025-73705161 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 119.9;Endometrial ciliated cells: 133.6;Exocrine glandular cells: 140.8;Pancreatic endocrine cells: 126.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 712.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052185 Approved Supported Nucleoplasm,Nucleoli Yes No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA052185: AB_2681753" "unprognostic (2.49e-1)" "unprognostic (1.87e-1)" "unprognostic (2.67e-2)" "unprognostic (4.79e-2)" "unprognostic (3.62e-3)" "unprognostic (8.54e-2)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.17e-1)" "unprognostic (9.16e-2)" "unprognostic (9.20e-2)" "unprognostic (6.71e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (1.46e-1)" "unprognostic (3.13e-3)" 39.8 49.2 34.5 40.0 36.7 58.7 43.4 36.4 39.8 36.3 41.0 48.6 47.0 38.6 72.3 41.7 58.9 34.5 87.9 36.1 39.0 53.3 47.2 38.5 52.6 37.0 36.1 37.8 70.8 49.2 45.1 30.7 36.3 37.8 47.7 20.3 55.9 42.2 128.0 43.8 40.3 41.4 36.4 42.1 44.9 130.0 36.6 44.7 56.5 78.4 51.7 51.9 32.8 38.5 142.1 151.8 53.6 429.2 72.0 64.2 91.1 95.1 83.3 118.5 96.1 211.4 182.6 163.6 48.9 99.5 204.0 97.0 124.8 91.0 108.4 116.6 147.1 72.0 174.8 86.7 91.2 200.3 98.8 57.3 102.2 103.2 93.9 59.7 77.4 130.3 285.4 288.9 103.7 219.6 128.0 277.8 130.2 317.8 172.2 110.5 106.8 712.0 132.5 100.2 163.4 124.4 126.3 329.2 146.5 53.0 207.9 159.0 85.2 101.8 130.3 130.0 208.3 99.5 192.6 275.5 232.3 155.6 218.0 54.8 64.9 60.6 112.0 74.2 124.9 175.3 127.1 122.5 122.9 153.5 132.8 121.5 11.9 125.4 68.0 190.9 150.6 132.6 34.5 36.7 36.4 39.8 36.1 39.0 37.0 36.1 36.3 36.4 36.6 38.5 67.0 44.8 64.5 0.0 26.5 0.0 0.0 0.0 0.0 0.0 75.4 85.7 0.0 0.0 42.7 46.0 0.0 75.7 64.1 0.0 97.8 119.9 0.0 133.6 51.2 28.6 0.0 0.0 0.0 140.8 82.7 24.5 0.0 79.6 46.7 49.2 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 21.2 0.0 0.0 0.0 0.0 126.0 0.0 0.0 16.5 0.0 0.0 103.5 78.7 0.0 0.0 0.0 26.4 0.0 0.0 0.0 0.0 106.7 28.1 73.0 0.0 0.0 C12orf43 "Custos, FLJ12448" ENSG00000157895 "Chromosome 12 open reading frame 43" Q96C57 12 121000486-121016502 "Predicted intracellular proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046148, HPA061739" Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Cluster 30: Non-specific - Translation" "Cluster 65: Brain - Ion transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Golgi apparatus" "HPA046148: AB_10965169, HPA061739: AB_2684597" "unprognostic (1.51e-1)" "unprognostic (5.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.75e-2)" "unprognostic (2.43e-1)" "unprognostic (3.24e-2)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (6.44e-4)" "unprognostic (3.53e-1)" "unprognostic (5.02e-2)" "unprognostic (2.54e-1)" "unprognostic (1.95e-1)" "unprognostic (2.45e-3)" "unprognostic (9.70e-2)" "unprognostic (2.49e-1)" "unprognostic (2.28e-1)" "unprognostic (1.36e-1)" 9.8 8.1 11.7 6.9 11.9 7.4 9.3 8.8 13.6 7.8 7.2 11.2 5.0 9.5 4.4 7.2 9.0 5.1 7.4 12.3 9.5 8.2 10.5 6.7 8.7 10.9 9.6 11.2 7.5 9.0 7.4 7.2 10.8 7.7 5.3 6.0 8.7 6.2 7.2 6.7 6.7 8.4 8.6 7.8 8.2 6.1 9.4 7.2 6.4 5.9 7.4 9.6 7.0 10.4 14.2 31.4 16.2 12.8 14.0 11.0 17.8 17.2 17.5 28.3 17.9 22.8 13.0 26.2 17.2 16.8 15.0 15.7 19.2 26.3 16.8 31.6 21.4 21.1 12.4 17.1 16.7 28.1 16.2 12.9 13.6 26.0 16.4 17.9 16.4 27.0 25.5 6.7 15.1 23.3 30.9 22.0 28.8 11.1 23.2 27.4 19.0 19.8 17.5 20.8 22.0 14.0 23.0 9.9 18.6 13.4 27.0 13.1 15.9 15.6 18.7 12.8 18.4 12.3 19.1 20.5 20.5 16.5 23.6 5.7 15.6 9.0 23.8 21.3 21.8 23.8 23.5 23.2 16.1 19.0 27.5 23.6 2.2 18.4 18.5 13.3 23.8 20.6 11.7 11.9 8.8 13.6 12.3 9.5 10.9 9.6 10.8 8.6 9.4 10.4 16.1 25.6 18.1 3.3 17.3 8.8 16.4 12.2 6.8 19.6 12.4 12.4 7.0 11.5 9.6 18.4 20.9 24.3 13.9 8.6 23.5 16.5 5.9 9.8 17.1 16.0 2.4 10.7 6.8 18.5 22.3 16.3 8.2 10.1 14.5 22.3 12.5 11.7 16.7 16.8 6.4 9.5 10.2 10.4 7.3 13.8 13.7 13.2 14.2 3.7 21.7 18.8 24.7 4.0 4.8 15.6 12.3 12.8 11.3 13.8 5.3 16.7 16.3 15.7 19.7 19.6 16.9 16.3 16.4 12.7 7.7 13.7 17.6 16.0 10.9 14.0 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 92.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 16 "hypothalamus: 2.9;thalamus: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 0.3 1.8 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.5 4.8 0.0 0.0 1.1 0.0 2.7 4.6 0.1 3.0 0.0 0.1 0.1 0.0 0.0 0.3 10.8 2.4 0.1 0.2 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 6.2 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.7 0.0 0.1 0.0 28.3 0.0 0.0 2.0 0.0 23.9 0.3 3.0 0.0 1.4 0.0 6.2 0.0 0.4 1.7 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 12.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.9 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 1.0 0.0 12.3 0.0 1.0 0.7 0.0 0.0 0.7 0.0 0.8 0.0 0.0 1.2 1.1 0.0 10.0 0.2 92.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 C17orf97 "LIAT1, LOC400566" ENSG00000187624 "Chromosome 17 open reading frame 97" Q6ZQX7 17 410325-431062 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 58.8" "Group enriched" "Detected in many" 5 "Early spermatids: 546.2;Late spermatids: 1313.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 7.0;U-2197: 9.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA023583 Approved Approved Nucleoli,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 18: U-2197 - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli Cytosol "HPA023583: AB_1853122" "unprognostic (6.62e-2)" "unprognostic (9.12e-3)" "unprognostic (2.64e-1)" "unprognostic (3.07e-3)" "unprognostic (7.73e-2)" "unprognostic (6.51e-2)" "unprognostic (6.91e-2)" "unprognostic (3.17e-2)" "unprognostic (1.82e-1)" "unprognostic (1.11e-1)" "unprognostic (5.12e-2)" "unprognostic (8.07e-2)" "unprognostic (1.98e-3)" "unprognostic (7.70e-3)" "unprognostic (2.90e-1)" "unprognostic (2.84e-2)" "unprognostic (4.19e-2)" 2.1 5.2 1.2 1.0 1.6 0.7 2.8 0.6 2.4 4.1 2.9 4.0 0.8 3.9 1.8 3.2 8.9 1.8 3.8 1.2 1.0 8.5 2.7 2.8 1.2 1.6 2.6 3.8 2.9 1.9 7.0 0.3 1.3 3.1 1.1 2.7 3.1 2.4 4.7 3.7 2.5 0.6 1.4 1.5 3.0 58.8 1.1 1.9 6.9 0.7 0.6 2.7 2.5 1.2 2.1 3.0 1.4 1.7 0.7 0.6 0.7 1.5 1.0 1.1 0.7 0.0 3.1 0.5 1.1 3.4 0.9 7.0 3.8 0.8 1.1 0.3 0.4 1.5 2.6 0.2 2.5 0.3 0.6 0.7 1.9 2.6 0.3 1.6 1.2 3.4 0.2 0.0 0.7 1.8 5.2 2.7 2.1 6.2 0.9 0.5 0.3 1.9 4.8 1.7 0.4 1.6 1.9 2.6 0.4 2.3 1.6 2.3 1.1 1.4 0.7 9.1 0.6 0.2 0.2 0.0 1.7 0.7 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.0 0.0 1.2 1.6 0.6 2.4 1.2 1.0 1.6 2.6 1.3 1.4 1.1 1.2 1.4 3.2 5.9 2.6 0.8 3.3 3.5 6.5 0.0 4.3 7.7 6.0 6.1 7.2 9.5 20.2 20.9 1.6 0.9 18.4 62.6 13.3 546.2 87.1 6.3 3.3 16.1 5.7 3.3 3.5 0.3 3.5 4.6 8.4 2.5 8.6 2.5 5.3 1.9 1.7 3.1 8.5 14.2 0.0 1.5 1313.1 8.4 2.0 3.6 1.9 3.1 13.5 0.0 0.5 0.9 4.7 6.4 6.4 0.1 4.5 3.8 28.0 55.8 26.4 6.6 3.4 4.6 156.2 12.4 1.8 1.0 0.8 0.8 15.4 10.4 1.6 C17orf98 LOC388381 ENSG00000275489 "Chromosome 17 open reading frame 98" A8MV24 17 38835086-38841438 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 19.5" "Cell type enriched" "Detected in some" 8 "Early spermatids: 263.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "hTCEpi: 5.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA051696 Uncertain Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Intermediate filaments" Nucleoli "HPA051696: AB_2681576" "unprognostic (2.30e-1)" "unprognostic (3.25e-4)" "unprognostic (1.46e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-3)" "unprognostic (1.14e-2)" "unprognostic (8.69e-3)" "unprognostic (2.56e-1)" "unprognostic (7.58e-2)" "unprognostic (9.02e-2)" 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.0 0.0 5.6 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 3.9 0.0 263.7 0.2 0.1 0.1 0.0 0.0 0.4 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.2 29.4 1.2 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 3.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972625-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 145.2;Late spermatids: 76.3;Spermatocytes: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 16.4 18.2 15.2 12.8 15.7 71.9 20.5 18.6 19.7 13.6 14.2 15.1 16.2 15.3 18.4 14.7 14.9 12.3 18.3 15.4 15.2 15.1 16.9 12.2 21.8 15.0 15.0 17.0 23.2 17.9 12.9 14.6 15.0 14.4 13.1 19.2 19.3 12.9 34.1 16.3 15.2 13.0 15.6 18.1 19.8 35.8 15.4 21.9 14.0 26.4 18.8 16.3 12.3 16.5 24.9 17.2 35.3 27.0 25.4 36.2 25.9 34.3 34.9 42.3 44.7 15.8 17.8 22.4 33.7 27.4 26.9 26.2 28.2 28.8 45.7 33.4 30.4 22.5 21.2 35.5 35.3 65.4 26.3 37.9 46.7 38.2 39.3 36.8 37.0 30.6 39.7 34.0 29.4 29.5 42.4 48.0 30.4 11.6 18.9 28.0 30.7 43.0 29.2 29.5 25.5 36.0 25.4 18.8 58.3 32.7 28.2 31.2 24.3 43.3 19.1 15.8 31.0 43.2 41.4 46.0 21.4 37.3 22.1 97.5 28.8 34.2 24.5 30.7 24.2 34.7 25.9 23.2 27.1 30.9 19.8 25.9 28.0 28.8 30.0 26.6 41.5 19.8 15.2 15.7 18.6 19.7 15.4 15.2 15.0 15.0 15.0 15.6 15.4 16.5 9.6 19.2 6.1 3.9 13.7 11.9 8.9 17.4 18.2 9.6 13.1 16.5 12.7 10.0 12.1 1.8 6.2 19.0 23.0 10.4 11.7 20.2 145.2 13.7 14.7 10.8 7.2 12.4 5.5 28.8 32.0 12.4 8.6 14.4 14.0 12.9 10.0 9.6 21.3 8.4 6.0 12.9 16.2 20.1 10.3 76.3 22.4 14.4 12.4 5.6 24.4 13.1 20.6 4.5 5.1 20.0 14.0 17.0 13.5 11.7 17.8 20.1 5.1 12.1 0.0 14.1 11.3 124.0 35.9 12.8 12.4 13.1 13.6 17.3 15.9 9.3 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774456-13778773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059928: AB_2684165, HPA061291: AB_2684469" "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 95.6 117.7 154.3 52.1 157.8 80.4 88.9 161.0 209.6 97.0 148.4 94.3 45.4 91.6 85.6 92.3 87.6 49.8 155.6 154.4 163.8 124.4 111.0 80.1 76.9 159.4 159.9 111.7 95.5 92.8 111.6 40.2 157.8 98.8 41.6 35.7 76.9 52.8 167.6 95.2 72.4 63.0 157.5 82.1 91.2 51.6 158.0 101.5 90.4 107.2 70.8 88.6 82.6 157.3 176.4 249.9 123.0 98.9 169.6 191.1 80.1 167.0 145.5 201.0 200.7 235.8 83.5 95.4 198.2 202.4 146.6 90.1 111.6 250.1 102.7 113.5 362.3 90.1 254.6 260.5 174.9 140.7 109.4 237.8 174.7 188.1 105.9 129.0 171.0 136.6 140.9 154.2 157.9 406.2 193.6 145.9 152.6 133.8 441.8 105.7 94.9 160.5 177.1 221.3 108.6 132.4 115.1 130.8 172.5 89.2 120.0 139.0 118.4 221.9 89.2 239.4 227.5 172.3 240.3 144.4 132.3 157.6 121.8 264.1 220.1 275.7 211.0 238.2 240.4 333.2 270.7 248.4 202.2 321.1 318.1 289.7 107.1 184.7 214.3 289.4 337.9 496.3 154.3 157.8 161.0 209.6 154.4 163.8 159.4 159.9 157.8 157.5 158.0 157.3 167.0 115.4 97.8 13.7 205.2 291.1 260.1 349.2 147.4 50.5 258.7 352.9 263.3 213.1 207.8 268.5 22.9 218.6 176.5 230.1 628.0 242.5 176.8 229.3 189.8 194.4 227.3 174.0 10.5 335.2 406.3 184.4 109.6 233.0 128.7 132.4 179.9 367.5 368.2 35.3 10.2 254.3 236.0 247.1 287.1 621.4 218.7 187.5 231.3 5.6 338.9 220.3 260.6 6.6 18.8 269.6 272.8 182.4 164.1 360.5 353.9 820.0 189.3 65.9 92.1 138.5 206.0 102.6 137.0 187.7 348.5 213.0 216.0 169.8 257.5 345.2 C1D "LRP1, Rrp47, SUN-CoR, SUNCOR" ENSG00000197223 "C1D nuclear receptor corepressor" Q13901 2 68041130-68110948 "Predicted intracellular proteins" "Apoptosis, rRNA processing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037413, HPA037588" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 34: Basophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA037413: AB_2675463, HPA037588: AB_10672907" "unprognostic (1.84e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (3.71e-3)" "unprognostic (2.03e-1)" "unprognostic (1.49e-2)" "unprognostic (4.01e-3)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.98e-1)" "unprognostic (3.90e-2)" "unprognostic (1.29e-2)" "unprognostic (4.24e-3)" "unprognostic (6.18e-2)" "unprognostic (2.50e-1)" "unprognostic (8.80e-2)" "unprognostic (1.01e-1)" 21.7 25.3 11.6 17.0 11.8 48.1 21.4 11.9 19.0 19.9 12.8 19.1 16.6 20.0 17.0 19.3 18.3 14.7 22.2 12.0 12.8 31.5 33.4 19.0 21.4 11.3 11.8 19.3 15.8 24.0 15.3 17.5 11.6 19.5 14.7 16.6 18.7 15.5 46.9 17.5 18.5 13.7 12.0 21.7 21.4 14.8 12.0 17.5 19.6 31.9 16.5 17.4 28.2 13.9 36.6 20.3 22.0 21.0 22.2 27.0 29.6 48.7 28.1 29.3 22.4 40.8 45.0 45.2 27.2 28.9 28.1 18.0 24.7 20.4 43.1 43.0 36.6 43.5 17.6 46.3 22.3 68.1 54.4 25.0 32.4 22.1 20.9 36.3 22.0 41.4 44.8 41.1 26.6 22.2 51.3 69.6 25.4 29.8 24.4 29.6 28.3 39.9 28.2 29.2 20.5 25.4 15.1 30.0 51.6 26.7 22.2 41.2 30.9 27.9 34.5 34.0 38.9 38.0 40.8 58.6 38.9 41.3 34.2 45.3 17.6 43.7 19.0 23.3 22.5 24.2 22.0 16.6 20.6 21.3 23.4 24.3 34.9 30.3 25.2 19.2 25.3 15.2 11.6 11.8 11.9 19.0 12.0 12.8 11.3 11.8 11.6 12.0 12.0 13.9 65.2 76.9 47.9 13.1 70.7 85.0 83.2 132.8 33.6 34.3 52.9 58.4 36.5 64.3 86.3 64.4 22.9 98.9 76.2 48.1 234.8 83.4 52.4 53.7 47.2 42.9 51.6 121.2 17.7 59.4 82.7 60.2 44.9 46.6 44.3 32.8 43.5 81.7 87.5 35.3 15.9 42.6 109.9 61.9 46.1 21.7 55.6 66.9 56.9 8.4 80.1 57.4 88.6 14.1 21.9 65.6 63.3 59.0 58.5 78.1 57.0 251.4 95.4 36.8 98.6 54.2 65.3 164.5 100.3 44.5 86.2 107.8 62.9 52.2 32.8 109.0 C1orf210 "MGC52423, TEMP" ENSG00000253313 "Chromosome 1 open reading frame 210" Q8IVY1 1 43281877-43285617 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 125.9;Paneth cells: 100.8;Proximal enterocytes: 128.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 14 "basophil: 2.2" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "A-431: 12.1;BEWO: 13.0;CACO-2: 12.6;CAPAN-2: 39.8;OE19: 33.1;SK-BR-3: 13.8;T-47d: 15.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013788 Uncertain Uncertain "Nucleoli,Nucleoli rim" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Nucleoli rim" "HPA013788: AB_1845637" "unprognostic (1.38e-2)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (1.92e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (3.54e-2)" "unprognostic (2.74e-1)" "unprognostic (2.01e-2)" "prognostic favorable (0.00e+0)" "unprognostic (7.57e-3)" "unprognostic (3.94e-1)" "unprognostic (1.00e-1)" "unprognostic (1.61e-2)" 0.2 0.1 0.3 2.9 0.3 0.2 14.5 0.7 0.5 8.2 0.3 32.4 43.9 1.3 13.0 17.0 6.1 9.9 0.1 0.3 0.2 21.8 6.2 9.0 0.1 0.3 0.4 0.1 22.8 10.3 8.4 1.6 0.4 8.1 30.2 0.5 19.5 3.8 0.0 16.2 38.7 1.2 0.2 0.1 29.1 0.3 0.3 1.0 16.9 0.0 2.3 3.2 8.1 0.8 12.1 0.0 0.0 0.1 0.0 0.0 13.0 0.0 0.0 0.0 0.0 12.6 39.8 0.0 0.3 0.0 0.0 9.0 0.0 5.6 0.0 0.0 0.0 0.1 0.2 0.7 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.0 0.0 0.2 0.1 33.1 0.0 0.1 0.1 0.4 1.0 7.8 4.6 0.3 0.1 13.8 0.0 2.1 15.2 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.3 0.7 0.5 0.3 0.2 0.3 0.4 0.4 0.2 0.3 0.8 0.1 22.4 16.1 0.3 0.6 1.1 6.2 11.5 2.8 0.0 22.4 12.8 0.0 28.6 13.8 22.0 0.0 12.9 0.0 125.9 29.4 21.3 0.1 8.5 1.4 0.2 33.6 0.0 0.0 33.7 3.9 0.2 25.5 14.2 0.0 0.0 0.0 1.2 0.7 0.0 0.0 42.4 8.2 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.3 100.8 0.0 0.0 6.6 128.1 39.6 7.3 0.0 0.0 0.0 0.7 0.3 0.0 8.9 2.6 4.7 0.3 0.0 37.0 8.8 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.1;pituitary gland: 13.5" "Cell type enriched" "Detected in many" 5 "Glandular and luminal cells: 107.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "OE19: 34.4;RPTEC TERT1: 29.9" HPA078864 Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA078864: " "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.2 0.4 0.2 0.6 0.2 0.2 0.2 0.2 2.2 0.7 0.3 0.5 1.0 1.3 0.0 0.1 0.0 0.4 0.1 0.2 2.5 5.1 2.4 0.5 0.2 1.0 0.8 0.1 4.0 0.0 13.5 0.1 0.7 0.6 0.6 0.2 1.2 0.1 0.3 0.5 0.5 0.0 0.1 0.1 2.0 0.1 0.3 2.1 0.1 0.0 0.5 3.6 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 34.4 0.2 0.1 0.0 0.2 29.9 0.7 1.3 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.2 2.2 0.2 2.5 1.0 0.8 0.7 0.1 0.3 0.1 0.6 0.0 0.0 0.3 0.3 0.5 1.8 3.8 0.0 0.9 4.3 6.2 1.4 0.0 2.7 0.0 0.0 0.0 0.0 1.2 1.9 2.8 0.0 11.7 14.6 3.9 20.8 0.0 0.0 6.6 0.0 1.2 3.6 107.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.2 14.2 0.0 0.8 0.0 0.0 0.8 0.0 0.0 1.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.8 2.2 0.3 0.0 1.1 0.2 0.0 1.0 1.4 0.0 0.0 0.0 1.1 0.0 1.1 0.1 1.0 1.1 C7orf50 "MGC11257, YCR016W" ENSG00000146540 "Chromosome 7 open reading frame 50" Q9BRJ6 7 996986-1138260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 295.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052281 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA052281: AB_2681784" "unprognostic (1.64e-1)" "unprognostic (1.48e-1)" "unprognostic (1.58e-1)" "unprognostic (3.74e-2)" "unprognostic (1.79e-2)" "unprognostic (1.28e-3)" "unprognostic (2.57e-3)" "unprognostic (1.94e-1)" "unprognostic (1.25e-1)" "unprognostic (1.57e-1)" "prognostic favorable (6.20e-6)" "unprognostic (1.57e-1)" "unprognostic (1.37e-2)" "unprognostic (3.37e-2)" "unprognostic (8.14e-2)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 42.3 40.6 74.8 17.5 70.8 13.4 43.2 63.1 103.3 53.3 58.8 74.1 15.4 55.8 12.6 46.7 56.2 12.9 96.1 71.5 64.8 79.1 59.2 45.5 16.8 73.4 66.2 69.8 108.5 19.7 140.0 16.7 65.0 66.0 8.8 8.8 41.2 32.3 70.0 32.9 35.1 15.1 67.5 39.5 60.4 38.6 75.2 11.1 74.7 22.5 10.9 64.1 41.4 65.3 167.9 104.8 34.5 105.2 18.2 25.8 72.2 73.3 35.6 63.8 54.0 74.3 69.9 49.9 47.1 47.4 80.9 104.1 41.6 88.6 12.6 47.7 84.0 45.8 75.1 102.6 73.7 58.7 30.2 37.0 69.3 59.6 54.4 28.0 44.1 41.5 82.7 46.5 29.0 241.6 27.3 156.3 84.2 74.8 153.7 79.4 12.8 83.0 30.2 45.6 78.7 112.8 60.2 70.6 103.9 22.7 169.7 106.6 51.6 36.9 162.9 110.9 97.5 39.3 57.2 45.8 74.1 96.0 119.0 18.1 129.4 400.1 97.1 136.4 69.4 123.7 79.1 82.6 208.0 165.6 59.9 69.8 15.1 44.8 134.1 60.5 104.9 116.7 74.8 70.8 63.1 103.3 71.5 64.8 73.4 66.2 65.0 67.5 75.2 65.3 42.9 35.3 57.2 16.0 115.8 23.2 43.4 81.6 12.5 74.0 89.2 80.9 72.2 44.3 55.9 66.2 18.8 73.5 42.2 40.5 295.4 89.2 8.5 55.9 30.9 44.3 90.8 21.2 34.1 85.5 78.6 51.6 27.0 37.5 55.8 88.1 37.5 37.7 163.1 57.2 30.8 64.6 73.2 67.5 71.0 7.5 37.0 68.8 71.2 15.9 108.9 140.2 66.9 20.6 17.5 64.2 27.0 44.4 52.4 52.4 9.9 152.0 54.4 73.3 26.3 30.8 73.0 20.4 42.8 34.2 24.4 46.5 60.4 48.0 62.2 39.0 C9orf152 bA470J20.2 ENSG00000188959 "Chromosome 9 open reading frame 152" Q5JTZ5 9 110190048-110208159 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.6;salivary gland: 25.4;stomach 1: 32.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 35.4;Intestinal goblet cells: 139.7;Ionocytes: 40.7;Paneth cells: 40.0;Undifferentiated cells: 79.8" "Cancer enhanced" "Detected in many" "prostate cancer: 27.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "OE19: 149.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA050769 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Nucleoli "HPA050769: AB_2681230" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (1.16e-1)" "prognostic favorable (7.22e-5)" "unprognostic (2.28e-1)" "unprognostic (1.79e-3)" "unprognostic (6.86e-2)" "unprognostic (1.34e-1)" "unprognostic (4.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (5.09e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (4.57e-1)" "unprognostic (2.49e-1)" "unprognostic (1.06e-2)" 0.1 0.0 0.5 2.1 0.4 0.0 12.4 0.2 0.4 10.4 0.1 32.8 19.0 2.3 0.0 3.0 3.7 5.5 0.0 0.4 0.1 0.2 0.8 5.8 0.0 0.6 0.4 0.0 5.1 0.0 0.1 0.0 0.6 17.0 41.6 0.0 25.4 1.4 0.0 5.4 15.1 1.2 0.2 0.1 32.9 0.0 0.5 0.1 0.1 0.0 0.2 1.2 0.4 0.6 0.0 1.3 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.2 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.1 0.0 149.2 0.2 0.0 0.0 0.2 0.0 0.6 0.1 0.1 0.0 9.3 0.0 0.0 18.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.2 0.4 0.4 0.1 0.6 0.4 0.6 0.2 0.5 0.6 0.4 9.6 16.3 0.3 0.2 0.3 3.4 5.9 6.2 0.0 20.5 10.8 0.1 20.0 14.5 0.0 0.0 0.0 0.1 35.4 0.0 6.0 0.0 4.0 2.0 0.5 25.9 0.0 0.1 11.1 0.0 0.2 25.0 13.9 0.0 0.0 0.0 3.3 0.1 0.0 0.1 139.7 40.7 0.0 1.0 0.0 0.0 0.6 10.6 0.0 0.0 0.0 0.0 0.0 0.1 3.9 40.0 0.0 0.0 12.4 4.4 0.0 5.2 0.0 0.0 0.4 0.9 0.0 0.0 10.9 0.4 0.0 0.4 0.0 79.8 5.5 CAB39 "CGI-66, MO25" ENSG00000135932 "Calcium binding protein 39" Q9Y376 2 230712842-230821075 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 188.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037112, HPA076632" Approved Approved Nucleoli,Cytosol NA NA 100000 "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli Cytosol "CAB037112: AB_1078367, HPA076632: " "unprognostic (4.36e-3)" "unprognostic (1.42e-1)" "unprognostic (2.17e-2)" "unprognostic (1.71e-1)" "unprognostic (3.19e-1)" "unprognostic (4.73e-2)" "unprognostic (2.50e-2)" "unprognostic (2.84e-2)" "unprognostic (9.16e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (1.04e-1)" "prognostic favorable (9.05e-6)" "unprognostic (1.59e-1)" "unprognostic (2.92e-1)" "unprognostic (8.93e-2)" "unprognostic (1.36e-1)" 43.7 31.0 30.1 55.2 32.9 50.9 29.6 31.5 40.6 26.5 29.3 53.7 48.0 30.7 35.0 55.8 30.0 41.3 55.6 34.3 33.9 54.1 38.6 40.0 58.0 36.5 34.5 29.2 33.1 42.5 17.1 35.5 36.4 39.9 56.0 45.6 34.4 31.2 188.5 34.3 51.2 40.4 34.0 38.0 46.2 41.3 33.6 45.1 37.3 127.8 59.1 49.4 30.5 39.5 131.6 30.0 39.8 34.0 48.2 59.8 45.3 73.7 91.8 45.4 47.2 36.6 140.0 33.8 56.5 64.5 76.5 59.1 44.8 138.5 91.9 142.1 35.1 90.5 36.9 39.5 40.9 126.6 100.8 42.5 79.1 58.5 128.4 51.8 57.1 46.1 153.9 30.3 43.8 45.6 59.1 77.9 39.8 53.4 52.0 67.8 59.3 33.5 84.6 104.9 43.2 26.4 55.2 68.2 59.9 44.7 16.9 72.4 73.1 63.9 24.3 68.2 61.0 39.0 31.8 53.8 45.4 72.4 53.4 4.0 3.6 6.0 4.7 4.4 4.8 3.0 5.8 6.1 3.0 2.4 4.7 6.5 10.3 9.3 4.3 2.2 6.2 2.4 30.1 32.9 31.5 40.6 34.3 33.9 36.5 34.5 36.4 34.0 33.6 39.5 41.6 64.1 37.5 42.1 29.6 97.8 44.2 23.0 23.3 14.4 28.3 18.9 69.1 17.2 30.5 51.5 33.3 20.8 32.3 162.5 29.4 26.0 12.0 41.4 25.2 29.6 20.4 32.0 85.1 32.7 18.7 24.1 28.5 39.5 20.3 16.6 28.2 29.3 56.8 28.6 69.3 48.5 24.4 81.2 72.4 13.5 17.4 66.2 30.2 93.7 49.6 39.6 29.9 58.8 64.3 72.3 62.4 32.0 37.0 84.4 54.6 39.8 55.6 40.5 13.1 27.5 27.3 30.8 29.5 31.2 85.1 23.1 52.0 18.9 34.8 88.6 CACHD1 "KIAA1573, VWCD1" ENSG00000158966 "Cache domain containing 1" Q5VU97 1 64470129-64693058 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Astrocytes: 283.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017202 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA 310000 "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nucleoli" "HPA017202: AB_1852423" "unprognostic (2.92e-2)" "unprognostic (2.91e-1)" "unprognostic (1.29e-2)" "unprognostic (1.02e-1)" "unprognostic (3.75e-1)" "unprognostic (1.01e-1)" "unprognostic (4.82e-2)" "unprognostic (4.32e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (8.16e-2)" "unprognostic (1.86e-1)" "unprognostic (1.24e-3)" "unprognostic (2.67e-2)" "unprognostic (3.89e-1)" "unprognostic (3.65e-1)" "unprognostic (2.13e-1)" 11.1 13.1 17.5 2.0 18.7 0.1 11.8 6.4 11.3 11.9 22.8 2.9 1.5 10.8 9.1 3.7 14.4 4.5 4.0 14.9 12.9 6.3 1.8 9.0 1.9 12.0 18.1 22.6 7.3 6.9 9.1 10.2 10.9 8.2 2.7 6.4 8.2 7.6 2.9 7.7 3.5 9.6 8.6 4.5 6.7 2.3 18.9 5.1 6.4 5.4 1.6 6.0 10.6 5.7 0.3 1.7 41.3 6.1 16.1 5.6 0.0 5.9 7.8 10.0 9.7 24.8 0.2 0.0 16.8 9.7 8.0 3.1 23.4 5.0 10.4 4.6 12.2 8.9 2.9 0.0 0.0 3.8 0.1 5.0 3.4 1.2 6.2 6.0 5.7 6.0 0.0 0.0 0.0 0.7 0.8 0.0 56.5 0.3 4.2 5.2 4.2 0.0 0.0 1.3 2.1 23.5 12.7 0.0 5.2 35.4 1.7 0.5 3.7 1.0 7.3 29.1 5.3 0.0 0.0 0.0 1.0 0.7 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.5 18.7 6.4 11.3 14.9 12.9 12.0 18.1 10.9 8.6 18.9 5.7 25.2 6.4 49.9 283.7 0.1 17.3 7.5 6.1 6.8 15.5 8.3 7.0 1.3 0.0 11.5 3.7 0.0 0.0 0.2 0.1 0.0 2.3 9.5 14.0 8.1 20.2 0.0 0.0 19.4 2.7 0.1 11.1 5.6 16.9 2.5 26.0 4.2 1.3 0.2 0.0 6.9 0.2 4.1 0.3 6.1 4.1 14.3 0.8 1.8 24.4 0.2 6.4 0.0 57.8 1.8 1.2 0.1 3.0 0.0 2.0 0.5 4.2 10.2 1.3 6.6 25.2 6.4 0.5 0.8 2.9 14.8 0.0 0.9 0.8 0.5 5.1 CASP8AP2 "CED-4, FLASH, FLJ11208, KIAA1315, RIP25" ENSG00000118412 "Caspase 8 associated protein 2" 6 89829894-89874436 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "brain: 2.6" "Cell type enhanced" "Detected in many" "Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053573 Approved "Nucleoli,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA053573: AB_2682194" "unprognostic (7.80e-2)" "unprognostic (1.47e-1)" "unprognostic (6.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.64e-2)" "unprognostic (1.22e-2)" "unprognostic (1.75e-4)" "unprognostic (4.58e-1)" "unprognostic (4.36e-3)" "unprognostic (2.20e-2)" "unprognostic (1.11e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.88e-5)" "unprognostic (2.35e-1)" "unprognostic (1.63e-1)" "unprognostic (4.16e-2)" "unprognostic (3.53e-1)" 0.6 0.3 0.4 0.4 1.0 0.2 0.5 2.6 1.2 0.7 0.3 0.9 0.0 0.7 0.0 0.4 0.6 0.1 0.4 0.6 0.4 0.4 0.2 0.5 0.4 0.5 0.5 0.5 0.5 0.1 0.4 0.1 0.8 0.5 0.1 0.0 0.4 0.0 0.8 0.4 0.5 0.2 0.8 0.4 0.3 0.3 0.7 0.6 0.6 0.7 0.2 0.6 0.5 1.9 0.4 1.0 1.3 1.0 0.1 0.4 0.3 2.1 0.2 0.7 0.5 0.8 0.5 2.4 0.7 1.0 0.8 0.7 2.5 0.6 0.7 3.7 3.5 4.0 3.0 0.0 0.0 2.6 1.1 0.2 0.2 1.6 0.6 0.2 0.8 1.4 4.4 1.3 0.6 0.7 1.6 0.0 0.2 0.2 1.3 3.3 3.8 0.9 0.0 3.2 1.4 0.8 1.8 0.0 0.5 0.5 0.4 1.2 1.6 0.3 0.5 1.6 1.6 0.2 2.8 1.3 0.5 1.4 1.4 14.4 1.5 5.6 6.2 2.6 5.9 5.5 7.1 6.5 1.9 6.3 5.4 5.6 3.1 12.6 2.3 4.9 6.6 2.3 0.4 1.0 2.6 1.2 0.6 0.4 0.5 0.5 0.8 0.8 0.7 1.9 27.3 32.1 14.5 26.1 26.8 0.0 9.1 0.0 13.6 19.5 13.3 16.4 47.5 7.2 11.8 7.3 6.2 20.5 21.4 12.7 3.9 15.1 5.9 9.6 22.1 21.1 2.4 35.7 32.3 12.3 15.8 21.4 11.7 13.7 15.8 31.8 9.7 6.9 12.4 35.3 33.5 11.7 0.0 11.5 0.0 4.7 23.0 16.1 0.0 33.7 26.9 18.1 34.0 23.6 38.2 9.3 10.3 25.9 14.4 13.2 11.8 7.2 13.8 25.5 19.7 30.6 25.1 47.2 74.2 15.7 0.0 10.9 24.7 16.7 14.6 9.1 CBS HIP4 ENSG00000160200 "Cystathionine beta-synthase" P35520 21 43053191-43076943 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" "Allosteric enzyme, Lyase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 174.9;pancreas: 99.0" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 2.3;Cardiomyocytes: 4.9;Hepatocytes: 3.6;Ionocytes: 2.0;Melanocytes: 5.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 51 "neutrophil: 5.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.0" "Cell line enhanced" "Detected in many" "BEWO: 177.5;HAP1: 172.8;HHSteC: 224.1;MCF7: 197.7;RPMI-8226: 197.4" "Low region specificity" "Detected in all" HPA001223 Supported Approved Nucleoli,Vesicles NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 48: Smooth muscle cells - ECM organization" Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (4.86e-2)" "unprognostic (1.48e-2)" "unprognostic (6.81e-2)" "unprognostic (1.12e-3)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.68e-4)" "unprognostic (3.62e-1)" "unprognostic (6.76e-3)" "unprognostic (1.06e-1)" "unprognostic (6.50e-2)" "unprognostic (2.13e-1)" "unprognostic (1.61e-2)" "unprognostic (6.73e-3)" "unprognostic (2.62e-1)" "unprognostic (1.92e-2)" "unprognostic (1.02e-1)" 6.6 2.8 42.5 1.0 39.5 0.2 3.4 58.5 55.3 12.3 29.3 4.8 3.0 4.5 0.0 2.0 5.8 1.2 7.7 41.4 40.3 3.8 174.9 10.2 2.7 42.5 44.6 30.3 99.0 2.5 8.8 1.2 42.7 12.7 0.9 2.5 19.9 1.1 1.1 2.3 7.0 2.3 38.4 1.7 16.5 2.0 48.1 0.7 17.4 1.2 1.4 11.6 6.2 45.4 30.0 17.0 31.3 113.4 48.9 31.5 177.5 39.5 10.0 15.6 15.4 53.7 1.5 0.1 19.2 67.2 0.3 1.5 172.8 13.2 3.1 0.0 20.5 12.3 73.1 63.8 224.1 7.9 19.1 21.7 1.4 16.0 16.4 13.2 38.6 85.6 138.7 118.1 11.1 197.7 16.1 0.1 20.3 65.7 29.4 0.0 0.2 197.4 0.5 15.5 57.8 85.1 78.5 5.4 44.4 18.4 27.0 91.2 5.4 0.8 42.5 0.3 4.8 34.8 30.2 41.2 19.0 11.0 53.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 42.5 39.5 58.5 55.3 41.4 40.3 42.5 44.6 42.7 38.4 48.1 45.4 0.2 0.0 0.5 0.7 0.0 0.4 0.0 2.3 0.0 0.2 0.5 0.1 4.9 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.2 0.8 1.2 0.0 0.1 0.0 0.1 0.0 3.6 0.2 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.9 0.2 5.4 0.0 0.0 0.5 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.2 1.7 0.1 0.1 0.1 0.0 0.3 0.6 0.0 0.6 0.0 1.0 0.1 0.1 0.0 0.2 0.1 CBSL ENSG00000274276 "Cystathionine beta-synthase like" P0DN79 21 6444869-6468040 "Enzymes, Predicted intracellular proteins" "Amino-acid biosynthesis, Cysteine biosynthesis" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "liver: 88.1;pancreas: 48.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 14 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.3" "Cell line enhanced" "Detected in many" "AN3-CA: 105.1;NTERA-2: 246.2;U-266/70: 75.7" HPA001223 Supported Approved Nucleoli,Vesicles NA NA 510000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 5: NTERA-2 - Transcription" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles Nucleoli "HPA001223: AB_1846112" "unprognostic (2.39e-1)" "unprognostic (1.54e-2)" "unprognostic (1.15e-1)" "unprognostic (4.78e-3)" "unprognostic (6.49e-2)" "unprognostic (1.42e-2)" "unprognostic (1.28e-2)" "unprognostic (6.62e-3)" "unprognostic (1.17e-1)" "unprognostic (3.62e-2)" "unprognostic (7.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.04e-1)" "unprognostic (3.17e-3)" "unprognostic (8.44e-2)" "unprognostic (2.46e-1)" "unprognostic (3.61e-1)" 3.8 1.2 0.9 0.8 0.8 0.1 1.7 1.6 1.3 7.5 0.3 2.3 2.0 1.8 1.4 1.0 5.6 1.0 4.4 0.6 0.9 1.6 88.1 4.8 0.1 1.3 1.6 14.7 48.5 2.2 4.4 0.8 1.1 6.1 0.0 1.1 4.6 8.9 0.6 1.2 3.7 0.0 0.6 1.2 8.2 1.0 1.6 0.2 12.3 0.0 0.4 5.0 3.1 1.3 0.1 0.0 36.3 105.1 0.0 0.0 1.4 23.3 15.2 8.9 29.3 0.2 18.2 0.0 0.1 0.0 17.1 12.1 0.2 13.5 5.6 0.0 35.4 0.0 0.0 0.0 1.0 0.0 16.1 12.8 51.5 0.1 23.1 0.0 0.2 0.8 0.7 41.5 0.3 0.0 18.9 2.6 246.2 0.5 0.0 0.3 0.0 0.3 40.5 0.0 38.7 58.5 0.0 3.4 44.9 0.0 0.1 0.1 0.0 2.7 0.0 17.3 4.4 75.7 29.6 0.3 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.8 1.6 1.3 0.6 0.9 1.3 1.6 1.1 0.6 1.6 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CC2D2B "bA248J23.4, bA690P14.3, C10orf130, C10orf131" ENSG00000188649 "Coiled-coil and C2 domain containing 2B" Q6DHV5 10 95907603-96033745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 8.7" "Cell type enhanced" "Detected in some" "Astrocytes: 25.8;Early spermatids: 10.8;Microglial cells: 15.0;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 7.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044091, HPA072122" Enhanced Approved "Nucleoli,Nucleoli rim" NA NA "Cluster 37: B-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" "HPA044091: AB_2732514, HPA072122: AB_2686489" "unprognostic (6.38e-2)" "unprognostic (5.95e-2)" "unprognostic (1.47e-1)" "unprognostic (5.00e-2)" "unprognostic (1.36e-1)" "unprognostic (1.19e-2)" "unprognostic (1.04e-1)" "unprognostic (2.39e-3)" "unprognostic (1.21e-1)" "unprognostic (3.63e-1)" "unprognostic (8.18e-3)" "unprognostic (2.11e-3)" "unprognostic (9.11e-4)" "unprognostic (1.93e-2)" "unprognostic (4.34e-1)" "unprognostic (5.45e-3)" "unprognostic (1.41e-1)" 0.7 1.9 0.9 1.9 2.7 2.5 0.5 1.2 1.6 0.8 3.4 0.9 1.0 1.5 0.4 0.8 0.9 1.5 1.1 0.5 3.5 0.9 0.6 0.8 1.3 2.1 0.9 1.1 0.4 0.7 0.3 1.1 2.6 0.6 0.3 2.8 1.0 0.4 2.2 2.4 0.6 1.2 1.0 1.2 1.0 8.7 2.2 0.2 3.0 0.2 0.2 0.8 0.8 5.4 1.1 4.4 3.7 7.4 0.2 0.4 4.1 3.8 0.4 0.7 0.1 3.3 0.8 4.4 3.0 0.0 3.8 3.0 0.3 0.3 0.0 4.9 8.5 9.7 3.5 2.8 0.0 9.8 0.7 0.7 0.0 0.4 0.1 1.3 0.3 1.4 7.8 2.9 0.9 2.6 4.6 3.1 7.9 3.3 6.8 12.1 3.4 3.8 0.7 0.8 6.5 3.2 3.9 1.0 2.5 4.4 6.8 4.9 3.7 4.3 4.5 3.0 5.7 2.6 11.7 0.2 3.3 8.4 2.8 0.0 0.3 0.0 0.5 0.1 0.9 1.2 0.4 0.3 0.3 1.2 0.4 0.1 0.3 0.2 0.2 0.3 0.2 0.1 0.9 2.7 1.2 1.6 0.5 3.5 2.1 0.9 2.6 1.0 2.2 5.4 1.1 0.0 0.0 25.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.8 0.2 0.4 1.1 0.0 0.0 3.2 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 15.0 0.2 0.0 0.0 13.6 7.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666737-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 8.2 9.5 13.8 12.3 13.7 17.7 7.6 13.5 17.5 10.7 14.2 9.3 11.4 7.5 5.5 23.1 7.8 6.1 6.5 13.7 13.8 10.2 10.8 7.7 16.3 14.4 14.3 6.7 8.2 7.0 6.2 7.7 14.7 11.7 5.8 2.8 9.9 6.4 7.7 22.8 10.7 6.0 13.4 15.6 8.8 10.4 14.5 11.8 7.8 4.5 11.5 9.8 13.8 14.3 38.0 62.8 21.5 35.3 13.9 13.1 35.2 41.6 19.7 53.0 30.6 55.1 22.8 33.8 22.4 21.2 36.6 47.9 34.5 43.8 30.6 19.4 51.7 51.6 30.1 48.0 20.7 46.6 37.5 19.8 26.3 47.6 26.3 14.6 37.4 41.1 53.3 19.1 28.3 34.5 45.7 56.6 46.9 32.9 59.8 55.4 34.6 24.1 19.8 29.6 45.1 57.7 41.1 87.8 37.1 28.9 58.8 48.3 27.8 82.0 53.5 34.9 65.9 53.1 28.7 36.8 30.8 42.9 48.8 2.2 7.7 11.7 11.5 9.6 6.3 10.4 8.7 8.8 7.5 13.2 9.2 8.8 3.3 13.1 11.9 12.9 9.8 5.9 13.8 13.7 13.5 17.5 13.7 13.8 14.4 14.3 14.7 13.4 14.5 14.3 17.9 22.4 17.0 5.9 29.8 31.7 22.8 19.7 74.6 6.8 17.4 13.7 6.7 15.7 20.9 12.9 2.1 25.7 31.5 19.7 19.6 25.2 1.7 26.5 32.9 20.3 7.2 37.5 4.5 21.4 41.0 16.5 29.0 29.4 19.6 28.1 15.4 11.8 24.3 18.5 4.6 17.0 14.2 12.9 11.5 1.7 13.7 16.8 16.0 4.7 24.2 13.8 37.0 4.0 5.0 35.2 16.0 13.5 25.7 40.0 12.4 15.9 21.6 9.1 6.6 13.7 22.3 30.8 44.9 57.0 34.4 20.8 29.7 22.8 22.4 24.2 CCDC171 "bA536D16.1, bA778P13.1, C9orf93, Em:AL513423.1, FLJ39267, FLJ46740" ENSG00000164989 "Coiled-coil domain containing 171" Q6TFL3 9 15553043-16061663 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.3" "Cell type enhanced" "Detected in many" "Early spermatids: 194.5;Excitatory neurons: 92.4;Inhibitory neurons: 70.6;Late spermatids: 172.4;Spermatocytes: 148.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Daudi: 7.5;HEL: 11.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA019803, HPA019806, HPA024133" Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA019803: AB_1845846, HPA019806: AB_1845847, HPA024133: AB_1845848" "unprognostic (1.35e-2)" "unprognostic (2.03e-4)" "unprognostic (7.22e-3)" "unprognostic (1.16e-1)" "unprognostic (1.43e-1)" "unprognostic (1.09e-1)" "unprognostic (1.51e-2)" "unprognostic (2.05e-2)" "unprognostic (2.18e-1)" "unprognostic (6.76e-3)" "unprognostic (5.37e-2)" "unprognostic (1.28e-1)" "unprognostic (2.92e-3)" "unprognostic (7.80e-2)" "unprognostic (4.90e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-3)" 0.8 1.1 2.3 0.7 2.8 2.1 1.6 3.7 3.2 1.4 0.0 0.9 0.8 5.8 1.1 1.0 2.0 1.5 1.0 2.5 0.3 1.2 0.4 1.1 1.1 1.5 0.3 2.9 1.3 1.4 1.1 0.9 2.0 1.1 1.1 5.5 0.8 1.2 0.8 2.4 1.0 3.3 0.2 0.6 1.4 11.3 0.5 4.8 2.0 1.1 1.0 0.8 0.9 3.3 1.4 0.7 1.6 1.6 0.9 1.9 1.0 1.0 0.8 1.0 1.1 0.4 0.6 7.5 0.5 0.6 1.9 0.3 0.7 1.0 1.1 1.6 0.7 11.7 1.2 1.0 1.3 1.6 1.4 1.1 1.9 0.8 1.5 0.8 0.5 4.1 0.3 2.0 1.2 0.5 3.3 1.5 1.3 0.6 1.6 3.8 1.2 0.2 0.7 1.1 2.3 1.1 2.1 0.7 2.8 1.3 0.9 1.1 0.8 2.1 1.2 0.6 0.7 1.1 1.4 4.8 0.9 1.0 1.5 2.4 0.2 0.0 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.6 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.0 2.3 2.8 3.7 3.2 2.5 0.3 1.5 0.3 2.0 0.2 0.5 3.3 4.4 0.0 7.5 56.8 2.6 2.8 5.8 1.8 7.4 27.7 5.0 8.0 8.5 0.0 5.9 3.7 16.7 6.7 1.4 3.6 5.9 2.9 194.5 24.3 7.8 3.8 1.2 3.8 92.4 3.5 4.1 5.7 8.2 12.9 1.3 7.6 3.3 0.8 1.9 10.1 70.6 3.5 6.1 1.0 1.1 172.4 5.9 2.1 0.0 16.9 1.6 12.5 5.2 54.8 63.1 2.5 1.0 6.0 1.9 0.8 2.8 2.1 12.0 44.0 13.1 11.6 5.7 148.2 40.6 5.4 3.3 5.6 3.6 10.7 4.9 3.7 CCDC58 FLJ33273 ENSG00000160124 "Coiled-coil domain containing 58" Q4VC31 3 122359591-122383231 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 114.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051965 Approved Approved Nucleoli,Mitochondria No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria Nucleoli "HPA051965: AB_2681676" "unprognostic (1.51e-1)" "unprognostic (1.23e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.53e-4)" "unprognostic (5.64e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (2.94e-5)" "unprognostic (2.72e-2)" "unprognostic (1.03e-2)" "unprognostic (4.98e-3)" "unprognostic (5.26e-3)" "unprognostic (1.84e-2)" "unprognostic (7.11e-3)" "unprognostic (1.03e-3)" "unprognostic (2.58e-1)" "unprognostic (1.86e-1)" "prognostic favorable (7.29e-4)" 14.7 21.0 16.9 15.7 17.8 18.0 19.0 18.2 28.2 10.7 18.4 28.5 22.5 11.7 24.6 23.2 10.6 13.4 27.3 17.1 17.6 46.8 49.8 9.0 23.3 17.8 18.1 13.1 13.8 14.9 7.8 14.4 18.2 11.1 29.1 17.1 11.3 10.6 78.8 15.0 18.6 11.4 17.4 12.1 16.4 9.4 18.1 16.2 18.3 47.2 21.5 22.6 12.5 18.3 135.1 41.9 78.2 50.2 28.5 39.8 100.6 50.5 54.3 119.4 116.4 118.4 66.4 98.0 84.6 38.6 92.7 91.9 127.9 86.3 142.5 34.1 45.3 115.9 28.5 145.6 47.5 174.5 39.5 33.0 43.9 73.5 79.8 50.7 55.9 85.8 133.6 41.6 63.7 67.2 111.7 123.6 150.0 147.2 78.1 72.8 92.9 120.1 83.7 70.3 78.8 38.4 58.5 61.5 150.5 65.3 61.2 112.8 32.6 66.4 86.1 28.6 102.3 32.9 47.5 217.4 75.7 83.3 60.0 0.9 7.7 2.7 15.2 16.7 18.0 20.9 19.9 20.1 16.5 19.2 23.0 22.2 1.4 19.2 14.2 29.2 17.2 6.7 16.9 17.8 18.2 28.2 17.1 17.6 17.8 18.1 18.2 17.4 18.1 18.3 5.7 3.2 17.0 8.1 18.1 15.3 19.1 21.4 21.1 10.5 14.1 10.4 32.0 20.0 22.2 12.9 10.4 21.8 8.4 19.6 54.8 31.4 0.5 24.7 20.5 13.7 5.4 14.1 11.3 30.0 44.7 12.8 16.8 26.2 21.5 14.4 10.8 50.5 17.8 0.0 13.2 27.7 16.2 8.7 7.6 1.5 12.8 8.9 8.8 2.8 19.8 9.7 16.5 11.6 11.8 31.9 14.7 8.2 12.5 30.7 23.9 114.0 22.5 9.6 13.1 15.1 41.8 23.1 31.0 30.8 18.5 15.2 10.9 11.8 35.1 23.0 CD1E ENSG00000158488 "CD1e molecule" P15812 1 158353696-158357553 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 69 "lymphoid tissue: 962.6" "Cell type enriched" "Detected in some" 13 "Langerhans cells: 549.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 14 "myeloid DC: 62.5" "Lineage enriched" "Detected in many" 14 "dendritic cells: 62.5" "Cell line enriched" "Detected in some" 43 "MOLT-4: 1276.2" "Not detected" "Not detected" "HPA057769, HPA070634" Uncertain Supported "Nucleoli,Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 63: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" "Golgi apparatus" Nucleoli "HPA057769: AB_2683522, HPA070634: " "unprognostic (7.94e-3)" "unprognostic (1.85e-5)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.76e-2)" "unprognostic (1.29e-2)" "unprognostic (2.33e-1)" "unprognostic (1.54e-3)" "unprognostic (1.24e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (8.55e-2)" "unprognostic (1.69e-2)" "unprognostic (1.50e-1)" "unprognostic (2.49e-1)" "unprognostic (8.50e-2)" "unprognostic (2.45e-1)" 0.7 0.5 0.0 4.4 0.0 0.0 1.8 0.0 0.0 2.1 0.0 2.1 2.2 1.1 0.4 7.9 0.9 4.8 1.0 0.0 0.0 0.8 1.5 3.1 6.4 0.0 0.0 0.6 0.3 0.5 0.1 0.0 0.0 1.1 5.6 0.0 1.5 0.6 0.4 13.9 2.8 0.9 0.0 5.1 4.7 0.5 0.0 962.6 0.8 0.2 9.9 2.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.1 0.0 0.0 0.5 1276.2 0.0 0.3 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 2.5 0.2 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.5 0.0 0.8 8.4 0.0 0.0 0.6 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.8 549.5 0.0 0.0 41.7 8.8 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.5 0.0 7.1 0.1 0.7 0.0 0.0 0.0 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619704 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 8.5;testis: 12.6" "Group enriched" "Detected in some" 4 "Early spermatids: 22.9;Late spermatids: 11.8;Spermatocytes: 8.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 19.6;HaCaT: 35.7;HeLa: 14.3;OE19: 9.3" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 71: Testis - DNA repair" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.4 2.4 1.0 1.0 1.0 0.4 1.0 1.1 1.0 2.4 0.5 0.6 2.3 0.2 0.9 8.5 0.7 0.6 1.4 0.8 0.8 0.9 1.3 1.2 0.8 1.0 1.0 0.2 0.3 0.1 0.5 1.4 0.9 0.6 0.7 0.4 2.6 0.3 2.6 3.4 1.2 0.2 0.7 0.4 2.2 12.6 1.1 0.3 2.1 0.8 2.3 1.8 4.2 1.2 3.0 8.4 0.3 2.8 0.4 0.8 0.2 0.7 2.0 0.3 1.0 7.7 19.6 0.3 0.5 1.8 2.1 35.7 0.6 0.4 0.4 3.2 0.3 0.2 14.3 0.4 0.3 0.1 0.3 0.6 1.2 0.9 0.6 0.1 0.2 0.5 0.0 1.5 1.1 0.2 0.6 0.5 0.3 9.3 1.1 0.1 0.6 0.0 2.4 5.1 0.2 0.1 2.7 2.5 0.2 0.9 0.2 0.2 1.8 0.6 1.8 0.2 0.5 1.0 4.0 0.1 2.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.0 1.1 1.0 0.8 0.8 1.0 1.0 0.9 0.7 1.1 1.2 0.9 0.0 0.5 1.3 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 22.9 0.5 0.1 0.3 0.0 0.0 2.5 0.2 0.0 0.2 3.6 0.8 0.0 0.2 0.4 0.2 0.1 0.0 2.3 0.2 0.0 0.0 0.0 11.8 0.6 0.2 0.0 1.0 0.0 0.1 0.0 1.5 2.2 1.8 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.2 0.0 0.1 0.0 8.6 0.5 0.6 0.0 0.0 0.0 2.5 0.0 0.3 CENPP "CENP-P, RP11-19J3.3" ENSG00000188312 "Centromere protein P" Q6IPU0 9 92325953-92620529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 21.4" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 63.3;Excitatory neurons: 73.4;Inhibitory neurons: 70.5;Microglial cells: 94.6;Oligodendrocytes: 74.5;Suprabasal keratinocytes: 100.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021787, HPA058945" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 28: Keratinocytes - Keratinization" Nucleoplasm Nucleoli "HPA021787: AB_1846524, HPA058945: AB_2683860" "unprognostic (5.48e-2)" "prognostic favorable (3.91e-4)" "unprognostic (1.20e-1)" "unprognostic (2.43e-3)" "unprognostic (2.64e-2)" "prognostic favorable (3.65e-4)" "unprognostic (4.88e-5)" "unprognostic (8.06e-2)" "unprognostic (3.51e-3)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (6.68e-3)" "unprognostic (9.20e-8)" "unprognostic (1.27e-2)" "unprognostic (5.12e-2)" "unprognostic (1.11e-1)" "unprognostic (2.04e-1)" 3.4 3.0 1.7 3.5 2.1 12.3 3.0 5.6 2.1 3.8 0.8 2.4 2.8 2.9 0.7 4.4 2.0 2.8 2.8 2.0 1.5 2.0 1.8 1.9 5.6 1.7 1.4 2.2 2.1 2.4 1.8 3.1 2.0 2.3 2.7 2.4 2.2 1.5 9.0 21.4 1.9 3.0 1.0 2.7 1.8 4.5 1.8 7.1 1.4 4.5 6.4 2.3 4.0 1.8 14.2 8.7 12.0 8.8 4.9 5.3 11.7 14.6 8.2 17.9 14.3 4.0 7.9 18.5 6.7 4.7 16.5 16.8 11.6 8.0 16.6 26.3 15.1 18.6 7.2 5.7 2.6 38.2 17.0 5.8 4.5 17.3 11.1 2.5 9.2 17.5 20.8 25.2 13.8 9.0 53.4 11.6 10.1 26.6 17.9 17.9 20.3 20.0 2.7 14.1 27.8 9.6 16.8 10.5 5.4 8.7 5.6 11.4 4.4 17.4 8.7 26.6 21.2 16.7 21.6 23.9 19.5 18.9 16.1 1.8 1.8 2.6 2.6 6.4 4.7 4.6 3.0 2.3 2.3 3.6 2.7 2.7 0.5 3.5 3.3 3.0 3.5 2.0 1.7 2.1 5.6 2.1 2.0 1.5 1.7 1.4 2.0 1.0 1.8 1.8 3.7 0.0 0.5 17.3 4.5 63.3 4.0 4.5 5.2 6.2 4.0 2.7 2.1 2.8 1.3 0.0 8.4 6.2 3.3 1.6 1.9 1.7 17.5 2.4 4.2 4.4 1.2 11.2 73.4 2.3 9.2 5.8 5.6 2.3 0.0 6.4 2.5 0.9 17.1 1.7 70.5 1.5 0.0 2.1 11.7 4.7 4.4 4.0 14.2 94.6 0.5 2.8 1.0 38.2 74.5 1.1 0.4 4.9 11.9 2.8 0.4 1.8 0.3 7.8 6.6 20.8 9.2 30.2 16.2 9.8 100.9 3.8 3.6 4.4 2.6 2.7 CHD7 "CRG, FLJ20357, FLJ20361, KIAA1416" ENSG00000171316 "Chromodomain helicase DNA binding protein 7" Q9P2D1 8 60678740-60868028 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 71.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 241.8;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 255.7;Rod photoreceptor cells: 198.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 15 "B-cells: 14.9;granulocytes: 17.6;T-cells: 6.6" "Cell line enhanced" "Detected in many" "AF22: 51.5;SCLC-21H: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053075 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Nucleoli "HPA053075: AB_2682035" "unprognostic (3.77e-2)" "unprognostic (3.28e-3)" "unprognostic (3.17e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (9.59e-2)" "unprognostic (1.14e-1)" "unprognostic (1.86e-3)" "unprognostic (3.41e-2)" "unprognostic (3.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (9.09e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-1)" "unprognostic (8.20e-2)" "unprognostic (2.17e-1)" 3.6 1.9 10.3 3.9 17.2 22.1 3.5 71.5 11.0 2.0 2.5 4.6 4.6 2.2 2.2 4.9 2.3 1.9 3.8 9.4 11.5 3.8 3.2 4.6 5.8 19.7 17.2 1.0 4.4 5.3 6.1 4.3 18.8 2.7 4.0 23.7 3.9 1.7 10.4 5.2 6.4 1.7 11.4 5.6 3.5 2.9 15.6 2.6 4.1 4.1 5.7 3.4 3.2 17.7 8.0 4.0 51.5 9.2 0.1 0.0 16.2 0.4 0.1 1.8 1.6 10.0 7.3 15.5 0.9 0.1 2.3 4.8 26.7 7.9 1.6 5.9 14.3 36.5 7.0 13.2 2.1 11.1 6.5 1.0 5.9 0.0 8.5 3.1 7.7 12.5 2.7 13.4 1.2 8.3 17.5 12.7 35.4 8.1 1.8 36.0 12.1 5.0 4.1 9.1 46.9 23.2 1.4 5.9 14.9 18.0 10.5 10.5 9.0 0.5 8.3 0.5 4.3 14.2 8.7 23.7 3.0 1.2 13.4 14.9 0.4 17.6 3.2 0.2 4.1 10.1 3.6 1.1 0.1 14.9 6.6 2.4 9.3 0.0 0.8 0.8 0.3 0.6 10.3 17.2 71.5 11.0 9.4 11.5 19.7 17.2 18.8 11.4 15.6 17.7 35.9 32.1 17.5 68.6 64.3 30.3 35.9 10.8 9.6 36.3 16.6 14.6 35.8 27.1 20.7 16.5 241.8 8.2 17.4 31.8 1.9 17.7 15.9 34.0 4.1 40.5 87.3 3.8 6.8 11.3 8.6 6.4 28.5 37.6 41.0 39.8 21.4 12.6 14.9 70.7 17.8 39.9 32.6 10.8 10.4 8.9 0.9 13.6 21.4 118.0 13.9 121.3 15.5 298.6 255.7 16.9 27.4 0.4 29.1 42.9 17.4 5.4 20.4 198.5 0.0 49.7 9.8 8.0 12.9 25.5 32.4 6.2 21.4 3.0 34.1 35.8 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046218-22065674 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 532.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 19.7 57.0 46.6 23.2 51.1 47.9 32.9 40.3 57.8 29.2 35.8 77.8 66.2 23.5 69.0 71.6 21.8 24.4 42.6 51.2 57.3 28.9 72.2 18.1 24.2 43.8 57.1 25.3 42.5 79.4 30.0 34.0 57.1 36.7 71.9 24.8 32.6 26.7 44.0 29.3 63.6 27.7 41.8 20.1 29.7 69.9 49.0 19.8 23.8 41.1 26.1 24.2 40.3 44.0 63.4 50.2 59.5 29.3 47.0 57.5 88.8 43.2 46.2 45.0 47.2 114.1 72.0 56.5 41.3 37.3 83.9 50.9 35.8 60.1 60.7 75.0 45.4 169.1 38.8 57.2 43.2 45.4 85.5 38.5 56.4 58.1 86.3 61.5 61.3 58.7 108.8 28.1 80.9 83.8 52.0 105.3 147.5 69.4 69.5 36.2 63.6 53.7 56.0 67.8 23.8 42.0 34.2 59.6 51.9 120.2 82.3 62.0 45.5 51.2 42.4 46.2 81.1 19.4 26.0 74.9 83.6 34.6 54.3 22.7 27.3 32.1 20.4 29.7 26.1 19.0 26.9 27.0 31.5 18.2 24.2 24.6 2.8 36.9 27.4 20.2 33.8 25.5 46.6 51.1 40.3 57.8 51.2 57.3 43.8 57.1 57.1 41.8 49.0 44.0 21.5 12.8 17.5 12.4 19.2 29.2 76.8 117.2 14.8 38.3 31.9 21.2 72.7 41.5 102.3 23.9 4.2 175.2 17.8 158.1 76.3 56.6 12.4 17.2 19.6 36.8 41.6 153.9 38.7 83.6 141.3 41.7 21.9 20.0 22.8 28.2 34.2 63.6 66.2 35.3 29.2 118.2 93.6 29.8 22.0 19.0 25.4 32.5 44.4 8.4 45.3 33.4 26.8 16.6 25.5 79.7 156.2 27.8 16.7 112.3 133.6 87.0 82.5 20.4 19.7 30.4 42.3 112.2 97.1 52.3 44.5 532.6 24.6 63.0 90.8 190.6 COQ5 MGC4767 ENSG00000110871 "Coenzyme Q5, methyltransferase" Q5HYK3 12 120503279-120534434 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049487 Approved Uncertain Nucleoli,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Mitochondria "HPA049487: AB_2680789" "unprognostic (1.46e-1)" "unprognostic (1.99e-2)" "unprognostic (1.32e-1)" "unprognostic (6.30e-3)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-1)" "unprognostic (1.60e-1)" "unprognostic (2.01e-2)" "unprognostic (6.20e-2)" "unprognostic (1.62e-1)" "unprognostic (8.37e-2)" "unprognostic (3.79e-2)" "unprognostic (2.02e-1)" "unprognostic (7.73e-2)" "unprognostic (2.00e-2)" "unprognostic (3.88e-2)" 22.7 29.9 22.3 15.9 25.3 11.3 24.1 24.5 29.0 19.7 26.7 24.7 23.4 17.9 23.0 20.4 22.2 14.4 40.7 22.1 23.4 38.9 60.7 15.4 23.3 24.9 24.2 20.5 20.6 21.6 18.1 23.3 24.8 18.9 24.7 26.3 22.4 15.8 98.5 17.6 20.0 18.2 22.8 21.1 19.3 24.7 24.3 22.3 25.7 69.2 23.4 17.2 17.6 29.5 35.7 56.1 49.2 14.2 63.5 48.5 33.7 42.3 27.6 42.5 26.9 22.5 29.2 35.6 48.8 44.7 29.9 37.7 44.2 47.2 43.3 45.4 26.3 47.4 35.0 37.8 51.8 52.2 28.7 46.8 50.2 40.0 46.1 66.0 38.0 67.5 47.4 25.3 49.7 46.9 30.3 60.0 43.2 25.4 43.2 55.9 49.8 52.0 55.2 26.7 37.0 29.8 30.7 15.5 58.3 51.2 77.8 42.6 37.9 29.1 33.4 21.8 28.5 53.9 48.5 40.5 33.3 48.9 35.8 28.6 44.3 32.3 39.7 44.9 39.0 45.6 42.4 43.2 61.0 52.7 56.8 45.5 9.3 60.6 43.5 40.3 57.2 54.4 22.3 25.3 24.5 29.0 22.1 23.4 24.9 24.2 24.8 22.8 24.3 29.5 14.4 12.8 12.8 7.2 15.5 7.8 11.5 33.5 10.8 12.6 17.5 15.2 30.5 18.6 18.1 14.7 14.6 73.0 12.9 16.1 46.9 32.3 59.8 17.8 12.1 15.4 15.0 17.5 5.7 20.0 45.6 16.5 11.7 11.3 17.2 24.0 15.4 42.4 46.3 5.0 7.8 17.0 22.4 12.8 10.1 23.1 16.4 13.6 23.2 3.7 29.0 18.0 23.7 6.6 17.5 11.0 23.9 18.8 11.0 11.2 35.8 66.7 22.4 15.6 6.6 16.3 14.4 34.7 14.8 14.3 8.9 58.3 15.0 32.8 28.1 10.9 COX7A2L "COX7AR, COX7RP, EB1, SIG81" ENSG00000115944 "Cytochrome c oxidase subunit 7A2 like" O14548 2 42333546-42425088 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059124, CAB073545" Enhanced Nucleoli,Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoli "CAB073545: , HPA059124: AB_2683912" "unprognostic (3.90e-1)" "unprognostic (1.02e-1)" "unprognostic (1.18e-1)" "unprognostic (5.45e-2)" "unprognostic (4.60e-2)" "unprognostic (1.27e-2)" "prognostic unfavorable (4.13e-5)" "unprognostic (1.17e-1)" "unprognostic (3.12e-1)" "unprognostic (1.66e-2)" "unprognostic (2.43e-1)" "unprognostic (7.07e-3)" "unprognostic (1.54e-2)" "unprognostic (2.76e-1)" "unprognostic (5.53e-2)" "unprognostic (6.19e-2)" "unprognostic (1.02e-1)" 79.5 222.7 53.9 18.7 57.5 56.9 78.3 53.1 62.5 93.0 56.1 84.0 32.5 74.8 42.8 60.8 81.0 22.7 102.6 56.2 56.9 130.2 113.9 64.0 32.3 54.8 53.2 127.6 89.8 71.8 128.0 22.8 55.9 71.6 39.2 62.4 67.2 32.4 83.3 72.1 66.0 28.0 53.0 65.9 99.9 54.5 54.8 42.0 56.6 39.3 35.0 74.2 70.4 53.4 72.1 50.7 49.0 54.0 92.4 121.8 55.8 58.2 85.8 51.5 66.0 56.9 48.9 63.1 54.8 71.9 70.0 30.3 65.5 65.9 80.1 99.5 47.5 46.0 31.9 95.5 106.2 66.5 42.5 123.7 128.6 55.5 132.6 78.5 77.4 49.7 64.1 101.1 83.9 68.6 75.3 96.8 45.3 91.6 48.1 40.7 87.5 51.6 84.6 57.4 55.8 63.7 25.7 60.4 166.1 58.2 43.2 73.3 60.1 45.4 61.2 55.3 57.1 84.1 98.7 46.0 63.1 68.8 39.9 103.7 78.6 43.2 57.9 71.1 75.6 72.6 70.4 67.1 84.4 61.9 77.8 67.0 34.1 69.1 80.1 99.0 87.3 189.3 53.9 57.5 53.1 62.5 56.2 56.9 54.8 53.2 55.9 53.0 54.8 53.4 150.7 32.1 76.3 11.4 152.5 265.6 197.9 387.2 135.5 114.8 206.8 237.6 158.7 171.6 173.4 149.0 37.5 228.1 163.4 103.8 645.6 239.1 27.4 189.5 133.3 144.0 288.7 188.7 28.2 229.5 316.2 128.5 123.8 175.9 87.0 155.8 132.1 222.3 234.0 131.2 26.1 285.8 282.8 236.3 225.1 26.3 161.8 161.6 220.5 19.7 298.4 326.8 166.9 13.6 24.5 202.1 173.0 158.7 167.7 214.2 247.1 492.4 160.9 123.6 111.7 137.6 175.2 220.4 270.8 162.7 245.5 329.6 161.8 296.2 257.0 241.7 CPS1 ENSG00000021826 "Carbamoyl-phosphate synthase 1" P31327 2 210477682-210679107 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Urea cycle" "Allosteric enzyme, Ligase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 1063.2" "Cell type enriched" "Detected in many" 19 "Hepatocytes: 2075.1" "Cancer enriched" "Detected in many" 8 "liver cancer: 136.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 347.6;SiHa: 65.1;SK-BR-3: 98.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB003781, HPA021400" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA 8300000 "Cluster 85: Liver - Metabolism" "Cluster 20: HeLa - Mitochondria" "Cluster 2: Hepatocytes - Metabolism" "Nucleoli, Nucleoli rim" "CAB003781: , HPA021400: AB_1847197" "unprognostic (1.67e-2)" "unprognostic (3.72e-2)" "unprognostic (4.02e-2)" "unprognostic (7.21e-7)" "unprognostic (3.81e-2)" "unprognostic (2.52e-1)" "prognostic favorable (6.93e-5)" "unprognostic (1.23e-2)" "unprognostic (2.65e-1)" "unprognostic (1.35e-2)" "unprognostic (5.38e-2)" "unprognostic (1.94e-3)" "unprognostic (2.38e-4)" "unprognostic (5.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.14e-2)" "unprognostic (3.74e-2)" 2.5 0.4 1.0 0.4 10.0 0.1 1.5 4.9 1.7 0.9 0.1 0.8 211.8 1.6 2.8 1.5 0.9 1.6 1.2 0.7 2.3 1.9 1063.2 1.0 0.3 6.9 8.7 2.9 0.8 0.1 0.9 2.5 6.0 0.8 0.4 0.3 0.5 0.8 0.6 1.4 123.4 2.1 3.4 1.2 0.6 6.0 5.8 0.3 1.7 0.5 0.2 0.6 0.7 6.3 0.9 9.7 14.0 11.7 11.6 16.5 18.0 6.1 6.4 6.3 9.2 1.8 0.0 2.7 0.4 5.3 9.6 3.0 0.5 10.8 15.9 0.0 4.5 10.0 347.6 15.2 2.8 4.0 0.0 9.2 6.2 12.8 13.0 18.7 0.4 4.2 10.3 0.8 10.4 2.8 0.3 0.7 6.3 0.0 1.8 0.7 14.6 1.6 13.2 0.2 0.5 1.1 65.1 98.9 8.1 20.0 0.1 1.6 7.7 17.5 5.8 5.9 13.0 0.0 0.7 0.0 12.5 11.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 10.0 4.9 1.7 0.7 2.3 6.9 8.7 6.0 3.4 5.8 6.3 0.4 12.8 8.4 6.2 3.6 2.2 0.6 0.9 1.2 1.4 1.3 1.5 1.1 15.7 3.9 1.8 8.4 0.4 0.4 0.1 0.0 0.2 35.5 1.0 2.1 2.0 0.0 18.7 12.1 0.2 0.4 2.6 0.0 1.6 3.8 0.3 16.8 2075.1 0.2 0.0 6.2 13.5 0.0 27.2 2.9 6.5 2.5 0.8 1.8 3.7 0.2 0.7 0.0 3.0 8.8 0.0 2.5 1.2 0.1 1.1 105.6 1.0 1.3 2.3 0.0 1.8 2.3 0.6 1.8 1.5 1.8 20.8 1.8 3.5 41.2 0.4 CRELD1 "AVSD2, CIRRIN" ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933816-9945406 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.3;hTERT-RPE1: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 32.7 37.3 63.6 11.4 63.5 9.3 24.8 69.1 94.4 27.7 59.1 57.5 14.0 31.3 17.0 18.0 34.9 16.5 73.2 63.9 65.7 43.0 57.1 27.5 12.4 64.7 63.0 32.5 27.6 22.7 70.9 17.9 66.3 47.6 12.1 16.4 26.3 34.5 48.9 20.1 25.9 22.2 58.6 28.6 35.6 23.6 65.5 10.5 67.6 26.4 9.2 33.6 24.4 68.2 6.4 8.1 19.3 8.8 30.1 17.6 110.3 26.7 8.0 6.1 11.7 11.1 20.7 8.4 57.6 17.7 27.7 4.5 10.4 17.6 4.9 15.2 9.2 7.3 15.2 28.2 68.7 3.3 29.3 21.7 32.3 15.2 13.6 77.2 28.8 11.1 9.5 10.4 6.1 15.5 3.6 19.3 5.7 30.1 6.6 4.8 3.1 21.6 25.9 9.9 6.9 26.7 12.6 10.3 24.3 27.5 27.9 17.0 21.7 12.1 19.5 16.2 6.3 10.7 14.2 15.2 27.3 7.8 13.0 12.3 10.2 9.3 11.9 9.8 12.2 7.9 8.9 11.5 6.9 8.7 11.3 10.4 1.8 13.8 12.9 12.3 7.2 9.5 63.6 63.5 69.1 94.4 63.9 65.7 64.7 63.0 66.3 58.6 65.5 68.2 24.7 19.2 17.5 43.4 14.1 9.7 26.2 48.5 15.9 21.5 17.5 15.0 41.9 31.5 24.0 16.5 16.7 23.7 15.1 10.9 7.9 19.6 6.8 10.3 7.0 20.2 27.0 7.8 38.0 4.4 11.5 20.1 19.4 12.9 21.0 18.8 19.2 14.9 20.6 32.0 37.1 19.1 38.7 8.8 9.0 10.1 32.0 10.0 12.4 15.0 13.9 18.3 27.8 14.6 21.7 8.7 20.4 26.4 15.3 31.4 18.8 11.1 13.2 15.8 26.3 11.0 17.1 68.0 26.5 9.6 12.4 22.2 15.4 11.2 15.4 20.2 CRISPLD2 "DKFZP434B044, LCRISP2, LGL1" ENSG00000103196 "Cysteine rich secretory protein LCCL domain containing 2" Q9H0B8 16 84819985-84920768 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 137.3;Fibroblasts: 185.5;Leydig cells: 271.5;Peritubular cells: 265.9;Skeletal myocytes: 146.2;Smooth muscle cells: 341.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "neutrophil: 87.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 87.2" "Cell line enhanced" "Detected in many" "ASC diff: 43.7;BEWO: 69.2;HHSteC: 161.4;HSkMC: 68.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 15.6" "HPA030054, HPA030055" Approved Approved Nucleoplasm,Nucleoli "Secreted to blood" No No 219000000000 "Cluster 1: Neutrophils - Mixed function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA030054: AB_2732452, HPA030055: AB_10611821" "unprognostic (8.91e-3)" "unprognostic (3.05e-1)" "unprognostic (2.63e-2)" "unprognostic (2.02e-2)" "unprognostic (7.12e-2)" "unprognostic (2.30e-1)" "unprognostic (2.11e-2)" "unprognostic (5.58e-3)" "unprognostic (1.48e-1)" "unprognostic (5.50e-2)" "unprognostic (2.67e-1)" "unprognostic (2.87e-2)" "prognostic unfavorable (1.97e-6)" "unprognostic (7.35e-3)" "unprognostic (3.38e-2)" "unprognostic (2.99e-3)" "unprognostic (5.15e-3)" 113.4 29.0 3.3 46.6 4.9 8.1 64.2 3.9 4.6 112.9 2.6 88.9 10.8 115.7 20.3 39.9 129.0 104.0 36.6 3.7 5.2 40.9 17.1 92.7 7.3 5.9 5.5 80.7 23.5 2.5 19.3 122.7 5.9 98.9 18.1 2.4 18.1 27.7 15.0 36.7 58.5 95.0 4.4 24.9 65.9 21.5 4.3 8.2 47.9 12.2 3.7 119.9 69.8 5.7 0.9 2.2 0.6 6.0 43.7 16.2 69.2 34.5 30.4 27.2 19.1 4.7 2.9 0.1 3.0 30.5 8.0 1.0 0.1 0.1 27.3 0.0 0.2 0.5 0.9 0.1 161.4 0.0 0.3 68.0 0.1 8.0 0.1 9.0 0.2 0.0 0.3 0.3 3.1 1.4 0.3 1.7 2.0 4.6 2.0 0.1 0.3 0.4 0.2 5.5 6.7 0.5 8.1 3.5 0.7 9.4 13.7 0.9 3.8 0.4 1.8 28.3 1.0 0.4 0.1 5.8 0.2 0.5 4.1 14.8 20.2 0.7 0.0 1.2 0.0 0.1 0.2 0.0 1.3 0.0 0.1 0.0 87.2 0.0 0.0 0.1 0.0 4.2 3.3 4.9 3.9 4.6 3.7 5.2 5.9 5.5 5.9 4.4 4.3 5.7 5.9 3.2 2.3 0.7 0.7 46.1 8.6 0.6 9.6 0.5 3.9 7.6 8.6 2.8 1.6 0.0 0.0 7.4 0.8 1.8 0.0 1.4 12.6 7.0 137.3 21.7 3.0 0.0 2.2 0.5 42.4 185.5 27.0 6.3 7.0 11.5 38.6 0.8 4.7 1.7 1.5 4.1 0.0 36.6 39.6 19.6 271.5 14.8 48.0 9.4 41.5 5.1 3.1 54.3 0.6 0.9 0.3 265.9 0.9 17.1 0.2 0.1 0.9 0.7 92.1 146.2 341.2 1.0 1.9 3.7 42.8 9.0 5.4 5.7 2.2 6.5 CSTB "CST6, EPM1, PME, STFB" ENSG00000160213 "Cystatin B" P04080 21 43772511-43776330 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "esophagus: 11304.7" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 2798.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017380, CAB047320, HPA058557" Enhanced Supported Nucleoli,Cytosol NA NA 8700000 "Cluster 51: Monocytes - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Cytosol Nucleoli "CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755" "unprognostic (1.69e-1)" "unprognostic (3.35e-1)" "unprognostic (2.09e-1)" "unprognostic (3.05e-2)" "unprognostic (3.05e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (6.66e-5)" "unprognostic (1.90e-1)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (1.27e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.10e-4)" "unprognostic (3.63e-1)" "unprognostic (4.88e-1)" "unprognostic (4.24e-2)" "unprognostic (1.24e-1)" 224.3 165.6 254.1 141.6 253.6 73.8 161.9 255.4 314.6 585.8 275.2 243.8 122.9 90.1 175.0 11304.7 154.1 150.7 192.2 252.8 263.0 144.7 189.4 290.1 176.4 258.4 257.8 136.1 116.2 154.4 70.1 132.1 259.6 137.3 194.7 78.9 738.3 138.6 100.1 256.9 135.6 110.4 257.5 125.8 249.9 71.7 262.8 268.2 147.9 197.4 1484.9 611.8 1001.9 262.9 1573.6 495.5 146.3 188.1 874.5 742.6 379.6 310.1 431.0 230.7 230.6 401.6 868.6 123.0 245.8 570.1 1814.0 260.5 384.4 405.7 153.5 529.0 388.4 332.4 385.3 473.8 753.0 85.5 267.1 754.5 439.6 621.2 314.7 389.3 331.2 111.8 276.9 681.1 359.7 431.4 100.1 267.6 336.0 1052.6 791.5 169.7 80.5 1472.0 669.1 2798.2 141.8 121.6 420.2 229.2 928.8 75.7 210.4 214.0 426.3 347.7 162.7 305.5 211.8 148.5 347.4 251.1 1432.5 430.2 242.3 390.1 505.5 313.1 242.9 840.3 224.5 198.5 315.4 255.4 766.1 172.7 221.0 217.6 445.6 152.4 1322.9 93.4 406.9 475.2 254.1 253.6 255.4 314.6 252.8 263.0 258.4 257.8 259.6 257.5 262.8 262.9 210.1 176.3 298.4 43.4 140.5 385.3 460.6 5910.7 191.2 69.8 317.8 345.1 105.7 268.8 4352.8 415.6 35.5 310.4 126.5 803.9 538.1 588.4 10.4 388.8 205.1 307.8 239.3 61.4 17.0 488.2 1199.4 238.6 297.7 458.8 228.2 131.5 250.6 464.5 2827.7 67.3 18.4 308.6 1462.8 483.4 1256.2 40.8 381.1 806.9 471.4 24.4 915.9 160.6 255.4 11.1 32.4 810.9 735.6 330.2 167.7 674.3 524.9 469.9 1997.3 72.9 118.3 86.5 320.0 33.7 111.7 4910.2 596.0 402.5 202.8 170.9 367.2 3198.3 CT45A1 "CT45-1, CT45.1" ENSG00000268940 "Cancer/testis antigen family 45 member A1" Q5HYN5 X 135713453-135723539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 7.8" "Group enriched" "Detected in some" 50 "Spermatocytes: 3.5;Spermatogonia: 6.7" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HMC-1: 246.0;Karpas-707: 112.8" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (6.58e-3)" "unprognostic (2.14e-1)" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 246.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 112.8 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 21.5 0.0 0.3 1.7 33.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.6 0.2 0.3 0.3 0.4 0.4 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A10 ENSG00000269586 "Cancer/testis antigen family 45 member A10" P0DMU9 X 135881063-135889086 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 9.2" "Cell type enriched" "Detected in some" 4 "Spermatogonia: 47.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 1.4" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 85.4;K-562: 26.9;Karpas-707: 94.7;U-266/84: 88.6" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" "unprognostic (3.55e-1)" "unprognostic (7.08e-3)" "unprognostic (2.08e-1)" 0.0 0.0 0.6 0.1 0.6 0.0 0.0 0.4 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.1 0.0 1.5 0.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 85.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 94.7 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 18.4 0.0 0.0 18.5 88.6 0.1 10.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.4 1.2 1.3 0.4 1.5 0.6 2.0 0.6 1.3 0.8 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A2 "CT45-2, CT45.2" ENSG00000271449 "Cancer/testis antigen family 45 member A2" Q5DJT8 X 135811668-135820012 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "RPMI-8226: 1.0" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 25: RPMI-8226 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A3 "CT45-3, CT45-4, CT45.3, CT45.4, CT45A4" ENSG00000269096 "Cancer/testis antigen family 45 member A3" Q8NHU0 X 135759846-135768191 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 9.5" "Cell type enhanced" "Detected in single" "Spermatogonia: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 94.7;T-47d: 63.5;U-266/84: 308.8" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.9 0.0 0.7 0.0 0.0 0.7 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.6 0.0 1.2 0.8 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 9.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 94.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.2 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.5 0.4 0.0 0.0 2.3 0.0 0.0 0.4 308.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.7 1.1 0.8 0.8 1.2 0.8 1.0 0.6 0.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A5 "CT45-5, CT45.5" ENSG00000228836 "Cancer/testis antigen family 45 member A5" P0DMU8 X 135777130-135785298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.8;pituitary gland: 1.9;testis: 3.5" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 1.3;Spermatogonia: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-266/84: 195.1" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.3 0.0 2.7 0.0 0.0 0.2 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.0 0.6 2.8 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.1 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 6.4 0.0 0.1 2.0 195.1 0.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 1.0 0.5 1.2 0.6 2.8 1.7 0.3 0.6 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A6 "CT45-6, CT45.6" ENSG00000278289 "Cancer/testis antigen family 45 member A6" P0DMU7 X 135794685-135802787 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 1.2;testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.1;HMC-1: 3.0;Karpas-707: 2.6;RPMI-8226: 4.5;U-266/84: 13.7" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 58: Brain - Synaptic function" "Cluster 16: U-266 - Nucleosome" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.9 0.3 0.3 0.5 0.3 0.5 0.2 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A7 ENSG00000273696 "Cancer/testis antigen family 45 member A7" P0DMV0 X 135829247-135837268 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "U-266/84: 70.4" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 16: U-266 - Nucleosome" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 70.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A8 ENSG00000278085 "Cancer/testis antigen family 45 member A8" P0DMV1 X 135846497-135854538 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HMC-1: 115.3" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 3: HMC-1 - Innate immune response" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 115.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CT45A9 ENSG00000270946 "Cancer/testis antigen family 45 member A9" P0DMV2 X 135863418-135871812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 29.9;HMC-1: 111.3;U-266/84: 49.2" "HPA044735, HPA044757, HPA046872, HPA046987" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Nucleoplasm, Nucleoli" "HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 111.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.8 49.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.3 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CTSB ENSG00000164733 "Cathepsin B" P07858 8 11842524-11869533 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 2744.5;Kupffer cells: 1774.9;Macrophages: 1224.3" "Cancer enriched" "Detected in all" 5 "thyroid cancer: 1446.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 390.6;classical monocyte: 610.1;intermediate monocyte: 467.3;myeloid DC: 287.4;non-classical monocyte: 307.6;plasmacytoid DC: 410.1" "Group enriched" "Detected in all" 6 "dendritic cells: 410.1;granulocytes: 390.6;monocytes: 610.1" "Cell line enhanced" "Detected in all" "BJ hTERT+: 1607.5;fHDF/TERT166: 1436.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000457, HPA018156, HPA048998" Enhanced Supported Nucleoli,Vesicles "Secreted to blood" NA NA 100000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 4: Macrophages - Innate immune response" Vesicles Nucleoli "CAB000457: , HPA018156: AB_1846069, HPA048998: " "unprognostic (5.74e-2)" "unprognostic (4.32e-2)" "unprognostic (1.38e-2)" "unprognostic (2.17e-2)" "unprognostic (2.98e-3)" "unprognostic (5.96e-2)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" "unprognostic (2.82e-2)" "unprognostic (1.06e-1)" "unprognostic (7.61e-2)" "unprognostic (8.30e-2)" "unprognostic (2.85e-1)" "unprognostic (7.39e-2)" "unprognostic (4.12e-2)" "prognostic favorable (5.76e-4)" "prognostic unfavorable (9.02e-4)" 443.9 304.5 65.6 399.7 71.2 87.0 249.0 65.9 77.2 583.2 101.0 312.4 120.8 379.2 116.9 421.6 368.4 230.6 447.0 64.7 95.5 420.6 497.2 428.9 289.6 100.4 90.8 169.1 135.4 79.6 156.8 253.2 107.4 255.5 159.3 33.6 437.3 156.6 237.4 184.7 260.2 316.1 91.9 521.1 194.3 33.2 204.5 60.9 1150.7 99.3 104.0 431.9 477.8 159.2 66.6 283.4 4.0 94.9 657.3 754.5 128.3 885.0 1607.5 258.4 299.5 10.3 294.4 1.5 32.2 1436.1 419.3 279.5 65.3 157.1 195.6 25.9 52.6 58.8 10.0 397.1 479.2 7.7 73.7 296.4 532.2 327.2 427.3 611.5 33.4 20.2 81.7 260.7 194.6 62.5 6.5 23.1 16.3 839.7 91.3 33.6 39.3 202.7 2.6 121.1 4.9 68.6 165.1 68.6 514.6 110.1 97.8 68.7 922.4 766.5 111.9 129.9 259.3 182.7 178.5 4.8 432.5 22.9 249.4 390.6 610.1 90.6 26.3 467.3 35.4 44.1 79.0 31.5 287.4 38.8 48.3 21.5 97.8 31.3 307.6 410.1 78.7 703.7 65.6 71.2 65.9 77.2 64.7 95.5 100.4 90.8 107.4 91.9 204.5 159.2 87.7 109.0 171.4 17.6 54.8 54.7 441.6 563.2 54.7 55.2 94.1 74.5 320.1 165.8 331.7 114.0 41.7 279.4 122.4 147.9 27.4 294.6 15.6 105.8 240.1 163.0 154.7 210.2 36.2 238.2 341.7 155.0 44.4 183.5 179.4 105.9 204.2 239.5 2744.5 58.9 42.8 94.2 158.7 1774.9 436.5 18.5 76.4 1224.3 161.9 70.3 373.1 117.4 24.7 19.1 12.9 363.9 154.0 92.9 47.3 295.5 198.6 351.8 180.8 40.0 39.5 39.4 149.9 10.8 21.0 160.3 40.5 649.6 56.0 32.1 139.6 321.4 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 466.3;Late spermatids: 567.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "CAB002676: , HPA064584: AB_2685294" "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 33.2 27.3 19.6 29.4 20.9 15.5 30.2 20.4 26.5 28.1 22.2 38.9 23.0 29.8 28.8 30.6 29.4 23.2 35.9 22.1 23.0 21.6 45.1 26.3 39.0 20.4 21.2 30.9 20.6 36.3 25.6 32.7 20.4 27.3 24.5 52.1 26.1 30.1 88.8 28.8 27.3 32.2 21.8 30.0 29.7 95.1 21.3 30.3 27.4 74.6 35.6 34.9 26.6 21.7 79.9 61.6 59.5 93.6 46.6 51.6 72.8 64.8 77.7 65.8 61.4 64.5 53.9 109.6 49.5 65.9 104.4 52.5 87.0 59.9 76.4 72.8 71.9 65.2 39.6 64.5 50.5 74.8 58.9 40.0 58.5 45.9 46.0 59.9 71.3 52.8 100.8 78.2 72.2 76.4 64.1 81.0 111.6 68.6 58.8 78.7 52.3 106.3 54.2 55.4 83.3 61.0 74.5 92.3 51.4 69.9 29.0 57.5 56.6 44.1 15.4 87.7 75.8 70.4 54.2 96.7 94.3 82.5 66.2 15.5 17.0 14.1 16.5 18.3 21.8 17.3 18.9 21.2 26.6 15.0 22.4 18.5 1.4 27.9 18.5 6.7 18.5 20.0 19.6 20.9 20.4 26.5 22.1 23.0 20.4 21.2 20.4 21.8 21.3 21.7 24.0 35.3 40.9 41.4 26.0 27.9 31.1 19.5 22.2 33.4 13.8 17.5 29.2 12.8 32.2 9.2 29.2 66.6 19.1 12.0 17.6 28.1 466.3 20.4 23.4 25.1 15.6 23.1 76.3 26.2 77.1 29.9 19.4 21.9 23.4 31.6 18.5 41.5 29.8 21.9 89.5 19.7 22.4 18.5 16.8 567.7 21.8 25.7 28.4 60.9 51.7 32.7 37.0 52.8 74.3 28.5 15.0 30.5 25.3 29.8 11.7 13.5 33.6 48.9 32.9 30.3 38.9 59.6 34.0 20.6 25.4 73.2 26.5 24.1 18.8 21.7 CUZD1 "ERG-1, UO-44" ENSG00000138161 "CUB and zona pellucida like domains 1" Q86UP6 10 122832158-122846175 "Predicted membrane proteins" "Cell adhesion, Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 1631 "pancreas: 2414.2" "Cell type enriched" "Detected in some" 6 "Exocrine glandular cells: 266.9" "Cancer enriched" "Detected in some" 54 "pancreatic cancer: 32.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 1.9;U-937: 1.2" "Not detected" "Not detected" "HPA068479, HPA068660, HPA074117" Enhanced Approved Nucleoli,Vesicles No No "Cluster 25: Pancreas - Digestion" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Vesicles "HPA068479: AB_2685995, HPA068660: AB_2686015, HPA074117: AB_2686663" "unprognostic (4.68e-2)" "unprognostic (3.48e-2)" "unprognostic (1.53e-2)" "unprognostic (1.52e-5)" "unprognostic (8.08e-2)" "unprognostic (5.20e-3)" "unprognostic (1.16e-4)" "unprognostic (4.19e-2)" "unprognostic (3.03e-2)" "unprognostic (5.15e-2)" "unprognostic (8.46e-2)" "unprognostic (6.64e-3)" "unprognostic (2.75e-3)" "unprognostic (4.48e-1)" "unprognostic (1.38e-1)" "unprognostic (1.56e-1)" "unprognostic (4.83e-4)" 0.4 0.2 0.2 0.2 0.3 0.8 0.4 0.2 0.5 0.6 0.2 0.6 0.5 0.4 0.4 0.5 0.4 0.0 0.4 0.3 0.2 0.9 0.2 0.5 0.2 0.2 0.2 1.0 2414.2 0.0 1.4 0.1 0.4 0.7 0.0 0.4 0.5 0.0 0.1 0.7 0.9 0.0 0.2 1.1 0.4 1.0 0.2 0.3 0.5 0.0 0.0 0.5 0.5 0.3 0.3 0.5 0.1 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.7 0.0 0.1 0.1 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.9 0.1 0.2 0.3 0.3 0.3 1.0 0.1 0.4 0.3 0.4 0.4 0.0 0.0 0.4 0.0 0.4 0.1 0.4 0.2 0.3 0.0 0.3 0.5 0.4 0.6 0.5 0.0 0.5 0.2 0.0 0.0 0.4 0.8 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.2 0.5 0.3 0.2 0.2 0.2 0.4 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.2 0.6 0.2 0.0 0.0 0.7 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 2.8 0.1 0.1 0.1 0.0 0.4 0.0 266.9 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 5.0 0.0 0.1 0.0 0.3 0.3 6.7 0.3 0.1 0.0 0.0 3.7 0.1 0.0 0.0 0.0 43.6 0.1 0.4 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.4 0.1 0.7 0.2 0.0 0.1 0.0 0.7 0.1 0.2 0.1 CYB561A3 CYBASC3 ENSG00000162144 "Cytochrome b561 family member A3" Q8NBI2 11 61348754-61362283 "Predicted membrane proteins" "Electron transport, Transport" "Oxidoreductase, Translocase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 251.4" "Cell type enhanced" "Detected in all" "dendritic cells: 145.1;Melanocytes: 320.2;Theca cells: 128.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 8 "memory B-cell: 314.5;naive B-cell: 386.6;plasmacytoid DC: 841.4" "Group enriched" "Detected in all" 9 "B-cells: 386.6;dendritic cells: 841.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045674, HPA052548" Approved Approved Nucleoli,Vesicles NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles Nucleoli "HPA045674: , HPA052548: AB_2681866" "unprognostic (2.61e-1)" "unprognostic (8.78e-2)" "unprognostic (4.16e-1)" "unprognostic (3.62e-2)" "unprognostic (1.37e-1)" "unprognostic (9.41e-3)" "unprognostic (7.41e-3)" "unprognostic (2.48e-1)" "unprognostic (1.90e-1)" "unprognostic (2.12e-1)" "unprognostic (2.22e-2)" "unprognostic (3.73e-1)" "unprognostic (2.53e-1)" "unprognostic (2.83e-1)" "unprognostic (3.71e-2)" "unprognostic (1.19e-1)" "unprognostic (1.80e-3)" 19.5 251.4 10.2 32.6 11.5 26.0 17.3 10.5 10.7 17.1 17.4 33.3 19.2 24.1 18.7 19.6 30.4 27.5 12.3 11.0 10.1 15.3 31.0 21.3 70.3 13.0 13.7 27.1 24.4 21.5 13.8 17.3 12.6 20.9 27.8 11.4 21.8 19.8 26.1 76.0 27.8 18.8 12.3 49.7 20.8 13.6 12.1 28.1 18.5 17.7 70.4 22.9 16.2 14.0 50.2 80.6 13.4 40.6 67.8 41.9 11.3 26.0 37.3 29.8 28.9 22.6 54.3 98.1 42.1 46.2 24.0 67.5 13.6 72.2 20.1 64.5 28.5 18.3 53.6 16.5 32.0 24.9 42.3 63.4 95.7 65.3 30.0 25.0 44.1 46.1 55.5 57.3 51.2 53.3 45.7 11.4 24.5 44.7 51.9 52.2 14.0 72.6 35.2 48.1 16.2 26.1 54.7 71.5 60.5 9.6 58.6 29.3 31.7 34.2 17.8 34.2 35.6 34.3 49.9 56.8 50.6 44.2 46.4 19.4 66.4 35.5 31.0 53.8 28.6 314.5 22.1 29.2 63.5 386.6 23.5 24.6 21.8 31.5 64.0 841.4 23.6 84.8 10.2 11.5 10.5 10.7 11.0 10.1 13.0 13.7 12.6 12.3 12.1 14.0 13.0 6.4 22.8 6.8 96.2 28.3 18.3 86.6 19.9 15.9 19.6 18.7 1.9 10.0 30.0 12.9 31.3 49.9 145.1 53.6 11.7 26.2 53.6 15.4 12.0 13.5 19.2 14.1 4.3 38.8 39.5 16.4 21.4 7.5 8.8 13.0 15.4 21.0 51.4 18.5 4.1 28.9 22.4 23.8 21.2 14.2 20.8 47.9 320.2 8.4 57.1 23.7 28.8 5.5 7.2 26.6 48.9 20.7 10.5 15.9 55.6 13.7 72.0 56.2 13.1 14.8 15.8 7.2 11.5 18.4 24.0 39.5 18.7 128.9 30.7 16.2 CYB5D1 FLJ32499 ENSG00000182224 "Cytochrome b5 domain containing 1" Q6P9G0 17 7857746-7862282 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.9;Endometrial ciliated cells: 45.5;Late spermatids: 42.6;Respiratory ciliated cells: 47.3;Skeletal myocytes: 41.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021632 Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 30: Non-specific - Translation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Golgi apparatus" "HPA021632: AB_1847368" "unprognostic (1.99e-1)" "unprognostic (2.91e-1)" "unprognostic (1.23e-1)" "unprognostic (5.10e-3)" "unprognostic (2.34e-1)" "unprognostic (4.44e-3)" "unprognostic (1.12e-1)" "unprognostic (2.16e-2)" "unprognostic (1.34e-1)" "unprognostic (2.69e-2)" "unprognostic (2.89e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-4)" "unprognostic (2.38e-2)" "unprognostic (1.25e-1)" "unprognostic (5.27e-3)" "unprognostic (1.79e-2)" 17.2 13.0 8.6 5.5 9.4 7.8 12.1 9.6 9.7 10.2 16.0 9.4 6.2 10.1 15.2 8.2 26.4 8.7 15.0 9.0 10.1 17.9 12.6 8.3 4.8 10.0 10.8 13.0 11.4 10.8 16.6 6.6 9.0 11.3 7.1 30.0 10.3 11.6 10.6 9.6 6.3 8.7 9.3 6.0 8.8 8.8 11.5 7.5 21.3 13.6 5.4 7.4 7.8 8.0 24.6 17.9 8.5 22.4 14.8 13.0 5.0 12.5 12.2 13.0 12.4 11.3 4.6 10.5 8.6 10.0 7.6 21.3 18.9 16.1 19.4 7.1 21.9 6.9 24.6 16.3 6.7 12.4 4.7 11.2 19.9 22.8 20.2 8.0 14.0 25.3 5.2 7.0 7.3 10.7 19.5 5.0 10.7 16.0 18.2 13.2 3.9 10.7 20.4 4.7 11.4 7.6 19.9 10.8 11.6 8.5 12.6 5.0 9.9 9.9 8.7 17.8 15.9 3.7 9.7 5.8 20.8 6.7 6.5 0.3 0.9 0.0 1.0 0.7 1.1 1.2 0.8 0.5 1.2 0.5 2.1 1.1 0.9 0.6 0.4 0.5 0.8 0.7 8.6 9.4 9.6 9.7 9.0 10.1 10.0 10.8 9.0 9.3 11.5 8.0 21.8 12.8 19.5 5.9 4.5 5.1 6.7 4.9 1.8 4.8 22.2 18.4 0.3 7.2 11.0 5.5 20.9 4.2 7.7 5.0 13.7 4.2 71.9 45.5 16.3 14.7 6.0 0.8 6.8 3.1 2.7 13.2 13.3 27.2 10.8 4.6 6.8 8.3 3.9 1.7 5.9 8.5 4.1 1.6 4.3 42.6 4.7 29.1 5.4 2.8 0.3 6.7 0.0 0.5 2.2 7.7 4.5 3.8 5.1 7.8 4.5 11.9 47.3 20.3 6.6 41.9 7.5 4.4 2.7 8.5 6.1 2.6 4.4 2.9 8.3 2.5 CYTH1 "B2-1, cytohesin-1, D17S811E, PSCD1" ENSG00000108669 "Cytohesin 1" Q15438 17 78674048-78782297 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 98.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047498 Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Nucleoli "HPA047498: " "unprognostic (3.82e-3)" "unprognostic (5.49e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (1.63e-1)" "prognostic favorable (6.48e-4)" "unprognostic (6.60e-2)" "unprognostic (3.47e-2)" "unprognostic (3.26e-1)" "unprognostic (9.69e-2)" "unprognostic (4.94e-2)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (2.21e-2)" "unprognostic (4.14e-2)" "unprognostic (1.27e-1)" "unprognostic (1.10e-1)" 30.5 26.2 41.1 52.4 53.2 69.0 23.4 45.5 45.2 16.1 38.0 30.1 22.6 12.5 8.6 50.8 16.4 25.7 31.0 40.3 45.5 22.8 33.8 44.5 78.9 52.3 50.8 10.2 29.3 10.7 14.8 27.1 51.7 24.6 32.9 82.9 32.0 8.1 35.9 31.3 41.3 16.6 44.3 57.5 43.0 15.8 50.2 58.9 26.2 22.9 89.0 25.0 25.6 68.5 24.6 16.9 16.6 14.3 11.2 14.1 15.9 11.4 10.0 13.6 15.9 10.7 26.8 18.2 11.1 15.0 23.3 21.2 8.1 29.6 10.9 38.4 22.5 7.4 22.9 19.8 8.0 15.3 70.5 6.9 23.9 15.5 15.9 9.3 44.4 59.9 12.4 68.1 16.3 12.5 98.7 13.6 4.2 39.7 14.9 25.9 18.4 64.3 14.8 16.9 9.5 34.6 20.0 38.2 16.6 16.7 18.8 17.7 21.2 10.7 15.6 17.1 11.8 78.5 39.0 66.0 7.9 15.1 11.4 150.2 41.6 85.6 96.5 51.5 69.1 63.6 79.6 78.5 35.9 55.4 86.4 74.7 85.9 59.0 48.8 49.3 66.2 93.6 41.1 53.2 45.5 45.2 40.3 45.5 52.3 50.8 51.7 44.3 50.2 68.5 65.9 60.9 52.1 48.3 83.4 41.2 31.0 28.1 45.5 65.5 18.4 14.9 18.8 18.6 34.5 5.5 110.5 3.0 123.6 50.4 7.9 12.1 29.6 62.6 17.4 58.9 27.6 11.2 29.9 18.5 8.3 16.5 58.6 110.3 36.0 13.7 27.8 28.7 48.9 43.7 58.9 49.3 34.6 80.2 135.1 46.1 4.4 76.8 37.4 61.8 121.7 21.1 122.6 52.3 170.9 42.7 32.8 5.3 88.6 39.0 16.3 6.9 50.5 78.3 6.6 8.6 10.4 16.0 15.6 54.8 34.4 7.3 113.1 10.6 20.6 58.4 DCTN3 DCTN-22 ENSG00000137100 "Dynactin subunit 3" O75935 9 34613545-34620523 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044905 Approved Approved Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoli "HPA044905: AB_10960996" "unprognostic (3.38e-1)" "unprognostic (4.13e-2)" "unprognostic (3.47e-1)" "unprognostic (6.79e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-1)" "unprognostic (2.92e-3)" "unprognostic (9.88e-2)" "unprognostic (4.41e-2)" "prognostic favorable (2.10e-5)" "unprognostic (1.26e-3)" "unprognostic (4.24e-3)" "prognostic favorable (5.76e-11)" "unprognostic (3.06e-1)" "unprognostic (2.25e-1)" "unprognostic (3.22e-1)" "unprognostic (4.43e-2)" 72.9 87.9 98.3 33.7 104.6 107.3 72.2 97.0 123.5 80.6 92.9 81.1 42.0 72.9 46.8 98.5 66.4 38.7 127.1 106.0 103.3 88.6 67.0 60.8 48.0 97.1 97.2 78.7 76.5 94.4 108.4 40.7 102.4 68.2 39.0 57.0 69.2 51.4 152.5 111.1 51.1 53.6 94.1 58.7 75.6 36.3 100.3 81.3 71.5 114.4 59.0 69.5 79.2 95.6 147.1 120.7 110.1 115.6 95.1 132.3 45.1 122.7 112.8 166.4 130.2 77.7 53.8 67.0 74.6 161.8 58.4 57.4 101.0 128.3 105.6 211.9 126.5 44.9 202.9 68.5 102.6 118.8 131.3 117.5 109.4 115.6 75.0 81.4 111.1 123.6 54.2 135.3 147.4 120.9 151.4 320.0 33.4 61.0 192.7 75.2 59.7 93.4 81.5 51.2 36.5 93.3 90.9 82.7 48.0 32.2 110.6 134.5 102.7 104.6 84.1 120.1 121.0 90.6 126.0 45.5 164.1 68.6 217.4 235.2 131.1 187.4 99.9 139.4 92.1 88.4 106.0 106.8 133.8 94.7 83.6 98.9 114.4 102.2 150.3 136.1 179.1 152.5 98.3 104.6 97.0 123.5 106.0 103.3 97.1 97.2 102.4 94.1 100.3 95.6 103.7 32.1 38.3 13.1 61.3 101.6 111.8 180.7 82.0 83.2 97.3 146.9 86.1 77.2 91.8 80.9 25.0 128.8 105.6 74.1 207.4 127.5 14.3 78.6 98.8 79.2 74.7 115.7 16.8 154.6 111.9 97.9 56.6 67.1 87.5 82.4 88.5 84.9 133.8 74.0 16.2 64.9 91.6 88.8 99.0 21.1 103.5 76.8 149.4 5.6 94.9 212.9 125.7 7.5 16.8 126.7 84.5 122.6 89.1 54.7 89.0 240.2 95.0 96.7 59.2 82.0 150.5 82.2 72.9 109.9 142.6 99.7 95.7 143.2 61.6 96.6 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103050686-103092194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 15.8 14.6 11.9 4.2 12.7 4.7 13.2 16.6 17.5 11.3 7.9 11.3 1.4 11.1 3.8 21.4 10.3 1.8 23.9 13.3 12.8 14.3 13.7 11.0 5.1 11.8 13.0 9.1 14.2 3.0 13.0 3.3 12.1 11.3 2.2 7.5 12.2 3.0 31.3 11.8 9.4 2.7 13.2 12.3 13.3 18.5 13.5 4.5 9.2 7.7 4.1 11.9 12.1 13.0 18.2 14.5 18.8 16.3 11.6 13.2 10.0 17.9 6.8 9.0 12.7 51.2 24.8 8.0 32.8 13.3 29.0 21.3 24.3 24.0 16.1 9.7 22.4 21.6 16.2 22.3 18.7 33.7 12.4 7.6 23.8 17.7 22.8 18.3 18.1 32.6 26.3 0.1 10.5 21.6 24.4 46.5 24.5 33.6 32.9 9.5 15.1 22.4 15.4 33.9 12.8 11.0 10.0 21.8 21.4 25.1 20.4 22.4 4.0 12.4 14.8 16.6 17.6 7.8 12.5 33.0 7.9 31.4 13.0 12.8 6.6 6.5 8.7 8.5 10.2 11.3 10.8 9.5 9.5 9.3 9.3 10.3 2.5 15.1 7.1 11.1 11.8 9.3 11.9 12.7 16.6 17.5 13.3 12.8 11.8 13.0 12.1 13.2 13.5 13.0 24.9 16.0 11.0 26.8 30.2 79.5 63.2 101.6 38.1 11.7 34.4 36.2 30.7 15.7 42.8 9.2 8.4 57.2 29.3 8.2 49.0 59.5 5.0 26.5 38.2 27.2 14.4 52.1 50.7 55.6 88.6 35.6 21.9 25.3 15.8 37.3 16.1 25.3 44.7 6.7 39.6 17.9 67.1 29.8 32.4 8.4 14.3 22.7 30.2 15.9 26.5 18.9 15.5 25.6 27.5 63.1 12.2 19.5 52.8 92.6 8.6 39.2 28.0 14.1 26.3 31.5 74.6 121.6 119.8 59.0 83.7 43.8 30.9 59.8 23.2 73.0 DCXR "DCR, HCR2, KIDCR, P34H, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 1851.6" "Cell type enhanced" "Detected in all" "Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4" "Group enriched" "Detected in all" 5 "liver cancer: 305.9;prostate cancer: 163.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 365.2;MCF7: 446.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 4000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 106.7 43.9 93.1 15.2 95.3 25.3 107.6 102.5 111.1 52.0 84.4 49.6 29.2 39.5 281.3 96.6 59.2 10.8 132.7 87.6 100.7 239.9 1851.6 61.0 16.6 102.4 98.0 70.0 71.6 46.1 63.9 20.2 105.9 138.0 20.9 9.7 103.4 33.6 187.3 87.6 44.4 10.4 91.8 35.8 167.0 44.8 105.9 26.1 60.7 80.6 19.6 48.9 62.1 94.9 50.3 68.2 32.8 56.4 123.2 31.8 80.4 25.0 33.9 68.5 48.4 122.0 21.3 100.3 47.4 35.9 9.4 57.4 59.6 52.6 24.1 21.4 145.9 96.9 48.8 365.2 143.2 75.6 114.5 44.6 62.2 22.7 79.8 16.0 41.1 61.1 112.4 76.3 36.5 446.2 63.7 184.1 35.0 242.9 71.3 57.9 42.0 135.3 53.3 71.9 85.5 51.0 35.5 287.5 46.0 19.7 213.4 74.5 20.5 36.6 45.0 48.9 48.2 73.7 56.2 50.2 31.4 83.0 26.7 49.5 92.6 77.9 66.5 92.0 64.1 86.8 83.0 64.7 151.3 99.2 117.7 85.4 47.2 108.9 88.1 121.6 98.9 110.1 93.1 95.3 102.5 111.1 87.6 100.7 102.4 98.0 105.9 91.8 105.9 94.9 29.0 51.3 198.2 16.6 133.6 58.5 200.3 113.5 109.8 16.0 301.8 269.2 120.7 183.0 123.4 178.4 18.8 372.1 116.6 152.9 812.0 41.4 6.0 67.0 50.9 44.6 54.7 335.7 4.7 42.6 450.6 65.0 151.4 102.3 64.7 62.7 138.5 3510.3 164.7 21.9 9.0 170.4 189.2 165.7 65.6 22.6 70.8 82.3 179.7 1.9 52.8 145.1 78.2 5.5 10.5 30.4 135.7 47.4 98.6 215.2 158.9 2919.4 55.4 26.5 19.7 40.6 79.6 10.3 48.2 219.9 73.2 342.6 135.7 118.6 154.6 178.8 DDA1 "C19orf58, MGC2594, PCIA1" ENSG00000130311 "DET1 and DDB1 associated 1" Q9BW61 19 17309518-17323298 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 416.9;Syncytiotrophoblasts: 253.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042134, HPA055272" Approved Approved Nucleoplasm,Nucleoli No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA042134: AB_10794169, HPA055272: AB_2682767" "unprognostic (1.30e-1)" "unprognostic (6.35e-3)" "unprognostic (3.13e-2)" "unprognostic (1.49e-3)" "unprognostic (5.38e-2)" "unprognostic (1.26e-2)" "unprognostic (3.41e-2)" "unprognostic (4.28e-2)" "unprognostic (1.92e-1)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (8.55e-2)" "unprognostic (1.48e-1)" "unprognostic (4.38e-2)" "unprognostic (6.33e-2)" "unprognostic (1.45e-1)" "unprognostic (3.15e-3)" 7.9 11.5 15.8 5.1 14.4 7.1 7.8 12.2 19.9 7.8 10.4 11.5 5.7 8.6 3.4 10.9 8.4 4.0 12.0 14.7 15.3 9.8 10.9 9.6 6.2 14.0 15.0 7.3 6.8 6.1 8.0 8.0 14.4 10.0 4.8 3.8 8.7 5.4 9.5 13.0 11.2 4.2 13.1 9.9 10.1 10.1 15.2 7.3 7.9 5.0 4.7 9.3 8.0 13.2 15.6 13.5 10.1 8.2 10.5 7.5 15.6 10.1 13.0 15.4 14.1 12.0 13.8 6.0 13.7 10.6 7.3 13.2 7.5 15.0 7.8 9.9 19.4 7.2 11.1 11.5 12.5 8.3 14.2 11.5 17.5 9.3 8.7 9.5 9.1 13.9 8.9 10.7 8.4 7.8 17.5 12.7 11.7 16.0 22.3 11.0 7.8 10.3 12.6 11.5 10.4 15.2 7.3 17.8 9.5 6.1 9.0 11.6 13.7 10.6 8.7 26.9 14.6 12.8 18.2 8.6 23.3 14.4 10.6 3.0 3.8 6.4 4.2 4.3 3.6 3.7 3.5 4.2 3.2 3.2 3.9 3.9 4.0 3.4 3.8 6.8 4.8 3.4 15.8 14.4 12.2 19.9 14.7 15.3 14.0 15.0 14.4 13.1 15.2 13.2 24.4 28.9 14.1 13.4 26.3 54.6 38.6 84.0 30.1 18.4 41.8 30.5 17.1 11.5 54.2 27.6 12.5 140.5 38.5 70.4 39.2 77.2 416.9 48.6 32.8 26.4 20.3 29.9 10.4 46.4 152.8 26.8 34.7 53.7 38.7 25.2 20.3 26.3 65.0 13.5 9.8 43.4 54.9 22.4 36.8 130.3 22.4 34.2 30.2 7.5 57.2 34.1 58.7 4.5 10.8 139.6 79.9 27.1 31.8 41.4 47.4 55.1 43.7 19.0 19.7 19.5 36.0 107.7 40.0 36.8 61.8 253.5 34.2 31.5 28.6 89.5 DDRGK1 "C20orf116, dJ1187M17.3, UFBP1" ENSG00000198171 "DDRGK domain containing 1" Q96HY6 20 3190350-3204685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" Dwarfism "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013373, HPA013705" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 24000 "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA013373: AB_2091955, HPA013705: AB_2668872" "unprognostic (2.99e-1)" "unprognostic (1.55e-1)" "unprognostic (3.42e-2)" "unprognostic (1.60e-1)" "unprognostic (6.54e-3)" "unprognostic (2.14e-1)" "unprognostic (1.19e-2)" "unprognostic (1.63e-1)" "unprognostic (4.10e-3)" "unprognostic (8.16e-2)" "unprognostic (5.44e-3)" "unprognostic (7.29e-2)" "prognostic favorable (2.01e-5)" "unprognostic (6.80e-3)" "unprognostic (1.43e-2)" "unprognostic (2.48e-2)" "unprognostic (6.90e-2)" 44.6 89.1 43.2 23.8 44.6 24.8 45.5 38.9 65.7 50.8 36.7 43.3 43.4 43.5 20.0 46.0 49.0 22.4 38.4 42.3 36.8 51.2 77.9 51.6 23.6 39.7 38.8 48.9 84.1 54.7 36.6 25.9 39.5 45.7 19.2 43.2 61.7 32.2 58.2 53.0 44.9 19.9 33.5 36.3 63.0 34.8 37.5 18.6 51.3 14.1 17.0 43.5 44.6 48.4 108.5 133.3 32.3 60.6 71.7 27.2 46.6 67.2 31.9 40.6 44.1 105.7 76.7 64.3 53.6 37.5 77.9 118.2 33.5 100.6 14.8 44.0 62.8 54.4 45.6 186.1 97.9 62.1 56.6 42.8 96.2 77.8 55.2 44.8 37.5 45.3 77.0 74.8 26.4 59.2 42.9 115.5 40.1 73.6 60.8 55.9 28.7 98.6 66.7 99.8 71.4 44.1 69.2 192.7 65.6 19.2 82.0 37.6 57.2 64.9 28.8 46.3 104.2 55.8 67.7 27.3 18.0 51.6 38.9 23.1 36.9 45.6 33.3 25.3 32.7 26.9 35.0 35.6 36.8 26.3 30.8 30.5 9.5 24.6 23.2 57.3 36.2 25.9 43.2 44.6 38.9 65.7 42.3 36.8 39.7 38.8 39.5 33.5 37.5 48.4 57.3 44.8 53.9 19.9 35.1 26.3 68.8 119.0 44.3 47.9 77.1 72.3 31.3 91.5 114.3 69.9 64.6 127.5 50.9 105.8 19.6 147.0 42.2 54.8 42.6 54.1 53.4 26.5 28.6 178.8 65.1 49.3 54.0 79.0 27.3 34.8 50.0 125.6 119.3 52.2 13.9 72.2 154.6 60.9 36.0 21.1 55.9 54.2 39.2 7.5 67.8 73.7 64.9 6.0 28.4 145.0 125.3 68.8 60.5 75.7 216.3 80.5 81.6 108.3 65.7 39.1 115.6 38.7 23.6 64.0 38.8 146.0 44.7 70.0 92.7 75.0 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073860-31104799 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065197 Supported Supported Nucleoplasm,Nucleoli No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 5.9 6.4 6.0 10.2 6.8 29.2 7.2 6.9 7.3 10.7 7.1 9.6 8.0 7.5 4.3 9.5 8.0 5.9 5.3 6.0 6.1 9.2 9.3 6.1 13.2 6.9 6.4 11.0 17.5 5.8 9.4 5.4 6.9 10.0 10.1 6.6 8.6 5.3 10.6 16.7 13.4 3.6 6.1 13.8 9.6 8.8 6.7 24.0 8.0 6.6 11.1 6.9 9.8 6.9 36.5 35.0 42.2 34.5 5.8 11.0 58.7 21.8 10.4 25.2 28.5 44.1 58.6 49.2 23.9 10.8 23.6 35.0 31.7 28.9 21.3 43.4 66.6 47.4 71.0 25.4 2.1 37.4 35.0 11.9 13.0 32.6 24.8 16.9 12.6 55.2 26.6 103.3 17.6 30.9 64.5 60.7 84.0 39.9 19.5 55.0 53.3 66.2 13.3 38.5 30.2 21.7 23.4 33.2 10.4 65.0 27.3 25.5 8.2 22.0 42.1 42.2 40.0 39.4 29.6 95.3 24.6 32.5 20.3 0.0 1.3 0.8 2.0 1.2 1.5 2.5 1.9 1.5 1.5 2.6 2.0 2.6 0.5 2.2 4.4 2.4 2.0 1.3 6.0 6.8 6.9 7.3 6.0 6.1 6.9 6.4 6.9 6.1 6.7 6.9 10.1 3.2 9.5 1.6 9.0 6.0 4.0 6.0 2.2 9.4 8.3 7.1 2.5 4.3 6.0 0.0 14.6 7.6 8.8 7.8 0.0 2.0 1.7 5.5 8.9 5.4 0.0 15.3 2.5 3.3 7.5 5.7 9.7 7.4 5.7 15.6 6.1 7.7 5.2 8.4 3.6 6.5 10.2 4.1 5.4 1.3 7.2 4.4 7.2 3.7 3.5 2.7 4.1 1.5 1.7 3.2 2.7 4.5 17.2 6.0 2.3 1.4 6.7 25.8 0.0 4.9 4.8 5.3 18.0 5.5 6.5 2.6 8.4 4.1 9.5 5.1 DDX23 "prp28, PRPF28, SNRNP100, U5-100K" ENSG00000174243 "DEAD-box helicase 23" Q9BUQ8 12 48829756-48852842 "Enzymes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038680, HPA039037" Approved Supported Nucleoplasm,Nucleoli NA NA 21000 "Cluster 2: Granulocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 39: CACO-2 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA038680: AB_10795401, HPA039037: AB_2676317" "unprognostic (1.32e-3)" "unprognostic (8.90e-2)" "unprognostic (8.92e-2)" "unprognostic (7.12e-2)" "unprognostic (5.34e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (3.03e-5)" "unprognostic (3.54e-2)" "unprognostic (5.68e-2)" "unprognostic (2.19e-2)" "unprognostic (1.69e-1)" "unprognostic (8.34e-2)" "unprognostic (5.94e-2)" "unprognostic (9.78e-2)" "unprognostic (6.88e-2)" "unprognostic (2.59e-2)" "unprognostic (1.44e-1)" 33.2 30.7 28.7 36.9 30.8 26.5 33.1 29.7 29.6 35.3 33.1 39.3 33.5 35.1 25.0 37.5 35.4 25.4 30.1 28.0 29.9 33.0 43.0 33.8 46.6 30.7 29.9 40.6 36.7 34.5 28.4 33.7 29.7 36.1 37.6 27.8 37.3 29.7 54.4 39.2 41.2 34.0 30.1 47.6 38.3 26.7 30.8 63.3 32.9 35.8 48.1 36.1 34.7 30.4 74.0 165.1 76.6 81.5 74.7 51.4 81.3 89.1 68.1 98.9 62.5 162.0 95.7 92.5 95.6 74.4 93.3 64.9 168.1 81.1 84.0 146.1 89.2 122.7 139.0 73.8 40.3 125.3 106.9 49.9 71.7 105.1 62.6 67.6 82.4 80.4 165.6 80.3 72.9 102.1 119.8 118.2 114.4 104.0 77.4 125.9 90.7 73.5 58.3 101.9 94.1 54.9 89.4 101.0 38.4 78.0 99.0 113.7 74.5 74.4 54.1 37.2 71.8 60.1 89.8 109.5 63.3 86.8 41.8 20.9 11.8 21.9 19.3 13.6 19.6 12.6 14.1 17.5 11.3 10.5 13.5 16.6 12.2 12.8 9.8 11.9 14.3 12.0 28.7 30.8 29.7 29.6 28.0 29.9 30.7 29.9 29.7 30.1 30.8 30.4 22.7 25.6 36.5 11.8 25.5 12.9 13.7 12.7 25.6 17.5 18.6 19.4 20.0 22.8 25.8 12.9 25.0 25.9 30.7 33.0 15.6 25.9 14.4 24.4 25.2 27.2 13.9 21.7 6.9 38.9 29.1 19.2 25.5 26.6 18.3 29.8 17.9 18.7 19.1 15.2 8.7 26.6 16.2 13.2 10.3 6.3 24.5 16.5 14.2 9.4 25.5 26.2 35.0 7.5 8.4 33.9 32.3 22.2 32.0 26.7 24.3 12.5 34.4 26.1 19.7 20.8 20.0 43.8 33.1 24.4 15.2 26.5 28.6 21.1 27.3 21.6 DDX24 ENSG00000089737 "DEAD-box helicase 24" Q9GZR7 14 94048287-94081212 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002554 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Cytosol" "HPA002554: AB_1078631" "unprognostic (7.48e-2)" "unprognostic (3.02e-2)" "unprognostic (8.95e-2)" "unprognostic (2.12e-1)" "unprognostic (2.31e-1)" "unprognostic (4.06e-3)" "unprognostic (8.81e-2)" "unprognostic (2.66e-3)" "unprognostic (2.77e-1)" "unprognostic (2.28e-2)" "unprognostic (1.60e-3)" "unprognostic (4.13e-2)" "prognostic favorable (3.06e-9)" "prognostic unfavorable (2.89e-4)" "unprognostic (6.15e-2)" "unprognostic (1.23e-1)" "unprognostic (5.66e-2)" 80.7 130.5 23.3 3.9 24.2 23.5 75.2 25.9 29.7 80.0 24.5 85.8 3.7 93.1 37.2 48.9 81.4 6.7 114.3 24.3 23.9 61.2 43.4 69.4 10.4 31.2 25.2 87.3 49.8 7.0 109.0 2.8 25.4 69.9 3.8 8.0 53.9 4.9 123.9 67.4 59.6 4.1 23.9 75.9 66.1 114.3 25.2 8.0 73.5 4.2 9.1 80.2 65.9 26.2 6.5 1.8 11.5 7.5 6.8 8.8 2.7 17.6 14.5 22.4 20.0 2.2 4.0 29.8 6.4 3.9 6.7 4.1 11.9 1.1 24.5 13.0 0.7 15.8 4.3 9.9 5.7 23.0 6.8 1.4 6.6 4.1 3.9 7.5 3.7 5.6 8.5 8.2 9.6 18.2 7.0 19.6 7.6 1.9 0.2 9.3 26.6 3.5 17.0 2.4 9.1 8.4 17.3 4.2 8.5 1.8 6.8 8.1 11.3 6.4 4.4 8.2 5.3 3.4 24.8 31.5 9.2 12.3 5.1 9.5 2.1 1.7 3.0 1.7 0.8 1.7 1.6 1.8 1.2 2.3 3.0 3.0 1.5 3.8 1.8 1.9 2.1 3.0 23.3 24.2 25.9 29.7 24.3 23.9 31.2 25.2 25.4 23.9 25.2 26.2 164.7 169.9 160.6 45.4 245.9 182.8 186.6 147.4 171.4 184.7 86.6 94.7 228.3 64.3 146.4 147.1 131.3 94.0 332.8 74.1 272.0 147.0 98.2 244.0 248.2 142.2 97.5 75.5 62.9 98.9 72.6 189.0 95.8 201.0 154.9 251.5 109.6 103.4 85.1 232.2 73.6 89.0 118.0 92.1 147.4 67.4 231.5 143.5 99.6 45.0 158.0 133.4 122.6 31.7 56.1 91.0 67.4 244.8 225.6 116.4 70.7 242.3 160.4 200.5 164.3 185.0 198.0 506.5 435.9 127.6 145.6 157.1 342.1 305.9 74.9 123.7 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177516961 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 26.5 29.0 15.1 28.7 16.1 22.3 25.4 13.1 21.9 26.1 13.7 26.5 24.8 25.2 16.8 33.7 30.6 18.3 18.9 17.8 14.2 26.8 27.1 24.5 24.7 15.8 13.7 28.6 23.5 31.2 18.0 22.8 16.0 22.3 19.3 14.6 28.7 19.1 43.4 35.0 28.7 20.1 12.8 26.7 26.7 17.9 16.2 24.3 29.0 20.3 25.0 24.8 27.6 16.4 62.1 71.4 42.4 44.9 43.4 45.2 125.1 58.4 35.1 47.1 36.1 107.7 61.3 67.2 83.3 57.6 67.6 47.8 57.2 128.5 33.2 175.4 68.0 90.5 70.8 66.5 52.5 89.3 82.3 48.7 47.0 45.3 59.0 43.5 53.4 68.1 72.3 50.0 55.6 135.5 80.6 45.9 62.0 59.0 61.3 72.7 48.1 86.2 50.5 78.8 45.0 41.9 64.6 83.2 56.5 27.1 54.6 110.2 51.3 74.4 42.8 43.6 87.6 49.6 75.9 120.1 81.3 100.1 47.0 14.3 31.4 22.3 18.3 28.5 23.5 17.0 18.3 16.8 27.2 14.4 14.6 18.8 9.2 25.8 31.4 11.2 18.8 25.6 15.1 16.1 13.1 21.9 17.8 14.2 15.8 13.7 16.0 12.8 16.2 16.4 17.0 25.6 17.8 7.8 20.6 21.0 22.9 37.9 18.2 16.9 17.5 16.5 9.0 25.8 24.3 9.2 2.1 46.6 22.9 22.9 41.1 42.1 11.2 16.1 16.5 22.3 11.4 25.2 6.0 39.6 63.2 17.6 17.3 19.2 29.8 21.3 16.1 18.0 48.8 8.4 6.4 27.0 18.3 23.5 15.4 22.9 14.9 22.2 12.4 4.7 34.6 23.9 20.6 5.0 3.9 33.5 23.9 21.1 23.2 19.0 29.5 40.1 20.5 10.3 13.1 14.5 29.0 24.5 26.7 26.2 20.3 37.5 19.0 25.6 31.0 22.7 DDX5 "G17P1, HLR1, p68" ENSG00000108654 "DEAD-box helicase 5" P17844 17 64498254-64508199 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005868, HPA020043, HPA071154" Supported Supported Nucleoplasm,Nucleoli No No 310000 "Cluster 18: Basophils - Vesicular transport" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "CAB005868: AB_446484, HPA020043: AB_1847572, HPA071154: " "unprognostic (6.64e-2)" "unprognostic (6.98e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.94e-2)" "unprognostic (5.08e-2)" "unprognostic (9.85e-2)" "unprognostic (5.80e-2)" "unprognostic (1.61e-2)" "unprognostic (3.17e-2)" "unprognostic (4.71e-2)" "unprognostic (3.03e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-1)" "unprognostic (2.08e-1)" "unprognostic (2.37e-1)" "unprognostic (2.17e-1)" "unprognostic (9.28e-3)" 202.9 124.0 75.2 75.7 80.0 219.5 163.4 93.4 91.3 190.4 122.8 176.8 36.1 181.7 61.9 136.9 181.2 186.4 109.8 83.6 83.8 113.6 157.5 185.9 124.7 85.5 79.7 134.2 83.3 177.7 118.9 119.4 79.0 122.8 157.7 211.7 112.0 144.8 165.7 130.6 116.3 274.6 65.4 127.5 137.1 88.7 83.2 272.5 172.8 107.5 157.5 228.2 128.9 100.2 204.7 85.5 353.1 144.4 316.2 316.7 134.1 221.4 349.8 306.9 300.3 98.2 105.3 299.7 102.0 364.8 238.1 87.1 361.6 291.5 428.2 107.7 76.0 211.2 84.5 81.6 216.6 383.9 186.3 301.4 306.8 270.2 264.1 241.5 362.2 303.6 174.3 247.3 284.0 108.7 520.4 44.8 159.5 294.5 32.0 310.1 286.7 239.1 201.8 145.6 151.0 305.7 181.5 167.6 284.0 326.5 138.5 132.1 158.2 123.0 146.3 170.0 207.3 112.2 283.9 622.0 166.6 140.5 184.2 232.6 160.6 170.0 117.2 143.3 149.8 111.5 105.4 125.4 148.5 106.3 107.6 109.4 86.6 112.2 197.1 85.5 135.9 319.9 75.2 80.0 93.4 91.3 83.6 83.8 85.5 79.7 79.0 65.4 83.2 100.2 990.8 535.2 690.9 200.8 909.4 879.5 1536.4 837.0 618.1 403.5 433.3 393.7 249.6 346.0 855.7 369.6 335.7 439.9 1284.6 521.5 334.6 476.2 603.0 1021.9 987.2 767.7 664.1 309.7 187.9 419.2 371.3 733.5 452.1 1288.8 874.3 647.9 528.7 254.3 445.8 420.6 165.7 475.9 801.5 577.8 629.4 136.9 415.4 833.2 432.2 280.1 800.2 587.1 777.5 291.6 325.7 464.2 598.6 437.8 661.5 537.7 552.6 287.5 737.9 550.4 493.0 1437.7 961.5 407.6 399.1 466.4 746.0 887.3 1043.4 745.0 424.7 1056.4 DDX52 ROK1 ENSG00000278053 "DExD-box helicase 52" Q9Y2R4 17 37609739-37643446 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 245.1;Glandular and luminal cells: 360.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056173 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA056173: AB_2683056" "unprognostic (1.05e-2)" "unprognostic (1.85e-1)" "prognostic favorable (9.41e-4)" "unprognostic (4.26e-2)" "unprognostic (9.96e-3)" "unprognostic (6.77e-2)" "prognostic unfavorable (2.44e-6)" "unprognostic (5.10e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "unprognostic (7.50e-2)" "unprognostic (2.43e-1)" "unprognostic (2.36e-1)" "unprognostic (6.95e-2)" "unprognostic (5.58e-1)" "unprognostic (1.26e-2)" "unprognostic (1.28e-1)" 1.8 2.5 1.6 1.0 1.6 4.2 1.7 2.3 2.0 2.0 2.1 2.2 2.0 2.2 3.9 3.1 1.6 1.8 1.8 1.6 1.7 2.6 2.8 1.8 2.1 1.7 1.6 1.5 2.9 2.2 1.4 1.7 1.9 1.7 2.2 2.1 1.9 1.7 2.5 2.8 3.3 1.8 1.4 2.0 2.4 1.8 1.7 1.5 1.3 1.8 2.1 2.4 1.9 2.2 4.7 10.2 1.0 9.4 5.2 4.6 4.0 6.3 5.4 8.1 7.7 6.6 1.7 2.8 4.2 4.3 1.5 4.4 10.5 7.2 11.0 6.5 12.8 5.9 6.6 4.6 5.1 7.8 3.1 4.5 7.6 5.5 6.3 4.1 9.4 2.7 0.9 1.7 4.7 1.6 11.9 4.3 5.4 2.6 0.8 7.3 8.4 4.9 9.9 5.8 6.6 5.5 7.5 1.8 5.2 5.0 3.3 6.1 6.7 6.6 4.2 3.6 7.3 2.2 3.8 4.9 5.3 4.6 5.2 0.9 0.5 0.7 0.8 0.7 0.6 0.6 0.8 0.6 0.4 0.6 0.7 0.9 0.4 0.8 0.4 1.2 0.5 0.2 1.6 1.6 2.3 2.0 1.6 1.7 1.7 1.6 1.9 1.4 1.7 2.2 28.5 41.7 19.7 17.3 29.4 34.5 33.9 41.2 26.2 34.0 25.4 22.7 33.3 18.6 41.4 27.6 33.3 35.4 47.4 28.7 35.2 76.6 245.1 105.8 77.7 32.3 26.3 42.7 19.4 52.3 31.1 28.1 29.6 360.4 27.3 40.8 28.5 37.2 26.1 47.1 19.3 30.1 34.6 25.8 12.6 97.8 24.5 24.1 17.8 19.7 53.8 26.0 33.0 29.7 23.0 56.8 20.5 24.0 25.4 35.8 35.7 40.2 32.0 36.0 26.3 26.7 34.1 29.6 56.0 33.4 33.2 25.0 30.3 43.7 46.8 49.5 DDX56 NOH61 ENSG00000136271 "DEAD-box helicase 56" Q9NY93 7 44565804-44575051 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019749, CAB037320" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "Mitotic chromosome" "CAB037320: , HPA019749: AB_1847579" "unprognostic (3.28e-1)" "unprognostic (1.05e-1)" "unprognostic (5.00e-2)" "unprognostic (1.93e-1)" "unprognostic (6.08e-3)" "unprognostic (2.12e-3)" "prognostic unfavorable (1.38e-5)" "unprognostic (5.17e-2)" "unprognostic (2.76e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-2)" "unprognostic (6.01e-3)" "prognostic unfavorable (8.41e-7)" "unprognostic (2.60e-1)" "unprognostic (2.88e-2)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 21.3 21.8 24.8 21.5 25.6 16.6 17.1 25.5 29.0 19.2 25.3 18.6 20.8 15.4 17.3 25.9 27.2 15.8 20.3 25.1 25.3 16.2 30.1 15.7 29.4 25.6 25.2 22.1 28.2 27.1 7.9 20.1 25.7 18.2 15.7 7.3 24.6 20.2 27.4 32.2 16.4 21.2 25.2 19.5 20.8 10.4 25.2 24.5 23.5 21.5 27.1 28.4 7.3 26.0 69.5 118.8 32.0 70.0 36.6 40.3 62.3 60.9 43.7 107.6 83.9 139.2 90.7 109.8 65.0 59.4 143.5 111.4 70.9 97.5 38.5 45.9 99.2 64.3 90.9 86.1 59.9 77.0 66.4 57.9 78.8 105.8 82.2 35.5 62.0 55.8 150.2 42.8 78.3 103.7 67.3 104.4 108.8 127.8 103.6 70.7 54.3 76.7 69.8 65.4 68.8 90.6 64.2 199.4 58.9 21.3 120.6 105.5 52.4 71.0 86.0 52.6 155.1 88.7 135.0 167.1 75.2 115.1 146.1 36.3 50.8 21.1 37.6 66.3 47.7 48.3 40.9 41.6 63.8 55.0 49.2 38.7 3.6 63.2 67.7 34.8 44.9 59.7 24.8 25.6 25.5 29.0 25.1 25.3 25.6 25.2 25.7 25.2 25.2 26.0 21.5 16.0 29.0 13.1 22.8 17.1 23.9 45.1 21.1 26.6 18.4 14.7 12.3 11.5 40.3 22.0 14.6 57.0 19.1 29.0 27.4 39.4 41.4 21.0 21.1 26.4 18.5 35.8 6.1 32.3 48.5 24.6 30.5 20.6 28.5 35.3 16.8 30.1 35.4 6.7 8.0 24.9 38.7 13.2 17.5 37.5 21.1 17.9 14.2 3.7 28.8 22.4 23.7 6.6 6.2 37.5 18.8 19.9 18.2 24.8 37.2 63.0 31.8 26.9 13.1 22.4 25.1 36.2 25.6 30.1 19.9 47.2 23.6 40.3 36.8 21.3 DEGS2 "C14orf66, DES2, FADS8" ENSG00000168350 "Delta 4-desaturase, sphingolipid 2" Q6QHC5 14 100143957-100159645 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;intestine: 34.8;skin 1: 54.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 82.8;Paneth cells: 77.0;Proximal enterocytes: 298.9;Respiratory ciliated cells: 144.8;Squamous epithelial cells: 86.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 3.5;eosinophil: 6.6;memory B-cell: 10.9;naive B-cell: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 10.9;granulocytes: 6.6" "Group enriched" "Detected in some" 16 "OE19: 69.3;T-47d: 104.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046644 Approved Nucleoplasm,Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 31: Skin - Epidermis development" "Cluster 6: T47d - Mammary gland" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA046644: AB_2797231" "unprognostic (8.18e-2)" "unprognostic (3.83e-3)" "unprognostic (2.33e-1)" "unprognostic (1.32e-2)" "unprognostic (3.55e-1)" "unprognostic (4.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.13e-2)" "unprognostic (2.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.94e-7)" "unprognostic (1.03e-3)" "unprognostic (1.26e-1)" "unprognostic (1.14e-1)" "prognostic favorable (1.66e-4)" 0.4 0.1 6.4 1.0 7.2 0.2 6.1 18.3 7.1 4.8 3.6 8.9 24.7 3.3 0.5 37.0 2.0 6.5 0.2 5.1 4.5 10.8 0.9 1.6 0.6 5.9 5.3 1.0 6.9 0.4 3.3 0.4 6.0 2.3 4.5 0.2 8.6 2.1 0.3 54.2 34.8 0.5 4.8 0.8 20.1 1.1 5.3 0.1 2.4 0.0 1.8 6.5 10.1 4.9 0.0 0.3 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 2.4 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.6 0.0 0.0 4.2 0.4 0.3 0.1 69.3 0.0 0.4 0.0 3.6 0.0 1.6 5.2 0.1 0.0 3.1 0.0 0.1 104.4 1.1 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.5 0.4 6.6 1.6 0.0 0.0 10.9 0.1 0.7 0.7 6.8 0.0 1.0 0.2 0.2 0.0 0.1 0.0 0.7 6.4 7.2 18.3 7.1 5.1 4.5 5.9 5.3 6.0 4.8 5.3 4.9 0.7 3.2 5.0 5.2 3.7 1.8 3.3 22.9 1.2 4.6 24.2 15.2 0.6 37.1 34.8 82.8 0.0 7.7 3.3 24.2 1.9 19.0 1.2 15.3 4.3 3.8 55.3 1.3 0.5 1.5 4.9 1.3 54.6 28.9 9.5 0.9 0.4 0.3 1.6 0.0 0.4 53.5 34.6 0.9 0.6 1.6 0.3 1.5 0.0 3.7 0.5 1.2 12.3 0.0 1.5 2.4 77.0 0.0 3.7 1.7 298.9 0.4 144.8 22.0 0.0 1.1 3.1 3.2 4.0 86.9 15.3 37.4 2.5 0.2 69.6 21.0 DENND5B MGC24039 ENSG00000170456 "DENN domain containing 5B" Q6ZUT9 12 31382226-31591136 "Predicted intracellular proteins, Predicted membrane proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 152.8;Excitatory neurons: 217.3;Inhibitory neurons: 246.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 121.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.4;naive B-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SuSa: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038865 Approved Approved Nucleoli,Microtubules NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Microtubules Nucleoli "HPA038865: AB_2676245" "unprognostic (5.41e-2)" "unprognostic (2.23e-2)" "unprognostic (4.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (3.08e-2)" "unprognostic (7.23e-2)" "unprognostic (2.13e-1)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (3.14e-1)" "unprognostic (8.27e-2)" "unprognostic (5.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.26e-1)" "unprognostic (2.60e-2)" 4.0 6.4 6.3 5.4 7.8 2.1 3.2 20.1 12.3 4.8 2.9 4.2 9.2 6.9 2.0 2.4 3.9 4.2 10.9 6.1 8.4 7.6 12.5 2.6 7.3 7.7 5.2 21.7 5.7 2.7 4.7 4.9 7.7 2.9 4.3 15.9 2.0 3.1 7.1 1.3 10.4 7.2 2.0 6.7 5.0 16.1 7.1 2.4 2.9 13.1 8.4 3.7 3.1 6.1 2.8 27.9 20.1 7.7 7.1 8.8 3.0 6.8 7.4 16.9 12.1 18.9 11.1 10.4 11.1 14.8 18.5 0.8 4.0 1.9 16.7 0.0 8.5 0.1 21.2 11.3 6.5 9.6 0.2 5.5 6.0 11.3 18.5 15.5 15.7 5.7 4.0 20.6 10.6 2.6 5.7 10.0 20.4 6.5 4.9 5.4 27.8 0.2 14.2 3.6 6.4 9.5 17.0 1.9 15.0 57.3 2.8 5.2 16.5 6.3 16.0 11.4 14.4 10.9 13.0 10.5 10.7 1.1 10.7 0.1 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.1 6.3 7.8 20.1 12.3 6.1 8.4 7.7 5.2 7.7 2.0 7.1 6.1 6.7 3.2 0.5 152.8 43.9 2.9 3.5 0.9 2.8 42.4 5.3 4.1 44.0 17.2 2.1 7.3 31.3 0.6 7.0 13.3 3.9 1.8 19.6 6.1 10.1 7.4 8.4 6.3 217.3 9.3 2.9 13.0 4.6 4.4 0.0 45.0 25.0 34.2 4.5 28.6 246.4 3.1 2.0 4.5 5.8 8.3 8.4 3.8 23.2 74.9 2.5 12.9 1.0 144.3 121.0 7.9 3.6 10.5 72.6 2.4 33.2 12.0 2.2 26.8 6.6 12.9 10.0 32.0 18.2 0.2 1.4 0.7 2.3 15.5 4.4 1.2 DFFB "CAD, CPAN, DFF-40, DFF40" ENSG00000169598 "DNA fragmentation factor subunit beta" O76075 1 3857267-3885429 "Predicted intracellular proteins" Apoptosis "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 4.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 45.9;Extravillous trophoblasts: 29.5;Oligodendrocytes: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004328, HPA052904" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli Nucleoplasm "CAB004328: AB_626776, HPA052904: AB_2681985" "unprognostic (2.98e-1)" "unprognostic (5.09e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-3)" "unprognostic (6.12e-2)" "unprognostic (1.83e-2)" "unprognostic (1.38e-2)" "unprognostic (1.28e-3)" "unprognostic (2.66e-2)" "unprognostic (1.79e-1)" "unprognostic (7.82e-3)" "unprognostic (4.07e-1)" "unprognostic (1.90e-2)" "unprognostic (9.86e-3)" "unprognostic (3.39e-1)" "unprognostic (2.27e-1)" "prognostic favorable (6.29e-5)" 1.3 1.1 0.6 1.2 0.7 1.0 1.1 0.5 0.9 1.7 0.0 1.5 4.6 1.6 0.0 0.8 1.3 1.4 0.7 0.7 0.5 0.7 0.4 1.0 1.6 1.5 0.9 1.7 2.4 0.5 0.6 1.3 0.7 0.8 0.8 0.2 1.3 0.7 0.5 0.6 2.0 0.4 0.4 1.9 1.2 0.4 0.6 1.2 0.8 0.5 0.9 1.4 1.0 1.5 3.2 3.3 2.0 4.7 0.6 1.6 1.1 2.7 1.2 4.1 2.8 2.6 2.8 2.6 2.2 0.5 0.8 1.7 0.7 3.2 0.2 9.0 9.7 10.7 1.2 3.2 3.3 8.7 7.9 0.4 0.8 2.4 1.9 0.8 4.1 7.5 7.4 1.6 0.1 1.8 6.1 4.8 2.2 3.9 7.4 4.9 1.2 4.4 1.3 0.6 3.3 5.1 2.3 6.5 10.7 0.0 1.1 3.8 4.1 1.5 1.1 6.5 2.5 2.9 4.6 5.4 1.2 9.0 2.0 3.6 3.7 5.0 3.4 3.8 2.0 2.1 2.5 3.1 5.1 1.0 2.1 3.2 1.2 2.3 7.4 0.0 4.7 2.9 0.6 0.7 0.5 0.9 0.7 0.5 1.5 0.9 0.7 0.4 0.6 1.5 3.3 3.2 4.6 4.2 3.0 0.6 1.0 1.4 1.8 5.5 1.9 2.7 1.3 2.8 1.7 1.8 45.9 3.5 7.3 1.6 1.9 1.9 1.4 3.3 4.6 3.1 2.4 2.5 17.0 1.6 29.5 3.2 1.5 2.5 0.0 4.6 2.5 1.8 2.9 15.2 18.0 4.2 0.0 5.4 1.4 1.2 1.2 3.7 0.0 8.4 2.5 3.9 15.5 5.5 22.7 1.8 1.5 4.9 3.1 0.6 5.0 2.4 1.1 17.9 0.0 1.7 3.2 1.7 2.5 1.7 0.3 1.4 6.0 3.3 4.4 0.7 DHRS3 "RDH17, retSDR1, Rsdr1, SDR1, SDR16C1" ENSG00000162496 "Dehydrogenase/reductase 3" O75911 1 12567910-12618210 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 323.7" "Cell type enhanced" "Detected in many" "Late spermatids: 409.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 86.8;MAIT T-cell: 63.1;memory CD4 T-cell: 46.9;memory CD8 T-cell: 41.0;myeloid DC: 24.0;naive CD4 T-cell: 79.2;naive CD8 T-cell: 50.1;NK-cell: 41.1" "Group enriched" "Detected in many" 5 "dendritic cells: 24.0;NK-cells: 41.1;T-cells: 86.8" "Cell line enhanced" "Detected in many" "A549: 107.4;CAPAN-2: 206.9;hTERT-RPE1: 196.7;SK-BR-3: 104.6;WM-115: 192.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010844 Supported Approved Nucleoli,Mitochondria NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 85: Liver - Metabolism" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Mitochondria" "HPA010844: AB_1847653" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.82e-2)" "unprognostic (1.74e-3)" "unprognostic (1.87e-1)" "unprognostic (3.68e-2)" "unprognostic (2.25e-3)" "unprognostic (5.06e-2)" "unprognostic (3.40e-2)" "unprognostic (5.18e-2)" "unprognostic (1.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.80e-1)" "unprognostic (1.02e-1)" "unprognostic (1.76e-1)" "prognostic favorable (2.65e-4)" "unprognostic (5.48e-2)" 150.9 21.6 38.3 18.6 37.8 13.8 115.8 34.8 41.1 89.8 96.3 60.8 50.2 34.6 25.3 117.1 53.9 33.5 73.2 38.0 38.0 87.8 323.7 56.4 18.0 57.2 37.8 38.8 108.4 31.3 48.8 19.6 40.1 169.6 21.2 8.6 67.0 48.2 76.2 71.9 52.5 16.8 40.6 27.0 87.1 20.2 41.3 10.4 121.2 24.7 8.9 73.0 107.0 44.2 18.1 107.4 0.1 42.7 54.9 5.0 11.9 6.2 0.3 0.2 0.4 11.8 206.9 0.1 5.2 57.7 17.6 79.9 21.4 10.6 0.2 0.1 36.3 16.5 11.3 57.3 8.5 0.3 0.3 27.9 13.5 0.3 0.5 196.7 18.0 0.7 24.3 0.3 0.3 3.0 4.4 1.0 6.8 18.5 40.3 0.5 0.1 20.2 0.1 36.6 1.3 2.0 35.0 104.6 6.6 13.2 10.3 4.8 13.5 0.5 2.2 30.3 0.4 3.3 0.2 0.2 23.9 1.4 192.8 9.2 0.8 0.1 86.8 0.5 63.1 0.6 46.9 41.0 24.0 0.7 79.2 50.1 4.7 41.1 1.1 3.0 1.4 48.2 38.3 37.8 34.8 41.1 38.0 38.0 57.2 37.8 40.1 40.6 41.3 44.2 139.5 96.1 55.9 26.8 3.4 25.6 136.0 114.8 59.2 2.0 17.5 22.6 42.3 45.8 93.4 20.2 18.8 34.4 35.5 83.8 23.5 99.3 99.6 69.8 50.2 54.1 25.1 23.6 3.7 163.1 45.0 56.4 32.1 83.7 15.8 2.6 73.5 181.3 67.1 0.0 3.3 33.0 42.7 69.6 8.4 409.5 22.7 43.6 7.2 17.8 11.5 15.3 38.1 1.0 0.6 129.6 69.5 9.8 3.5 76.2 112.6 52.9 82.8 2.4 0.0 10.5 30.8 1.9 1.4 51.7 27.0 26.3 28.3 7.9 33.0 156.8 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839347-182887982 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 38.7 30.5 13.6 47.4 15.8 131.4 53.2 19.0 19.7 43.7 17.0 40.2 32.6 49.4 33.0 32.2 45.9 31.1 28.5 13.1 16.0 49.9 36.9 38.6 56.9 15.2 13.6 52.8 30.5 68.2 21.1 44.6 16.3 39.6 47.1 66.5 32.5 44.3 30.3 31.1 36.3 50.8 16.6 40.9 34.5 50.4 14.6 88.7 48.0 37.7 70.2 54.0 30.0 25.5 165.7 158.8 223.0 122.3 113.7 87.8 219.2 143.5 130.3 203.6 137.0 175.8 124.2 264.3 133.7 129.6 121.7 138.8 342.6 155.2 225.7 108.3 169.5 176.4 121.0 119.6 62.5 258.3 115.0 78.6 75.8 200.4 53.4 91.6 161.7 132.9 281.8 91.9 165.1 142.3 263.6 61.1 282.8 173.9 96.8 236.0 208.0 151.0 127.0 187.8 160.0 183.2 203.2 125.0 83.2 186.4 148.4 140.9 127.6 125.3 138.8 128.9 195.9 93.6 167.2 305.0 79.0 137.0 174.5 7.7 21.3 16.1 23.4 22.5 26.2 20.5 19.8 21.1 29.9 16.6 21.6 23.7 8.0 20.0 19.7 14.2 20.1 21.2 13.6 15.8 19.0 19.7 13.1 16.0 15.2 13.6 16.3 16.6 14.6 25.5 43.6 41.7 74.1 59.1 54.5 53.7 61.2 42.7 38.7 59.6 43.3 38.9 43.9 30.0 60.8 51.5 52.1 50.9 70.2 38.6 19.6 49.0 26.8 79.2 67.4 50.7 53.8 74.5 49.4 50.8 47.5 48.0 37.8 109.8 44.9 67.7 36.0 28.0 40.8 28.6 55.5 40.9 30.5 35.4 35.1 45.8 60.3 44.7 30.2 55.3 55.9 42.7 42.2 55.3 70.3 52.3 28.0 47.0 52.4 48.3 35.4 38.0 67.7 77.1 39.5 73.9 54.1 69.9 68.2 51.7 47.2 49.5 59.2 60.9 54.4 55.4 DLG3 "KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102" ENSG00000082458 "Discs large MAGUK scaffold protein 3" Q92796 X 70444835-70505490 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 55.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001733, HPA078130" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 12: NES - Nervous system development" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA001733: AB_1078675, HPA078130: AB_2686879" "prognostic unfavorable (1.69e-4)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (2.77e-1)" "unprognostic (4.65e-2)" "unprognostic (3.44e-2)" "unprognostic (3.64e-1)" "unprognostic (1.20e-2)" "unprognostic (7.79e-2)" "unprognostic (7.92e-2)" "unprognostic (1.26e-1)" "unprognostic (5.98e-2)" "prognostic favorable (1.72e-10)" "unprognostic (3.36e-2)" "unprognostic (5.45e-2)" "unprognostic (1.51e-2)" "unprognostic (1.97e-3)" 3.6 3.7 14.6 4.9 16.0 0.6 11.7 8.3 19.2 10.9 9.5 18.6 13.4 8.3 25.5 20.4 19.1 10.7 7.9 19.7 10.1 16.7 1.7 8.8 3.6 6.1 9.5 11.9 35.2 36.3 11.6 5.9 9.0 11.4 18.9 10.5 23.2 10.8 1.2 11.8 16.0 9.0 6.6 20.0 17.3 1.8 10.9 4.6 15.3 2.0 7.4 10.3 12.2 12.9 6.9 3.1 18.9 8.1 4.8 5.8 13.2 4.0 4.5 2.2 2.2 19.4 15.8 0.0 9.1 4.0 1.6 14.5 37.1 8.8 1.4 8.1 11.3 0.0 17.4 10.7 9.4 0.2 2.6 6.1 5.7 2.8 6.1 19.4 0.8 12.9 3.7 26.5 2.1 24.1 15.8 0.1 31.9 55.5 22.3 14.7 9.3 3.0 12.8 20.7 8.9 0.5 3.2 36.9 7.3 15.6 19.4 0.0 1.5 2.5 2.5 2.4 3.0 17.3 13.9 8.4 3.7 0.1 3.7 0.0 0.0 0.0 0.5 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.3 0.4 0.0 0.5 0.0 0.0 0.7 0.1 14.6 16.0 8.3 19.2 19.7 10.1 6.1 9.5 9.0 6.6 10.9 12.9 2.2 19.2 22.5 4.6 1.7 0.8 5.5 10.8 7.4 20.2 16.8 10.4 17.2 22.8 17.5 9.2 0.0 6.3 7.0 36.7 11.7 15.0 0.0 27.7 5.7 1.8 25.7 0.8 24.8 24.9 2.6 7.4 17.9 15.8 1.3 6.4 3.6 0.3 0.6 5.0 24.5 23.7 4.1 0.3 1.2 0.3 1.5 1.3 1.8 7.5 1.8 11.6 3.1 20.1 5.4 21.6 19.3 6.4 5.7 13.9 26.1 6.0 31.5 6.3 6.6 4.0 11.1 2.9 2.9 13.1 2.0 1.6 8.1 2.5 21.4 10.5 DMXL1 ENSG00000172869 "Dmx like 1" Q9Y485 5 119037772-119249138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.3;Inhibitory neurons: 147.3;Oligodendrocytes: 224.0" "Cancer enhanced" "Detected in all" "prostate cancer: 14.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036431, HPA036432" Approved Approved Nucleoli,Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Cytosol "HPA036431: AB_10669791, HPA036432: AB_2675120" "unprognostic (2.47e-1)" "unprognostic (4.84e-2)" "unprognostic (7.87e-3)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (5.80e-3)" "unprognostic (2.80e-1)" "unprognostic (6.77e-2)" "unprognostic (1.40e-1)" "unprognostic (4.88e-2)" "unprognostic (5.93e-2)" "unprognostic (2.26e-1)" "prognostic favorable (5.16e-5)" "unprognostic (4.04e-2)" "unprognostic (3.99e-1)" "unprognostic (2.12e-2)" "unprognostic (5.18e-2)" 7.0 4.8 3.1 7.3 7.0 25.9 9.2 7.8 5.1 7.4 11.9 6.8 6.2 8.7 5.7 8.2 6.6 7.5 6.1 3.5 5.3 13.8 7.1 6.6 10.1 7.4 4.5 10.4 12.0 11.8 2.6 7.2 8.0 27.2 7.1 9.0 8.0 5.8 4.1 8.4 6.1 8.2 6.3 8.2 7.9 5.8 5.6 10.3 13.4 7.3 9.7 6.2 4.5 15.2 10.4 8.0 8.8 9.0 9.3 12.2 9.4 8.4 8.4 8.3 9.6 9.6 6.2 20.2 8.5 10.8 12.9 6.1 9.9 10.0 10.7 15.6 9.9 14.2 14.0 3.4 7.8 9.4 11.8 9.8 5.5 9.6 7.9 8.5 11.0 12.4 12.1 13.3 6.7 6.5 12.6 5.3 4.8 3.6 4.7 9.8 16.3 7.9 6.4 11.9 8.2 8.3 14.5 5.2 12.6 9.4 8.6 10.7 10.7 9.8 8.2 9.9 9.0 12.4 9.4 17.6 12.2 9.1 8.0 4.1 4.9 3.6 2.4 4.4 3.0 8.8 1.9 2.0 3.4 9.1 3.0 1.8 3.8 1.3 8.9 8.3 2.6 2.7 3.1 7.0 7.8 5.1 3.5 5.3 7.4 4.5 8.0 6.3 5.6 15.2 23.7 28.9 20.1 93.4 56.5 13.6 16.5 17.7 22.8 36.8 22.8 15.4 25.7 7.2 17.6 16.5 25.0 12.6 27.5 16.2 17.6 12.0 10.2 19.8 21.1 16.7 6.0 19.1 122.3 20.1 10.3 20.4 27.5 25.0 14.0 15.6 11.0 15.6 16.6 21.9 147.3 12.2 10.2 21.9 19.9 12.1 15.2 31.0 33.8 68.4 29.1 16.9 25.7 111.6 224.0 14.1 11.6 15.4 27.2 36.0 15.8 32.5 13.9 22.6 13.1 28.6 24.7 28.0 23.2 35.0 18.8 16.3 24.3 17.8 11.3 15.0 DNAJC21 "DNAJA5, GS3, JJJ1" ENSG00000168724 "DnaJ heat shock protein family (Hsp40) member C21" Q5F1R6 5 34929559-34958964 "Disease related genes, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040789 Approved Supported Nucleoli,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA040789: AB_10794147" "unprognostic (1.37e-1)" "unprognostic (6.01e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-1)" "unprognostic (2.69e-1)" "unprognostic (1.42e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (1.77e-3)" "unprognostic (3.04e-2)" "unprognostic (6.68e-3)" "unprognostic (5.99e-2)" "unprognostic (6.02e-2)" "unprognostic (9.27e-3)" "unprognostic (1.54e-1)" "unprognostic (3.26e-1)" "unprognostic (2.57e-1)" "unprognostic (6.02e-2)" 18.2 12.7 9.5 13.8 10.9 24.1 16.1 10.0 12.1 22.2 9.9 20.1 15.2 16.3 14.3 20.7 11.4 13.6 32.0 8.3 11.0 23.0 23.0 17.5 18.5 10.7 10.5 11.8 20.0 19.4 8.1 24.5 10.7 18.1 18.5 9.3 15.8 17.5 58.4 15.1 15.8 18.2 10.2 12.6 18.8 61.4 10.6 18.0 18.0 42.3 19.7 20.8 16.7 11.0 36.2 25.3 32.0 41.6 39.1 46.4 57.1 47.4 38.9 37.7 25.2 41.6 42.8 75.9 20.1 44.3 46.6 24.3 37.9 49.0 43.8 45.2 27.8 41.7 90.7 35.2 64.6 60.7 37.7 33.2 44.8 41.6 67.7 26.2 35.3 27.8 65.6 59.7 28.1 30.4 51.3 45.2 22.6 39.8 21.4 45.5 79.2 33.7 37.9 44.9 16.5 17.5 128.1 59.4 40.2 35.2 40.1 64.4 43.4 46.5 44.7 27.8 37.7 40.2 40.0 51.0 37.6 71.8 25.1 2.2 1.5 4.7 1.7 1.2 2.5 3.1 2.5 1.6 2.5 2.0 2.5 2.5 0.4 4.0 2.0 2.3 3.4 1.0 9.5 10.9 10.0 12.1 8.3 11.0 10.7 10.5 10.7 10.2 10.6 11.0 53.5 76.9 111.3 23.8 42.0 37.0 73.9 22.4 33.6 52.6 57.0 56.6 151.1 47.1 36.1 36.8 43.8 51.2 59.1 34.6 88.0 21.5 117.5 49.2 77.8 44.9 18.0 40.0 26.9 30.5 25.7 44.4 32.6 68.4 8.2 42.0 37.5 59.5 24.3 75.7 40.4 36.9 6.1 31.4 32.9 47.7 40.4 38.8 37.4 15.0 50.8 31.2 45.3 20.1 32.1 26.6 27.7 38.0 41.4 85.8 28.2 62.5 22.8 73.0 13.1 57.0 44.0 117.4 50.3 43.4 46.7 65.7 52.7 51.4 41.4 77.1 DPH5 CGI-30 ENSG00000117543 "Diphthamide biosynthesis 5" Q9H2P9 1 100989623-101026088 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046439, HPA076234" Approved Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" Nucleoli "HPA046439: AB_2679667, HPA076234: AB_2797274" "unprognostic (1.31e-1)" "unprognostic (3.37e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (3.57e-2)" "unprognostic (8.59e-2)" "unprognostic (8.12e-2)" "unprognostic (1.37e-2)" "unprognostic (2.56e-1)" "unprognostic (1.58e-2)" "unprognostic (2.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.88e-1)" "unprognostic (9.00e-2)" 12.5 23.2 17.2 8.4 17.8 10.7 28.8 17.3 22.5 23.2 18.3 14.6 7.1 17.2 23.8 13.7 26.2 11.6 23.5 17.4 18.7 19.5 25.3 10.1 18.1 17.8 18.0 49.8 31.4 20.0 15.5 12.3 17.8 15.0 17.5 8.8 11.9 17.1 20.8 15.0 11.2 19.7 17.6 15.4 14.1 9.8 19.0 29.0 20.7 25.0 25.4 14.7 13.3 18.0 28.1 30.1 40.1 37.0 48.3 154.7 34.9 24.9 42.9 41.0 34.5 35.3 7.7 46.0 33.2 22.2 23.1 20.0 47.5 41.1 62.6 20.0 35.8 22.1 26.7 71.4 84.1 33.4 13.8 97.1 63.9 38.8 118.6 67.4 64.8 33.4 62.6 16.7 70.3 26.3 40.7 36.7 31.5 15.2 46.4 37.8 51.1 32.6 50.0 25.7 44.2 22.2 13.7 36.2 114.0 29.6 27.3 18.3 25.1 23.0 28.7 28.8 34.4 20.0 24.1 31.9 31.5 29.6 7.9 5.7 7.5 4.6 16.1 8.9 21.7 19.2 17.9 17.7 13.6 15.1 24.0 20.9 2.7 24.7 10.6 9.8 12.8 10.2 17.2 17.8 17.3 22.5 17.4 18.7 17.8 18.0 17.8 17.6 19.0 18.0 8.1 6.4 14.6 17.0 30.3 15.8 17.0 24.2 19.9 5.3 18.7 12.3 23.8 21.5 12.7 7.3 0.0 26.2 10.1 4.7 23.5 14.0 1.8 14.2 19.6 11.2 10.2 17.7 12.0 18.4 27.8 13.5 5.6 8.2 25.4 29.0 12.1 29.3 18.9 1.7 14.6 15.0 22.4 28.4 13.1 3.0 27.1 14.0 12.4 8.4 27.7 16.5 27.8 27.2 28.3 8.9 12.9 13.9 10.3 10.8 8.1 30.9 16.8 6.5 6.6 16.6 12.5 15.7 17.6 17.0 18.0 13.0 19.4 33.4 23.7 11.3 DRICH1 C22orf43 ENSG00000189269 "Aspartate rich 1" Q6PGQ1 22 23608452-23632321 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 17.0;testis: 46.4" "Group enriched" "Detected in some" 44 "Early spermatids: 405.5;Late spermatids: 589.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CACO-2: 11.1" HPA020446 Approved Nucleoplasm,Nucleoli No No "Cluster 68: Epididymis - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "HPA020446: AB_1853151" "unprognostic (7.48e-3)" "unprognostic (3.91e-2)" "unprognostic (2.02e-2)" "unprognostic (6.22e-4)" "unprognostic (6.46e-2)" "unprognostic (8.35e-4)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.06e-2)" "unprognostic (2.65e-2)" "unprognostic (5.73e-4)" "unprognostic (3.05e-1)" "unprognostic (1.92e-1)" "unprognostic (8.65e-2)" "unprognostic (8.68e-3)" "unprognostic (7.70e-4)" "unprognostic (1.08e-3)" 0.8 1.4 1.3 1.1 1.5 3.7 2.2 3.0 1.9 1.0 2.4 1.3 1.1 3.3 17.0 0.6 1.7 1.8 0.4 0.9 1.1 2.6 0.7 1.3 2.3 1.1 1.2 3.0 2.4 9.2 1.4 0.8 1.1 1.4 1.3 3.9 1.5 2.0 0.2 3.3 1.1 1.5 0.7 2.0 0.8 46.4 1.1 1.4 1.7 0.0 0.8 0.6 0.7 1.0 0.5 0.6 1.5 0.4 1.8 0.4 1.3 0.0 0.0 0.0 0.0 11.1 0.4 0.7 0.1 0.4 0.3 1.1 2.1 0.1 0.3 0.1 1.0 0.4 1.1 0.5 0.6 0.2 1.6 0.8 0.9 0.3 0.0 0.6 0.3 0.3 0.9 0.2 0.1 0.5 0.2 0.5 0.1 0.5 0.6 1.2 0.0 0.0 0.3 1.2 0.6 0.5 0.0 0.9 0.7 0.3 0.2 0.0 0.3 0.0 1.8 1.7 0.2 0.6 1.1 0.1 1.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.5 3.0 1.9 0.9 1.1 1.1 1.2 1.1 0.7 1.1 1.0 0.1 0.0 0.0 4.9 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.1 0.3 0.1 0.0 0.1 405.5 0.4 0.0 0.3 1.8 0.0 9.1 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 11.3 0.4 0.0 0.0 0.0 589.5 4.1 0.2 0.0 3.7 0.0 0.0 0.0 1.5 1.4 0.1 1.2 1.5 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 4.4 2.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 DTD1 "bA379J5.3, bA555E18.1, C20orf88, DUEB, HARS2, MGC119131, MGC41905, pqn-68" ENSG00000125821 "D-aminoacyl-tRNA deacylase 1" Q8TEA8 20 18587942-18766644 "Enzymes, Predicted intracellular proteins" "DNA replication" "DNA-binding, Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040981 Uncertain Uncertain Nucleoli,Cytosol NA NA 350000 "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" "Nucleoli, Cytosol" "HPA040981: AB_10673268" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (1.82e-1)" "unprognostic (5.94e-2)" "unprognostic (1.83e-1)" "unprognostic (2.90e-1)" "unprognostic (1.27e-3)" "unprognostic (9.67e-2)" "unprognostic (1.72e-1)" "unprognostic (1.81e-1)" "unprognostic (6.84e-2)" "unprognostic (1.32e-1)" "unprognostic (9.09e-3)" "unprognostic (2.42e-1)" "unprognostic (8.44e-2)" "unprognostic (2.59e-2)" "unprognostic (8.53e-2)" 23.5 21.1 7.0 3.7 7.0 4.5 21.5 7.2 7.6 18.9 7.1 15.6 2.7 19.7 4.8 26.6 18.6 3.2 17.5 7.1 7.6 25.6 10.8 16.0 4.1 7.3 6.9 17.6 20.4 7.7 33.8 3.4 7.4 13.7 4.2 6.6 21.9 3.1 29.1 27.4 13.7 4.0 7.2 15.3 16.2 19.1 7.3 2.1 19.3 6.7 4.5 17.1 19.4 7.3 10.1 15.7 15.8 16.2 8.8 12.2 9.1 4.3 12.3 10.5 11.3 10.0 11.4 0.1 4.1 13.6 13.9 5.3 13.1 25.0 10.4 6.8 3.2 10.2 4.0 18.7 22.8 9.4 8.2 10.2 22.4 11.8 42.1 8.7 16.5 3.0 7.0 22.5 15.3 24.9 1.7 23.8 11.0 13.5 9.9 0.0 16.6 11.1 16.6 8.2 16.6 13.0 4.4 20.4 23.6 7.1 12.3 9.2 10.2 14.3 3.8 17.7 14.5 5.5 10.2 4.6 8.6 13.9 11.1 1.7 0.7 0.4 1.8 1.0 0.8 1.1 0.6 1.0 1.5 0.7 0.5 0.5 0.9 1.4 1.0 0.2 0.4 0.6 7.0 7.0 7.2 7.6 7.1 7.6 7.3 6.9 7.4 7.2 7.3 7.3 35.5 35.3 24.0 32.0 26.8 23.6 40.9 48.3 22.2 42.4 27.9 33.0 18.8 28.6 23.1 42.3 2.1 26.7 24.7 9.9 43.0 71.9 38.4 16.2 33.1 36.4 23.3 22.1 41.9 87.4 37.8 29.9 13.7 17.8 42.5 24.6 35.7 11.2 47.8 43.7 60.6 23.5 28.5 23.5 35.9 21.8 18.0 27.1 42.7 12.2 42.8 58.2 38.1 53.3 52.2 90.6 19.1 19.5 24.6 50.6 9.3 73.8 22.8 34.9 0.0 30.1 27.5 93.5 124.2 33.2 35.7 12.4 35.5 42.7 26.8 31.9 DUSP1 "CL100, HVH1, MKP-1, PTPN10" ENSG00000120129 "Dual specificity phosphatase 1" P28562 5 172768096-172771195 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Stress response" "Hydrolase, Protein phosphatase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 2357.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 7426.8" "Lineage enriched" "Detected in all" 9 "granulocytes: 7426.8" "Cell line enhanced" "Detected in all" "HHSteC: 201.0;hTCEpi: 359.3;REH: 202.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069577 Approved Nucleoli,Cytosol NA Yes "Cluster 50: Neutrophils - Cellular senescence" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" Nucleoli Cytosol "HPA069577: AB_2686156" "unprognostic (1.51e-1)" "unprognostic (1.24e-1)" "unprognostic (9.73e-2)" "unprognostic (8.17e-2)" "unprognostic (4.64e-1)" "unprognostic (1.58e-3)" "unprognostic (4.18e-2)" "unprognostic (6.94e-2)" "unprognostic (3.11e-1)" "unprognostic (1.43e-2)" "unprognostic (2.23e-1)" "unprognostic (1.51e-2)" "unprognostic (2.76e-2)" "prognostic unfavorable (3.11e-5)" "unprognostic (2.69e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-3)" 922.6 515.4 84.9 364.9 85.8 692.4 586.1 134.8 121.1 501.3 134.7 336.1 66.0 382.3 42.0 526.6 677.4 570.5 395.3 79.4 114.6 281.2 721.3 719.9 178.6 132.0 90.3 541.2 240.1 116.5 319.5 297.3 104.1 438.5 228.5 202.7 350.3 356.9 251.8 1054.1 170.3 452.7 123.7 304.7 396.0 68.1 115.4 131.3 612.9 451.3 56.2 778.1 610.0 121.2 10.7 26.5 8.2 11.5 175.6 102.2 14.0 170.3 49.3 111.9 45.0 29.2 12.4 3.5 48.6 120.4 128.1 4.7 8.1 42.3 52.1 95.8 22.4 2.3 63.1 12.6 201.0 1.2 3.8 98.1 359.3 50.9 82.1 58.2 35.6 7.4 9.0 66.1 73.1 12.6 5.7 5.0 7.4 8.2 7.7 202.2 15.3 32.3 80.2 5.4 35.5 14.9 46.2 76.9 6.3 34.1 6.7 1.9 94.1 79.1 39.8 77.8 13.4 13.6 8.4 3.1 70.3 1.8 3.3 931.4 584.5 1640.7 85.0 589.2 212.6 57.6 75.6 88.6 263.4 54.1 35.9 40.7 7426.8 114.5 791.6 14.3 68.1 409.9 84.9 85.8 134.8 121.1 79.4 114.6 132.0 90.3 104.1 123.7 115.4 121.2 1856.5 410.3 341.0 23.8 918.4 1279.8 1140.5 456.9 1810.4 73.0 464.2 567.7 211.3 739.2 243.1 211.5 27.1 316.2 618.9 633.7 56.7 335.9 71.6 531.6 990.9 870.4 715.5 193.5 11.9 88.7 407.2 1367.4 597.3 1013.7 301.1 175.8 781.4 345.7 1043.0 48.8 13.4 891.8 207.5 1525.5 2357.3 40.3 384.9 1965.5 542.5 66.5 173.3 1159.3 33.0 6.6 4.1 226.3 683.3 311.1 952.2 685.7 736.1 35.5 218.0 190.5 769.2 720.7 671.9 12.9 24.6 1996.9 1956.6 582.0 1015.2 223.4 415.8 676.6 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488013-63499239 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 1638.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 347.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 37: Myocytes - Muscle contraction" Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 0.9 32.7 59.3 1.4 81.3 0.0 1.7 17.1 347.2 2.8 0.0 5.1 0.7 0.3 1.1 9.7 0.4 2.4 358.0 73.4 97.3 1.3 3.0 0.8 0.6 95.0 2.9 0.5 6.5 16.2 111.5 0.0 76.3 9.6 0.4 37.2 19.5 0.8 1638.0 6.8 1.9 0.8 0.0 0.3 8.5 1.2 30.7 0.2 0.7 320.7 0.1 2.2 1.8 125.0 0.5 71.0 0.8 16.8 0.0 0.6 7.9 10.0 1.3 51.6 16.3 9.8 41.5 0.0 110.4 0.5 13.4 38.8 240.0 0.7 115.9 0.5 13.1 0.0 24.1 4.1 2.9 0.0 13.4 1.4 2.2 0.1 1.0 0.2 0.0 0.0 3.4 0.2 0.5 405.9 1.4 0.5 11.4 95.6 96.5 8.0 0.2 10.2 2.4 3.9 187.0 89.9 90.0 12.6 1.6 2.2 157.2 3.8 0.0 0.3 202.9 0.7 1.8 0.3 0.9 1.4 0.9 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 59.3 81.3 17.1 347.2 73.4 97.3 95.0 2.9 76.3 0.0 30.7 125.0 0.1 0.0 0.0 9.4 0.7 0.4 0.9 0.0 0.0 130.8 11.8 4.6 125.5 1.5 0.6 0.0 12.5 0.0 1.1 0.4 0.0 1.3 0.2 0.5 0.3 2.2 0.0 0.0 35.5 0.2 0.2 3.6 4.6 1.4 5.7 1.0 1.1 0.1 0.0 269.2 37.2 0.0 0.0 0.3 0.7 0.5 0.0 0.6 0.0 15.0 0.0 11.7 0.0 14.6 12.7 0.3 0.0 0.0 0.3 2.6 0.0 0.5 0.0 50.9 0.0 49.9 3.4 0.0 0.3 0.0 1.8 0.0 1.5 0.0 0.5 1.1 EID3 "FLJ25832, NSE4B, NSMCE4B" ENSG00000255150 "EP300 interacting inhibitor of differentiation 3" Q8N140 12 104303739-104305205 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "testis: 61.2" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 78.5;Early spermatids: 72.8;Spermatocytes: 306.8" "Cancer enhanced" "Detected in many" "testis cancer: 5.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 9.1;BJ: 8.5;BJ hTERT+: 6.9;BJ hTERT+ SV40 Large T+ RasG12V: 6.8;HeLa: 8.9" "Not detected" "Not detected" HPA059367 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059367: AB_2683992" "unprognostic (1.25e-1)" "unprognostic (5.41e-3)" "unprognostic (5.82e-2)" "unprognostic (8.21e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (8.02e-2)" "unprognostic (5.88e-5)" "unprognostic (1.06e-1)" "unprognostic (1.31e-1)" "unprognostic (1.66e-2)" "unprognostic (5.38e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.96e-5)" "unprognostic (8.70e-2)" "unprognostic (3.54e-1)" "unprognostic (2.04e-3)" "unprognostic (2.87e-2)" 2.8 3.1 1.8 3.5 1.7 5.3 2.4 2.1 2.2 3.2 2.8 3.1 0.8 2.7 2.7 1.8 3.1 2.7 2.0 1.9 2.4 1.8 1.4 3.0 6.2 6.6 3.1 4.1 2.5 1.2 3.7 1.7 2.2 3.3 0.9 6.6 1.4 5.5 0.6 2.7 2.7 2.3 1.6 3.0 2.2 61.2 2.4 3.7 1.5 0.9 3.9 2.4 2.1 2.0 0.3 9.1 0.3 0.9 2.0 2.0 1.7 8.5 6.9 4.0 6.8 0.2 0.5 0.1 0.0 1.9 1.8 0.2 0.3 0.7 5.9 0.5 0.1 1.7 8.9 1.4 2.9 0.1 0.5 2.7 0.0 2.5 0.5 0.4 0.6 0.4 0.1 0.5 2.5 0.1 3.1 1.3 0.4 0.1 1.8 0.2 0.0 0.1 2.2 0.3 0.1 0.0 5.6 0.4 0.2 0.2 0.0 0.0 1.3 0.1 0.3 2.0 0.4 0.4 0.2 0.1 0.2 0.0 0.9 0.0 0.3 0.5 4.4 1.4 4.6 2.3 5.6 5.4 0.2 2.3 7.9 5.0 0.7 6.2 0.9 0.5 7.3 2.2 1.8 1.7 2.1 2.2 1.9 2.4 6.6 3.1 2.2 1.6 2.4 2.0 4.7 0.0 6.0 0.0 5.9 13.4 78.5 5.9 1.8 4.9 2.4 3.9 1.4 2.8 2.7 1.8 27.1 2.4 11.1 2.4 0.0 3.5 72.8 13.8 9.6 14.0 0.0 6.6 0.0 1.3 1.6 12.7 5.1 21.1 1.3 6.1 5.3 3.0 1.9 11.8 0.0 1.2 4.1 4.7 26.8 23.5 8.7 6.8 1.8 0.0 4.0 7.5 6.2 0.0 0.0 4.9 4.5 4.5 4.3 47.6 1.2 1.7 7.5 18.6 6.6 7.6 8.4 306.8 44.3 1.4 7.7 2.5 11.1 15.6 1.0 46.9 EIF2S2 "EIF2, EIF2beta, PPP1R67" ENSG00000125977 "Eukaryotic translation initiation factor 2 subunit beta" P20042 20 34088309-34112243 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034415, HPA041262, HPA041332" Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 480000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 39: CACO-2 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum" Nucleoli "CAB034415: AB_2095998, HPA041262: AB_2677381, HPA041332: AB_2677417" "unprognostic (5.76e-3)" "unprognostic (7.12e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.02e-1)" "unprognostic (1.47e-3)" "prognostic unfavorable (3.23e-5)" "unprognostic (9.36e-3)" "unprognostic (2.39e-1)" "unprognostic (6.55e-3)" "unprognostic (3.04e-3)" "unprognostic (1.25e-2)" "prognostic unfavorable (9.64e-10)" "unprognostic (2.52e-2)" "unprognostic (1.82e-1)" "unprognostic (1.04e-1)" "unprognostic (1.12e-2)" 50.7 49.2 40.1 44.0 42.1 45.0 42.3 43.1 54.5 34.8 39.8 45.8 38.3 33.7 37.9 61.2 30.6 32.5 46.2 39.0 41.7 54.0 59.2 46.8 52.8 44.3 41.3 32.0 81.4 35.8 27.7 54.2 43.9 35.0 42.8 23.7 43.5 33.9 100.8 39.0 37.6 40.5 43.6 37.9 50.8 37.1 41.6 46.6 42.4 64.0 56.3 63.1 37.9 48.4 211.9 139.1 103.4 125.5 99.1 149.3 196.6 188.7 180.2 184.1 184.6 493.4 144.5 188.5 135.1 171.9 204.1 194.5 169.7 310.6 222.0 61.0 92.3 373.8 110.0 254.5 254.7 241.9 116.7 153.6 259.1 182.7 270.2 125.8 195.5 273.7 223.6 174.8 153.5 135.8 226.0 201.3 100.6 243.7 251.1 128.2 176.0 176.2 145.5 174.2 104.7 71.3 209.3 125.2 403.7 119.2 189.9 282.4 132.8 208.7 129.0 132.5 179.8 162.4 153.8 195.9 196.5 185.0 155.1 54.2 77.1 64.8 54.7 89.0 68.1 84.8 77.2 77.2 75.8 71.2 72.0 72.8 47.3 74.9 83.8 105.3 96.1 64.0 40.1 42.1 43.1 54.5 39.0 41.7 44.3 41.3 43.9 43.6 41.6 48.4 157.4 169.9 162.1 13.7 167.8 180.5 326.3 384.9 81.4 60.5 171.7 154.6 145.1 223.1 241.7 139.8 31.3 359.2 139.6 145.7 307.2 344.2 314.9 182.9 160.1 199.2 126.7 300.7 17.6 529.2 394.4 128.5 110.6 139.1 144.4 80.1 253.4 497.1 243.0 42.1 17.1 229.6 215.7 223.1 119.3 163.7 126.5 147.0 119.2 16.9 286.8 92.8 126.7 17.1 25.2 519.3 133.8 129.4 182.6 292.7 141.5 335.0 207.7 95.3 111.7 102.6 226.6 446.4 211.6 132.7 174.5 641.7 124.0 220.6 200.4 343.8 EIF3L "EIF3EIP, EIF3S11, EIF3S6IP, HSPC021, HSPC025" ENSG00000100129 "Eukaryotic translation initiation factor 3 subunit L" Q9Y262 22 37848868-37889407 "Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003028 Approved Approved Nucleoplasm,Nucleoli NA NA 72000 "Cluster 44: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Nucleoli Nucleoplasm "HPA003028: AB_1078726" "unprognostic (2.07e-2)" "unprognostic (3.02e-2)" "unprognostic (5.06e-3)" "unprognostic (3.20e-1)" "unprognostic (3.79e-3)" "unprognostic (9.86e-2)" "unprognostic (1.35e-1)" "unprognostic (9.65e-2)" "unprognostic (2.66e-1)" "unprognostic (5.81e-3)" "unprognostic (2.35e-1)" "unprognostic (9.74e-2)" "prognostic favorable (6.11e-4)" "unprognostic (1.48e-1)" "unprognostic (1.42e-1)" "unprognostic (2.42e-1)" "unprognostic (2.03e-3)" 97.1 80.1 22.7 37.1 22.8 86.3 149.4 25.4 33.6 113.2 22.8 105.4 56.9 85.1 41.9 84.0 100.4 21.2 76.6 23.4 22.2 101.2 64.4 56.9 52.1 22.5 22.8 200.2 257.9 36.7 64.0 52.8 22.7 71.5 63.4 26.8 92.2 78.3 162.0 123.7 73.3 42.2 22.0 57.6 143.9 34.8 23.4 44.3 87.3 43.1 82.1 90.1 86.8 24.0 74.9 44.1 113.7 83.4 107.4 238.0 81.5 69.4 165.4 109.1 147.5 71.6 53.5 253.7 19.2 81.5 38.3 46.1 127.2 96.0 127.1 34.1 211.2 90.0 56.6 33.4 66.9 240.5 73.6 128.8 106.9 81.7 120.7 189.5 138.1 82.4 75.5 67.6 127.4 30.2 65.5 112.0 65.5 90.0 106.7 73.1 156.0 76.0 82.2 44.3 82.4 129.1 68.9 80.1 88.7 127.6 60.7 95.4 67.4 68.3 81.6 42.1 57.1 40.5 68.3 97.0 64.0 103.9 57.1 46.5 162.0 42.4 81.4 148.1 134.2 131.7 116.9 98.2 241.1 113.1 161.8 125.5 22.8 111.3 129.4 116.9 124.2 299.1 22.7 22.8 25.4 33.6 23.4 22.2 22.5 22.8 22.7 22.0 23.4 24.0 128.9 118.6 210.9 16.6 299.0 397.0 491.6 449.3 278.9 61.3 366.9 299.8 2.5 217.3 238.0 66.2 29.2 699.0 255.0 77.5 416.7 234.3 137.6 94.8 159.4 171.1 197.3 277.2 18.9 461.8 628.9 166.1 101.9 108.3 222.3 318.1 183.1 116.1 256.6 25.2 23.2 236.3 187.2 299.7 418.0 341.2 222.4 229.8 227.7 11.2 447.0 149.1 216.3 11.6 19.3 212.4 211.4 212.1 170.5 306.2 180.7 328.2 90.2 51.1 164.3 278.3 267.4 121.9 128.5 301.9 429.6 703.2 221.6 239.9 378.4 435.0 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784919 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA047083: AB_2679924, HPA050396: AB_2681111" "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.0 9.6 11.2 9.6 12.4 7.9 10.8 11.5 13.3 8.6 8.7 8.3 7.5 10.2 10.3 9.1 6.9 8.5 9.5 9.8 12.4 9.7 13.9 6.6 10.8 12.8 12.3 12.5 6.5 10.0 5.3 11.3 14.2 9.5 9.8 9.0 6.2 7.3 12.6 10.8 6.8 8.8 12.8 9.9 7.8 14.1 12.6 9.7 10.5 12.2 9.7 12.3 7.1 13.4 30.4 24.3 24.1 13.0 18.8 23.3 14.9 28.9 18.5 21.5 19.4 26.0 29.2 38.4 15.1 14.5 40.2 45.9 36.0 30.3 41.4 11.1 18.1 49.5 10.2 64.2 25.4 59.4 13.2 18.7 23.0 33.1 28.2 16.0 17.0 18.7 70.9 17.9 27.1 22.6 46.7 39.8 25.9 27.0 17.1 30.6 61.1 30.4 16.7 22.3 25.9 16.2 23.8 41.8 42.4 22.1 20.5 27.3 23.2 36.2 24.2 25.7 59.1 17.9 43.4 45.7 14.7 27.2 33.2 2.7 8.7 2.7 10.5 11.1 12.3 18.2 12.2 11.6 8.9 17.4 14.9 13.8 0.5 15.1 14.0 19.3 10.0 4.6 11.2 12.4 11.5 13.3 9.8 12.4 12.8 12.3 14.2 12.8 12.6 13.4 71.5 22.4 45.0 36.6 60.4 61.8 63.8 50.5 44.3 92.8 31.4 53.2 61.7 50.1 47.6 33.1 45.9 47.8 55.3 53.8 33.2 55.0 80.5 35.3 61.4 50.8 48.5 34.5 56.2 42.1 39.2 48.5 32.6 34.0 26.0 55.4 45.0 51.5 45.1 95.9 59.7 49.7 28.5 35.3 22.4 30.2 65.3 35.3 26.6 34.7 57.6 58.0 33.0 53.8 63.6 56.0 48.8 73.7 26.8 62.8 47.6 38.4 34.6 81.9 32.9 117.0 78.0 210.4 175.5 31.5 53.6 41.5 40.8 71.9 61.5 42.2 ETV6 TEL ENSG00000139083 "ETS variant transcription factor 6" P41212 12 11649674-11895377 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 137.2;Microglial cells: 216.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 85.1;NB-4: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000264 Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoli Cytosol "HPA000264: AB_611466" "unprognostic (4.03e-3)" "unprognostic (3.08e-2)" "unprognostic (7.54e-3)" "unprognostic (2.60e-1)" "unprognostic (2.07e-1)" "unprognostic (1.35e-3)" "unprognostic (2.74e-2)" "unprognostic (4.02e-2)" "unprognostic (3.16e-1)" "unprognostic (9.46e-2)" "prognostic unfavorable (9.38e-5)" "unprognostic (1.15e-1)" "prognostic unfavorable (4.66e-8)" "unprognostic (1.33e-2)" "unprognostic (5.99e-2)" "unprognostic (8.92e-2)" "prognostic favorable (1.54e-5)" 16.9 8.8 4.8 16.3 4.4 40.9 20.0 4.8 5.6 9.4 3.6 15.2 7.5 7.9 11.1 9.5 8.0 9.7 6.6 4.2 4.7 9.2 9.3 16.2 12.8 9.2 6.0 5.0 9.6 5.6 5.3 8.1 6.9 13.5 11.2 2.6 33.3 6.8 5.5 24.3 14.1 9.2 6.8 16.7 8.4 3.5 6.8 17.3 8.9 2.7 14.7 15.0 8.4 6.3 5.6 7.5 6.7 11.6 5.0 4.7 8.1 4.1 6.9 5.2 6.1 0.5 25.9 4.7 4.0 7.0 6.1 7.1 3.0 12.4 6.2 85.1 1.4 29.9 4.0 2.8 6.2 32.0 31.2 9.3 7.5 5.1 10.5 9.9 15.9 21.3 2.3 15.3 4.7 3.6 18.1 45.3 10.9 5.9 2.0 5.1 6.3 12.3 11.9 34.8 1.3 6.8 8.1 7.7 7.7 10.6 2.6 19.9 18.1 11.6 9.8 3.9 8.8 6.7 5.5 2.6 7.6 0.2 13.6 6.2 4.5 5.9 1.1 5.6 1.6 2.3 1.7 1.1 3.5 1.7 1.0 0.6 9.8 2.1 6.8 5.3 1.2 1.2 4.8 4.4 4.8 5.6 4.2 4.7 9.2 6.0 6.9 6.8 6.8 6.3 38.3 6.4 9.6 84.2 37.7 14.9 31.8 27.2 10.8 3.1 66.7 57.8 9.1 21.5 30.7 14.7 6.2 15.0 21.5 45.7 1.9 17.9 17.6 45.3 17.5 37.5 32.4 33.6 63.6 35.9 4.3 12.9 20.9 69.7 10.8 24.0 38.6 10.9 18.3 0.0 117.7 28.9 22.4 53.3 137.2 4.5 7.8 62.6 28.4 216.4 55.7 4.3 8.2 106.6 37.0 38.6 31.6 10.9 71.4 34.2 15.4 11.5 39.3 3.9 19.7 17.6 34.2 0.6 5.4 17.3 22.4 8.6 20.9 21.5 22.5 71.8 EXOSC2 "hRrp4p, p7, RRP4, Rrp4p" ENSG00000130713 "Exosome component 2" Q13868 9 130693721-130704894 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "rRNA processing" RNA-binding "Deafness, Disease variant, Dwarfism, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021756, HPA021790" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA021756: AB_2670809, HPA021790: AB_1848320" "unprognostic (8.19e-2)" "unprognostic (1.93e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (4.36e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.39e-5)" "unprognostic (8.33e-3)" "unprognostic (4.82e-2)" "unprognostic (1.48e-1)" "unprognostic (8.55e-2)" "unprognostic (1.20e-3)" "unprognostic (4.73e-2)" "unprognostic (6.57e-2)" "unprognostic (3.01e-1)" "unprognostic (5.05e-2)" "unprognostic (1.41e-1)" 9.1 8.2 8.6 13.8 8.7 9.9 12.6 8.9 11.1 8.9 8.6 10.3 7.7 12.8 6.8 10.0 12.8 5.6 8.8 8.9 8.9 9.7 13.0 6.7 13.0 8.5 8.6 14.8 9.9 11.5 3.2 9.2 8.4 9.3 11.9 10.6 7.1 9.0 15.0 8.4 8.3 12.9 8.9 8.3 8.2 4.1 8.6 14.6 8.4 12.0 15.8 10.1 8.6 9.3 39.9 79.7 46.6 41.2 16.8 18.9 34.0 58.6 28.1 57.4 44.1 64.4 33.7 79.0 31.2 31.8 62.9 71.0 75.8 58.8 62.9 46.9 36.7 63.1 75.2 45.3 31.3 96.7 39.9 24.0 21.7 80.8 94.1 21.1 41.6 52.3 70.1 33.1 41.0 70.3 68.2 27.3 57.8 109.3 51.0 52.3 85.8 85.5 27.5 36.4 28.6 31.8 68.3 51.4 31.1 32.8 53.5 34.1 25.5 56.1 43.5 50.2 83.3 16.8 71.4 117.2 40.0 55.0 44.7 1.7 7.3 6.0 10.0 8.3 10.6 11.6 10.2 8.9 10.4 10.0 11.1 9.4 1.6 16.5 5.7 7.1 10.1 7.7 8.6 8.7 8.9 11.1 8.9 8.9 8.5 8.6 8.4 8.9 8.6 9.3 7.6 6.4 20.5 3.6 13.5 10.6 12.6 7.7 8.0 12.4 6.1 8.3 8.7 4.3 5.7 3.7 6.2 19.1 10.6 6.0 5.9 13.4 1.4 3.8 11.4 8.0 1.2 23.5 5.3 11.3 22.8 9.8 5.1 4.5 12.7 14.0 7.1 10.7 12.8 5.0 5.2 7.9 4.1 2.5 5.7 1.7 8.4 7.8 7.2 1.9 5.4 14.7 13.4 4.5 4.0 8.3 2.7 7.9 13.7 14.2 5.0 10.4 6.7 15.0 6.6 11.7 10.2 5.8 10.9 10.6 8.4 8.3 10.1 11.9 10.0 8.1 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397359 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli Nucleoplasm "HPA053150: AB_2682058, HPA055677: AB_2682882" "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 12.9 19.4 18.6 14.1 20.2 17.4 14.0 18.9 26.1 12.5 15.1 13.3 11.4 11.3 4.2 21.4 15.1 6.6 16.8 18.8 17.8 9.9 21.7 7.3 22.0 20.8 18.4 14.3 28.6 5.9 7.2 7.4 19.2 11.0 7.2 2.3 16.4 8.4 41.7 23.0 10.8 7.2 19.0 14.3 13.6 11.4 18.3 14.8 11.6 23.1 11.8 14.7 13.9 22.1 58.2 123.5 15.1 48.8 10.7 13.5 39.4 24.5 13.1 44.6 37.0 72.5 47.5 92.9 64.8 12.9 22.8 25.1 33.1 31.3 12.2 66.7 117.3 42.7 45.5 55.7 32.1 76.7 41.8 16.3 69.0 35.6 33.8 12.1 21.1 57.7 57.5 70.2 14.2 88.1 70.2 58.6 56.6 85.2 59.9 66.9 40.9 94.8 17.6 43.1 64.4 47.8 34.6 62.4 68.2 10.5 31.1 95.6 16.2 45.9 37.4 30.1 76.9 109.6 138.5 106.3 34.9 116.0 39.0 15.2 68.2 1.9 41.3 77.7 47.9 66.0 43.3 40.9 110.1 74.0 63.2 55.4 5.0 62.1 48.6 118.7 37.0 48.6 18.6 20.2 18.9 26.1 18.8 17.8 20.8 18.4 19.2 19.0 18.3 22.1 16.1 3.2 4.8 2.3 21.3 30.5 29.0 29.6 44.9 5.5 30.1 44.2 8.4 22.8 16.9 18.4 4.2 28.4 23.5 12.7 37.2 21.7 9.1 5.5 16.7 11.1 8.5 28.0 5.0 21.4 124.0 13.1 16.3 9.1 5.1 24.7 7.1 20.3 28.8 6.7 4.8 18.4 20.3 11.8 13.3 8.5 16.8 18.9 14.2 2.8 18.9 7.0 18.6 4.0 4.3 17.2 15.3 12.4 21.3 28.0 6.6 34.9 12.7 4.1 6.6 17.8 16.0 17.0 33.1 47.4 33.2 21.2 17.0 31.5 34.2 23.8 EXOSC9 "p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p" ENSG00000123737 "Exosome component 9" Q06265 4 121801318-121817021 "Disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 154.0;Spermatocytes: 170.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041838, HPA048257, CAB070171" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli Nucleoplasm "CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331" "unprognostic (7.36e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-2)" "unprognostic (2.23e-1)" "unprognostic (2.78e-1)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (7.89e-2)" "unprognostic (3.73e-2)" "unprognostic (1.66e-2)" "unprognostic (9.25e-2)" "unprognostic (9.85e-3)" "prognostic unfavorable (6.49e-4)" "unprognostic (3.28e-2)" "unprognostic (6.66e-2)" "unprognostic (1.68e-1)" "unprognostic (7.21e-2)" 14.7 14.3 9.2 16.7 9.9 37.9 14.4 10.5 15.3 11.9 8.4 11.7 9.3 12.9 14.4 12.3 12.9 8.1 15.7 9.4 9.9 11.8 16.0 13.6 25.8 9.3 9.2 12.9 11.2 14.7 11.0 14.1 9.3 10.4 12.6 9.9 11.9 9.3 21.6 13.9 12.0 10.2 9.0 15.8 11.7 43.4 9.2 32.8 10.1 18.6 21.1 14.8 11.9 10.4 66.3 29.9 76.7 44.4 10.7 20.6 39.2 83.7 45.4 114.6 84.5 32.5 53.2 113.9 20.1 50.5 35.7 23.2 83.1 38.1 95.6 51.1 39.9 56.8 43.4 43.0 26.0 98.5 51.1 16.1 20.1 77.8 20.3 23.7 56.0 72.6 102.2 42.3 110.0 38.9 154.6 78.6 42.7 25.2 34.7 80.6 134.4 52.4 41.4 21.0 51.3 53.7 28.8 45.5 52.3 38.9 38.2 64.2 35.2 50.4 76.5 44.4 80.9 63.0 49.7 132.5 52.4 67.8 34.2 15.8 14.5 23.4 17.6 21.1 18.5 20.7 20.9 25.4 17.9 22.4 22.1 22.6 3.8 14.4 21.3 15.9 24.9 14.0 9.2 9.9 10.5 15.3 9.4 9.9 9.3 9.2 9.3 9.0 9.2 10.4 20.4 44.8 19.1 4.9 20.8 12.7 15.5 31.7 18.8 10.7 6.7 10.7 13.2 17.2 25.4 3.7 10.4 31.4 21.5 5.7 1.9 23.7 154.0 10.9 15.6 17.6 6.0 27.0 10.4 30.5 31.3 15.8 7.7 11.8 31.0 25.4 10.0 5.5 24.5 16.8 8.8 9.8 28.5 11.9 10.1 21.8 13.1 16.3 8.8 11.2 22.2 15.3 16.5 6.6 10.9 20.2 9.2 10.9 22.9 8.4 6.5 8.5 16.8 17.7 6.6 23.4 21.8 170.4 62.8 14.1 14.8 10.9 26.2 16.5 11.6 12.1 FAM102B "DKFZp779B126, SYM-3B" ENSG00000162636 "Family with sequence similarity 102 member B" Q5T8I3 1 108560089-108644900 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028451 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 20: HeLa - Mitochondria" "Cluster 41: Macrophages - Immune response" "Nucleoli, Cytosol" "HPA028451: AB_10602497" "unprognostic (1.30e-1)" "unprognostic (2.19e-1)" "unprognostic (4.08e-3)" "unprognostic (3.87e-2)" "unprognostic (1.11e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-3)" "unprognostic (3.10e-1)" "unprognostic (2.62e-2)" "unprognostic (1.32e-2)" "unprognostic (2.17e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.47e-6)" "unprognostic (1.06e-1)" "unprognostic (2.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.86e-1)" 9.1 3.9 8.1 10.5 9.7 21.2 10.7 5.1 9.2 7.4 0.1 13.3 11.0 6.5 4.2 6.0 5.1 14.7 6.6 9.4 8.6 3.2 4.9 7.8 9.0 4.1 6.8 5.3 3.8 7.5 3.8 5.9 8.1 6.3 14.6 3.6 13.7 7.8 1.3 3.7 11.2 8.8 3.0 8.8 7.6 8.6 5.6 8.7 3.5 6.0 8.2 16.4 4.4 5.0 6.9 4.9 9.7 5.2 17.0 10.2 6.4 4.0 5.4 6.1 10.3 1.8 6.8 7.6 3.6 10.4 6.3 13.1 33.2 1.4 7.8 5.1 4.8 10.6 35.8 0.8 4.3 14.0 19.8 5.5 1.4 9.0 0.5 12.3 4.0 12.5 26.3 41.2 14.4 28.4 9.0 10.0 7.6 16.2 24.6 20.8 24.5 1.6 1.7 7.9 31.4 9.3 15.9 27.4 8.3 6.8 5.8 22.5 0.7 9.8 18.4 8.6 15.5 7.6 1.9 7.1 14.4 10.8 5.3 2.9 0.4 0.4 0.3 0.9 0.2 0.3 0.3 0.4 1.0 0.3 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.1 8.1 9.7 5.1 9.2 9.4 8.6 4.1 6.8 8.1 3.0 5.6 5.0 5.9 0.0 2.2 12.1 6.1 6.1 2.3 1.0 4.6 3.9 10.1 7.2 1.9 10.0 2.2 1.8 0.0 2.4 17.2 15.6 1.9 2.7 15.3 2.1 7.8 5.5 7.2 3.8 54.9 6.1 2.7 16.3 6.6 5.2 7.6 3.6 8.2 1.2 9.7 0.0 27.9 8.1 0.0 25.1 43.2 6.9 14.3 27.5 5.4 52.5 15.2 1.2 11.3 25.1 7.2 4.5 10.5 20.7 11.9 1.9 4.5 1.0 1.8 1.1 0.0 3.2 6.5 4.4 6.4 6.5 3.7 3.4 16.4 36.2 13.8 4.6 FAM133A "CT115, FLJ37659, RP1-32F7.2" ENSG00000179083 "Family with sequence similarity 133 member A" Q8N9E0 X 93674013-93712274 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.5;choroid plexus: 3.3;testis: 7.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.6;Early spermatids: 18.8;Excitatory neurons: 13.1;Horizontal cells: 20.2;Inhibitory neurons: 24.0;Late spermatids: 28.6;Oligodendrocyte precursor cells: 22.6;Oligodendrocytes: 15.6;Spermatocytes: 26.4;Spermatogonia: 39.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 14.5;Karpas-707: 46.0;U-2197: 23.9;U-266/70: 35.7;U-266/84: 82.6" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 65: Brain - Ion transport" "Cluster 16: U-266 - Nucleosome" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (1.67e-3)" "unprognostic (4.45e-1)" "unprognostic (4.05e-2)" "unprognostic (3.86e-3)" "unprognostic (4.22e-2)" "unprognostic (8.76e-2)" "unprognostic (1.09e-2)" "unprognostic (7.42e-2)" "unprognostic (1.39e-2)" "unprognostic (7.12e-4)" "unprognostic (1.67e-3)" "unprognostic (2.13e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-3)" 0.0 1.2 5.2 0.0 5.2 0.0 0.2 4.3 9.5 0.5 3.3 0.1 0.0 0.3 0.2 0.0 0.3 0.1 0.9 4.7 6.3 0.0 0.0 0.0 0.0 4.6 5.6 0.4 0.0 0.0 2.2 0.0 5.8 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.2 4.5 0.0 0.0 7.6 5.8 0.0 0.2 0.0 0.0 0.0 0.1 4.7 0.3 2.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 3.8 46.0 0.0 0.0 0.0 0.0 1.1 0.0 11.6 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 1.9 0.3 0.0 0.0 0.0 0.9 1.1 23.9 1.0 35.7 82.6 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.2 4.3 9.5 4.7 6.3 4.6 5.6 5.8 4.5 5.8 4.7 0.1 0.0 0.0 3.6 0.0 0.6 0.0 0.0 0.0 13.6 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.8 0.0 0.4 0.1 0.0 0.0 13.1 0.0 0.1 0.5 0.0 0.0 0.0 3.0 0.7 0.0 0.0 20.2 24.0 0.0 0.0 0.0 0.3 28.6 1.2 0.1 0.0 1.0 0.0 2.9 0.0 22.6 15.6 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.2 26.4 39.0 0.0 0.1 0.0 0.1 3.7 0.0 0.0 FAM133B MGC40405 ENSG00000234545 "Family with sequence similarity 133 member B" Q5BKY9 7 92560758-92590393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066175, HPA069513" Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoli Nucleoplasm "HPA066175: AB_2685629, HPA069513: AB_2686143" "unprognostic (5.54e-2)" "unprognostic (4.42e-1)" "unprognostic (1.07e-1)" "unprognostic (1.26e-1)" "unprognostic (1.61e-1)" "unprognostic (6.70e-2)" "unprognostic (2.42e-2)" "unprognostic (1.54e-2)" "unprognostic (2.87e-3)" "unprognostic (8.56e-3)" "unprognostic (1.11e-1)" "unprognostic (8.85e-2)" "unprognostic (2.73e-3)" "unprognostic (9.01e-3)" "unprognostic (3.16e-1)" "unprognostic (1.87e-1)" "unprognostic (2.38e-2)" 14.4 13.7 21.5 12.7 23.5 35.5 16.2 25.6 43.1 15.8 20.5 13.6 13.4 14.3 22.4 13.6 13.2 9.8 11.1 21.5 20.6 13.0 16.6 11.1 16.6 22.1 21.8 16.7 15.8 11.8 12.5 10.6 23.1 13.7 11.9 9.5 13.2 11.1 16.2 14.4 13.2 10.8 21.1 14.0 13.1 8.2 23.3 17.3 14.0 15.1 14.6 13.6 14.3 26.8 24.5 12.1 34.5 55.4 20.8 22.8 20.0 29.1 29.9 26.4 32.5 21.1 27.6 43.5 26.5 19.0 22.7 19.9 28.5 17.5 40.0 22.4 37.5 35.2 20.6 43.9 20.5 36.8 27.6 14.6 17.8 20.4 24.5 21.0 16.1 31.6 46.0 50.4 29.9 30.8 58.8 59.2 50.0 22.6 16.8 42.9 36.9 34.0 26.7 27.5 35.1 31.7 26.3 29.3 32.1 32.9 27.7 26.6 19.8 28.7 46.6 37.4 30.5 12.1 14.4 76.3 18.8 48.5 39.6 15.9 13.8 14.0 12.7 15.0 18.5 30.3 16.4 17.2 13.7 23.4 19.5 17.3 5.8 15.2 11.4 31.2 21.0 7.7 21.5 23.5 25.6 43.1 21.5 20.6 22.1 21.8 23.1 21.1 23.3 26.8 157.6 57.7 64.3 23.8 146.2 114.3 196.1 130.7 84.2 83.7 120.3 113.2 27.8 184.5 87.9 88.3 75.0 61.7 258.3 126.9 99.7 93.3 47.8 174.1 167.5 89.3 137.3 119.5 28.0 87.0 62.0 99.6 59.1 294.0 87.0 76.3 109.9 120.9 72.4 55.5 27.1 118.7 95.6 121.2 155.1 19.2 102.6 116.5 76.5 27.2 112.5 104.8 121.5 27.6 57.8 89.2 122.3 88.8 139.3 126.1 84.2 98.1 55.1 73.8 52.6 207.3 107.0 100.9 115.7 75.4 104.8 70.6 151.7 78.5 113.3 137.9 FAM193B "FLJ10404, IRIZIO, KIAA1931" ENSG00000146067 "Family with sequence similarity 193 member B" Q96PV7 5 177519789-177554563 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035847, HPA035848" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nucleoli" "HPA035847: , HPA035848: AB_10601320" "unprognostic (6.58e-3)" "unprognostic (1.07e-1)" "unprognostic (8.95e-3)" "unprognostic (2.94e-1)" "unprognostic (1.81e-1)" "unprognostic (1.15e-3)" "unprognostic (4.07e-2)" "unprognostic (1.48e-2)" "unprognostic (1.91e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-3)" "unprognostic (2.78e-2)" "prognostic unfavorable (3.71e-8)" "unprognostic (1.08e-1)" "unprognostic (1.35e-1)" "unprognostic (3.15e-1)" "prognostic favorable (1.30e-5)" 37.0 25.6 23.4 24.5 19.7 58.0 40.9 22.1 25.9 52.2 14.5 38.6 22.0 38.4 14.1 34.8 41.1 17.2 27.7 24.3 19.2 41.4 51.0 45.3 31.7 16.0 16.5 51.4 52.1 11.2 37.9 21.5 15.0 50.6 15.8 20.6 37.2 17.3 22.1 55.0 49.5 14.7 12.5 70.3 36.7 31.9 27.7 30.9 41.4 7.9 22.3 34.6 43.6 18.8 10.4 13.5 29.3 25.7 14.3 13.5 63.2 9.0 9.8 14.9 14.1 36.6 19.4 19.4 13.8 9.0 18.9 17.7 13.6 19.2 11.1 43.5 13.9 13.7 22.9 17.8 8.3 13.6 27.5 13.6 21.1 12.5 13.8 26.6 15.3 30.4 13.4 18.7 10.9 34.5 24.9 39.4 20.4 9.0 10.6 40.4 6.4 16.7 14.2 29.1 27.2 17.2 10.6 30.0 9.8 22.2 29.5 18.4 19.1 16.4 13.5 10.8 11.2 20.1 9.2 16.1 13.1 21.8 13.9 0.0 0.4 0.1 0.5 0.0 0.3 0.1 0.2 0.4 0.2 0.2 0.1 0.1 0.6 0.5 0.2 0.3 0.1 0.2 23.4 19.7 22.1 25.9 24.3 19.2 16.0 16.5 15.0 12.5 27.7 18.8 16.9 19.2 26.7 45.1 8.5 8.7 5.8 7.2 11.4 11.5 12.1 18.3 14.6 20.0 11.2 11.0 18.8 5.0 11.9 14.3 0.0 6.1 6.1 8.3 10.2 12.5 8.4 6.1 41.0 8.9 8.3 11.7 22.4 10.8 5.1 14.1 12.1 13.8 5.0 11.8 39.3 15.6 6.1 10.0 8.2 8.4 9.9 10.6 8.8 21.5 8.3 7.3 9.2 39.2 38.0 6.0 8.4 5.3 6.9 7.7 9.8 2.8 10.7 12.5 6.6 12.4 11.1 15.4 13.2 11.8 12.9 4.5 10.4 8.6 11.7 6.7 FAM204A "bA319I23.1, C10orf84, FLJ13188" ENSG00000165669 "Family with sequence similarity 204 member A" Q9H8W3 10 118297925-118342328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038182, HPA062025" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA038182: AB_10669519, HPA062025: AB_2684663" "unprognostic (1.60e-2)" "unprognostic (1.42e-1)" "unprognostic (1.35e-2)" "unprognostic (8.45e-2)" "unprognostic (8.52e-3)" "unprognostic (4.47e-2)" "unprognostic (2.42e-2)" "unprognostic (2.13e-2)" "unprognostic (9.68e-2)" "unprognostic (1.32e-1)" "unprognostic (3.33e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (8.59e-4)" "unprognostic (5.55e-2)" "unprognostic (8.33e-2)" "unprognostic (1.22e-1)" "unprognostic (6.76e-3)" 27.9 19.3 15.7 22.5 16.9 54.4 31.4 13.4 23.6 22.2 11.5 27.5 20.9 26.6 32.2 26.1 20.0 21.8 35.3 17.1 16.1 27.7 29.0 25.0 27.4 15.8 14.8 28.4 24.8 30.3 14.1 20.9 14.8 20.7 24.1 15.9 25.3 22.1 36.7 18.7 18.5 26.5 15.0 24.8 21.7 49.2 16.0 28.4 29.3 27.6 27.9 25.8 17.1 15.8 56.4 24.9 40.2 56.2 39.1 42.4 22.8 43.6 81.4 61.6 55.4 29.4 51.2 39.7 26.3 47.2 27.7 47.3 34.0 45.5 55.6 62.8 42.0 33.0 23.4 26.2 58.4 86.7 44.9 29.4 54.8 45.3 94.3 51.7 53.3 50.2 35.3 45.5 51.6 31.5 53.6 80.1 28.6 24.7 22.0 45.2 77.7 29.3 56.0 28.2 25.8 40.5 29.9 27.7 66.8 19.6 44.0 61.7 37.4 32.2 30.1 28.8 67.4 32.4 31.0 57.0 62.8 92.2 33.3 73.5 57.5 70.4 36.9 64.2 39.0 50.6 41.8 34.4 59.6 35.2 35.6 41.8 32.0 34.4 69.3 43.0 51.5 57.1 15.7 16.9 13.4 23.6 17.1 16.1 15.8 14.8 14.8 15.0 16.0 15.8 71.9 60.9 55.7 54.5 66.0 55.6 63.0 60.9 63.7 38.8 61.0 67.4 78.6 52.9 47.3 44.1 73.0 39.5 84.8 30.2 135.0 85.5 255.8 62.5 79.4 67.8 41.9 59.5 49.9 113.7 49.8 72.4 41.8 60.3 68.4 140.6 64.6 49.8 62.4 33.7 48.3 56.0 63.1 69.4 76.2 132.0 76.4 73.0 60.5 27.2 77.2 62.5 92.7 53.3 45.4 95.3 68.9 70.0 62.9 54.6 35.4 115.7 44.2 55.4 26.3 73.7 78.3 258.5 170.3 55.6 50.6 30.6 62.8 62.6 48.4 61.6 FAM207A "C21orf70, PRED56" ENSG00000160256 "Family with sequence similarity 207 member A" Q9NSI2 21 44940012-44976989 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034178, HPA036354, HPA036559" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 36: HEL - Hemostasis" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "CAB034178: AB_1564323, HPA036354: AB_10672242, HPA036559: " "unprognostic (1.83e-1)" "unprognostic (9.07e-2)" "unprognostic (4.99e-3)" "unprognostic (1.05e-2)" "unprognostic (1.37e-2)" "unprognostic (1.14e-3)" "prognostic unfavorable (7.04e-4)" "unprognostic (3.23e-2)" "unprognostic (4.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.84e-2)" "unprognostic (7.94e-2)" "prognostic unfavorable (7.80e-4)" "unprognostic (1.81e-1)" "unprognostic (2.56e-1)" "unprognostic (4.12e-1)" "unprognostic (5.77e-2)" 19.8 20.9 9.8 11.3 11.0 12.6 17.6 13.9 16.1 14.3 5.7 22.3 11.1 15.1 2.1 17.9 14.5 2.2 53.6 10.6 9.8 20.3 31.1 13.0 9.3 11.1 10.8 11.6 21.5 6.0 9.4 5.3 10.7 14.2 3.7 6.1 15.7 5.7 43.3 18.5 14.3 4.8 7.7 23.8 20.2 27.3 12.3 9.4 10.5 14.4 6.5 21.4 13.4 10.0 48.4 51.9 17.2 22.2 8.3 11.4 40.9 32.4 8.7 24.4 19.6 88.1 14.8 49.0 68.7 11.5 35.5 31.8 23.9 35.5 9.7 35.9 72.8 144.6 36.4 75.2 33.1 47.7 18.1 19.9 20.4 22.0 19.2 10.5 26.7 41.6 83.9 33.5 18.6 86.7 45.2 74.3 58.2 36.0 72.1 44.0 18.4 85.7 23.5 19.0 84.0 35.7 43.0 50.7 51.4 12.2 35.4 33.8 35.2 20.4 42.3 27.5 70.8 70.0 65.5 47.6 16.3 81.1 29.1 3.1 4.0 4.1 1.8 4.1 1.8 7.7 3.2 4.3 3.8 5.0 3.5 3.5 2.4 4.4 4.7 8.9 4.0 2.3 9.8 11.0 13.9 16.1 10.6 9.8 11.1 10.8 10.7 7.7 12.3 10.0 13.8 0.0 7.5 5.5 25.6 19.2 31.7 35.3 27.9 22.7 41.4 57.7 22.6 34.3 22.7 18.4 4.2 36.9 28.8 60.0 46.9 68.1 14.8 30.6 30.1 23.3 26.4 29.2 3.2 63.5 70.7 23.3 16.8 20.9 10.2 48.6 26.4 56.3 68.4 6.7 3.8 34.3 12.2 33.3 18.4 38.5 14.6 24.9 24.9 1.0 51.7 36.9 41.2 6.0 2.9 59.3 34.8 12.8 29.4 77.9 84.1 90.2 15.2 18.3 32.9 17.7 36.2 82.0 42.0 35.1 21.0 30.8 19.5 70.7 44.3 39.9 FAM32A "DKFZP586O0120, OTAG-12" ENSG00000105058 "Family with sequence similarity 32 member A" Q9Y421 19 16185380-16192046 "Predicted intracellular proteins" "Apoptosis, Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051712 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA051712: AB_2681582" "unprognostic (3.20e-2)" "unprognostic (1.44e-3)" "unprognostic (1.25e-1)" "unprognostic (1.16e-3)" "unprognostic (1.23e-2)" "unprognostic (2.75e-1)" "unprognostic (3.31e-2)" "unprognostic (1.37e-2)" "unprognostic (3.86e-3)" "unprognostic (1.18e-3)" "unprognostic (1.56e-1)" "unprognostic (9.31e-2)" "unprognostic (3.23e-2)" "unprognostic (4.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (6.49e-3)" 64.5 69.9 64.9 48.2 66.4 94.6 57.1 60.5 69.3 44.6 57.3 68.8 78.2 57.2 49.5 69.6 45.3 53.8 54.8 66.2 62.1 60.7 95.3 51.4 60.9 62.9 63.1 43.3 52.8 54.0 37.8 61.4 63.5 50.0 57.8 28.1 56.3 47.4 50.8 73.3 74.9 52.9 60.1 67.7 68.9 30.6 65.8 64.1 48.6 49.1 59.5 63.4 49.8 64.3 102.8 76.7 118.3 76.8 137.1 104.7 111.8 97.1 109.8 117.5 128.3 106.1 120.4 67.6 165.2 126.4 84.4 76.8 122.4 106.2 102.6 89.6 134.2 125.5 66.2 95.6 110.4 159.4 141.0 121.6 109.4 94.5 86.2 103.8 128.4 137.2 100.2 96.6 117.6 136.0 124.4 165.9 170.6 168.9 187.7 129.3 81.9 111.6 129.6 100.6 101.6 154.3 82.3 77.2 107.8 84.5 65.5 179.5 120.5 90.8 53.9 167.4 123.5 114.5 204.5 107.8 132.0 191.7 80.2 278.1 266.5 547.9 127.5 339.2 136.3 152.9 122.0 140.3 228.8 159.1 146.2 160.5 220.6 161.5 390.0 157.5 185.6 343.3 64.9 66.4 60.5 69.3 66.2 62.1 62.9 63.1 63.5 60.1 65.8 64.3 59.2 44.8 46.2 3.3 54.7 46.7 32.4 61.7 40.9 26.8 56.5 51.9 36.8 55.8 45.6 36.8 20.9 100.9 65.3 119.8 92.0 102.1 17.9 39.5 56.5 58.7 67.8 49.6 6.2 103.5 108.2 52.5 40.2 53.3 62.7 55.0 45.7 99.8 86.5 42.1 6.9 63.8 34.6 75.5 45.8 40.7 38.8 57.2 58.7 6.5 93.4 56.4 84.5 7.1 7.1 136.4 157.3 52.3 49.1 49.6 120.1 85.5 37.8 24.5 26.3 27.9 61.0 26.5 44.3 47.7 53.3 105.8 53.5 56.0 59.6 54.8 FAM90A1 FLJ10408 ENSG00000171847 "Family with sequence similarity 90 member A1" Q86YD7 12 8221260-8227618 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cholangiocytes: 1.5;Early spermatids: 1.5;Excitatory neurons: 1.4;Inhibitory neurons: 1.2;Late spermatids: 1.1;Muller glia cells: 1.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.9;HDLM-2: 7.6;NTERA-2: 17.6" HPA060078 Approved Nucleoplasm,Nucleoli NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Nucleoli "HPA060078: " "unprognostic (2.10e-1)" "unprognostic (1.68e-1)" "unprognostic (5.21e-2)" "prognostic unfavorable (3.92e-4)" "unprognostic (2.69e-3)" "unprognostic (1.94e-4)" "unprognostic (4.37e-3)" "unprognostic (4.43e-2)" "unprognostic (3.93e-2)" "unprognostic (3.97e-2)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (5.30e-5)" "unprognostic (1.50e-1)" "unprognostic (5.15e-2)" "unprognostic (2.04e-1)" "unprognostic (2.06e-2)" 0.4 2.0 3.3 1.2 3.9 0.4 0.3 1.4 3.8 0.5 0.0 0.4 0.8 1.6 1.3 1.0 1.4 2.3 1.8 4.0 0.7 0.7 0.1 1.3 1.0 0.0 0.0 4.2 1.7 0.3 1.9 0.6 0.0 1.5 0.1 4.4 2.0 0.7 0.7 2.0 0.5 0.4 0.0 0.8 0.6 1.8 0.0 0.1 2.5 0.1 0.4 0.3 0.4 1.3 0.0 0.0 0.7 1.2 0.2 0.0 4.9 0.3 0.4 0.1 0.0 0.0 2.0 0.3 0.8 0.1 0.2 0.0 3.2 0.0 0.0 7.6 0.4 0.4 0.0 0.1 0.0 0.1 0.0 0.4 1.2 0.2 0.1 2.2 0.2 0.7 2.8 0.4 0.0 1.0 0.1 2.5 17.6 0.0 0.0 0.2 0.1 0.0 1.1 0.4 0.2 0.4 0.0 0.0 0.1 0.2 0.0 0.8 0.0 0.7 0.0 0.2 0.1 0.3 2.8 0.0 1.8 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 3.9 1.4 3.8 4.0 0.7 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.6 0.6 0.4 0.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.5 0.1 0.2 0.2 0.0 0.4 1.4 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.4 0.0 0.3 0.0 1.2 0.5 0.0 0.3 0.0 1.1 0.0 0.2 0.0 0.0 0.1 1.3 0.0 0.5 0.4 0.5 0.1 0.0 0.5 0.1 0.0 0.2 0.0 0.3 0.0 0.2 0.2 0.4 0.4 0.6 0.1 0.0 0.1 0.0 0.4 0.1 FAM90A10P FAM90A10 ENSG00000285950 "Family with sequence similarity 90 member A10, pseudogene" A6NDY2 8 7768977-7771988 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A14P FAM90A14 ENSG00000285814 "Family with sequence similarity 90 member A14, pseudogene" P0C7W9 8 7715443-7718453 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A16P FAM90A16 ENSG00000285620 "Family with sequence similarity 90 member A16, pseudogene" A6NEW6 8 7730739-7733749 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A17P FAM90A17 ENSG00000285720 "Family with sequence similarity 90 member A17, pseudogene" A6NEW6 8 7746034-7749044 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A18P FAM90A18 ENSG00000285913 "Family with sequence similarity 90 member A18, pseudogene" A6NE21 8 7723091-7726101 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A19P FAM90A19 ENSG00000285657 "Family with sequence similarity 90 member A19, pseudogene" A6NE21 8 7753682-7756692 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A22P FAM90A22 ENSG00000285687 "Family with sequence similarity 90 member A22, pseudogene" A8MWA6 8 7571995-7575006 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A23P FAM90A23 ENSG00000285765 "Family with sequence similarity 90 member A23, pseudogene" A8MXZ1 8 7579644-7582653 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A26 FAM90A26P ENSG00000229924 "Family with sequence similarity 90 member A26" D6RGX4 4 9170409-9176730 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " "unprognostic (1.80e-2)" "unprognostic (3.76e-1)" "unprognostic (1.56e-1)" "unprognostic (1.37e-2)" "unprognostic (2.32e-3)" "unprognostic (1.08e-1)" "unprognostic (5.86e-2)" "unprognostic (4.41e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A7P FAM90A7 ENSG00000285975 "Family with sequence similarity 90 member A7, pseudogene" A6NKC0 8 7556700-7559712 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A8P FAM90A8 ENSG00000285937 "Family with sequence similarity 90 member A8, pseudogene" A6NJQ4 8 7738387-7741396 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM90A9P FAM90A9 ENSG00000285607 "Family with sequence similarity 90 member A9, pseudogene" A6NNJ1 8 7761330-7764340 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA060078 Uncertain Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA060078: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAR2 "FLJ10462, MLSTD1, SDR10E2" ENSG00000064763 "Fatty acyl-CoA reductase 2" Q96K12 12 29149103-29340980 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 36.2;intestine: 34.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 114.3;Inhibitory neurons: 172.1;Microglial cells: 63.7;Syncytiotrophoblasts: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 50.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 76.2;HUVEC TERT2: 84.0;NB-4: 74.2;SK-BR-3: 89.6;TIME: 68.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015884 Approved Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoli "HPA015884: AB_1853998" "unprognostic (6.32e-2)" "unprognostic (2.40e-2)" "unprognostic (1.50e-3)" "unprognostic (3.33e-3)" "unprognostic (2.41e-1)" "unprognostic (4.13e-3)" "unprognostic (4.30e-2)" "unprognostic (1.18e-1)" "unprognostic (3.11e-2)" "unprognostic (6.37e-2)" "unprognostic (5.70e-3)" "unprognostic (1.92e-1)" "prognostic unfavorable (4.93e-4)" "unprognostic (2.10e-1)" "unprognostic (2.23e-1)" "unprognostic (1.33e-1)" "unprognostic (5.22e-3)" 8.3 9.0 4.1 9.3 8.3 17.1 9.3 1.2 8.5 4.3 0.0 34.5 17.6 5.6 36.2 7.4 3.6 5.2 6.6 6.2 9.2 5.0 3.8 11.3 7.9 1.2 2.9 2.3 3.2 1.3 2.4 18.1 1.3 2.6 28.2 9.4 4.4 1.9 6.3 9.0 19.2 7.6 1.4 12.2 4.9 9.2 5.2 7.0 4.4 2.6 3.0 6.5 3.7 4.9 2.5 4.9 4.9 1.2 6.8 26.9 2.1 21.3 24.7 5.8 5.4 8.2 28.0 3.7 5.4 3.4 4.3 1.5 13.4 0.2 1.4 1.8 32.2 76.2 10.7 2.7 14.7 30.0 24.0 7.5 0.2 8.7 11.0 14.3 84.0 2.9 6.6 2.7 0.9 0.8 19.9 74.2 19.3 1.6 54.5 16.1 7.9 3.1 25.7 7.2 8.6 7.9 4.8 89.6 37.8 9.7 4.1 28.2 68.2 15.6 4.6 5.6 9.3 4.4 4.9 1.8 24.5 38.5 13.7 3.8 22.8 50.0 5.0 13.9 3.4 2.0 8.3 6.2 8.1 1.8 2.9 3.2 41.0 4.0 8.0 3.1 16.1 9.6 4.1 8.3 1.2 8.5 6.2 9.2 1.2 2.9 1.3 1.4 5.2 4.9 9.1 0.0 3.3 7.8 0.6 1.3 0.1 0.2 0.6 2.0 1.4 0.8 12.1 0.0 1.4 0.0 0.0 16.0 1.1 35.7 0.0 0.1 31.5 0.4 2.9 11.9 7.2 4.6 114.3 0.2 19.6 4.8 5.6 0.4 10.8 0.0 9.7 0.0 19.3 5.0 172.1 21.8 0.0 22.2 3.7 6.4 1.2 12.2 16.0 63.7 6.9 0.5 1.0 24.6 6.9 3.3 36.8 0.4 8.0 0.4 15.1 0.4 3.2 1.2 0.0 4.2 3.6 16.6 1.0 0.3 0.3 193.9 4.2 0.9 23.7 0.3 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 60.4;intestine: 60.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 3.6 0.9 1.9 2.8 1.7 0.3 1.8 2.7 2.0 15.7 0.2 60.1 2.9 60.4 3.6 7.0 21.2 8.8 17.2 1.6 1.3 1.0 0.5 1.1 0.9 0.8 1.1 4.5 0.7 0.6 0.7 0.9 0.9 16.9 4.8 0.6 3.2 29.4 4.9 1.4 7.3 28.9 0.5 0.6 11.1 3.0 1.8 0.4 1.5 1.8 0.2 26.3 10.1 1.0 0.7 1.2 0.2 0.8 0.5 0.5 0.1 0.2 0.0 0.3 0.0 0.8 0.9 0.3 0.7 0.2 0.4 0.8 0.6 0.4 0.0 0.8 0.6 0.3 1.1 2.2 0.1 0.4 0.1 0.2 0.2 0.1 0.5 0.1 0.2 2.2 0.0 1.1 0.0 4.9 0.7 0.7 1.7 0.8 0.4 0.7 0.0 2.4 0.3 0.3 5.3 0.2 0.6 1.0 0.3 0.0 1.9 0.6 0.8 0.3 1.0 0.5 0.2 0.7 1.5 0.8 0.5 3.7 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.6 0.6 0.6 0.0 0.4 1.0 0.4 0.1 0.7 0.0 1.6 0.0 0.2 1.9 1.7 2.7 2.0 1.6 1.3 0.8 1.1 0.9 0.5 1.8 1.0 1.4 0.0 0.0 1.0 3.4 0.1 1.8 0.4 0.6 10.1 4.7 8.6 7.7 2.8 0.7 7.3 4.2 0.7 2.7 2.3 9.8 1.2 0.9 3.2 5.8 1.3 4.9 2.5 1.5 1.1 1.2 3.4 7.7 5.8 0.0 0.9 3.9 4.0 0.7 0.0 1.8 6.1 0.0 1.6 0.4 0.5 0.3 1.7 0.0 0.0 0.7 10.6 2.1 1.5 0.5 0.8 3.0 11.3 9.1 1.7 1.9 4.0 0.1 3.8 0.0 6.2 8.1 3.8 3.2 4.4 0.9 0.5 4.4 2.7 4.0 0.8 FBXO11 "FBX11, UBR6" ENSG00000138081 "F-box protein 11" Q86XK2 2 47789316-47906498 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002690 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA002690: AB_1848448" "unprognostic (1.18e-1)" "unprognostic (8.65e-3)" "unprognostic (3.93e-2)" "unprognostic (2.05e-2)" "unprognostic (7.92e-2)" "unprognostic (1.42e-1)" "unprognostic (3.85e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-2)" "unprognostic (9.82e-2)" "unprognostic (5.77e-2)" "unprognostic (2.33e-2)" "unprognostic (3.21e-2)" "unprognostic (1.55e-1)" "unprognostic (3.71e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" 27.9 19.6 24.5 19.1 25.9 32.2 20.9 32.7 28.7 21.1 21.0 19.7 16.8 33.1 24.8 18.7 22.2 20.9 22.8 26.5 25.6 21.7 26.8 22.5 25.7 22.8 23.1 34.4 19.6 30.2 17.5 23.0 24.0 22.7 20.1 33.3 16.5 20.4 28.3 19.1 17.3 29.7 22.9 24.2 19.1 41.0 25.9 22.5 26.1 28.7 27.7 22.1 16.9 25.2 52.8 26.9 62.9 53.9 42.6 40.2 37.2 36.0 48.6 32.6 31.9 22.9 25.9 32.8 45.4 50.2 40.5 25.6 42.5 37.1 47.9 22.3 21.5 31.6 21.3 36.6 41.0 33.5 32.1 39.3 41.7 28.8 48.2 51.9 42.1 16.6 31.3 33.9 40.4 25.5 31.7 32.8 38.2 34.7 26.2 40.9 58.3 25.5 47.1 42.5 44.1 52.3 34.2 31.5 54.6 46.4 14.7 27.9 46.4 40.2 37.2 27.5 40.0 28.9 16.5 60.9 27.4 30.8 42.1 4.3 1.1 2.1 1.5 1.2 1.6 2.1 1.4 1.7 1.4 1.5 2.6 1.7 2.6 2.2 1.1 2.0 1.6 1.1 24.5 25.9 32.7 28.7 26.5 25.6 22.8 23.1 24.0 22.9 25.9 25.2 40.6 16.0 39.0 100.9 34.1 67.0 44.4 22.0 24.5 45.1 22.3 15.1 11.0 15.7 24.9 18.4 33.3 19.6 37.8 24.7 11.7 17.2 34.4 38.6 40.3 39.4 23.9 17.1 151.4 15.2 16.0 37.0 23.4 48.6 29.1 37.3 33.2 20.0 25.5 55.5 134.8 17.1 24.4 40.1 81.4 40.4 30.1 51.8 35.6 137.7 30.9 30.2 25.7 138.7 143.8 25.8 17.1 39.9 36.3 44.3 17.3 14.6 37.4 42.5 19.7 42.3 34.6 86.6 50.7 24.2 59.0 36.0 35.6 33.4 19.5 65.1 FBXO36 "Fbx36, FLJ37592" ENSG00000153832 "F-box protein 36" Q8NEA4 2 229922302-230013119 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 35.5;Early spermatids: 61.7;Endometrial ciliated cells: 40.8;Respiratory ciliated cells: 53.0;Spermatocytes: 55.8" "Cancer enhanced" "Detected in all" "testis cancer: 9.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053865 Approved Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 6: T47d - Mammary gland" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli" "HPA053865: AB_2682282" "unprognostic (4.39e-3)" "unprognostic (6.51e-2)" "unprognostic (2.38e-2)" "prognostic favorable (2.28e-4)" "unprognostic (2.43e-1)" "unprognostic (1.06e-1)" "unprognostic (1.15e-2)" "unprognostic (2.38e-2)" "unprognostic (2.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.28e-2)" "unprognostic (8.04e-2)" "unprognostic (7.79e-3)" "unprognostic (3.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-2)" "unprognostic (2.68e-1)" 1.9 3.7 4.6 0.7 4.2 0.8 3.5 4.3 4.5 3.0 3.9 1.2 1.4 2.5 2.8 1.6 11.0 1.7 1.2 3.7 4.4 5.1 1.6 2.3 0.9 5.8 5.6 2.4 1.6 4.3 2.7 1.6 5.1 2.9 1.2 9.0 2.3 2.5 0.8 3.0 1.4 1.7 5.4 0.8 1.7 6.0 4.4 1.5 7.4 0.8 1.0 1.3 1.5 5.1 1.0 1.9 2.3 0.9 1.1 6.8 4.6 1.2 3.2 1.7 2.9 0.7 3.1 0.1 0.6 2.2 2.1 0.8 1.1 0.6 2.9 0.3 0.7 0.4 0.6 1.2 4.4 0.8 0.3 7.2 5.2 3.2 2.4 2.2 1.8 3.4 1.4 0.6 2.0 4.2 1.7 1.9 6.1 2.2 2.2 2.0 0.6 0.5 3.0 0.8 2.2 2.8 2.0 1.6 0.8 2.6 3.4 1.4 1.3 2.8 1.0 4.6 0.5 2.1 1.8 0.7 3.4 0.4 2.1 0.0 0.5 0.0 0.8 0.4 0.6 1.1 0.6 0.6 1.3 0.7 1.4 0.8 0.2 1.0 0.3 0.6 1.2 0.5 4.6 4.2 4.3 4.5 3.7 4.4 5.8 5.6 5.1 5.4 4.4 5.1 3.1 9.6 1.1 11.4 1.1 3.8 2.9 8.3 1.2 8.3 4.3 4.3 3.7 0.0 9.9 11.0 35.5 1.9 0.6 2.3 15.6 6.2 61.7 40.8 4.9 2.3 0.0 2.5 19.5 6.6 2.0 3.7 3.1 4.7 0.0 4.2 1.4 2.7 1.1 10.1 22.1 1.6 14.2 1.6 3.0 10.5 3.4 1.2 3.6 5.6 2.9 7.5 4.1 12.5 12.5 6.2 0.5 4.1 0.7 3.0 2.2 12.2 53.0 28.8 6.6 2.8 4.2 55.8 8.6 3.2 4.5 2.2 1.5 9.1 1.4 1.9 FEN1 "FEN-1, MF1, RAD2" ENSG00000168496 "Flap structure-specific endonuclease 1" P39748 11 61792911-61797238 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 46.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 87.5;Extravillous trophoblasts: 70.9;Spermatocytes: 61.0;Spermatogonia: 62.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002262, HPA006748" Enhanced Enhanced Nucleoplasm,Nucleoli NA Yes 160000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB002262: AB_563729, HPA006748: AB_1848494" "unprognostic (1.82e-1)" "unprognostic (2.71e-2)" "unprognostic (3.76e-2)" "unprognostic (2.77e-1)" "unprognostic (1.26e-1)" "unprognostic (6.45e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (1.50e-2)" "unprognostic (9.82e-2)" "prognostic favorable (7.85e-4)" "unprognostic (2.82e-3)" "unprognostic (5.86e-2)" "prognostic unfavorable (5.73e-6)" "prognostic favorable (9.46e-4)" "unprognostic (1.10e-1)" "unprognostic (4.49e-3)" "unprognostic (4.04e-2)" 5.9 10.4 7.8 21.3 7.8 39.5 10.2 10.9 9.9 6.2 9.6 15.5 11.2 6.3 7.1 14.2 5.7 4.3 6.6 8.0 7.7 5.8 9.9 5.6 34.0 10.0 8.3 3.9 6.8 5.6 8.3 12.9 10.7 6.2 16.1 17.4 6.1 5.9 13.1 9.6 11.4 8.9 6.8 12.8 8.4 19.1 9.1 46.0 4.8 9.6 37.4 8.1 4.9 8.1 154.6 139.7 149.3 81.3 14.9 18.0 94.9 133.3 76.1 160.9 181.4 123.4 112.8 222.6 100.3 57.3 150.5 158.3 214.3 117.7 163.3 117.8 117.6 117.6 187.7 127.3 11.0 184.7 115.4 12.7 15.8 148.1 39.0 23.3 63.1 122.1 181.3 155.1 136.0 195.4 259.7 165.4 165.3 120.3 134.7 173.8 173.7 228.9 64.4 144.7 170.0 140.7 89.6 115.0 79.1 70.1 167.4 127.1 43.2 141.5 178.1 182.3 134.6 120.4 204.3 228.9 98.4 121.9 124.6 24.7 6.7 14.2 16.2 12.9 16.8 14.4 12.3 15.1 8.0 14.8 14.0 13.8 2.7 20.0 12.9 24.5 25.2 10.3 7.8 7.8 10.9 9.9 8.0 7.7 10.0 8.3 10.7 6.8 9.1 8.1 2.7 0.0 2.2 0.3 14.0 10.3 5.2 18.2 7.4 23.8 7.4 7.4 5.8 5.7 7.7 0.0 12.5 53.0 15.9 6.7 7.9 17.3 21.7 4.2 5.5 5.5 4.8 87.5 2.0 12.2 70.9 8.6 7.1 6.3 0.0 18.6 1.1 7.2 25.7 15.2 2.4 8.0 18.3 5.4 6.8 14.4 5.6 6.2 5.4 0.0 12.4 31.3 13.4 1.5 3.1 12.2 9.4 7.2 45.3 6.5 3.7 5.7 6.4 23.3 0.0 6.8 12.2 61.0 62.1 11.3 6.1 30.9 11.0 9.0 22.0 5.2 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423237-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 63.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Fibroblasts: 216.6;Leydig cells: 83.3;Proximal tubular cells: 53.4;Smooth muscle cells: 71.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 112.1;ASC TERT1: 66.1;BJ: 45.6;fHDF/TERT166: 50.3;HSkMC: 84.8;RH-30: 119.7;U-138 MG: 56.5" "Region enriched" "Detected in some" 6 "cerebellum: 8.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 43.8 4.5 3.4 31.5 3.9 0.1 8.5 4.2 5.2 29.4 2.1 11.1 3.7 29.2 4.3 9.5 15.4 46.0 10.5 3.3 4.8 4.5 1.4 12.9 8.3 4.6 4.6 13.4 2.2 3.6 2.2 23.5 5.1 16.2 9.6 8.4 5.1 12.0 2.2 2.6 3.6 26.9 4.1 1.8 5.5 2.3 4.5 3.0 7.4 23.8 4.8 63.3 10.3 4.5 0.2 0.0 0.2 0.3 112.1 66.1 0.1 45.6 25.7 0.0 0.1 0.0 0.3 0.2 0.2 50.3 0.4 0.9 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 10.6 0.3 0.1 84.8 0.8 9.4 0.0 0.3 0.0 0.0 0.1 0.3 5.4 0.1 0.0 0.1 0.2 0.1 0.3 0.1 119.7 0.1 0.1 0.1 1.8 0.6 0.4 0.0 0.4 0.2 0.2 0.2 0.2 56.5 0.5 1.1 0.2 0.5 0.4 0.0 13.3 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 4.2 5.2 3.3 4.8 4.6 4.6 5.1 4.1 4.5 4.5 16.1 12.8 19.3 2.0 2.2 14.4 16.8 1.3 1.2 7.9 11.1 9.5 46.8 7.2 0.5 9.2 2.1 6.2 3.2 0.2 119.3 2.0 3.3 8.8 46.2 5.2 0.0 2.7 1.9 0.6 3.3 216.6 2.0 29.2 1.3 0.6 1.8 2.7 2.0 3.3 3.3 0.0 2.0 1.6 15.9 4.0 83.3 1.9 7.2 1.0 0.2 9.8 2.1 1.5 2.9 0.6 0.0 4.9 0.7 9.4 0.0 53.4 0.3 6.1 6.6 43.6 71.6 0.6 0.7 1.8 12.6 2.9 2.9 2.9 0.1 8.4 FKBP15 "FKBP133, KIAA0674, PPP1R76, WAFL" ENSG00000119321 "FKBP prolyl isomerase 15" Q5T1M5 9 113161006-113221318 "Predicted intracellular proteins" "Endocytosis, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 23.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007979 Approved Approved Nucleoli,Cytosol NA NA 9800 "Cluster 14: Monocytes - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoli Cytosol "HPA007979: AB_1848615" "unprognostic (2.81e-1)" "unprognostic (2.51e-1)" "unprognostic (2.55e-3)" "unprognostic (1.61e-3)" "unprognostic (2.54e-1)" "unprognostic (2.67e-1)" "unprognostic (2.16e-3)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (8.68e-3)" "unprognostic (1.02e-1)" "unprognostic (6.45e-2)" "unprognostic (4.28e-3)" "unprognostic (1.47e-1)" "prognostic unfavorable (4.92e-4)" "unprognostic (3.44e-2)" "unprognostic (5.62e-3)" 17.8 14.8 7.0 17.0 10.5 13.1 15.3 8.7 8.9 17.0 8.1 15.0 9.6 14.8 8.5 16.2 14.7 8.3 14.9 7.8 8.8 12.2 15.2 23.9 15.9 12.5 9.4 14.9 13.4 12.0 15.4 14.2 11.6 14.9 10.2 12.5 17.1 7.3 18.1 20.3 16.7 10.9 8.7 31.0 14.1 5.9 10.9 11.0 15.7 7.6 13.5 16.3 16.4 15.4 13.4 13.2 9.4 8.8 15.6 14.8 12.1 16.6 20.8 15.6 14.2 8.1 13.3 21.7 7.1 18.6 31.2 30.0 10.4 14.0 15.3 16.6 7.1 8.8 16.3 8.0 12.7 18.7 20.9 15.0 13.8 16.1 17.4 18.3 15.1 13.3 10.9 13.4 15.7 19.2 13.8 9.7 8.8 17.4 10.6 12.5 19.1 7.5 11.2 12.2 8.0 8.1 19.5 15.5 8.5 11.6 17.7 6.2 19.9 18.4 6.9 19.2 16.9 12.2 13.0 9.4 19.7 10.3 14.9 2.5 11.3 1.8 3.2 13.9 2.7 1.8 1.9 2.0 7.9 3.1 2.4 1.9 6.4 4.4 23.3 3.3 2.0 4.7 7.0 10.5 8.7 8.9 7.8 8.8 12.5 9.4 11.6 8.7 10.9 15.4 11.1 16.0 26.7 23.5 14.9 5.7 6.2 9.6 11.4 13.7 7.0 5.6 15.4 7.2 14.3 14.7 27.1 13.8 17.3 9.7 1.9 12.7 1.2 13.4 13.9 12.5 4.8 14.7 25.1 13.6 12.4 14.7 11.7 10.0 11.4 13.3 17.2 9.3 61.3 11.8 25.0 8.6 8.2 58.4 13.6 1.7 16.8 57.5 7.2 27.2 31.2 8.0 18.6 21.1 30.1 17.3 8.1 15.8 8.8 6.1 9.2 5.4 15.9 16.1 19.7 10.0 9.2 7.1 10.5 11.1 4.1 12.2 14.9 14.5 8.2 10.5 FOXI1 "FKHL10, FREAC6" ENSG00000168269 "Forkhead box I1" Q12951 5 170105897-170109734 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 44.0;salivary gland: 11.4" "Cell type enriched" "Detected in some" 4 "Ionocytes: 132.2" "Group enriched" "Detected in many" 7 "breast cancer: 5.8;renal cancer: 23.1" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 16 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 16 "granulocytes: 1.5" "Group enriched" "Detected in some" 5 "MCF7: 1.4;SuSa: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA071469 Enhanced Supported Nucleoli,Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 12: NES - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA071469: AB_2686403" "unprognostic (3.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.09e-1)" "unprognostic (2.48e-2)" "unprognostic (8.06e-2)" "unprognostic (7.47e-2)" "unprognostic (2.73e-1)" "unprognostic (1.52e-2)" "unprognostic (9.71e-3)" "unprognostic (4.88e-3)" "unprognostic (6.20e-2)" "unprognostic (1.34e-2)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 44.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.5 0.1 0.0 0.1 3.0 0.0 0.0 11.4 1.5 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.5 0.2 0.0 0.0 7.6 6.5 0.3 0.0 0.3 1.8 0.0 0.0 0.1 0.0 27.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 132.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.0 FP565260.1 ENSG00000275464 "Periodic tryptophan protein 2 homolog" 21 5130871-5154658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.4" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 9.2 9.2 6.4 9.9 8.8 12.1 7.4 7.2 8.0 5.9 4.9 8.5 9.1 6.8 1.7 8.3 7.8 7.3 7.5 7.1 6.8 9.0 6.8 7.1 13.4 7.6 7.2 6.7 7.7 6.5 6.0 7.9 9.1 6.5 8.4 3.5 6.7 4.7 10.1 8.6 8.2 7.3 6.8 11.5 7.6 7.1 7.2 6.7 6.6 3.2 5.3 11.4 7.1 13.7 32.0 24.0 15.4 24.2 6.6 5.0 9.1 0.2 0.0 0.1 0.1 0.4 20.1 0.3 14.1 10.5 20.8 21.0 42.9 19.0 0.0 7.4 15.1 102.4 12.4 11.9 10.4 47.6 29.1 17.8 22.5 25.5 20.1 5.0 20.1 16.5 56.8 11.6 6.6 28.4 34.4 33.1 60.4 36.5 29.3 54.0 14.2 28.8 13.5 25.3 16.6 27.3 25.5 38.4 14.9 4.2 31.5 24.9 10.2 12.0 29.7 0.3 32.9 13.9 16.0 63.5 20.4 62.3 16.7 3.3 7.3 6.9 18.5 12.6 21.2 11.0 11.3 13.5 8.7 11.2 11.1 15.2 4.1 9.9 18.2 5.5 8.5 11.6 6.4 8.8 7.2 8.0 7.1 6.8 7.6 7.2 9.1 6.8 7.2 13.7 0.9 0.0 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 1.9 0.0 0.0 2.5 0.0 0.0 2.7 1.1 0.8 0.0 9.3 0.0 0.8 1.1 0.9 0.0 0.0 0.0 8.0 1.4 0.9 0.0 0.9 5.1 0.6 0.0 0.0 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.3 1.2 0.4 0.9 0.0 GET3 "ARSA-I, ASNA1, TRC40" ENSG00000198356 "Guided entry of tail-anchored proteins factor 3, ATPase" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 37000 "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 47.5 61.6 56.4 39.4 58.2 66.2 46.5 59.0 72.8 48.4 62.4 43.0 39.9 49.8 41.0 58.1 47.0 39.3 62.0 59.6 58.4 61.6 38.4 40.8 48.3 55.4 57.3 41.9 48.2 73.3 48.2 28.0 57.9 34.3 28.7 36.4 47.3 31.4 67.6 59.1 38.7 33.9 55.9 43.4 50.9 60.2 58.9 46.9 56.3 58.6 38.1 46.3 43.3 57.3 143.7 116.5 60.7 132.3 118.6 72.4 74.6 72.4 99.7 137.5 107.6 90.3 69.6 64.8 111.0 95.4 157.5 75.2 84.5 97.6 65.4 100.9 132.7 54.3 82.4 105.3 125.8 83.5 104.9 83.6 84.1 111.3 66.1 89.2 99.4 75.9 71.3 86.8 109.5 320.4 112.9 68.1 154.6 92.0 215.6 82.2 93.6 128.4 130.2 120.7 111.6 95.5 97.3 131.3 119.8 51.5 108.2 80.5 85.5 193.3 65.4 217.1 172.4 153.9 279.4 61.7 136.2 137.0 109.0 33.6 44.3 26.3 24.8 34.3 21.2 20.3 22.0 22.2 44.8 17.0 15.7 19.5 15.6 16.7 42.9 29.4 34.2 35.8 56.4 58.2 59.0 72.8 59.6 58.4 55.4 57.3 57.9 55.9 58.9 57.3 14.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 106.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 80.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 110.7 1.7 0.0 0.0 0.0 GIN1 "FLJ20125, GIN-1, TGIN1, ZH2C2" ENSG00000145723 "Gypsy retrotransposon integrase 1" Q9NXP7 5 103086000-103120138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037402, HPA061362" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA037402: AB_10672790, HPA061362: AB_2684491" "unprognostic (3.89e-2)" "unprognostic (5.52e-2)" "unprognostic (1.57e-2)" "unprognostic (1.53e-1)" "unprognostic (7.98e-2)" "unprognostic (1.81e-1)" "unprognostic (4.64e-2)" "unprognostic (3.02e-2)" "unprognostic (4.66e-2)" "unprognostic (3.01e-2)" "unprognostic (9.60e-3)" "unprognostic (1.20e-1)" "prognostic favorable (1.63e-4)" "unprognostic (1.89e-1)" "unprognostic (4.39e-1)" "unprognostic (3.14e-2)" "unprognostic (3.08e-2)" 2.2 4.0 1.8 2.9 2.0 0.6 4.3 3.0 3.5 3.4 1.3 2.5 2.5 3.2 3.6 2.2 3.2 1.7 6.7 1.7 2.3 4.3 4.3 2.3 3.6 2.2 2.1 5.4 2.9 5.2 1.1 2.4 2.1 3.5 3.2 7.2 3.0 3.6 7.8 2.4 2.5 2.8 2.2 3.0 3.2 4.7 2.2 4.2 4.1 6.9 3.5 2.7 1.7 3.2 4.0 4.7 5.8 4.0 2.8 7.1 4.4 5.6 3.8 4.0 3.6 2.6 5.3 2.5 5.0 2.2 3.5 4.7 5.4 7.9 5.3 3.3 4.4 3.5 4.2 3.1 5.5 3.5 2.3 2.6 8.7 3.6 7.3 4.8 3.0 4.1 3.3 3.6 6.4 2.9 4.6 2.3 4.6 3.3 7.0 4.0 6.4 6.0 5.3 3.4 5.1 3.2 4.3 2.8 5.6 4.1 8.7 5.9 2.4 4.0 2.5 4.4 4.2 4.4 3.5 3.6 5.3 5.6 3.5 0.4 1.4 2.8 1.7 1.8 2.0 2.6 2.4 2.6 1.7 2.6 2.8 3.0 2.1 2.3 4.0 1.7 4.4 1.4 1.8 2.0 3.0 3.5 1.7 2.3 2.2 2.1 2.1 2.2 2.2 3.2 5.4 9.6 5.3 11.4 6.1 0.9 4.7 12.5 4.0 9.4 3.5 4.4 18.7 2.8 6.5 5.5 0.0 7.7 3.6 2.9 23.5 8.0 1.6 4.3 6.5 3.9 4.2 1.7 9.1 4.3 4.9 4.7 4.1 3.1 16.5 6.1 3.3 4.5 5.5 0.0 12.2 4.0 10.2 3.5 2.0 0.7 5.0 4.8 0.0 4.7 4.8 9.3 5.2 23.1 23.7 4.0 4.7 6.8 2.6 3.6 4.5 8.8 7.6 13.4 6.6 4.0 6.5 23.8 12.2 2.7 2.0 8.2 6.1 5.7 3.6 3.0 GLE1 "GLE1L, hGLE1, LCCS1" ENSG00000119392 "GLE1 RNA export mediator" Q53GS7 9 128504719-128542288 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041689, HPA043538, HPA061560" Supported Supported "Nuclear membrane,Nucleoli" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear membrane" Nucleoli "HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560" "unprognostic (8.74e-3)" "unprognostic (2.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (7.49e-4)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (7.91e-2)" "unprognostic (1.90e-1)" "unprognostic (1.91e-1)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.95e-2)" "unprognostic (4.00e-2)" "prognostic favorable (7.04e-4)" "unprognostic (2.62e-1)" "unprognostic (1.99e-3)" "unprognostic (5.64e-2)" 11.6 14.0 9.2 15.7 9.2 15.1 15.7 12.4 11.3 13.0 13.4 17.4 16.2 11.6 10.8 16.4 14.1 7.8 14.9 8.9 8.8 14.1 16.3 12.3 20.4 8.7 9.2 16.2 9.5 17.6 14.1 9.2 8.6 11.8 18.3 16.5 11.1 12.4 22.5 19.1 15.8 12.9 8.4 15.2 12.9 32.0 9.3 25.9 13.3 12.4 22.2 12.8 12.3 8.9 29.6 54.5 26.2 44.9 25.3 25.5 34.6 29.2 24.9 40.2 28.4 36.8 20.1 59.6 23.0 33.0 38.6 101.4 45.9 41.7 34.5 56.9 29.8 30.6 57.8 34.6 28.5 49.9 38.8 18.1 39.7 45.6 48.5 22.3 22.9 54.7 44.7 51.0 46.7 68.6 49.5 35.2 22.2 79.1 46.7 49.8 64.2 79.0 27.3 26.1 30.9 23.1 71.3 42.7 25.9 21.1 78.9 34.9 17.0 42.5 28.1 50.2 41.2 50.9 131.9 45.9 39.9 37.5 46.8 40.0 21.1 24.4 22.1 26.0 18.1 13.4 17.2 20.0 22.1 20.5 15.2 17.7 18.0 27.4 27.5 13.0 22.3 19.8 9.2 9.2 12.4 11.3 8.9 8.8 8.7 9.2 8.6 8.4 9.3 8.9 4.0 9.6 9.0 11.1 11.4 6.5 5.3 10.4 8.6 7.6 8.8 7.6 13.0 5.7 7.2 7.3 8.4 16.1 6.9 13.2 5.9 11.7 77.0 12.2 7.4 3.6 5.4 12.0 14.0 6.2 11.7 7.6 10.2 9.4 9.5 10.9 4.6 14.2 15.7 10.1 15.5 12.7 8.2 15.1 5.7 58.1 10.2 13.5 3.6 10.3 20.0 8.9 15.5 18.1 15.5 8.3 8.0 6.4 13.4 6.1 16.3 13.7 12.6 8.6 13.1 7.7 7.3 51.3 25.5 14.4 6.8 13.3 12.1 7.1 14.1 5.4 GLI2 "HPE9, THP1, THP2" ENSG00000074047 "GLI family zinc finger 2" P10070 2 120735623-120992653 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Disease variant, Holoprosencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 10.9" "Cell type enhanced" "Detected in some" "Astrocytes: 39.5;Fibroblasts: 10.4;Leydig cells: 25.1;Peritubular cells: 30.9;Skeletal myocytes: 16.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 20.1;hTEC/SVTERT24-B: 13.1;U-2 OS: 17.9;WM-115: 18.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "CAB008558, HPA074275" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nucleoli" "CAB008558: AB_2111910, HPA074275: AB_2686677" "unprognostic (6.76e-2)" "unprognostic (2.51e-1)" "unprognostic (1.05e-1)" "unprognostic (9.83e-3)" "unprognostic (4.63e-2)" "unprognostic (2.04e-1)" "unprognostic (9.43e-2)" "unprognostic (1.65e-2)" "unprognostic (2.19e-3)" "unprognostic (2.58e-1)" "unprognostic (9.23e-3)" "unprognostic (1.81e-2)" "unprognostic (4.49e-10)" "unprognostic (1.13e-1)" "unprognostic (8.88e-2)" "unprognostic (2.32e-2)" "unprognostic (1.42e-3)" 1.6 1.0 1.9 0.9 2.2 0.0 1.4 1.4 1.3 4.3 0.6 3.4 0.4 4.7 1.2 0.8 2.8 2.1 2.3 1.1 1.9 1.4 0.4 2.0 0.3 2.1 2.1 10.9 0.3 0.1 1.8 0.8 1.8 2.9 0.6 0.0 1.4 1.1 0.9 2.7 1.6 1.9 1.6 0.8 1.6 2.4 1.8 1.3 1.0 0.4 0.3 3.1 2.4 0.9 0.0 10.3 20.1 5.5 3.2 4.0 0.0 5.8 1.8 2.4 2.4 0.0 0.5 0.0 0.9 5.2 0.9 0.3 4.3 0.2 1.9 0.0 2.1 0.4 6.1 0.2 3.8 0.0 1.2 2.3 0.0 13.1 0.0 2.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 10.6 1.6 4.3 0.1 2.2 3.5 0.0 0.0 2.0 2.1 3.8 0.0 0.2 4.3 0.1 0.0 5.1 0.0 17.9 2.5 0.0 0.0 0.1 0.0 7.4 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 2.2 1.4 1.3 1.1 1.9 2.1 2.1 1.8 1.6 1.8 0.9 0.3 0.0 0.0 39.5 0.0 2.0 0.1 0.5 0.6 0.0 0.1 0.9 1.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.3 6.1 0.5 0.0 0.0 0.7 0.2 0.1 10.4 0.0 1.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 1.5 2.1 25.1 0.1 0.0 2.8 0.0 0.0 1.0 3.0 0.3 1.0 0.0 30.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 16.0 3.4 0.1 3.6 0.1 1.7 0.0 0.0 7.9 0.0 0.1 GMPR2 ENSG00000100938 "Guanosine monophosphate reductase 2" Q9P2T1 14 24232422-24239242 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 123.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000904, HPA067884, HPA068782" Approved Approved Nucleoplasm,Nucleoli No No 50000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 1: Thyroid gland - Transcription" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA000904: AB_1078998, HPA067884: AB_2685916, HPA068782: AB_2686032" "unprognostic (1.95e-2)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.03e-1)" "unprognostic (9.86e-2)" "unprognostic (5.98e-2)" "unprognostic (3.24e-1)" "unprognostic (5.21e-3)" "unprognostic (9.24e-2)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "prognostic favorable (2.21e-5)" "unprognostic (2.30e-1)" "unprognostic (1.96e-1)" "unprognostic (2.29e-1)" "unprognostic (1.12e-2)" 45.0 92.1 24.5 19.7 25.7 19.3 44.3 25.8 30.2 44.7 28.2 44.2 30.9 38.2 29.9 38.7 44.9 32.0 39.6 24.8 25.7 70.1 56.0 38.8 26.9 26.2 25.6 51.2 49.0 67.7 48.1 22.7 26.8 41.7 25.5 18.8 41.8 26.3 40.6 35.2 45.8 21.2 26.0 55.9 50.7 21.9 26.1 28.4 58.4 19.8 27.3 43.1 40.3 26.2 27.1 34.2 29.0 26.7 50.9 74.7 40.0 32.1 59.2 47.3 55.7 38.8 24.6 34.7 22.5 49.8 25.5 43.6 42.4 69.2 69.5 19.0 25.5 24.3 25.0 159.1 46.8 53.7 51.4 72.2 54.9 23.6 47.7 61.1 69.7 52.3 12.5 33.3 46.6 51.8 50.1 57.1 34.3 39.5 37.3 33.5 24.2 22.6 69.1 52.7 22.0 36.2 16.9 45.8 52.6 39.5 38.6 41.1 36.2 23.0 15.8 32.0 20.6 59.4 63.1 21.8 16.6 38.9 20.2 24.3 34.2 15.0 19.7 27.5 21.6 13.7 21.5 23.7 35.9 15.9 19.3 20.2 56.0 14.9 27.9 15.8 31.5 26.5 24.5 25.7 25.8 30.2 24.8 25.7 26.2 25.6 26.8 26.0 26.1 26.2 25.2 25.6 18.7 10.7 23.2 11.0 44.5 49.9 27.3 19.6 24.8 32.9 12.5 38.6 35.7 53.3 4.2 67.2 22.6 35.6 101.8 43.6 18.3 29.6 16.6 26.3 10.3 20.6 7.8 33.0 48.5 18.8 17.9 20.0 31.7 29.7 16.8 24.8 50.0 18.5 8.0 19.8 30.5 46.6 14.6 10.5 28.9 32.5 21.4 9.4 32.1 43.3 25.7 7.5 11.7 33.7 32.1 25.2 21.2 19.0 50.2 123.1 43.2 19.7 26.3 16.0 24.5 19.8 10.3 20.7 10.7 49.3 24.6 51.3 28.4 30.5 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595937 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced "Nucleoli,Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Nucleoli rim" "HPA027163: AB_10601655, HPA060026: AB_2684191" "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favorable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 27.8 22.4 11.1 24.8 12.1 49.9 30.4 12.5 13.5 21.7 13.1 22.8 17.8 22.8 24.4 26.4 20.1 19.4 21.6 10.9 12.1 19.2 31.6 22.7 26.5 13.0 12.0 20.4 20.8 20.9 19.3 23.5 12.7 18.2 25.5 11.7 23.2 14.2 50.6 29.5 18.7 24.4 12.1 19.6 21.9 30.2 13.5 26.1 16.0 29.0 32.7 35.2 21.2 14.1 66.5 33.5 63.9 66.4 49.8 57.1 102.9 98.6 68.5 89.3 90.4 92.6 75.2 107.8 62.7 73.5 50.8 60.6 105.1 80.5 121.1 62.6 83.5 108.4 66.4 74.5 66.5 143.3 73.7 36.2 72.6 122.4 144.3 42.7 65.2 47.1 146.8 74.6 87.3 58.2 77.7 85.9 165.8 48.2 65.9 81.8 114.7 121.8 75.0 70.7 76.9 71.1 74.2 73.4 73.1 93.8 52.7 82.5 53.0 59.1 83.9 127.2 138.6 69.9 67.8 185.8 68.3 113.2 77.3 23.2 28.1 24.4 22.5 36.3 26.0 28.1 21.0 24.6 39.8 21.1 21.9 21.2 2.8 33.5 35.3 29.0 28.2 21.7 11.1 12.1 12.5 13.5 10.9 12.1 13.0 12.0 12.7 12.1 13.5 14.1 18.5 16.0 48.1 6.5 29.7 63.3 84.3 37.2 27.3 8.8 17.5 14.5 21.9 12.8 63.3 7.3 10.4 37.2 27.8 18.2 27.4 52.9 54.0 27.2 31.0 28.1 17.3 17.7 6.4 62.3 49.4 40.8 23.9 29.7 48.1 29.5 11.0 18.3 32.0 6.7 5.3 27.3 24.4 17.9 29.6 13.5 23.9 27.7 8.8 8.4 31.7 21.1 25.7 3.5 5.7 51.5 21.9 19.2 32.4 68.3 15.7 18.8 54.4 9.6 0.0 44.8 34.8 46.7 45.6 29.5 52.8 46.1 28.3 20.6 27.5 56.5 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594301-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 24.5 19.5 12.1 16.7 12.4 10.6 18.9 8.7 17.3 14.9 8.0 19.8 8.9 19.9 9.1 21.7 16.6 6.8 23.0 11.5 12.4 26.5 21.4 14.9 16.8 12.5 13.0 15.0 19.6 15.6 10.1 9.6 12.8 19.2 13.0 2.9 16.3 10.6 79.0 17.3 16.2 14.3 9.9 18.6 19.3 13.1 11.7 11.8 14.4 31.9 19.0 22.8 16.1 14.7 54.6 67.6 31.2 46.3 28.1 20.4 44.0 66.0 27.8 53.3 30.7 74.9 44.8 131.6 55.0 47.8 34.3 38.7 68.9 59.4 54.5 38.2 65.2 82.1 65.2 57.3 26.2 174.9 48.3 25.0 51.1 96.9 79.3 13.1 36.6 44.0 135.5 31.8 40.7 96.2 82.0 39.8 138.9 92.5 71.4 72.9 52.1 96.3 35.0 58.4 50.4 75.8 59.6 146.7 41.6 31.9 46.2 89.3 52.8 50.7 66.0 53.4 121.1 57.8 69.5 169.9 45.7 89.7 79.7 0.1 9.4 0.1 20.9 17.9 20.4 29.1 21.2 24.0 17.5 30.7 24.1 25.1 0.4 19.0 22.0 11.1 15.7 12.6 12.1 12.4 8.7 17.3 11.5 12.4 12.5 13.0 12.8 9.9 11.7 14.7 17.0 32.1 38.3 5.2 36.0 73.7 65.9 32.5 26.2 7.7 23.8 25.4 27.2 25.8 33.4 16.5 8.4 35.6 19.5 26.5 25.4 51.9 12.9 19.1 53.7 32.5 37.0 42.9 6.4 57.1 53.0 29.0 23.0 20.1 57.7 24.3 18.5 46.9 37.4 8.4 4.6 26.1 10.2 13.6 21.3 11.4 26.8 19.0 23.2 2.8 18.8 6.9 23.7 1.5 3.3 53.0 17.5 26.7 23.8 92.5 7.8 34.3 14.9 6.4 32.9 66.0 45.4 47.4 44.3 33.5 62.7 15.5 26.3 38.6 43.6 51.5 GPR161 RE2 ENSG00000143147 "G protein-coupled receptor 161" Q8N6U8 1 168079543-168137667 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 41.5;smooth muscle: 27.6" "Cell type enriched" "Detected in many" 8 "Horizontal cells: 158.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 44.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015576, HPA072047" Uncertain Uncertain Nucleoplasm,Nucleoli Yes No "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm Nucleoli "HPA015576: AB_1849283, HPA072047: AB_2686484" "unprognostic (1.45e-1)" "unprognostic (3.78e-2)" "unprognostic (2.68e-2)" "unprognostic (1.58e-3)" "unprognostic (1.87e-1)" "unprognostic (6.84e-2)" "unprognostic (3.24e-3)" "unprognostic (1.48e-1)" "unprognostic (1.19e-1)" "unprognostic (5.04e-2)" "unprognostic (5.45e-2)" "unprognostic (1.31e-2)" "unprognostic (5.57e-6)" "unprognostic (3.93e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-2)" "unprognostic (6.34e-2)" 3.5 1.1 3.8 5.3 2.8 0.2 2.7 3.3 4.0 6.7 1.1 8.4 1.5 41.5 3.6 9.8 10.7 5.6 3.1 3.8 2.4 1.4 0.4 4.2 0.9 3.7 9.4 7.3 11.7 5.4 1.7 2.2 3.8 9.5 3.2 2.1 1.8 11.8 1.0 2.1 3.3 27.6 2.8 2.0 2.9 1.7 4.1 2.0 1.7 1.9 1.3 4.6 5.4 2.7 11.7 7.1 28.0 18.1 6.6 11.7 0.0 11.1 11.9 9.2 9.7 44.9 1.8 0.0 6.0 16.6 17.2 33.9 6.9 10.7 5.3 4.4 8.8 4.2 5.8 0.1 2.8 1.2 2.8 4.2 6.9 7.9 12.7 21.3 18.7 3.6 3.9 0.1 14.2 1.0 1.3 0.2 11.5 19.4 11.0 3.4 12.1 0.0 4.9 3.1 5.7 24.6 12.0 0.4 32.2 10.6 6.3 1.4 25.4 18.9 9.7 25.6 12.7 0.0 0.0 0.0 5.0 0.0 4.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.8 2.8 3.3 4.0 3.8 2.4 3.7 9.4 3.8 2.8 4.1 2.7 5.8 3.2 1.1 13.7 0.1 2.2 5.7 2.5 5.2 2.2 2.2 4.2 3.6 0.0 1.4 0.0 0.0 0.5 0.0 2.8 0.0 4.1 0.4 1.3 19.4 9.1 0.0 0.0 10.8 8.0 0.4 12.3 1.1 1.8 0.0 15.3 8.9 0.1 0.8 158.2 10.9 1.5 0.0 2.5 6.3 0.9 7.5 2.0 1.8 3.7 1.1 3.2 0.0 9.5 0.4 2.6 2.4 17.0 0.0 10.9 0.0 0.1 1.1 2.1 19.7 8.8 15.1 0.3 3.3 2.7 1.4 0.4 1.0 0.7 2.5 2.7 GPRIN3 "FLJ42625, GRIN3" ENSG00000185477 "GPRIN family member 3" Q6ZVF9 4 89236383-89307800 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 78.7;Macrophages: 53.9;Sertoli cells: 78.9;T-cells: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 102.6;RPMI-8226: 27.7;SCLC-21H: 27.2;U-266/70: 15.9;U-266/84: 13.2" "Region enhanced" "Detected in many" "basal ganglia: 16.2" "HPA043148, HPA057666, HPA059092" Enhanced Approved Nucleoplasm,Nucleoli No NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoli Nucleoplasm "HPA043148: AB_2678341, HPA057666: AB_2683496, HPA059092: AB_2683902" "unprognostic (9.05e-2)" "unprognostic (4.92e-2)" "prognostic favorable (7.22e-5)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (1.07e-3)" "unprognostic (3.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.17e-2)" "unprognostic (2.22e-1)" "unprognostic (1.34e-3)" "unprognostic (3.13e-1)" "prognostic favorable (8.33e-4)" "unprognostic (1.91e-1)" "unprognostic (5.35e-2)" "unprognostic (3.93e-1)" "unprognostic (7.82e-4)" 2.7 1.2 4.1 9.0 9.5 7.8 1.4 17.8 3.1 2.2 0.9 5.3 6.2 1.4 0.7 0.9 0.9 3.5 4.0 2.2 7.3 3.9 2.0 6.9 10.2 4.3 6.5 3.2 5.1 0.6 2.9 1.0 4.5 0.8 7.1 3.5 1.5 0.6 1.0 0.6 5.3 1.4 4.1 7.1 3.6 0.4 5.0 2.8 1.3 3.2 7.9 2.7 1.0 5.9 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.8 0.1 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 102.6 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.7 0.0 27.7 0.3 0.1 27.2 0.6 0.0 0.1 1.1 1.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 15.9 13.2 0.1 0.5 0.0 0.0 0.0 0.3 0.0 2.8 1.0 3.8 0.2 2.7 2.2 0.9 0.0 1.1 1.1 0.0 1.9 1.5 0.0 3.4 1.0 4.1 9.5 17.8 3.1 2.2 7.3 4.3 6.5 4.5 4.1 5.0 5.9 11.1 0.0 22.6 10.1 6.7 1.1 0.9 0.1 0.0 12.2 1.6 1.7 20.3 8.6 5.0 3.7 0.0 0.2 51.2 17.4 1.9 2.0 0.2 5.8 3.4 11.7 78.7 6.5 21.7 9.4 0.1 3.0 15.8 15.0 7.6 12.2 1.8 0.4 18.7 26.9 32.7 38.0 0.0 28.2 29.0 0.0 0.3 53.9 1.8 41.2 7.4 1.0 23.7 26.2 0.5 1.3 11.0 1.2 48.6 0.3 16.3 1.9 0.7 10.8 78.9 3.3 32.7 0.1 0.8 0.3 1.0 0.3 76.9 0.7 26.2 0.5 GRB2 NCKAP2 ENSG00000177885 "Growth factor receptor bound protein 2" P62993 17 75318076-75405709 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 340.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002589, HPA030749, HPA030750" Approved Supported Nucleoplasm,Nucleoli NA NA 400000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Nucleoli "CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591" "unprognostic (4.83e-3)" "unprognostic (1.85e-1)" "unprognostic (1.14e-1)" "unprognostic (3.42e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (6.04e-7)" "unprognostic (1.01e-2)" "unprognostic (2.73e-1)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.89e-2)" "unprognostic (1.08e-2)" "unprognostic (8.13e-2)" "unprognostic (3.40e-2)" "unprognostic (1.56e-1)" "unprognostic (1.58e-1)" 55.7 58.0 66.1 98.3 64.8 127.1 40.3 56.6 66.1 35.9 49.9 54.7 57.3 46.4 31.5 51.0 39.5 43.2 53.3 71.0 68.7 50.5 54.0 65.5 116.9 64.1 64.8 39.3 35.0 39.8 42.6 64.5 61.5 41.8 52.6 24.1 40.6 45.8 48.8 36.3 60.6 58.9 67.5 92.2 44.6 18.5 68.5 83.1 37.6 39.1 107.3 67.5 36.1 72.3 98.6 87.7 58.9 71.1 64.1 54.5 129.5 91.2 70.5 89.3 87.3 75.8 66.7 128.9 57.9 97.0 77.5 58.5 84.0 76.1 89.8 63.4 76.5 137.2 55.7 111.8 57.3 162.8 259.0 55.2 78.0 112.9 55.8 62.3 128.3 125.3 95.5 88.8 64.9 127.4 160.3 160.5 40.5 98.9 81.3 113.7 123.8 94.9 82.7 75.0 66.6 101.1 83.7 85.4 114.7 102.8 94.4 264.9 83.4 100.0 71.0 81.8 104.9 161.1 127.3 205.5 79.1 125.8 75.3 134.5 136.1 164.9 52.3 160.9 45.0 94.5 48.0 52.2 101.2 96.5 46.8 47.8 273.8 51.5 185.1 71.9 56.5 102.9 66.1 64.8 56.6 66.1 71.0 68.7 64.1 64.8 61.5 67.5 68.5 72.3 73.5 60.9 62.2 18.3 210.5 47.0 45.7 31.0 67.7 35.7 45.6 37.5 59.7 41.5 46.9 16.5 31.3 71.9 137.6 74.4 52.8 64.8 3.0 52.9 56.4 60.9 41.9 55.5 41.5 63.4 340.9 47.2 47.9 57.6 124.4 30.0 41.7 42.3 260.3 35.3 41.1 46.4 22.4 182.0 243.8 5.6 25.1 259.9 46.2 81.5 237.0 47.1 73.2 31.7 41.5 77.2 69.6 41.8 236.3 63.3 60.1 69.9 55.1 46.4 6.6 34.6 50.5 27.4 49.9 76.3 44.8 87.2 109.0 59.7 44.9 92.7 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;dendritic cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 18.1 28.8 24.2 9.9 24.4 16.6 16.7 21.5 32.6 31.2 40.5 21.2 8.8 26.7 7.8 65.2 24.6 11.5 38.5 24.6 21.8 25.4 21.7 20.3 12.2 20.4 20.8 24.4 35.3 18.6 47.8 11.0 19.6 40.4 9.7 18.3 24.9 12.6 50.2 51.0 18.5 15.5 17.0 21.3 24.7 26.6 22.2 18.6 34.6 20.8 11.2 19.7 35.1 21.7 27.8 60.1 43.3 50.7 37.8 30.4 24.6 29.5 33.0 40.2 34.0 45.0 25.6 30.5 42.3 36.4 30.6 30.3 55.4 37.6 32.9 13.7 53.1 25.2 49.8 63.8 21.3 29.1 32.2 37.5 28.0 49.5 21.8 26.9 40.2 34.6 31.7 24.2 32.0 67.6 32.5 34.8 58.4 15.1 28.3 59.7 53.4 31.4 25.2 28.7 54.4 36.5 29.8 24.9 18.6 34.4 44.8 21.8 43.2 40.2 24.0 25.6 30.7 25.6 24.8 30.2 16.6 31.7 30.2 2.6 3.4 3.5 31.9 3.2 23.0 3.1 3.6 15.8 4.3 2.2 3.7 10.0 2.5 12.2 3.3 6.6 4.0 6.9 24.2 24.4 21.5 32.6 24.6 21.8 20.4 20.8 19.6 17.0 22.2 21.7 16.9 19.2 23.9 29.7 10.8 18.4 7.3 14.3 23.3 45.5 10.6 11.9 27.4 10.0 17.2 12.9 93.8 7.8 86.2 18.4 5.9 11.8 2.8 40.4 37.3 18.0 30.0 7.2 30.2 11.5 4.3 22.5 19.9 22.3 19.0 26.1 13.9 13.7 10.9 26.9 33.9 17.6 18.3 10.3 7.7 4.5 19.3 12.9 3.6 14.0 10.0 15.0 52.5 17.1 23.4 15.8 9.3 15.8 29.6 13.9 10.2 9.0 30.8 35.1 13.1 16.4 15.1 17.2 18.2 34.8 20.6 4.2 32.7 25.7 12.2 6.7 GZF1 "dJ322G13.2, ZBTB23, ZNF336" ENSG00000125812 "GDNF inducible zinc finger protein 1" Q9H116 20 23362182-23373062 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024520 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 32: T-cells - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA024520: AB_10963938" "unprognostic (3.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (5.65e-2)" "prognostic unfavorable (9.81e-7)" "unprognostic (8.98e-2)" "unprognostic (2.66e-1)" "unprognostic (8.70e-2)" "unprognostic (3.88e-2)" "unprognostic (1.92e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (1.13e-3)" "unprognostic (1.45e-1)" 5.9 18.7 9.6 5.5 10.4 31.5 5.0 11.1 10.9 6.0 9.2 6.5 3.9 6.5 5.3 4.4 6.5 5.5 12.4 9.4 9.8 7.7 6.4 6.0 5.2 10.0 12.8 9.2 5.2 6.7 7.9 6.4 9.9 5.9 4.1 10.5 5.0 6.8 9.4 4.7 4.8 5.7 10.6 5.3 5.4 13.3 11.7 5.5 7.0 8.1 4.4 5.8 4.6 10.4 8.2 14.2 8.9 9.0 10.3 10.0 7.1 9.8 9.0 9.9 9.2 10.9 6.4 16.6 8.5 8.5 19.3 14.3 10.3 13.2 11.2 2.8 6.7 15.4 6.0 14.7 13.4 9.3 9.0 10.1 9.6 10.7 16.3 13.8 6.7 11.4 10.6 25.2 14.3 10.9 14.5 11.6 6.6 11.5 19.3 9.5 21.3 11.6 7.4 8.2 13.7 7.8 8.7 15.4 20.9 7.3 10.2 13.4 8.7 16.0 9.2 12.1 10.6 20.5 9.0 14.4 4.7 41.8 8.8 0.0 1.6 0.8 0.7 0.9 0.5 1.0 1.0 1.0 1.6 0.6 0.9 1.0 1.2 0.5 1.2 1.3 0.3 0.9 9.6 10.4 11.1 10.9 9.4 9.8 10.0 12.8 9.9 10.6 11.7 10.4 9.8 6.4 9.6 5.5 12.6 10.8 3.1 3.8 8.6 12.6 6.0 6.9 19.7 1.5 4.7 3.7 18.8 4.9 8.7 3.9 7.9 3.6 18.9 10.4 9.7 8.4 5.4 4.0 6.6 3.3 3.2 8.3 7.1 17.8 13.9 8.2 2.2 5.2 8.7 6.7 7.6 4.2 4.1 13.2 28.8 27.5 9.3 23.9 1.8 1.0 2.5 10.3 5.2 4.5 5.6 4.0 4.6 8.2 11.6 3.2 2.8 3.8 7.7 13.4 0.0 8.8 11.5 20.7 8.9 7.6 8.4 5.6 7.9 14.0 3.7 1.8 HAP1 "HAP2, hHLP1, HIP5, HLP" ENSG00000173805 "Huntingtin associated protein 1" P54257 17 41717742-41734644 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 68.4" "Cell type enriched" "Detected in many" 4 "Glandular and luminal cells: 66.5" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "REH: 96.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA023394, HPA076992" Enhanced Supported Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 14: REH - Unknown function" "Cluster 44: Endometrium - Transcription" Cytosol Nucleoli "HPA023394: AB_1850492, HPA076992: AB_2686822" "unprognostic (2.84e-3)" "unprognostic (3.74e-3)" "unprognostic (2.42e-2)" "unprognostic (2.30e-1)" "unprognostic (7.53e-2)" "unprognostic (4.90e-2)" "unprognostic (1.64e-1)" "unprognostic (1.32e-1)" "unprognostic (6.11e-2)" "unprognostic (8.76e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.38e-1)" "unprognostic (2.46e-2)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-2)" "unprognostic (9.29e-2)" 0.6 1.5 24.8 0.3 18.9 0.1 1.0 14.8 21.6 14.5 10.2 2.1 2.7 3.4 1.6 1.1 2.6 1.5 0.1 18.3 58.8 3.3 0.4 0.9 0.2 26.7 26.4 1.2 1.0 0.0 11.6 1.5 24.5 1.9 0.5 0.8 1.5 1.3 0.2 1.6 1.5 0.6 20.3 3.5 11.0 2.1 68.4 2.8 5.0 0.1 0.2 0.5 1.9 16.8 0.2 3.1 1.4 3.1 0.0 0.0 0.3 0.3 0.1 0.6 0.1 1.9 0.2 0.2 1.1 0.2 0.5 13.1 6.7 0.5 0.0 0.0 3.4 0.0 1.8 0.1 0.3 0.0 0.6 0.0 1.6 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.0 1.5 0.1 0.2 1.6 18.7 0.8 96.0 0.0 3.7 0.6 1.0 0.4 0.1 0.7 0.4 0.1 1.5 2.4 0.0 0.0 0.0 1.3 0.1 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.0 24.8 18.9 14.8 21.6 18.3 58.8 26.7 26.4 24.5 20.3 68.4 16.8 1.1 0.0 1.7 3.3 0.3 3.1 7.3 1.0 6.8 1.6 1.6 6.7 3.6 0.0 1.9 0.0 2.1 1.5 0.5 1.1 0.0 0.3 0.5 11.5 7.6 3.2 0.0 0.0 1.0 0.9 0.7 3.4 7.7 66.5 0.0 0.2 1.4 0.8 0.5 0.0 5.4 0.6 4.1 0.6 2.2 0.6 0.3 1.2 0.0 0.0 0.4 0.6 2.1 14.6 0.3 1.5 0.2 0.7 0.3 5.3 0.2 0.2 1.7 1.8 0.0 10.6 2.3 0.1 4.7 8.4 3.1 15.7 0.9 0.1 1.1 3.5 HDDC2 "C6orf74, CGI-130, dJ167O5.2" ENSG00000111906 "HD domain containing 2" Q7Z4H3 6 125219962-125302078 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035677 Approved Approved Nucleoplasm,Nucleoli NA NA 44000 "Cluster 37: B-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA035677: AB_10603768" "unprognostic (8.34e-2)" "unprognostic (5.41e-2)" "unprognostic (6.52e-2)" "unprognostic (6.25e-2)" "unprognostic (2.78e-2)" "unprognostic (6.39e-3)" "unprognostic (1.04e-3)" "unprognostic (1.76e-1)" "unprognostic (2.18e-1)" "unprognostic (2.38e-2)" "unprognostic (8.59e-3)" "unprognostic (5.13e-2)" "unprognostic (4.56e-2)" "unprognostic (2.54e-1)" "unprognostic (3.68e-2)" "unprognostic (1.80e-2)" "unprognostic (9.54e-2)" 47.4 84.4 58.0 20.1 65.9 19.7 42.1 59.5 98.5 47.2 78.4 38.8 20.3 36.2 29.6 49.7 37.0 15.1 82.3 60.8 64.5 75.6 22.9 31.9 27.1 65.1 66.8 41.1 44.5 49.4 50.0 15.7 63.0 38.5 22.1 31.5 45.8 23.8 118.1 39.0 30.6 13.6 60.8 27.6 43.7 58.7 61.6 22.2 40.3 60.7 24.8 39.2 39.5 60.7 29.7 81.2 46.2 191.3 23.0 30.8 59.7 36.4 41.4 30.9 33.1 122.7 30.4 119.9 80.8 57.4 89.0 26.5 53.1 41.1 36.5 46.7 166.8 55.2 43.6 125.1 65.0 76.6 45.3 56.0 61.8 49.6 104.6 44.6 20.2 67.8 205.1 51.4 59.5 162.7 61.2 73.8 57.7 79.9 58.8 92.8 37.2 25.2 68.7 34.1 84.0 44.5 43.9 84.8 88.8 35.4 50.2 126.6 18.2 37.7 44.5 58.8 75.8 72.1 48.2 110.1 56.0 122.6 80.4 13.8 33.4 6.7 53.3 30.6 43.8 71.2 57.7 72.6 36.1 59.4 71.3 78.2 7.3 62.1 29.0 38.3 55.7 44.0 58.0 65.9 59.5 98.5 60.8 64.5 65.1 66.8 63.0 60.8 61.6 60.7 23.0 25.6 41.2 22.5 39.3 44.6 64.3 114.9 70.6 62.6 73.5 114.4 119.9 37.1 55.3 62.5 14.6 86.6 56.0 35.0 338.5 86.0 61.3 50.9 60.7 24.2 64.5 33.4 17.1 98.0 156.4 67.5 33.6 37.5 38.0 84.8 9.3 21.3 112.2 69.0 17.9 76.4 77.3 54.2 20.4 42.1 91.0 34.6 80.0 15.0 31.7 90.5 155.5 19.1 10.6 58.5 45.3 114.7 47.4 101.9 72.3 254.8 38.9 25.0 39.5 83.9 72.6 124.5 74.6 88.6 43.0 45.7 47.6 145.8 84.1 57.9 HDHD3 "C9orf158, MGC12904" ENSG00000119431 "Haloacid dehalogenase like hydrolase domain containing 3" Q9BSH5 9 113373419-113376999 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 156.4" "Cell type enhanced" "Detected in many" "Distal enterocytes: 214.0;Exocrine glandular cells: 156.4;Paneth cells: 208.6;Proximal enterocytes: 254.0;Proximal tubular cells: 275.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 73.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020427, HPA024158, HPA024585" Enhanced Enhanced Nucleoli,Vesicles NA NA "Cluster 24: B-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli Vesicles "HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565" "unprognostic (1.30e-1)" "prognostic favorable (2.72e-4)" "unprognostic (3.01e-2)" "unprognostic (1.31e-2)" "unprognostic (8.24e-3)" "unprognostic (1.57e-2)" "unprognostic (6.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.76e-2)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (5.87e-2)" "prognostic favorable (3.54e-7)" "unprognostic (2.16e-2)" "unprognostic (1.84e-1)" "unprognostic (4.68e-1)" "unprognostic (1.19e-3)" 12.2 156.4 16.8 11.1 18.0 8.4 19.5 16.2 19.3 19.9 14.5 59.7 82.9 13.4 14.9 42.1 16.5 17.8 22.4 15.8 17.7 56.3 122.8 10.2 10.2 15.7 17.0 19.9 53.0 68.4 23.1 5.0 16.2 30.4 35.9 8.0 52.2 16.1 8.8 28.3 68.5 7.7 15.7 17.6 50.1 7.0 18.5 6.7 38.7 5.7 7.6 17.6 21.1 15.5 7.4 20.8 4.4 12.3 10.7 4.7 37.0 5.4 10.1 8.6 9.3 38.3 36.1 16.2 6.6 3.0 17.0 28.3 7.0 8.3 2.9 22.9 16.1 22.4 12.5 24.1 12.5 1.4 16.6 7.4 17.4 7.0 19.7 9.9 4.5 14.9 18.0 4.0 4.1 48.3 10.4 6.5 9.9 73.7 16.1 8.5 0.0 13.2 11.0 15.4 11.1 7.0 9.3 39.4 14.0 9.5 24.8 4.7 4.5 1.7 0.1 1.4 1.9 9.7 20.2 6.8 2.1 0.1 1.3 0.2 3.7 8.2 12.4 2.1 14.0 14.8 14.2 11.5 6.1 16.6 14.5 11.1 2.4 8.2 0.2 14.1 17.1 8.5 16.8 18.0 16.2 19.3 15.8 17.7 15.7 17.0 16.2 15.7 18.5 15.5 4.1 9.6 10.1 24.5 19.7 9.9 20.6 26.6 10.8 10.3 38.6 31.2 15.8 80.1 32.6 23.9 10.4 29.4 11.7 214.0 86.1 84.8 0.2 20.9 6.4 9.4 40.3 15.4 9.2 156.4 16.5 8.6 112.7 22.3 7.6 122.4 9.7 85.4 20.6 1.7 10.4 80.4 28.5 6.5 3.7 2.0 14.3 6.9 10.6 6.5 13.7 12.1 15.5 5.5 4.9 104.8 208.6 9.1 9.3 23.7 254.0 275.1 33.3 13.8 6.6 5.5 11.1 0.3 6.0 42.9 14.6 31.6 14.0 26.0 94.6 51.4 HECTD1 KIAA1131 ENSG00000092148 "HECT domain E3 ubiquitin protein ligase 1" Q9ULT8 14 31100112-31207804 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 218.4" "Cell type enhanced" "Detected in all" "Urothelial cells: 302.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002929, HPA054461" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Nucleoli" "HPA002929: AB_1850574, HPA054461: AB_2682496" "unprognostic (6.71e-2)" "unprognostic (4.86e-2)" "unprognostic (5.31e-2)" "unprognostic (1.25e-1)" "unprognostic (1.64e-1)" "unprognostic (6.99e-2)" "unprognostic (1.32e-1)" "unprognostic (7.03e-2)" "unprognostic (2.29e-2)" "unprognostic (3.13e-2)" "unprognostic (3.60e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.20e-6)" "unprognostic (6.53e-2)" "unprognostic (1.22e-1)" "unprognostic (1.07e-1)" "unprognostic (9.91e-3)" 43.0 48.6 27.8 23.1 33.6 54.0 37.6 58.6 33.7 43.5 34.0 38.3 25.1 37.0 30.7 74.6 33.8 26.7 47.2 27.2 30.9 37.0 74.3 32.9 28.7 30.2 30.1 38.5 34.7 56.5 34.4 35.5 32.5 30.7 31.2 66.9 42.6 31.0 218.4 50.8 33.6 30.8 28.0 30.4 43.7 42.7 31.3 26.3 51.3 133.6 37.3 39.8 51.5 36.6 95.1 54.6 49.2 30.4 144.0 77.2 44.7 54.8 54.1 47.4 39.7 41.0 47.8 72.1 57.8 97.3 34.0 62.6 63.2 47.7 69.6 44.5 24.9 75.6 44.3 163.9 66.9 81.8 52.7 66.3 64.4 52.2 80.9 63.6 87.5 42.2 54.4 32.1 72.8 72.4 31.8 31.7 36.0 76.6 47.5 53.6 58.0 30.4 71.3 93.2 36.2 40.8 79.8 54.5 49.0 56.3 58.7 49.5 93.4 56.6 42.9 41.9 49.0 34.3 52.9 79.0 28.0 37.3 49.7 9.1 5.7 8.3 4.5 4.8 5.2 4.8 5.2 4.1 6.4 6.3 4.2 4.3 3.0 6.3 3.8 5.3 5.6 2.4 27.8 33.6 58.6 33.7 27.2 30.9 30.2 30.1 32.5 28.0 31.3 36.6 63.4 48.1 80.8 84.5 60.7 86.7 93.5 61.2 48.3 98.9 40.8 28.6 108.1 25.8 94.8 71.7 98.0 70.2 72.1 40.9 11.7 44.2 3.6 101.6 83.0 60.0 48.7 41.2 89.9 36.1 42.9 59.9 96.8 118.1 32.9 81.6 46.4 84.7 29.0 65.6 101.1 33.0 63.1 43.9 34.5 8.7 69.0 54.0 33.8 90.9 65.1 40.9 78.2 100.0 127.9 52.6 33.9 74.4 71.1 106.3 37.1 22.4 148.4 194.5 46.0 77.4 78.9 50.6 100.0 83.7 114.9 140.0 61.4 97.0 44.5 302.9 HERPUD2 FLJ22313 ENSG00000122557 "HERPUD family member 2" Q9BSE4 7 35632659-35697459 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 329.7;Late spermatids: 660.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015630, HPA076087" Approved Approved "Nucleoli,Nucleoli rim" No No "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Nucleoli rim" "HPA015630: AB_1850609, HPA076087: AB_2686774" "unprognostic (1.85e-2)" "unprognostic (5.31e-3)" "unprognostic (2.76e-1)" "unprognostic (3.79e-1)" "unprognostic (3.46e-1)" "unprognostic (2.73e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (2.30e-2)" "unprognostic (7.95e-2)" "unprognostic (5.13e-2)" "unprognostic (1.95e-1)" "unprognostic (5.42e-2)" "unprognostic (6.54e-2)" 17.4 13.6 17.1 19.7 19.8 33.6 14.7 18.6 19.1 17.3 19.4 16.2 15.9 21.0 15.0 21.2 16.6 19.3 16.6 16.4 16.2 16.1 23.5 21.1 21.5 17.9 17.3 32.6 28.9 14.3 10.3 17.7 17.2 15.1 16.8 23.0 14.8 12.8 16.4 23.1 16.8 17.9 16.5 24.3 17.1 26.0 18.2 18.0 23.3 14.4 19.8 18.3 16.0 21.2 36.4 13.1 25.5 28.2 34.0 26.7 18.0 25.4 31.3 14.6 16.9 15.3 39.3 28.2 35.0 28.9 58.4 41.7 12.7 16.8 22.4 17.0 16.3 18.5 17.1 12.6 29.3 17.2 20.9 31.5 31.4 18.1 29.6 32.9 24.8 32.9 28.2 34.8 27.3 19.3 21.1 31.3 19.5 23.8 15.9 22.6 34.0 20.0 20.4 16.4 23.8 37.9 35.3 30.5 23.0 42.2 31.5 25.0 28.9 26.1 29.4 24.5 19.9 45.0 57.4 28.0 24.9 27.9 48.0 8.8 7.4 23.2 11.0 8.4 12.6 4.8 9.7 12.0 6.3 7.0 6.1 8.6 12.4 13.7 11.3 3.8 10.1 5.7 17.1 19.8 18.6 19.1 16.4 16.2 17.9 17.3 17.2 16.5 18.2 21.2 30.8 25.6 17.1 66.6 48.1 16.8 17.0 9.0 20.5 14.1 12.0 12.7 12.8 20.0 11.8 5.5 8.4 17.6 57.4 19.8 17.6 25.0 329.7 20.5 19.3 21.5 14.3 27.4 25.8 28.9 25.0 23.2 24.5 25.5 36.8 24.4 24.3 21.8 17.5 11.8 44.2 11.8 12.2 25.1 20.0 660.5 27.4 27.3 23.2 31.9 28.5 24.0 40.2 37.2 34.7 34.7 16.0 25.2 42.8 17.9 24.3 12.7 11.1 13.9 13.1 26.5 26.6 45.0 18.7 19.9 15.8 31.1 83.2 16.6 14.2 20.3 HES7 bHLHb37 ENSG00000179111 "Hes family bHLH transcription factor 7" Q9BYE0 17 8120592-8124106 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 2.1" "Cell type enhanced" "Detected in some" "Melanocytes: 3.6;Smooth muscle cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 6.0;Daudi: 6.0;HAP1: 8.3;HDLM-2: 6.5;HeLa: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA072105 Uncertain Approved Nucleoplasm,Nucleoli No NA "Cluster 43: Testis - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Nucleoli "HPA072105: AB_2686488" "unprognostic (1.98e-1)" "unprognostic (7.91e-3)" "unprognostic (1.16e-3)" "unprognostic (1.08e-2)" "unprognostic (2.11e-1)" "unprognostic (4.99e-2)" "unprognostic (2.84e-1)" "unprognostic (5.13e-2)" "unprognostic (1.32e-2)" "unprognostic (2.04e-1)" "unprognostic (2.74e-1)" "unprognostic (1.22e-5)" "unprognostic (2.99e-2)" "unprognostic (4.79e-2)" "unprognostic (2.69e-2)" "unprognostic (1.55e-1)" 0.3 0.1 0.2 0.0 0.2 0.0 0.3 1.7 1.6 0.7 0.0 0.3 0.0 0.7 0.0 0.3 0.5 0.1 0.9 0.5 0.2 2.1 0.0 0.9 0.1 0.2 0.0 0.9 0.1 0.4 0.4 0.6 0.2 0.4 0.0 0.5 0.6 0.0 0.2 0.5 0.2 0.0 0.3 0.4 0.2 1.1 0.2 0.0 0.5 0.0 0.1 0.2 0.7 0.4 6.0 0.4 0.5 1.8 0.1 0.2 0.2 0.3 0.5 0.5 2.2 0.1 0.3 6.0 0.1 0.0 1.0 0.7 8.3 0.7 0.0 6.5 3.9 0.2 13.9 0.1 0.7 0.7 0.8 0.1 1.1 1.8 4.4 1.0 0.1 1.0 0.2 2.9 0.2 0.1 0.1 0.3 0.2 0.5 1.5 0.6 0.3 1.2 0.2 0.0 0.3 2.9 0.3 0.0 0.3 0.0 0.0 0.0 0.6 0.0 1.3 1.4 2.1 3.9 0.9 0.4 0.6 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.7 1.6 0.5 0.2 0.2 0.0 0.2 0.3 0.2 0.4 0.9 0.0 0.0 1.0 0.2 2.2 1.0 0.3 1.2 2.3 2.3 1.7 1.3 0.0 0.1 1.8 0.0 0.0 0.8 0.2 0.0 0.1 1.7 0.2 0.1 1.7 0.0 0.0 1.1 0.0 0.0 1.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 2.0 0.3 1.8 0.0 0.0 0.5 3.6 0.0 0.6 0.9 0.0 1.0 0.0 0.0 0.0 0.4 0.1 1.6 0.0 0.1 0.2 0.7 0.0 1.5 5.9 0.1 0.6 1.0 1.6 0.3 0.3 0.0 0.2 0.2 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 275.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Supported Nucleoplasm,Nucleoli NA NA 72000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 17: WM-115 - Nervous system development" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 28.1 9.0 22.1 79.6 20.9 184.0 27.4 17.8 27.3 93.3 2.6 59.9 118.7 22.8 16.7 275.1 41.0 39.2 35.8 24.1 23.3 89.2 20.0 46.5 139.3 24.3 19.1 4.7 31.9 15.0 15.4 82.4 21.1 27.7 57.2 32.2 69.7 12.6 119.7 141.6 103.6 9.7 15.4 68.7 73.3 80.1 22.9 156.0 31.5 35.1 154.7 100.1 109.6 25.2 1418.7 547.0 274.2 192.9 124.8 916.6 1193.8 556.0 628.8 421.5 233.4 361.3 960.0 658.9 273.1 229.1 264.0 294.7 326.2 991.8 332.3 146.0 228.2 202.6 177.1 488.2 263.7 732.1 227.3 396.1 109.4 765.1 395.8 1083.8 1290.0 369.3 832.0 32.9 596.0 143.0 650.0 898.8 1340.9 697.5 950.3 947.6 6.2 728.0 286.6 128.4 477.0 202.5 59.3 278.3 533.3 430.2 112.2 775.8 1132.1 218.5 691.2 321.3 528.0 260.5 444.5 867.4 461.2 301.7 1115.0 18.7 26.6 35.5 24.4 26.8 32.2 63.5 45.0 39.0 79.6 39.5 52.0 42.9 6.7 20.1 26.5 86.6 55.8 30.7 22.1 20.9 17.8 27.3 24.1 23.3 24.3 19.1 21.1 15.4 22.9 25.2 11.0 28.9 21.7 2.3 117.8 432.3 947.5 181.3 109.8 29.0 88.8 47.4 30.8 28.6 106.1 40.5 4.2 894.3 70.3 173.5 46.9 755.3 7.2 50.5 14.6 113.9 117.0 268.3 5.4 277.5 799.8 72.0 79.5 115.3 66.7 8.3 18.2 12.3 377.2 11.8 5.7 226.4 97.6 74.0 149.9 24.5 5.6 94.3 90.7 1.0 74.3 44.1 33.0 4.5 2.7 1838.5 249.1 2.6 198.2 1483.3 174.5 15.8 21.7 41.9 0.0 18.6 77.7 40.2 417.6 224.7 361.4 822.8 66.6 0.9 364.3 1681.0 HMGB2 HMG2 ENSG00000164104 "High mobility group box 2" P26583 4 173331376-173334432 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "bone marrow: 2347.2;lymphoid tissue: 939.2" "Cell type enhanced" "Detected in all" "Erythroid cells: 1915.4;Extravillous trophoblasts: 872.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 798.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 2454.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003506, CAB037206, HPA053314, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli "Secreted to blood" NA Yes 1200000 "Cluster 46: Basophils - DNA binding" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: AB_2682109, HPA073663: " "unprognostic (2.82e-1)" "unprognostic (8.52e-3)" "unprognostic (2.56e-1)" "unprognostic (8.37e-2)" "unprognostic (8.05e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.13e-4)" "unprognostic (4.41e-2)" "prognostic unfavorable (7.04e-4)" "unprognostic (9.65e-2)" "prognostic unfavorable (7.60e-12)" "unprognostic (1.60e-2)" "unprognostic (2.83e-2)" "unprognostic (2.68e-2)" "unprognostic (1.21e-2)" 90.3 31.0 36.3 146.1 38.4 2347.2 89.1 35.4 49.9 79.0 33.0 117.1 93.2 92.3 47.3 115.6 78.8 43.5 85.8 33.2 38.3 74.3 37.8 83.8 390.4 37.5 36.8 118.9 27.2 18.3 35.4 111.0 38.0 46.9 122.2 134.1 59.8 35.2 72.4 75.1 108.7 65.5 36.3 159.5 66.0 136.0 36.1 939.2 56.4 57.0 388.9 68.2 86.1 40.1 498.2 114.6 976.8 444.4 118.2 118.2 375.1 366.3 271.3 386.7 345.7 329.0 673.6 1645.5 79.2 203.0 207.4 190.3 645.0 196.1 601.0 1004.0 303.4 1823.2 308.8 487.8 115.7 1642.8 683.4 114.7 59.2 194.2 439.1 211.5 402.8 866.1 703.9 2282.4 358.9 409.9 2454.9 1513.7 355.4 289.4 199.3 1226.7 499.7 620.4 227.0 208.8 838.6 759.0 365.5 209.6 166.6 340.8 291.1 1173.2 236.0 175.5 513.6 219.0 554.9 734.8 437.1 1869.4 149.1 1178.4 464.4 798.0 135.9 407.0 94.1 57.6 86.2 72.5 137.8 131.1 112.8 57.6 88.4 85.3 316.7 83.0 49.1 43.2 266.4 107.6 36.3 38.4 35.4 49.9 33.2 38.3 37.5 36.8 38.0 36.3 36.1 40.1 167.0 28.9 64.1 5.9 153.2 158.8 141.5 131.8 75.1 48.9 75.3 107.8 229.0 38.6 78.3 55.2 35.5 472.6 222.9 116.5 142.8 25.9 30.4 71.2 71.7 128.0 74.7 1915.4 2.7 16.1 872.5 121.5 63.2 76.5 110.6 210.5 171.7 26.5 210.1 45.4 4.7 191.2 109.9 295.0 142.9 33.1 105.3 233.9 67.6 6.5 241.9 81.8 132.8 1.0 4.8 11.3 75.2 57.6 268.6 114.2 65.4 51.0 149.8 143.5 78.9 71.7 134.4 493.6 400.9 233.6 134.0 128.7 289.5 42.3 284.7 89.0 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990771 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 136.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 419.1;Extravillous trophoblasts: 820.7;Syncytiotrophoblasts: 1400.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 11.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 738.7;U-698: 675.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062583, HPA073663" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Nucleoli "HPA062583: AB_2684800, HPA073663: " "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 8.9 13.7 10.5 19.7 10.5 85.6 15.6 10.4 20.3 34.0 6.5 43.9 27.1 16.4 44.8 26.1 16.9 9.7 11.3 14.5 13.9 19.6 101.4 15.9 25.2 13.0 11.2 5.9 17.2 85.4 4.2 136.6 11.3 13.9 32.4 3.1 23.8 15.9 53.5 19.2 28.1 13.8 10.2 21.2 16.1 40.1 13.4 65.2 14.3 8.9 35.8 18.7 10.5 9.5 263.5 115.5 351.9 184.2 14.5 42.9 437.4 112.9 73.6 127.9 66.1 91.6 106.0 183.0 354.8 87.5 72.3 123.3 324.4 738.7 143.3 125.6 94.7 159.4 110.2 145.6 21.5 243.9 78.0 33.9 171.6 52.5 131.5 32.7 168.3 110.5 84.5 105.4 154.2 201.9 269.3 186.2 209.2 171.0 138.1 325.4 286.3 103.6 95.2 125.3 252.7 164.4 167.4 177.7 56.0 199.3 157.8 158.5 128.0 53.0 123.9 169.9 253.1 94.9 128.7 675.7 63.1 121.3 109.9 0.0 4.3 11.3 0.4 3.0 0.1 2.7 2.0 2.9 6.1 0.5 0.0 0.2 0.7 0.8 5.0 3.1 5.8 2.5 10.5 10.5 10.4 20.3 14.5 13.9 13.0 11.2 11.3 10.2 13.4 9.5 10.4 38.5 31.2 0.7 15.1 23.7 18.9 158.6 12.5 0.5 24.2 16.0 16.0 8.6 123.5 31.3 2.1 419.1 4.5 32.1 37.2 82.4 232.3 61.9 18.9 19.6 65.7 136.1 1.3 86.5 820.7 17.6 22.4 55.9 8.2 44.2 13.6 84.4 101.0 0.0 3.7 37.0 219.7 20.8 43.7 75.9 3.7 22.1 21.4 2.8 23.6 4.1 1.0 1.5 0.5 91.5 35.7 3.4 47.1 27.5 31.8 66.5 113.3 1.8 0.0 39.8 29.0 22.7 50.2 41.1 20.3 1400.2 10.1 10.4 60.7 18.5 HMGN2 HMG17 ENSG00000198830 "High mobility group nucleosomal binding domain 2" P05204 1 26472440-26476642 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018371, HPA077364" Supported Supported Nucleoplasm,Nucleoli NA NA 640000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB018371: , HPA077364: AB_2686835" "unprognostic (3.10e-2)" "unprognostic (6.88e-2)" "unprognostic (3.10e-3)" "unprognostic (4.13e-2)" "unprognostic (4.06e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (2.36e-1)" "unprognostic (2.44e-3)" "unprognostic (2.86e-2)" "unprognostic (1.05e-3)" "unprognostic (5.23e-3)" "prognostic unfavorable (3.92e-4)" "unprognostic (3.00e-2)" "unprognostic (2.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.15e-1)" 216.3 225.6 180.2 254.5 187.3 1137.3 234.8 179.6 251.3 328.1 162.5 280.3 176.3 283.8 359.3 291.1 293.4 142.9 192.5 170.6 183.1 259.7 212.9 259.2 436.5 185.1 178.8 394.6 252.5 160.4 328.7 214.9 188.4 281.6 301.1 285.0 217.1 162.8 251.8 242.8 270.0 235.8 188.7 324.3 224.7 160.4 175.8 916.1 306.1 133.5 534.0 245.1 250.7 211.6 1074.5 304.8 1192.5 496.5 112.0 251.6 390.8 517.2 331.2 1089.4 835.7 305.8 1073.1 1107.2 443.1 482.3 338.4 627.8 1564.6 565.6 1001.7 684.2 906.7 1222.2 401.5 360.2 197.7 2793.6 738.7 254.9 303.4 602.1 369.1 245.1 541.7 866.8 964.3 643.0 623.0 690.8 1906.1 1363.3 922.7 1463.0 619.6 1384.3 1598.6 776.5 380.3 278.6 1064.5 641.1 1384.3 498.7 651.4 304.9 759.0 1508.9 322.3 536.9 920.4 977.1 943.6 641.2 899.2 1266.9 338.9 2989.0 1056.9 331.8 530.8 1430.5 279.2 622.3 267.3 532.2 379.7 343.3 531.5 505.6 412.4 337.7 462.4 355.5 690.4 704.7 746.7 1084.6 180.2 187.3 179.6 251.3 170.6 183.1 185.1 178.8 188.4 188.7 175.8 211.6 128.7 342.9 394.4 28.1 459.3 288.6 323.8 383.2 211.1 180.2 353.0 241.3 93.4 221.6 314.8 261.1 141.8 898.7 325.2 227.2 371.7 218.4 204.3 328.9 291.1 190.3 576.9 980.4 14.4 268.7 606.4 435.4 263.5 278.1 383.0 375.0 185.6 147.5 763.0 94.2 22.2 564.5 193.3 434.3 467.9 53.5 185.8 477.5 227.7 15.0 655.6 376.0 399.6 15.1 36.9 93.7 304.4 151.9 669.5 250.4 238.0 320.4 495.6 370.2 124.9 249.0 325.7 306.4 412.0 585.8 213.4 923.4 369.5 351.9 613.2 314.0 HOMEZ KIAA1443 ENSG00000215271 "Homeobox and leucine zipper encoding" Q8IX15 14 23272422-23299447 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 34.4" "Group enriched" "Detected in all" 6 "Early spermatids: 309.7;Late spermatids: 78.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036316, HPA036317" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 15: RT4 - Unknown function" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA036316: AB_2675056, HPA036317: AB_10669787" "unprognostic (3.70e-2)" "unprognostic (7.58e-2)" "unprognostic (6.36e-2)" "unprognostic (3.93e-2)" "unprognostic (9.11e-2)" "unprognostic (5.23e-2)" "unprognostic (1.20e-2)" "unprognostic (1.59e-2)" "unprognostic (1.37e-1)" "prognostic favorable (2.41e-5)" "unprognostic (2.23e-1)" "unprognostic (1.77e-1)" "prognostic favorable (1.17e-11)" "unprognostic (2.62e-1)" "unprognostic (2.00e-1)" "prognostic favorable (1.75e-4)" "unprognostic (3.23e-1)" 6.1 4.9 4.6 4.7 6.2 1.5 6.7 5.9 5.8 6.5 4.0 6.7 7.3 5.3 8.0 9.8 7.0 5.2 7.8 4.8 5.5 9.4 6.2 6.1 4.6 6.8 5.5 9.9 7.8 8.8 3.6 5.7 6.3 6.5 6.2 6.0 7.0 9.6 9.0 7.7 5.0 7.2 4.9 5.6 7.8 34.4 6.7 9.4 7.3 14.9 7.9 10.9 5.7 6.4 7.0 7.2 13.0 12.3 19.8 8.7 14.8 7.2 9.4 6.8 8.7 3.3 14.6 15.2 6.1 7.1 16.0 23.3 17.3 18.0 8.5 8.4 6.6 5.2 6.0 14.1 25.8 7.6 4.4 13.5 17.7 5.4 11.8 15.1 13.1 17.0 15.6 6.0 11.8 16.1 5.9 5.2 5.3 21.3 4.1 9.2 9.7 6.7 12.5 28.5 4.2 5.2 6.9 19.3 7.8 19.7 12.0 8.9 14.6 4.7 2.1 5.9 3.3 25.1 11.3 5.0 2.5 5.5 7.2 2.9 5.0 7.3 3.5 4.5 2.8 2.6 3.0 2.9 4.8 2.3 3.2 3.9 0.8 2.4 3.4 2.9 4.1 2.9 4.6 6.2 5.9 5.8 4.8 5.5 6.8 5.5 6.3 4.9 6.7 6.4 3.7 6.4 7.0 4.6 5.6 2.8 18.4 19.9 9.1 5.8 7.0 5.7 6.9 12.8 14.4 23.9 6.2 6.9 4.6 6.8 13.7 11.0 309.7 4.4 4.2 5.7 3.6 5.0 1.9 10.9 6.6 5.2 13.7 6.9 3.8 8.2 5.3 6.9 8.7 10.1 2.0 9.2 8.2 6.1 5.1 78.9 6.8 5.8 3.6 6.5 15.1 6.9 5.2 3.0 6.8 9.1 5.5 7.5 6.1 16.3 8.6 19.8 12.9 3.7 6.6 4.7 4.7 15.2 5.3 10.1 5.1 9.3 4.2 3.8 7.9 29.1 HORMAD1 "CT46, DKFZP434A1315" ENSG00000143452 "HORMA domain containing 1" Q86X24 1 150698060-150720895 "Predicted intracellular proteins" "Differentiation, Meiosis, Oogenesis, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 117.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 727.7" "Cancer enhanced" "Detected in many" "testis cancer: 6.9" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 5.6;HeLa: 4.9;hTCEpi: 19.4;SiHa: 6.1;SuSa: 6.5;THP-1: 11.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA028346, HPA037850" Enhanced Approved Nucleoplasm,Nucleoli Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 83: Testis - Spermatogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Nucleoli "HPA028346: AB_2672564, HPA037850: AB_10696358" "unprognostic (7.21e-2)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (8.15e-2)" "unprognostic (9.06e-2)" "unprognostic (3.91e-3)" "unprognostic (4.08e-2)" "unprognostic (1.76e-1)" "unprognostic (1.50e-1)" "unprognostic (1.72e-1)" "unprognostic (1.56e-2)" "unprognostic (5.17e-3)" "unprognostic (3.79e-9)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" 0.2 0.0 0.1 0.5 0.1 0.5 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.4 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.4 0.1 0.4 0.0 0.0 6.8 0.2 0.1 0.0 0.9 0.1 117.8 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.6 0.0 0.0 0.0 0.1 0.0 0.1 4.9 0.0 0.0 0.1 0.1 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.1 0.0 0.1 6.5 0.0 11.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.2 5.4 0.0 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.0 0.0 3.4 0.0 0.3 0.0 0.1 88.3 0.5 0.1 0.5 0.0 0.0 2.7 0.0 2.1 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.8 0.0 2.0 0.0 0.0 1.3 0.9 35.1 5.3 0.8 0.0 1.0 1.5 0.0 0.0 1.0 0.1 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.5 0.0 32.9 0.0 0.4 727.7 163.5 0.0 9.2 2.2 0.0 0.3 0.2 0.1 HOXD9 "HOX4, HOX4C" ENSG00000128709 "Homeobox D9" P28356 2 176122719-176124937 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 42.2;endometrium 1: 57.8;kidney: 52.1" "Cell type enhanced" "Detected in many" "Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 80 "spinal cord: 8.0" HPA068683 Supported Nucleoplasm,Nucleoli NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Nucleoli" "HPA068683: AB_2686018" "unprognostic (1.89e-1)" "unprognostic (9.41e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (1.37e-1)" "unprognostic (1.03e-2)" "prognostic favorable (9.58e-4)" "prognostic unfavorable (1.08e-5)" "unprognostic (6.62e-2)" "unprognostic (4.58e-2)" "unprognostic (1.54e-2)" "unprognostic (2.56e-3)" "unprognostic (6.71e-2)" "unprognostic (4.77e-3)" "unprognostic (8.38e-2)" "unprognostic (5.94e-2)" "unprognostic (1.89e-1)" "unprognostic (9.44e-2)" 11.6 6.4 0.0 1.3 0.0 0.0 13.9 0.0 0.0 42.2 0.0 29.3 0.1 57.8 14.8 3.5 16.1 0.9 0.2 0.0 0.0 52.1 0.1 0.7 2.4 0.5 0.0 11.1 0.3 0.3 0.0 0.5 0.1 32.3 2.9 0.0 1.2 8.0 1.6 5.8 3.0 15.2 0.5 2.4 0.5 5.6 0.1 0.5 1.4 0.2 0.8 6.1 35.3 0.8 0.1 0.0 0.0 0.0 0.5 0.4 0.2 1.6 1.1 1.3 1.1 0.0 0.0 0.0 11.3 1.6 0.8 7.6 0.1 0.0 0.9 0.0 16.1 0.0 0.8 0.0 0.1 0.0 0.0 3.6 0.6 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 19.0 7.1 4.3 21.7 5.5 0.0 13.2 1.1 0.0 0.0 16.9 0.0 3.6 5.3 6.0 0.0 0.0 0.0 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.5 0.1 0.8 38.4 0.0 0.0 0.0 0.4 2.4 1.9 0.0 0.0 0.0 0.8 0.5 0.7 0.0 0.0 23.9 0.0 0.0 1.0 8.5 37.2 0.0 0.2 0.8 10.9 39.2 7.8 0.0 0.0 0.0 0.2 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 3.0 1.3 34.2 0.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 26.7 0.0 1.1 0.0 3.0 0.0 0.0 39.5 1.9 3.3 2.2 1.4 0.1 1.8 0.0 1.1 13.9 3.8 0.8 HS1BP3 HS1-BP3,FLJ14249 ENSG00000118960 "HCLS1 binding protein 3" Q53T59 2 20560448-20651130 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035050 Approved Approved Nucleoli,Cytosol No No 54000 "Cluster 18: Basophils - Vesicular transport" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoli Cytosol "HPA035050: AB_10601816" "unprognostic (4.52e-2)" "unprognostic (5.93e-2)" "unprognostic (2.67e-1)" "unprognostic (4.39e-1)" "unprognostic (4.61e-2)" "unprognostic (1.45e-3)" "prognostic unfavorable (2.97e-5)" "unprognostic (2.06e-3)" "unprognostic (1.88e-2)" "unprognostic (2.16e-1)" "unprognostic (9.53e-2)" "unprognostic (8.00e-2)" "prognostic favorable (2.30e-4)" "unprognostic (1.80e-1)" "unprognostic (1.19e-1)" "unprognostic (1.02e-1)" "unprognostic (3.20e-1)" 18.5 31.0 16.4 10.0 20.6 13.7 15.9 17.9 19.6 21.5 19.4 33.6 13.1 22.2 13.3 18.6 19.4 16.4 23.3 16.9 17.5 24.8 57.4 18.5 9.2 20.4 19.3 17.5 14.5 13.1 16.3 15.5 19.4 26.7 12.6 3.7 16.7 17.5 13.0 23.3 17.7 21.1 15.8 18.4 22.0 13.8 21.3 7.4 17.8 10.1 7.6 29.2 17.8 23.3 20.3 23.1 11.5 14.1 58.8 39.2 22.7 7.6 34.9 17.7 23.0 18.2 24.0 13.5 5.9 11.1 80.1 12.5 23.1 24.0 8.6 17.4 19.1 7.2 11.3 61.2 54.8 5.5 30.5 42.1 53.8 20.0 36.5 20.7 34.1 11.9 4.7 28.3 20.5 17.4 2.5 9.3 9.6 29.9 16.4 13.3 23.3 13.4 39.0 24.4 10.9 16.7 5.4 23.4 45.0 23.2 14.6 11.2 21.7 17.3 18.5 27.0 11.7 19.9 24.5 12.9 37.3 25.8 18.7 17.9 14.7 14.5 6.0 13.9 4.2 6.8 3.6 4.7 9.9 4.3 3.0 3.3 17.7 3.8 18.3 3.6 3.4 8.6 16.4 20.6 17.9 19.6 16.9 17.5 20.4 19.3 19.4 15.8 21.3 23.3 17.6 6.4 17.9 3.3 8.2 4.5 7.4 5.6 2.2 4.0 6.2 8.0 6.2 8.6 10.9 7.3 0.0 9.8 6.5 12.5 17.6 21.4 20.8 9.3 9.4 8.4 6.7 7.0 2.6 14.9 17.8 9.7 8.2 12.5 2.5 8.5 11.0 9.2 30.7 15.2 2.5 7.3 12.2 20.1 5.5 42.7 8.4 13.9 14.2 4.7 13.1 8.9 15.5 3.0 5.4 9.7 11.9 10.5 4.9 5.2 21.6 28.2 10.4 5.3 0.0 7.1 17.1 16.7 10.5 5.8 5.3 17.5 6.3 7.8 7.7 4.5 HTD2 ENSG00000255154 "Hydroxyacyl-thioester dehydratase type 2" P86397 3 58306262-58320193 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.1" "Cell type enhanced" "Detected in some" "Club cells: 1.3;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066812, HPA077228" Approved Supported Nucleoli,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" Mitochondria Nucleoli "HPA066812: AB_2685727, HPA077228: " "unprognostic (1.95e-1)" "unprognostic (3.20e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "unprognostic (2.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.56e-1)" "unprognostic (2.05e-1)" "unprognostic (9.19e-3)" "unprognostic (1.11e-1)" "unprognostic (7.41e-2)" "unprognostic (1.04e-1)" "unprognostic (1.99e-1)" "unprognostic (7.50e-2)" "unprognostic (3.86e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-2)" 7.7 7.2 4.3 6.5 5.0 7.2 8.7 7.3 5.5 6.8 4.7 8.9 12.1 8.4 5.9 8.7 7.8 6.8 12.5 4.8 5.6 11.1 15.2 5.7 6.8 3.6 4.6 12.1 7.4 12.0 5.7 6.7 4.6 7.1 9.1 9.2 7.4 8.6 44.1 7.9 8.7 7.6 4.3 7.2 7.0 7.4 4.5 6.6 10.4 37.8 8.0 6.9 4.9 5.5 10.4 7.1 10.9 8.7 11.6 11.2 15.1 13.8 10.2 17.0 14.4 15.9 7.7 19.9 4.0 10.1 12.8 8.7 18.5 12.6 16.8 11.0 13.1 13.7 16.1 13.9 11.3 16.7 11.4 15.1 15.1 17.3 11.4 11.0 14.6 14.3 12.2 19.9 11.1 6.4 11.2 8.9 17.2 10.2 17.3 7.2 7.2 14.7 12.5 13.8 7.0 10.5 8.4 9.4 17.2 12.1 10.9 15.9 8.1 14.5 10.8 14.3 17.2 15.4 27.6 15.7 12.7 11.9 9.8 17.9 19.2 29.2 19.7 23.7 21.5 28.1 20.0 25.2 20.2 27.6 27.5 21.3 13.6 24.9 20.4 24.5 15.6 15.7 4.3 5.0 7.3 5.5 4.8 5.6 3.6 4.6 4.6 4.3 4.5 5.5 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IDH3G ENSG00000067829 "Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No 19000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 52.0 67.1 45.5 38.5 50.0 60.3 49.9 47.8 61.3 44.1 46.5 57.2 52.3 50.7 23.5 50.2 44.8 35.0 91.9 54.9 48.8 68.5 49.2 42.0 40.3 50.5 45.7 49.3 48.3 45.5 47.9 28.3 52.3 43.8 34.6 24.4 51.7 39.9 100.5 51.7 54.7 34.5 43.9 51.8 52.2 32.1 49.1 35.2 48.0 82.9 34.9 44.3 43.2 47.2 94.9 90.0 47.3 65.9 74.4 59.4 62.0 47.3 64.1 80.5 84.3 76.0 66.5 121.4 80.2 74.7 68.2 67.2 72.6 69.2 30.0 38.9 101.7 43.0 118.9 59.0 85.5 61.6 87.5 76.1 48.0 64.4 69.4 50.4 65.3 50.3 24.7 60.4 64.7 138.5 72.0 76.0 21.6 84.2 118.0 62.7 43.3 105.8 94.4 61.1 59.5 42.8 30.2 96.3 48.0 20.8 39.6 51.9 56.0 49.9 34.1 76.8 112.5 89.0 22.6 152.1 81.8 75.8 57.6 178.1 159.3 165.8 71.8 163.9 68.0 68.5 73.2 71.2 163.1 78.9 57.9 63.7 57.8 86.5 169.6 101.3 107.5 140.1 45.5 50.0 47.8 61.3 54.9 48.8 50.5 45.7 52.3 43.9 49.1 47.2 44.4 35.3 33.8 5.5 49.2 80.9 67.5 103.9 37.5 34.9 48.4 57.9 55.1 50.1 55.0 51.5 29.2 99.8 48.2 145.0 207.4 93.4 132.0 42.2 39.4 44.6 62.3 41.4 5.6 90.5 98.7 48.2 47.9 39.8 93.8 43.6 43.2 35.4 131.0 18.5 6.4 107.0 79.3 98.0 77.0 284.2 53.4 75.6 67.6 3.7 116.4 50.8 64.9 3.0 5.0 73.5 133.8 58.6 49.7 35.6 222.4 253.1 50.7 49.3 52.6 47.4 68.2 15.9 18.3 50.3 77.4 110.8 55.2 103.0 112.7 64.2 IER5 ENSG00000162783 "Immediate early response 5" Q5VY09 1 181088700-181092900 "Predicted intracellular proteins" "Stress response, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 282.8;Macrophages: 276.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029894 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA029894: AB_10601433" "unprognostic (1.18e-1)" "unprognostic (1.31e-1)" "unprognostic (2.55e-1)" "prognostic favorable (2.42e-7)" "unprognostic (1.00e-2)" "unprognostic (1.47e-1)" "unprognostic (2.63e-3)" "prognostic unfavorable (1.18e-4)" "unprognostic (2.81e-3)" "unprognostic (8.37e-2)" "unprognostic (1.46e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (2.36e-4)" "unprognostic (1.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.09e-1)" 12.8 6.3 9.5 11.2 10.2 49.5 8.4 10.1 19.3 10.2 11.2 10.6 5.6 14.8 2.5 26.5 15.2 6.1 27.8 10.7 9.7 5.8 6.7 23.2 9.4 10.0 9.2 3.3 5.2 1.8 5.2 11.0 9.1 5.6 5.6 1.1 6.8 3.7 33.4 22.1 13.3 8.3 9.8 32.7 9.0 5.4 10.3 8.7 5.0 16.5 10.8 10.9 13.3 12.8 25.3 21.8 11.7 10.3 15.9 21.9 31.3 43.6 45.9 24.1 21.4 6.1 13.8 8.3 18.9 16.9 16.9 45.5 3.8 29.7 15.6 47.6 18.7 7.4 11.5 4.1 24.9 8.6 23.1 15.7 29.5 28.0 18.7 18.3 16.6 6.9 31.0 36.5 43.3 11.5 8.6 13.8 12.2 9.5 10.8 9.8 20.4 31.6 8.8 13.7 16.9 18.2 22.1 21.3 51.7 14.2 17.0 7.5 25.3 17.3 30.5 19.9 26.8 23.9 9.1 6.5 13.5 9.0 4.9 3.6 1.4 2.7 1.0 5.5 1.2 4.0 0.8 1.4 1.1 3.0 0.1 0.5 1.2 1.1 5.3 0.2 1.3 0.7 9.5 10.2 10.1 19.3 10.7 9.7 10.0 9.2 9.1 9.8 10.3 12.8 156.4 22.4 66.7 3.6 124.8 69.8 163.7 24.2 53.5 24.2 198.1 197.7 110.9 21.5 25.9 9.2 37.5 10.9 131.1 94.2 0.0 10.6 5.1 66.7 83.0 87.2 56.4 32.0 8.7 6.9 56.4 74.7 50.0 67.3 36.1 35.0 41.4 5.6 50.9 8.4 2.8 110.6 6.1 149.5 282.8 11.9 12.2 276.4 46.2 11.2 56.1 17.8 17.5 0.5 1.3 21.9 54.8 9.4 61.5 94.9 35.0 1.5 27.4 21.3 0.0 177.9 102.8 3.6 5.4 115.9 59.7 34.2 151.3 15.5 62.0 146.8 IFI27L2 "FAM14A, TLH29" ENSG00000119632 "Interferon alpha inducible protein 27 like 2" Q9H2X8 14 94127779-94130253 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 446.8" HPA049588 Approved Nucleoli,Cytosol "Intracellular and membrane" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 48: Smooth muscle cells - ECM organization" Cytosol Nucleoli "HPA049588: " "unprognostic (9.70e-3)" "unprognostic (2.71e-1)" "unprognostic (2.16e-1)" "unprognostic (1.76e-1)" "unprognostic (2.45e-1)" "unprognostic (2.80e-2)" "unprognostic (7.46e-3)" "unprognostic (4.76e-2)" "unprognostic (4.69e-2)" "unprognostic (1.58e-2)" "unprognostic (4.79e-3)" "unprognostic (3.96e-2)" "unprognostic (8.13e-2)" "unprognostic (2.03e-1)" "unprognostic (3.88e-1)" "unprognostic (5.09e-2)" "unprognostic (3.52e-2)" 47.8 114.5 148.9 42.4 157.0 46.6 43.1 159.2 207.3 76.4 142.8 57.3 22.5 51.5 14.5 73.9 54.1 46.4 108.2 149.3 169.0 68.2 10.2 60.0 57.9 162.6 152.7 78.8 27.8 55.0 83.3 10.7 162.3 35.8 20.4 51.6 26.7 21.6 8.8 52.5 52.8 25.6 160.9 72.2 35.5 31.1 160.1 46.9 35.1 9.9 50.5 41.6 72.1 171.9 61.5 39.3 10.8 90.8 70.1 166.5 7.6 118.1 129.9 92.3 99.6 12.1 28.0 29.0 128.3 134.2 59.1 81.6 8.8 150.5 36.8 185.4 3.0 44.0 41.0 4.6 98.5 53.2 116.7 163.1 55.8 50.5 39.0 162.6 49.1 108.5 3.8 446.8 107.5 128.3 32.3 33.9 16.4 41.9 49.2 1.9 40.2 42.2 137.8 25.2 24.1 28.7 3.8 0.0 78.4 22.9 146.4 87.6 65.9 61.5 35.0 79.5 30.1 171.8 164.4 10.4 201.7 124.1 39.2 167.4 238.3 48.0 153.4 167.9 99.4 214.2 140.6 168.4 184.2 201.3 104.2 134.9 37.6 44.3 121.5 153.5 203.5 217.4 148.9 157.0 159.2 207.3 149.3 169.0 162.6 152.7 162.3 160.9 160.1 171.9 86.5 38.5 50.9 10.1 71.8 92.8 73.1 218.3 111.0 27.2 47.9 103.6 162.8 50.1 55.8 178.4 20.9 2.3 79.3 58.2 178.1 159.2 8.2 78.1 113.7 70.1 99.6 20.6 1.6 29.1 2.7 133.0 43.8 11.6 90.7 64.8 121.1 4.2 190.8 23.5 3.6 193.8 57.0 163.7 107.6 31.1 183.0 119.1 236.5 0.0 134.7 181.0 137.0 5.5 13.9 68.1 150.2 115.5 104.4 23.7 125.6 113.3 61.8 113.3 124.9 70.4 87.7 8.3 22.1 105.2 66.9 2.9 92.2 92.7 82.8 55.9 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP U3 small nucleolar ribonucleoprotein 3" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 28: Keratinocytes - Keratinization" "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 45.8 61.8 37.1 26.4 38.7 29.3 43.9 39.3 49.1 36.9 46.6 43.4 36.6 30.1 30.4 79.8 32.7 14.2 53.1 38.3 41.6 49.6 90.4 33.9 34.9 38.7 36.7 33.3 50.6 23.2 40.1 21.1 39.5 39.7 24.4 17.8 44.8 22.2 71.5 71.6 51.6 14.0 40.0 63.0 50.9 16.8 38.7 34.7 36.1 33.1 38.4 35.1 47.4 41.2 75.1 82.9 39.5 68.8 68.6 39.0 58.5 61.6 48.8 49.3 56.6 64.1 64.3 88.7 65.5 32.2 54.5 121.7 131.1 100.0 43.4 67.2 157.3 93.6 64.9 112.8 50.6 95.9 62.5 36.1 81.0 39.8 48.8 36.6 32.8 71.3 122.8 70.4 45.4 89.9 76.3 232.9 106.4 75.7 86.4 82.1 48.4 98.3 68.1 100.2 67.1 69.4 52.2 89.8 119.4 56.8 78.5 87.9 37.6 64.0 51.9 46.4 84.6 95.4 188.5 100.3 70.7 153.2 43.0 80.6 109.0 85.2 137.4 87.3 148.8 143.2 131.5 133.8 117.4 127.3 150.7 144.3 13.7 126.4 87.4 119.3 140.9 192.2 37.1 38.7 39.3 49.1 38.3 41.6 38.7 36.7 39.5 40.0 38.7 41.2 85.9 38.5 41.6 6.5 81.4 228.5 93.1 177.0 149.7 22.4 72.1 79.4 12.1 77.2 89.7 40.5 14.6 106.8 79.0 47.5 144.8 105.2 1.6 71.7 54.9 74.0 43.9 56.8 6.8 105.9 106.5 63.0 78.0 70.9 48.7 50.8 76.4 114.1 94.2 21.9 7.1 71.2 93.6 54.3 106.6 6.6 60.9 51.0 97.8 8.4 118.0 58.2 152.4 6.0 10.2 113.7 56.0 44.0 66.5 107.0 113.8 209.5 65.2 23.7 26.3 46.1 50.7 13.9 38.2 144.4 237.4 54.9 83.3 77.2 98.8 86.9 INTS3 "C1orf60, FLJ21919, INT3, SOSS-A" ENSG00000143624 "Integrator complex subunit 3" Q68E01 1 153728050-153774808 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074391 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA074391: AB_2686685" "unprognostic (2.36e-1)" "unprognostic (1.94e-2)" "unprognostic (8.75e-3)" "unprognostic (6.97e-3)" "unprognostic (3.26e-1)" "unprognostic (4.48e-2)" "unprognostic (1.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.75e-1)" "unprognostic (2.45e-1)" "prognostic favorable (5.42e-4)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.21e-1)" "unprognostic (1.85e-1)" "unprognostic (1.18e-3)" "unprognostic (8.29e-2)" 14.3 18.7 1.7 10.8 2.0 2.9 14.7 0.5 3.2 16.8 0.9 16.1 4.2 18.3 13.4 12.1 20.7 9.7 13.0 2.2 2.1 15.9 11.8 14.9 8.6 2.7 0.9 23.3 13.0 8.2 17.8 9.6 1.3 11.9 6.5 3.6 12.1 11.3 14.9 12.2 12.9 9.4 0.0 13.2 16.7 12.8 4.4 6.7 15.3 8.3 7.7 13.6 14.4 1.5 26.2 15.8 14.0 19.2 21.3 17.4 19.1 18.2 8.7 21.7 17.4 8.5 24.5 21.3 37.8 24.2 11.8 27.0 28.0 18.7 10.2 24.6 23.0 15.4 37.7 3.8 13.8 18.8 20.5 12.3 7.5 9.5 11.7 17.5 14.4 13.8 19.2 14.6 9.0 8.5 18.6 10.0 23.6 25.5 26.8 24.5 6.4 13.1 8.1 24.7 11.8 15.5 18.9 39.7 11.4 18.4 13.3 25.3 6.1 22.7 6.7 18.1 18.1 17.1 13.7 19.5 24.9 8.9 11.3 0.0 0.8 0.9 0.9 0.5 0.8 0.3 0.3 0.5 1.2 0.3 0.2 0.5 0.8 0.7 2.9 0.3 0.5 0.2 1.7 2.0 0.5 3.2 2.2 2.1 2.7 0.9 1.3 0.0 4.4 1.5 29.1 22.4 22.8 59.7 11.9 10.5 9.5 10.4 15.9 23.7 20.2 22.4 4.6 10.0 11.7 31.3 20.9 13.9 11.6 9.2 0.0 11.9 13.1 39.3 29.4 21.5 12.1 10.9 30.8 8.4 13.4 16.3 23.9 38.8 5.7 32.9 26.7 13.9 12.2 21.9 26.1 16.5 8.2 9.1 22.0 7.6 9.6 14.6 7.2 30.0 17.6 15.4 14.4 27.2 29.7 9.9 14.9 12.0 11.6 10.6 9.8 13.3 25.9 22.4 26.3 11.2 16.5 10.2 12.2 13.9 10.2 10.3 10.0 20.2 14.0 12.2 IRX2 ENSG00000170561 "Iroquois homeobox 2" Q9BZI1 5 2745845-2751677 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 24.0;salivary gland: 30.6;skin 1: 28.2" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 109.0;Alveolar cells type 2: 74.2;Basal keratinocytes: 202.1;Breast glandular cells: 147.4;Breast myoepithelial cells: 159.8;Suprabasal keratinocytes: 131.3" "Cancer enhanced" "Detected in many" "breast cancer: 14.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 93.2;BEWO: 56.4;HaCaT: 32.0;hTCEpi: 68.9;SK-BR-3: 39.1" "Group enriched" "Detected in many" 5 "midbrain: 26.5;pons and medulla: 20.9;thalamus: 11.2" "Region enhanced" "Detected in some" "pons: 5.1" "HPA050895, HPA054669" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Nucleoli" "HPA050895: AB_2616458, HPA054669: AB_2682566" "unprognostic (9.79e-2)" "unprognostic (1.93e-2)" "unprognostic (8.48e-2)" "unprognostic (5.50e-3)" "unprognostic (8.12e-2)" "unprognostic (3.07e-3)" "unprognostic (1.33e-1)" "unprognostic (7.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.07e-1)" "prognostic favorable (8.84e-4)" "unprognostic (2.62e-2)" "unprognostic (3.98e-7)" "unprognostic (4.40e-2)" "unprognostic (2.49e-1)" "unprognostic (3.67e-2)" "unprognostic (8.97e-2)" 3.8 0.1 2.0 0.0 2.7 0.0 24.0 4.9 1.0 0.6 0.4 0.7 0.0 0.0 3.1 4.5 0.2 0.0 1.5 0.8 2.8 21.5 0.0 18.1 0.2 20.7 8.2 0.0 2.0 2.9 1.6 5.6 22.3 3.6 0.3 1.1 30.6 0.9 0.3 28.2 0.0 0.0 4.2 0.0 15.7 2.1 4.7 0.5 1.8 0.6 0.2 0.2 2.0 4.2 10.7 0.0 93.2 0.0 5.4 3.9 56.4 5.4 3.4 5.0 4.0 11.8 0.0 0.0 0.0 11.5 0.0 32.0 0.1 24.6 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.3 68.9 2.4 20.1 0.0 0.0 0.0 0.0 0.0 3.6 19.1 0.0 0.1 10.2 25.7 0.0 0.0 5.7 0.0 22.7 0.0 3.5 0.0 18.6 39.1 0.0 14.3 4.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.7 4.9 1.0 0.8 2.8 20.7 8.2 22.3 4.2 4.7 4.2 5.5 109.0 74.2 0.0 0.2 202.1 17.6 33.1 31.9 1.4 147.4 159.8 2.7 0.0 23.9 7.3 0.0 27.8 1.2 3.0 27.4 0.1 5.0 0.1 0.4 2.9 0.0 0.0 0.0 0.0 18.6 15.0 15.3 0.0 1.3 0.1 0.0 0.0 3.3 0.0 0.0 2.5 14.2 0.0 15.4 10.4 0.0 0.7 19.6 0.0 0.0 0.3 0.0 1.5 0.0 0.3 2.9 0.0 0.1 23.5 0.2 0.6 13.0 2.5 0.0 3.6 14.6 9.4 9.4 20.1 131.3 15.2 0.9 0.0 2.8 8.3 JADE3 "JADE-3, KIAA0215, PHF16" ENSG00000102221 "Jade family PHD finger 3" Q92613 X 46912276-47061242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 37.2;Oligodendrocytes: 36.8;Spermatocytes: 42.7;Spermatogonia: 35.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 1.8;naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 65.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006007, HPA064697" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA006007: AB_1079605, HPA064697: AB_2685326" "unprognostic (1.39e-1)" "unprognostic (2.53e-1)" "unprognostic (2.24e-1)" "unprognostic (1.52e-3)" "unprognostic (1.18e-2)" "unprognostic (3.01e-2)" "unprognostic (1.05e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-3)" "unprognostic (4.55e-2)" "unprognostic (8.97e-3)" "unprognostic (2.82e-1)" "unprognostic (4.25e-2)" "unprognostic (4.42e-2)" "unprognostic (2.69e-1)" "unprognostic (8.18e-2)" "unprognostic (9.70e-2)" 3.5 10.7 3.5 3.1 4.9 2.0 6.3 5.1 5.1 5.6 2.7 3.6 2.2 6.0 15.9 3.5 3.9 3.2 3.1 3.2 4.1 3.7 7.6 3.6 4.9 6.6 4.4 7.1 8.3 3.3 1.1 15.4 6.2 4.2 3.4 2.5 3.5 7.2 1.7 3.3 4.6 5.0 5.0 5.0 4.1 12.1 5.2 7.2 4.1 2.6 6.1 4.7 2.6 8.8 12.1 10.6 17.2 11.9 6.2 4.6 65.7 7.1 5.9 7.8 8.7 12.3 10.3 0.1 4.9 5.2 11.6 4.7 21.1 5.7 11.2 32.6 13.8 9.6 11.9 12.0 10.2 7.3 5.0 3.5 7.8 5.5 17.7 4.8 14.9 18.1 6.7 5.6 6.1 12.5 26.5 8.9 13.6 7.8 9.0 27.0 19.4 16.9 6.6 11.0 14.8 13.1 20.4 18.7 11.3 28.3 12.4 7.6 9.3 8.2 14.2 11.7 4.7 4.3 4.0 22.7 2.3 6.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 3.5 4.9 5.1 5.1 3.2 4.1 6.6 4.4 6.2 5.0 5.2 8.8 4.1 0.0 7.8 1.0 14.4 4.2 2.3 1.8 2.2 1.5 9.9 4.2 5.4 1.5 1.6 5.5 0.0 9.6 0.1 2.0 0.0 2.4 1.1 3.9 3.9 5.1 8.4 6.5 5.5 3.6 10.3 2.0 2.6 4.4 0.0 9.7 6.1 13.3 1.8 0.0 12.7 2.6 6.1 1.0 5.7 3.7 4.7 1.4 3.6 14.0 2.8 1.2 1.0 37.2 36.8 3.1 1.1 3.8 1.9 4.1 0.5 2.9 1.2 2.3 6.6 1.9 2.8 42.7 35.3 5.8 8.1 14.2 0.7 3.5 2.4 3.7 KCNC4 "C1orf30, HKSHIIIC, Kv3.4" ENSG00000116396 "Potassium voltage-gated channel subfamily C member 4" Q03721 1 110210314-110283100 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Hepatic stellate cells: 50.3;Rod photoreceptor cells: 41.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 38.5;U-87 MG: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014740 Approved Nucleoli,Cytosol NA NA "Cluster 65: Brain - Ion transport" "Cluster 44: HDLM-2 - Immune response" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli, Cytosol" "HPA014740: AB_1855580" "unprognostic (9.16e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-2)" "unprognostic (3.72e-1)" "unprognostic (4.12e-2)" "unprognostic (6.13e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (2.03e-1)" "unprognostic (4.26e-2)" "unprognostic (1.26e-1)" "unprognostic (3.04e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-1)" "unprognostic (1.83e-1)" "unprognostic (1.25e-2)" 3.1 4.0 24.9 2.2 9.7 1.1 3.6 2.3 11.3 3.8 0.0 2.1 1.2 2.7 1.2 2.4 3.6 4.2 4.2 20.4 9.0 7.9 0.8 2.8 2.2 21.6 12.3 3.6 5.6 6.8 6.1 2.8 23.7 3.3 1.2 7.5 7.1 3.1 4.9 3.7 2.3 1.6 4.7 4.2 3.4 2.5 11.1 1.9 2.7 5.8 1.6 3.0 3.4 2.2 4.1 2.7 0.4 3.3 1.2 0.3 6.3 13.5 1.4 0.9 0.8 7.2 1.4 5.8 6.1 4.0 3.4 5.5 1.7 1.0 0.5 38.5 4.1 0.5 5.4 0.8 0.4 3.6 1.5 0.2 0.3 2.2 0.2 0.7 5.5 2.8 1.2 1.9 0.1 0.6 3.6 1.1 2.7 1.1 6.8 4.5 0.1 1.0 4.2 0.1 1.0 1.0 0.6 11.9 1.3 3.0 1.5 2.1 2.5 1.5 7.0 1.1 0.5 5.0 3.2 1.0 19.5 3.5 13.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.9 9.7 2.3 11.3 20.4 9.0 21.6 12.3 23.7 4.7 11.1 2.2 11.0 0.0 1.1 8.5 2.6 3.2 15.7 2.5 12.0 4.7 10.6 9.3 8.9 8.6 2.0 3.7 41.7 0.4 1.7 10.0 0.0 6.8 0.5 7.9 2.8 14.0 13.2 0.8 13.4 17.0 0.4 4.3 5.1 19.8 1.3 3.4 50.3 0.4 1.3 3.3 10.0 4.8 0.0 2.2 1.1 0.9 1.5 1.5 1.8 7.5 1.4 3.8 0.0 6.0 1.7 11.8 7.1 4.1 1.2 11.0 2.3 0.6 2.5 41.1 26.3 4.2 8.4 0.7 7.4 4.1 3.0 1.1 2.6 0.4 8.3 9.7 KCTD6 "KCASH3, MGC27385" ENSG00000168301 "Potassium channel tetramerization domain containing 6" Q8NC69 3 58492096-58502360 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "T-47d: 62.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036100, HPA036101" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 38: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 6: T47d - Mammary gland" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Mitochondria" "HPA036100: AB_10673230, HPA036101: AB_2674941" "unprognostic (8.63e-3)" "unprognostic (1.28e-2)" "unprognostic (3.37e-2)" "unprognostic (5.71e-2)" "unprognostic (9.00e-3)" "unprognostic (2.45e-2)" "prognostic unfavorable (4.57e-4)" "unprognostic (3.19e-2)" "unprognostic (1.81e-1)" "unprognostic (4.67e-3)" "unprognostic (9.36e-3)" "unprognostic (7.48e-2)" "prognostic favorable (8.63e-4)" "unprognostic (1.56e-2)" "unprognostic (1.71e-1)" "unprognostic (3.48e-1)" "unprognostic (2.44e-2)" 9.7 9.3 32.4 5.2 34.1 17.1 12.8 41.4 40.7 13.6 35.5 12.5 6.6 13.8 30.9 14.1 13.7 9.9 10.2 37.5 30.2 20.9 17.1 7.7 8.6 32.7 33.9 14.7 8.2 11.2 20.5 12.8 32.2 11.1 9.0 45.8 7.7 10.2 8.7 8.6 8.0 12.6 31.4 11.1 8.3 6.8 31.1 8.5 14.0 12.5 8.8 9.7 14.5 43.0 10.2 9.5 27.8 12.0 23.9 16.9 10.4 12.0 10.7 17.4 20.3 9.2 5.5 20.0 3.9 8.6 20.3 5.4 22.8 7.0 15.4 20.7 10.4 9.3 24.4 11.2 11.3 7.1 7.2 10.4 10.8 13.8 8.7 41.0 11.6 6.9 5.2 9.2 15.2 9.6 11.0 11.3 20.4 9.1 17.8 10.9 7.7 14.3 16.7 4.7 15.5 13.6 6.6 15.5 8.7 21.2 62.9 5.3 6.3 15.6 14.4 20.1 18.4 10.1 16.9 23.6 13.7 14.8 12.2 27.2 16.3 11.4 14.5 17.0 16.9 14.3 10.6 13.8 23.1 11.3 11.9 10.1 5.3 9.6 12.5 8.9 11.4 8.2 32.4 34.1 41.4 40.7 37.5 30.2 32.7 33.9 32.2 31.4 31.1 43.0 5.7 3.2 2.7 30.3 6.9 8.9 10.5 4.1 8.6 20.8 6.7 4.6 8.8 10.0 8.0 9.2 25.0 10.1 10.7 4.2 19.6 8.5 5.0 3.8 6.8 8.7 9.1 8.6 14.8 4.0 6.8 11.9 2.0 3.9 0.0 52.2 8.9 6.9 6.7 25.2 19.7 4.4 10.2 9.1 14.3 2.2 10.8 6.5 12.4 5.6 11.7 23.2 10.3 14.1 19.6 3.7 5.8 12.0 3.7 9.3 4.5 28.4 3.7 19.2 0.0 9.3 8.2 13.8 22.9 11.5 10.1 8.8 5.0 12.9 6.4 4.0 KDM7A "JHDM1D, KIAA1718" ENSG00000006459 "Lysine demethylase 7A" Q6ZMT4 7 140084746-140176983 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012114 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 33: Neutrophils - Chromatin organization" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 44: HDLM-2 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA012114: AB_1852429" "unprognostic (1.55e-1)" "unprognostic (1.44e-1)" "unprognostic (2.54e-1)" "unprognostic (4.08e-3)" "unprognostic (3.52e-1)" "unprognostic (1.69e-2)" "unprognostic (4.00e-1)" "unprognostic (3.44e-2)" "unprognostic (2.56e-1)" "unprognostic (3.84e-2)" "unprognostic (9.74e-2)" "unprognostic (1.29e-1)" "unprognostic (9.55e-2)" "unprognostic (3.42e-1)" "unprognostic (2.59e-1)" "unprognostic (2.10e-1)" "unprognostic (1.18e-1)" 6.6 2.1 2.1 6.9 1.6 16.4 4.7 3.8 3.9 9.5 1.5 8.4 8.2 6.6 1.4 7.0 2.9 4.5 4.1 2.7 1.6 3.6 6.7 4.8 7.0 2.5 2.5 2.1 4.5 4.1 1.3 9.1 2.8 3.3 9.3 5.8 5.1 2.1 12.6 7.5 8.3 4.4 2.4 5.6 9.3 7.7 3.7 6.7 2.8 13.2 8.0 5.7 3.7 3.0 0.8 0.4 2.7 2.8 2.4 2.3 5.4 1.2 1.7 0.4 0.5 0.2 0.4 1.9 1.9 1.3 1.4 1.0 3.7 2.3 0.8 10.8 2.3 0.1 0.4 5.1 2.5 1.8 1.9 2.4 5.1 1.4 8.0 1.3 2.6 5.0 6.1 8.2 0.5 0.8 3.6 3.1 4.3 6.3 1.5 3.8 0.2 4.0 0.9 1.2 4.7 5.8 2.8 6.5 2.7 4.3 8.8 0.7 4.6 0.5 1.0 1.7 0.8 2.9 0.4 6.2 1.5 5.0 1.0 0.6 0.8 0.3 0.3 0.4 0.3 0.5 0.5 0.5 1.1 1.1 0.5 0.3 2.2 0.6 0.2 0.4 0.4 0.3 2.1 1.6 3.8 3.9 2.7 1.6 2.5 2.5 2.8 2.4 3.7 3.0 34.4 16.0 25.5 25.5 30.6 49.8 44.8 17.7 8.0 11.8 11.1 7.4 14.6 8.6 30.1 16.5 27.1 12.3 17.8 36.7 1.9 7.2 5.2 17.0 18.2 23.8 52.7 32.4 35.3 9.4 2.8 20.0 30.5 28.7 8.2 12.2 18.5 18.5 10.7 6.7 34.8 38.0 12.2 31.4 86.7 4.9 7.8 35.4 3.6 96.5 34.7 4.3 10.3 35.7 36.0 12.2 28.7 4.1 11.8 35.3 26.9 3.3 33.3 9.2 6.6 14.9 17.8 31.2 14.3 12.3 46.5 37.9 18.5 3.4 27.2 50.0 KIAA0319L "AAVR, KIAA1837" ENSG00000142687 "KIAA0319 like" Q8IZA0 1 35433492-35557950 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 47.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072692 Supported Supported "Nucleoli,Golgi apparatus" NA NA 1100000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Nucleoli "HPA072692: AB_2686549" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (4.23e-3)" "unprognostic (1.75e-1)" "unprognostic (1.30e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (5.92e-5)" "unprognostic (3.41e-3)" "unprognostic (1.19e-1)" "unprognostic (1.44e-1)" "unprognostic (2.05e-2)" "unprognostic (3.79e-1)" "prognostic favorable (1.27e-4)" "unprognostic (1.47e-1)" "unprognostic (1.26e-1)" "unprognostic (5.44e-2)" "unprognostic (1.84e-1)" 14.3 26.6 28.3 13.0 28.0 15.9 27.8 23.4 28.0 25.6 28.9 25.6 26.3 14.4 26.2 18.3 35.1 21.3 44.5 28.0 27.6 38.2 34.2 30.9 17.7 26.9 29.2 14.9 42.1 45.6 26.9 30.6 25.5 34.9 30.0 34.1 33.5 18.5 37.7 20.1 24.8 14.4 24.8 20.1 34.4 17.1 32.4 17.8 41.4 40.1 16.8 15.8 15.1 24.9 13.5 19.6 39.8 31.5 52.7 36.9 37.8 17.9 37.8 25.5 37.5 21.2 52.9 15.0 48.0 19.6 38.1 26.1 29.7 28.8 28.9 23.8 21.7 20.3 23.4 23.6 41.3 16.9 26.8 52.3 36.2 29.5 38.0 84.3 42.2 18.1 27.2 21.0 35.2 13.6 10.1 14.3 45.3 37.4 11.7 11.3 33.8 18.7 41.8 32.4 8.7 24.6 25.8 30.6 53.3 86.9 32.3 23.1 43.6 17.4 18.7 14.9 28.0 31.1 26.7 9.8 44.3 21.8 17.7 8.8 19.4 9.4 5.0 6.1 4.8 3.4 4.1 4.7 5.6 4.1 5.5 4.0 47.2 9.8 4.0 3.7 4.0 8.7 28.3 28.0 23.4 28.0 28.0 27.6 26.9 29.2 25.5 24.8 32.4 24.9 24.2 73.7 74.1 85.2 18.3 7.9 14.4 16.5 15.4 74.8 33.9 26.0 55.0 47.1 42.4 35.0 108.4 33.3 16.6 35.4 3.9 19.2 9.6 21.0 17.7 24.6 21.6 14.7 93.2 32.5 22.5 19.4 28.5 30.8 21.5 42.7 28.9 47.4 19.1 63.9 95.2 59.5 16.2 31.4 7.6 7.5 17.4 19.2 14.2 62.8 31.4 30.5 29.9 115.1 99.3 30.3 27.6 17.3 17.2 26.0 36.8 17.5 45.4 61.9 6.6 24.5 15.7 22.5 21.2 17.8 9.2 31.2 21.9 30.1 31.2 14.8 KIAA1841 ENSG00000162929 KIAA1841 Q6NSI8 2 61065871-61138034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 11.2" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 56.3;Excitatory neurons: 91.2;Inhibitory neurons: 78.5;Oligodendrocytes: 63.8;Respiratory ciliated cells: 58.0;Rod photoreceptor cells: 45.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051240 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli" "HPA051240: AB_2681401" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" "unprognostic (2.35e-3)" "unprognostic (1.08e-1)" "unprognostic (1.19e-1)" "unprognostic (1.18e-2)" "unprognostic (5.71e-8)" "unprognostic (1.13e-1)" "unprognostic (5.06e-3)" "unprognostic (7.53e-2)" "unprognostic (6.09e-2)" "unprognostic (8.92e-2)" "unprognostic (7.85e-6)" "unprognostic (8.54e-2)" "unprognostic (1.04e-2)" "unprognostic (3.51e-1)" "unprognostic (2.25e-1)" 2.4 1.6 3.2 1.8 3.7 1.1 1.8 4.1 6.2 4.2 1.2 3.2 2.6 1.8 2.2 1.6 3.4 1.3 2.5 3.4 3.3 1.2 1.0 3.6 1.5 5.2 3.2 1.0 1.6 1.3 3.3 1.6 5.7 4.2 3.7 11.2 1.4 1.3 1.8 3.9 2.8 2.4 2.2 1.4 2.5 3.7 5.2 2.5 1.8 2.2 1.6 1.5 1.8 6.1 5.1 10.9 12.5 5.3 6.5 7.7 4.3 10.1 2.2 4.8 4.4 3.4 3.2 2.1 2.6 7.5 9.8 6.3 8.2 3.3 6.7 10.0 3.0 2.2 6.9 8.8 3.5 2.5 2.0 3.7 4.9 8.8 3.1 5.3 7.1 3.0 2.1 1.7 13.5 0.4 2.1 1.7 3.9 5.9 2.5 6.7 10.5 0.5 5.4 10.6 7.5 4.7 11.8 2.6 3.4 9.1 1.8 2.7 9.4 7.8 3.1 6.5 6.8 1.0 3.1 3.0 5.6 1.8 5.5 0.4 0.5 1.8 0.4 0.7 0.4 0.5 0.4 0.2 0.5 0.1 0.0 0.3 1.3 0.5 1.0 0.3 1.5 0.2 3.2 3.7 4.1 6.2 3.4 3.3 5.2 3.2 5.7 2.2 5.2 6.1 12.9 6.4 5.8 26.1 1.5 2.5 3.2 4.4 1.8 14.5 3.5 2.8 7.0 2.8 11.6 3.7 56.3 1.1 4.5 7.5 0.0 3.8 4.0 22.4 8.3 8.0 7.7 5.5 91.2 6.2 2.7 8.0 14.8 4.5 1.3 18.6 7.1 0.9 5.8 8.4 78.5 5.3 4.1 5.9 5.3 2.6 3.7 5.2 3.6 22.5 9.1 5.1 7.2 19.1 63.8 9.2 8.4 1.9 2.0 4.0 4.7 0.8 58.0 45.4 0.0 4.4 7.5 10.5 20.7 4.8 3.3 0.4 4.0 0.9 4.7 2.7 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 112.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved "Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Mitotic chromosome" "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favorable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favorable (1.69e-4)" 10.6 10.8 7.6 11.6 7.2 13.3 10.7 11.7 9.0 11.8 5.2 14.0 8.9 11.6 4.4 11.9 12.0 6.7 8.9 7.8 7.7 14.0 14.6 11.4 16.1 7.6 7.0 12.2 18.4 10.3 13.1 5.4 7.4 13.2 10.9 6.2 11.8 7.8 12.5 11.9 13.7 7.1 6.3 19.8 14.0 12.5 7.3 15.6 13.1 6.4 13.4 11.5 12.9 7.1 16.6 29.7 14.8 22.8 6.0 7.9 23.3 15.1 14.5 24.8 11.6 43.9 23.3 25.6 19.6 12.1 8.8 26.6 23.1 20.0 18.0 4.2 24.9 15.0 20.6 29.4 14.9 14.3 14.8 3.6 10.7 21.9 25.0 12.4 20.8 42.5 48.3 13.4 17.1 72.0 32.7 40.3 25.5 18.9 21.8 31.3 17.3 15.3 15.0 19.2 22.5 21.4 31.9 16.4 7.8 12.6 25.8 22.0 13.4 13.1 23.3 7.1 29.5 63.2 23.4 112.0 13.2 35.2 9.7 0.0 7.8 5.9 18.3 10.8 16.2 7.8 7.2 14.1 6.0 7.7 7.3 11.3 0.6 25.7 16.0 8.0 6.8 8.7 7.6 7.2 11.7 9.0 7.8 7.7 7.6 7.0 7.4 6.3 7.3 7.1 8.4 0.0 16.8 11.1 14.7 4.6 10.9 6.8 12.5 17.8 12.7 9.9 9.9 14.3 14.2 9.2 27.1 14.4 36.1 16.5 11.7 12.3 61.6 8.9 6.0 8.8 24.0 16.0 9.1 16.7 9.4 9.0 19.4 11.4 3.8 17.7 12.1 13.3 13.3 11.8 10.1 15.9 8.2 13.3 6.1 79.9 6.5 9.9 8.8 7.5 10.2 6.5 77.2 7.1 9.2 13.1 9.3 7.5 35.9 15.1 13.8 25.1 9.0 18.0 0.0 16.7 8.5 22.8 11.8 8.6 6.7 11.9 25.5 11.6 21.8 16.5 KLLN killin ENSG00000227268 "Killin, p53 regulated DNA replication inhibitor" B2CW77 10 87859158-87863533 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Cell cycle" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.5" "Cell type enhanced" "Detected in many" "granulocytes: 5.7;Sertoli cells: 6.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "JURKAT: 5.0;Karpas-707: 5.1" HPA074502 Supported Nucleoplasm,Nucleoli No No "Cluster 42: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA074502: AB_2686695" "unprognostic (4.53e-2)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (3.71e-1)" "unprognostic (6.53e-2)" "unprognostic (1.37e-1)" "unprognostic (3.59e-1)" "unprognostic (1.09e-1)" "unprognostic (2.07e-1)" "unprognostic (3.12e-3)" "unprognostic (1.57e-2)" "unprognostic (4.79e-4)" "unprognostic (1.38e-2)" "unprognostic (1.00e-1)" "unprognostic (9.02e-4)" "unprognostic (1.60e-1)" 1.0 0.7 1.0 0.6 0.7 0.5 0.6 1.5 1.6 0.7 0.6 0.9 0.4 0.5 1.0 0.4 1.4 0.4 0.5 0.7 0.9 0.9 0.9 0.4 0.8 0.5 0.6 0.4 0.2 0.5 0.5 0.6 0.6 0.4 0.8 1.0 0.3 0.5 4.5 0.4 0.4 0.5 0.3 0.8 0.6 1.0 0.6 1.0 0.7 0.5 0.8 0.3 0.3 1.5 0.8 1.0 1.1 0.7 0.5 0.3 0.8 0.7 0.9 0.5 0.7 0.6 2.6 2.0 0.3 0.2 0.5 0.9 0.7 0.8 0.4 0.5 0.3 0.7 1.5 0.6 0.6 1.4 0.5 0.6 0.8 0.7 0.8 0.9 0.3 5.0 0.4 5.1 0.5 1.8 4.1 1.6 0.4 0.6 0.5 2.6 0.1 2.6 0.4 0.8 0.4 1.0 0.9 0.6 0.1 0.7 1.6 1.2 0.3 0.5 0.3 0.9 0.3 2.9 3.3 2.9 0.9 2.9 0.6 1.6 0.3 0.6 0.2 0.5 0.4 0.4 0.3 0.3 0.3 0.5 0.4 0.3 2.5 0.6 0.8 0.5 0.2 0.2 1.0 0.7 1.5 1.6 0.7 0.9 0.5 0.6 0.6 0.3 0.6 1.5 0.6 0.0 0.0 0.3 0.5 0.1 0.3 0.2 0.6 1.7 1.0 1.3 2.7 1.5 1.3 0.0 0.0 0.7 2.0 3.0 0.0 0.2 3.9 0.8 0.9 0.6 0.0 0.8 0.4 0.2 0.4 1.1 3.6 0.4 5.7 0.3 0.7 0.4 0.3 3.3 0.5 1.8 0.0 1.3 0.0 2.0 0.0 0.6 0.0 0.0 0.3 1.6 0.0 0.0 0.1 0.3 2.5 0.0 0.2 0.3 1.8 1.9 2.3 1.0 6.6 1.1 2.9 0.3 1.2 0.6 0.4 0.5 0.7 0.3 1.3 0.2 KRCC1 FLJ22333 ENSG00000172086 "Lysine rich coiled-coil 1" Q9NPI7 2 88027205-88064252 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045618, HPA052666" Approved Approved Nucleoli,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Nucleoli "HPA045618: AB_10960406, HPA052666: AB_2681907" "unprognostic (7.37e-3)" "unprognostic (1.30e-1)" "unprognostic (2.09e-1)" "unprognostic (1.01e-2)" "unprognostic (1.22e-1)" "unprognostic (2.59e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-2)" "unprognostic (1.46e-1)" "unprognostic (4.83e-2)" "unprognostic (2.22e-1)" "unprognostic (6.04e-2)" "unprognostic (1.99e-2)" "unprognostic (2.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-3)" 28.2 21.0 20.1 28.7 22.8 10.1 38.4 21.7 28.0 33.0 20.7 45.9 32.0 23.9 41.7 32.2 27.1 22.2 31.7 19.9 21.6 31.9 43.6 21.9 38.0 23.2 22.0 24.6 28.6 34.1 15.7 21.9 23.7 25.2 43.8 14.5 24.8 26.0 29.1 25.8 35.7 22.9 21.8 30.7 27.2 15.2 21.7 31.5 33.2 34.6 32.4 24.4 24.9 24.9 29.4 17.8 27.4 20.1 64.1 75.3 20.2 45.5 50.3 23.7 23.1 1.6 38.5 41.4 16.0 28.9 36.1 14.8 6.3 9.4 26.7 43.7 8.7 8.0 4.4 2.8 46.7 12.2 5.5 38.0 46.3 15.9 33.7 61.9 27.1 32.9 11.5 20.2 51.7 25.0 14.1 16.9 20.9 42.3 11.8 28.3 5.0 4.5 36.0 15.8 21.1 21.3 17.3 23.7 54.8 20.1 16.7 49.2 38.2 28.0 2.1 46.5 14.5 45.3 33.6 32.5 30.1 32.0 67.5 59.4 21.6 77.7 18.8 23.8 21.7 36.6 23.0 23.2 25.7 32.5 25.8 21.0 35.8 31.6 21.5 22.5 34.3 16.8 20.1 22.8 21.7 28.0 19.9 21.6 23.2 22.0 23.7 21.8 21.7 24.9 24.2 35.3 41.7 29.4 61.8 33.0 32.6 49.9 53.5 11.9 50.9 50.9 41.3 40.0 49.0 35.0 2.1 46.1 24.8 109.1 60.7 50.5 16.7 34.4 37.8 31.6 41.6 28.2 14.5 70.9 16.3 42.5 17.3 30.9 43.1 28.4 37.9 59.5 48.6 10.1 13.9 56.8 26.4 40.3 39.8 5.3 47.8 38.8 28.4 44.0 53.6 35.9 58.7 34.7 53.5 51.4 79.6 43.2 29.6 62.6 60.4 76.0 62.6 5.4 19.7 40.3 29.7 41.0 20.7 45.4 42.6 41.9 37.2 32.2 72.4 26.4 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1 regulator of NFKB signaling" O95751 X 141111605-141177129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 123.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9" "Region enriched" "Detected in many" 5 "cerebellum: 19.2" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 32.3 34.0 4.7 0.9 5.5 0.1 28.0 2.9 8.5 45.8 0.2 18.8 0.9 53.9 1.8 21.4 48.5 1.6 15.1 6.2 5.8 33.2 4.8 19.6 0.8 5.3 5.0 46.8 19.3 10.5 123.3 0.0 5.0 34.3 0.3 3.4 55.1 5.9 5.5 31.5 12.5 2.0 1.2 14.2 18.4 10.8 5.0 0.9 53.7 0.4 0.7 33.1 30.6 6.0 0.0 24.7 3.0 8.4 5.0 6.2 0.0 5.0 5.8 6.3 8.8 0.0 8.0 0.0 4.2 7.7 6.1 10.4 3.4 7.1 4.5 0.0 6.6 0.0 11.7 0.0 2.0 0.0 1.9 10.9 3.6 5.5 2.9 5.1 5.7 0.0 0.1 0.0 5.7 31.9 0.0 0.0 3.3 0.0 34.3 0.0 2.7 0.0 7.7 4.7 0.0 3.2 0.0 4.0 0.0 1.6 5.1 0.0 11.9 0.0 6.8 0.0 21.9 0.0 0.0 0.0 3.5 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.8 0.9 2.5 0.8 0.2 2.1 2.2 1.4 0.0 6.4 0.0 1.4 2.6 1.0 4.7 5.5 2.9 8.5 6.2 5.8 5.3 5.0 5.0 1.2 5.0 6.0 8.6 0.0 5.3 4.2 4.9 6.0 16.8 4.6 16.5 29.3 23.8 20.2 2.2 30.0 8.2 23.9 8.4 2.8 5.7 0.1 43.0 13.8 0.7 7.8 13.5 12.8 5.4 0.8 9.4 14.0 1.8 16.1 3.6 6.0 2.5 8.8 12.8 0.1 0.9 20.2 9.9 0.4 8.2 0.3 1.8 1.1 22.1 1.0 3.6 7.5 0.3 21.2 5.2 7.1 15.0 13.7 0.2 38.7 0.9 11.9 0.0 43.8 4.6 13.0 13.1 15.3 26.2 0.9 7.6 16.7 6.8 1.5 5.2 13.5 0.3 15.0 LEKR1 FLJ16641 ENSG00000197980 "Leucine, glutamate and lysine rich 1" 3 156825481-157046129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 12.8" "Cell type enhanced" "Detected in many" "Early spermatids: 96.8;Late spermatids: 47.7;Respiratory ciliated cells: 28.0;Spermatocytes: 65.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.3;U-266/70: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044039, HPA047774" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA044039: AB_10794288, HPA047774: " "unprognostic (5.42e-2)" "unprognostic (1.17e-1)" "unprognostic (3.22e-2)" "unprognostic (8.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.94e-1)" "unprognostic (2.29e-3)" "unprognostic (1.98e-2)" "unprognostic (7.55e-2)" "unprognostic (2.20e-1)" "unprognostic (5.66e-3)" "unprognostic (3.50e-2)" "unprognostic (5.99e-2)" "unprognostic (6.59e-2)" "unprognostic (3.28e-1)" "unprognostic (2.17e-3)" "unprognostic (1.80e-2)" 0.9 1.0 0.7 0.3 1.0 0.2 1.6 0.9 0.7 0.5 1.9 0.6 1.0 0.7 3.4 0.3 3.8 0.4 0.9 0.9 1.1 1.4 0.7 0.6 1.0 1.9 1.7 0.9 1.0 1.5 1.5 0.2 1.5 0.9 0.6 1.8 0.6 0.6 0.2 0.4 0.6 0.4 1.6 0.5 0.9 12.8 1.1 0.7 2.3 0.2 0.4 0.5 0.2 1.0 3.3 1.2 0.0 0.7 0.4 0.2 0.1 0.1 0.5 0.6 0.5 0.1 1.7 0.0 0.9 0.4 1.2 1.2 0.0 0.3 1.3 0.5 0.3 1.0 0.1 0.0 0.0 1.0 0.2 1.5 0.8 0.1 0.9 0.3 0.3 0.0 0.7 0.6 1.2 1.2 0.0 0.7 1.0 0.9 0.7 0.0 0.8 0.8 1.0 0.2 1.9 0.7 1.0 0.7 0.0 0.2 2.2 1.8 0.0 0.1 0.3 0.2 0.5 2.9 0.5 0.0 0.5 0.7 1.0 0.6 0.0 0.0 0.2 0.0 0.4 0.8 0.4 0.0 0.3 0.9 0.4 0.2 0.0 0.7 0.0 0.5 0.6 0.1 0.7 1.0 0.9 0.7 0.9 1.1 1.9 1.7 1.5 1.6 1.1 1.0 0.5 0.0 1.1 19.9 6.3 1.3 1.1 1.4 2.8 1.2 2.7 3.9 1.5 1.5 2.8 3.7 2.1 0.3 0.7 1.5 3.9 0.7 96.8 20.7 1.4 0.6 0.0 2.1 6.5 1.6 0.1 1.1 9.7 2.8 1.3 1.4 0.0 1.8 0.2 3.3 11.8 0.9 0.0 1.6 1.3 47.7 1.5 1.8 1.8 3.7 1.1 1.7 0.0 8.0 8.0 1.0 0.6 1.9 2.5 0.7 1.2 5.4 28.0 4.8 0.0 0.6 1.4 65.2 4.3 2.2 0.9 0.1 2.3 1.1 0.9 0.8 LEMD1 "CT50, LEMP-1" ENSG00000186007 "LEM domain containing 1" Q68G75 1 205381378-205455954 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "epididymis: 14.8;testis: 55.1" "Cell type enriched" "Detected in many" 4 "Late spermatids: 4203.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.6" "Group enriched" "Detected in many" 5 "cerebellum: 2.6;medulla oblongata: 2.4;midbrain: 1.2;pons: 2.8;thalamus: 2.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 39.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in single" 6 "cerebellum: 3.9" HPA045425 Approved Nucleoli,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Cytosol" "HPA045425: AB_10960538" "unprognostic (1.78e-1)" "unprognostic (2.00e-1)" "unprognostic (1.88e-2)" "unprognostic (4.20e-3)" "unprognostic (7.27e-2)" "unprognostic (1.48e-1)" "unprognostic (2.72e-2)" "unprognostic (1.01e-1)" "prognostic favorable (1.26e-4)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.31e-1)" "unprognostic (5.66e-6)" "unprognostic (2.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (1.38e-2)" 0.1 0.3 0.2 0.0 0.2 0.0 0.3 2.6 0.4 0.3 0.0 0.0 0.6 0.3 14.8 0.8 1.6 0.1 0.0 0.1 0.4 1.0 0.0 0.4 0.0 2.4 1.2 0.6 0.0 0.0 0.5 0.1 2.8 0.2 0.0 1.4 1.9 0.4 0.0 0.4 0.2 0.1 0.4 0.0 0.9 55.1 2.2 0.0 0.6 0.0 0.7 0.1 0.5 0.3 4.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 39.6 0.0 3.7 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 1.3 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 2.6 0.4 0.1 0.4 2.4 1.2 2.8 0.4 2.2 0.3 0.0 0.0 2.6 1.0 0.0 0.0 1.2 8.4 4.6 12.1 1.6 0.9 0.0 0.0 6.4 0.0 4.2 0.1 0.0 0.0 0.0 1.9 968.7 0.8 0.1 0.7 0.0 0.0 1.4 0.7 0.1 0.2 0.0 1.1 0.0 0.6 1.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 4203.7 12.8 1.1 0.0 0.0 0.0 1.3 0.0 1.0 0.5 6.8 0.1 13.9 0.0 8.5 0.3 4.3 1.6 0.7 6.6 0.0 0.4 15.6 9.7 0.7 0.0 0.4 0.1 0.1 0.3 4.4 LEUTX ENSG00000213921 "Leucine twenty homeobox" A8MZ59 19 39776595-39786291 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA041498 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA041498: AB_10796346" "unprognostic (6.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LLPH "C12orf31, hLLP, MGC14817" ENSG00000139233 "LLP homolog, long-term synaptic facilitation factor" Q9BRT6 12 66116555-66130750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048920, HPA058786" Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli "Mitotic chromosome" "HPA048920: AB_2680556, HPA058786: AB_2683820" "unprognostic (3.60e-3)" "unprognostic (4.94e-2)" "unprognostic (4.07e-2)" "unprognostic (3.03e-2)" "unprognostic (2.13e-1)" "unprognostic (4.31e-2)" "prognostic unfavorable (6.44e-7)" "unprognostic (7.15e-2)" "unprognostic (1.30e-2)" "unprognostic (8.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.07e-2)" "unprognostic (3.87e-2)" "unprognostic (9.65e-3)" "unprognostic (2.49e-2)" "unprognostic (3.37e-1)" "unprognostic (2.94e-2)" 21.6 34.4 12.3 24.4 13.5 50.3 18.6 12.7 16.0 13.2 11.2 20.1 19.2 15.2 18.6 19.5 13.2 14.7 23.2 12.8 13.7 20.9 21.2 15.5 26.3 13.5 14.3 17.6 17.2 17.0 10.7 17.5 13.7 15.3 20.3 7.4 14.5 14.1 29.7 13.8 18.2 19.4 13.0 18.2 19.1 22.1 13.5 22.1 17.3 25.3 25.6 27.3 14.0 14.2 77.0 61.1 36.4 44.2 42.6 40.8 44.5 87.0 56.4 63.9 53.6 52.8 31.0 87.0 70.6 58.6 50.7 63.6 57.2 52.9 85.7 78.4 48.8 94.5 41.7 47.3 49.8 162.5 61.8 41.9 53.6 53.7 58.3 50.1 56.6 44.1 81.5 60.9 76.1 81.3 74.1 110.4 77.9 61.6 63.0 61.9 67.2 62.7 63.3 90.8 36.3 45.1 57.0 58.3 97.4 38.0 77.4 89.5 60.5 48.3 71.3 60.9 80.4 45.7 77.6 130.2 65.4 76.0 76.8 34.3 32.0 35.5 27.8 38.0 32.0 29.2 32.3 30.6 31.3 27.5 27.4 29.2 43.8 27.4 48.4 27.0 38.9 28.8 12.3 13.5 12.7 16.0 12.8 13.7 13.5 14.3 13.7 13.0 13.5 14.2 34.2 12.8 33.9 2.9 47.6 27.1 53.9 86.3 30.1 15.9 24.5 28.4 25.1 41.5 64.3 31.3 4.2 66.3 49.4 34.1 66.5 68.3 63.3 40.5 45.4 32.5 13.8 33.4 5.0 71.3 70.4 34.8 35.7 46.6 89.4 61.2 35.7 60.2 64.2 21.9 4.4 31.1 85.5 50.4 26.5 17.0 43.8 45.6 35.6 3.7 84.1 30.8 59.8 3.0 5.8 96.3 43.3 30.1 27.3 46.3 44.0 86.5 35.8 15.2 26.3 29.7 36.8 126.6 48.6 30.6 30.5 72.7 43.8 126.4 36.1 60.6 LRP10 "DKFZP564C1940, LRP9, MGC8675, MST087, MSTP087" ENSG00000197324 "LDL receptor related protein 10" Q7Z4F1 14 22871740-22881713 "Predicted membrane proteins" Endocytosis Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 367.2;Pancreatic endocrine cells: 314.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 59.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 59.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000932 Approved Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA000932: AB_2281523" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (3.72e-2)" "unprognostic (4.59e-2)" "unprognostic (1.72e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (3.54e-7)" "prognostic unfavorable (9.17e-4)" "unprognostic (8.32e-2)" "unprognostic (1.48e-2)" "unprognostic (1.97e-2)" "unprognostic (4.55e-2)" "prognostic favorable (6.31e-5)" "unprognostic (3.06e-2)" "unprognostic (8.81e-2)" "unprognostic (2.27e-1)" "unprognostic (4.14e-2)" 81.8 48.7 27.3 67.4 34.1 80.3 74.9 30.6 25.4 87.1 53.5 111.1 94.8 100.3 26.5 173.4 76.0 108.7 68.1 24.1 33.2 79.2 45.1 79.9 49.7 53.8 33.0 76.8 74.6 87.7 28.8 57.0 35.2 70.0 55.9 10.4 95.2 95.1 45.7 94.6 91.3 76.1 36.9 62.5 99.8 15.5 35.1 38.9 63.3 36.0 53.8 104.7 100.0 38.8 78.9 94.3 20.4 53.4 269.9 155.4 68.6 121.6 228.6 75.1 103.4 29.1 272.4 41.2 59.5 275.8 85.9 109.8 13.3 139.2 29.5 67.5 14.3 14.4 48.4 20.5 120.0 33.0 125.4 170.8 159.4 112.7 57.9 207.3 138.8 18.7 17.9 153.8 102.8 90.3 9.3 10.0 4.4 75.8 125.6 20.8 20.6 41.5 79.1 137.8 1.8 22.1 67.3 127.5 52.4 15.2 67.1 23.5 146.3 114.9 32.5 60.4 51.1 71.6 45.6 18.7 59.6 13.2 50.2 15.3 4.7 34.6 9.7 4.7 9.5 7.3 11.9 11.3 4.6 4.9 10.1 5.8 59.1 5.4 5.5 3.8 12.4 7.3 27.3 34.1 30.6 25.4 24.1 33.2 53.8 33.0 35.2 36.9 35.1 38.8 78.4 105.8 60.9 13.1 60.5 38.5 95.8 69.1 40.9 2.3 68.0 51.7 30.4 115.8 100.4 82.8 0.0 67.9 60.7 367.2 9.8 173.3 14.1 45.5 35.3 64.2 66.5 69.7 0.2 238.5 96.5 71.8 86.6 80.6 34.9 40.2 81.4 43.2 58.7 0.0 0.2 125.4 57.0 55.0 46.8 16.5 56.8 44.1 55.2 10.3 82.2 91.4 127.7 3.5 7.3 314.0 289.6 73.0 89.8 127.3 259.8 47.6 85.8 8.8 65.7 38.8 70.4 5.4 7.9 74.6 47.5 132.4 58.2 24.6 109.1 154.1 LRRC10B ENSG00000204950 "Leucine rich repeat containing 10B" A6NIK2 11 61508749-61511018 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 42.4;fallopian tube: 28.7;pituitary gland: 33.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 49.3;Muller glia cells: 9.5;Respiratory ciliated cells: 37.2;Sertoli cells: 19.7;Smooth muscle cells: 20.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 5.8" "Region enhanced" "Detected in many" "basal ganglia: 42.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "AF22: 9.7;RH-30: 10.5;SCLC-21H: 5.4" "Region enriched" "Detected in many" 7 "basal ganglia: 222.5" "Group enriched" "Detected in many" 5 "basal ganglia: 30.9;hippocampal formation: 24.2" HPA047619 Uncertain Approved Nucleoplasm,Nucleoli No NA "Cluster 10: Brain - Neuronal signaling" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Nucleoli "HPA047619: AB_2680106" "unprognostic (9.95e-2)" "unprognostic (2.67e-2)" "unprognostic (4.92e-2)" "unprognostic (1.26e-2)" "unprognostic (2.11e-1)" "unprognostic (1.32e-1)" "unprognostic (6.10e-2)" "unprognostic (9.22e-2)" "unprognostic (4.88e-3)" "unprognostic (1.62e-1)" "unprognostic (9.21e-3)" "unprognostic (2.52e-2)" "unprognostic (5.27e-4)" "unprognostic (5.07e-2)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (6.63e-2)" 3.7 0.9 11.1 0.4 42.4 0.0 2.9 0.5 11.2 5.9 3.6 2.2 0.3 4.9 1.9 0.5 28.7 0.3 1.7 13.5 5.2 2.2 0.1 4.9 0.0 4.0 4.0 2.3 1.3 2.2 33.7 0.5 2.1 1.6 0.3 0.1 1.3 0.5 0.7 0.9 1.4 1.6 3.1 0.4 2.9 5.9 7.9 2.7 1.6 0.9 0.0 1.1 2.5 3.4 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 10.5 0.0 0.0 0.0 5.4 0.5 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 42.4 0.5 11.2 13.5 5.2 4.0 4.0 2.1 3.1 7.9 3.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.6 0.4 1.1 0.0 3.5 1.8 0.0 0.0 0.0 0.1 0.0 0.0 3.2 49.3 0.5 0.4 4.2 0.0 1.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.8 6.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.5 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 37.2 0.2 19.7 0.7 20.6 0.8 1.1 0.0 0.3 0.1 0.1 0.2 0.1 0.1 LRRC23 "B7, LRPB7" ENSG00000010626 "Leucine rich repeat containing 23" Q53EV4 12 6873569-6914241 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 101.8" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 204.6;Respiratory ciliated cells: 244.2;Rod photoreceptor cells: 138.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA037766, HPA057533" Enhanced Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli, Nucleoli rim" "HPA037766: AB_10672609, HPA057533: AB_2683459" "prognostic favorable (6.02e-4)" "unprognostic (7.51e-2)" "unprognostic (2.69e-3)" "unprognostic (4.37e-3)" "unprognostic (1.23e-1)" "unprognostic (5.90e-2)" "unprognostic (7.94e-3)" "unprognostic (1.42e-1)" "unprognostic (3.54e-2)" "unprognostic (4.64e-1)" "unprognostic (2.00e-1)" "unprognostic (3.84e-2)" "unprognostic (2.29e-1)" "unprognostic (6.57e-2)" "unprognostic (1.60e-1)" "unprognostic (2.68e-1)" "unprognostic (6.25e-2)" 2.5 3.2 11.3 1.1 11.4 2.5 3.6 11.1 11.2 5.2 20.5 3.4 0.9 5.0 12.5 1.8 101.8 3.0 4.7 11.3 12.4 6.2 2.5 8.9 1.8 18.6 22.4 4.8 2.1 6.7 7.4 2.2 16.9 3.6 2.1 25.1 2.8 3.7 6.3 2.4 2.0 3.6 16.6 2.4 3.4 26.3 12.6 3.1 6.2 5.8 2.7 2.9 2.6 13.2 5.2 9.9 1.6 3.6 7.2 5.4 5.8 2.0 7.0 3.3 6.3 2.1 10.4 4.5 2.2 5.4 9.6 1.3 2.9 4.3 7.1 3.6 1.5 3.2 3.7 4.1 5.8 1.8 3.0 3.8 7.8 6.4 5.7 8.6 4.6 11.0 1.9 2.5 3.9 5.9 4.0 1.2 1.0 7.7 2.8 3.7 8.1 5.3 6.6 1.5 2.6 6.3 3.2 4.3 6.6 10.2 2.2 4.1 2.0 3.3 8.6 3.8 2.3 2.3 1.6 3.8 8.1 2.3 4.8 0.6 2.7 6.4 2.2 2.6 3.0 5.7 2.2 1.9 2.6 2.8 2.4 2.4 0.5 4.0 2.6 3.9 0.1 1.3 11.3 11.4 11.1 11.2 11.3 12.4 18.6 22.4 16.9 16.6 12.6 13.2 12.6 0.0 22.4 11.4 12.6 6.5 10.0 15.1 11.4 17.8 15.3 19.3 8.2 20.0 34.4 12.9 50.1 8.2 9.4 5.2 37.2 13.6 43.4 204.6 13.1 9.7 18.0 7.4 5.8 17.3 12.5 12.6 10.7 12.9 5.7 12.1 14.6 7.5 13.5 13.5 4.4 8.6 16.2 11.9 8.9 47.0 8.4 13.7 8.8 6.5 11.0 38.6 11.3 1.5 6.4 15.3 4.7 12.4 10.5 6.4 4.5 46.5 244.2 138.1 13.1 21.1 13.5 63.6 13.1 8.4 5.8 4.5 11.8 7.1 5.6 7.3 LSM3 "SMX4, USS2, YLR438C" ENSG00000170860 "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated" P62310 3 14178817-14201122 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 752.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044966 Approved Approved Nucleoplasm,Nucleoli NA NA 30000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Nucleoplasm "HPA044966: AB_2679159" "unprognostic (3.84e-3)" "unprognostic (7.00e-3)" "unprognostic (3.61e-2)" "unprognostic (2.87e-2)" "unprognostic (2.27e-1)" "unprognostic (2.19e-1)" "unprognostic (2.94e-3)" "unprognostic (5.01e-2)" "unprognostic (2.70e-2)" "unprognostic (1.23e-1)" "unprognostic (2.73e-2)" "unprognostic (8.07e-3)" "unprognostic (4.93e-3)" "unprognostic (5.57e-2)" "unprognostic (2.88e-1)" "unprognostic (1.46e-1)" "unprognostic (1.89e-3)" 12.6 10.8 12.1 11.0 12.6 18.9 12.6 13.2 16.6 8.7 12.1 12.1 12.4 9.1 10.4 12.1 8.2 6.5 17.4 12.6 12.7 23.3 18.4 8.2 12.9 12.3 12.0 9.4 9.5 11.0 9.0 10.3 12.5 9.8 11.2 10.7 9.2 8.3 30.1 10.1 12.9 8.1 12.4 9.7 10.5 12.3 12.6 16.8 10.7 22.4 11.8 10.3 8.7 13.2 36.0 28.6 30.1 31.3 13.8 16.0 76.3 29.0 19.3 36.6 34.8 32.6 27.6 39.5 23.5 20.3 25.7 16.4 34.5 28.4 36.0 37.5 42.3 41.8 38.1 31.5 7.1 47.3 29.0 12.0 20.2 36.8 15.6 16.4 19.1 34.0 45.9 30.7 27.4 41.5 50.4 64.2 52.1 40.2 38.5 27.4 37.3 43.5 34.6 36.7 16.8 27.2 33.2 46.1 28.6 34.3 53.2 59.7 17.3 23.3 37.2 28.3 50.6 21.4 67.3 73.6 29.5 45.9 33.8 44.1 18.9 30.0 14.8 23.7 17.7 27.3 17.1 17.5 18.3 21.7 18.4 19.7 17.8 21.9 20.3 28.7 22.9 25.7 12.1 12.6 13.2 16.6 12.6 12.7 12.3 12.0 12.5 12.4 12.6 13.2 114.2 67.3 94.3 11.4 118.2 97.8 135.4 328.8 115.5 52.5 124.2 171.4 263.4 155.8 164.6 126.9 18.8 391.8 114.2 158.2 485.2 220.4 337.8 111.2 97.8 104.5 104.7 111.9 8.3 265.5 409.6 120.0 67.8 115.2 138.2 142.4 128.8 234.8 235.5 55.5 8.3 195.4 175.0 132.9 115.0 153.1 140.1 119.6 97.8 5.6 202.4 180.7 170.0 7.1 13.3 219.2 196.7 139.9 154.2 110.2 203.9 752.2 122.3 68.2 105.2 111.5 117.9 288.5 295.5 150.8 101.2 318.4 93.6 144.6 205.7 177.2 LURAP1L "bA3L8.2, C9orf150, FLJ38505, LRAP35b, MGC46502" ENSG00000153714 "Leucine rich adaptor protein 1 like" Q8IV03 9 12775020-12823060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 90.2;Paneth cells: 88.8;Prostatic glandular cells: 104.3;Urothelial cells: 140.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 100.6;hTERT-HME1: 81.9;T-47d: 118.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024407 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 6: T47d - Mammary gland" "Cluster 35: Glandular cells - Unknown function" Nucleoli Nucleoplasm "HPA024407: AB_10603780" "unprognostic (1.20e-1)" "unprognostic (2.15e-1)" "unprognostic (7.45e-2)" "unprognostic (1.73e-2)" "unprognostic (2.08e-2)" "unprognostic (5.61e-3)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-2)" "unprognostic (1.56e-2)" "unprognostic (3.67e-2)" "unprognostic (5.68e-3)" "unprognostic (4.38e-1)" "unprognostic (5.67e-2)" "unprognostic (1.53e-1)" "unprognostic (1.02e-2)" 14.6 9.3 3.4 5.5 4.6 0.1 10.6 11.8 6.1 10.9 2.5 19.9 4.1 6.2 3.3 4.6 6.6 11.8 4.4 3.5 4.2 5.4 32.2 25.0 3.9 5.2 4.6 4.2 19.6 0.8 5.5 21.0 5.0 6.9 9.4 4.7 27.7 6.7 2.5 12.2 9.2 8.3 5.7 10.4 12.5 0.5 4.7 1.2 8.7 3.4 2.0 12.1 12.4 5.8 2.2 7.1 0.0 2.3 11.0 15.1 0.0 3.9 20.2 5.1 5.4 0.0 2.6 0.0 1.5 20.6 24.3 3.0 0.0 0.4 3.9 0.0 0.8 1.1 6.7 4.0 100.6 0.0 0.0 6.0 9.7 17.4 81.9 8.6 3.3 0.0 0.0 25.8 3.1 1.8 0.0 0.0 0.1 9.6 7.8 0.0 1.3 0.1 20.7 1.2 15.5 1.5 4.7 2.9 3.8 1.7 118.5 0.4 1.3 4.5 0.7 11.7 2.8 0.1 0.0 0.0 7.2 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.4 4.6 11.8 6.1 3.5 4.2 5.2 4.6 5.0 5.7 4.7 5.8 9.6 9.6 18.4 1.3 0.7 90.2 34.4 19.3 5.2 10.2 60.1 26.2 7.1 20.0 40.2 1.8 2.1 1.0 0.5 58.7 7.9 66.6 5.0 11.5 3.2 7.8 26.7 0.0 18.4 11.8 2.7 19.7 10.2 29.2 10.8 12.9 1.8 30.2 0.6 18.5 41.6 12.8 24.4 0.0 8.4 0.8 9.3 2.3 26.6 6.5 0.0 4.3 0.0 8.0 44.1 27.5 88.8 3.0 0.0 104.3 20.7 5.5 16.1 10.2 39.5 8.0 47.4 0.1 0.6 2.9 64.4 1.1 1.9 1.3 49.5 140.4 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 14.8;parathyroid gland: 54.2" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 17.6;Excitatory neurons: 26.2;Horizontal cells: 20.2;Melanocytes: 19.6;Rod photoreceptor cells: 18.5;Sertoli cells: 65.7;Smooth muscle cells: 15.4" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.1;basal ganglia: 11.6;cerebral cortex: 14.8;hippocampal formation: 14.5;white matter: 9.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MOLT-4: 19.7;SK-MEL-30: 75.0;U-698: 23.2;WM-115: 50.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 10 "amygdala: 23.2;basal ganglia: 66.8;cerebral cortex: 45.5;hippocampal formation: 36.3;olfactory bulb: 26.7" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 3.7 1.7 13.1 1.5 11.6 0.1 3.0 0.0 14.8 2.0 0.0 1.3 0.5 2.9 0.9 5.3 1.6 3.5 5.0 14.5 0.6 4.7 0.7 7.0 1.1 0.0 0.1 1.2 1.5 54.2 2.2 6.5 0.3 2.8 0.4 3.5 1.4 1.1 1.9 4.6 0.9 2.5 0.0 0.5 1.4 7.5 2.3 1.9 2.7 2.0 0.5 2.3 1.7 9.2 0.1 0.0 9.7 8.3 0.0 0.0 1.2 5.0 0.1 4.3 3.7 0.3 0.1 11.1 3.5 3.1 1.6 0.2 0.5 0.2 2.0 0.0 0.1 0.0 0.0 0.2 0.7 0.0 1.7 0.9 0.1 1.8 0.0 0.6 0.0 11.7 0.0 0.1 14.4 0.0 19.7 0.1 12.2 0.0 0.0 0.0 15.6 0.0 2.7 0.4 14.8 12.9 0.0 0.0 75.0 8.2 0.1 0.4 0.0 5.1 3.5 0.1 1.5 0.1 0.1 23.2 0.1 1.1 50.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.1 11.6 0.0 14.8 14.5 0.6 0.0 0.1 0.3 0.0 2.3 9.2 3.9 0.0 0.0 1.6 0.0 1.3 0.8 1.0 17.6 1.8 0.3 11.3 4.6 0.0 0.1 0.0 4.2 7.1 0.4 0.0 1.9 0.0 0.5 0.6 1.3 3.2 0.0 0.0 26.2 0.0 2.3 2.4 0.0 0.5 0.0 3.5 0.0 0.0 0.9 20.2 2.9 0.0 2.0 0.0 0.0 0.8 1.2 0.2 19.6 1.9 0.0 0.9 0.0 6.0 0.8 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 18.5 65.7 1.1 15.4 0.2 1.1 7.3 0.1 0.8 1.4 2.5 0.0 0.0 M1AP "C2orf65, D6Mm5e, SPATA37" ENSG00000159374 "Meiosis 1 associated protein" Q8TC57 2 74557883-74648338 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 8.0" "Group enriched" "Detected in some" 4 "Spermatocytes: 16.2;Spermatogonia: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "NTERA-2: 2.1;RT4: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045420, HPA059302" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Mitochondria Nucleoli "HPA045420: AB_10961177, HPA059302: AB_2683972" "unprognostic (1.76e-1)" "unprognostic (6.58e-3)" "unprognostic (1.26e-2)" "unprognostic (2.87e-1)" "unprognostic (9.15e-2)" "unprognostic (1.35e-3)" "unprognostic (1.86e-1)" "unprognostic (2.17e-3)" "unprognostic (3.42e-1)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (2.15e-2)" "unprognostic (6.11e-2)" "unprognostic (7.74e-2)" "unprognostic (1.87e-1)" "unprognostic (1.67e-1)" "unprognostic (1.46e-1)" 0.3 0.2 1.1 0.1 0.7 2.5 0.5 0.0 1.2 2.5 0.8 0.1 0.1 1.1 0.3 0.1 2.6 0.1 0.0 1.1 0.6 1.0 0.0 0.4 0.1 0.0 0.2 0.0 0.3 1.3 1.8 0.1 0.0 0.1 0.0 0.5 0.9 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.4 8.0 1.7 0.6 2.0 0.0 0.3 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.0 1.2 1.1 0.6 0.0 0.2 0.0 0.2 1.7 0.3 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.4 0.4 0.0 0.1 3.7 0.0 0.5 0.1 0.2 0.0 0.3 3.1 2.2 0.1 0.0 0.0 0.4 3.1 0.0 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.1 3.8 0.0 1.0 0.8 0.0 1.6 0.8 3.9 0.0 2.0 0.0 2.8 0.4 0.5 0.0 0.0 0.4 0.2 0.0 0.0 0.5 0.2 0.0 0.1 1.8 1.4 0.0 0.1 0.0 16.2 22.5 0.0 0.0 0.3 0.1 0.0 0.1 0.1 MACROD2 "C20orf133, dJ631M13.5" ENSG00000172264 "Mono-ADP ribosylhydrolase 2" A1Z1Q3 20 13995369-16053197 "Metabolic proteins, Predicted intracellular proteins" "DNA damage" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 349.7;Excitatory neurons: 752.7;Inhibitory neurons: 1058.5;Oligodendrocyte precursor cells: 672.0;Oligodendrocytes: 301.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 8.9;naive B-cell: 13.2;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "B-cells: 13.2;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "EFO-21: 15.5;Karpas-707: 19.1;RT4: 8.4;SCLC-21H: 10.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049076 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA049076: " "unprognostic (1.70e-1)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (5.68e-3)" "unprognostic (2.03e-1)" "unprognostic (1.63e-3)" "unprognostic (1.24e-1)" "unprognostic (2.32e-2)" "unprognostic (3.02e-1)" "unprognostic (2.96e-2)" "unprognostic (4.02e-1)" "unprognostic (7.83e-2)" "unprognostic (4.15e-5)" "unprognostic (9.80e-2)" "unprognostic (9.91e-3)" "unprognostic (3.23e-1)" "unprognostic (2.02e-2)" 1.9 3.1 3.9 2.2 8.4 1.2 2.8 2.3 4.7 3.1 0.1 1.3 0.7 5.0 2.3 1.4 7.3 2.8 1.1 4.8 2.8 3.9 1.8 10.9 4.0 3.3 3.6 2.9 2.9 2.5 2.2 1.1 3.7 4.7 1.3 4.9 1.3 9.9 1.5 2.7 0.9 4.0 2.1 5.0 2.3 5.1 7.3 1.8 2.6 0.6 5.3 4.5 1.2 4.3 1.0 0.4 3.0 1.2 0.8 0.7 0.5 0.3 2.1 1.2 0.7 0.4 0.7 2.0 15.5 1.4 2.6 1.5 0.3 0.7 1.9 1.0 0.9 1.2 1.2 2.4 3.4 0.3 0.3 1.9 1.3 0.0 0.5 1.1 1.1 0.2 1.4 19.1 3.1 0.5 0.5 0.8 0.9 7.1 0.6 1.2 0.5 4.0 2.2 8.4 10.6 1.9 1.6 0.2 0.6 1.1 1.0 1.8 0.7 1.4 3.2 0.3 0.0 0.7 0.3 2.1 0.9 1.0 1.7 0.1 0.5 0.5 0.2 1.2 0.2 8.9 0.2 0.2 0.4 13.2 0.2 0.3 3.4 0.1 1.6 0.2 0.0 0.5 3.9 8.4 2.3 4.7 4.8 2.8 3.3 3.6 3.7 2.1 7.3 4.3 1.6 51.3 203.8 349.7 18.3 4.5 49.8 1.4 5.2 94.0 7.6 6.9 5.9 11.5 37.5 12.9 39.6 7.1 0.1 1.8 9.8 11.9 35.4 8.6 2.5 3.0 1.2 0.4 752.7 1.6 0.4 4.6 9.2 6.7 1.3 7.6 7.1 4.8 0.9 8.4 1058.5 4.5 0.0 0.3 2.1 62.2 3.4 0.9 3.6 87.1 0.0 10.2 0.0 672.0 301.4 6.6 1.7 17.7 2.8 6.2 2.4 8.6 9.8 20.3 6.6 2.1 6.0 23.7 18.8 5.8 6.7 2.1 0.9 13.2 2.8 5.4 MAD2L2 "FANCV, MAD2B, POLZ2, REV7" ENSG00000116670 "Mitotic arrest deficient 2 like 2" Q9UI95 1 11674480-11691650 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.1;Late spermatids: 522.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008110, HPA024176, HPA024612" Approved Supported Nucleoli,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" Cytosol Nucleoli "CAB008110: AB_217976, HPA024176: AB_2671467, HPA024612: " "unprognostic (1.26e-2)" "unprognostic (2.55e-1)" "unprognostic (2.43e-1)" "unprognostic (3.27e-1)" "unprognostic (2.41e-1)" "unprognostic (6.84e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (4.60e-2)" "unprognostic (1.24e-1)" "unprognostic (9.09e-3)" "unprognostic (1.54e-1)" "unprognostic (9.27e-2)" "unprognostic (8.43e-2)" "unprognostic (2.36e-1)" 25.6 19.5 30.3 22.2 32.0 59.8 25.2 33.2 35.9 23.5 27.6 24.6 11.6 19.3 15.0 14.6 20.4 13.4 26.5 30.2 33.1 37.7 49.8 29.6 27.7 34.9 30.2 21.7 39.9 13.3 22.7 10.6 31.7 22.3 7.5 5.0 28.6 11.2 49.3 23.5 17.1 15.5 31.6 25.2 28.8 64.3 35.3 55.1 15.4 31.5 26.1 23.1 17.8 35.9 62.8 57.2 90.8 106.8 28.6 55.1 37.3 56.5 64.8 110.4 97.8 75.2 59.2 87.6 67.6 58.1 64.4 27.4 115.1 60.1 60.5 133.3 129.6 40.1 87.5 93.4 50.2 80.5 62.7 36.1 60.7 81.0 68.9 41.6 51.4 116.7 165.6 138.3 55.5 94.6 365.6 381.3 235.1 25.9 91.2 245.6 100.2 109.6 40.8 13.5 167.8 118.1 93.6 36.5 168.1 61.2 52.6 172.1 26.8 90.7 114.1 85.6 81.8 109.5 82.0 233.7 67.2 281.5 71.8 45.3 85.2 42.8 82.1 97.3 66.8 58.5 55.4 64.8 100.8 43.8 37.0 54.9 36.7 43.3 86.8 139.1 69.9 92.0 30.3 32.0 33.2 35.9 30.2 33.1 34.9 30.2 31.7 31.6 35.3 35.9 24.8 0.0 5.0 4.2 26.1 38.6 26.5 35.7 18.8 5.7 26.9 26.9 15.9 11.5 14.1 14.7 4.2 18.2 49.6 3.7 50.9 40.8 148.1 8.4 21.6 28.2 34.0 69.5 1.7 76.6 50.7 30.6 12.2 11.4 14.0 17.3 29.6 59.1 41.7 11.8 2.3 10.6 54.9 36.4 88.1 522.5 31.1 32.5 48.0 1.9 82.6 10.8 53.5 4.0 5.5 40.7 4.5 17.0 42.9 35.8 4.5 29.6 6.0 3.5 39.5 25.1 26.5 76.0 40.6 14.3 34.7 8.3 37.7 18.8 8.6 17.6 MAGEH1 APR1 ENSG00000187601 "MAGE family member H1" Q9H213 X 55452127-55453566 "Predicted membrane proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "epididymis: 515.9" "Cell type enhanced" "Detected in many" "Peritubular cells: 63.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011324, HPA011971" Uncertain Supported "Nucleoli,Nucleoli rim" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Nucleoli rim" "HPA011324: AB_1853499, HPA011971: " "unprognostic (2.50e-1)" "unprognostic (3.01e-1)" "unprognostic (4.07e-2)" "prognostic unfavorable (1.37e-4)" "unprognostic (3.95e-2)" "unprognostic (8.50e-2)" "unprognostic (1.13e-2)" "unprognostic (9.93e-3)" "unprognostic (1.47e-1)" "unprognostic (3.20e-3)" "prognostic favorable (2.60e-4)" "unprognostic (6.37e-2)" "unprognostic (1.81e-2)" "unprognostic (1.29e-3)" "unprognostic (1.90e-1)" "unprognostic (3.95e-2)" "unprognostic (2.52e-1)" 20.2 29.9 46.8 17.6 48.2 5.1 18.4 40.9 59.3 29.6 59.4 21.0 10.2 30.9 515.9 10.0 45.3 18.1 24.1 47.1 60.0 25.5 19.6 23.5 22.7 41.9 47.7 36.3 28.1 25.5 54.1 20.9 45.7 48.8 11.5 22.0 18.6 44.3 12.9 11.3 17.1 27.3 45.5 20.4 25.3 33.8 50.3 32.0 28.6 16.9 17.0 17.9 16.7 48.8 0.1 5.7 32.6 0.0 51.5 31.0 0.4 36.0 32.9 9.7 26.0 0.1 7.4 0.0 48.2 36.4 18.4 4.9 12.5 13.5 15.2 42.5 2.0 11.4 0.0 4.6 17.0 0.6 14.1 25.8 1.2 5.6 4.1 9.1 15.0 12.0 6.5 43.8 10.8 22.0 30.8 9.8 9.3 0.0 6.8 19.1 4.1 24.0 17.9 0.0 0.2 24.5 0.0 9.5 15.5 24.4 4.7 8.5 17.7 13.3 15.4 8.2 1.9 25.9 35.1 4.9 24.8 15.8 17.2 14.0 9.0 20.5 21.5 14.3 19.4 18.9 35.4 24.6 13.7 17.9 48.2 30.5 1.2 18.9 18.5 28.5 52.1 19.0 46.8 48.2 40.9 59.3 47.1 60.0 41.9 47.7 45.7 45.5 50.3 48.8 24.9 6.4 14.4 4.9 18.3 8.0 7.8 20.0 5.2 36.7 8.0 14.1 10.4 18.6 12.5 12.9 10.4 2.8 15.7 1.9 13.7 32.2 1.6 2.8 33.5 29.0 15.8 3.0 14.2 10.7 2.0 42.9 3.1 1.9 12.7 11.1 32.9 14.0 15.0 37.0 17.5 8.4 4.1 3.8 11.2 4.0 47.2 6.2 21.4 6.5 9.3 56.8 23.7 18.6 28.4 4.7 8.8 63.9 39.8 13.7 0.8 20.1 6.7 19.6 26.3 44.5 35.0 1.4 2.7 3.3 6.3 1.6 19.9 19.7 4.6 4.8 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33485182-33501262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 9.9 6.2 4.7 9.3 4.8 9.2 8.9 5.1 5.7 6.6 4.1 5.7 5.4 7.2 5.1 8.0 5.9 6.5 7.0 4.5 6.4 7.2 9.0 5.6 11.1 5.3 6.3 7.5 9.3 5.9 4.5 7.8 5.8 6.1 6.5 4.0 5.6 5.6 8.4 7.4 5.0 7.7 5.3 6.5 5.4 5.6 5.5 8.8 8.5 8.0 10.8 12.2 5.1 6.0 14.1 19.3 13.2 30.6 15.2 18.1 19.9 25.0 16.2 26.4 24.6 28.5 12.0 49.7 23.8 22.1 22.5 18.3 45.6 27.8 35.0 10.8 12.3 46.9 13.2 25.6 22.9 19.3 27.4 19.1 24.8 34.8 40.4 9.4 19.6 33.5 59.5 27.5 22.0 16.1 68.9 22.4 71.4 34.4 13.2 23.9 20.1 22.2 22.2 23.7 33.6 26.7 15.5 21.1 30.4 16.2 14.7 19.5 17.8 24.9 19.3 32.6 28.9 13.8 16.4 50.4 15.3 39.7 27.0 0.0 2.4 0.6 3.2 5.0 3.6 2.0 3.2 2.8 2.9 2.5 4.0 4.3 0.4 4.4 7.9 3.0 2.6 2.3 4.7 4.8 5.1 5.7 4.5 6.4 5.3 6.3 5.8 5.3 5.5 6.0 12.8 16.0 9.7 3.6 12.8 15.6 15.2 5.6 13.1 5.1 7.9 9.0 12.9 10.0 11.3 9.2 2.1 11.5 7.8 3.9 7.9 10.6 1.8 9.8 19.8 12.7 1.8 15.8 5.8 7.8 15.8 15.8 8.2 10.5 9.5 10.8 5.3 7.3 8.7 10.1 6.0 6.7 6.1 5.3 4.7 1.3 9.0 7.8 1.8 2.8 7.7 2.9 10.3 7.1 4.7 11.5 5.0 7.5 12.1 15.3 4.1 10.2 10.5 5.1 6.6 17.6 14.4 13.8 19.2 12.7 14.9 7.5 9.9 13.8 7.4 12.3 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542703-67807117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Astrocytes: 119.5;Early spermatids: 138.1;Excitatory neurons: 201.4;Inhibitory neurons: 169.3;Late spermatids: 212.4;Microglial cells: 87.1;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favorable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 14.3 14.8 9.2 6.3 9.8 10.3 12.4 11.2 14.1 13.2 4.6 15.7 9.2 11.5 6.1 8.7 12.1 8.8 15.0 11.6 9.9 9.9 10.0 9.7 8.5 9.6 6.5 17.2 13.2 18.8 10.2 11.1 9.4 9.4 8.8 11.2 10.5 10.6 23.2 14.5 10.1 8.9 5.6 9.0 11.6 13.8 7.3 17.2 10.6 17.8 7.6 11.8 11.1 12.3 9.0 23.4 13.8 16.3 20.0 34.9 10.9 8.8 17.8 16.3 17.7 9.4 15.8 14.8 18.2 14.8 17.7 13.3 23.8 14.3 13.4 21.6 23.7 20.2 17.0 10.3 25.1 12.3 12.1 23.9 18.3 11.8 26.6 35.7 21.7 33.6 18.0 24.1 13.6 11.6 20.1 14.7 19.4 10.4 11.3 19.7 16.0 24.9 9.8 16.3 8.6 13.4 9.9 14.5 36.5 23.6 18.2 23.7 18.2 16.7 10.9 11.7 12.1 33.7 43.4 17.5 22.4 27.6 12.3 10.9 5.8 5.6 5.6 4.4 8.3 4.8 5.3 6.7 8.1 4.3 7.3 7.0 1.4 9.4 5.4 3.0 6.2 4.4 9.2 9.8 11.2 14.1 11.6 9.9 9.6 6.5 9.4 5.6 7.3 12.3 7.9 6.4 5.8 119.5 10.0 6.9 8.1 3.7 8.6 12.6 8.6 6.1 8.1 5.7 3.2 5.5 10.4 13.4 10.2 13.2 7.9 9.3 138.1 4.4 5.0 7.6 9.5 9.4 201.4 8.5 10.7 9.7 7.7 3.9 2.5 12.3 12.5 8.7 10.0 5.0 169.3 9.2 4.1 10.1 6.1 212.4 12.5 7.9 10.6 87.1 7.2 17.9 11.3 146.3 146.5 7.5 12.5 11.7 5.6 5.3 12.2 9.7 4.0 8.2 0.0 7.9 6.3 11.9 13.0 9.9 8.2 9.9 10.4 11.6 10.4 4.6 MAP3K9 "MEKK9, MLK1, PRKE1" ENSG00000006432 "Mitogen-activated protein kinase kinase kinase 9" P80192 14 70722526-70809534 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.7;retina: 9.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.6;Inhibitory neurons: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000942 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 6: Brain - Smell perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA000942: AB_1079360" "unprognostic (1.20e-1)" "unprognostic (3.75e-1)" "unprognostic (4.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.16e-3)" "unprognostic (2.45e-2)" "unprognostic (3.75e-5)" "unprognostic (2.58e-1)" "unprognostic (4.20e-2)" "unprognostic (4.38e-2)" "unprognostic (1.53e-2)" "unprognostic (2.48e-2)" "unprognostic (4.23e-6)" "unprognostic (5.71e-3)" "unprognostic (6.86e-3)" "unprognostic (1.79e-1)" "unprognostic (2.35e-1)" 0.2 1.0 3.3 1.0 4.6 0.7 1.3 10.7 22.7 0.9 0.4 1.5 1.5 0.4 1.5 5.1 1.0 0.4 0.5 4.0 3.2 1.4 0.7 1.9 1.4 8.6 3.0 0.6 2.2 2.7 1.1 0.6 7.7 0.9 1.5 9.6 1.7 0.5 0.8 4.0 1.4 0.2 0.3 0.9 1.6 5.5 10.0 0.9 2.7 0.4 3.6 0.7 1.8 6.8 22.3 10.5 2.0 2.5 0.0 0.0 6.7 0.5 0.3 2.1 1.9 7.8 8.6 4.5 2.8 0.1 4.7 10.3 6.5 12.8 2.2 3.0 1.7 0.2 4.1 5.2 0.3 0.5 0.9 0.1 6.5 1.5 12.7 3.7 0.0 4.1 1.7 1.0 0.5 9.4 3.7 0.5 4.2 9.0 4.5 1.3 3.9 0.9 4.6 10.9 13.8 3.0 6.3 7.7 1.2 3.7 6.9 0.8 0.0 0.0 8.5 0.0 3.5 2.2 5.6 2.4 3.4 0.4 1.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.2 0.2 0.0 0.0 0.2 0.0 3.3 4.6 10.7 22.7 4.0 3.2 8.6 3.0 7.7 0.3 10.0 6.8 0.3 6.4 13.4 6.8 3.9 8.7 13.7 9.4 6.8 17.7 11.2 4.8 2.3 14.3 12.4 7.3 12.5 2.8 1.7 5.7 1.9 6.1 19.8 7.4 0.7 0.8 8.4 0.0 49.6 4.8 1.6 1.0 4.1 8.5 1.3 1.8 1.1 4.8 1.2 30.3 58.1 4.0 4.1 0.8 1.9 20.0 0.6 0.8 3.6 5.6 0.4 3.2 0.0 8.5 1.3 11.1 3.9 0.0 2.8 15.8 2.6 2.8 7.1 12.7 0.0 0.8 1.3 8.0 8.4 12.6 9.1 4.0 3.7 6.0 5.8 27.9 MBD3L3 ENSG00000182315 "Methyl-CpG binding domain protein 3 like 3" A6NE82 19 7056209-7058640 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA051259 Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 43: Cardiomyocytes - Nuclear processes" "Nucleoplasm, Nucleoli" "HPA051259: AB_2681411" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MCM10 "CNA43, DNA43, PRO2249" ENSG00000065328 "Minichromosome maintenance 10 replication initiation factor" Q7L590 10 13161558-13211110 "Predicted intracellular proteins" "DNA damage, DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 9.2;lymphoid tissue: 8.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 11.8;Erythroid cells: 23.5;Extravillous trophoblasts: 20.9;Plasma cells: 15.3;Spermatocytes: 15.8;Spermatogonia: 12.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045899, HPA071952" Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA045899: AB_10960529, HPA071952: AB_2686477" "unprognostic (9.76e-3)" "unprognostic (1.60e-1)" "unprognostic (2.31e-1)" "unprognostic (2.29e-3)" "unprognostic (1.41e-1)" "unprognostic (6.58e-3)" "unprognostic (1.78e-8)" "unprognostic (2.42e-3)" "unprognostic (3.51e-2)" "unprognostic (6.26e-2)" "unprognostic (2.78e-4)" "unprognostic (7.81e-2)" "unprognostic (0.00e+0)" "unprognostic (8.87e-2)" "unprognostic (1.29e-1)" "unprognostic (9.73e-2)" "unprognostic (1.05e-1)" 1.2 0.1 0.0 3.3 0.1 9.2 0.8 0.1 0.2 0.4 0.1 1.7 1.5 0.4 0.1 1.9 0.2 0.2 0.1 0.0 0.0 0.1 0.7 0.3 4.8 0.0 0.1 0.2 0.1 0.2 0.1 2.1 0.1 0.1 2.2 0.1 0.3 0.0 0.5 1.1 1.2 0.8 0.0 1.0 0.8 1.5 0.2 8.1 0.3 0.1 4.5 0.6 0.6 0.1 38.0 42.0 48.6 36.9 1.6 2.9 21.2 38.7 5.9 42.7 44.0 41.3 26.4 56.7 17.1 9.9 15.7 43.3 69.0 22.8 39.2 29.7 32.9 70.9 17.6 27.7 0.0 36.6 30.8 0.6 0.8 43.3 4.0 3.5 14.0 45.0 85.2 37.6 23.4 34.0 87.7 15.7 28.9 36.3 10.3 68.3 43.0 34.6 9.8 13.7 9.7 36.6 31.3 22.0 5.9 25.2 27.7 24.9 8.6 27.0 50.3 41.0 42.4 11.7 49.0 74.3 17.2 39.6 21.5 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.9 0.3 0.1 0.1 0.7 0.4 0.1 0.1 0.0 0.4 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 1.7 0.0 0.0 0.0 1.8 1.7 0.4 0.8 0.0 0.0 0.8 0.5 2.4 0.0 0.8 0.0 0.0 11.8 0.8 2.4 0.0 0.4 1.0 0.3 1.2 1.4 0.0 23.5 0.4 0.2 20.9 1.8 1.1 1.0 0.0 7.2 0.0 0.2 5.3 0.0 0.4 1.2 2.0 0.6 0.4 1.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.1 0.4 15.3 0.2 0.2 0.0 0.0 0.0 0.0 0.4 6.4 15.8 12.9 3.6 0.4 3.4 1.2 0.8 3.1 0.4 MCOLN3 "FLJ11006, TRP-ML3, TRPML3" ENSG00000055732 "Mucolipin 3" Q8TDD5 1 85018082-85048500 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 43.5;epididymis: 13.9;parathyroid gland: 35.3" "Group enriched" "Detected in many" 7 "Enteroendocrine cells: 113.6;Melanocytes: 151.2" "Cancer enriched" "Detected in many" 6 "melanoma: 8.0" "Group enriched" "Detected in some" 5 "cerebral cortex: 4.0;hippocampal formation: 3.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.9;HAP1: 12.7;RH-30: 15.7;SK-MEL-30: 29.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018106, HPA062137" Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 50: Fibroblasts - ECM organization" "Nucleoli, Cytosol" "HPA018106: AB_1853647, HPA062137: AB_2684695" "unprognostic (5.91e-2)" "unprognostic (1.24e-1)" "unprognostic (1.49e-2)" "unprognostic (3.21e-5)" "unprognostic (2.25e-1)" "unprognostic (8.80e-3)" "unprognostic (3.97e-3)" "unprognostic (1.13e-1)" "unprognostic (2.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.45e-3)" "unprognostic (3.09e-2)" "unprognostic (7.32e-5)" "unprognostic (6.36e-3)" "unprognostic (2.61e-1)" "unprognostic (6.11e-2)" "unprognostic (6.43e-2)" 3.0 43.5 0.7 0.2 0.2 0.0 2.2 0.0 4.0 5.1 3.3 1.0 5.4 5.7 13.9 0.3 1.7 0.3 4.4 3.5 0.1 5.0 0.1 4.5 0.1 0.0 0.1 2.1 7.4 35.3 7.0 2.5 0.1 0.3 1.0 0.1 3.7 0.6 0.2 4.3 2.2 1.9 0.2 0.9 2.6 0.6 0.5 4.3 1.9 1.1 0.2 0.4 2.4 0.0 9.0 2.0 0.0 0.0 6.6 5.9 2.4 0.1 12.9 3.2 8.8 0.6 1.5 0.0 0.9 0.1 3.0 0.0 12.7 4.2 2.0 3.6 8.6 0.0 0.7 0.0 0.0 0.0 0.0 0.6 1.5 2.6 1.5 3.2 0.0 0.0 0.0 0.0 6.3 0.7 0.0 0.0 1.0 0.0 1.1 0.0 15.7 0.0 0.4 0.0 0.5 0.0 0.4 0.0 29.3 0.9 5.2 6.5 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.0 4.0 3.5 0.1 0.0 0.1 0.1 0.2 0.5 0.0 16.6 16.0 1.7 0.0 0.0 8.7 3.5 7.0 0.6 0.0 4.2 1.9 6.8 11.5 2.5 3.7 0.0 9.0 0.1 0.3 0.0 1.7 0.4 0.8 8.1 2.0 113.6 0.0 1.2 9.6 0.2 18.4 1.5 1.9 0.0 0.3 0.0 0.1 3.5 0.0 0.4 2.5 6.1 0.0 7.1 0.1 1.8 3.2 151.2 2.8 1.6 0.0 0.0 0.0 0.1 3.6 12.9 0.0 0.3 1.4 4.1 3.4 0.7 0.0 6.6 6.3 1.2 1.8 4.1 0.4 3.4 2.6 1.4 1.0 3.8 0.6 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 4.5;prostate: 7.3;skeletal muscle: 4.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5" "Cancer enriched" "Detected in many" 4 "prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 4.5 1.4 2.4 0.0 2.7 0.1 3.0 1.7 3.5 0.5 0.5 1.4 0.1 0.1 0.0 0.3 0.2 0.0 1.3 2.7 2.1 0.7 0.8 0.2 0.0 1.7 1.5 0.2 1.2 0.2 1.0 0.0 1.9 7.3 0.0 0.2 2.1 0.1 4.5 0.2 0.5 0.0 1.2 0.1 0.5 1.3 2.6 0.0 0.5 0.3 0.0 0.3 0.4 2.0 3.5 1.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 1.3 0.0 0.4 0.0 0.2 0.0 0.0 3.1 3.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.0 0.1 0.5 0.8 0.0 0.0 5.7 0.1 0.0 0.8 0.0 0.0 2.6 0.1 0.7 1.1 0.8 0.0 0.0 0.4 0.0 0.0 0.2 2.0 0.6 1.3 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.7 1.7 3.5 2.7 2.1 1.7 1.5 1.9 1.2 2.6 2.0 1.7 0.0 1.1 2.6 2.9 0.3 2.8 5.1 0.6 11.6 52.2 58.9 6.3 17.2 33.9 1.8 10.4 3.0 3.2 40.1 11.7 18.6 5.3 0.3 0.3 2.1 6.1 3.0 2.8 43.0 0.2 3.5 0.5 0.9 4.5 22.1 4.2 12.8 2.0 8.4 3.0 7.4 12.2 1.6 2.1 2.1 1.2 2.5 7.2 1.0 2.1 19.2 2.1 1.5 1.7 4.8 17.9 0.0 4.6 35.7 7.2 16.2 8.7 20.6 0.0 4.0 3.7 41.5 21.7 2.0 0.3 0.3 2.2 18.0 15.5 6.2 METTL5 HSPC133 ENSG00000138382 "Methyltransferase like 5" Q9NRN9 2 169810081-169824931 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038223 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Cytosol "HPA038223: AB_10672509" "unprognostic (2.55e-2)" "unprognostic (8.41e-2)" "unprognostic (4.73e-1)" "unprognostic (3.94e-2)" "unprognostic (1.65e-1)" "unprognostic (1.25e-3)" "prognostic unfavorable (6.64e-5)" "unprognostic (2.78e-2)" "unprognostic (7.53e-2)" "unprognostic (1.24e-2)" "unprognostic (2.15e-3)" "unprognostic (3.15e-2)" "prognostic unfavorable (3.06e-8)" "unprognostic (8.53e-2)" "unprognostic (1.70e-1)" "unprognostic (1.95e-2)" "unprognostic (6.87e-3)" 51.1 39.5 41.3 27.7 42.5 34.0 50.2 41.0 57.0 30.4 36.1 53.7 29.4 29.4 63.0 36.6 29.2 25.1 65.5 41.9 45.2 38.5 46.9 24.1 35.4 41.0 42.5 25.7 54.1 36.7 30.2 30.7 42.4 32.5 42.2 30.5 47.1 32.1 92.9 32.7 33.0 36.6 43.7 26.4 43.0 24.3 45.1 30.8 37.7 73.5 38.4 42.3 31.5 45.0 97.1 52.5 74.6 83.1 66.9 99.6 122.6 80.1 74.8 95.4 76.1 164.2 111.2 122.8 95.0 66.0 126.8 98.5 103.0 167.9 133.3 95.3 73.8 185.8 40.6 181.8 90.9 235.9 87.6 73.6 220.2 121.2 147.7 99.4 90.0 165.8 176.0 99.9 123.1 93.8 113.7 190.5 101.4 125.5 98.5 113.7 70.0 190.6 167.0 87.5 90.5 67.6 51.5 80.2 146.0 84.2 75.7 104.6 62.2 103.4 84.5 65.4 104.3 97.0 158.8 206.3 86.3 113.7 95.3 45.5 26.0 21.1 39.9 32.5 61.5 65.0 54.8 53.9 32.0 56.3 56.5 52.3 7.7 45.3 31.8 49.5 57.8 34.8 41.3 42.5 41.0 57.0 41.9 45.2 41.0 42.5 42.4 43.7 45.1 45.0 67.1 12.8 28.8 6.8 49.1 38.6 88.9 105.2 47.8 24.8 64.0 111.4 83.1 50.1 65.4 44.1 16.7 96.1 43.2 36.1 111.6 115.6 3.9 61.0 34.8 48.6 60.6 70.9 10.8 146.2 117.4 43.8 24.5 43.1 46.3 35.1 46.4 49.5 77.2 23.5 11.0 66.7 59.0 36.9 33.3 8.7 50.4 35.9 55.2 9.4 53.7 51.6 53.5 7.1 13.2 149.7 48.8 60.2 48.1 92.5 72.2 115.8 61.3 23.0 52.6 47.2 66.5 49.2 97.4 56.2 40.9 39.1 47.6 48.4 69.3 89.2 MFSD9 MGC11332 ENSG00000135953 "Major facilitator superfamily domain containing 9" Q8NBP5 2 102714630-102736888 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055293, HPA061859" Approved Approved "Nucleoli,Nucleoli rim" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 15: RT4 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli, Nucleoli rim" "HPA055293: AB_2682775, HPA061859: AB_2684627" "unprognostic (1.27e-2)" "unprognostic (5.07e-2)" "unprognostic (5.00e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (8.38e-4)" "unprognostic (2.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.32e-1)" "unprognostic (2.60e-2)" "unprognostic (2.98e-1)" "unprognostic (1.06e-1)" "unprognostic (8.42e-2)" "unprognostic (6.88e-3)" "unprognostic (1.94e-1)" "unprognostic (2.16e-1)" "unprognostic (3.33e-1)" "unprognostic (2.28e-2)" 2.8 2.2 1.4 2.9 1.4 4.1 2.6 4.3 2.0 3.6 1.8 6.4 8.7 1.8 2.8 4.5 1.8 2.3 1.4 1.9 1.7 4.6 10.5 2.2 3.2 1.4 1.6 2.4 9.2 4.1 3.4 2.4 1.5 2.6 5.8 2.4 4.9 3.1 1.3 2.9 7.2 1.9 1.3 2.7 4.7 1.2 1.7 4.5 2.9 1.2 3.6 3.3 2.2 1.2 3.1 2.4 3.0 5.2 3.6 1.6 6.1 1.9 1.9 2.8 2.8 8.6 4.1 2.7 3.1 1.2 4.3 4.7 4.8 1.8 1.8 11.5 4.4 4.5 3.1 10.9 3.0 3.6 6.2 1.6 6.1 1.7 0.9 2.9 1.8 8.8 2.7 1.3 1.4 2.9 3.7 7.2 2.3 7.4 3.1 2.8 4.9 2.8 5.9 9.4 5.8 4.1 1.7 6.1 6.9 3.2 2.3 5.7 1.3 1.9 4.0 3.2 2.7 3.6 2.9 1.8 2.1 8.4 2.6 1.3 0.3 1.5 1.2 0.6 0.9 0.8 0.9 0.8 0.6 0.6 0.9 1.1 1.0 1.0 0.5 1.2 0.7 0.7 1.4 1.4 4.3 2.0 1.9 1.7 1.4 1.6 1.5 1.3 1.7 1.2 1.6 0.0 1.5 1.0 4.1 3.3 3.2 3.7 2.8 1.5 4.1 1.3 3.1 1.5 5.4 7.3 4.2 8.2 4.3 15.9 0.0 5.8 12.8 3.3 2.0 1.6 3.0 1.7 5.4 8.6 9.1 3.3 7.1 5.3 3.8 3.0 1.4 11.5 4.8 0.0 12.2 8.7 10.2 2.9 1.4 4.5 0.9 2.6 0.0 1.9 4.3 1.4 7.2 4.0 1.3 11.4 8.0 1.2 8.9 4.2 10.4 3.6 3.9 2.8 6.6 2.1 2.4 1.0 5.3 4.3 4.4 11.5 5.1 3.1 7.2 8.2 MIS18BP1 "C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1" ENSG00000129534 "MIS18 binding protein 1" Q6P0N0 14 45203190-45253540 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 40.7" "Cell type enhanced" "Detected in many" "Granulosa cells: 145.1;monocytes: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006504 Approved Approved Nucleoli,Cytosol NA Yes "Cluster 14: Monocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 41: Macrophages - Immune response" Nucleoli Cytosol "HPA006504: AB_1078317" "unprognostic (2.12e-1)" "unprognostic (1.06e-1)" "unprognostic (2.58e-2)" "unprognostic (1.44e-2)" "unprognostic (1.51e-1)" "unprognostic (1.05e-2)" "prognostic unfavorable (3.83e-4)" "unprognostic (4.18e-1)" "unprognostic (1.36e-2)" "unprognostic (3.33e-1)" "unprognostic (3.32e-2)" "unprognostic (2.32e-3)" "unprognostic (3.31e-2)" "unprognostic (5.49e-2)" "unprognostic (2.30e-1)" "unprognostic (2.97e-1)" "unprognostic (2.21e-1)" 8.6 3.7 1.5 14.1 1.4 40.7 10.7 0.9 1.6 7.3 1.1 8.0 8.4 10.2 5.3 7.1 6.7 7.7 3.8 1.4 1.7 3.7 4.1 9.5 23.2 2.1 1.9 12.2 4.6 2.3 1.3 10.6 2.4 6.3 10.1 1.2 6.7 5.8 1.3 8.6 9.6 9.6 1.9 15.2 8.5 13.5 1.5 24.4 6.8 3.8 21.7 7.8 3.9 2.8 54.1 20.0 40.7 18.0 12.1 17.2 30.0 36.4 19.2 29.7 36.5 10.7 50.7 73.6 15.5 18.5 12.8 37.0 23.9 18.5 55.3 39.5 15.3 44.5 23.2 13.8 8.1 103.7 39.7 12.5 7.4 17.6 16.5 19.4 36.7 14.1 19.7 17.2 29.1 19.9 44.1 45.9 30.8 26.5 24.9 51.5 16.4 28.5 15.3 22.3 28.4 12.3 16.2 24.6 13.1 24.1 29.5 58.1 20.4 15.7 47.4 19.5 16.6 15.3 21.5 34.5 8.8 42.6 22.8 64.5 28.8 35.8 7.9 28.5 8.5 28.5 7.5 6.8 21.5 25.5 5.0 5.1 17.8 10.8 53.8 31.0 10.9 9.1 1.5 1.4 0.9 1.6 1.4 1.7 2.1 1.9 2.4 1.9 1.5 2.8 54.6 25.6 27.8 6.8 87.7 20.1 11.6 17.7 19.4 8.4 24.3 27.3 13.3 7.2 26.1 9.2 16.7 40.9 91.6 17.1 5.9 14.0 3.5 29.2 47.6 43.5 27.6 72.6 34.5 11.1 42.5 32.5 35.7 28.0 43.6 145.1 30.4 7.3 35.4 0.0 7.6 25.8 18.3 89.8 30.9 6.8 55.3 115.7 5.4 74.0 150.1 5.1 55.6 9.5 11.1 13.5 47.7 60.5 73.5 25.0 12.1 5.0 20.9 7.6 0.0 13.9 23.3 80.0 105.4 32.5 26.3 19.4 54.5 77.9 29.9 24.6 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226690-35276998 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 40.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4" "Cancer enhanced" "Detected in many" "renal cancer: 11.4;testis cancer: 10.8" "Region enriched" "Detected in all" 5 "cerebellum: 40.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 51.5" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 3.4 1.0 6.1 0.5 5.8 0.7 0.5 40.0 8.1 0.7 3.5 0.7 2.1 1.3 0.1 0.3 2.2 0.6 0.6 6.0 5.6 7.8 0.5 4.7 0.4 4.4 5.6 0.4 5.8 0.3 3.8 0.2 5.4 1.7 0.2 2.5 0.5 4.2 0.3 1.2 1.4 2.0 2.7 0.4 0.6 0.4 7.2 0.0 0.7 0.1 0.0 0.4 0.3 4.8 0.6 36.3 0.1 0.2 0.2 0.0 1.0 1.9 2.3 3.8 2.0 56.0 9.7 0.0 15.8 2.5 1.2 0.6 8.5 0.0 1.6 0.2 0.3 1.9 1.2 0.6 0.0 0.1 0.4 0.2 0.2 0.1 0.1 1.0 0.1 0.1 0.1 0.5 0.4 0.5 0.1 0.2 13.6 0.1 2.4 0.1 0.2 0.0 24.6 0.1 14.1 9.7 2.5 0.7 0.3 2.9 0.5 0.3 0.6 7.4 17.7 1.8 0.7 0.3 0.2 0.1 1.6 0.2 1.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 6.1 5.8 40.0 8.1 6.0 5.6 4.4 5.6 5.4 2.7 7.2 4.8 0.3 16.0 1.5 5.2 0.0 0.1 0.2 0.0 0.0 3.9 0.2 0.8 0.5 8.6 1.3 1.8 0.0 0.1 0.1 0.7 5.9 8.5 0.6 0.8 0.3 1.4 0.0 0.0 24.6 0.9 0.1 0.6 0.0 0.5 0.0 0.1 0.4 0.4 0.0 15.2 38.4 0.1 0.0 0.6 0.0 0.0 0.3 0.1 1.8 10.3 0.0 0.2 0.0 12.5 12.0 1.9 0.1 0.0 0.0 0.4 2.3 11.4 0.0 0.4 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.0 0.2 0.0 0.1 0.1 MPHOSPH6 MPP6 ENSG00000135698 "M-phase phosphoprotein 6" Q99547 16 82147798-82170224 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003674, HPA026948" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nucleoli" "CAB003674: , HPA026948: AB_1854077" "unprognostic (2.58e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-2)" "unprognostic (2.01e-1)" "unprognostic (3.57e-1)" "unprognostic (2.97e-3)" "prognostic unfavorable (4.36e-5)" "unprognostic (2.00e-2)" "unprognostic (2.29e-3)" "prognostic favorable (3.41e-5)" "unprognostic (7.52e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (3.05e-1)" "unprognostic (2.95e-1)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "unprognostic (9.43e-2)" 19.8 21.3 26.7 25.5 26.8 20.0 72.5 29.6 32.8 23.6 19.1 22.7 13.8 25.8 22.4 36.2 15.9 16.5 13.9 26.7 28.3 17.8 15.9 18.7 24.7 22.1 24.7 13.4 9.0 16.2 21.3 24.4 23.1 15.3 24.9 31.6 26.0 13.0 18.0 40.1 15.9 22.8 21.7 16.7 15.7 14.1 27.5 20.7 11.6 17.5 26.2 34.7 21.0 28.4 67.8 36.2 79.0 38.9 37.7 52.7 43.5 71.1 84.7 60.6 29.3 58.5 38.4 55.2 42.0 39.2 44.7 69.2 76.2 73.6 80.8 41.3 49.9 44.5 31.2 106.5 37.5 111.9 65.9 33.6 64.7 36.2 102.8 30.5 70.6 75.7 106.2 15.3 93.4 54.8 86.5 131.2 72.4 83.4 49.5 105.5 36.6 36.5 55.3 69.8 54.1 23.3 119.6 52.5 53.6 32.4 92.2 68.6 56.0 56.5 56.3 50.2 51.3 22.4 58.0 217.9 51.0 89.9 73.2 26.1 38.3 36.9 38.2 46.5 48.5 35.6 38.7 39.9 44.9 29.2 41.1 38.8 4.9 33.1 33.8 27.2 44.3 28.3 26.7 26.8 29.6 32.8 26.7 28.3 22.1 24.7 23.1 21.7 27.5 28.4 13.2 19.2 38.3 20.5 22.9 38.7 40.3 123.9 19.4 14.5 74.3 50.0 31.5 14.3 66.2 20.2 10.4 56.9 23.0 21.7 50.9 45.2 6.5 13.9 18.5 19.3 9.0 23.1 38.5 28.1 46.1 31.4 15.8 22.0 18.3 21.9 20.0 19.0 49.6 20.2 35.6 20.7 40.7 29.1 42.7 7.5 11.1 55.9 32.0 12.2 56.0 61.1 34.0 29.7 17.1 56.4 28.4 10.1 22.3 38.6 12.2 46.5 32.7 24.5 19.7 15.4 30.1 36.9 57.5 30.6 54.0 32.8 27.4 26.3 34.0 48.1 MRPL40 "MRP-L22, NLVCF" ENSG00000185608 "Mitochondrial ribosomal protein L40" Q9NQ50 22 19432545-19436075 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006181 Uncertain Supported Nucleoli,Mitochondria NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoli "HPA006181: AB_1079411" "unprognostic (4.12e-2)" "prognostic favorable (7.57e-4)" "unprognostic (2.64e-2)" "unprognostic (1.29e-1)" "unprognostic (5.76e-2)" "unprognostic (4.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.60e-2)" "unprognostic (4.08e-2)" "unprognostic (1.19e-2)" "unprognostic (2.16e-1)" "unprognostic (1.18e-3)" "unprognostic (2.67e-2)" "unprognostic (1.75e-1)" "unprognostic (8.07e-2)" "unprognostic (2.29e-1)" "unprognostic (3.14e-2)" 39.4 54.4 59.9 26.1 61.6 28.3 47.6 63.9 79.7 50.0 60.3 33.6 26.1 31.3 77.4 35.6 54.8 31.5 100.7 59.0 62.3 69.1 118.8 28.9 35.5 62.5 60.6 44.5 57.1 85.0 11.2 30.7 62.5 46.4 35.9 35.0 72.1 43.0 135.8 29.2 24.7 32.6 63.6 27.1 33.8 31.4 61.7 29.7 79.0 142.0 40.9 36.4 7.0 65.0 84.8 83.8 26.9 64.0 111.5 98.8 45.4 62.1 95.6 116.9 133.6 105.5 49.0 73.2 71.0 93.7 67.8 82.9 118.8 141.2 122.6 69.8 129.7 72.8 76.0 184.4 158.1 117.7 46.1 102.3 123.6 101.1 179.8 77.3 95.6 35.0 265.8 91.2 127.5 106.9 44.9 77.6 22.7 190.2 100.3 49.7 110.6 44.2 135.9 67.9 45.6 48.3 100.7 94.0 159.7 60.2 80.2 52.9 60.6 118.6 127.3 41.6 64.0 78.1 115.7 147.6 79.2 71.6 99.5 45.1 88.3 76.6 71.7 108.9 82.7 162.7 72.4 74.6 100.1 155.6 85.9 75.6 10.4 90.5 90.2 106.5 91.9 103.5 59.9 61.6 63.9 79.7 59.0 62.3 62.5 60.6 62.5 63.6 61.7 65.0 43.3 44.8 35.3 8.8 53.8 40.4 73.3 181.9 52.3 31.0 59.4 85.9 86.1 71.4 106.6 47.8 12.5 129.6 42.9 35.2 260.3 83.8 114.9 104.4 61.9 40.3 34.9 27.1 3.6 97.9 128.9 55.9 32.1 46.1 33.7 44.2 40.0 146.3 135.6 21.9 5.8 47.8 91.6 43.6 40.0 152.4 72.4 42.9 85.4 4.7 73.9 120.4 37.0 3.5 12.0 73.9 48.6 72.2 92.6 53.6 89.8 254.9 163.5 50.3 46.0 53.9 74.3 82.9 72.1 64.8 38.5 62.9 35.1 103.8 49.3 52.2 MRPS27 KIAA0264 ENSG00000113048 "Mitochondrial ribosomal protein S27" Q92552 5 72219403-72320646 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 101.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071751 Approved Supported Nucleoli,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Nucleoli "HPA071751: AB_2686442" "unprognostic (3.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.14e-3)" "unprognostic (3.60e-2)" "unprognostic (2.23e-2)" "unprognostic (1.63e-1)" "unprognostic (1.79e-2)" "unprognostic (7.20e-3)" "unprognostic (2.12e-1)" "unprognostic (3.22e-3)" "unprognostic (5.07e-2)" "unprognostic (3.26e-2)" "unprognostic (6.58e-3)" "unprognostic (1.33e-1)" "unprognostic (5.27e-2)" "unprognostic (7.73e-2)" "unprognostic (3.95e-2)" 25.5 36.1 23.8 21.8 25.3 18.9 31.8 23.6 27.8 27.0 33.8 26.2 20.4 25.8 27.6 32.4 31.3 19.0 55.5 25.0 23.1 30.5 38.5 17.5 36.9 24.6 24.1 39.5 27.1 32.7 20.9 21.2 24.6 25.2 31.5 17.7 22.4 30.3 58.7 31.7 22.0 26.9 24.5 25.9 25.7 15.1 25.0 30.7 35.6 89.1 41.9 29.7 26.0 24.1 49.7 65.2 56.8 94.4 73.1 93.5 73.0 46.7 66.4 86.9 69.7 81.9 68.5 128.2 63.8 54.8 94.9 54.0 111.8 166.1 93.6 48.6 69.2 66.0 71.3 91.1 72.7 58.4 49.0 88.1 68.7 91.3 101.5 79.0 94.2 92.2 67.2 37.5 73.0 59.7 87.8 70.4 65.7 35.8 40.4 92.0 94.4 131.5 80.7 52.4 87.5 46.7 78.5 63.8 58.5 52.2 97.8 69.9 54.1 35.3 51.8 50.3 85.2 37.7 61.0 89.1 60.9 94.6 57.0 15.5 23.4 8.1 24.9 27.5 37.1 36.1 30.6 30.4 44.2 32.1 35.2 37.9 3.2 43.3 23.0 16.6 34.6 31.5 23.8 25.3 23.6 27.8 25.0 23.1 24.6 24.1 24.6 24.5 25.0 24.1 13.9 9.6 11.7 32.7 27.6 20.4 22.3 21.6 23.3 11.4 26.5 22.2 101.9 7.2 15.6 11.0 16.7 41.5 18.6 9.1 25.4 20.5 2.2 16.1 21.8 17.2 16.2 36.8 43.9 17.3 48.2 18.8 17.9 12.1 7.6 29.3 15.7 34.8 24.8 10.1 38.4 21.0 8.2 28.6 13.3 4.4 19.0 15.0 10.6 30.0 31.4 15.3 17.5 38.7 51.1 14.9 15.3 25.2 16.8 13.5 10.7 28.8 12.6 13.2 13.1 18.2 17.6 10.3 18.7 32.3 17.6 28.9 21.2 30.4 31.4 14.8 MRPS31 IMOGN38 ENSG00000102738 "Mitochondrial ribosomal protein S31" Q92665 13 40729128-40771190 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 412.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039083, HPA046344" Uncertain Supported Nucleoli,Mitochondria NA NA "Cluster 46: Basophils - DNA binding" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria Nucleoli "HPA039083: AB_2676340, HPA046344: AB_2679629" "unprognostic (9.62e-3)" "unprognostic (2.62e-1)" "unprognostic (1.82e-2)" "unprognostic (3.26e-1)" "unprognostic (1.04e-1)" "unprognostic (2.15e-2)" "unprognostic (5.96e-3)" "unprognostic (1.84e-3)" "unprognostic (2.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.72e-3)" "unprognostic (3.92e-2)" "unprognostic (3.13e-3)" "unprognostic (2.80e-2)" "unprognostic (1.66e-3)" "unprognostic (1.86e-2)" "unprognostic (2.54e-2)" 11.7 14.8 9.1 14.0 9.6 14.4 16.9 10.5 12.5 10.7 9.1 15.8 14.8 16.6 13.8 14.7 15.1 10.2 24.0 8.7 9.5 19.6 28.8 11.5 23.5 9.6 9.7 19.2 10.4 14.3 7.5 12.6 10.1 11.3 15.6 13.7 13.7 11.0 27.5 13.5 15.3 15.2 9.3 13.2 15.0 17.9 9.2 17.8 19.6 26.2 24.9 13.2 10.0 11.8 19.0 17.9 29.5 19.5 19.8 23.2 29.6 23.7 16.5 30.7 20.5 46.0 27.4 110.5 22.6 13.7 41.3 48.8 37.4 29.6 36.2 29.4 28.1 45.9 12.7 29.7 16.5 47.4 21.3 18.8 21.4 25.3 21.2 20.3 23.8 31.2 31.3 11.3 19.8 21.5 37.2 46.2 28.7 64.2 20.9 35.0 24.3 20.8 40.3 21.6 12.9 18.7 16.5 27.0 39.3 35.1 23.7 41.5 14.6 9.5 16.0 22.3 24.9 8.7 17.4 55.7 19.5 33.3 18.6 30.9 15.3 24.9 29.4 16.4 28.8 36.8 32.5 29.9 19.5 33.5 38.5 34.3 11.3 28.7 18.4 19.1 36.5 17.8 9.1 9.6 10.5 12.5 8.7 9.5 9.6 9.7 10.1 9.3 9.2 11.8 27.5 48.1 19.2 24.5 35.0 9.7 33.0 106.0 33.0 35.1 22.4 31.6 73.7 28.6 77.2 22.0 18.8 62.7 31.2 18.7 109.5 43.0 74.9 55.5 38.6 32.5 23.4 29.8 28.8 33.6 41.5 27.9 18.8 38.1 23.4 32.8 37.9 76.9 26.0 42.1 37.8 37.4 91.6 17.0 12.5 14.2 35.4 18.1 19.6 26.2 39.8 32.3 32.0 36.7 45.1 30.0 19.5 30.5 52.1 15.8 32.4 93.4 412.5 51.2 46.0 39.5 38.1 72.6 49.8 30.2 13.4 68.0 37.7 45.2 35.5 25.5 MTUS1 "ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1" ENSG00000129422 "Microtubule associated scaffold protein 1" Q9ULD2 8 17643795-17800917 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 408.9;Alveolar cells type 2: 281.0;Oligodendrocytes: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.4" "Lineage enriched" "Detected in single" 19 "T-cells: 1.8" "Cell line enhanced" "Detected in many" "A549: 115.7;AN3-CA: 100.1;HUVEC TERT2: 296.8;SK-MEL-30: 84.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067903, HPA069795" Enhanced Nucleoli,Microtubules No No "Cluster 32: T-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Microtubules" "HPA067903: AB_2685921, HPA069795: AB_2686198" "unprognostic (3.20e-1)" "unprognostic (3.29e-1)" "prognostic favorable (1.05e-4)" "unprognostic (2.50e-2)" "unprognostic (2.27e-1)" "unprognostic (7.72e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-3)" "unprognostic (2.44e-1)" "unprognostic (9.73e-2)" "unprognostic (7.93e-3)" "unprognostic (3.33e-1)" "prognostic favorable (2.76e-4)" "unprognostic (2.04e-1)" "unprognostic (2.38e-2)" "unprognostic (2.53e-3)" "unprognostic (2.43e-1)" 52.9 39.0 65.6 13.4 100.4 0.3 45.0 97.4 81.7 34.5 59.3 36.6 32.6 31.4 22.6 38.0 28.7 37.9 85.6 66.0 76.9 26.2 56.8 40.4 9.0 106.4 90.8 51.4 98.2 65.2 22.9 70.0 104.2 31.9 39.1 56.9 49.9 24.7 106.2 26.0 33.4 38.2 75.7 16.1 42.2 12.2 87.6 22.8 27.3 167.4 14.5 35.8 31.0 151.1 21.9 115.7 18.5 100.1 0.1 0.6 33.2 1.1 7.8 0.6 2.3 8.7 7.8 2.8 8.5 0.0 4.8 22.2 30.8 10.9 1.1 15.8 13.2 0.0 19.2 55.8 6.6 0.0 0.4 9.1 16.4 2.4 33.3 0.0 296.8 7.7 0.0 43.3 0.1 5.7 4.4 5.7 26.5 44.1 2.9 0.1 17.0 11.5 5.9 44.4 9.2 2.2 14.8 26.6 84.7 11.0 19.2 0.3 61.4 0.1 24.0 0.1 0.2 5.9 3.5 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 65.6 100.4 97.4 81.7 66.0 76.9 106.4 90.8 104.2 75.7 87.6 151.1 408.9 70.5 281.0 139.1 2.9 21.0 56.4 38.9 58.1 0.0 42.7 31.6 141.6 55.8 88.4 20.2 0.0 23.8 1.6 58.5 11.7 50.1 18.5 71.4 53.8 154.5 15.0 0.0 6.1 174.2 40.0 83.8 94.8 144.2 9.5 7.6 29.3 71.2 58.2 0.0 81.8 47.3 22.4 4.1 16.1 24.5 76.4 9.0 28.4 174.3 2.7 0.0 2.1 39.2 469.2 56.5 19.1 57.2 15.3 77.9 52.4 10.4 49.4 0.0 19.7 69.7 60.1 2.4 8.3 45.3 20.3 54.0 7.1 79.8 49.3 81.3 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 201.5;Spermatocytes: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 20.4 37.4 31.8 15.2 33.6 9.2 27.0 32.8 46.7 22.1 35.9 31.2 22.8 18.7 39.3 38.1 28.9 14.5 49.8 33.3 34.4 46.4 30.8 15.6 14.2 33.9 32.0 21.1 26.3 48.1 29.5 25.8 33.2 26.4 35.5 47.3 20.4 22.6 74.4 23.4 20.2 25.7 34.0 15.6 24.4 64.3 33.5 18.2 20.4 70.9 20.8 25.1 24.7 35.6 52.2 31.0 60.8 37.8 40.0 45.9 58.3 54.5 52.0 49.8 58.3 53.1 55.8 66.4 91.4 49.1 79.9 34.5 67.1 67.6 67.9 66.6 49.4 63.9 39.1 94.9 62.7 98.9 20.7 51.1 83.5 52.2 89.1 60.3 72.0 64.3 86.8 50.2 59.6 47.4 34.9 102.9 58.3 101.8 45.5 0.0 44.0 60.8 142.4 93.3 87.0 74.4 45.7 60.9 120.7 116.4 33.7 64.0 63.5 49.2 43.5 52.1 57.9 55.4 62.1 79.8 61.1 49.7 60.8 8.0 9.3 4.1 9.6 15.8 13.1 18.9 12.4 11.1 14.8 13.7 14.9 15.4 0.0 19.6 14.4 12.1 16.9 9.9 31.8 33.6 32.8 46.7 33.3 34.4 33.9 32.0 33.2 34.0 33.5 35.6 34.4 19.2 22.6 50.6 20.8 31.1 36.2 130.9 37.5 0.0 38.2 43.8 69.2 31.5 63.6 57.0 0.0 78.8 11.1 38.8 201.5 51.8 22.3 60.9 25.7 31.4 41.5 19.5 106.0 39.5 63.3 30.2 28.1 33.9 43.1 25.7 16.4 33.7 47.8 0.0 106.3 47.7 103.7 21.7 15.7 18.8 35.4 19.6 35.6 43.1 26.1 0.0 12.3 93.5 180.2 49.8 26.1 32.7 23.1 48.2 39.6 106.3 63.8 0.0 39.5 24.9 52.4 247.8 127.1 56.5 41.9 65.0 18.8 55.8 52.6 53.7 MXD3 "bHLHc13, MAD3" ENSG00000213347 "MAX dimerization protein 3" Q9BW11 5 177301461-177312757 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.7;Granulosa cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 16.7" "Group enriched" "Detected in many" 5 "B-cells: 4.1;granulocytes: 16.7;monocytes: 10.9" "Cell line enhanced" "Detected in many" "HDLM-2: 176.0" "Group enriched" "Detected in many" 5 "amygdala: 1.8;basal ganglia: 2.0;cerebral cortex: 1.1;hippocampal formation: 1.0;white matter: 2.4" "Low region specificity" "Detected in all" HPA070111 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli" "HPA070111: AB_2686228" "unprognostic (2.78e-1)" "unprognostic (1.32e-2)" "unprognostic (2.11e-1)" "unprognostic (3.63e-1)" "unprognostic (8.26e-2)" "unprognostic (6.18e-3)" "prognostic unfavorable (3.60e-4)" "unprognostic (3.32e-1)" "unprognostic (6.84e-2)" "unprognostic (3.12e-2)" "unprognostic (4.97e-2)" "unprognostic (2.84e-2)" "unprognostic (3.33e-16)" "unprognostic (8.55e-3)" "unprognostic (2.22e-1)" "unprognostic (1.61e-1)" "unprognostic (3.22e-3)" 5.8 5.1 1.9 6.5 2.1 39.3 6.1 1.6 4.6 7.1 2.0 9.4 7.1 5.6 1.4 13.2 7.9 1.0 4.8 1.7 2.0 6.3 14.2 8.3 7.8 2.7 2.0 5.5 12.1 0.4 8.5 1.9 2.6 9.9 0.8 0.4 6.7 1.8 4.0 10.8 10.8 1.2 1.6 19.0 8.1 6.8 2.7 10.5 7.1 0.4 2.4 6.8 7.8 4.0 24.2 16.8 9.9 27.3 0.6 1.3 16.8 31.2 10.0 13.6 13.0 11.9 24.6 12.9 12.6 4.2 7.8 12.1 1.1 3.6 0.7 176.0 22.1 7.7 25.5 16.3 1.4 7.5 21.3 1.1 1.8 0.9 0.6 1.2 12.7 55.1 4.6 39.0 2.8 31.2 64.9 19.7 3.7 7.8 28.2 31.5 30.9 18.7 3.1 3.7 24.3 20.3 19.9 19.9 11.1 1.6 31.3 18.4 9.5 16.5 41.6 13.1 17.0 51.1 18.6 14.8 12.9 24.3 9.7 4.1 3.1 9.9 0.7 9.1 0.0 1.8 0.2 0.1 2.1 4.1 0.1 0.4 16.7 1.0 10.9 1.3 0.9 1.7 1.9 2.1 1.6 4.6 1.7 2.0 2.7 2.0 2.6 1.6 2.7 4.0 1.9 3.2 3.6 5.2 4.9 5.6 2.5 4.9 0.6 2.6 7.0 5.1 2.2 2.8 4.6 5.5 0.0 16.7 4.8 8.9 0.0 1.3 15.5 3.8 3.7 4.1 1.8 45.7 3.4 3.9 6.6 6.0 8.6 3.4 9.5 24.5 4.6 4.3 10.3 3.3 3.0 10.9 4.1 6.0 5.0 2.2 1.8 6.5 3.6 1.9 5.2 1.7 2.1 2.0 3.6 2.3 3.4 1.5 18.5 3.9 4.4 0.8 6.6 2.3 0.0 2.1 4.4 1.0 6.2 10.2 5.7 13.1 5.6 1.9 12.5 3.4 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555386 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No 47000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 12.3 11.0 3.8 13.4 3.8 11.4 15.9 1.3 7.6 13.3 0.8 11.9 9.6 14.6 4.6 17.0 15.2 6.2 11.0 5.0 4.2 9.8 10.8 11.4 13.8 5.2 4.9 14.1 24.4 6.7 12.7 5.2 3.5 17.1 5.1 3.8 18.9 10.1 27.9 22.0 12.9 7.3 2.1 14.0 12.4 8.1 3.4 7.4 11.2 8.0 8.7 14.9 13.8 3.8 60.1 90.0 11.9 56.2 15.4 17.1 40.8 39.8 17.5 39.5 30.8 67.1 24.4 80.4 47.2 23.9 19.8 74.2 50.1 61.3 19.0 40.3 133.8 38.8 58.3 62.2 25.2 45.5 34.7 25.7 34.6 58.8 29.1 11.0 26.6 45.0 64.2 37.1 18.2 51.4 54.2 19.5 56.0 19.1 48.0 69.8 19.7 54.0 9.8 45.5 25.5 48.5 40.8 29.7 28.2 8.6 27.5 19.1 34.3 35.1 31.5 32.7 118.6 32.1 26.5 34.4 32.5 53.9 45.3 0.0 1.9 0.3 2.8 1.6 3.4 2.9 2.3 3.1 2.9 1.7 2.5 2.8 0.1 2.4 3.4 2.1 1.0 2.7 3.8 3.8 1.3 7.6 5.0 4.2 5.2 4.9 3.5 2.1 3.4 3.8 13.4 9.6 14.5 4.6 13.1 12.9 6.8 7.1 12.0 8.2 12.9 14.4 4.1 8.6 13.3 3.7 12.5 2.9 5.8 9.2 0.0 7.7 0.5 6.7 15.3 17.0 11.4 7.2 11.3 12.7 5.4 10.2 10.7 8.5 5.1 12.2 8.6 7.8 6.5 10.1 6.1 8.0 4.1 4.5 6.8 0.6 5.6 6.3 3.6 7.5 3.8 3.8 6.2 3.5 6.5 8.2 4.5 12.0 13.7 13.9 4.6 3.2 12.2 6.2 6.6 10.8 12.9 2.6 11.1 12.8 11.9 1.1 9.7 13.8 12.4 6.2 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940550-15947007 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 9.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 84.2;Granulosa cells: 26.4" "Cancer enriched" "Detected in many" 5 "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 44.1;BEWO: 239.1;HMC-1: 57.3;NTERA-2: 91.3;RH-30: 63.3;SuSa: 40.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.4 0.8 3.5 0.6 3.5 0.9 0.4 3.1 3.9 1.5 0.8 0.6 1.6 0.9 0.1 0.7 0.5 0.3 1.2 3.4 3.0 3.3 0.8 0.7 1.6 4.4 3.9 5.1 0.2 0.1 0.3 9.5 3.7 0.1 0.5 1.0 4.7 0.2 0.4 1.4 0.9 0.3 3.3 0.3 4.6 3.6 3.5 2.9 2.9 0.7 1.2 0.5 0.4 5.9 0.0 0.0 44.1 0.0 0.0 0.0 239.1 0.0 0.0 0.0 0.0 3.5 0.0 0.0 4.2 0.0 0.0 0.1 1.9 0.0 0.0 0.0 0.2 16.8 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.0 0.8 0.4 0.2 91.3 2.1 0.0 0.0 63.3 12.8 0.0 3.1 1.0 16.0 0.0 0.1 0.0 40.9 0.1 0.0 0.0 0.0 1.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.5 3.1 3.9 3.4 3.0 4.4 3.9 3.7 3.3 3.5 5.9 0.8 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 2.6 0.1 0.9 0.7 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.0 1.2 0.5 0.1 2.7 0.0 4.2 2.0 0.0 84.2 1.0 2.6 0.8 0.0 26.4 0.0 0.6 2.4 0.0 4.2 0.9 0.0 0.0 0.0 0.2 0.0 0.3 0.0 1.0 0.1 1.0 0.0 10.1 7.5 0.3 1.1 0.4 0.0 0.0 0.4 3.2 0.0 0.2 0.0 4.2 0.7 1.3 3.7 0.3 0.0 11.5 0.0 9.4 0.3 0.0 MYL3 "CMH8, MLC1SB, MLC1V, VLC1" ENSG00000160808 "Myosin light chain 3" P08590 3 46835111-46882172 "Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 9155.0;skeletal muscle: 5135.3;tongue: 2074.2" "Cell type enriched" "Detected in some" 53 "Cardiomyocytes: 3626.2" "Group enriched" "Detected in many" 4 "head and neck cancer: 3.0;prostate cancer: 3.4;renal cancer: 8.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.6;HSkMC: 8.7;RPTEC TERT1: 34.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA016564, CAB018662, HPA046859, HPA063034" Enhanced Approved Nucleoli,Mitochondria NA NA 7300000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoli, Mitochondria" "CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (3.11e-1)" "unprognostic (2.64e-2)" "unprognostic (5.55e-2)" "unprognostic (1.51e-1)" "unprognostic (1.77e-1)" "unprognostic (4.44e-2)" "unprognostic (9.67e-3)" "unprognostic (3.37e-2)" "unprognostic (4.72e-3)" "unprognostic (3.63e-2)" "unprognostic (1.08e-1)" "unprognostic (7.88e-2)" "prognostic favorable (1.22e-8)" "unprognostic (1.16e-3)" "unprognostic (9.45e-3)" "unprognostic (7.18e-5)" "unprognostic (2.53e-3)" 5.8 4.1 11.3 0.9 11.1 1.5 8.9 11.4 14.8 6.7 8.4 2.5 1.6 3.3 3.4 157.0 4.2 3.6 9155.0 11.0 12.8 50.3 4.1 5.7 3.3 15.2 13.0 5.2 2.7 1.3 1.7 4.7 12.1 25.1 0.8 1.9 19.6 1.5 5135.3 4.0 2.3 2.0 13.2 7.9 2.1 2.3 12.6 0.7 2.4 2074.2 0.5 2.4 4.7 13.2 0.5 0.7 0.4 0.3 4.4 1.5 3.6 0.7 0.4 0.4 0.6 8.6 0.8 1.6 1.4 0.1 0.2 0.5 0.4 0.1 0.7 0.3 0.1 0.8 2.6 0.3 0.7 0.9 0.8 8.7 0.2 0.3 0.1 0.2 0.1 0.5 0.4 1.2 0.2 1.2 0.3 0.5 1.0 0.4 0.4 0.9 0.3 0.1 34.2 1.3 0.6 0.4 0.3 0.7 0.1 0.7 0.3 0.5 0.2 1.0 0.8 0.6 0.3 0.5 0.4 0.7 0.3 0.8 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.4 0.1 0.1 0.3 0.0 0.1 0.4 0.0 0.0 11.3 11.1 11.4 14.8 11.0 12.8 15.2 13.0 12.1 13.2 12.6 13.2 0.7 0.0 0.0 1.0 0.0 0.8 0.2 0.0 0.0 0.2 2.3 0.1 3626.2 0.0 0.0 1.8 0.0 0.4 0.0 0.0 54.8 0.0 2.4 0.1 2.2 32.8 0.0 0.0 0.1 0.0 16.4 23.7 0.0 0.0 0.0 0.0 1.1 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.6 12.8 1.2 0.7 0.0 0.0 0.0 2.8 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 68.1 0.0 0.4 6.6 27.9 20.4 0.2 0.5 0.0 0.4 0.8 0.4 0.1 0.0 0.0 MYL5 ENSG00000215375 "Myosin light chain 5" Q02045 4 673580-682033 "Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 66.1" "Cell type enhanced" "Detected in many" "Late spermatids: 87.3;Proximal enterocytes: 55.5;Rod photoreceptor cells: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 60.4" "Not detected" "Not detected" "HPA037381, HPA039262" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA037381: AB_10672484, HPA039262: AB_2676418" "unprognostic (6.30e-3)" "unprognostic (1.42e-2)" "unprognostic (5.67e-2)" "unprognostic (1.38e-1)" "unprognostic (1.23e-1)" "unprognostic (5.53e-2)" "unprognostic (1.33e-1)" "unprognostic (4.77e-3)" "unprognostic (2.38e-1)" "unprognostic (8.39e-2)" "unprognostic (1.61e-3)" "unprognostic (1.05e-1)" "unprognostic (2.80e-1)" "unprognostic (2.95e-2)" "unprognostic (3.01e-1)" "unprognostic (1.10e-2)" "unprognostic (1.91e-2)" 17.9 21.4 21.8 7.0 21.8 11.4 16.6 21.9 36.0 10.6 19.4 20.7 20.7 7.4 17.8 20.0 7.9 8.3 10.4 21.0 20.4 19.4 22.2 11.0 11.0 22.8 21.1 7.7 9.9 15.3 13.7 5.1 22.3 18.2 13.0 66.1 13.3 8.9 24.6 18.6 25.2 5.6 20.9 16.1 12.3 22.2 21.9 10.0 13.6 8.3 10.3 11.2 13.3 23.5 4.3 6.9 24.8 13.2 60.4 41.2 11.9 10.2 13.6 10.2 9.3 8.4 17.7 4.9 4.8 16.6 7.3 6.2 4.0 7.0 3.0 9.2 5.0 7.4 11.7 7.9 21.0 11.3 6.5 31.3 6.5 8.1 8.4 14.8 6.3 10.4 7.7 6.5 12.7 8.0 6.1 7.8 5.2 8.8 10.4 5.4 5.3 3.0 16.9 19.9 11.3 6.4 3.4 8.5 7.2 8.0 13.7 10.2 10.4 8.7 1.6 7.5 6.0 24.7 5.3 2.9 9.5 10.1 4.6 15.5 8.2 1.5 3.3 5.5 4.2 8.7 5.6 2.0 7.7 12.7 6.7 6.8 5.8 18.4 12.3 14.5 2.6 5.8 21.8 21.8 21.9 36.0 21.0 20.4 22.8 21.1 22.3 20.9 21.9 23.5 4.5 0.0 11.9 2.3 11.7 12.0 6.8 12.8 18.2 6.3 12.9 14.5 1.4 7.2 5.7 7.3 20.9 7.3 9.2 22.7 11.7 9.6 22.2 9.1 6.9 5.9 5.4 4.2 1.4 4.7 5.4 7.5 13.7 5.3 13.9 4.9 10.4 18.3 22.7 11.8 1.3 11.4 6.1 21.2 8.6 87.3 7.2 12.4 7.2 1.0 22.8 22.2 13.4 0.5 1.6 6.1 13.2 3.8 5.1 8.3 55.5 42.6 8.2 74.3 6.6 21.7 5.6 14.1 4.4 21.2 13.4 5.5 5.9 14.7 15.4 9.7 MYSM1 KIAA1915 ENSG00000162601 "Myb like, SWIRM and MPN domains 1" Q5VVJ2 1 58643440-58700077 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, Chromatin regulator, DNA-binding, Hydrolase, Metalloprotease, Protease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054291, HPA057306" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA054291: AB_2682438, HPA057306: " "unprognostic (2.95e-3)" "unprognostic (3.64e-2)" "unprognostic (3.20e-2)" "unprognostic (8.68e-2)" "unprognostic (2.08e-2)" "prognostic favorable (5.09e-5)" "unprognostic (8.12e-3)" "unprognostic (9.63e-3)" "unprognostic (5.72e-3)" "unprognostic (3.74e-1)" "unprognostic (2.25e-1)" "unprognostic (4.56e-2)" "unprognostic (2.38e-3)" "unprognostic (4.22e-2)" "unprognostic (1.83e-1)" "unprognostic (8.45e-2)" "unprognostic (1.44e-2)" 11.2 7.5 4.0 4.4 3.9 12.5 12.0 4.3 5.9 11.9 4.2 11.8 5.4 10.6 6.2 10.0 10.2 3.1 10.5 4.1 3.9 7.2 8.0 10.1 6.3 3.9 3.7 13.2 12.1 5.9 8.7 4.4 3.9 9.6 4.4 8.4 11.8 4.1 10.0 10.5 12.6 3.6 3.7 11.4 9.9 4.4 3.9 5.3 11.5 3.1 4.9 9.3 11.1 4.4 10.1 2.6 5.0 6.7 6.0 7.2 10.5 5.9 5.6 5.1 3.9 5.3 4.2 10.3 1.8 3.8 4.8 7.4 7.7 2.1 11.0 6.2 4.3 11.3 2.1 5.1 7.4 19.6 9.7 5.4 5.9 7.5 3.8 6.1 1.2 4.2 12.6 6.3 6.8 2.6 7.8 16.3 11.4 3.5 3.5 7.3 16.4 6.1 4.6 3.8 5.8 6.6 4.4 9.4 13.9 9.0 3.1 10.6 4.9 9.3 4.6 6.4 11.3 10.8 5.8 13.9 5.8 13.7 11.6 0.9 0.3 0.1 0.3 0.4 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.4 1.0 0.1 0.5 0.4 0.4 0.1 4.0 3.9 4.3 5.9 4.1 3.9 3.9 3.7 3.9 3.7 3.9 4.4 36.5 22.4 33.7 47.7 26.0 19.1 22.8 13.5 30.7 19.5 25.6 21.0 28.2 10.0 35.1 11.0 25.0 8.4 36.6 22.1 15.6 8.8 3.9 22.1 34.8 25.4 16.2 14.1 87.4 9.4 5.7 20.8 19.9 36.9 56.3 30.1 23.9 16.3 11.3 18.5 58.2 17.0 24.4 13.9 14.2 6.3 12.8 22.2 8.8 35.6 21.3 12.7 22.6 58.3 106.9 12.7 13.1 17.3 29.5 19.3 19.2 8.8 21.2 27.8 26.3 28.8 21.5 15.5 20.6 25.0 18.5 11.4 30.8 22.0 18.5 26.4 NAA10 "ARD1, ARD1A, DXS707, TE2" ENSG00000102030 "N-alpha-acetyltransferase 10, NatA catalytic subunit" P41227 X 153929225-153935080 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006269, HPA030711" Supported Supported Nucleoli,Cytosol No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoli "CAB006269: AB_425759, HPA030711: AB_2673579" "unprognostic (7.57e-2)" "unprognostic (1.40e-2)" "unprognostic (1.81e-2)" "unprognostic (1.19e-1)" "unprognostic (1.02e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (1.22e-1)" "unprognostic (1.68e-1)" "unprognostic (1.04e-1)" "unprognostic (9.01e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (3.29e-8)" "unprognostic (1.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.29e-2)" "unprognostic (7.48e-3)" 38.4 39.5 19.6 17.2 20.1 13.2 34.6 20.4 27.2 26.5 19.2 34.1 15.3 32.3 15.1 40.5 24.4 10.3 56.3 20.0 21.8 34.1 35.9 26.0 19.7 20.8 20.3 23.8 45.8 13.7 22.5 12.5 20.8 27.6 10.2 7.3 25.3 12.2 98.4 30.9 24.9 18.1 20.4 28.8 35.9 9.1 21.2 10.2 21.7 24.9 15.3 35.9 26.8 20.4 133.4 136.0 25.8 83.0 36.7 36.9 71.2 46.3 28.6 63.8 57.0 88.5 41.0 102.0 147.6 38.7 79.2 63.0 57.9 56.8 23.9 42.1 255.2 36.8 85.8 91.3 49.1 71.4 76.8 28.8 62.2 57.9 59.1 30.7 72.0 39.2 75.1 41.5 41.6 172.8 115.0 106.4 42.9 124.4 189.0 90.1 65.7 111.5 47.7 59.7 54.0 65.7 18.7 71.0 113.7 23.9 38.4 58.8 41.1 25.6 88.5 89.5 142.0 86.3 107.2 196.0 34.7 91.0 75.5 35.3 53.1 81.3 60.0 65.3 78.1 75.2 63.4 65.6 69.4 77.7 37.4 56.7 49.8 64.7 76.0 75.9 102.9 70.6 19.6 20.1 20.4 27.2 20.0 21.8 20.8 20.3 20.8 20.4 21.2 20.4 126.9 9.6 30.2 27.1 76.0 70.1 66.1 90.6 68.3 29.5 82.6 113.8 45.1 47.1 52.8 38.6 12.5 125.9 77.0 94.5 95.9 121.1 2.9 46.0 60.7 98.7 58.1 78.9 18.6 149.9 179.0 57.3 76.5 43.4 67.9 64.2 77.8 78.7 123.1 37.0 14.6 92.2 54.9 66.5 96.0 12.5 46.6 66.4 119.2 9.4 84.8 37.9 85.5 14.1 19.1 144.6 75.2 46.6 104.3 136.9 91.5 197.0 40.2 30.4 65.7 56.6 98.3 7.6 33.1 120.7 90.5 108.8 74.8 97.7 110.3 85.9 NACC2 "BEND9, BTBD14A, BTBD31, MGC23427" ENSG00000148411 "NACC family member 2" Q96BF6 9 136006537-136095289 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 120.6" "Cell type enriched" "Detected in many" 4 "Late spermatids: 305.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 49.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047924, HPA052962" Approved Approved Nucleoli,Mitochondria NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Mitochondria" "HPA047924: AB_2680212, HPA052962: AB_2681998" "unprognostic (1.13e-2)" "unprognostic (1.52e-1)" "unprognostic (1.90e-2)" "unprognostic (8.73e-3)" "unprognostic (1.31e-1)" "unprognostic (1.32e-1)" "unprognostic (9.25e-3)" "unprognostic (2.25e-2)" "unprognostic (1.23e-1)" "unprognostic (4.92e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-1)" "prognostic favorable (8.28e-5)" "prognostic favorable (8.63e-4)" "unprognostic (1.71e-1)" "unprognostic (4.98e-2)" "unprognostic (4.12e-2)" 12.3 11.4 80.9 8.7 100.0 2.0 8.0 115.6 74.1 9.7 26.5 32.7 6.2 20.9 4.1 8.5 12.8 7.2 16.7 52.8 81.0 7.5 9.6 9.5 3.4 113.2 104.9 7.7 7.6 4.6 6.4 2.6 112.3 11.8 3.8 4.9 7.9 17.3 17.0 4.5 9.9 15.6 85.8 8.1 13.6 6.5 120.6 1.0 5.8 6.8 2.0 23.2 7.3 91.9 6.1 32.7 3.6 49.0 15.4 8.6 4.5 14.6 9.7 4.6 1.6 14.0 10.6 0.0 17.1 23.2 7.4 23.3 7.9 7.9 1.5 18.6 7.1 4.1 33.3 17.6 15.6 0.0 7.4 14.4 7.2 4.3 4.3 18.8 13.0 0.0 12.8 0.1 9.0 20.5 0.0 11.6 11.0 9.7 20.2 0.0 3.8 10.0 19.2 6.9 1.2 1.5 20.6 17.0 18.2 16.2 17.4 37.9 21.6 12.3 13.9 10.5 10.1 0.1 0.0 0.3 16.2 1.4 25.2 1.9 2.2 0.8 0.8 1.7 0.3 0.0 0.3 0.7 1.2 0.0 0.2 0.2 2.7 0.2 1.7 0.1 0.2 0.8 80.9 100.0 115.6 74.1 52.8 81.0 113.2 104.9 112.3 85.8 120.6 91.9 14.3 12.8 5.0 69.9 0.8 4.6 4.9 9.0 3.4 3.4 6.7 5.6 28.5 7.2 7.9 5.5 0.0 0.7 7.0 12.4 0.0 12.6 76.2 18.9 9.8 18.5 2.4 1.7 2.5 13.4 2.1 10.9 7.7 6.0 2.5 1.5 17.9 33.2 7.8 3.3 21.1 4.4 0.0 38.4 8.0 305.5 18.0 16.6 5.4 21.5 45.3 17.1 12.3 40.7 45.1 18.3 9.2 19.2 2.1 11.8 6.7 13.6 12.5 1.9 26.3 14.0 15.8 2.4 12.6 6.8 5.1 0.4 5.7 1.4 5.3 7.6 NARF "DKFZp434G0420, FLJ10067, IOP2" ENSG00000141562 "Nuclear prelamin A recognition factor" Q9UHQ1 17 82458180-82490537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 292.6;Late spermatids: 474.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053006 Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Nucleoli "HPA053006: AB_2682013" "unprognostic (1.84e-1)" "prognostic favorable (1.15e-4)" "unprognostic (2.00e-1)" "unprognostic (1.10e-2)" "unprognostic (4.14e-1)" "unprognostic (6.52e-2)" "unprognostic (6.62e-3)" "unprognostic (2.37e-2)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (3.42e-3)" "unprognostic (3.80e-3)" "prognostic unfavorable (1.48e-10)" "unprognostic (3.57e-1)" "unprognostic (7.72e-2)" "unprognostic (2.47e-2)" "unprognostic (1.83e-2)" 19.2 18.0 17.2 12.4 18.5 32.9 17.4 19.5 21.7 15.8 16.1 23.4 10.3 14.5 5.8 21.5 16.1 7.7 38.7 17.7 16.8 19.6 23.1 15.1 10.7 17.8 17.0 16.9 20.6 6.6 18.7 7.4 17.8 17.0 6.5 11.5 18.4 8.2 49.2 25.1 19.1 7.1 15.8 28.7 23.3 59.1 16.9 14.6 16.5 25.9 8.9 19.9 16.3 19.1 21.2 23.3 32.8 50.6 15.2 14.3 18.2 13.1 12.7 21.2 21.2 23.6 8.4 14.0 13.6 9.8 23.8 18.6 23.8 15.5 14.2 15.3 55.7 29.0 30.4 27.7 13.1 30.9 50.6 21.9 26.4 16.5 5.7 20.7 39.2 44.9 67.5 9.6 9.2 18.1 51.2 49.8 13.7 16.3 44.1 42.6 34.3 21.6 9.7 23.3 40.1 55.9 32.1 21.3 38.8 20.7 18.4 23.2 21.7 26.4 22.4 22.4 21.7 94.1 38.4 30.1 24.3 20.6 15.9 94.5 33.0 96.2 34.2 30.0 38.1 38.2 33.1 33.7 32.0 40.9 37.7 31.2 156.0 53.7 23.9 26.2 44.1 38.6 17.2 18.5 19.5 21.7 17.7 16.8 17.8 17.0 17.8 15.8 16.9 19.1 45.2 12.8 23.2 25.1 50.7 37.3 32.9 55.4 28.5 38.1 30.4 30.1 43.2 21.5 40.0 5.5 54.2 32.4 87.9 38.5 39.2 53.3 194.2 46.2 23.3 53.1 56.9 292.6 30.6 66.7 57.7 30.1 80.5 25.3 52.7 24.4 45.7 18.5 34.3 50.5 31.6 32.4 95.6 23.8 35.3 474.5 25.1 39.3 62.2 15.0 56.7 24.2 72.1 12.5 20.8 65.7 29.6 18.0 89.9 23.7 41.9 22.1 61.6 37.3 13.1 36.9 36.0 152.5 87.6 20.7 35.4 30.6 57.4 28.4 36.3 30.2 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105617-34147670 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 20.6 24.2 16.0 17.3 15.4 20.4 19.6 14.7 17.4 20.1 14.0 17.0 10.2 20.0 13.7 25.7 19.2 9.4 18.4 15.1 15.4 19.5 22.3 14.9 23.4 14.3 13.6 23.1 25.3 16.8 17.5 15.1 14.7 19.4 15.5 16.3 16.7 12.2 24.8 28.9 17.5 15.5 12.6 22.8 18.7 22.0 15.6 19.4 17.2 12.5 27.5 20.3 20.5 16.9 40.0 55.5 29.3 62.0 34.2 30.2 33.6 38.8 28.5 48.4 38.4 62.6 22.6 127.6 28.3 33.0 41.8 59.5 110.5 59.4 59.5 35.9 70.2 58.0 44.5 58.9 31.0 147.3 40.7 31.1 40.0 31.5 88.3 22.8 37.4 60.6 128.6 43.5 40.8 76.0 120.5 65.7 41.9 69.3 65.7 89.3 98.0 53.7 27.8 68.5 43.1 32.6 52.3 54.9 23.6 28.2 55.0 41.0 30.5 42.8 34.0 63.7 72.8 47.0 61.0 120.3 43.3 60.0 43.4 0.7 8.3 2.8 11.7 13.7 15.5 12.2 12.6 13.4 15.5 10.6 12.7 13.2 0.9 15.0 12.9 11.6 12.0 9.1 16.0 15.4 14.7 17.4 15.1 15.4 14.3 13.6 14.7 12.6 15.6 16.9 8.5 6.4 20.7 10.4 12.7 12.2 11.3 6.9 12.5 12.2 8.8 10.2 12.6 7.2 15.1 14.7 12.5 18.1 8.0 5.8 5.9 9.2 6.1 10.1 18.3 10.9 7.2 21.0 22.8 9.6 13.4 14.5 5.6 12.2 5.1 17.3 5.7 7.5 12.0 11.8 21.7 8.9 4.1 5.5 4.4 3.4 9.3 8.5 1.8 6.5 12.9 5.3 7.2 11.6 16.0 8.7 3.5 13.2 9.8 14.8 3.7 5.8 10.6 11.0 13.1 19.6 8.4 20.5 21.6 13.1 13.8 14.4 11.0 19.7 14.3 7.6 NEPRO "C3orf17, DKFZP434F2021, NET17" ENSG00000163608 "Nucleolus and neural progenitor protein" Q6NW34 3 113002444-113019861 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Theca cells: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069654 Supported Nucleoplasm,Nucleoli Yes No "Cluster 15: NK-cells - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA069654: AB_2686164" "unprognostic (8.45e-3)" "unprognostic (3.84e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.13e-4)" "unprognostic (2.29e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (4.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.49e-2)" "unprognostic (4.98e-2)" "unprognostic (1.72e-2)" "unprognostic (9.29e-3)" "unprognostic (5.40e-2)" "unprognostic (1.69e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (3.28e-2)" 6.7 6.7 4.7 7.0 5.4 10.6 8.8 6.9 6.5 6.5 6.3 7.0 7.1 8.4 10.3 6.0 6.5 7.4 8.4 5.2 4.9 6.3 5.9 6.4 12.3 5.8 5.3 8.1 8.2 6.9 6.6 6.7 5.6 6.6 5.4 11.7 6.9 6.1 18.7 10.8 7.0 5.8 5.1 8.8 8.3 11.3 5.3 9.4 11.5 7.7 7.8 6.7 5.3 7.9 13.6 10.9 17.3 13.0 5.5 10.1 9.2 12.6 8.1 6.9 4.7 10.1 8.5 17.6 6.6 4.3 9.6 13.7 12.7 5.8 9.4 3.5 8.0 27.3 10.0 7.5 10.0 17.4 9.4 15.7 10.0 5.5 14.2 18.8 6.1 17.2 9.5 13.5 5.2 8.6 15.1 10.3 18.1 12.0 14.0 12.1 13.7 9.3 7.8 11.2 11.9 17.3 7.3 9.1 21.4 12.7 10.4 14.7 12.4 9.4 9.3 3.6 9.1 13.3 11.2 20.6 15.2 13.6 7.0 1.9 1.3 1.6 2.2 1.6 2.3 1.8 2.6 1.9 1.8 1.4 3.2 3.2 0.8 4.3 0.7 1.3 1.2 1.4 4.7 5.4 6.9 6.5 5.2 4.9 5.8 5.3 5.6 5.1 5.3 7.9 16.3 9.6 12.8 0.0 7.6 0.0 0.0 0.0 0.0 0.0 17.4 16.9 0.0 0.0 10.5 18.4 0.0 18.4 23.4 0.0 17.6 14.1 0.0 11.9 20.7 6.3 0.0 0.0 0.0 12.6 15.5 9.3 0.0 16.1 17.7 24.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 9.3 0.0 0.0 0.0 0.0 14.4 0.0 0.0 4.5 0.0 0.0 14.8 8.7 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 20.4 9.1 33.9 0.0 0.0 NIP7 "CGI-37, FLJ10296, HSPC031, KD93" ENSG00000132603 "Nucleolar pre-rRNA processing protein NIP7" Q9Y221 16 69337996-69343106 "Predicted intracellular proteins" "Ribosome biogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040856, HPA059850" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA040856: AB_2677171, HPA059850: AB_2684142" "unprognostic (2.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.76e-1)" "unprognostic (8.02e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.04e-3)" "unprognostic (1.37e-3)" "unprognostic (5.72e-2)" "unprognostic (3.86e-2)" "prognostic unfavorable (6.69e-5)" "unprognostic (6.99e-2)" "unprognostic (1.18e-2)" "unprognostic (1.38e-1)" "unprognostic (1.28e-1)" "unprognostic (1.58e-1)" "unprognostic (3.33e-2)" 17.9 14.1 7.1 17.9 7.5 26.2 16.0 7.8 8.1 11.4 9.6 16.6 14.4 11.3 14.2 17.2 12.1 12.9 7.7 7.8 7.3 13.2 17.2 10.6 23.6 7.7 7.3 7.4 10.3 11.4 5.2 14.5 8.1 9.8 16.1 3.5 8.5 8.9 8.7 12.7 12.0 14.1 7.6 13.1 11.5 12.3 8.1 21.4 11.2 9.8 26.9 24.9 8.6 8.5 57.9 39.7 31.2 43.0 44.0 38.5 48.8 52.7 40.6 87.8 62.7 66.7 61.6 105.5 57.1 48.3 36.5 60.1 63.7 80.0 112.5 28.9 51.2 53.8 27.0 83.6 42.6 118.1 34.0 42.2 63.1 83.1 88.7 25.7 50.5 60.7 115.1 17.5 62.3 69.8 78.6 81.9 94.4 50.9 47.7 108.6 34.3 95.7 54.6 38.8 41.3 57.8 107.8 31.0 59.8 35.0 44.3 72.4 43.5 63.5 54.7 49.5 97.0 54.4 45.0 250.2 37.9 69.4 63.4 16.7 12.7 9.8 28.4 14.9 29.9 28.9 25.2 33.3 22.8 21.1 23.3 30.1 4.3 24.8 21.4 20.7 28.9 16.9 7.1 7.5 7.8 8.1 7.8 7.3 7.7 7.3 8.1 7.6 8.1 8.5 28.2 3.2 12.7 3.9 33.7 53.7 58.1 34.6 45.5 8.8 21.7 18.3 5.5 14.3 21.1 20.2 16.7 33.2 33.2 14.7 21.5 35.9 43.8 24.5 32.0 28.3 3.0 37.9 5.1 26.1 36.5 24.0 11.2 23.2 17.7 20.5 18.2 12.1 24.8 11.8 4.5 12.7 30.5 12.2 19.2 41.4 17.1 14.7 19.6 1.9 18.3 9.2 35.0 3.0 6.4 37.5 16.6 17.3 15.6 46.2 14.6 28.9 25.6 8.1 13.1 35.2 25.9 40.7 43.8 43.0 52.6 25.6 33.2 36.2 20.8 42.2 NKIRAS2 "DKFZP434N1526, kappaB-Ras2, KBRAS2" ENSG00000168256 "NFKB inhibitor interacting Ras like 2" Q9NYR9 17 42011382-42025644 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062861 Approved Nucleoplasm,Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA062861: AB_2684884" "unprognostic (2.53e-1)" "unprognostic (1.09e-3)" "unprognostic (2.31e-2)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.56e-4)" "unprognostic (9.37e-3)" "unprognostic (2.89e-2)" "unprognostic (2.56e-1)" "unprognostic (6.96e-2)" "unprognostic (3.18e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.76e-1)" "unprognostic (2.70e-1)" "unprognostic (3.25e-2)" "unprognostic (5.42e-3)" 21.7 15.7 14.1 20.8 17.1 25.6 18.4 15.3 15.4 18.8 15.6 20.8 15.2 19.0 11.0 32.7 14.4 17.8 45.8 14.3 12.0 16.9 19.3 16.7 17.8 14.8 13.3 16.0 13.3 19.4 10.8 33.9 13.1 16.1 16.3 13.7 16.2 18.0 50.0 26.6 16.2 26.4 12.1 15.1 16.9 20.8 15.5 22.1 13.5 36.8 19.0 20.8 20.1 15.0 22.4 42.5 57.4 31.1 39.8 26.8 33.7 36.4 28.1 56.6 41.6 43.6 31.3 37.4 57.3 38.6 38.4 47.1 47.3 28.6 29.6 30.6 54.2 32.9 37.1 33.0 62.8 45.8 25.9 41.0 50.8 38.1 29.8 38.6 71.3 47.8 47.1 36.9 33.8 23.7 87.3 30.4 34.4 30.0 30.0 67.9 63.7 35.8 40.3 23.2 68.5 90.0 26.6 84.0 38.6 55.6 51.5 55.5 50.3 36.2 38.8 40.5 41.5 47.4 82.7 30.0 24.6 27.5 52.2 54.5 54.2 46.1 14.2 45.1 14.1 15.4 14.2 14.4 43.5 17.1 14.4 14.0 30.7 27.0 50.0 48.4 13.4 25.2 14.1 17.1 15.3 15.4 14.3 12.0 14.8 13.3 13.1 12.1 15.5 15.0 26.6 16.0 10.3 3.9 19.0 17.0 18.7 27.2 12.5 21.0 19.9 17.1 26.3 10.0 23.8 16.5 20.9 52.3 13.8 19.1 21.5 30.0 27.8 11.9 18.5 27.1 19.2 21.2 5.4 28.1 39.7 20.1 11.2 16.3 14.0 28.1 19.2 15.6 37.9 23.5 4.8 17.5 42.7 31.1 29.1 6.6 19.6 27.8 10.6 5.6 37.2 24.7 14.4 1.5 4.5 30.4 14.7 18.4 13.3 20.8 20.9 19.0 10.9 26.6 6.6 15.3 24.5 34.7 41.3 21.0 25.7 62.3 12.8 23.3 15.2 21.6 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119606443 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 4.4 6.5 11.3 5.7 11.8 6.9 5.4 9.6 16.9 4.2 7.3 3.7 4.1 3.9 4.0 5.6 4.4 3.5 4.1 11.5 13.1 6.1 6.0 4.1 8.7 11.2 10.1 6.1 3.8 5.2 5.5 6.5 11.5 4.1 3.5 5.3 4.0 3.5 5.5 6.2 4.3 4.0 9.4 5.9 4.1 1.9 11.4 9.5 4.6 4.6 8.4 6.3 4.3 10.6 17.9 18.3 10.4 11.3 8.7 8.5 15.5 10.7 8.5 14.1 15.0 19.8 15.3 31.8 18.4 9.2 12.1 20.4 43.8 16.4 17.2 16.4 28.9 16.8 20.3 12.9 8.3 33.5 11.8 9.5 13.2 16.3 19.2 9.6 14.1 15.3 18.5 12.6 12.5 27.6 20.8 25.2 23.1 26.2 19.9 16.5 15.2 32.7 18.8 12.7 16.7 14.2 15.2 23.1 16.5 10.6 9.7 20.0 12.2 8.7 9.5 19.3 27.1 10.5 14.1 32.9 9.3 36.3 10.1 1.1 0.5 0.7 1.0 0.8 1.1 1.3 1.2 1.3 0.6 1.2 1.9 1.6 0.1 0.5 0.3 0.9 1.8 0.8 11.3 11.8 9.6 16.9 11.5 13.1 11.2 10.1 11.5 9.4 11.4 10.6 5.4 6.4 8.9 5.9 11.1 19.4 10.4 4.1 6.8 13.3 6.1 6.9 4.5 8.6 3.1 5.5 27.1 14.4 8.5 3.0 1.9 4.2 0.1 6.1 7.4 7.0 10.7 2.5 20.6 3.6 14.3 6.1 3.1 8.1 14.7 6.6 3.3 3.9 6.4 8.4 20.6 4.4 10.2 7.5 33.1 0.6 7.8 11.6 5.4 7.5 5.6 4.4 1.0 9.0 9.2 4.1 1.9 6.8 5.2 10.7 3.6 4.4 3.9 7.9 0.0 10.1 7.2 1.7 1.9 6.9 25.7 14.9 15.7 6.9 7.4 9.5 NKX2-3 "CSX3, NKX2.3, NKX2C, NKX4-3" ENSG00000119919 "NK2 homeobox 3" Q8TAU0 10 99532942-99536524 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 38.9;lymphoid tissue: 31.4;salivary gland: 15.7" "Group enriched" "Detected in some" 4 "Endothelial cells: 2.2;Hepatic stellate cells: 4.2" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.7;REH: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA047561 Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 14: B-cells - Humoral immune response" "Cluster 14: REH - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoli, Cytosol" "HPA047561: AB_2680088" "unprognostic (5.70e-2)" "unprognostic (2.95e-1)" "unprognostic (2.70e-4)" "unprognostic (6.34e-3)" "unprognostic (3.92e-2)" "unprognostic (7.40e-2)" "unprognostic (1.20e-1)" "unprognostic (4.91e-2)" "unprognostic (1.12e-1)" "unprognostic (1.19e-1)" "unprognostic (1.53e-2)" "unprognostic (3.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" 1.4 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 38.9 11.5 0.0 0.0 0.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 4.9 0.0 15.7 0.0 0.0 0.0 22.4 3.6 0.0 31.4 2.5 0.1 0.0 0.0 1.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 NLE1 "FLJ10458, NLE" ENSG00000073536 "Notchless homolog 1" Q9NVX2 17 35128730-35142304 "Predicted intracellular proteins" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018807 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA018807: AB_1848658" "unprognostic (9.19e-2)" "unprognostic (8.40e-2)" "unprognostic (4.69e-2)" "unprognostic (4.27e-2)" "unprognostic (2.52e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (8.64e-8)" "unprognostic (8.67e-3)" "unprognostic (1.98e-1)" "unprognostic (1.26e-2)" "unprognostic (6.49e-2)" "unprognostic (3.90e-2)" "unprognostic (2.00e-1)" "unprognostic (4.21e-2)" "unprognostic (1.75e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (6.39e-4)" 7.3 7.4 5.0 5.8 5.0 6.2 8.8 5.1 5.3 7.4 3.4 5.6 4.0 6.8 2.9 8.4 7.4 3.1 4.2 5.0 4.5 6.5 7.3 4.6 6.8 4.7 4.0 12.0 23.7 3.9 4.2 4.9 4.0 6.0 4.0 2.5 7.6 4.6 8.0 6.8 5.1 4.1 3.5 6.2 7.6 4.4 5.0 6.6 5.1 3.5 5.4 7.4 5.8 4.6 15.9 36.8 12.5 22.7 6.9 11.4 19.6 14.0 12.7 24.4 19.3 26.1 14.8 34.9 18.6 12.0 18.0 21.0 26.8 35.6 15.1 5.6 44.2 14.9 18.2 33.2 10.3 29.9 12.0 12.9 19.0 25.6 38.3 10.7 15.5 33.9 42.4 12.7 14.6 22.1 47.1 25.5 23.6 13.5 16.6 37.6 20.9 38.5 14.3 14.8 25.6 14.8 13.1 13.4 17.1 11.1 32.4 22.4 14.5 13.3 18.3 13.0 47.4 9.8 7.8 29.1 9.3 24.9 25.8 0.1 2.2 0.0 4.0 2.4 6.2 3.4 3.8 4.2 3.4 4.6 5.2 3.5 0.3 1.8 1.2 0.8 2.1 2.2 5.0 5.0 5.1 5.3 5.0 4.5 4.7 4.0 4.0 3.5 5.0 4.6 4.7 3.2 1.1 0.3 8.6 8.7 8.6 7.4 9.6 4.7 12.3 14.0 2.6 10.0 3.7 3.7 2.1 12.1 2.4 3.9 0.0 8.9 1.0 2.1 5.4 5.0 4.9 8.8 1.3 15.4 20.9 7.4 6.6 2.8 3.8 9.4 5.3 6.6 7.6 1.7 1.5 8.1 2.0 4.6 2.6 5.4 4.1 2.8 1.8 1.0 3.8 1.9 2.1 1.0 0.7 8.5 3.6 4.9 5.1 8.6 3.4 7.1 2.8 3.1 0.0 6.5 7.2 4.2 6.5 12.5 10.1 4.9 4.1 9.2 13.4 5.5 NMD3 CGI-07 ENSG00000169251 "NMD3 ribosome export adaptor" Q96D46 3 161104696-161253532 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035019 Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA035019: AB_10600922" "unprognostic (1.37e-2)" "unprognostic (2.71e-1)" "unprognostic (9.50e-2)" "unprognostic (9.39e-3)" "unprognostic (1.95e-3)" "unprognostic (1.18e-2)" "unprognostic (1.03e-1)" "unprognostic (4.41e-2)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (2.03e-5)" "unprognostic (7.97e-2)" "unprognostic (5.57e-2)" "unprognostic (6.17e-2)" "unprognostic (8.71e-2)" "unprognostic (2.26e-2)" "unprognostic (5.86e-3)" 26.9 21.5 13.1 18.1 13.8 64.7 32.3 19.3 14.1 27.0 12.8 18.6 17.6 26.3 15.3 24.4 20.2 22.6 40.0 11.2 14.2 29.2 77.7 19.7 22.3 10.8 13.4 26.4 34.9 21.9 12.7 25.6 11.8 27.7 21.2 17.0 32.8 20.0 60.3 17.2 15.4 28.3 12.1 21.1 42.5 16.0 13.0 18.7 25.2 34.5 24.7 39.3 16.5 13.9 68.7 39.2 37.8 38.6 46.3 63.1 51.9 76.3 57.9 55.9 64.8 66.5 54.9 86.4 94.8 53.8 39.3 43.8 60.9 56.1 86.4 90.2 37.4 89.0 31.4 41.7 50.7 108.0 51.7 53.2 40.9 39.7 129.1 59.4 61.4 29.9 66.3 46.3 66.8 155.7 49.6 41.3 47.4 82.1 61.7 59.8 54.5 87.9 53.1 153.2 59.8 37.3 43.5 105.2 63.9 40.9 78.3 49.0 54.2 44.1 31.5 51.3 93.4 75.6 54.5 87.1 55.5 69.5 61.5 30.5 16.6 8.9 16.5 17.6 25.9 17.3 19.2 20.4 19.8 15.6 25.3 20.1 3.6 35.4 11.4 11.0 26.8 20.7 13.1 13.8 19.3 14.1 11.2 14.2 10.8 13.4 11.8 12.1 13.0 13.9 30.6 19.2 14.6 22.9 25.3 64.9 52.9 23.8 34.7 24.7 26.8 16.5 43.9 21.5 25.1 11.0 14.6 33.3 25.2 14.0 35.2 25.6 19.3 13.8 29.6 30.1 13.8 32.2 16.6 38.9 48.8 34.0 31.1 19.3 25.4 20.3 22.1 41.6 23.4 30.3 15.3 19.4 26.4 33.1 47.0 7.0 25.4 21.6 24.9 12.2 26.1 12.8 21.6 19.6 18.2 33.0 13.9 27.4 20.9 46.7 19.7 39.9 18.5 20.8 26.3 29.1 87.5 39.2 27.4 33.4 74.3 56.6 25.8 24.4 21.2 72.7 NOC4L "MGC3162, NET49, Noc4, UTP19" ENSG00000184967 "Nucleolar complex associated 4 homolog" Q9BVI4 12 132144457-132152473 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 72.6;Late spermatids: 80.3;Spermatogonia: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053424 Supported Nucleoplasm,Nucleoli No No "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoli Nucleoplasm "HPA053424: AB_2682147" "unprognostic (9.44e-2)" "unprognostic (1.96e-2)" "unprognostic (5.44e-2)" "unprognostic (8.48e-2)" "unprognostic (1.13e-1)" "unprognostic (4.63e-2)" "unprognostic (4.79e-3)" "unprognostic (8.08e-2)" "unprognostic (1.06e-1)" "unprognostic (1.64e-1)" "unprognostic (8.36e-3)" "unprognostic (1.76e-1)" "unprognostic (3.85e-3)" "unprognostic (1.05e-1)" "unprognostic (2.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.61e-1)" 12.6 11.5 2.0 3.3 2.0 6.1 12.8 1.9 3.1 13.1 1.5 11.1 4.2 12.6 1.6 13.8 11.9 1.9 10.8 2.6 2.2 13.2 13.4 10.5 3.6 2.4 1.9 14.4 13.6 2.4 11.3 2.7 2.1 11.1 1.8 0.8 11.5 2.2 24.3 15.6 11.3 1.8 1.5 13.5 12.3 33.2 2.0 3.5 11.7 3.2 2.3 11.4 11.2 2.7 14.4 26.0 5.7 9.0 2.8 3.0 29.0 9.7 5.0 12.0 6.5 21.4 6.7 21.8 10.4 5.0 7.1 12.7 10.2 10.7 2.5 8.7 28.3 14.7 8.8 14.4 7.6 17.3 16.5 4.3 7.2 9.2 7.3 4.5 8.3 16.8 25.4 4.9 4.8 17.1 16.6 40.6 16.7 8.6 20.7 21.2 6.3 19.5 6.3 10.6 13.9 11.0 8.2 11.1 7.5 3.3 15.6 10.7 11.1 7.0 17.7 11.3 16.5 12.4 8.2 19.1 10.6 14.8 15.0 1.6 8.4 4.3 7.5 11.7 7.2 9.1 6.9 7.5 11.1 10.7 5.9 5.7 1.2 5.8 9.1 13.1 6.2 5.9 2.0 2.0 1.9 3.1 2.6 2.2 2.4 1.9 2.1 1.5 2.0 2.7 10.9 9.6 9.1 2.3 15.5 22.3 15.6 20.6 12.0 8.2 11.5 12.1 8.0 20.0 12.4 3.7 0.0 32.3 15.5 15.6 7.9 35.5 72.6 12.1 8.4 13.6 7.3 7.8 2.2 32.9 33.9 14.6 15.3 11.1 15.9 15.8 10.4 11.6 24.9 8.4 2.0 14.5 24.4 11.0 15.8 80.3 14.6 13.2 14.2 1.9 14.5 8.3 6.2 1.5 3.1 28.0 11.2 7.9 12.0 15.4 19.2 21.7 6.2 6.2 19.7 14.2 15.0 37.1 77.1 11.2 21.6 30.5 13.6 24.4 22.7 15.0 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461353-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 19.0 22.0 15.6 13.5 15.5 19.9 17.8 14.3 17.6 19.8 14.5 15.3 8.7 19.5 9.3 29.7 17.1 8.0 20.5 16.5 14.4 21.4 27.0 18.1 14.3 15.2 14.6 19.3 28.4 13.6 24.3 12.1 15.1 23.5 11.8 6.8 17.3 10.1 31.0 27.9 16.2 13.7 13.9 23.5 18.0 28.8 15.8 13.8 17.3 12.0 16.0 22.9 20.6 15.6 37.5 52.3 20.0 45.6 30.5 20.6 33.6 41.2 30.8 46.7 39.3 57.8 13.5 65.3 18.3 46.4 20.7 25.7 58.8 59.1 49.5 41.5 23.9 33.8 62.9 33.1 29.8 78.2 47.0 23.7 48.0 62.9 60.9 19.7 31.6 23.5 54.8 24.5 38.1 33.1 43.3 77.1 71.4 42.0 47.6 36.9 19.9 33.5 36.7 44.1 23.3 31.8 34.0 43.9 14.9 21.3 17.7 44.1 34.7 28.2 38.5 36.6 72.7 22.9 34.4 54.5 25.3 40.6 33.4 0.0 3.0 0.2 3.6 5.9 4.1 2.8 2.7 3.6 5.0 2.2 3.3 3.2 0.1 2.8 6.3 2.7 3.0 2.7 15.6 15.5 14.3 17.6 16.5 14.4 15.2 14.6 15.1 13.9 15.8 15.6 4.8 3.2 12.9 5.2 5.7 20.0 6.6 3.7 4.0 6.5 6.7 6.5 6.6 4.3 8.6 3.7 6.2 4.2 5.4 3.8 3.9 6.3 30.4 7.1 7.7 6.5 10.2 5.7 11.6 4.0 6.1 4.8 9.2 13.6 3.8 7.3 4.2 8.8 5.0 3.3 7.3 5.6 2.0 1.6 4.0 22.0 5.9 3.4 5.4 4.7 3.8 4.2 4.1 6.0 5.9 5.7 2.1 6.0 4.8 10.6 2.4 3.0 6.0 3.8 0.0 6.9 4.5 2.7 5.6 9.5 25.9 3.0 4.9 7.0 7.2 9.5 NOL8 "C9orf34, FLJ20736, Nop132" ENSG00000198000 "Nucleolar protein 8" Q76FK4 9 92297358-92325636 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044440, HPA062922" Uncertain Supported "Nucleoli,Mitotic chromosome" Yes No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoli "Mitotic chromosome" "HPA044440: AB_10963212, HPA062922: " "unprognostic (3.44e-2)" "unprognostic (1.67e-1)" "unprognostic (9.72e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (9.73e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (1.85e-1)" "unprognostic (6.16e-3)" "unprognostic (5.17e-1)" "unprognostic (1.98e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (1.02e-5)" "unprognostic (4.69e-2)" "unprognostic (5.38e-2)" "unprognostic (4.58e-1)" "unprognostic (5.53e-2)" 8.6 5.8 4.2 8.0 5.8 6.8 10.0 5.0 5.3 8.2 5.2 8.6 6.0 9.8 7.4 8.7 7.4 6.5 6.8 4.1 5.3 7.2 5.5 6.9 12.0 5.6 5.4 11.2 7.1 12.6 3.2 7.6 5.6 7.4 8.3 5.8 7.8 8.5 6.3 7.2 5.9 9.9 4.6 9.8 6.2 6.1 6.0 12.6 10.5 6.2 12.6 8.6 5.1 7.1 18.9 27.1 13.4 24.2 28.5 24.3 19.8 19.7 14.9 20.9 18.7 11.2 18.5 54.2 16.3 20.1 33.8 39.9 43.5 25.8 22.3 36.3 21.4 37.1 25.9 22.4 20.3 63.2 30.5 24.0 23.5 22.0 31.6 16.7 23.7 16.3 60.7 17.1 22.5 29.7 42.7 24.8 21.4 28.4 26.8 29.8 37.9 23.0 10.6 13.4 23.0 12.3 25.3 25.1 18.0 17.3 9.5 21.2 24.9 18.3 14.0 26.7 25.0 17.7 37.5 26.7 18.5 37.4 26.6 18.9 8.3 11.3 11.4 10.8 15.8 13.0 11.3 11.8 12.1 12.9 13.3 11.7 3.1 13.2 15.7 10.2 13.8 7.1 4.2 5.8 5.0 5.3 4.1 5.3 5.6 5.4 5.6 4.6 6.0 7.1 25.4 19.2 33.4 15.7 33.8 13.0 18.4 15.3 21.1 17.9 14.7 20.6 28.4 14.3 19.8 11.0 10.4 19.5 37.7 10.1 15.6 23.5 13.9 17.9 46.2 23.9 9.0 37.6 12.1 12.9 20.1 25.8 23.9 20.8 52.4 30.6 16.1 11.5 26.5 28.6 12.5 16.9 6.1 17.7 12.1 9.4 32.0 23.9 10.6 18.7 34.5 12.4 43.3 15.6 25.9 16.1 11.2 23.7 36.5 23.3 10.3 15.8 21.2 17.7 6.6 29.3 21.5 73.3 50.2 25.4 15.9 14.6 30.1 33.4 20.3 12.2 NOL9 "FLJ23323, Grc3, NET6" ENSG00000162408 "Nucleolar protein 9" Q5SY16 1 6521347-6554513 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Kinase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036347 Supported "Nucleoli,Intermediate filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 2: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA036347: AB_2675076" "unprognostic (3.03e-1)" "unprognostic (4.93e-2)" "unprognostic (4.99e-2)" "unprognostic (3.14e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (2.48e-1)" "unprognostic (1.31e-1)" "unprognostic (8.90e-2)" "unprognostic (1.44e-3)" "unprognostic (2.32e-1)" "unprognostic (3.80e-2)" "unprognostic (3.32e-2)" "unprognostic (3.40e-1)" "unprognostic (3.54e-2)" "unprognostic (4.65e-2)" 3.8 4.6 4.5 3.5 5.0 7.5 3.7 4.9 5.6 4.7 1.9 5.0 2.4 5.0 3.6 4.7 4.3 2.3 4.5 6.2 4.2 4.4 5.3 3.2 5.2 3.3 3.8 4.8 6.0 3.4 4.0 3.0 3.8 4.1 3.1 4.3 3.6 3.1 7.0 6.0 4.8 3.9 2.7 8.8 4.5 3.7 4.6 3.8 3.4 4.5 5.1 4.5 3.8 4.0 6.4 9.1 5.0 15.2 6.6 4.0 5.4 6.3 4.1 6.4 6.8 12.6 8.6 17.9 7.3 7.1 5.5 8.3 10.2 8.6 10.9 7.3 5.5 12.2 14.7 9.9 6.6 10.4 6.4 5.8 2.6 13.6 11.8 3.7 7.6 7.8 14.3 7.3 6.6 11.2 10.2 9.2 6.9 5.0 8.7 12.7 11.7 8.3 5.1 5.8 9.7 4.4 9.7 12.1 8.1 5.1 7.9 4.8 10.0 10.1 8.1 7.2 10.6 6.1 6.2 31.9 9.4 11.4 4.9 3.5 1.9 1.6 3.1 1.9 3.2 2.9 4.5 2.9 1.3 3.7 4.6 3.8 1.2 1.7 3.2 3.5 3.2 1.2 4.5 5.0 4.9 5.6 6.2 4.2 3.3 3.8 3.8 2.7 4.6 4.0 15.0 19.2 19.5 9.4 16.2 15.4 6.9 6.9 10.8 17.1 9.8 13.2 15.0 11.5 7.4 7.3 14.6 14.8 17.3 6.7 15.6 8.9 6.0 13.7 19.7 15.2 6.7 11.6 18.9 8.6 12.6 15.3 11.7 15.6 5.1 18.3 14.3 13.2 9.1 10.1 18.5 10.9 4.1 13.8 7.3 17.0 9.6 8.6 1.8 10.3 13.4 8.1 12.3 13.0 20.1 9.0 6.2 12.8 17.9 7.3 7.6 10.7 9.0 18.2 0.0 22.6 12.7 11.7 21.5 16.0 14.8 12.7 17.3 19.1 13.2 7.3 NOP14 "C4orf9, NOL14, RES4-25, UTP2" ENSG00000087269 "NOP14 nucleolar protein" P78316 4 2937933-2963406 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039596, HPA055652" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA039596: AB_2676590, HPA055652: AB_2682876" "unprognostic (4.70e-2)" "unprognostic (6.47e-2)" "prognostic favorable (3.93e-5)" "unprognostic (7.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (9.10e-4)" "unprognostic (2.41e-2)" "unprognostic (8.62e-2)" "unprognostic (2.09e-1)" "unprognostic (1.30e-1)" "unprognostic (2.55e-3)" "unprognostic (1.16e-1)" "unprognostic (1.27e-3)" "unprognostic (1.44e-1)" "unprognostic (7.15e-2)" "unprognostic (4.77e-2)" 17.5 15.7 4.6 18.4 5.9 22.9 16.5 11.2 5.1 13.2 6.9 13.7 12.4 13.2 6.0 18.3 12.2 9.3 13.0 4.3 5.8 11.5 19.0 12.4 23.4 5.5 5.4 19.2 24.6 11.1 11.0 12.1 5.6 11.6 12.7 7.1 13.9 9.0 41.7 22.3 13.6 11.5 4.6 15.2 15.4 7.7 6.1 15.7 15.5 14.6 19.7 19.8 14.6 6.8 52.7 43.8 25.6 52.9 33.6 37.9 44.6 47.4 33.5 48.2 39.6 57.5 54.1 148.0 32.8 38.7 35.1 35.5 71.1 61.5 51.6 28.4 67.8 117.8 40.5 52.6 44.3 129.3 49.2 38.6 54.2 54.7 49.5 23.9 41.3 44.6 108.7 50.9 37.0 37.7 137.4 94.4 66.6 48.0 70.7 87.8 38.7 49.3 24.1 83.2 52.6 30.9 39.4 28.8 37.9 23.0 55.0 50.3 51.7 40.3 23.3 49.6 88.3 37.9 65.8 124.8 41.9 93.6 42.6 1.0 2.1 0.4 2.8 2.4 4.9 2.1 3.4 4.3 2.5 3.5 4.1 3.1 0.2 3.2 1.6 3.1 2.5 2.1 4.6 5.9 11.2 5.1 4.3 5.8 5.5 5.4 5.6 4.6 6.1 6.8 13.3 19.2 30.5 3.6 22.2 25.9 23.4 11.6 27.9 9.6 12.2 12.2 20.2 12.8 23.9 1.8 14.6 16.8 21.0 11.8 11.7 19.5 2.6 13.6 27.8 16.5 9.0 22.3 4.7 24.0 18.4 16.3 20.9 16.4 20.8 25.9 8.6 24.3 11.0 20.2 5.7 11.6 4.1 7.0 12.1 2.6 12.5 14.6 0.0 3.7 15.3 6.3 10.3 3.0 4.7 21.3 6.5 9.8 28.1 27.1 5.1 14.1 12.0 7.7 13.1 23.3 19.7 11.8 19.1 32.5 32.5 11.5 24.1 38.5 17.0 21.4 NOVA1 NOVA-1 ENSG00000139910 "NOVA alternative splicing regulator 1" P51513 14 26443090-26598033 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 85.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 222.9;Excitatory neurons: 414.9;Oligodendrocyte precursor cells: 1269.7;Oligodendrocytes: 319.5" "Cancer enriched" "Detected in many" 5 "glioma: 14.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 53.3;ASC diff: 25.6;HAP1: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004155 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 70: Brain - Nervous system development" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Nucleoplasm "HPA004155: AB_1079497" "unprognostic (1.46e-1)" "unprognostic (4.43e-3)" "unprognostic (6.55e-3)" "unprognostic (4.00e-2)" "unprognostic (6.69e-3)" "unprognostic (4.29e-2)" "unprognostic (3.74e-3)" "unprognostic (2.41e-1)" "unprognostic (5.21e-1)" "unprognostic (4.32e-2)" "unprognostic (5.04e-4)" "unprognostic (2.40e-1)" "unprognostic (1.93e-3)" "unprognostic (9.27e-4)" "unprognostic (9.20e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-4)" 23.4 5.4 44.0 2.4 39.7 0.1 28.9 85.4 56.3 12.1 18.9 11.6 1.4 8.5 4.9 2.9 6.7 4.8 3.3 38.8 65.3 6.1 0.9 1.4 3.4 50.3 51.2 5.0 1.2 2.4 19.3 0.1 48.5 5.6 5.1 13.4 2.7 15.9 4.3 4.7 3.6 9.5 49.2 0.9 3.3 8.8 71.1 1.2 3.4 8.7 4.5 5.9 8.4 45.5 0.0 11.6 53.3 0.0 25.6 14.6 0.1 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.7 0.7 7.1 0.1 23.7 0.2 0.0 0.0 1.8 0.0 0.1 0.3 8.5 0.0 2.1 16.8 0.0 3.6 2.9 17.8 10.3 8.7 0.0 0.1 8.4 0.0 9.8 0.1 13.5 0.0 10.9 1.3 14.8 0.2 6.8 9.1 15.5 9.4 0.0 0.0 0.0 4.2 1.1 0.0 0.0 6.5 7.7 5.2 1.4 0.0 0.0 0.0 8.8 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 44.0 39.7 85.4 56.3 38.8 65.3 50.3 51.2 48.5 49.2 71.1 45.5 24.8 0.0 1.5 141.0 0.2 5.2 5.9 0.0 4.6 222.9 51.5 29.6 1.1 5.7 0.0 14.7 4.2 0.1 1.4 6.6 9.8 0.4 20.1 0.6 15.0 9.4 65.9 0.0 414.9 0.4 0.0 188.8 0.5 0.2 0.0 18.2 38.6 0.5 0.2 136.3 203.5 7.1 0.0 0.6 10.5 16.5 150.4 2.1 3.6 93.7 0.0 32.3 0.0 1269.7 319.5 2.0 11.7 65.8 1.9 6.7 0.3 30.3 4.4 12.0 6.6 28.6 17.7 163.1 64.3 0.7 3.1 0.0 1.5 30.0 8.4 0.6 NPM2 ENSG00000158806 "Nucleophosmin/nucleoplasmin 2" Q86SE8 8 22024125-22036897 "Predicted intracellular proteins" Fertilization "Chaperone, Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.0;parathyroid gland: 39.2" "Cell type enhanced" "Detected in many" "Bipolar cells: 29.4;Cone photoreceptor cells: 20.9;Excitatory neurons: 21.3;Inhibitory neurons: 21.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 10.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "eosinophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 17.7;HEL: 14.5;Hep G2: 32.4;JURKAT: 9.5;THP-1: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041070 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 62: Horizontal cells - Visual perception" "Nucleoplasm, Nucleoli" "HPA041070: AB_2677285" "unprognostic (1.40e-2)" "unprognostic (3.30e-2)" "unprognostic (3.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.55e-1)" "unprognostic (2.06e-1)" "unprognostic (1.61e-1)" "unprognostic (3.03e-2)" "unprognostic (5.30e-3)" "unprognostic (1.01e-1)" "prognostic favorable (9.02e-4)" "unprognostic (2.23e-1)" "prognostic favorable (3.18e-6)" "unprognostic (8.05e-3)" "unprognostic (2.89e-1)" "unprognostic (1.42e-1)" "unprognostic (1.30e-1)" 0.6 18.4 11.0 0.1 16.9 1.2 2.1 7.4 40.0 4.9 2.2 1.1 2.2 5.0 0.9 1.0 3.2 1.9 2.3 12.4 9.2 6.6 1.6 1.8 0.6 7.5 7.6 1.5 11.0 39.2 18.5 0.5 10.0 6.6 1.0 5.7 2.7 1.4 0.3 2.2 1.2 3.6 2.3 12.5 1.9 5.1 7.1 2.9 25.3 0.3 0.4 2.0 2.3 13.5 3.9 0.5 0.2 0.2 0.9 0.0 1.5 0.5 0.5 2.4 4.9 1.6 3.6 0.0 1.1 0.0 0.2 17.7 0.5 0.0 1.4 0.1 0.5 14.5 1.0 32.4 3.1 1.9 1.3 0.5 2.3 0.0 0.3 3.7 0.0 9.5 0.5 0.0 0.1 0.0 0.2 3.9 0.7 6.4 0.4 0.3 1.4 0.8 5.6 0.1 3.8 0.2 0.0 0.1 4.6 0.0 0.7 11.2 0.0 0.0 0.3 0.6 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 0.0 0.2 0.6 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 11.0 16.9 7.4 40.0 12.4 9.2 7.5 7.6 10.0 2.3 7.1 13.5 0.1 0.0 1.1 1.0 0.7 0.1 9.7 3.7 0.6 29.4 3.1 5.2 2.1 5.7 8.8 0.0 20.9 0.1 0.5 0.6 3.9 9.4 15.1 1.1 0.3 0.6 11.4 0.4 21.3 8.0 0.2 1.7 1.5 1.1 0.0 1.4 2.5 0.5 4.6 6.7 21.9 2.1 2.0 0.0 0.3 14.4 0.6 0.9 10.6 1.9 1.0 0.9 0.0 2.5 1.6 4.3 0.8 0.4 0.6 3.4 0.5 14.6 7.7 4.2 0.0 0.4 1.6 0.5 0.9 1.1 1.1 0.3 2.7 7.6 1.2 5.8 NRG2 "Don-1, HRG2, NTAK" ENSG00000158458 "Neuregulin 2" O14511 5 139846779-140043299 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 71.5;Excitatory neurons: 89.9;Inhibitory neurons: 136.6;Oligodendrocyte precursor cells: 142.2;Oligodendrocytes: 50.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;HDLM-2: 4.0;Karpas-707: 4.4;PC-3: 11.1;RPTEC TERT1: 5.8;SCLC-21H: 4.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038935, HPA047973" Approved Supported Nucleoplasm,Nucleoli "Secreted in other tissues" No NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Nucleoli "HPA038935: AB_10672833, HPA047973: AB_2680226" "unprognostic (8.66e-4)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (6.04e-2)" "unprognostic (3.22e-1)" "unprognostic (2.96e-2)" "unprognostic (8.66e-3)" "unprognostic (1.11e-1)" "unprognostic (3.99e-1)" "unprognostic (1.88e-1)" "unprognostic (4.26e-3)" "unprognostic (4.00e-2)" "unprognostic (7.79e-3)" "unprognostic (3.64e-3)" "unprognostic (9.54e-2)" "unprognostic (2.23e-2)" "unprognostic (2.07e-2)" 2.3 3.4 2.9 0.5 2.8 0.0 3.3 8.5 3.1 5.8 0.0 2.1 0.2 1.2 1.1 1.6 3.3 1.2 1.2 2.0 2.4 0.8 0.1 0.4 0.8 3.2 2.6 7.5 2.7 8.1 3.5 0.3 3.0 3.1 0.1 1.3 6.5 1.9 5.0 3.6 0.7 0.3 1.5 1.7 0.8 2.1 2.6 0.5 0.7 0.1 0.4 3.1 1.8 2.3 0.0 1.6 0.1 6.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.3 0.0 2.8 2.1 0.3 0.1 0.1 4.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.6 0.1 0.1 0.0 4.4 0.0 0.2 0.0 0.0 0.1 0.0 11.1 0.1 0.0 0.0 5.8 1.5 4.2 2.5 0.0 2.7 2.6 0.0 0.0 0.0 0.1 1.9 0.3 0.0 1.3 0.8 0.0 0.0 2.7 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.8 8.5 3.1 2.0 2.4 3.2 2.6 3.0 1.5 2.6 2.3 15.9 0.0 0.0 71.5 1.6 2.8 9.7 0.9 29.0 16.6 4.0 16.0 2.2 0.0 0.5 1.8 0.0 0.1 3.2 0.1 1.9 0.4 0.6 2.6 8.2 2.6 0.0 0.0 89.9 2.2 0.0 2.7 0.5 0.4 0.0 1.3 1.8 0.0 0.1 6.7 136.6 0.1 0.0 0.3 1.3 0.6 9.6 0.6 3.6 8.4 0.3 11.2 5.2 142.2 50.8 0.5 0.0 10.1 2.7 2.6 0.0 1.7 1.0 1.0 6.6 10.9 2.2 2.7 9.4 1.0 0.3 0.0 2.8 4.0 0.1 6.2 NSA2 "FLJ94393, HCLG1, HUSSY-29, TINP1" ENSG00000164346 "NSA2 ribosome biogenesis factor" O95478 5 74766991-74780113 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043487 Approved Enhanced Nucleoplasm,Nucleoli No No "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Nucleoli" "HPA043487: AB_2678507" "unprognostic (4.79e-3)" "unprognostic (1.92e-1)" "unprognostic (5.49e-2)" "unprognostic (7.80e-2)" "unprognostic (1.54e-1)" "unprognostic (4.07e-2)" "unprognostic (6.14e-3)" "unprognostic (4.24e-1)" "unprognostic (2.15e-2)" "unprognostic (9.14e-2)" "unprognostic (8.66e-2)" "unprognostic (1.03e-1)" "unprognostic (4.92e-2)" "unprognostic (3.98e-1)" "unprognostic (1.64e-1)" "unprognostic (2.31e-2)" "unprognostic (1.44e-1)" 32.0 36.5 17.1 33.2 18.9 39.3 28.7 19.3 22.2 43.7 15.6 36.4 30.4 29.9 25.0 26.7 35.0 12.2 28.3 17.4 19.0 30.9 26.6 20.3 36.9 19.1 17.9 60.4 37.7 20.6 28.1 17.3 19.2 28.5 22.8 22.6 28.1 11.5 67.9 22.2 26.0 16.9 19.9 25.8 31.2 31.8 18.2 23.5 22.1 19.0 32.0 35.9 30.6 20.4 65.2 35.4 42.5 57.6 26.6 48.9 64.8 45.8 24.5 29.5 24.9 61.2 62.3 53.0 94.0 27.3 70.2 39.6 34.6 51.9 41.9 36.1 53.7 27.9 65.8 68.3 24.8 47.9 61.7 32.4 48.2 39.8 29.6 46.5 25.5 47.3 28.0 42.8 32.2 50.1 81.4 120.4 28.3 27.8 29.9 58.4 49.8 100.5 37.7 70.9 45.3 58.5 27.8 52.8 135.7 32.6 49.5 135.8 28.0 22.0 67.4 41.8 133.3 42.7 61.1 90.0 54.6 84.3 33.3 9.3 12.1 7.5 16.3 20.6 23.5 27.1 24.6 24.7 18.5 19.5 28.7 29.8 2.2 21.4 15.9 17.2 26.4 10.3 17.1 18.9 19.3 22.2 17.4 19.0 19.1 17.9 19.2 19.9 18.2 20.4 125.8 80.1 95.9 6.5 237.4 94.1 162.1 95.9 215.1 34.6 164.2 218.3 83.7 140.2 94.5 62.5 14.6 142.3 183.7 122.9 150.6 143.1 418.6 145.2 303.6 101.1 139.6 129.2 13.1 237.9 196.2 107.6 112.1 192.8 119.2 165.4 129.2 207.7 137.4 50.5 13.2 234.6 52.9 233.2 100.2 159.1 278.4 161.9 83.6 7.5 229.6 85.8 188.4 10.1 13.4 181.2 147.9 171.5 139.4 144.4 147.5 281.7 55.9 37.7 138.1 132.8 138.0 250.2 96.3 171.7 86.0 135.4 176.1 176.8 246.1 192.5 NSUN5 "FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL" ENSG00000130305 "NOP2/Sun RNA methyltransferase 5" Q96P11 7 73302516-73308826 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020536, HPA045590, HPA046867" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847" "unprognostic (3.94e-1)" "unprognostic (1.12e-1)" "unprognostic (3.79e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.92e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (3.54e-1)" "unprognostic (2.46e-1)" "unprognostic (2.72e-1)" "unprognostic (2.26e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (3.21e-2)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-2)" 13.9 11.6 9.8 9.7 11.3 33.4 14.1 11.7 12.9 15.3 9.1 18.6 8.9 18.7 3.2 17.7 15.5 4.2 17.7 9.8 10.9 17.4 16.2 12.1 14.2 12.8 10.8 13.0 24.0 6.6 12.8 6.1 11.7 15.5 4.3 3.2 14.6 6.3 37.9 19.7 17.7 6.2 11.6 24.4 16.3 20.7 11.0 13.0 13.6 8.1 9.4 18.6 14.7 13.3 34.7 46.4 12.3 29.3 4.8 6.3 48.4 15.3 9.1 23.6 25.3 63.0 24.3 55.3 10.6 7.7 34.6 28.9 23.7 15.2 8.1 36.6 57.0 20.7 35.8 36.4 20.0 45.9 26.0 8.3 25.7 20.0 17.3 5.2 3.1 40.4 71.0 12.7 10.8 83.2 39.3 91.6 52.1 24.9 34.9 48.9 9.5 79.8 10.1 17.1 33.2 54.6 27.9 72.5 36.4 12.8 47.9 37.1 5.3 0.2 34.8 34.7 11.1 49.6 73.8 80.8 0.5 65.6 2.5 23.7 21.5 24.0 19.6 19.6 15.7 32.2 22.3 20.4 25.0 46.2 31.0 26.5 27.4 26.8 14.8 31.5 26.9 23.2 9.8 11.3 11.7 12.9 9.8 10.9 12.8 10.8 11.7 11.6 11.0 13.3 11.1 6.4 7.4 14.4 38.2 17.0 20.0 32.8 14.8 27.5 23.0 25.0 20.4 27.1 21.3 36.8 12.5 37.7 27.3 18.3 37.2 35.8 17.4 18.1 12.7 8.9 3.6 19.1 9.2 33.0 48.9 17.2 21.4 15.5 26.6 50.5 5.3 21.0 36.6 32.0 9.3 18.3 26.4 21.0 10.8 21.6 29.2 20.2 21.4 3.7 39.9 13.2 36.0 10.1 12.1 29.1 20.5 20.7 24.9 12.6 28.4 25.1 21.8 23.1 6.6 20.8 16.8 64.2 56.7 15.1 21.3 21.8 24.9 16.2 23.1 14.3 NUB1 "BS4, NUB1L, NYREN18" ENSG00000013374 "Negative regulator of ubiquitin like proteins 1" Q9Y5A7 7 151341772-151378449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 249.4;monocytes: 559.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021220, HPA050722, HPA053648" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 14: B-cells - Humoral immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nucleoli" "HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217" "unprognostic (7.04e-3)" "unprognostic (2.47e-2)" "unprognostic (1.84e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" "unprognostic (3.22e-2)" "prognostic unfavorable (8.70e-4)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "unprognostic (2.67e-2)" "unprognostic (2.10e-1)" "unprognostic (8.76e-2)" "unprognostic (2.69e-2)" "unprognostic (9.44e-2)" "unprognostic (1.45e-1)" "unprognostic (2.64e-2)" "unprognostic (5.83e-3)" 36.7 33.2 23.5 47.0 24.3 30.7 31.3 24.5 23.0 32.5 23.2 36.0 62.1 32.7 18.1 27.7 31.6 33.8 33.6 21.1 24.1 28.9 35.5 36.4 62.8 25.9 24.8 35.2 40.1 40.7 25.8 30.7 25.3 31.4 30.2 31.7 41.8 28.5 52.8 29.3 56.9 21.1 24.2 54.7 36.6 52.0 24.5 46.2 47.3 32.4 40.6 30.2 28.0 26.7 78.0 34.8 45.9 26.9 47.0 56.6 38.7 61.2 55.8 45.5 52.2 34.2 67.3 84.5 78.5 38.8 58.3 38.0 27.9 40.0 29.2 74.2 46.4 30.8 32.1 21.9 65.2 72.0 38.0 36.4 46.4 32.9 31.3 56.4 30.6 41.4 81.5 2.5 37.3 42.0 126.9 55.0 73.0 79.4 45.6 69.4 47.9 12.8 33.3 37.9 42.9 71.8 116.3 48.7 60.4 31.7 33.9 40.6 62.7 38.2 13.7 51.8 58.9 78.5 64.0 73.7 77.9 60.6 64.4 18.2 20.5 28.5 25.9 27.1 30.8 26.9 22.6 26.6 18.1 26.0 24.5 23.5 37.6 33.6 34.9 25.2 19.8 23.8 23.5 24.3 24.5 23.0 21.1 24.1 25.9 24.8 25.3 24.2 24.5 26.7 61.0 73.7 66.4 14.0 52.7 24.9 33.8 36.4 39.9 38.4 31.0 32.3 57.4 34.3 51.4 25.8 12.5 49.3 91.8 53.4 60.7 52.1 249.4 59.5 46.5 45.8 29.3 17.1 13.6 69.8 43.0 42.3 29.0 47.9 72.2 45.1 33.2 40.5 30.0 48.8 19.4 40.9 18.3 37.1 45.8 34.2 44.1 46.7 16.0 18.7 559.4 57.7 74.2 11.1 23.0 52.3 20.5 41.0 22.3 48.7 56.5 37.8 55.7 41.4 26.3 39.5 43.3 160.4 12.5 25.8 29.0 50.1 60.0 40.2 26.0 33.1 NUCKS1 NUCKS ENSG00000069275 "Nuclear casein kinase and cyclin dependent kinase substrate 1" Q9H1E3 1 205712822-205750182 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062351, HPA063843" Supported Supported Nucleoplasm,Nucleoli No No 13000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm Nucleoli "HPA062351: AB_2684745, HPA063843: AB_2685134" "unprognostic (1.68e-1)" "unprognostic (3.92e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.87e-1)" "unprognostic (2.93e-1)" "unprognostic (9.20e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-2)" "unprognostic (5.16e-3)" "unprognostic (1.18e-3)" "unprognostic (1.37e-1)" "unprognostic (5.82e-3)" "unprognostic (7.45e-3)" "unprognostic (1.44e-1)" "unprognostic (2.25e-2)" "unprognostic (7.57e-2)" 63.3 57.2 88.6 43.3 98.3 33.4 72.8 86.2 102.7 70.8 53.7 52.5 29.5 83.4 62.0 54.4 71.8 46.7 98.3 80.7 88.8 70.4 104.2 48.7 61.2 93.8 87.8 108.9 41.2 96.1 39.0 49.6 94.1 71.7 48.1 81.4 46.8 71.1 113.7 51.4 33.2 69.8 94.6 56.5 43.0 25.8 87.9 97.4 98.1 101.6 60.7 47.8 45.2 115.8 223.5 134.6 354.2 140.8 96.0 131.7 166.1 157.3 161.3 215.6 172.6 74.4 250.0 246.1 89.0 154.2 68.2 160.0 272.6 131.9 245.7 118.6 135.8 160.3 113.2 81.8 70.6 255.0 54.9 105.1 116.9 128.6 221.7 115.6 171.4 156.3 261.9 76.7 170.7 258.1 233.2 128.0 363.0 88.9 99.4 239.1 436.4 141.1 121.4 135.4 146.9 270.9 232.2 183.3 127.5 272.4 280.3 189.9 172.8 164.5 144.8 190.0 282.8 69.9 88.0 192.6 112.8 140.5 226.2 5.6 3.2 3.9 9.1 4.9 8.8 5.6 8.3 8.0 4.6 6.9 10.1 10.7 0.6 10.7 4.2 7.3 5.5 3.8 88.6 98.3 86.2 102.7 80.7 88.8 93.8 87.8 94.1 94.6 87.9 115.8 258.4 214.7 283.4 73.4 179.5 258.1 277.4 212.9 282.9 356.2 221.2 229.7 412.4 318.8 241.8 303.5 73.0 301.5 174.5 125.5 385.4 202.5 61.3 227.0 410.3 254.5 179.0 324.2 85.9 171.5 381.3 356.5 131.0 299.5 215.4 329.0 258.5 668.2 264.1 316.3 88.7 219.2 116.0 216.8 266.4 52.6 512.0 164.0 174.3 71.2 162.1 546.9 195.7 56.8 126.2 117.2 113.2 485.2 128.2 295.3 49.4 384.5 187.8 200.2 315.5 458.0 358.1 70.0 104.1 321.4 243.9 177.2 190.5 443.9 265.1 220.8 NUDT14 UGPP ENSG00000183828 "Nudix hydrolase 14" O95848 14 105172938-105181323 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 176.1;Proximal enterocytes: 206.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046755, HPA058759" Approved Approved Nucleoli,Microtubules NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoli "HPA046755: AB_10963433, HPA058759: AB_2683809" "unprognostic (1.05e-2)" "unprognostic (6.01e-2)" "unprognostic (1.89e-1)" "unprognostic (2.44e-1)" "unprognostic (1.91e-1)" "unprognostic (3.55e-1)" "unprognostic (1.05e-3)" "unprognostic (9.17e-3)" "unprognostic (2.02e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.16e-3)" "unprognostic (3.13e-1)" "prognostic favorable (1.18e-5)" "unprognostic (1.89e-1)" "unprognostic (1.02e-1)" "unprognostic (7.21e-3)" "unprognostic (2.38e-1)" 16.5 23.9 17.4 3.5 20.1 2.1 19.3 19.9 28.4 9.0 27.5 14.5 12.5 6.4 3.5 17.5 8.9 6.4 27.5 19.9 21.5 28.8 19.5 20.1 5.9 19.0 17.4 6.4 40.4 16.0 61.1 3.2 19.1 18.6 2.9 4.7 17.2 2.9 31.6 14.1 16.3 1.8 17.9 12.5 17.6 13.9 17.2 3.6 22.1 12.7 2.1 8.4 11.3 21.1 18.1 24.2 2.1 9.4 2.8 3.3 38.1 5.0 6.5 8.0 11.5 17.5 18.7 1.3 24.4 2.6 17.8 22.7 1.1 13.6 0.7 9.5 17.7 4.0 10.4 12.2 19.9 4.8 46.7 4.7 16.7 1.9 1.4 3.4 15.9 8.8 6.4 2.9 2.8 52.5 0.6 0.0 12.6 42.7 33.5 9.4 21.9 10.8 8.8 51.2 32.8 4.8 9.0 0.2 21.7 3.9 18.8 23.1 38.3 13.2 5.8 9.5 5.1 1.4 1.0 2.2 19.4 5.5 4.9 6.2 40.5 1.2 12.6 40.8 7.5 12.8 9.6 8.0 33.5 10.2 9.4 10.8 1.3 15.2 68.6 17.0 6.0 19.2 17.4 20.1 19.9 28.4 19.9 21.5 19.0 17.4 19.1 17.9 17.2 21.1 66.1 12.8 28.5 5.2 12.4 38.9 101.7 123.4 52.9 12.1 46.8 78.5 54.5 40.0 41.2 35.0 18.8 44.7 16.1 88.2 176.1 94.1 3.1 59.3 8.0 61.6 37.3 10.1 5.9 30.8 18.2 14.7 30.5 31.0 38.8 11.9 27.1 28.0 137.0 35.3 3.0 62.6 73.2 27.4 27.1 9.8 11.5 33.9 46.2 12.2 35.6 38.3 22.6 0.5 5.8 51.2 132.4 3.8 7.7 51.9 206.9 169.1 65.7 19.1 0.0 39.0 11.4 12.4 48.5 30.4 19.0 38.2 26.8 5.2 75.4 82.2 NUDT16 FLJ31265 ENSG00000198585 "Nudix hydrolase 16" Q96DE0 3 131381671-131388830 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Kupffer cells: 179.8;Proximal enterocytes: 334.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 41.7;eosinophil: 47.0;intermediate monocyte: 54.6;myeloid DC: 32.4;neutrophil: 34.0;non-classical monocyte: 63.4" "Group enriched" "Detected in all" 4 "dendritic cells: 32.4;granulocytes: 47.0;monocytes: 63.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060452, HPA062492" Uncertain Supported Nucleoplasm,Nucleoli NA NA 38000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 45: Intestine - Brush border" "Cluster 18: U-2197 - ECM organization" "Cluster 45: Enterocytes - Digestion" "Nucleoplasm, Nucleoli" "HPA060452: AB_2684279, HPA062492: AB_2684781" "unprognostic (4.85e-3)" "prognostic favorable (9.39e-5)" "unprognostic (3.19e-3)" "unprognostic (9.21e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (9.96e-2)" "unprognostic (1.15e-1)" "unprognostic (5.16e-2)" "unprognostic (1.94e-1)" "unprognostic (1.77e-1)" "unprognostic (5.88e-2)" "prognostic favorable (1.05e-7)" "unprognostic (3.29e-1)" "unprognostic (1.62e-1)" "unprognostic (2.00e-2)" "unprognostic (9.44e-2)" 30.6 19.0 39.3 15.2 40.1 10.4 22.9 35.9 49.3 17.1 28.6 25.6 22.2 19.4 11.0 11.1 22.7 9.8 32.9 34.1 38.3 27.7 33.8 26.2 12.3 40.7 39.6 25.2 14.7 48.6 15.8 8.1 40.9 17.8 19.5 18.8 16.1 13.6 24.7 11.6 57.6 12.6 41.7 36.0 21.3 12.2 41.2 6.7 24.4 24.5 10.1 20.9 14.0 40.8 20.8 10.8 17.5 9.2 34.3 31.0 8.1 16.5 15.1 10.9 11.3 16.8 9.0 3.4 14.1 15.4 21.5 14.8 15.7 10.4 17.3 10.4 11.5 8.7 15.3 16.4 22.0 14.9 15.4 27.8 9.0 7.2 19.5 9.7 17.2 0.0 10.2 17.4 10.7 21.5 0.0 4.0 13.6 20.6 16.0 11.6 12.6 26.1 10.8 16.6 8.6 15.0 9.9 9.9 15.6 14.7 21.6 11.7 17.1 17.7 7.6 32.8 13.0 17.1 18.1 0.5 11.5 11.2 10.0 7.2 41.7 47.0 6.0 54.6 6.2 11.2 6.0 5.5 32.4 10.5 5.3 5.4 34.0 9.8 63.4 4.3 10.7 17.4 39.3 40.1 35.9 49.3 34.1 38.3 40.7 39.6 40.9 41.7 41.2 40.8 56.1 16.0 41.1 4.6 13.0 8.4 12.3 21.1 10.8 22.8 22.2 20.2 85.2 44.3 23.9 20.2 8.4 21.0 11.5 58.8 68.4 24.7 77.8 27.2 25.5 33.0 25.3 17.9 5.6 36.9 26.1 27.8 36.2 33.1 19.6 23.0 78.1 107.5 65.1 43.7 3.0 74.7 18.3 179.8 25.3 37.5 26.4 73.6 17.8 3.7 64.6 14.2 17.5 3.0 4.6 31.1 66.7 39.5 14.3 19.5 334.3 109.4 19.8 19.2 26.3 22.1 30.7 28.2 6.3 15.4 5.4 7.3 15.1 68.2 48.5 16.0 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629937 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 218.9" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 10.3 5.3 6.9 1.9 8.7 3.2 9.9 10.3 10.4 10.1 6.9 12.4 14.2 4.3 2.2 57.6 5.0 1.6 78.9 6.2 8.6 25.5 58.7 6.1 1.8 9.2 8.7 4.6 13.1 12.0 3.0 1.7 8.6 9.3 5.4 0.8 24.1 4.3 58.8 31.7 11.6 1.5 8.4 4.5 9.1 4.4 9.2 2.5 20.4 41.8 3.7 3.7 12.6 9.1 33.5 13.3 5.1 8.4 4.7 5.9 8.1 6.9 3.2 2.7 2.8 11.0 8.5 35.1 10.6 5.4 3.9 16.1 5.9 4.1 0.3 34.3 14.7 2.0 6.1 34.2 1.4 11.2 16.0 3.6 8.1 3.4 1.1 0.7 6.0 42.6 9.9 30.1 2.2 55.9 18.6 16.0 3.1 58.7 28.0 11.4 2.7 218.9 8.4 5.8 2.6 3.7 1.8 18.7 7.1 1.8 10.2 4.6 1.6 7.1 10.1 45.7 1.3 21.6 15.3 7.1 5.0 14.8 4.1 0.0 1.1 1.1 2.9 4.7 2.5 3.2 1.7 3.5 4.6 6.4 1.5 1.8 0.0 9.5 13.7 12.4 1.3 2.1 6.9 8.7 10.3 10.4 6.2 8.6 9.2 8.7 8.6 8.4 9.2 9.1 8.7 0.0 6.5 6.2 12.0 12.1 12.7 9.4 17.6 4.5 42.3 39.9 79.5 15.7 12.1 29.5 0.0 29.7 7.2 76.5 84.1 14.3 3.3 8.2 11.0 9.2 2.4 34.5 0.6 23.9 21.4 12.5 23.4 13.8 8.9 3.7 8.6 222.8 9.4 5.0 0.7 102.5 12.2 5.3 10.8 8.0 5.0 5.0 28.4 0.0 2.5 7.9 4.1 1.0 2.9 9.9 26.4 5.3 15.7 18.5 139.4 237.1 4.5 7.8 6.6 7.8 17.7 13.9 8.8 129.6 25.6 17.4 7.6 6.6 69.8 25.0 NUFIP1 "NUFIP, Rsa1" ENSG00000083635 "Nuclear FMR1 interacting protein 1" Q9UHK0 13 44939249-44989471 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029958, HPA029959" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "HPA029958: AB_10598911, HPA029959: AB_10602308" "unprognostic (2.01e-1)" "unprognostic (5.32e-3)" "unprognostic (1.58e-1)" "unprognostic (2.04e-1)" "unprognostic (1.70e-2)" "unprognostic (2.98e-3)" "unprognostic (2.32e-1)" "unprognostic (1.45e-2)" "unprognostic (2.91e-2)" "unprognostic (9.74e-3)" "unprognostic (4.52e-1)" "unprognostic (3.95e-2)" "unprognostic (3.73e-2)" "unprognostic (4.04e-2)" "unprognostic (4.89e-2)" "unprognostic (3.31e-1)" "unprognostic (5.24e-2)" 3.2 3.7 3.2 2.8 3.4 7.9 4.6 2.9 4.6 3.6 2.1 2.6 2.8 4.5 5.5 3.3 3.5 2.4 2.5 3.3 3.0 4.0 4.1 2.3 3.7 2.6 3.2 4.3 3.8 4.0 1.8 3.0 2.9 3.4 3.0 2.6 3.3 3.2 4.8 3.4 2.4 4.0 2.9 3.0 2.8 5.5 3.1 3.6 3.9 3.9 3.8 4.2 2.6 3.9 7.4 5.7 9.5 7.9 6.4 6.6 11.3 8.6 7.4 15.6 9.9 15.6 11.5 21.5 7.0 8.0 9.4 11.3 17.9 12.2 20.2 6.6 14.0 16.4 3.7 14.0 10.5 21.3 6.4 6.9 11.0 10.5 15.8 6.0 7.9 10.9 13.3 3.5 11.1 8.5 17.8 13.4 22.5 19.5 9.3 17.3 9.0 13.1 9.5 6.3 5.2 11.5 7.3 9.9 9.6 8.9 7.5 11.8 6.0 7.9 6.8 10.3 11.9 4.8 7.9 26.7 8.9 14.8 11.4 0.0 2.6 0.8 2.5 2.6 4.7 4.0 2.9 2.8 3.4 4.1 4.5 3.4 0.2 5.9 1.8 4.5 1.7 1.8 3.2 3.4 2.9 4.6 3.3 3.0 2.6 3.2 2.9 2.9 3.1 3.9 11.3 6.4 12.2 6.2 10.5 15.4 11.8 16.7 23.9 7.8 9.8 16.3 4.5 4.3 15.4 5.5 12.5 15.7 11.7 4.2 17.6 14.0 37.2 14.0 21.7 10.9 5.4 14.5 19.2 16.7 15.9 11.9 7.7 18.6 17.7 14.1 7.1 9.7 10.8 8.4 16.9 5.3 12.2 3.4 5.5 63.2 10.8 7.9 8.8 7.5 6.9 9.7 7.2 16.6 14.4 10.8 1.6 11.3 5.0 8.6 3.2 14.8 6.6 6.8 6.6 20.3 15.6 27.1 31.6 14.3 16.6 8.8 9.9 15.7 8.4 7.1 NWD1 ENSG00000188039 "NACHT and WD repeat domain containing 1" Q149M9 19 16719847-16817963 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "choroid plexus: 192.4" "Group enriched" "Detected in some" 4 "Astrocytes: 41.4;Endometrial ciliated cells: 83.9;Respiratory ciliated cells: 92.0" "Cancer enriched" "Detected in many" 6 "prostate cancer: 9.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-937: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075476 Approved Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoli, Cytosol" "HPA075476: " "unprognostic (5.29e-3)" "unprognostic (3.08e-2)" "unprognostic (3.05e-2)" "prognostic favorable (2.55e-4)" "unprognostic (2.49e-1)" "unprognostic (4.20e-4)" "unprognostic (6.54e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.94e-2)" "unprognostic (1.76e-1)" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (5.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.25e-1)" 0.0 0.0 5.4 0.0 6.2 0.1 0.2 7.6 4.9 1.3 192.4 0.5 0.0 0.2 0.4 0.2 12.6 0.2 0.0 12.2 5.2 0.2 0.0 1.3 0.0 6.2 8.8 0.0 1.5 0.0 0.7 0.0 6.1 6.8 0.1 1.1 1.3 1.8 0.0 0.2 0.0 0.0 3.2 0.0 0.8 0.2 10.1 0.2 0.7 0.0 0.0 0.1 0.0 3.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 2.4 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 6.2 7.6 4.9 12.2 5.2 6.2 8.8 6.1 3.2 10.1 3.7 0.0 0.0 1.5 41.4 0.3 0.3 1.7 3.5 0.0 0.2 0.5 0.3 0.9 0.0 4.5 0.0 0.0 0.1 0.0 0.4 0.0 0.1 17.9 83.9 0.8 0.3 1.2 0.0 2.4 0.0 0.2 0.3 0.0 3.7 0.0 0.1 0.0 0.0 0.1 0.0 1.4 0.6 2.0 0.0 0.4 3.3 0.6 0.3 0.0 0.0 0.0 8.9 0.0 1.5 1.2 0.2 0.4 0.0 0.0 4.0 0.0 0.1 92.0 0.6 0.0 1.1 1.4 0.0 0.2 0.0 0.1 1.1 0.4 0.0 0.4 1.4 OARD1 "C6orf130, dJ34B21.3, MGC19570, TARG1" ENSG00000124596 "O-acyl-ADP-ribose deacylase 1" Q9Y530 6 41033627-41097787 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 193.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 294.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029036 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA029036: AB_10602336" "unprognostic (2.33e-2)" "unprognostic (5.23e-2)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (6.50e-2)" "unprognostic (1.45e-1)" "unprognostic (3.62e-2)" "unprognostic (7.06e-2)" "unprognostic (5.54e-2)" "unprognostic (3.99e-3)" "unprognostic (3.46e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.13e-4)" "unprognostic (4.78e-1)" "unprognostic (7.85e-2)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" 20.9 25.5 26.4 20.3 30.5 26.3 30.1 28.5 32.3 19.5 26.5 28.8 31.4 17.6 38.3 23.3 30.1 19.3 22.0 26.0 28.4 44.3 59.2 17.3 28.5 29.7 28.3 35.7 40.6 34.9 22.6 20.0 30.4 25.0 31.1 43.8 25.6 22.0 25.5 21.6 30.2 15.0 28.8 23.0 39.5 58.6 28.2 39.7 30.9 37.1 33.4 20.0 20.1 35.6 44.2 25.0 55.8 40.6 32.1 37.6 36.9 28.0 36.5 29.1 31.4 39.7 33.1 61.7 29.3 15.4 32.1 33.4 38.1 33.1 41.0 53.2 18.6 73.8 28.0 75.4 29.1 50.1 47.6 28.7 45.6 28.1 102.2 26.5 20.3 77.4 95.4 48.8 32.2 59.0 88.1 55.1 51.4 294.4 17.3 36.8 52.4 54.7 58.0 21.4 60.5 38.7 25.5 25.2 88.6 43.2 41.9 42.3 21.9 32.0 39.3 20.0 43.6 65.8 72.7 140.1 25.2 48.5 27.1 49.1 21.8 42.4 26.2 23.3 34.3 45.7 30.6 26.6 26.8 43.2 37.2 36.9 20.8 45.0 28.2 26.0 37.2 22.7 26.4 30.5 28.5 32.3 26.0 28.4 29.7 28.3 30.4 28.8 28.2 35.6 30.5 16.0 40.9 7.8 49.8 28.6 40.3 51.8 38.7 63.2 47.5 41.1 43.4 52.9 40.6 60.7 45.9 89.5 44.1 28.5 86.1 42.9 164.2 43.3 19.6 34.2 22.1 56.4 2.9 48.0 60.2 23.5 37.8 29.8 48.2 21.7 35.0 69.5 45.6 42.1 3.9 52.2 50.8 53.4 37.0 153.8 28.3 33.4 35.6 3.7 42.1 75.9 59.8 4.0 13.1 34.6 44.0 25.9 29.3 37.1 63.0 112.9 56.6 70.5 26.3 23.9 26.7 193.0 148.0 43.4 29.3 45.6 47.5 34.2 61.7 32.4 ORC4 "HsORC4, ORC4L, Orc4p" ENSG00000115947 "Origin recognition complex subunit 4" O43929 2 147930396-148021604 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA replication" DNA-binding "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015124, HPA064562" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli" "CAB015124: AB_2157883, HPA064562: AB_2685287" "unprognostic (5.04e-2)" "unprognostic (6.56e-2)" "unprognostic (4.51e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (8.28e-2)" "unprognostic (6.45e-2)" "prognostic unfavorable (4.98e-8)" "unprognostic (5.55e-2)" "unprognostic (8.00e-2)" "unprognostic (1.81e-2)" "unprognostic (4.92e-2)" "unprognostic (1.19e-1)" "prognostic favorable (4.10e-6)" "unprognostic (2.49e-1)" "unprognostic (1.34e-1)" "unprognostic (1.62e-1)" "unprognostic (1.95e-3)" 9.7 11.2 11.5 10.1 13.1 19.3 14.6 21.6 16.3 9.0 8.7 12.6 12.0 12.0 11.0 10.6 14.2 9.7 11.6 12.8 10.8 20.5 12.8 9.3 10.9 9.6 7.9 16.7 8.2 16.2 7.6 10.1 10.0 12.1 13.8 19.7 13.4 10.3 15.0 9.3 11.4 11.5 7.6 8.9 9.4 15.5 10.9 15.7 15.6 10.9 11.9 10.2 6.6 14.4 22.8 19.3 37.2 20.4 14.2 13.9 39.9 25.2 21.3 31.3 31.0 47.9 22.6 29.3 26.8 15.1 27.7 22.4 43.4 25.2 32.4 20.6 36.1 40.2 19.0 32.8 18.8 25.9 14.5 11.9 29.4 34.0 13.9 23.3 21.4 27.5 38.8 14.9 21.2 23.8 20.1 20.9 42.3 18.9 28.0 21.6 24.9 26.5 34.5 46.3 35.0 27.4 22.6 24.7 30.1 33.6 18.9 12.2 15.5 23.5 23.2 17.3 23.4 14.7 37.9 27.5 19.1 20.0 14.6 24.1 13.1 18.3 13.6 17.5 13.9 14.1 12.9 13.9 16.4 14.5 13.4 13.5 18.8 19.3 14.0 8.3 15.1 11.7 11.5 13.1 21.6 16.3 12.8 10.8 9.6 7.9 10.0 7.6 10.9 14.4 21.5 83.3 62.5 53.5 26.0 26.0 21.8 47.1 27.3 48.7 20.3 24.0 25.9 11.5 66.1 12.9 39.6 40.3 27.3 21.7 45.0 31.6 34.0 47.9 17.6 23.8 22.9 46.5 88.4 17.2 48.2 27.7 14.3 26.1 45.5 28.3 19.2 17.1 23.8 53.8 91.4 18.9 28.5 18.8 20.7 15.7 22.4 19.7 21.4 34.7 22.0 33.8 24.7 69.9 71.3 18.3 15.4 21.4 12.8 24.4 23.2 55.4 85.8 37.5 32.9 23.2 31.5 61.2 26.8 22.6 24.9 32.7 25.6 16.9 21.8 20.6 OSBPL3 "KIAA0704, ORP-3, ORP3, OSBP3" ENSG00000070882 "Oxysterol binding protein like 3" Q9H4L5 7 24796540-24981634 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 123.1;Excitatory neurons: 176.1;Inhibitory neurons: 272.2;Microglial cells: 94.6;Plasma cells: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 113.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000691, HPA048401" Enhanced Supported Nucleoli,Cytosol NA Yes "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoli "HPA000691: AB_1854814, HPA048401: AB_2680386" "unprognostic (3.57e-1)" "unprognostic (1.14e-1)" "unprognostic (6.11e-3)" "unprognostic (3.89e-2)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (1.57e-3)" "unprognostic (4.51e-2)" "unprognostic (2.26e-1)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (2.34e-1)" "unprognostic (7.95e-3)" "unprognostic (3.38e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-2)" "unprognostic (2.06e-2)" 2.6 1.2 3.6 6.8 4.2 4.1 3.9 2.8 5.9 10.2 3.8 5.9 9.3 2.2 0.8 7.6 5.1 5.0 2.6 3.9 4.4 16.0 1.2 8.6 11.3 3.8 3.7 5.2 1.9 14.1 2.0 3.9 3.5 2.2 6.0 1.3 3.7 2.5 3.3 10.3 7.6 3.7 3.1 6.8 8.5 2.8 4.5 8.3 9.8 2.0 14.4 13.3 6.5 5.1 40.2 10.7 7.8 14.4 17.3 34.5 17.5 44.5 49.3 20.4 32.1 27.0 52.0 22.2 6.2 47.8 26.9 34.6 23.6 33.4 31.4 13.5 9.8 5.3 16.4 20.4 24.5 15.3 113.8 17.0 27.2 26.7 31.8 26.0 31.0 19.0 28.4 30.1 34.9 0.0 9.4 18.7 15.3 38.1 13.7 7.5 21.6 9.1 20.4 28.2 1.6 16.1 30.3 21.5 6.7 23.0 11.1 1.5 37.1 9.1 17.9 49.4 33.7 20.7 32.8 55.6 19.5 24.7 102.0 5.8 1.9 1.5 8.5 1.7 7.3 3.3 5.3 5.6 3.3 1.6 1.8 3.5 0.4 7.7 1.2 2.3 9.5 2.5 3.6 4.2 2.8 5.9 3.9 4.4 3.8 3.7 3.5 3.1 4.5 5.1 2.2 0.0 26.1 123.1 18.3 12.1 8.0 8.8 21.6 0.3 3.8 4.4 5.5 5.7 22.2 25.8 0.0 8.4 13.2 3.8 3.9 3.5 0.3 24.6 2.3 3.6 1.8 11.1 176.1 3.9 2.1 3.1 19.4 31.9 0.0 0.4 3.6 0.5 10.8 0.0 272.2 1.7 20.3 12.7 9.3 0.3 0.6 13.2 16.0 94.6 7.8 4.8 14.4 44.2 3.6 24.4 4.5 0.0 91.7 5.2 3.3 0.5 53.1 0.2 0.0 3.4 4.6 0.5 5.0 16.5 8.0 4.0 18.5 20.3 4.5 16.5 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 135.2;Excitatory neurons: 303.6;Inhibitory neurons: 219.7;Oligodendrocyte precursor cells: 100.0;Oligodendrocytes: 506.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;HAP1: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Approved Nucleoli,Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 1.2 0.5 6.6 0.4 9.5 0.0 1.0 7.6 8.6 1.3 0.0 1.4 0.3 1.3 0.5 0.7 1.1 0.3 1.3 6.9 5.9 0.9 0.4 0.8 0.4 8.5 6.9 0.9 1.4 1.2 1.5 0.0 8.2 0.6 0.4 1.6 0.7 0.4 1.1 2.6 0.9 0.6 5.6 0.6 0.8 4.1 8.3 0.3 1.0 0.2 0.4 0.8 0.8 20.5 0.0 0.0 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 0.8 0.0 0.2 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.0 0.1 3.6 1.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 9.5 7.6 8.6 6.9 5.9 8.5 6.9 8.2 5.6 8.3 20.5 3.5 3.2 0.0 135.2 0.1 0.4 0.7 0.0 1.8 25.7 1.1 1.3 3.2 0.0 0.6 1.8 2.1 0.0 4.3 1.3 0.0 0.5 1.4 0.4 1.2 1.3 3.6 0.0 303.6 1.0 0.1 1.8 0.5 0.4 0.0 1.0 1.4 0.8 0.2 25.2 219.7 1.7 0.0 0.0 0.3 2.0 0.9 0.3 1.8 28.1 0.2 3.9 13.4 100.0 506.1 0.3 0.7 2.6 2.6 1.9 0.4 1.7 0.0 3.1 0.0 4.1 1.5 4.6 8.3 1.8 0.4 0.1 3.1 0.9 1.5 1.0 OTULINL "FAM105A, FLJ11127, NET20" ENSG00000145569 "OTU deubiquitinase with linear linkage specificity like" Q9NUU6 5 14581792-14616180 "Enzymes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.3" "Cell type enhanced" "Detected in some" "Collecting duct cells: 29.5;dendritic cells: 36.7;Endometrial stromal cells: 16.6;Hofbauer cells: 100.7;Macrophages: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.7;HMC-1: 55.6;OE19: 16.1;THP-1: 16.9;U-937: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046638 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoli, Cytosol" "HPA046638: AB_2679731" "unprognostic (1.47e-1)" "unprognostic (6.64e-3)" "unprognostic (1.92e-2)" "unprognostic (1.15e-3)" "unprognostic (6.26e-2)" "unprognostic (1.13e-3)" "unprognostic (2.33e-2)" "unprognostic (2.27e-2)" "unprognostic (6.44e-2)" "unprognostic (2.42e-1)" "prognostic favorable (1.02e-4)" "unprognostic (2.13e-1)" "unprognostic (1.33e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.14e-1)" "unprognostic (8.79e-3)" 3.1 2.7 1.2 6.8 1.1 30.3 4.1 1.3 1.6 3.8 4.8 12.3 6.6 1.5 1.4 1.7 1.4 2.7 0.9 1.1 1.8 3.6 1.4 13.1 5.4 2.3 1.5 2.0 7.6 1.2 2.5 4.2 2.1 8.3 13.3 0.5 1.4 10.0 0.4 1.7 9.4 2.5 2.4 7.9 3.3 2.5 1.9 3.4 2.8 0.8 3.6 5.2 3.1 3.6 0.0 0.8 1.6 0.0 0.3 0.0 6.9 2.0 1.8 0.5 1.0 2.8 1.7 0.1 1.1 0.9 2.8 0.1 3.7 1.6 0.7 1.1 4.9 4.6 17.7 0.4 1.7 0.1 55.6 0.1 0.3 0.2 0.0 0.0 0.1 2.9 0.0 7.1 0.2 1.4 0.0 1.7 2.5 16.1 11.9 0.5 0.7 2.0 0.0 13.9 6.0 7.0 0.9 0.6 0.0 1.7 0.6 16.9 0.0 0.9 4.4 0.4 1.6 0.0 0.0 0.1 1.0 27.2 0.4 0.2 33.4 0.3 5.5 16.2 7.3 0.1 6.7 7.2 33.8 0.1 9.0 9.1 8.6 19.2 12.7 25.0 12.8 24.6 1.2 1.1 1.3 1.6 1.1 1.8 2.3 1.5 2.1 2.4 1.9 3.6 10.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 7.4 7.9 0.0 0.0 0.0 29.5 0.0 0.9 36.7 0.0 1.9 0.4 0.0 0.9 16.6 1.1 0.0 0.0 0.0 6.2 2.2 1.4 0.0 1.2 0.0 0.5 0.0 0.0 100.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.3 0.0 0.0 12.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.4 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.4 8.8 0.2 0.0 0.0 P2RX6 "MGC129625, P2RXL1, P2X6, P2XM" ENSG00000099957 "Purinergic receptor P2X 6" O15547 22 21009808-21028830 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 3.4;skeletal muscle: 12.4;tongue: 7.7" "Cell type enhanced" "Detected in some" "Bipolar cells: 7.6;Excitatory neurons: 8.9;Inhibitory neurons: 7.9;Ionocytes: 8.2;Skeletal myocytes: 20.8" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 9.7;LHCN-M2: 6.7;RH-30: 4.2;U-87 MG: 11.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028776, HPA028777" Approved Approved Nucleoli,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 50: Fibroblasts - ECM organization" "Nucleoli, Cytosol" "HPA028776: AB_2672771, HPA028777: AB_2672772" "unprognostic (1.81e-2)" "unprognostic (5.15e-3)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.28e-2)" "unprognostic (1.79e-5)" "unprognostic (1.70e-2)" "unprognostic (6.20e-2)" "unprognostic (1.49e-1)" "unprognostic (2.59e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-2)" "unprognostic (2.88e-10)" "unprognostic (2.81e-1)" "unprognostic (1.38e-1)" "unprognostic (7.33e-2)" "unprognostic (2.39e-3)" 0.3 1.1 0.0 0.3 0.2 0.0 0.1 1.0 2.6 0.1 0.4 0.1 0.0 0.2 0.0 0.2 0.3 0.8 1.3 1.0 1.5 0.2 0.1 0.3 0.2 3.4 0.4 0.3 0.1 0.0 1.3 0.8 3.4 0.3 0.0 0.3 0.2 0.7 12.4 0.1 0.1 0.1 0.1 1.6 0.2 1.1 0.6 0.0 0.0 7.7 0.0 0.2 0.1 1.2 0.0 0.4 0.7 0.2 0.1 0.0 0.8 0.1 1.7 0.7 1.2 0.0 0.0 0.0 1.1 0.4 2.9 1.3 0.0 0.1 0.1 0.2 0.0 1.9 0.9 0.0 2.8 0.0 2.4 0.3 0.0 1.2 0.0 9.7 0.0 0.0 2.1 0.6 6.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.2 3.1 1.2 0.1 0.5 0.1 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.2 0.0 0.0 11.7 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 2.6 1.0 1.5 3.4 0.4 3.4 0.1 0.6 1.2 0.2 0.0 0.6 0.3 0.1 0.1 0.8 0.8 0.6 7.6 0.0 0.4 2.4 0.0 0.2 1.8 0.0 0.5 0.0 0.1 0.0 0.0 2.2 1.8 0.5 0.2 3.5 2.7 8.9 0.0 0.4 1.4 0.0 0.7 2.5 0.1 1.8 0.1 0.1 1.7 7.9 0.7 8.2 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 1.1 0.0 5.0 3.3 0.0 0.0 0.4 0.1 0.2 0.0 0.3 3.2 1.1 0.0 20.8 0.4 1.6 0.4 0.3 0.1 0.4 0.5 0.1 0.1 0.2 P3H1 "GROS1, LEPRE1, LEPRECAN, MGC117314" ENSG00000117385 "Prolyl 3-hydroxylase 1" Q32P28 1 42746335-42767084 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Extravillous trophoblasts: 56.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 193.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012113, HPA016980" Approved Approved Nucleoli,Vesicles "Intracellular and membrane" NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" Vesicles Nucleoli "HPA012113: AB_2668626, HPA016980: AB_2669498" "unprognostic (3.24e-1)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (4.57e-1)" "unprognostic (2.03e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.95e-7)" "unprognostic (5.41e-2)" "unprognostic (2.70e-3)" "unprognostic (9.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.41e-2)" "unprognostic (1.23e-1)" "unprognostic (2.67e-2)" "unprognostic (1.60e-3)" 12.4 11.1 3.6 8.7 3.5 6.1 10.2 3.6 4.4 13.4 7.3 8.3 2.4 13.8 6.1 4.4 9.8 12.0 9.1 3.8 3.8 7.2 13.3 11.6 5.1 5.2 3.5 12.8 6.8 5.9 15.5 37.4 3.8 7.5 5.4 1.3 6.7 5.9 3.0 7.6 7.4 20.3 3.4 11.5 6.7 15.2 3.8 7.6 7.6 3.9 5.1 12.3 8.5 3.6 8.7 22.3 48.7 115.0 112.8 85.4 20.1 101.8 131.9 71.9 121.7 11.3 18.8 13.0 79.7 193.0 29.2 7.8 20.9 25.9 49.2 19.5 26.3 30.5 32.2 32.6 65.2 30.9 34.0 73.8 17.4 72.6 30.9 102.4 102.9 18.3 17.5 16.1 49.0 4.7 20.6 17.8 53.1 4.7 16.0 19.9 71.9 17.7 38.2 4.9 10.2 17.3 62.5 1.7 45.8 85.2 3.7 127.0 85.1 53.8 47.2 43.4 41.2 14.5 17.5 11.9 61.5 41.5 77.0 5.0 18.9 16.8 8.3 20.4 8.8 4.1 6.3 7.0 23.6 3.3 5.1 5.3 1.8 17.8 26.3 10.9 12.4 9.3 3.6 3.5 3.6 4.4 3.8 3.8 5.2 3.5 3.8 3.4 3.8 3.6 13.7 3.2 2.3 5.9 10.5 0.0 6.4 0.0 6.2 10.2 4.5 6.5 5.0 7.2 0.6 11.0 25.0 47.9 11.1 0.4 0.0 11.5 17.1 3.2 30.1 16.4 6.1 11.3 12.9 7.6 56.6 34.4 3.6 4.4 1.3 28.8 16.8 11.3 17.6 15.2 10.8 2.5 0.0 8.7 0.0 10.8 19.3 11.7 0.0 9.4 10.5 3.5 6.2 9.5 6.9 7.4 2.0 16.1 11.2 3.4 1.7 1.9 0.7 22.1 0.0 17.2 22.3 30.6 18.8 3.5 0.0 17.5 9.6 27.0 1.9 4.5 PARP1 "ADPRT, ARTD1, PARP, PPOL" ENSG00000143799 "Poly(ADP-ribose) polymerase 1" P09874 1 226360210-226408154 "Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "DNA-binding, Glycosyltransferase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 469.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727" Supported Supported Enhanced Nucleoplasm,Nucleoli NA NA 150000 "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Nucleoli "CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240" "unprognostic (2.02e-1)" "unprognostic (9.40e-2)" "unprognostic (7.44e-3)" "unprognostic (1.32e-1)" "unprognostic (4.29e-1)" "unprognostic (9.22e-2)" "prognostic unfavorable (3.40e-4)" "unprognostic (2.20e-1)" "unprognostic (3.62e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (1.35e-5)" "unprognostic (2.38e-2)" "unprognostic (1.82e-1)" "unprognostic (3.14e-2)" "unprognostic (2.64e-1)" 32.0 26.4 33.9 63.9 41.9 29.4 29.5 46.2 33.2 26.2 20.6 43.5 29.3 30.2 19.8 31.3 28.9 20.4 55.1 30.3 36.2 22.4 37.1 27.4 125.5 48.4 39.7 27.5 50.8 94.7 38.0 58.2 47.7 40.7 37.2 44.9 28.9 46.4 94.5 21.1 36.8 45.6 41.9 57.7 29.6 40.5 40.9 64.6 28.4 70.2 150.8 38.7 24.6 58.1 182.4 108.9 295.4 209.3 75.9 61.3 137.1 101.3 119.1 178.2 144.9 175.4 98.1 559.3 147.2 80.9 77.9 135.1 411.6 132.4 144.4 204.1 396.6 216.2 135.9 114.5 44.6 372.2 93.3 61.7 50.5 144.2 101.3 49.3 140.5 132.2 346.9 291.8 94.1 99.6 114.7 110.0 476.2 290.5 165.1 334.2 484.5 533.4 76.4 144.5 264.0 229.2 165.2 190.3 100.1 205.3 159.6 225.8 99.3 93.3 140.9 120.6 235.1 110.9 151.8 472.6 78.2 125.7 214.3 11.1 11.7 12.3 31.2 20.5 45.3 72.2 37.3 36.7 28.2 69.9 28.2 32.5 2.2 22.0 42.3 16.2 49.3 25.7 33.9 41.9 46.2 33.2 30.3 36.2 48.4 39.7 47.7 41.9 40.9 58.1 33.4 54.5 73.6 13.7 169.1 72.3 83.9 56.4 51.2 96.1 58.8 43.3 115.0 44.3 69.8 57.0 141.8 469.2 53.8 27.7 72.4 88.9 34.1 53.3 66.5 62.0 75.0 100.5 16.5 107.0 111.7 49.8 37.8 55.2 122.1 116.2 34.2 69.4 139.6 90.9 17.5 50.0 57.0 47.8 35.7 20.5 40.0 48.3 62.2 16.9 76.9 80.1 95.8 10.1 31.9 48.5 24.2 35.0 186.9 82.8 25.6 48.5 56.4 118.1 46.0 58.7 48.0 88.8 199.6 77.2 48.2 137.6 85.0 103.5 61.9 41.7 PARP2 "ADPRTL2, ARTD2" ENSG00000129484 "Poly(ADP-ribose) polymerase 2" Q9UGN5 14 20343615-20357904 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052003 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA052003: AB_2681689" "unprognostic (3.93e-1)" "unprognostic (7.92e-2)" "unprognostic (4.12e-1)" "unprognostic (1.24e-1)" "unprognostic (3.40e-2)" "unprognostic (7.30e-2)" "prognostic unfavorable (6.48e-4)" "unprognostic (1.97e-2)" "unprognostic (4.43e-2)" "unprognostic (9.35e-3)" "unprognostic (1.44e-2)" "unprognostic (1.42e-2)" "unprognostic (3.37e-3)" "unprognostic (2.83e-1)" "unprognostic (9.19e-2)" "unprognostic (1.91e-1)" "unprognostic (2.89e-2)" 17.7 21.1 21.1 10.7 22.0 26.8 17.5 21.4 31.4 18.1 16.4 19.3 12.8 20.9 17.8 14.6 17.5 10.0 17.1 22.5 21.0 15.5 17.2 13.5 14.5 19.5 18.9 22.9 17.9 11.1 21.0 12.9 19.8 13.9 14.0 26.4 14.2 13.4 32.4 19.2 14.2 15.8 19.0 16.5 16.3 23.8 19.8 11.9 16.7 27.1 17.9 13.8 15.3 22.1 55.5 39.5 59.7 45.3 19.4 18.4 43.4 60.2 32.5 74.8 91.8 36.8 51.3 40.4 26.5 19.0 64.8 50.1 78.3 27.5 87.8 32.4 38.3 37.2 46.6 63.3 17.3 77.9 20.4 12.5 23.0 45.5 51.1 20.5 38.5 48.0 39.2 53.4 52.3 33.5 40.1 33.0 33.0 62.8 60.0 49.7 79.7 26.5 30.0 28.2 41.3 28.3 65.3 36.8 17.9 37.4 34.2 25.8 26.6 45.3 68.1 31.5 48.1 49.3 67.7 53.4 19.0 33.3 51.4 1.9 5.0 0.5 8.9 4.8 11.7 6.8 8.4 7.9 5.5 4.1 9.0 8.6 0.1 7.6 2.6 5.6 5.3 4.8 21.1 22.0 21.4 31.4 22.5 21.0 19.5 18.9 19.8 19.0 19.8 22.1 12.1 25.6 6.5 7.2 9.5 6.5 10.5 16.1 18.8 29.2 7.4 10.0 14.0 5.7 19.9 7.3 12.5 25.8 10.2 4.5 7.9 12.8 9.3 9.9 13.3 11.0 4.8 30.3 17.6 8.7 22.2 11.6 7.7 11.3 8.2 18.4 6.8 10.1 11.9 30.3 15.5 5.0 14.2 4.6 5.1 9.8 11.5 6.6 8.8 9.4 4.2 20.7 6.2 6.0 9.3 10.1 4.5 17.0 19.1 4.5 5.3 7.4 28.0 23.2 6.6 9.8 18.5 20.9 41.5 11.3 4.8 14.9 6.2 16.7 7.4 7.0 PAX9 ENSG00000198807 "Paired box 9" P55771 14 36657568-36679362 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "esophagus: 81.0;lymphoid tissue: 20.5;parathyroid gland: 43.0;salivary gland: 51.8" "Cell type enhanced" "Detected in some" "Basal respiratory cells: 45.3;Basal squamous epithelial cells: 174.8;Ionocytes: 40.7;Squamous epithelial cells: 172.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 12.3;HDLM-2: 58.3;PC-3: 18.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA001572, CAB016239" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 44: HDLM-2 - Immune response" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoli Nucleoplasm "CAB016239: AB_2159984, HPA001572: " "unprognostic (3.09e-1)" "prognostic favorable (5.38e-4)" "unprognostic (1.56e-2)" "unprognostic (2.80e-2)" "unprognostic (1.40e-2)" "unprognostic (1.43e-2)" "unprognostic (5.93e-3)" "unprognostic (2.71e-3)" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (2.41e-2)" "unprognostic (9.44e-2)" "unprognostic (2.31e-4)" "unprognostic (1.43e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-1)" 0.1 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 7.3 0.1 0.7 0.0 0.2 0.3 81.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.1 43.0 2.2 0.0 0.0 3.7 0.1 0.0 51.8 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 20.5 0.7 0.0 8.5 0.7 7.1 0.0 5.3 2.3 0.0 2.5 2.1 3.8 2.0 0.0 0.3 0.0 0.0 1.6 1.8 1.6 0.8 0.0 0.5 11.4 2.1 12.3 0.0 58.3 7.3 0.9 1.2 0.0 0.0 0.0 4.2 0.7 6.0 0.0 1.9 0.0 0.0 5.3 2.3 0.3 0.2 7.3 0.9 0.0 0.1 1.9 18.9 0.0 0.0 0.0 0.0 6.9 3.4 0.0 1.3 7.0 1.4 0.9 5.1 0.0 0.0 0.0 0.6 2.2 1.0 0.0 0.1 4.4 0.7 0.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.4 45.3 174.8 0.0 1.6 1.3 0.4 0.0 25.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 0.0 0.6 0.0 0.4 0.0 0.2 0.2 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 40.7 0.0 0.3 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 20.9 0.0 0.0 26.8 0.0 0.0 0.1 2.0 2.4 0.9 172.0 0.3 0.1 0.1 0.0 0.6 12.1 PCID2 FLJ11305 ENSG00000126226 "PCI domain containing 2" Q5JVF3 13 113177536-113208715 "Predicted intracellular proteins" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069107, HPA073074" Uncertain Approved Nucleoplasm,Nucleoli NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA069107: AB_2686088, HPA073074: AB_2686568" "unprognostic (2.53e-2)" "unprognostic (2.94e-2)" "unprognostic (4.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (1.73e-3)" "unprognostic (1.50e-1)" "unprognostic (1.89e-1)" "unprognostic (1.47e-1)" "unprognostic (3.02e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (4.24e-6)" "unprognostic (1.41e-2)" "unprognostic (5.41e-3)" "unprognostic (1.45e-1)" "unprognostic (6.28e-2)" 22.2 29.0 16.6 15.8 17.4 15.5 22.9 19.0 18.8 27.0 18.3 25.2 12.1 23.0 23.0 19.3 25.9 17.1 37.7 16.8 17.3 20.1 23.8 18.6 25.8 16.4 16.6 33.7 23.9 19.1 22.6 15.5 16.4 24.7 18.5 10.7 23.8 19.2 29.1 18.9 20.2 21.8 16.5 24.7 24.4 45.3 17.6 24.4 20.8 24.4 23.0 23.9 22.4 18.8 62.9 26.3 39.1 34.7 70.2 52.3 27.4 47.2 70.7 64.4 59.1 51.9 57.7 50.2 30.7 64.5 81.6 38.8 62.9 42.8 71.2 44.3 62.1 64.8 68.1 45.9 70.0 110.4 25.5 43.3 46.6 40.4 71.1 51.4 51.3 68.5 50.4 19.9 73.6 30.3 59.4 77.9 38.9 115.1 33.2 53.4 43.4 48.0 58.8 31.3 52.0 31.9 29.5 72.2 55.9 39.3 39.9 133.4 33.5 19.0 68.7 27.9 36.2 30.4 30.4 70.4 65.3 74.1 44.2 28.2 25.5 20.0 68.9 34.4 81.6 39.7 58.0 72.5 26.0 39.5 52.2 54.6 3.9 22.6 33.2 24.8 64.7 54.7 16.6 17.4 19.0 18.8 16.8 17.3 16.4 16.6 16.4 16.5 17.6 18.8 26.5 19.2 16.7 16.3 28.4 21.5 29.1 37.8 17.6 23.6 25.5 32.3 27.8 21.5 23.7 14.7 16.7 30.2 38.5 7.8 27.4 22.8 52.8 26.8 35.7 26.2 7.8 32.8 43.6 13.8 24.7 33.8 18.8 21.7 10.8 39.0 18.9 18.4 20.2 37.0 33.7 15.6 16.2 18.2 14.0 18.1 41.3 17.2 16.0 26.2 24.0 19.0 38.1 25.1 40.4 18.1 15.8 40.6 16.8 46.3 13.6 23.6 30.4 23.8 19.7 37.4 30.9 204.4 72.7 17.6 24.7 31.1 43.7 33.0 20.1 25.3 PCTP STARD2 ENSG00000141179 "Phosphatidylcholine transfer protein" Q9UKL6 17 55751051-55842830 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 98.0" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 68.5;Hepatocytes: 72.8;Syncytiotrophoblasts: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 241.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 94.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA022979 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli" "HPA022979: AB_2671018" "unprognostic (1.14e-1)" "unprognostic (5.20e-2)" "unprognostic (4.27e-2)" "unprognostic (7.35e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (3.43e-6)" "unprognostic (9.35e-3)" "unprognostic (2.69e-1)" "unprognostic (2.07e-1)" "unprognostic (8.65e-2)" "unprognostic (6.63e-3)" "unprognostic (1.16e-1)" "unprognostic (5.36e-3)" "unprognostic (1.26e-1)" "unprognostic (4.93e-1)" "unprognostic (6.89e-3)" "unprognostic (3.04e-1)" 15.3 8.5 8.0 10.4 8.0 11.4 12.4 8.1 8.9 10.7 8.3 23.1 18.1 7.4 28.3 10.7 9.0 9.7 19.0 7.7 9.2 29.7 98.0 18.8 9.9 8.7 9.5 8.3 11.8 13.4 7.9 28.7 8.7 9.6 23.8 4.2 10.8 23.1 18.9 6.4 16.5 10.7 8.1 15.5 19.0 13.3 9.9 5.9 8.5 19.3 8.9 13.4 7.9 8.0 21.2 19.3 13.9 5.1 18.4 17.7 36.6 8.1 10.3 12.5 12.1 22.0 26.7 5.9 61.0 12.7 11.8 11.5 8.2 13.7 11.2 94.8 19.5 51.9 5.7 40.2 16.3 20.0 39.5 14.7 17.3 7.6 13.5 15.2 24.8 17.7 38.4 20.2 13.7 18.7 16.0 16.1 15.4 0.0 16.9 8.1 20.5 4.9 13.4 15.6 7.1 16.1 4.2 8.7 34.6 30.4 23.6 33.8 18.2 14.7 10.4 16.2 10.9 57.9 19.4 3.6 13.2 32.7 25.5 77.3 60.9 241.1 9.4 52.6 5.6 8.6 6.1 9.7 49.0 5.3 3.6 8.2 63.3 27.5 58.9 3.9 11.8 29.3 8.0 8.0 8.1 8.9 7.7 9.2 8.7 9.5 8.7 8.1 9.9 8.0 13.1 3.2 8.1 25.5 4.2 1.0 2.4 6.6 2.8 4.0 5.4 4.8 15.7 15.7 3.2 9.2 2.1 51.6 5.2 17.8 11.7 13.0 18.3 6.4 6.0 10.3 13.1 12.2 16.5 13.7 68.5 8.2 7.7 6.3 15.2 7.1 10.4 72.8 22.1 1.7 26.4 17.1 8.2 25.2 5.1 20.0 16.4 20.1 12.4 9.4 15.1 4.0 11.3 19.6 4.2 9.5 10.1 25.9 5.3 1.7 13.9 40.6 3.8 2.3 13.1 4.3 8.9 17.9 7.7 6.6 1.4 67.2 5.6 8.2 16.2 2.6 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133808 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 176.1;Cone photoreceptor cells: 221.0;Rod photoreceptor cells: 176.3;Spermatocytes: 164.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 12.0 12.4 13.8 11.9 14.3 10.0 11.9 18.0 18.2 16.2 12.2 15.8 9.9 16.5 12.7 17.8 13.6 8.4 11.4 14.2 13.3 10.3 12.5 10.2 14.5 14.2 13.5 16.8 11.2 11.6 10.9 11.9 14.6 13.0 9.3 10.8 10.0 11.9 13.1 11.1 11.3 13.3 12.0 13.4 11.0 18.9 14.2 15.7 12.5 8.7 15.1 14.8 14.0 16.7 18.2 14.9 24.8 25.7 24.4 34.2 15.0 20.4 22.6 24.7 18.8 18.2 19.7 34.9 21.7 16.5 18.5 33.5 63.9 14.7 17.7 21.3 17.0 33.9 12.8 15.9 22.5 46.6 21.8 20.0 22.0 13.6 25.4 23.7 19.8 25.6 44.0 27.6 21.7 13.9 48.7 33.2 30.1 21.1 13.3 42.7 31.8 39.0 15.2 28.5 20.4 24.3 22.8 19.1 31.3 27.0 15.4 37.7 20.0 25.2 24.6 14.8 31.9 49.1 60.4 24.9 22.7 50.5 13.2 2.1 1.4 0.9 2.0 1.2 1.7 2.3 1.9 1.8 1.3 2.4 2.0 1.9 0.3 3.3 1.2 1.8 1.5 0.7 13.8 14.3 18.0 18.2 14.2 13.3 14.2 13.5 14.6 12.0 14.2 16.7 33.6 0.0 14.3 10.1 46.3 38.0 67.8 6.0 89.4 176.1 33.1 40.9 17.7 21.5 11.1 29.5 221.0 55.3 55.8 17.2 29.4 9.0 5.9 26.8 51.8 36.5 14.4 27.5 31.0 8.2 32.6 38.4 20.4 28.2 19.7 49.0 31.1 19.4 23.6 75.7 32.9 26.9 6.1 23.2 22.8 8.9 58.1 24.7 12.4 9.4 14.5 47.2 45.3 15.1 28.9 7.3 11.6 48.2 37.9 56.8 14.2 22.7 8.5 176.3 46.0 45.5 38.8 164.6 107.3 48.8 39.9 71.4 49.5 60.3 26.1 51.5 PDK3 ENSG00000067992 "Pyruvate dehydrogenase kinase 3" Q15120 X 24465270-24550466 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 71.6;Excitatory neurons: 92.8;Inhibitory neurons: 78.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046583, HPA072492" Approved Supported Nucleoli,Mitochondria NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 6: T47d - Mammary gland" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria Nucleoli "HPA046583: AB_2679707, HPA072492: AB_2686526" "unprognostic (5.41e-3)" "unprognostic (5.43e-3)" "unprognostic (5.35e-3)" "unprognostic (3.40e-1)" "unprognostic (4.05e-3)" "unprognostic (5.38e-2)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.51e-1)" "unprognostic (5.57e-2)" "unprognostic (1.35e-1)" "unprognostic (1.39e-2)" "unprognostic (2.02e-1)" "unprognostic (1.72e-1)" "unprognostic (1.02e-1)" "unprognostic (2.92e-1)" "unprognostic (2.28e-2)" "unprognostic (9.43e-3)" 4.4 2.0 4.4 5.6 6.2 8.9 8.8 1.4 7.5 3.5 2.5 6.1 8.2 2.8 10.9 3.9 5.9 3.2 7.4 13.2 4.7 8.8 4.7 5.0 7.9 2.6 4.2 4.8 2.9 6.7 5.8 4.1 2.4 4.6 5.3 6.0 11.1 2.9 1.4 6.8 8.3 4.5 0.9 7.7 6.9 11.6 9.1 6.3 2.3 1.8 8.0 4.2 4.1 4.2 11.5 5.2 4.2 8.0 0.2 0.0 5.0 3.4 2.4 4.1 6.9 0.5 13.9 10.4 2.3 0.8 11.6 2.1 12.3 8.4 10.4 9.7 6.0 5.3 6.1 3.3 1.4 4.6 5.8 0.9 3.6 1.1 1.2 0.5 6.8 10.9 0.9 16.5 0.5 20.9 9.4 6.0 8.1 12.2 5.6 5.0 8.0 17.3 4.1 21.4 2.6 4.0 17.9 8.0 5.5 7.3 9.6 1.9 0.1 3.3 3.6 5.8 4.2 11.0 8.9 12.9 8.7 7.7 6.4 13.3 15.4 37.9 11.8 19.6 16.5 7.5 9.1 10.3 12.2 7.3 7.6 8.6 57.6 13.3 18.8 3.5 8.3 12.4 4.4 6.2 1.4 7.5 13.2 4.7 2.6 4.2 2.4 0.9 9.1 4.2 3.9 3.2 2.0 19.6 15.2 4.6 9.5 13.5 30.1 3.5 11.1 8.1 6.6 1.5 5.2 1.8 0.0 5.5 16.6 4.2 3.9 4.3 71.6 2.1 2.9 3.8 4.2 14.3 92.8 5.1 32.1 4.9 5.6 2.8 5.7 4.9 5.3 5.3 15.0 8.4 78.0 2.9 10.2 19.8 7.4 35.9 3.7 17.4 16.0 35.6 10.3 3.7 25.7 19.6 14.0 2.1 0.3 5.7 19.0 5.9 13.3 14.2 2.4 3.5 0.0 2.0 10.6 10.2 8.3 6.8 4.4 17.8 18.2 9.7 4.1 8.4 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" P16284 17 64319415-64413776 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 455.1" "Cell type enhanced" "Detected in many" "Adipocytes: 672.9;Endothelial cells: 468.2;Hepatic stellate cells: 275.3;Macrophages: 143.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 702.3" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 5 "HUVEC TERT2: 773.0;TIME: 537.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004690, HPA004871" Enhanced Approved "Nucleoli,Plasma membrane" NA NA 110000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" Nucleoli "HPA004690: AB_1078462, HPA004871: " "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 195.6 21.4 20.3 78.9 21.4 35.5 128.5 21.9 25.3 54.9 21.7 37.9 29.7 51.1 9.2 54.3 45.1 88.6 70.3 18.0 22.2 43.6 22.4 204.9 68.0 24.7 23.1 10.7 21.3 29.9 9.7 455.1 24.1 23.5 37.7 4.0 33.4 24.5 35.7 36.2 39.4 83.5 26.3 94.9 30.9 5.0 28.1 62.4 69.8 97.0 60.4 84.0 35.7 22.2 0.1 0.3 1.3 0.1 1.1 1.5 0.4 0.2 0.3 0.0 0.1 4.7 0.1 4.2 121.1 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 95.0 1.8 2.2 3.7 0.5 0.3 0.3 0.0 0.8 0.2 1.6 773.0 34.1 2.3 57.8 0.1 0.4 33.3 8.1 0.1 0.0 9.1 1.4 15.3 3.8 0.0 0.1 0.4 0.3 1.8 0.0 0.1 0.2 0.0 48.5 537.8 0.8 0.5 0.9 0.2 3.4 6.3 6.8 1.6 6.7 0.1 54.8 263.9 219.2 19.8 419.6 18.9 26.7 2.2 46.6 154.0 32.7 36.3 68.6 392.0 40.3 702.3 88.6 2.1 224.2 20.3 21.4 21.9 25.3 18.0 22.2 24.7 23.1 24.1 26.3 28.1 22.2 672.9 16.0 37.9 0.7 24.4 0.0 0.5 0.0 4.0 0.0 4.8 4.6 23.3 1.5 3.1 9.2 0.0 0.5 50.1 0.0 0.0 0.8 0.9 1.1 1.1 468.2 0.0 17.9 1.2 0.2 4.0 22.0 0.0 1.6 8.8 0.0 275.3 3.0 45.8 0.0 1.2 0.0 0.0 110.4 0.0 1.1 2.5 143.9 0.0 47.8 93.8 0.3 26.8 0.5 1.3 0.1 0.0 1.9 109.1 1.3 0.0 0.5 7.3 1.2 0.0 6.9 15.8 0.1 0.5 1.6 0.0 0.8 21.2 4.3 0.1 1.0 PELP1 MNAR ENSG00000141456 "Proline, glutamate and leucine rich protein 1" Q8IZL8 17 4669774-4704337 "Predicted intracellular proteins" Transcription "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053966, HPA056028, HPA060760" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 3: Monocytes - Immune response regulation" "Nucleoplasm, Nucleoli" "HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355" "unprognostic (8.81e-2)" "unprognostic (1.22e-2)" "unprognostic (2.81e-3)" "unprognostic (2.24e-1)" "unprognostic (1.39e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (6.44e-4)" "unprognostic (2.72e-1)" "unprognostic (2.76e-1)" "unprognostic (4.31e-2)" "prognostic favorable (4.07e-5)" "unprognostic (2.20e-2)" "unprognostic (4.05e-2)" "unprognostic (1.31e-2)" "unprognostic (3.31e-1)" "unprognostic (8.32e-2)" "unprognostic (5.15e-2)" 14.2 17.8 34.9 13.4 34.1 10.9 14.9 29.9 33.1 19.9 21.2 18.3 11.8 21.5 6.2 19.5 19.8 8.8 23.1 33.4 30.7 16.8 17.7 13.1 16.3 34.2 33.3 21.9 17.5 15.5 23.5 11.4 33.8 20.5 7.5 8.7 15.3 12.2 46.8 18.7 17.4 10.8 31.8 20.5 17.5 32.8 33.6 12.5 17.2 18.1 12.0 19.5 17.0 33.9 41.8 89.8 34.8 55.3 26.5 19.5 77.9 29.6 20.5 40.1 42.7 88.1 30.0 100.0 44.4 23.4 28.5 62.6 65.1 46.3 22.6 52.1 93.2 44.6 45.1 72.0 34.2 36.4 57.5 23.9 28.2 49.5 41.3 20.7 30.2 52.9 54.7 42.6 22.4 57.2 68.9 42.7 57.3 40.2 29.7 71.7 30.8 49.3 28.2 31.2 34.8 46.5 50.8 36.9 39.4 33.1 44.6 24.3 30.7 30.9 43.5 47.3 57.9 22.7 42.5 41.6 34.9 37.1 40.6 0.2 0.7 2.0 0.9 1.0 0.9 0.8 0.9 0.7 0.8 1.3 0.9 1.3 0.2 1.3 1.2 1.1 0.6 0.7 34.9 34.1 29.9 33.1 33.4 30.7 34.2 33.3 33.8 31.8 33.6 33.9 10.4 22.4 30.1 11.1 18.5 14.8 14.8 15.7 21.1 24.0 13.5 12.4 22.6 8.6 20.9 9.2 16.7 30.9 15.3 11.8 1.9 15.9 64.7 16.6 17.3 13.7 12.6 14.1 10.6 14.6 28.3 16.6 16.8 17.6 30.9 21.1 5.0 10.6 16.9 35.3 13.0 18.6 12.2 6.0 20.4 27.0 9.3 10.4 10.6 5.6 65.1 10.7 5.2 5.0 11.5 11.4 11.7 19.2 23.6 19.3 8.3 4.7 22.3 17.8 6.6 16.8 14.8 31.3 67.5 20.0 16.3 21.2 17.4 16.6 21.9 13.0 PFKL ENSG00000141959 "Phosphofructokinase, liver type" P17858 21 44300051-44327376 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Glycolysis "Allosteric enzyme, Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 273.7;Proximal enterocytes: 331.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030047 Approved Uncertain Nucleoli,Mitochondria NA NA 1100000 "Cluster 39: Non-specific - mRNA processing" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Mitochondria" "HPA030047: AB_10602815" "unprognostic (6.21e-3)" "unprognostic (2.93e-1)" "unprognostic (4.46e-2)" "unprognostic (1.23e-2)" "unprognostic (1.87e-2)" "unprognostic (1.23e-1)" "unprognostic (1.10e-1)" "unprognostic (6.98e-2)" "unprognostic (9.75e-2)" "prognostic unfavorable (4.41e-4)" "unprognostic (5.69e-2)" "unprognostic (5.40e-2)" "unprognostic (1.55e-1)" "unprognostic (4.99e-1)" "unprognostic (2.49e-1)" "unprognostic (8.06e-2)" "unprognostic (3.01e-2)" 62.7 36.1 36.5 41.6 40.3 45.2 57.3 43.8 40.7 60.0 36.0 79.5 99.9 47.9 12.9 79.7 42.9 40.9 41.5 35.6 29.7 95.4 60.6 51.0 42.1 54.0 45.6 42.6 40.0 21.1 38.8 41.7 50.3 47.6 24.9 23.8 58.5 38.1 18.8 68.7 92.2 18.6 48.4 59.6 64.6 44.7 54.3 26.0 47.7 17.8 23.1 57.5 58.2 57.7 127.9 54.8 38.4 111.2 58.0 43.2 167.6 93.9 60.2 53.3 51.9 74.5 27.5 74.9 108.8 62.5 50.3 67.6 30.3 84.4 12.3 62.9 67.7 152.5 47.2 123.4 45.1 116.1 93.1 57.0 51.0 54.5 27.0 80.6 79.2 53.9 95.9 83.7 36.9 161.3 50.8 89.9 60.2 114.0 60.2 122.1 35.7 206.6 23.9 139.0 67.0 49.7 137.3 114.9 60.7 15.4 90.9 101.6 116.7 80.4 50.9 53.0 37.1 159.7 45.6 31.1 132.9 89.7 65.4 17.7 71.5 17.2 37.8 119.0 31.2 41.0 48.9 34.4 83.4 54.5 28.3 22.9 14.0 26.1 126.8 52.4 78.5 84.2 36.5 40.3 43.8 40.7 35.6 29.7 54.0 45.6 50.3 48.4 54.3 57.7 56.2 22.4 27.9 53.2 45.3 35.7 40.3 95.2 37.0 74.6 41.3 36.6 14.4 27.1 51.6 92.0 66.7 119.6 38.7 273.7 99.7 85.5 2.3 40.7 29.6 49.0 46.3 45.6 15.7 51.4 174.8 44.6 126.4 83.1 41.9 61.2 40.7 70.0 108.6 30.3 9.3 131.4 57.0 64.7 44.5 8.2 39.1 60.0 69.4 29.0 129.4 67.6 33.0 10.1 41.7 52.7 174.2 55.7 39.2 54.9 331.6 142.4 33.7 53.6 26.3 21.3 47.8 1.8 12.2 42.3 36.1 160.8 31.8 31.2 178.6 54.2 PGRMC1 HPR6.6 ENSG00000101856 "Progesterone receptor membrane component 1" O00264 X 119236245-119244466 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 677.4" "Cell type enhanced" "Detected in all" "Hepatocytes: 520.4;Theca cells: 907.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002877, HPA064724" Enhanced Supported "Nucleoli,Endoplasmic reticulum" NA NA 1200000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" Nucleoli "HPA002877: AB_1079602, HPA064724: " "unprognostic (6.97e-2)" "unprognostic (1.99e-1)" "unprognostic (1.72e-1)" "unprognostic (4.35e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (3.02e-4)" "unprognostic (1.58e-3)" "unprognostic (9.28e-2)" "unprognostic (4.66e-2)" "unprognostic (6.20e-2)" "unprognostic (3.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (3.06e-3)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (1.11e-1)" 108.0 171.3 97.9 37.5 102.5 25.1 106.0 83.8 115.5 135.4 96.3 98.2 109.3 154.5 273.3 57.0 149.0 56.9 38.6 102.3 127.0 235.4 677.4 62.1 27.6 97.2 109.3 93.3 40.2 113.9 59.1 44.9 126.1 127.6 87.3 80.5 71.4 200.4 15.7 53.2 131.9 85.2 106.1 41.4 77.1 46.5 112.8 33.4 89.0 27.0 29.3 77.3 65.0 116.9 165.6 102.4 196.3 227.7 414.2 196.9 127.1 243.0 281.0 126.1 155.7 124.5 196.6 47.3 259.5 253.8 147.3 128.3 216.5 102.1 168.8 50.8 248.7 53.7 88.5 141.0 69.0 88.4 27.5 204.7 56.5 153.8 79.2 93.5 82.6 55.7 57.2 28.8 150.3 176.5 66.9 64.7 515.8 179.4 170.3 78.5 123.1 68.5 168.7 123.9 182.9 81.7 178.1 291.7 98.9 188.2 67.4 56.2 64.2 87.6 127.7 312.6 233.6 29.9 59.2 51.0 238.8 138.6 170.6 21.0 20.1 20.4 8.7 19.9 11.8 5.8 12.0 12.9 17.0 5.5 12.0 10.1 9.1 8.8 18.4 12.0 13.4 50.2 97.9 102.5 83.8 115.5 102.3 127.0 97.2 109.3 126.1 106.1 112.8 116.9 109.1 125.0 91.4 16.0 19.0 94.1 131.3 67.4 81.4 199.1 110.8 95.1 17.1 120.1 76.7 73.5 68.8 88.2 25.8 170.5 68.4 93.0 4.2 119.7 264.2 81.9 57.7 37.6 36.5 73.0 138.6 153.1 50.4 122.4 40.5 197.0 66.4 520.4 51.8 65.6 58.5 85.0 81.4 35.0 51.2 9.0 172.1 111.1 103.2 15.0 26.5 109.8 18.6 108.6 91.3 68.9 144.7 181.7 22.6 118.8 375.5 295.1 105.4 92.4 105.2 99.2 111.1 68.2 77.2 69.3 87.7 62.1 32.1 907.9 137.6 127.9 PHF6 "BFLS, BORJ, CENP-31, KIAA1823, MGC14797" ENSG00000156531 "PHD finger protein 6" Q8IWS0 X 134373312-134428791 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease variant, Epilepsy, Hypotrichosis, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001023 Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA001023: AB_1079606" "unprognostic (2.38e-3)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (3.04e-3)" "unprognostic (6.03e-3)" "unprognostic (5.20e-3)" "prognostic unfavorable (3.38e-4)" "unprognostic (1.81e-1)" "unprognostic (4.85e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (9.96e-4)" "unprognostic (1.09e-1)" "unprognostic (5.96e-2)" "unprognostic (4.84e-2)" "unprognostic (7.45e-2)" "unprognostic (1.28e-1)" "unprognostic (1.29e-2)" 6.7 18.0 6.6 14.2 7.9 8.4 10.8 10.3 9.3 8.3 6.2 9.1 8.9 9.7 32.7 8.2 7.9 6.6 6.7 7.1 8.4 10.2 7.7 6.8 25.3 8.3 7.8 33.3 9.5 16.3 6.2 9.3 8.4 9.2 10.3 12.0 13.2 11.0 5.0 8.3 8.8 8.1 8.6 13.3 9.3 9.2 7.7 20.8 13.2 6.8 29.8 8.6 7.1 11.5 28.2 22.9 98.7 40.8 17.9 22.9 18.7 27.6 22.1 29.1 35.6 13.9 28.5 45.1 61.8 16.9 28.3 24.6 69.4 31.3 48.6 37.2 32.1 44.3 37.7 16.1 19.2 44.2 23.3 15.3 23.2 31.7 39.2 29.1 41.1 43.1 32.6 21.8 35.8 18.7 71.3 21.8 30.1 38.3 31.0 69.6 36.0 34.5 30.7 33.8 34.1 39.9 21.2 19.3 29.5 29.0 18.0 24.0 31.5 26.8 19.2 34.0 42.9 11.1 27.3 60.5 17.7 51.4 34.3 5.9 6.3 4.1 8.0 6.6 8.7 18.7 8.2 7.3 9.5 12.4 9.6 8.2 2.6 11.0 8.4 11.7 9.1 5.5 6.6 7.9 10.3 9.3 7.1 8.4 8.3 7.8 8.4 8.6 7.7 11.5 25.5 22.4 18.4 13.1 42.7 13.0 14.3 28.7 22.2 22.4 17.5 20.3 16.3 11.5 17.8 16.5 18.8 11.8 27.1 9.9 23.5 14.2 3.7 13.0 29.1 18.7 11.4 31.3 27.8 13.8 7.6 17.2 14.8 18.7 24.6 149.5 20.0 15.2 15.1 18.5 23.4 12.5 10.2 15.5 10.2 3.1 20.8 20.2 7.2 29.0 25.3 27.9 21.6 33.2 46.7 14.4 18.7 15.4 23.1 12.3 9.5 19.8 16.5 19.7 26.3 21.0 21.9 10.3 22.0 25.7 11.5 4.7 22.6 69.3 17.7 11.5 PHTF1 PHTF ENSG00000116793 "Putative homeodomain transcription factor 1" Q9UMS5 1 113696831-113759489 "Plasma proteins, Predicted membrane proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 198.5;Excitatory neurons: 93.4;Inhibitory neurons: 102.6;Late spermatids: 124.5;Spermatocytes: 130.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059486 Approved "Nucleoli,Nuclear bodies" No No "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "Nuclear bodies" Nucleoli "HPA059486: " "unprognostic (1.52e-1)" "unprognostic (3.33e-1)" "unprognostic (2.58e-2)" "unprognostic (4.54e-2)" "unprognostic (5.92e-2)" "unprognostic (1.62e-2)" "unprognostic (6.55e-2)" "unprognostic (1.30e-1)" "unprognostic (3.30e-3)" "unprognostic (1.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.21e-6)" "unprognostic (1.26e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.25e-1)" 5.8 8.0 7.8 6.5 7.7 18.7 3.9 15.5 8.5 5.1 18.9 4.8 3.5 5.0 7.2 2.5 10.5 6.9 5.6 7.4 9.2 8.6 8.1 8.1 5.6 7.7 7.7 3.0 6.8 11.5 12.1 6.8 9.1 4.3 4.9 14.2 4.0 5.1 4.6 1.8 4.1 6.6 6.2 8.6 6.7 30.4 8.0 3.3 4.7 2.9 6.3 6.3 3.0 7.3 28.5 14.7 40.5 21.5 20.1 18.0 9.4 25.6 34.0 22.3 36.4 16.0 22.3 8.1 35.3 17.8 16.6 15.3 15.6 10.2 25.7 33.8 15.5 19.6 30.0 18.5 16.4 24.4 26.7 15.0 2.7 29.9 6.6 32.3 41.9 0.0 12.0 36.1 27.4 41.9 0.3 23.6 32.4 10.6 21.3 25.5 60.8 16.3 35.9 12.3 27.7 26.0 28.7 13.9 16.1 20.9 5.6 19.6 44.4 17.5 23.8 32.6 25.2 48.9 53.5 14.8 43.0 20.8 48.6 1.4 1.2 2.5 1.3 0.7 1.1 1.7 1.6 1.6 2.1 0.7 0.0 1.2 2.8 2.2 0.9 1.5 2.9 0.9 7.8 7.7 15.5 8.5 7.4 9.2 7.7 7.7 9.1 6.2 8.0 7.3 12.5 6.4 10.5 34.3 16.7 2.4 6.8 7.9 6.8 30.1 8.7 6.0 8.5 14.3 10.0 5.5 54.2 19.9 22.9 4.7 9.8 12.6 198.5 51.7 18.7 19.7 19.2 12.0 93.4 20.9 10.1 10.8 15.8 9.6 21.5 13.6 10.0 9.0 12.6 28.6 102.6 3.1 18.3 13.4 19.2 124.5 8.1 18.0 5.4 21.5 11.0 6.6 18.6 25.1 13.6 19.6 1.2 9.1 31.0 8.3 1.4 5.9 58.7 43.9 0.0 13.5 12.2 130.8 41.3 6.1 1.7 26.4 23.1 16.9 4.6 7.7 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 8.6 12.9 5.4 9.2 7.5 5.9 10.9 7.6 6.1 9.8 9.6 11.7 14.5 10.5 11.2 10.5 15.5 9.5 7.7 5.3 6.0 14.7 15.3 10.0 9.1 7.8 6.8 12.5 16.4 33.2 9.4 12.3 7.6 12.5 12.9 10.5 13.0 11.9 6.8 10.0 11.3 8.6 6.8 11.3 13.1 12.2 6.2 11.4 20.0 4.7 10.2 9.4 8.6 9.8 30.5 51.5 14.4 20.8 12.5 13.8 25.6 12.7 22.0 30.0 24.5 19.0 30.2 17.1 22.7 15.4 41.8 21.6 24.2 39.6 18.0 19.0 15.7 10.3 31.2 14.5 24.5 13.9 17.1 17.1 42.8 26.8 43.7 23.9 15.8 25.1 11.4 23.7 24.9 16.8 16.5 15.9 9.2 18.9 20.8 16.9 11.6 18.8 32.9 20.8 11.9 16.1 17.5 42.8 10.0 15.7 32.2 9.1 9.7 21.8 19.1 11.8 23.6 14.4 22.9 7.1 23.4 10.3 27.8 5.3 5.1 6.3 6.4 6.7 6.6 3.5 3.5 7.3 10.4 4.8 4.5 5.4 1.8 5.7 4.6 7.3 6.0 3.5 5.4 7.5 7.6 6.1 5.3 6.0 7.8 6.8 7.6 6.8 6.2 9.8 6.3 3.2 13.9 4.6 7.9 2.5 4.5 7.9 8.6 9.1 6.1 3.8 3.1 14.3 12.2 16.5 2.1 21.0 10.2 13.3 0.0 13.6 1.2 11.3 5.5 5.2 3.0 2.1 1.7 14.0 16.0 5.6 11.7 10.1 7.0 7.9 4.2 11.7 11.6 11.8 1.9 7.4 8.2 6.6 4.2 1.0 4.4 5.8 3.6 2.8 6.7 14.3 5.2 1.5 3.9 8.4 7.7 3.0 8.7 3.7 11.4 7.4 16.1 11.8 6.6 5.1 4.8 20.0 10.4 6.7 2.0 22.6 7.2 7.2 10.8 4.0 PJA1 "FLJ11830, RNF70" ENSG00000181191 "Praja ring finger ubiquitin ligase 1" Q8NG27 X 69160851-69165521 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 160.0" "Cell type enhanced" "Detected in many" "Early spermatids: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000595 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA000595: AB_1079826" "unprognostic (3.40e-2)" "unprognostic (2.28e-1)" "unprognostic (4.03e-2)" "unprognostic (2.58e-3)" "unprognostic (5.44e-2)" "unprognostic (1.30e-2)" "unprognostic (1.26e-3)" "unprognostic (4.61e-2)" "unprognostic (3.82e-3)" "unprognostic (1.84e-2)" "unprognostic (6.10e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.44e-5)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (2.01e-1)" "unprognostic (2.10e-1)" 22.9 14.5 46.8 8.7 50.5 3.6 19.4 37.2 78.0 19.9 33.0 15.4 6.4 16.4 160.0 12.3 16.0 11.1 15.0 47.1 48.9 19.2 9.4 13.8 10.0 38.9 41.7 25.8 14.5 38.7 28.1 17.3 40.6 15.3 7.6 17.6 10.6 32.4 7.9 14.6 11.1 16.0 40.1 13.3 14.0 26.4 49.0 10.0 22.7 8.8 12.1 17.4 15.1 43.5 27.3 19.6 62.9 43.7 21.3 22.5 18.7 17.8 22.0 16.7 22.3 17.1 25.8 4.4 26.7 28.1 39.2 24.0 99.0 34.9 21.2 20.2 33.0 8.1 16.0 10.9 25.7 4.9 14.4 23.1 23.6 28.6 17.0 15.8 19.0 13.2 7.8 3.0 16.9 14.1 2.1 8.4 43.4 23.1 32.0 20.0 28.2 6.9 23.4 22.6 46.4 30.7 28.6 4.9 22.2 50.1 7.7 7.0 17.8 13.9 22.6 41.7 8.3 0.0 0.2 9.1 15.3 13.1 19.4 6.6 6.8 2.1 29.6 9.2 34.3 16.4 26.1 27.5 7.3 22.8 26.5 31.3 2.3 30.0 6.5 8.9 17.5 19.4 46.8 50.5 37.2 78.0 47.1 48.9 38.9 41.7 40.6 40.1 49.0 43.5 4.7 16.0 4.8 2.9 9.7 41.0 19.4 30.8 23.9 16.8 5.0 6.2 7.1 4.3 14.8 3.7 8.4 35.6 5.9 1.0 15.6 24.9 74.7 3.9 10.4 6.6 5.4 10.8 8.1 11.7 15.3 18.2 7.1 5.8 4.5 27.9 6.8 1.7 7.0 5.0 8.3 3.6 6.1 2.9 9.9 32.7 27.1 5.7 5.4 2.8 2.9 30.6 14.4 5.0 3.7 18.0 1.7 19.5 7.7 17.0 0.5 6.5 4.4 6.1 6.6 9.4 16.3 1.4 1.5 11.2 29.5 20.8 11.2 27.0 2.6 22.5 PLEKHM1 KIAA0356 ENSG00000225190 "Pleckstrin homology and RUN domain containing M1" Q9Y4G2 17 45435900-45490749 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 6.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.5" "Cell line enhanced" "Detected in many" "OE19: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025018, HPA039473" Approved Supported Nucleoli,Vesicles NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoli "HPA025018: AB_1855465, HPA039473: AB_2676526" "unprognostic (1.52e-1)" "unprognostic (3.13e-2)" "unprognostic (4.29e-2)" "prognostic favorable (1.28e-6)" "unprognostic (8.71e-2)" "unprognostic (3.06e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.20e-2)" "unprognostic (1.88e-1)" "unprognostic (2.93e-2)" "unprognostic (4.02e-1)" "unprognostic (3.93e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" 7.0 6.4 2.9 5.5 2.9 9.7 6.2 3.5 3.8 12.9 3.2 6.5 3.5 5.7 1.0 31.7 5.9 5.3 6.2 2.8 3.1 3.6 3.6 8.8 4.8 3.7 3.1 4.9 6.1 4.4 5.7 2.9 3.2 5.1 3.6 1.6 14.4 0.9 12.3 11.8 6.2 2.0 2.8 6.8 5.6 3.4 3.4 5.4 6.5 7.2 4.8 6.8 13.6 3.7 7.3 11.0 1.7 5.4 8.4 4.8 0.1 3.3 4.9 1.9 2.6 4.2 6.0 5.2 3.4 3.9 14.1 1.7 4.1 1.9 1.6 13.7 3.5 0.0 5.6 6.9 2.0 0.0 4.3 2.2 4.9 0.9 8.0 3.8 10.0 0.0 5.2 6.2 9.1 6.0 5.2 1.1 1.7 26.6 9.0 2.8 5.6 5.3 6.0 16.8 3.2 2.1 3.2 4.5 5.2 4.8 10.1 5.3 19.1 12.7 3.6 5.2 5.9 0.6 6.2 1.8 7.7 2.8 5.8 2.8 1.2 1.0 0.2 0.3 0.0 1.2 0.6 0.2 0.3 0.3 0.2 0.0 6.5 0.7 0.4 0.2 0.5 0.2 2.9 2.9 3.5 3.8 2.8 3.1 3.7 3.1 3.2 2.8 3.4 3.7 12.6 12.8 18.1 7.8 17.5 18.0 18.1 10.3 6.8 10.4 11.7 8.4 8.7 15.7 12.7 12.9 16.7 4.8 24.3 25.6 5.9 8.1 4.3 24.9 11.1 12.1 13.8 10.8 13.5 8.2 4.7 12.1 19.9 27.9 1.3 5.4 12.8 8.1 9.1 16.8 13.3 13.0 4.1 27.9 15.2 2.0 7.2 21.1 7.2 9.4 13.7 7.3 14.4 7.5 20.8 18.3 17.7 7.9 22.9 27.2 8.6 10.5 11.9 8.2 0.0 17.7 7.6 7.6 3.7 10.0 16.3 8.6 18.5 9.3 12.2 43.1 PLOD2 LH2 ENSG00000152952 "Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2" O00469 3 146069440-146163653 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Dioxygenase, Oxidoreductase" "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 130.9;Basal respiratory cells: 115.1;Distal enterocytes: 143.7;Extravillous trophoblasts: 130.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBF TERT88: 636.0;hTERT-RPE1: 723.8;U-87 MG: 566.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025898, HPA069126" Approved Uncertain Nucleoli,Cytosol "Intracellular and membrane" NA NA 21000 "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Nucleoli, Cytosol" "CAB025898: , HPA069126: " "unprognostic (8.68e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (2.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.34e-2)" "unprognostic (1.29e-3)" "prognostic unfavorable (7.64e-10)" "prognostic unfavorable (1.42e-4)" "unprognostic (2.97e-2)" "unprognostic (3.36e-2)" "unprognostic (6.27e-3)" "unprognostic (2.24e-1)" "prognostic unfavorable (4.99e-11)" "prognostic unfavorable (2.83e-4)" "unprognostic (6.07e-2)" "unprognostic (4.06e-2)" "unprognostic (4.41e-3)" 63.1 20.1 13.4 35.6 14.5 1.1 18.6 15.1 17.2 10.2 19.4 36.2 42.2 23.5 13.4 18.2 11.4 41.5 22.1 13.3 15.1 26.1 57.3 12.9 3.8 23.1 18.1 20.5 18.7 16.5 7.9 80.6 16.3 13.2 29.9 56.6 9.5 16.2 3.0 3.9 35.0 46.8 17.8 5.4 20.1 8.5 20.6 10.5 90.0 3.9 5.5 25.7 10.0 17.6 134.5 94.3 29.0 9.5 102.5 109.6 73.2 465.5 141.6 247.7 463.0 7.2 13.4 0.0 88.8 79.5 113.1 27.8 34.0 400.5 636.0 0.6 53.5 33.3 84.3 66.9 262.5 0.1 0.6 192.9 56.5 215.2 104.1 723.8 347.7 0.1 45.1 1.8 441.6 48.8 0.3 0.6 18.5 0.3 40.0 0.2 19.2 0.6 105.0 6.5 14.5 0.5 370.3 39.4 39.9 135.1 107.5 4.2 440.4 304.2 92.2 97.8 280.7 138.9 20.9 0.5 566.5 0.4 55.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 13.4 14.5 15.1 17.2 13.3 15.1 23.1 18.1 16.3 17.8 20.6 17.6 29.1 16.0 11.4 130.9 0.4 7.0 6.4 115.1 30.1 17.1 23.7 10.2 14.3 44.3 47.0 27.6 35.5 9.2 0.3 143.7 9.8 64.5 0.5 35.4 13.8 24.3 19.8 4.6 22.8 53.1 130.6 68.1 19.9 38.7 0.0 42.7 21.0 65.2 5.1 0.0 46.4 19.5 22.4 1.0 2.5 1.2 13.1 3.0 14.2 21.5 0.7 53.8 0.0 64.3 6.0 82.4 48.8 4.9 1.3 8.9 50.5 8.2 33.0 24.7 19.7 36.9 47.2 11.0 18.0 27.5 5.5 18.7 1.0 24.5 25.1 5.6 PNKP PNK ENSG00000039650 "Polynucleotide kinase 3'-phosphatase" Q96T60 19 49859882-49878351 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006782 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA006782: AB_1855496" "prognostic favorable (9.18e-4)" "unprognostic (1.87e-1)" "unprognostic (4.31e-2)" "unprognostic (4.23e-1)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (3.36e-1)" "unprognostic (1.58e-1)" "unprognostic (3.71e-2)" "unprognostic (1.70e-1)" "unprognostic (4.55e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.24e-2)" "unprognostic (3.68e-3)" 18.9 45.1 12.0 21.0 12.9 26.4 21.2 12.8 16.2 21.1 24.2 21.6 16.0 21.3 13.5 19.4 22.9 10.6 23.9 14.4 11.9 27.3 22.4 22.2 17.5 14.0 14.0 23.7 28.6 16.7 36.8 11.1 14.3 25.3 13.1 10.1 21.6 12.4 18.5 17.8 22.8 11.5 12.8 37.2 25.0 21.2 13.3 12.3 31.9 7.8 15.3 19.4 18.0 14.1 27.5 17.4 19.1 27.2 15.8 13.4 28.6 43.4 21.2 18.7 17.7 17.5 34.2 18.4 13.6 13.6 11.3 23.5 6.1 25.9 10.9 22.3 27.2 30.0 36.7 14.8 12.2 25.8 36.3 13.2 13.0 17.9 11.0 16.9 26.3 23.4 14.9 34.3 24.7 18.8 28.7 23.5 16.0 28.3 37.4 24.3 15.9 34.7 21.0 68.5 20.6 33.4 19.3 52.5 9.2 14.5 10.2 14.8 36.0 37.6 24.9 9.6 35.8 38.7 16.5 13.0 33.8 12.3 30.8 1.8 12.3 16.7 9.2 11.5 7.9 9.1 7.8 7.3 9.8 12.2 5.7 5.0 23.4 3.9 18.1 5.5 9.1 5.8 12.0 12.9 12.8 16.2 14.4 11.9 14.0 14.0 14.3 12.8 13.3 14.1 23.6 16.0 23.6 5.9 47.2 13.4 35.4 29.9 25.6 40.9 28.1 23.7 11.1 21.5 19.1 20.2 81.3 44.5 37.7 40.0 23.5 42.5 15.0 25.2 28.5 26.6 30.5 17.1 6.0 39.9 35.1 19.1 31.6 28.0 29.1 54.6 35.0 20.1 39.5 33.7 6.0 31.7 24.4 27.7 19.0 32.9 59.4 26.8 14.2 8.4 46.1 18.4 96.8 6.0 5.7 44.6 22.3 44.8 40.4 33.6 27.1 36.1 33.8 73.9 19.7 17.9 20.1 19.4 28.9 23.3 13.1 49.3 39.2 83.0 34.1 35.6 PNMA6A "MGC15827, PNMA6C" ENSG00000235961 "PNMA family member 6A" P0CW24 X 153072454-153075019 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.5" "Cell type enhanced" "Detected in some" "Bipolar cells: 27.0;Distal tubular cells: 11.7;Horizontal cells: 23.5;Muller glia cells: 21.1;Proximal tubular cells: 27.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 16 "eosinophil: 2.0" "Lineage enriched" "Detected in single" 21 "granulocytes: 2.0" "Cell line enhanced" "Detected in some" "HHSteC: 7.5;HMC-1: 6.7;SK-MEL-30: 6.9;U-2 OS: 14.7;U-698: 8.5" "HPA045007, HPA052115" Uncertain Uncertain Nucleoli,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 65: Brain - Ion transport" "Cluster 9: U-2 OS - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Mitochondria Nucleoli "HPA045007: AB_2679181, HPA052115: AB_2681734" "unprognostic (2.14e-2)" "unprognostic (2.35e-1)" "unprognostic (2.33e-2)" "unprognostic (4.12e-3)" "unprognostic (4.39e-2)" "unprognostic (3.44e-2)" "unprognostic (9.27e-3)" "unprognostic (2.15e-1)" "unprognostic (1.85e-1)" "unprognostic (2.46e-1)" "unprognostic (7.76e-4)" "unprognostic (5.75e-3)" "prognostic favorable (1.93e-5)" "unprognostic (4.61e-2)" "unprognostic (3.04e-1)" "unprognostic (4.04e-3)" "unprognostic (3.22e-2)" 1.9 1.8 17.3 0.2 16.8 0.4 1.1 8.8 26.5 3.1 3.4 1.7 0.6 2.4 5.9 0.4 3.0 1.0 2.1 16.5 16.7 8.2 10.2 0.6 0.4 16.4 13.1 5.1 0.9 2.2 11.9 0.2 16.1 0.5 0.2 3.5 1.0 0.6 0.5 1.1 0.9 0.7 8.9 0.9 1.2 1.7 17.3 0.2 3.1 0.7 0.3 0.4 0.7 16.7 0.0 5.3 0.1 1.5 0.0 0.0 0.0 0.9 0.2 0.3 0.0 0.0 0.5 0.0 1.8 0.4 0.9 0.0 2.8 0.0 0.0 0.0 0.6 0.0 0.3 0.2 7.5 3.3 6.7 1.1 0.0 0.1 0.0 0.2 0.2 5.6 1.4 0.0 0.1 0.4 1.1 0.0 3.3 5.9 0.0 0.0 0.0 0.0 0.3 0.0 3.2 1.9 0.4 0.0 6.9 0.3 0.0 4.2 0.0 0.0 14.7 0.0 0.0 5.7 4.6 8.5 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.3 16.8 8.8 26.5 16.5 16.7 16.4 13.1 16.1 8.9 17.3 16.7 0.2 0.0 0.0 4.6 0.5 0.0 0.3 0.0 0.0 27.0 0.3 0.5 2.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 1.5 0.0 0.4 3.4 0.4 0.0 0.0 8.1 0.2 0.0 2.4 0.0 0.8 0.0 6.5 0.7 2.9 4.0 23.5 9.6 0.0 0.0 0.8 0.4 0.7 2.8 0.8 0.0 1.9 0.0 21.1 0.0 4.5 1.4 0.3 0.0 3.0 0.7 0.1 0.0 27.0 0.0 8.7 0.0 0.8 1.9 1.0 2.8 0.0 0.0 0.0 0.7 0.9 0.0 0.1 PNO1 "KHRBP1, RRP20" ENSG00000115946 "Partner of NOB1 homolog" Q9NRX1 2 68157888-68176238 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056928 Supported Nucleoplasm,Nucleoli NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA056928: " "unprognostic (1.81e-3)" "unprognostic (4.83e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (5.88e-2)" "unprognostic (1.66e-3)" "prognostic unfavorable (3.04e-8)" "unprognostic (5.82e-2)" "unprognostic (2.59e-2)" "unprognostic (1.16e-1)" "unprognostic (9.13e-3)" "unprognostic (3.33e-2)" "unprognostic (1.46e-2)" "unprognostic (1.42e-1)" "unprognostic (2.58e-1)" "unprognostic (3.74e-2)" "unprognostic (7.66e-2)" 15.1 14.2 6.4 12.1 8.0 19.5 11.6 7.0 11.8 7.6 6.9 9.7 7.6 9.8 11.2 11.1 8.8 9.9 10.2 12.0 7.3 14.1 12.6 8.6 12.6 6.7 6.9 7.0 12.7 12.5 7.1 12.7 6.8 10.0 9.1 19.0 7.1 10.8 20.1 9.1 6.7 11.5 6.7 8.2 8.8 8.9 6.9 8.1 12.5 12.6 12.2 19.8 7.6 7.4 37.8 40.1 18.5 30.5 22.5 18.3 46.0 34.7 23.0 39.1 27.8 77.9 21.9 51.4 28.5 23.6 54.0 31.6 60.6 41.9 61.3 35.2 40.6 49.7 17.4 58.2 34.6 40.2 22.4 24.1 30.2 39.4 45.0 11.3 29.1 32.7 69.7 27.3 35.7 27.4 39.9 38.1 52.0 68.7 43.1 33.3 45.2 54.8 29.8 31.7 32.7 24.0 26.1 32.4 57.8 29.7 22.9 22.4 21.2 44.2 48.0 40.1 97.9 21.6 33.1 78.1 36.3 59.1 62.1 0.9 12.6 2.8 12.2 18.1 19.1 19.2 13.8 14.4 16.8 14.5 16.0 14.6 2.4 15.0 13.0 11.8 16.0 21.3 6.4 8.0 7.0 11.8 12.0 7.3 6.7 6.9 6.8 6.7 6.9 7.4 23.7 16.0 13.2 3.3 29.9 83.2 62.8 29.5 25.6 22.7 18.6 18.4 11.9 18.6 36.2 7.3 12.5 39.5 20.2 7.9 19.6 36.7 33.5 28.7 37.7 25.5 17.3 21.4 10.6 29.8 43.5 28.3 9.7 20.9 31.6 13.6 12.5 15.8 26.0 18.5 9.0 12.1 30.5 10.4 38.7 7.7 12.5 20.7 12.4 4.7 18.9 21.0 14.4 7.1 10.4 29.1 5.8 16.6 27.8 56.6 4.6 34.7 28.6 51.3 6.6 40.4 29.6 28.9 41.7 21.0 56.1 47.6 25.7 20.5 20.2 37.6 PNRC1 "B4-2, PROL2, PRR2" ENSG00000146278 "Proline rich nuclear receptor coactivator 1" Q12796 6 89080751-89085160 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 1848.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HHSteC: 212.8;hTCEpi: 234.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029839, HPA066513" Approved Approved Nucleoplasm,Nucleoli NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Nucleoli" "HPA029839: AB_10601247, HPA066513: AB_2685684" "unprognostic (9.02e-3)" "unprognostic (7.65e-2)" "unprognostic (3.01e-2)" "unprognostic (2.31e-2)" "unprognostic (6.10e-2)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.78e-1)" "unprognostic (5.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.96e-2)" "unprognostic (6.29e-2)" "prognostic unfavorable (6.88e-6)" "unprognostic (8.63e-3)" "unprognostic (2.05e-1)" "unprognostic (1.03e-1)" "unprognostic (5.09e-2)" 232.7 171.7 61.6 145.9 66.3 368.1 135.4 84.0 67.5 93.8 47.9 158.4 70.2 100.6 80.4 91.4 204.4 139.3 132.5 58.3 74.2 103.5 318.1 159.6 134.1 87.7 65.7 222.5 89.2 86.8 78.5 122.6 73.0 95.0 77.5 129.8 91.9 84.3 460.6 147.5 94.3 130.3 69.5 139.6 104.6 50.1 57.4 165.9 105.6 163.4 111.2 141.4 98.5 80.4 12.1 12.0 25.3 42.4 96.7 166.6 16.9 16.0 110.6 29.5 69.0 10.2 34.5 25.9 71.2 19.4 116.3 40.5 13.3 23.9 45.6 31.8 36.3 4.7 69.8 31.9 212.8 25.0 57.9 117.6 234.4 19.6 90.1 107.9 49.4 30.3 4.1 81.0 33.3 11.5 6.8 124.7 7.0 13.9 23.1 29.1 30.0 21.5 70.2 21.1 15.7 42.2 40.3 56.3 44.0 73.6 27.9 119.4 44.8 23.1 13.2 16.2 5.9 118.3 64.0 9.0 46.3 20.6 14.9 32.8 17.3 103.8 18.3 19.0 19.0 20.7 22.1 19.7 11.3 23.0 24.9 25.9 100.9 19.2 17.9 18.7 19.0 10.5 61.6 66.3 84.0 67.5 58.3 74.2 87.7 65.7 73.0 69.5 57.4 80.4 405.7 141.1 149.8 36.2 747.6 968.9 776.8 98.9 1286.2 130.6 412.5 381.5 188.6 230.2 65.2 90.1 50.1 235.8 662.8 158.1 234.8 203.5 103.4 528.4 655.3 356.1 248.0 284.1 10.0 238.2 78.6 720.1 225.8 955.1 164.6 153.2 238.5 207.6 229.4 72.3 15.5 200.7 34.6 452.6 1848.0 41.5 481.9 898.3 439.4 39.4 763.5 403.3 440.8 20.1 41.5 143.0 184.6 377.3 530.6 738.5 211.1 319.2 61.5 134.8 420.7 731.3 725.6 51.9 64.6 840.2 1250.8 274.5 735.8 214.3 136.9 472.8 POLE3 "CHARAC17, CHRAC17, CHRAC2, p17, Ybl1" ENSG00000148229 "DNA polymerase epsilon 3, accessory subunit" Q9NRF9 9 113407235-113410675 "FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" DNA-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047945 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA047945: AB_2680218" "unprognostic (9.55e-2)" "unprognostic (3.39e-3)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (6.52e-2)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.04e-2)" "unprognostic (1.60e-2)" "unprognostic (1.10e-1)" "unprognostic (4.59e-3)" "unprognostic (2.31e-3)" "unprognostic (1.75e-2)" "unprognostic (1.56e-2)" "unprognostic (1.04e-1)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" 25.4 32.9 20.3 34.9 20.9 113.5 31.7 24.7 24.2 25.8 17.3 29.6 25.4 25.2 26.0 39.7 28.2 18.0 26.4 21.2 19.7 23.6 38.1 23.7 53.6 21.9 19.6 22.6 27.4 26.7 11.2 26.6 21.5 23.0 32.8 16.4 27.2 22.8 79.1 37.3 26.3 27.8 20.8 33.0 24.9 41.1 19.8 55.1 21.8 56.4 56.7 28.5 24.8 21.5 85.0 103.3 71.2 107.6 39.8 35.3 62.5 110.3 56.0 122.1 95.6 96.5 75.0 305.5 66.9 65.0 74.5 141.4 140.3 121.4 112.0 58.8 84.7 158.9 97.7 99.5 42.4 333.5 92.2 40.5 82.2 106.3 135.5 44.3 86.0 152.7 225.7 165.6 85.9 215.1 230.6 178.4 92.1 180.7 184.8 232.4 296.3 171.8 53.4 79.8 153.8 88.7 160.2 100.0 89.4 43.0 149.7 148.1 71.3 90.0 122.3 115.2 191.2 86.0 301.5 407.4 82.2 193.5 110.1 77.4 85.4 90.4 83.8 87.0 104.2 86.3 78.9 79.8 83.3 82.4 84.8 79.3 17.5 77.4 71.6 83.6 102.0 135.2 20.3 20.9 24.7 24.2 21.2 19.7 21.9 19.6 21.5 20.8 19.8 21.5 37.2 38.5 30.2 2.0 61.4 93.8 30.8 37.0 66.0 15.0 51.9 49.9 43.6 21.5 35.8 31.3 6.2 60.7 73.9 28.9 43.0 35.7 5.1 45.4 53.7 33.9 24.6 101.6 4.7 45.4 62.5 37.6 22.4 44.1 57.5 41.4 25.7 43.1 49.3 13.5 3.9 36.9 28.5 36.5 66.4 16.4 35.8 44.7 40.9 1.9 60.3 29.9 48.4 3.5 3.6 37.6 13.9 42.5 67.8 36.0 18.3 34.4 35.5 18.3 13.1 47.9 45.7 40.2 93.1 87.6 94.9 34.9 65.5 36.3 42.5 22.6 POP4 RPP29 ENSG00000105171 "POP4 homolog, ribonuclease P/MRP subunit" O95707 19 29606283-29617237 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042748, HPA064577" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 9: U-2 OS - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA042748: AB_10964774, HPA064577: " "unprognostic (5.88e-2)" "unprognostic (2.78e-2)" "unprognostic (7.21e-2)" "unprognostic (4.00e-3)" "unprognostic (4.50e-2)" "unprognostic (5.73e-2)" "prognostic unfavorable (3.31e-4)" "unprognostic (8.35e-2)" "unprognostic (2.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.20e-2)" "unprognostic (9.47e-2)" "unprognostic (5.84e-2)" "unprognostic (4.21e-1)" "unprognostic (1.77e-2)" "unprognostic (5.23e-3)" "unprognostic (8.08e-3)" 11.3 13.6 8.9 5.2 9.4 6.3 10.6 10.0 9.5 8.8 8.5 11.1 4.7 9.7 3.8 13.3 7.7 2.5 14.1 9.1 9.6 13.4 14.4 8.1 5.9 10.1 9.5 7.8 9.5 3.9 8.3 3.7 9.8 8.8 2.9 3.6 10.5 3.2 18.8 11.6 10.5 3.5 9.7 11.4 11.6 12.8 9.8 5.0 9.2 4.0 4.7 9.6 9.3 10.5 44.5 61.9 5.3 5.4 7.8 3.9 26.5 42.1 4.9 9.3 9.3 28.6 10.5 35.2 72.1 7.3 10.1 20.6 10.8 10.0 5.3 79.9 65.1 42.0 19.4 18.2 7.5 51.4 21.6 4.4 8.0 7.9 4.8 5.0 8.2 18.5 34.8 8.0 8.2 36.9 29.7 8.6 10.3 13.6 39.5 19.0 44.7 18.0 5.6 17.1 15.1 16.6 44.4 15.4 18.5 5.0 15.5 12.5 30.0 13.4 40.5 23.1 37.1 30.3 59.7 44.1 17.1 24.8 13.5 73.1 39.7 40.3 35.5 52.1 26.1 48.1 34.2 37.5 39.9 36.4 27.1 32.4 23.3 36.5 43.0 33.2 53.0 45.8 8.9 9.4 10.0 9.5 9.1 9.6 10.1 9.5 9.8 9.7 9.8 10.5 26.4 22.4 20.0 4.9 29.8 12.6 20.0 61.0 15.9 16.6 18.5 21.0 26.1 27.1 29.6 33.1 8.4 53.4 25.8 29.5 80.3 59.5 18.2 29.8 21.5 27.1 17.4 21.4 4.6 78.3 45.0 22.8 17.3 22.6 26.0 22.1 25.4 40.2 62.1 11.8 4.3 27.5 46.8 26.2 18.3 15.3 16.4 27.3 24.9 0.0 57.4 34.1 52.5 4.0 5.8 66.2 26.6 28.2 33.6 20.3 39.4 72.4 38.0 15.5 26.3 18.6 27.8 71.0 15.4 21.4 16.1 47.3 27.4 31.7 26.2 19.5 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581402 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 27.0 51.3 5.2 5.6 6.1 9.5 25.6 6.0 8.9 20.7 6.1 24.6 6.0 21.8 2.4 25.9 20.1 5.1 42.5 5.5 5.9 38.3 40.5 19.0 10.8 6.1 5.7 17.2 25.2 7.3 26.2 2.1 6.4 24.3 2.8 1.2 25.2 4.8 22.9 22.4 24.6 3.5 6.2 31.8 25.4 10.2 5.8 7.9 27.4 3.6 4.3 24.3 21.0 6.4 22.2 43.4 3.8 8.7 10.1 4.5 14.7 14.2 5.7 13.6 11.2 36.6 6.6 13.4 26.9 7.8 6.1 15.7 8.0 30.1 1.1 41.4 42.1 13.5 20.3 26.5 12.1 11.7 11.3 14.1 11.2 13.5 2.4 3.4 8.9 30.2 18.2 5.6 7.5 45.0 18.9 11.2 8.0 14.6 36.5 20.5 9.8 28.5 11.5 18.5 7.4 8.7 27.7 6.5 15.7 2.8 27.5 20.7 11.8 8.1 13.2 13.6 19.8 16.1 35.8 16.7 20.5 21.6 13.3 4.5 12.7 3.1 17.7 14.9 16.4 25.2 14.2 16.2 16.8 18.0 17.6 16.3 0.9 16.0 14.1 26.6 15.8 20.8 5.2 6.1 6.0 8.9 5.5 5.9 6.1 5.7 6.4 6.2 5.8 6.4 24.2 12.8 27.6 10.1 47.8 19.6 38.6 83.7 34.1 22.0 37.5 50.4 60.5 37.1 59.3 77.3 14.6 51.7 49.3 21.6 154.6 44.9 1.7 39.9 30.5 25.4 22.1 30.1 6.4 44.9 42.9 33.8 32.6 24.8 54.6 24.0 24.3 58.3 53.2 18.5 6.9 30.5 54.9 19.8 21.7 5.0 36.1 35.7 49.8 7.5 33.4 79.3 52.5 10.6 8.2 40.0 21.9 37.6 56.8 23.6 31.2 136.2 45.2 34.4 19.7 27.5 39.4 22.7 43.8 53.3 24.7 17.6 46.1 106.3 44.2 33.5 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706121-100707486 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 25.6 31.7 30.1 18.1 31.6 33.9 26.6 33.4 38.6 24.2 23.8 27.9 19.3 27.7 11.0 34.0 21.3 9.8 37.6 32.3 30.8 25.8 67.1 18.2 17.3 30.1 27.8 18.1 31.3 16.6 22.8 16.6 30.8 22.6 9.2 9.6 29.0 13.5 69.0 50.2 22.3 12.1 29.4 22.7 26.4 12.5 29.1 15.6 16.8 31.9 12.0 25.4 24.9 33.9 115.7 115.3 47.2 78.4 25.1 23.9 92.0 65.6 32.4 73.7 73.1 159.8 71.0 97.5 105.1 30.0 81.4 70.4 70.1 79.5 36.8 82.7 212.4 44.9 75.0 166.5 42.1 69.2 49.8 27.6 30.2 76.2 74.8 20.9 41.6 68.9 157.4 77.8 39.8 330.4 158.0 232.9 135.2 77.8 164.4 123.6 50.0 159.4 45.3 65.2 90.4 92.3 54.5 156.2 78.7 42.0 50.0 66.2 41.3 92.0 117.7 191.0 127.6 34.0 99.4 175.8 61.0 115.1 104.6 106.3 63.2 72.4 54.7 64.7 50.7 60.3 54.6 54.3 55.3 47.7 49.5 52.0 39.0 78.9 70.3 51.2 69.8 62.5 30.1 31.6 33.4 38.6 32.3 30.8 30.1 27.8 30.8 29.4 29.1 33.9 30.5 19.2 17.0 2.9 29.7 105.0 32.0 57.2 56.3 26.1 61.6 64.1 27.9 37.1 31.5 35.0 6.2 148.2 25.8 51.8 93.9 75.4 2.1 31.2 32.3 37.2 40.2 50.1 5.2 87.4 181.3 37.3 25.0 35.1 17.7 32.4 33.5 99.0 66.1 32.0 6.0 61.7 67.1 27.3 40.7 7.9 42.0 22.4 56.9 2.8 38.7 41.8 41.2 4.0 5.8 92.2 47.6 37.2 55.1 75.6 69.8 86.1 27.8 21.3 46.0 29.8 52.2 9.2 45.5 74.7 119.2 139.3 27.2 39.9 55.8 43.5 POPDC3 "bA355M14.1, MGC22671, POP3" ENSG00000132429 "Popeye domain containing 3" Q9HBV1 6 105157900-105180014 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "heart muscle: 23.0;skeletal muscle: 96.3;tongue: 29.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 42.8;Early spermatids: 88.0;Excitatory neurons: 16.6;Late spermatids: 18.2;Oligodendrocytes: 15.0;Skeletal myocytes: 32.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "GAMG: 25.9;RH-30: 15.8;SH-SY5Y: 15.4;U-87 MG: 14.2;WM-115: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA012514 Approved Nucleoli,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli, Cytosol" "HPA012514: " "unprognostic (2.17e-1)" "unprognostic (2.15e-2)" "unprognostic (3.65e-1)" "unprognostic (1.14e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (4.43e-4)" "unprognostic (2.24e-3)" "prognostic unfavorable (5.79e-4)" "unprognostic (2.81e-1)" "unprognostic (1.69e-1)" "unprognostic (5.12e-3)" "unprognostic (2.37e-1)" "unprognostic (2.83e-9)" "unprognostic (6.25e-2)" "unprognostic (1.24e-1)" "unprognostic (3.75e-3)" "unprognostic (1.33e-2)" 0.5 0.3 5.1 0.3 6.8 0.0 0.2 5.8 10.0 0.5 4.8 2.5 0.1 0.9 1.5 1.8 0.4 0.7 23.0 6.2 6.2 0.2 0.0 0.1 0.1 6.3 6.4 0.2 0.1 0.1 4.4 0.7 6.2 0.8 0.0 0.5 1.3 0.3 96.3 0.2 0.5 0.0 6.3 0.0 3.2 3.9 6.0 0.0 0.2 29.6 0.0 1.3 0.4 9.7 1.3 1.6 0.5 0.2 2.7 6.8 0.6 2.9 2.5 4.5 5.2 0.0 1.6 0.1 1.1 5.5 25.9 0.0 1.7 1.5 3.6 0.0 4.1 0.0 1.1 0.0 0.1 0.0 0.0 2.3 0.3 7.5 1.0 1.4 0.3 0.1 3.4 7.0 12.8 0.0 0.0 1.5 3.0 0.0 6.3 0.5 15.8 0.0 0.0 0.0 7.5 15.4 0.0 0.1 11.5 1.4 0.0 6.2 6.5 3.4 0.0 2.1 10.7 0.0 0.0 0.0 14.2 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 6.8 5.8 10.0 6.2 6.2 6.3 6.4 6.2 6.3 6.0 9.7 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 42.8 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.1 88.0 1.5 1.0 0.4 0.0 0.0 16.6 0.0 1.2 2.0 0.0 5.6 0.0 0.1 0.0 0.0 0.3 0.0 4.9 0.0 2.0 0.0 0.0 18.2 0.6 0.7 0.0 2.8 2.0 0.0 0.0 0.5 15.0 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 32.0 3.5 2.9 5.1 0.0 0.0 0.1 0.1 0.0 0.0 0.7 PPIL3 CyPJ ENSG00000240344 "Peptidylprolyl isomerase like 3" Q9H2H8 2 200870907-200889303 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040765, HPA062187" Approved Approved Nucleoplasm,Nucleoli NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA040765: AB_2677125, HPA062187: AB_2684706" "unprognostic (8.96e-3)" "unprognostic (6.07e-2)" "unprognostic (5.34e-2)" "unprognostic (8.16e-2)" "unprognostic (2.69e-2)" "unprognostic (9.61e-2)" "unprognostic (8.31e-2)" "unprognostic (8.05e-2)" "unprognostic (1.40e-2)" "prognostic favorable (1.19e-4)" "unprognostic (5.23e-2)" "unprognostic (6.60e-2)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.14e-1)" "unprognostic (5.96e-2)" "unprognostic (2.21e-2)" "unprognostic (4.87e-2)" 13.0 16.4 15.2 19.8 14.9 35.1 25.4 17.0 22.3 15.7 13.9 19.0 14.6 20.2 28.4 18.6 22.5 13.0 18.2 14.6 16.8 18.4 21.9 15.0 32.2 15.7 15.5 35.4 12.1 14.0 14.9 17.7 16.8 15.1 19.5 25.8 17.1 18.2 18.0 18.0 18.1 12.4 15.4 17.5 19.0 21.1 15.5 30.1 20.8 11.1 32.5 16.2 12.5 18.2 19.9 18.3 53.0 23.5 42.5 90.8 17.5 32.0 35.3 37.1 37.2 13.0 37.5 19.5 32.0 35.4 41.9 24.6 19.3 38.1 33.2 41.4 43.8 84.0 48.3 90.6 21.3 79.7 39.8 32.7 37.7 30.3 47.1 62.0 25.3 38.4 67.4 46.3 46.3 32.4 61.7 67.2 32.9 19.8 28.9 23.3 30.5 29.1 49.6 30.4 22.2 21.1 31.3 29.9 51.7 62.3 24.6 36.9 34.2 51.4 28.8 31.2 26.2 45.5 51.0 94.2 39.6 36.2 33.7 36.2 17.5 19.7 17.5 16.4 25.5 35.2 20.9 17.7 30.9 26.7 25.3 27.6 4.5 31.8 23.1 25.6 30.3 14.6 15.2 14.9 17.0 22.3 14.6 16.8 15.7 15.5 16.8 15.4 15.5 18.2 12.5 0.0 11.5 16.0 33.6 31.7 43.1 71.5 37.5 12.0 23.7 28.2 18.5 15.7 30.4 16.5 10.4 50.3 24.8 9.7 56.7 26.0 44.1 16.1 21.4 16.2 9.5 25.5 19.3 16.1 51.6 22.1 16.3 13.4 26.0 17.2 13.6 19.4 47.0 3.3 18.1 25.3 48.8 32.1 59.1 9.5 36.7 26.8 28.4 9.4 30.2 23.1 37.0 15.1 19.7 18.2 18.1 28.2 24.5 15.9 25.4 59.7 28.7 11.9 19.7 18.2 39.6 45.7 22.6 34.5 46.3 30.8 31.1 8.9 29.4 35.6 PPM1B "PP2CB, PP2CBETA, PPC2BETAX" ENSG00000138032 "Protein phosphatase, Mg2+/Mn2+ dependent 1B" O75688 2 44167969-44244384 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 218.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA016745 Approved Approved Nucleoli,Cytosol NA NA 75000 "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli, Cytosol" "HPA016745: AB_1855622" "unprognostic (5.49e-2)" "unprognostic (2.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.96e-3)" "unprognostic (1.92e-2)" "unprognostic (1.48e-1)" "unprognostic (1.04e-1)" "unprognostic (1.50e-2)" "unprognostic (1.58e-1)" "unprognostic (1.94e-1)" "unprognostic (2.25e-1)" "unprognostic (6.71e-2)" "unprognostic (1.70e-2)" "unprognostic (3.81e-2)" "unprognostic (1.06e-1)" "unprognostic (1.34e-1)" "unprognostic (1.75e-2)" 40.2 20.4 41.2 19.5 48.0 44.0 23.9 45.1 61.8 23.0 43.1 28.6 20.3 23.9 30.0 22.5 21.2 21.8 33.3 38.6 42.1 29.0 44.0 21.9 28.7 41.4 44.1 22.9 32.4 35.8 18.9 18.8 42.1 30.6 28.7 49.9 27.0 23.3 129.4 20.5 21.7 22.8 40.2 26.4 23.1 21.4 42.7 36.0 22.8 86.5 27.0 24.7 21.4 50.9 37.1 32.8 41.8 31.2 51.3 23.8 47.6 27.9 32.0 28.2 24.8 43.8 23.3 40.7 42.4 32.4 23.0 19.6 47.6 18.2 41.6 41.7 18.4 42.9 19.9 30.8 41.4 38.6 34.1 23.0 31.5 22.5 37.9 22.2 23.5 18.4 31.7 41.5 25.7 30.6 38.6 61.5 52.4 33.4 11.0 40.5 46.6 27.1 66.3 36.9 33.7 42.5 25.3 37.4 33.5 62.3 20.2 26.7 21.6 24.7 35.5 20.6 27.8 36.2 25.5 37.7 13.4 63.2 18.3 6.9 2.2 8.1 4.6 3.0 3.9 4.2 4.3 3.9 3.7 4.5 5.8 4.0 6.1 3.2 3.6 3.6 4.3 1.1 41.2 48.0 45.1 61.8 38.6 42.1 41.4 44.1 42.1 40.2 42.7 50.9 17.4 19.2 20.8 78.4 49.3 60.5 40.3 14.4 35.3 51.9 31.8 19.9 55.4 38.6 24.0 40.5 64.6 31.5 68.6 64.5 46.9 42.5 68.5 44.1 33.3 22.0 40.2 32.8 95.9 46.4 29.7 33.7 35.2 62.4 26.6 27.4 20.3 55.0 26.8 107.7 91.8 31.5 30.5 55.2 63.0 43.0 35.8 45.0 56.9 38.4 46.7 57.5 51.5 112.6 218.0 44.7 46.6 33.8 51.9 71.2 26.8 41.0 16.9 147.5 26.3 33.5 32.4 48.5 27.7 36.6 62.4 64.6 63.8 29.5 37.3 88.7 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 4.4 2.4 2.7 2.2 5.2 5.9 3.9 14.8 4.6 4.5 5.0 3.1 2.9 4.3 2.9 3.5 3.7 3.1 2.9 3.3 3.4 2.8 2.8 3.6 2.7 4.0 3.5 6.3 3.3 2.3 2.4 5.9 4.7 3.1 3.5 6.4 3.1 2.2 4.0 2.9 2.7 3.0 3.4 3.8 2.7 5.5 3.7 4.4 2.9 3.1 2.3 2.8 4.0 9.1 3.8 6.9 7.5 6.4 5.0 3.1 10.7 5.8 3.6 3.4 4.9 7.1 2.0 9.9 4.5 3.7 1.3 3.4 4.9 2.2 4.6 1.9 11.1 7.4 6.7 8.1 4.2 2.9 5.3 2.7 3.6 5.1 3.0 2.8 7.9 4.1 5.4 4.0 3.7 34.4 8.1 4.4 3.5 3.4 5.2 9.5 9.6 6.6 3.1 4.2 10.5 7.4 7.1 2.4 1.6 8.0 2.8 3.9 5.7 4.7 12.5 3.5 3.3 6.7 7.7 7.3 1.7 2.9 3.8 9.9 16.1 18.0 7.6 12.5 6.8 8.9 6.3 7.0 16.0 6.2 6.8 7.0 24.7 8.6 8.1 7.0 10.6 9.8 2.7 5.2 14.8 4.6 3.3 3.4 4.0 3.5 4.7 3.4 3.7 9.1 40.9 32.1 7.7 15.0 23.1 21.0 6.2 3.3 52.3 13.1 14.2 9.8 6.3 8.6 4.6 5.5 4.2 17.6 19.4 15.0 3.9 6.6 68.9 14.0 15.5 25.2 14.4 14.1 19.6 6.6 6.4 14.7 10.2 15.6 1.3 7.2 23.6 4.2 8.8 3.3 20.8 11.4 6.1 21.4 19.2 12.8 13.7 16.1 3.6 28.1 12.3 7.0 6.2 20.6 38.6 5.4 10.2 7.5 24.5 7.8 8.7 5.1 3.6 10.4 0.0 12.1 14.0 43.8 15.0 34.4 18.0 38.6 18.1 6.0 11.5 7.7 PPM1E "CaMKP-N, KIAA1072, POPX1, PP2CH" ENSG00000175175 "Protein phosphatase, Mg2+/Mn2+ dependent 1E" Q8WY54 17 58755854-58985179 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 39.2;retina: 22.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 220.9;Horizontal cells: 77.4;Inhibitory neurons: 288.4;Oligodendrocyte precursor cells: 109.1" "Cancer enhanced" "Detected in some" "glioma: 2.7;prostate cancer: 3.0" "Group enriched" "Detected in many" 4 "cerebral cortex: 31.6;hippocampal formation: 39.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 12.2;HAP1: 19.9;MOLT-4: 9.9;SCLC-21H: 9.1;SH-SY5Y: 18.7;THP-1: 8.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018462, HPA019263" Approved Approved Nucleoplasm,Nucleoli Yes No "Cluster 46: Basophils - DNA binding" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Nucleoplasm "HPA018462: AB_1855623, HPA019263: AB_1855624" "unprognostic (2.50e-2)" "unprognostic (5.75e-2)" "unprognostic (8.12e-2)" "unprognostic (2.99e-2)" "unprognostic (5.30e-1)" "unprognostic (8.19e-2)" "unprognostic (3.96e-1)" "unprognostic (1.52e-1)" "unprognostic (3.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.80e-5)" "unprognostic (4.97e-2)" "unprognostic (1.23e-7)" "unprognostic (1.05e-4)" "unprognostic (1.64e-2)" "unprognostic (1.27e-1)" "unprognostic (9.12e-2)" 0.1 5.5 5.3 0.1 4.8 0.0 0.1 1.0 31.6 0.2 0.0 0.1 0.1 0.3 0.9 0.0 1.5 0.1 1.0 39.2 7.3 0.7 1.0 0.2 0.2 1.9 4.2 0.2 0.6 0.3 1.3 0.0 3.2 1.4 0.0 22.3 0.2 0.0 0.0 0.0 0.2 0.3 0.3 0.2 0.5 6.7 8.0 0.2 0.1 0.1 0.2 0.1 0.1 2.3 0.0 0.1 12.2 0.6 0.0 0.0 0.9 0.0 0.0 0.9 1.4 0.0 0.0 8.0 0.1 0.1 2.7 0.0 19.9 0.0 0.5 0.2 5.9 0.0 0.2 0.0 1.3 0.6 2.6 0.3 1.6 0.1 0.0 0.6 0.0 4.9 2.1 0.0 0.0 3.6 9.9 0.0 3.5 0.0 1.0 0.0 1.5 0.0 0.0 0.0 9.1 18.7 0.3 0.0 1.3 0.1 0.0 8.7 0.0 0.0 2.2 0.0 2.9 0.1 0.1 5.4 0.3 0.0 2.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 4.8 1.0 31.6 39.2 7.3 1.9 4.2 3.2 0.3 8.0 2.3 0.1 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 22.0 0.1 0.4 3.3 0.0 1.8 0.0 31.3 0.0 0.0 0.1 0.0 0.0 30.8 3.9 0.1 0.3 3.0 0.0 220.9 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 1.4 0.1 77.4 288.4 0.0 0.0 0.3 0.0 17.6 0.0 0.1 0.0 5.6 0.0 4.2 0.0 109.1 38.4 0.0 0.2 0.4 0.0 1.3 0.0 0.1 0.0 13.8 0.0 0.0 0.5 12.1 2.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 PRAG1 "DKFZp761P0423, NACK, PEAK2, PRAGMIN, SgK223" ENSG00000275342 "PEAK1 related, kinase-activating pseudokinase 1" Q86YV5 8 8317736-8386439 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.0;thyroid gland: 23.2" "Cell type enhanced" "Detected in many" "Adipocytes: 45.9;Breast glandular cells: 14.1;Breast myoepithelial cells: 11.0;Hofbauer cells: 18.3" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 35.0" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 50.2;NTERA-2: 32.1;SuSa: 32.1" "Low region specificity" "Detected in all" "HPA011776, HPA012066" Uncertain Uncertain "Nucleoli,Focal adhesion sites" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 7: Non-specific - Mitochondria" Nucleoli "Focal adhesion sites" "HPA011776: , HPA012066: AB_1847706" "unprognostic (7.04e-3)" "unprognostic (7.90e-2)" "unprognostic (2.32e-1)" "unprognostic (2.95e-2)" "unprognostic (1.60e-1)" "unprognostic (2.92e-1)" "unprognostic (1.05e-1)" "unprognostic (4.78e-3)" "unprognostic (2.64e-3)" "unprognostic (5.19e-2)" "unprognostic (4.95e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.81e-4)" "unprognostic (5.27e-2)" "unprognostic (1.23e-1)" "unprognostic (5.04e-2)" "unprognostic (5.22e-3)" 8.7 1.0 9.2 5.2 12.0 0.6 9.4 35.0 5.8 2.8 0.0 5.3 11.3 1.7 0.2 5.5 5.6 2.3 6.1 5.3 1.4 3.7 2.7 5.2 8.1 1.2 3.0 3.8 3.3 2.2 1.5 5.7 1.8 2.5 4.1 0.2 5.0 1.5 7.4 7.5 11.6 1.4 0.1 8.4 4.8 2.2 4.6 3.0 23.2 3.4 6.1 2.3 2.8 1.8 6.2 50.2 5.6 0.7 0.0 0.3 14.1 12.8 2.7 4.9 2.0 25.0 14.4 10.2 8.6 6.1 13.5 21.9 1.0 15.3 1.0 0.5 1.6 0.0 6.2 14.2 5.3 1.5 15.4 1.2 9.8 0.8 2.2 2.9 10.2 1.5 0.0 0.1 3.8 8.5 1.4 4.8 32.1 19.5 12.9 6.6 6.0 2.5 7.2 17.5 2.8 1.9 4.9 13.9 5.0 32.1 10.8 6.3 13.7 0.5 12.9 0.0 3.2 0.8 1.1 13.9 3.1 3.4 7.4 0.0 0.2 0.9 0.4 0.0 0.3 1.2 0.6 0.2 0.3 0.9 1.6 1.3 0.0 0.5 0.8 1.9 0.0 0.2 9.2 12.0 35.0 5.8 5.3 1.4 1.2 3.0 1.8 0.1 4.6 1.8 45.9 9.6 6.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 14.1 11.0 0.0 0.0 0.0 0.0 0.0 7.5 5.3 0.0 0.0 9.0 0.0 3.0 1.4 5.6 0.0 0.0 0.0 3.1 7.2 2.5 0.0 1.7 2.5 1.7 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.9 0.0 0.0 2.7 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.8 2.3 7.4 0.0 0.0 PRDM1 "BLIMP1, PRDI-BF1" ENSG00000057657 "PR/SET domain 1" O75626 6 105993463-106109939 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.2" "Cell type enhanced" "Detected in many" "dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4" "Group enriched" "Detected in many" 5 "granulocytes: 12.5;T-cells: 34.0" "Cell line enhanced" "Detected in many" "Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0" "Region enriched" "Detected in single" 6 "olfactory bulb: 3.6" "Low region specificity" "Detected in many" "HPA030033, HPA075427" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA030033: AB_10601050, HPA075427: " "unprognostic (9.60e-2)" "unprognostic (3.28e-2)" "unprognostic (1.71e-1)" "unprognostic (1.98e-2)" "unprognostic (4.03e-1)" "unprognostic (3.77e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" "unprognostic (2.42e-1)" "unprognostic (1.81e-1)" "unprognostic (3.50e-2)" "unprognostic (7.56e-2)" "prognostic unfavorable (9.81e-5)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (2.45e-3)" "unprognostic (7.90e-2)" 6.6 2.1 1.6 20.0 1.6 20.3 6.8 5.5 1.8 15.7 3.1 15.2 9.2 17.2 1.3 55.2 5.5 12.7 1.7 1.5 2.8 2.5 4.5 10.1 15.9 3.2 1.8 4.9 1.9 2.5 1.4 5.1 2.7 3.4 17.2 1.3 9.3 2.4 4.3 9.1 12.6 5.5 2.4 13.6 15.2 1.2 2.9 4.2 9.0 2.2 27.8 19.6 20.2 3.4 1.4 0.5 1.1 0.0 1.6 2.1 0.2 7.2 23.3 2.3 3.7 1.4 9.2 2.0 0.4 13.8 0.3 0.5 0.0 3.6 2.5 21.7 0.1 0.4 4.9 0.0 3.6 0.8 1.6 2.3 11.6 3.3 9.7 0.7 2.9 1.0 1.4 212.1 0.4 0.0 0.1 0.5 0.8 1.4 0.0 0.5 0.0 42.4 2.1 0.3 0.0 0.3 1.0 0.9 0.0 1.6 1.0 2.4 1.5 3.1 1.8 2.1 7.2 81.5 57.0 4.9 5.1 1.3 2.1 2.4 0.8 11.1 22.1 1.2 34.0 2.5 20.5 20.2 0.5 1.0 1.8 11.3 12.5 4.7 0.3 0.4 29.4 2.6 1.6 1.6 5.5 1.8 1.5 2.8 3.2 1.8 2.7 2.4 2.9 3.4 93.1 0.0 5.1 0.3 42.1 19.5 8.6 15.0 3.4 0.6 2.8 3.4 1.5 0.0 19.1 3.7 52.1 0.7 199.8 129.8 0.0 0.3 0.9 15.9 101.0 41.1 1.8 6.1 1.8 0.2 0.7 18.5 19.4 62.6 3.8 9.9 6.4 2.5 19.8 0.0 19.2 15.0 10.2 38.0 199.2 0.3 0.0 64.5 37.4 23.4 30.4 0.5 89.6 0.5 0.1 7.8 103.7 1.2 786.9 4.0 3.2 0.3 13.0 1.1 0.0 5.3 30.1 0.5 2.3 43.9 41.5 0.7 184.3 1.6 8.7 91.9 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 4.9 10.0 5.7 7.2 5.6 4.2 8.0 5.6 5.7 6.1 13.8 7.9 6.1 7.0 8.0 6.8 8.8 6.0 3.9 5.2 6.9 12.0 7.1 4.6 9.6 6.1 6.5 8.6 10.9 9.6 8.4 7.3 5.3 8.5 7.2 6.4 6.5 7.8 1.8 5.6 7.2 5.9 5.5 8.3 7.4 6.6 8.2 10.3 7.0 3.1 8.7 7.9 5.0 6.0 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 5.7 5.6 5.6 5.7 5.2 6.9 6.1 6.5 5.3 5.5 8.2 6.0 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 PTCH2 ENSG00000117425 "Patched 2" Q9Y6C5 1 44819844-44843253 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6" "Cell type enhanced" "Detected in many" "Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7" "Cancer enhanced" "Detected in many" "testis cancer: 9.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 11.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA046839 Supported "Nucleoli,Plasma membrane" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" "Plasma membrane" Nucleoli "HPA046839: " "unprognostic (6.54e-5)" "unprognostic (1.05e-1)" "unprognostic (7.29e-3)" "unprognostic (3.65e-3)" "unprognostic (3.89e-1)" "unprognostic (7.42e-3)" "unprognostic (3.01e-1)" "unprognostic (2.94e-2)" "unprognostic (1.51e-1)" "unprognostic (8.67e-2)" "prognostic favorable (5.74e-5)" "unprognostic (2.92e-1)" "unprognostic (5.74e-6)" "unprognostic (1.55e-2)" "unprognostic (4.86e-2)" "unprognostic (6.31e-2)" "unprognostic (6.81e-2)" 4.2 3.1 6.1 0.8 3.5 9.4 3.4 6.8 6.8 5.1 3.6 3.6 1.0 6.4 1.6 0.9 4.3 2.5 1.3 3.1 4.4 1.3 1.3 1.0 2.3 2.9 4.8 24.6 1.0 59.1 9.9 0.3 2.0 3.0 0.9 3.6 75.2 1.3 2.0 3.6 1.8 1.2 1.6 2.4 2.0 25.6 6.5 0.8 4.6 0.8 0.7 3.1 3.4 4.8 0.2 0.3 1.0 2.5 0.8 0.9 1.0 0.8 1.6 0.5 0.4 0.2 0.4 1.1 0.4 0.4 0.5 0.0 1.1 0.0 0.2 2.1 1.9 0.6 1.0 0.8 0.3 0.7 1.1 0.3 0.4 1.0 0.1 1.7 0.1 1.0 0.7 1.1 0.0 0.5 1.4 2.1 0.3 0.1 0.4 1.0 0.2 0.5 0.2 0.0 1.5 0.6 0.3 0.4 0.8 0.5 0.2 1.2 0.1 0.2 0.5 1.3 0.5 1.9 11.6 3.2 0.6 3.0 0.4 2.5 1.9 0.1 0.5 0.9 1.0 1.0 0.6 0.6 1.2 1.4 0.7 0.6 0.6 0.9 0.9 3.6 0.3 0.2 6.1 3.5 6.8 6.8 3.1 4.4 2.9 4.8 2.0 1.6 6.5 4.8 2.8 0.0 1.1 14.0 13.4 0.5 0.7 1.0 0.6 0.8 4.8 8.0 1.0 7.2 1.0 1.8 2.1 2.4 6.8 7.8 0.0 5.5 2.3 9.3 13.5 2.7 11.5 1.3 23.7 1.8 1.6 14.3 28.1 8.5 0.0 4.4 0.7 7.9 6.7 8.4 27.3 4.9 2.0 24.5 2.2 8.0 107.8 17.3 0.0 5.6 3.9 2.4 2.1 9.5 2.6 2.1 2.5 68.1 67.1 0.8 13.6 0.2 1.7 1.2 13.1 5.4 5.6 5.0 3.6 0.6 1.6 2.3 7.5 138.7 5.5 0.2 PTPN6 "HCP, HCPH, PTP-1C, SHP-1, SHP1" ENSG00000111679 "Protein tyrosine phosphatase non-receptor type 6" P29350 12 6946468-6961316 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 131.8;lymphoid tissue: 153.5" "Cell type enhanced" "Detected in many" "B-cells: 214.6;granulocytes: 137.3;Hofbauer cells: 191.6;Kupffer cells: 146.5;Langerhans cells: 118.2;Macrophages: 152.1;NK-cells: 154.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 170.9;HL-60: 154.3;HMC-1: 648.7;THP-1: 259.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001466, CAB004572, CAB072845" Enhanced Supported Nucleoplasm,Nucleoli NA NA 6000000 "Cluster 51: Monocytes - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" Nucleoplasm Nucleoli "CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930" "unprognostic (4.28e-3)" "prognostic favorable (1.87e-4)" "prognostic unfavorable (5.42e-4)" "prognostic favorable (6.65e-4)" "unprognostic (6.54e-2)" "unprognostic (7.92e-2)" "unprognostic (2.36e-1)" "unprognostic (1.44e-2)" "unprognostic (6.93e-3)" "unprognostic (3.57e-1)" "unprognostic (1.41e-2)" "unprognostic (2.61e-1)" "unprognostic (1.60e-3)" "unprognostic (1.98e-3)" "unprognostic (2.60e-2)" "unprognostic (5.91e-2)" "prognostic favorable (2.64e-8)" 14.4 15.6 3.7 102.5 3.9 131.8 11.0 4.3 4.2 11.1 6.0 21.9 30.4 6.2 10.2 12.8 13.9 20.3 4.9 3.6 5.2 12.2 19.3 49.7 153.5 7.0 4.6 2.9 11.9 13.7 10.0 19.8 6.3 11.7 21.3 0.7 17.0 9.0 2.0 18.8 42.0 12.3 5.9 128.0 28.0 3.1 6.3 71.3 12.6 4.5 127.3 27.0 7.5 10.6 16.4 30.8 0.2 0.1 0.1 0.0 28.5 0.0 0.0 0.0 0.0 16.5 36.0 11.9 8.4 0.0 0.0 18.3 0.3 21.6 0.0 7.3 6.5 170.9 3.4 13.9 0.0 154.3 648.7 0.1 15.4 0.0 6.5 0.0 0.0 60.0 0.3 1.3 0.0 34.5 55.4 92.2 8.3 38.0 5.1 50.4 0.2 86.5 16.7 30.2 2.7 0.0 5.2 24.9 0.2 20.9 7.7 259.8 0.4 0.0 0.2 0.1 0.2 0.4 0.2 5.5 0.4 66.3 0.5 676.7 368.3 1112.5 263.4 728.6 169.3 595.0 125.3 195.9 377.0 650.0 142.7 182.6 674.8 238.6 1117.7 98.7 146.8 789.3 3.7 3.9 4.3 4.2 3.6 5.2 7.0 4.6 6.3 5.9 6.3 10.6 10.5 6.4 13.8 0.7 214.6 9.1 8.2 18.8 29.6 0.0 8.6 10.0 2.1 11.5 15.3 5.5 0.0 25.6 77.7 16.0 15.6 15.8 50.4 12.1 1.5 7.5 24.7 22.9 0.9 15.4 18.3 3.0 25.0 11.8 137.3 10.9 8.9 11.6 191.6 0.0 0.9 13.2 18.3 146.5 118.2 10.5 0.9 152.1 14.2 3.7 99.7 0.5 154.5 2.0 0.1 12.6 16.9 0.0 53.5 3.9 22.8 14.3 17.2 0.5 6.6 1.6 4.0 0.3 1.3 14.6 8.7 18.5 86.2 24.5 15.6 7.8 PTTG1 "EAP1, HPTTG, PTTG, securin, TUTR1" ENSG00000164611 "PTTG1 regulator of sister chromatid separation, securin" O95997 5 160421855-160428739 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 160.1;lymphoid tissue: 144.9;testis: 175.6" "Cell type enhanced" "Detected in many" "Early spermatids: 770.5;Erythroid cells: 415.9;Langerhans cells: 412.3;Spermatocytes: 708.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "T-reg: 218.0" "Lineage enriched" "Detected in all" 7 "T-cells: 218.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008373, HPA008890, HPA045034" Enhanced Supported Nucleoli,Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoli "CAB008373: AB_592493, HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (6.48e-2)" "unprognostic (1.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.46e-3)" "unprognostic (5.81e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.62e-6)" "unprognostic (7.50e-3)" "unprognostic (5.24e-2)" "unprognostic (3.47e-2)" "unprognostic (2.13e-3)" "unprognostic (6.70e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.17e-2)" "unprognostic (1.72e-1)" "unprognostic (4.23e-2)" "unprognostic (3.35e-2)" 3.7 3.5 4.2 25.2 5.3 160.1 10.9 4.1 11.5 9.6 4.0 33.9 24.6 4.8 9.6 59.7 5.0 6.1 3.5 8.1 6.6 3.0 5.3 8.7 81.5 3.9 4.8 1.8 1.5 2.3 4.3 21.2 4.2 3.1 44.1 2.4 10.3 2.7 2.5 36.0 24.1 19.2 4.0 18.6 11.8 175.6 5.3 127.0 79.3 1.3 144.9 12.5 19.9 4.7 345.4 178.2 385.8 279.5 64.4 63.3 120.8 177.5 406.1 463.4 503.5 341.1 294.9 373.3 154.7 204.2 527.5 176.1 243.5 496.1 661.2 428.3 220.3 196.7 241.8 208.6 13.0 181.5 165.6 29.6 81.5 315.4 189.5 139.9 333.4 243.3 160.7 282.3 485.4 162.3 220.7 446.1 197.5 279.3 251.4 199.4 452.4 320.7 239.6 82.6 241.0 151.3 258.6 156.3 535.6 309.3 319.9 195.7 144.8 208.3 275.9 164.9 531.3 239.2 235.6 432.3 225.9 310.4 379.6 9.7 3.2 10.3 25.5 8.7 9.6 30.9 52.3 60.6 23.9 23.5 12.7 31.4 3.0 14.6 5.8 22.6 218.0 19.8 4.2 5.3 4.1 11.5 8.1 6.6 3.9 4.8 4.2 4.0 5.3 4.7 11.8 6.4 21.5 0.0 40.0 247.9 64.5 163.6 142.3 3.4 15.8 40.5 4.0 4.3 31.1 5.5 0.0 125.4 38.3 17.7 3.9 5.8 770.5 22.7 9.3 20.6 6.0 415.9 1.3 5.3 196.2 35.6 28.1 16.7 37.5 66.2 18.5 7.1 87.5 0.0 1.6 39.2 126.1 36.3 412.3 105.1 11.1 39.1 87.2 0.0 24.7 3.5 6.2 0.0 0.6 3.0 10.7 7.9 91.4 54.1 9.0 2.0 17.1 1.0 6.6 18.6 43.2 708.0 57.3 232.0 156.1 31.9 73.7 16.8 70.3 50.3 PTTG2 ENSG00000250254 "Pituitary tumor-transforming 2" Q9NZH5 4 37960398-37961128 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 4.7;Early spermatids: 5.2;Langerhans cells: 12.9;Smooth muscle cells: 3.7;Spermatocytes: 4.3;Suprabasal keratinocytes: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008890, HPA045034" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoli "HPA008890: AB_1079717, HPA045034: AB_2679192" "unprognostic (3.29e-1)" "unprognostic (4.41e-4)" "unprognostic (1.11e-1)" "unprognostic (2.07e-2)" "unprognostic (1.74e-2)" "unprognostic (9.58e-2)" "unprognostic (2.27e-1)" "unprognostic (2.74e-1)" "unprognostic (7.07e-2)" "unprognostic (2.74e-2)" "unprognostic (2.20e-1)" "unprognostic (3.46e-2)" "unprognostic (1.64e-1)" "unprognostic (1.34e-1)" "unprognostic (3.32e-1)" "unprognostic (8.60e-5)" 0.2 0.0 0.5 0.2 0.7 1.1 0.1 0.6 1.0 0.4 0.2 1.4 0.0 0.5 0.3 0.1 0.5 0.2 1.0 1.0 0.0 0.3 0.3 0.4 0.2 0.3 0.1 0.2 0.2 0.1 0.2 0.1 0.4 0.3 0.1 0.0 0.1 0.2 0.7 0.1 0.4 0.3 0.1 0.9 0.3 0.0 0.1 0.1 0.2 0.6 0.2 0.6 0.3 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.7 0.6 1.0 1.0 0.0 0.3 0.1 0.4 0.1 0.1 1.0 0.3 0.0 0.0 0.0 0.8 4.7 0.7 0.7 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.0 0.6 1.5 0.0 0.0 0.0 5.2 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.6 12.9 0.5 0.6 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.2 0.0 0.0 0.6 3.7 4.3 0.2 0.0 2.8 0.0 0.6 0.0 0.2 0.4 PUS7L DKFZP434G1415 ENSG00000129317 "Pseudouridine synthase 7 like" Q9H0K6 12 43718992-43758793 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056203, HPA058750" Uncertain Approved "Nucleoli,Nuclear speckles" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" Nucleoli "HPA056203: AB_2683064, HPA058750: AB_2683807" "unprognostic (3.41e-3)" "unprognostic (1.03e-1)" "unprognostic (2.51e-3)" "unprognostic (1.83e-1)" "unprognostic (3.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.87e-4)" "unprognostic (1.11e-1)" "unprognostic (8.11e-3)" "unprognostic (1.37e-2)" "unprognostic (3.49e-1)" "unprognostic (2.54e-2)" "unprognostic (1.80e-3)" "unprognostic (1.32e-1)" "unprognostic (2.56e-1)" "unprognostic (2.50e-2)" "unprognostic (9.27e-2)" 2.7 3.1 3.3 4.9 3.6 3.5 5.4 6.8 5.2 4.1 0.3 3.8 3.8 3.6 3.7 4.8 2.9 3.8 2.7 2.9 2.6 3.1 3.2 2.4 5.7 2.6 2.0 4.7 4.3 4.4 4.1 4.0 2.7 4.0 4.5 11.7 4.0 3.5 1.7 3.7 3.6 3.1 1.1 3.4 3.9 3.0 3.2 5.1 5.7 1.7 5.9 3.4 2.7 3.7 11.2 8.3 7.2 4.1 4.9 17.4 12.8 9.6 8.1 12.6 9.6 29.9 7.9 25.7 11.9 11.9 7.3 9.9 10.5 9.7 21.5 7.9 6.5 18.8 9.2 11.2 6.1 30.3 11.7 7.2 7.1 13.1 13.5 11.6 9.2 14.9 33.3 10.9 29.7 4.5 15.8 7.8 13.3 0.0 8.8 14.7 16.9 15.4 5.6 8.5 12.1 3.9 11.9 12.8 5.1 8.5 15.1 8.4 6.7 12.8 8.4 15.0 15.2 9.6 17.7 25.5 11.8 49.1 4.3 6.4 1.9 2.2 2.1 1.7 2.7 2.1 2.3 2.3 2.1 2.8 2.0 2.9 1.3 2.5 1.6 2.3 1.0 1.5 3.3 3.6 6.8 5.2 2.9 2.6 2.6 2.0 2.7 1.1 3.2 3.7 30.5 9.6 17.2 29.0 41.1 11.6 19.0 30.8 22.8 68.9 24.2 16.0 12.3 14.3 21.2 25.8 68.8 34.3 34.4 13.5 41.1 20.4 2.5 14.9 28.5 23.3 19.3 25.2 49.5 23.2 23.3 26.5 28.5 18.9 17.1 43.7 16.8 20.8 20.4 43.7 79.5 25.2 18.3 25.0 10.5 4.2 20.2 20.3 12.4 15.0 24.6 33.1 35.0 41.7 51.2 18.2 17.0 26.7 48.7 16.9 19.6 22.7 9.2 106.1 19.7 28.1 18.1 25.2 35.3 19.9 11.1 24.2 32.7 36.3 30.0 13.9 PVRIG "C7orf15, CD112R, MGC2463" ENSG00000213413 "PVR related immunoglobulin domain containing" Q6DKI7 7 100218241-100221490 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 10.7;lymphoid tissue: 38.1" "Cell type enhanced" "Detected in some" "B-cells: 3.4;granulocytes: 2.5;Horizontal cells: 3.3;NK-cells: 4.1;Plasma cells: 1.9;T-cells: 6.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 33 "gdT-cell: 233.3;MAIT T-cell: 277.1;memory B-cell: 139.3;memory CD4 T-cell: 153.0;memory CD8 T-cell: 231.4;naive B-cell: 124.3;naive CD4 T-cell: 169.5;naive CD8 T-cell: 167.1;NK-cell: 263.0;T-reg: 136.0" "Group enriched" "Detected in all" 39 "B-cells: 139.3;NK-cells: 263.0;T-cells: 277.1" "Group enriched" "Detected in some" 28 "Daudi: 96.5;JURKAT: 55.9;MOLT-4: 107.2;U-698: 32.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA047497 Uncertain Approved "Nucleoli,Endoplasmic reticulum" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 58: T-cells - T-cell receptor" "Nucleoli, Endoplasmic reticulum" "HPA047497: AB_2680069" "unprognostic (1.63e-2)" "unprognostic (1.28e-2)" "unprognostic (2.21e-3)" "unprognostic (5.13e-2)" "unprognostic (9.89e-2)" "unprognostic (1.53e-3)" "unprognostic (1.35e-3)" "unprognostic (1.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.81e-1)" "unprognostic (5.58e-2)" "unprognostic (5.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.17e-1)" "unprognostic (2.43e-2)" "unprognostic (4.12e-1)" "unprognostic (2.71e-3)" 0.7 0.3 0.7 6.4 3.2 1.7 0.3 3.7 3.1 0.3 0.0 1.0 0.8 0.4 0.0 0.5 0.4 0.8 0.2 0.5 1.2 0.5 1.3 1.2 18.8 4.7 1.9 0.8 0.7 0.0 0.2 0.1 2.4 0.4 0.1 0.6 1.1 0.0 2.5 0.3 10.7 0.0 0.1 24.2 1.9 0.8 2.8 38.1 0.7 0.0 4.5 1.0 0.5 6.7 0.3 2.0 1.0 0.3 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.1 0.2 96.5 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 55.9 0.2 0.4 0.0 0.2 107.2 0.0 0.3 0.1 0.2 0.4 0.1 1.2 0.0 0.2 2.1 0.5 0.0 0.1 0.0 0.7 0.1 0.2 0.2 0.1 0.8 0.1 0.0 0.2 0.1 32.0 0.0 0.1 0.0 0.9 0.7 0.3 233.3 1.1 277.1 139.3 153.0 231.4 0.7 124.3 169.5 167.1 5.7 263.0 1.0 1.1 136.0 104.4 0.7 3.2 3.7 3.1 0.5 1.2 4.7 1.9 2.4 0.1 2.8 6.7 0.0 0.0 0.6 0.3 3.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.2 2.5 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.8 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 PWP2 "EHOC-17, PWP2H, UTP1" ENSG00000241945 "PWP2 small subunit processome component" Q15269 21 44107373-44131181 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 10.7;Basal respiratory cells: 9.6;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 82.9;Daudi: 84.3;U-266/84: 66.6" HPA024573 Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (1.85e-1)" "unprognostic (4.73e-2)" "unprognostic (2.67e-1)" "unprognostic (6.81e-2)" "unprognostic (2.06e-1)" "unprognostic (8.39e-2)" "unprognostic (3.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.76e-1)" "unprognostic (3.31e-3)" "unprognostic (9.48e-2)" "unprognostic (1.50e-1)" "unprognostic (6.36e-4)" "unprognostic (6.37e-5)" "unprognostic (6.12e-2)" "unprognostic (5.62e-2)" "unprognostic (1.55e-1)" 4.0 3.2 3.3 3.2 4.4 0.9 3.3 3.6 4.4 4.2 2.4 3.6 1.5 3.3 2.6 3.5 5.7 0.5 3.7 3.5 3.2 2.6 3.0 3.2 3.0 3.5 3.5 2.9 4.1 1.9 2.2 2.5 4.2 3.0 0.3 1.2 3.4 1.4 5.0 4.9 3.7 0.5 3.2 4.5 4.6 3.1 3.4 5.6 2.9 7.2 6.9 4.1 3.2 5.7 4.7 0.5 1.5 3.6 10.4 11.4 28.5 39.2 16.9 44.3 29.5 82.9 1.4 84.3 1.4 0.0 4.5 4.2 1.5 26.4 24.7 24.4 59.5 10.8 15.6 19.2 6.2 6.8 2.9 0.7 0.0 27.1 0.0 10.1 1.7 39.2 32.5 33.8 17.1 1.1 0.2 2.1 1.5 4.1 3.3 4.8 0.2 44.1 0.0 1.2 26.8 5.4 2.2 3.0 24.2 14.6 0.9 3.2 20.9 19.6 3.1 42.4 4.3 47.6 66.6 3.7 1.8 10.6 28.4 0.5 2.2 2.5 4.7 2.7 5.8 5.1 4.0 5.1 1.8 3.4 3.7 4.6 1.1 2.7 3.7 2.2 3.3 3.0 3.3 4.4 3.6 4.4 3.5 3.2 3.5 3.5 4.2 3.2 3.4 5.7 0.4 0.0 2.0 0.3 3.2 10.7 0.1 9.6 3.4 0.7 1.1 0.3 4.5 0.0 5.4 0.0 0.0 0.1 2.3 4.6 1.9 0.0 0.1 0.2 0.2 2.0 2.4 4.8 0.0 0.0 2.0 1.8 1.1 0.4 0.0 0.3 2.2 0.3 1.9 0.0 0.0 3.8 6.1 5.4 4.9 0.0 1.2 0.4 1.8 0.0 0.6 0.5 3.1 0.0 0.0 0.0 2.4 0.0 1.5 1.2 1.8 0.3 4.6 0.3 0.0 1.4 3.7 1.4 1.7 0.8 8.5 0.7 2.6 0.5 4.6 0.3 PYHIN1 "IFIX, MGC23885" ENSG00000163564 "Pyrin and HIN domain family member 1" Q6K0P9 1 158930796-158977059 "Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 23.1" "Group enriched" "Detected in many" 5 "dendritic cells: 165.9;NK-cells: 324.4;T-cells: 104.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 4 "gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3" "Group enriched" "Detected in many" 5 "NK-cells: 36.8;T-cells: 97.3" "Cell line enriched" "Detected in some" 6 "U-698: 49.1" "HPA051224, HPA055373" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli Nucleoplasm "HPA051224: AB_2681394, HPA055373: " "unprognostic (1.64e-3)" "unprognostic (1.75e-3)" "unprognostic (2.93e-3)" "unprognostic (2.64e-3)" "unprognostic (3.99e-2)" "unprognostic (3.57e-3)" "unprognostic (2.44e-3)" "unprognostic (2.10e-2)" "unprognostic (1.52e-1)" "unprognostic (1.47e-3)" "unprognostic (3.94e-2)" "unprognostic (2.23e-1)" "unprognostic (1.70e-6)" "unprognostic (1.83e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-2)" "unprognostic (4.45e-3)" 2.3 0.6 0.2 8.3 0.3 5.5 1.2 0.2 0.4 1.0 0.4 1.7 1.6 1.1 0.8 0.8 0.9 3.8 0.6 0.3 0.4 0.7 3.2 3.7 23.1 0.7 0.3 0.8 0.3 0.2 0.3 0.9 0.6 1.0 2.1 0.1 1.6 0.5 0.3 0.5 5.4 0.7 0.2 13.9 2.7 0.4 0.5 3.7 1.4 0.6 12.5 3.3 0.8 1.2 0.0 0.0 0.0 0.0 0.7 0.4 0.6 0.0 0.2 0.0 0.1 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.9 0.0 0.2 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.1 0.1 0.0 0.0 0.9 0.0 49.1 0.0 7.7 0.0 1.5 0.3 0.4 97.3 0.4 56.3 14.8 40.8 74.7 0.3 8.7 13.5 45.1 3.5 36.8 0.5 0.6 67.3 21.0 0.2 0.3 0.2 0.4 0.3 0.4 0.7 0.3 0.6 0.2 0.5 1.2 1.3 12.8 2.8 1.0 17.0 0.4 0.6 0.0 0.0 0.5 1.2 0.9 0.6 0.0 2.0 3.7 0.0 0.1 165.9 0.1 0.0 0.1 0.3 0.5 0.3 1.2 0.0 7.4 0.5 0.0 0.0 2.7 2.6 0.2 2.5 0.1 3.9 1.2 2.7 0.0 0.5 0.0 0.0 5.0 1.5 0.3 0.0 3.5 1.8 6.5 2.3 0.5 324.4 0.0 0.2 0.0 0.0 0.0 37.9 0.6 0.0 0.6 5.3 1.1 0.0 0.7 0.7 0.1 0.2 0.1 0.6 0.1 104.7 0.0 0.2 0.4 RABGEF1 "rabex-5, RABEX5" ENSG00000154710 "RAB guanine nucleotide exchange factor 1" Q9UJ41 7 66682164-66811464 "Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 76.7" "Cell type enhanced" "Detected in many" "Astrocytes: 91.4;Excitatory neurons: 124.5;Inhibitory neurons: 151.1;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 244.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001407 Supported Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Nucleoli "HPA001407: AB_1856024" "unprognostic (6.65e-2)" "unprognostic (6.44e-4)" "unprognostic (7.32e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (4.06e-5)" "unprognostic (3.77e-1)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (8.51e-2)" "unprognostic (3.32e-1)" "unprognostic (4.64e-4)" "unprognostic (6.45e-2)" "prognostic favorable (1.27e-4)" "unprognostic (1.43e-1)" "unprognostic (5.55e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" 16.2 14.1 15.0 11.2 14.9 76.7 13.0 14.9 18.8 13.1 15.6 10.7 8.0 11.5 10.0 19.6 8.8 14.2 9.8 15.2 16.1 11.5 14.8 10.5 11.5 15.6 14.7 12.0 9.7 14.8 4.4 13.2 15.3 12.0 11.9 49.8 8.6 17.3 13.0 23.9 9.2 12.4 14.3 9.4 10.5 25.1 15.5 13.2 15.9 13.3 16.9 19.1 14.1 17.6 47.5 10.2 10.0 16.9 32.1 45.2 10.4 40.9 52.8 42.6 40.2 12.2 28.5 22.4 13.9 60.7 28.2 17.7 16.8 22.3 59.0 14.9 11.2 12.5 14.6 11.8 25.5 21.5 16.9 22.2 28.5 54.9 60.4 33.2 11.3 13.7 21.6 13.9 42.9 19.2 13.2 27.7 15.0 20.2 19.3 12.2 20.1 14.7 37.4 19.5 12.2 17.8 16.8 37.5 19.6 15.6 19.4 12.3 14.0 65.8 12.2 42.4 32.0 19.8 28.7 25.1 31.6 23.0 18.6 18.3 6.5 7.8 7.4 5.7 8.1 9.1 6.3 8.9 6.1 12.5 6.3 6.3 11.8 13.8 12.9 8.1 5.1 6.4 15.0 14.9 14.9 18.8 15.2 16.1 15.6 14.7 15.3 14.3 15.5 17.6 7.3 12.8 12.8 91.4 11.5 4.1 11.4 3.2 10.2 9.9 11.5 7.7 4.8 4.3 10.9 5.5 16.7 3.8 13.2 10.0 11.7 5.4 5.4 13.6 12.5 5.7 18.0 3.0 124.5 5.5 3.8 14.6 8.6 22.0 14.0 8.8 5.7 8.0 4.8 8.4 151.1 4.3 2.0 15.2 5.0 2.8 5.9 19.9 1.8 60.9 6.2 5.5 7.2 100.5 244.1 18.1 13.4 9.4 15.2 13.4 4.4 5.5 11.9 18.9 0.0 10.6 8.5 8.4 6.5 8.3 6.7 13.5 9.5 7.0 5.5 12.3 RBBP5 "RBQ3, SWD1" ENSG00000117222 "RB binding protein 5, histone lysine methyltransferase complex subunit" Q15291 1 205086142-205122015 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049042, HPA058085" Uncertain Supported Nucleoplasm,Nucleoli No No "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA049042: AB_2680610, HPA058085: AB_2683600" "unprognostic (8.72e-2)" "unprognostic (6.35e-2)" "unprognostic (2.14e-2)" "unprognostic (1.36e-2)" "unprognostic (1.60e-1)" "unprognostic (1.17e-1)" "unprognostic (4.61e-3)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.88e-1)" "unprognostic (2.75e-1)" "unprognostic (4.98e-2)" "unprognostic (6.90e-2)" "unprognostic (3.78e-3)" "unprognostic (4.95e-2)" "unprognostic (1.28e-1)" "unprognostic (4.88e-2)" 6.3 8.2 4.7 7.2 5.3 9.5 7.9 6.4 6.4 7.8 2.7 7.0 7.1 8.1 7.5 7.0 7.5 6.1 6.4 5.7 5.3 12.4 11.0 6.6 11.3 3.4 3.8 9.5 8.2 9.4 6.1 6.5 3.8 6.9 8.0 9.8 7.6 6.9 8.7 8.5 6.7 7.1 4.3 9.3 6.7 6.1 4.5 13.2 9.8 9.9 12.8 7.5 5.2 6.4 16.3 16.9 16.0 19.0 21.8 12.5 17.3 15.2 12.9 19.0 18.8 17.9 19.1 25.3 11.3 11.1 15.5 18.2 26.9 10.1 22.4 21.6 14.5 21.2 16.4 14.6 14.1 26.9 16.6 10.1 12.9 17.6 15.0 12.7 15.4 17.9 41.6 25.2 16.0 15.0 26.1 11.3 26.1 14.2 27.9 22.9 33.9 31.6 13.2 11.7 25.0 20.1 21.3 22.3 19.2 19.0 24.2 14.9 11.8 15.6 16.6 23.1 20.2 12.2 18.3 30.6 13.9 16.5 24.5 22.0 4.9 7.9 8.0 6.4 8.5 7.8 7.4 8.1 5.4 6.2 7.1 8.7 11.6 8.2 8.3 6.0 8.1 3.5 4.7 5.3 6.4 6.4 5.7 5.3 3.4 3.8 3.8 4.3 4.5 6.4 14.7 19.2 12.2 11.4 31.0 26.9 9.7 5.9 15.9 14.5 18.9 14.6 7.1 8.6 13.4 22.0 29.2 9.1 25.2 15.8 9.8 12.1 7.3 13.1 14.0 13.2 12.1 23.1 19.9 11.6 10.7 13.5 9.7 21.0 13.9 25.6 17.2 21.8 10.9 16.8 15.7 14.0 10.2 15.6 25.9 3.2 12.8 17.9 19.6 8.4 15.6 12.6 15.5 14.6 21.2 13.6 9.8 16.1 25.9 13.5 14.7 28.8 13.2 18.3 19.7 21.9 14.1 10.2 20.4 14.6 33.8 10.8 27.9 12.6 15.8 13.4 RBM43 "C2orf38, FLJ45645" ENSG00000184898 "RNA binding motif protein 43" Q6ZSC3 2 151247940-151261863 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.4;HSkMC: 18.5" "Low region specificity" "Detected in all" HPA038204 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Nucleoplasm "HPA038204: AB_10669520" "unprognostic (3.50e-2)" "unprognostic (5.45e-2)" "unprognostic (2.41e-1)" "unprognostic (1.52e-1)" "unprognostic (1.15e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-1)" "unprognostic (1.12e-1)" "unprognostic (2.16e-1)" "unprognostic (1.29e-1)" "unprognostic (9.72e-3)" "unprognostic (2.57e-2)" "unprognostic (3.43e-3)" "unprognostic (1.22e-2)" "unprognostic (3.07e-2)" "unprognostic (1.12e-2)" "unprognostic (9.94e-2)" 5.2 8.7 2.4 4.2 2.3 6.7 6.9 1.6 2.3 7.5 3.5 4.2 3.0 7.6 9.4 3.2 12.3 6.8 3.2 2.1 2.7 7.0 6.7 6.1 6.9 2.9 2.9 15.4 4.0 5.1 2.9 5.7 2.3 6.5 4.4 1.8 5.2 7.7 3.4 4.7 3.9 5.7 2.8 7.9 4.6 3.6 2.9 7.0 12.3 2.5 4.7 3.8 3.1 3.0 3.5 2.2 3.5 4.7 9.4 20.4 2.3 4.0 9.2 5.0 7.2 0.1 5.7 2.7 1.5 7.3 2.7 1.7 1.1 4.6 2.5 4.2 2.5 6.6 1.0 0.2 9.1 8.2 2.2 18.5 5.0 4.0 3.0 7.4 10.7 2.9 2.7 3.0 6.8 3.5 4.7 3.9 1.3 0.1 4.2 3.2 4.1 1.6 8.4 3.0 1.3 4.2 3.8 2.8 7.8 0.6 4.1 5.2 6.1 3.7 3.3 3.2 1.7 1.1 0.8 0.0 9.7 3.3 2.3 1.0 0.7 3.0 1.2 0.9 2.0 1.2 1.6 1.5 0.5 1.3 2.0 1.5 0.8 2.7 2.4 0.2 0.8 0.6 2.4 2.3 1.6 2.3 2.1 2.7 2.9 2.9 2.3 2.8 2.9 3.0 26.5 3.2 8.9 2.9 9.6 3.3 3.2 5.8 5.7 6.7 8.6 14.9 2.6 11.5 5.7 18.4 0.0 6.8 8.4 1.7 27.4 6.8 3.0 30.9 17.2 16.9 6.1 8.8 1.0 5.9 4.7 21.8 5.6 9.4 3.8 13.4 20.7 9.1 5.1 6.7 1.3 6.9 4.1 10.4 4.3 2.4 28.0 8.2 3.6 2.8 12.3 22.1 13.4 4.0 0.9 4.6 5.6 29.0 5.5 2.8 5.5 18.2 26.3 1.3 0.0 18.4 13.0 0.5 3.6 7.3 3.1 1.4 13.5 30.4 3.7 2.2 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein X-linked 2" Q9Y388 X 130401987-130413656 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 37: B-cells - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 15.6 12.2 26.3 10.1 26.1 11.8 14.6 26.1 48.8 21.7 23.6 17.3 10.4 16.8 16.4 13.8 16.3 9.9 13.9 26.3 27.4 14.4 13.0 11.6 14.1 25.8 26.3 18.0 16.5 10.5 11.9 10.5 26.1 15.0 11.6 11.2 11.9 12.3 12.4 17.4 12.8 13.2 25.3 15.1 14.5 7.0 26.2 17.2 12.6 10.0 16.6 16.6 15.6 27.9 22.7 23.3 23.4 24.3 23.1 41.3 23.2 21.0 21.1 23.2 25.4 17.5 27.6 21.8 48.9 16.1 31.1 24.4 37.2 19.2 33.4 20.2 32.5 19.8 22.6 18.6 20.2 30.6 22.8 30.2 27.1 25.9 36.1 33.8 26.1 27.2 17.2 18.8 26.4 39.2 36.4 37.9 17.4 40.0 37.2 27.4 22.7 29.5 23.7 18.0 26.8 32.0 13.2 28.0 39.1 18.8 18.2 22.2 17.5 19.0 15.5 44.8 43.6 24.6 27.9 30.5 22.9 49.5 23.9 9.3 6.8 8.6 7.7 7.7 8.2 10.9 10.0 10.7 5.9 9.0 10.6 9.7 6.0 7.3 7.2 7.7 16.5 4.1 26.3 26.1 26.1 48.8 26.3 27.4 25.8 26.3 26.1 25.3 26.2 27.9 30.5 19.2 19.0 5.5 32.9 32.1 29.0 42.8 22.8 22.0 27.5 33.0 22.6 22.8 40.1 11.0 10.4 33.1 28.4 14.1 15.6 34.2 3.8 21.0 43.5 31.9 40.7 19.4 7.4 35.6 40.8 27.3 13.7 18.3 35.5 27.8 45.0 24.5 34.5 16.8 8.2 23.6 36.7 47.6 24.4 5.8 32.3 27.6 28.4 2.8 41.5 23.3 41.2 7.1 9.4 29.8 18.1 44.0 17.9 26.4 17.9 39.5 27.9 12.5 32.9 30.8 29.8 30.2 53.3 22.4 29.7 25.9 32.0 31.9 29.2 22.9 RBMY1A1 "RBM1, RBM2, YRRM1, YRRM2" ENSG00000234414 "RNA binding motif protein Y-linked family 1 member A1" P0DJD3 Y 21511372-21549326 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Activator, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 96 "testis: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "U-266/84: 15.1" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1B ENSG00000242875 "RNA binding motif protein Y-linked family 1 member B" A6NDE4 Y 21511338-21549094 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 74: Testis - Spermatogenesis" Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1D ENSG00000244395 "RNA binding motif protein Y-linked family 1 member D" P0C7P1 Y 21880076-21894526 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1E ENSG00000242389 "RNA binding motif protein Y-linked family 1 member E" A6NEQ0 Y 21903618-21918067 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 2.6" "Group enriched" "Detected in some" 6 "Spermatocytes: 1.7;Spermatogonia: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "U-266/84: 2.3" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1F MGC33094 ENSG00000169800 "RNA binding motif protein Y-linked family 1 member F" Q15415 Y 22168542-22182982 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 26 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 325 "U-266/70: 29.7;U-266/84: 35.2" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Nucleoplasm, Nucleoli" "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.7 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RBMY1J ENSG00000226941 "RNA binding motif protein Y-linked family 1 member J" Q15415 Y 22403461-22417881 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 193 "U-266/70: 25.2;U-266/84: 13.3" "HPA001534, HPA053147, HPA057723" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" Nucleoplasm Nucleoli "HPA001534: AB_2178972, HPA053147: AB_2682056, HPA057723: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.2 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RDM1 "MGC33977, RAD52B" ENSG00000278023 "RAD52 motif containing 1" Q8NG50 17 35918066-35930773 "Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 11.9" "Group enriched" "Detected in some" 15 "Early spermatids: 59.4;Late spermatids: 81.9;Spermatocytes: 25.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "memory CD8 T-cell: 2.6" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Cell line enhanced" "Detected in many" "HEK 293: 11.5;JURKAT: 17.7" "Low region specificity" "Detected in all" "HPA024794, HPA067546" Enhanced Supported Nucleoli,Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli Cytosol "HPA024794: AB_1856039, HPA067546: AB_2732769" "unprognostic (9.36e-2)" "unprognostic (2.40e-2)" "unprognostic (8.00e-2)" "unprognostic (4.57e-3)" "unprognostic (1.91e-2)" "unprognostic (1.26e-1)" "unprognostic (2.06e-4)" "unprognostic (5.95e-2)" "unprognostic (1.83e-2)" "unprognostic (1.71e-2)" "unprognostic (2.58e-2)" "unprognostic (3.24e-2)" "unprognostic (1.06e-8)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "unprognostic (7.00e-3)" "unprognostic (1.53e-1)" 0.1 0.1 0.6 0.5 0.4 0.5 0.3 1.2 0.6 0.2 0.1 0.5 0.8 0.0 0.5 0.3 0.2 0.1 0.0 0.6 0.5 0.1 0.2 0.1 1.1 0.2 0.3 0.0 0.0 0.0 0.3 0.4 0.4 0.1 0.8 0.4 0.0 0.1 0.0 0.7 0.6 0.1 0.0 0.3 0.4 11.9 0.5 2.4 0.3 0.0 1.5 0.1 0.1 0.3 4.8 4.2 1.8 2.4 0.1 0.0 1.9 0.9 0.1 1.1 2.1 7.0 6.6 5.6 2.2 0.4 5.1 0.9 3.6 2.9 3.6 2.6 11.5 2.9 2.0 0.0 0.0 0.3 1.5 0.0 0.4 0.3 0.6 1.5 0.1 17.7 2.1 0.0 0.4 4.3 1.5 3.0 0.7 9.0 3.1 1.1 0.0 0.0 1.3 2.4 2.8 1.1 0.4 1.4 3.7 5.1 8.9 0.7 0.0 0.1 2.6 0.0 0.6 5.5 1.5 2.2 2.9 1.7 1.0 0.0 0.0 0.0 0.7 0.0 1.3 0.0 0.8 2.6 0.1 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.5 0.2 0.6 0.4 1.2 0.6 0.6 0.5 0.2 0.3 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 3.7 0.4 0.1 0.0 0.1 59.4 0.9 0.2 0.1 1.2 0.4 0.6 0.0 1.0 0.3 0.5 0.3 0.0 1.5 0.4 0.6 1.8 0.0 0.3 0.7 0.0 0.0 0.3 81.9 0.6 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.0 0.0 0.4 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.3 0.2 25.6 2.7 0.4 0.0 0.7 0.6 0.1 1.6 0.7 REXO4 "hPMC2, XPMC2H" ENSG00000148300 "REX4 homolog, 3'-5' exonuclease" Q9GZR2 9 133406059-133418096 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047006 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA047006: AB_2679900" "unprognostic (2.69e-2)" "unprognostic (3.76e-1)" "unprognostic (8.13e-2)" "unprognostic (1.30e-1)" "unprognostic (6.77e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.76e-6)" "unprognostic (2.15e-3)" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.14e-3)" "unprognostic (1.55e-2)" "prognostic favorable (2.65e-4)" "unprognostic (2.25e-2)" "unprognostic (2.86e-2)" "unprognostic (9.20e-2)" "unprognostic (1.20e-1)" 12.6 15.7 8.6 6.7 8.9 5.1 12.3 9.0 9.4 16.0 8.1 14.8 5.7 12.7 3.8 18.2 12.2 4.5 16.3 8.7 8.6 15.6 22.6 10.5 8.7 8.7 8.7 18.0 21.4 5.1 13.0 5.8 8.9 15.7 3.9 3.5 13.1 4.7 35.4 17.0 14.3 3.9 8.7 18.8 14.1 18.2 8.8 8.3 12.8 9.7 6.6 16.2 15.1 9.2 9.8 22.2 10.3 15.1 10.5 10.7 18.2 16.4 9.3 17.0 11.2 26.8 12.3 31.5 11.0 9.0 13.9 26.0 21.5 17.2 9.7 20.5 19.8 17.2 23.7 21.1 13.0 39.4 16.1 10.1 14.4 17.9 24.4 13.0 12.6 16.8 38.3 13.5 11.0 28.1 27.9 23.7 20.8 35.0 32.2 19.7 16.7 31.5 10.8 9.1 29.1 15.9 17.4 20.2 19.4 10.1 24.7 15.7 11.1 30.9 16.1 14.7 20.3 8.8 11.5 21.6 11.5 22.5 18.7 0.4 1.3 2.0 1.9 1.3 2.2 2.4 2.0 2.0 1.1 2.8 2.5 2.7 0.1 3.9 1.1 1.8 2.0 1.0 8.6 8.9 9.0 9.4 8.7 8.6 8.7 8.7 8.9 8.7 8.8 9.2 16.8 22.4 15.0 4.9 29.7 25.0 22.3 12.9 10.2 26.6 27.0 23.5 9.9 21.5 8.5 25.8 22.9 37.5 27.8 24.2 19.6 29.2 38.2 36.6 34.5 17.4 13.2 7.6 4.4 28.7 36.2 14.7 7.1 32.7 17.7 24.2 19.6 26.8 21.3 16.8 4.6 22.2 4.1 22.4 11.5 83.3 28.9 13.2 7.2 1.9 37.9 17.6 51.5 1.5 5.0 30.6 21.7 24.0 18.4 25.3 30.8 28.2 10.4 34.1 19.7 13.1 16.9 51.6 65.9 10.7 27.6 31.5 24.9 16.4 35.8 13.7 RGCC "bA157L14.2, C13orf15, RGC-32, RGC32" ENSG00000102760 "Regulator of cell cycle" Q9H4X1 13 41457550-41470871 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 415.4;lung: 694.9" "Cell type enhanced" "Detected in many" "Adipocytes: 1286.2;Basal prostatic cells: 676.2;Langerhans cells: 590.1;Prostatic glandular cells: 1415.5;T-cells: 532.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive CD4 T-cell: 159.9;T-reg: 90.9" "Lineage enriched" "Detected in many" 15 "T-cells: 159.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.5;BJ hTERT+: 316.0;Daudi: 105.1;U-698: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035638, HPA063701" Enhanced Supported Nucleoplasm,Nucleoli "Intracellular and membrane" No No 910000 "Cluster 20: T-cells - T-cell receptor" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA035638: AB_10670152, HPA063701: AB_2685096" "unprognostic (1.39e-3)" "unprognostic (4.61e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.28e-1)" "unprognostic (4.27e-2)" "unprognostic (2.85e-1)" "unprognostic (1.49e-3)" "unprognostic (1.49e-2)" "unprognostic (3.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.19e-1)" "unprognostic (1.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.04e-3)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.42e-3)" 197.6 21.5 186.3 27.7 226.9 415.4 132.6 218.8 236.7 36.1 148.2 34.7 16.9 43.6 7.6 18.6 31.1 42.2 145.9 195.8 196.6 56.9 25.0 694.9 38.1 209.1 204.8 9.1 41.3 48.1 35.3 150.7 205.3 61.5 9.2 5.7 111.5 19.0 47.3 58.0 29.1 33.5 186.7 37.0 37.8 24.8 198.2 70.5 144.0 61.8 21.0 47.5 39.6 241.0 1.1 0.5 34.9 0.0 6.7 57.5 1.4 0.8 316.0 0.2 1.2 44.8 0.7 105.1 0.9 4.0 0.1 1.0 1.2 2.1 0.4 11.1 5.1 0.0 7.9 3.5 3.3 3.7 1.2 4.5 6.7 1.2 43.1 0.6 36.1 24.0 8.3 0.1 1.0 0.3 24.0 2.3 0.5 4.7 0.8 0.1 0.0 0.1 0.3 0.0 1.3 0.4 0.3 0.0 0.7 3.0 0.9 20.1 24.6 0.2 3.8 2.2 0.4 0.2 0.1 111.9 0.3 2.4 0.8 0.0 0.8 0.1 5.6 0.5 5.6 5.3 46.5 14.7 6.1 10.7 159.9 35.0 0.6 0.4 0.1 1.8 90.9 10.2 186.3 226.9 218.8 236.7 195.8 196.6 209.1 204.8 205.3 186.7 198.2 241.0 1286.2 246.8 39.8 57.5 131.8 86.5 676.2 15.2 14.2 1.0 269.9 314.7 25.8 1.5 37.5 3.7 2.1 6.4 249.2 3.0 35.2 0.6 42.3 103.0 47.2 474.6 84.8 322.7 2.5 0.0 9.3 205.1 65.2 69.0 48.9 0.3 31.8 2.5 349.1 0.0 1.2 22.1 14.2 32.0 590.1 13.2 8.1 315.9 193.9 36.5 6.4 1.5 4.1 51.8 115.3 0.3 4.5 2.2 371.2 1415.5 0.1 0.8 33.7 3.1 124.9 45.4 116.0 155.3 5.0 11.2 65.1 11.1 532.4 43.8 7.8 159.7 RIOX2 "FLJ14393, JMJD10, mdig, MINA, MINA53, NO52" ENSG00000170854 "Ribosomal oxygenase 2" Q8IUF8 3 97941818-97972457 "Predicted intracellular proteins" "Ribosome biogenesis, Transcription, Transcription regulation" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.7;Distal tubular cells: 49.0;Endometrial ciliated cells: 25.7;Extravillous trophoblasts: 43.5;Syncytiotrophoblasts: 31.2;Theca cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 109.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007603, HPA008080, CAB013458" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 8: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "CAB013458: AB_2533432, HPA007603: AB_1853957, HPA008080: AB_1853960" "prognostic unfavorable (4.41e-4)" "unprognostic (8.64e-2)" "unprognostic (1.59e-3)" "unprognostic (2.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.53e-3)" "unprognostic (1.64e-3)" "unprognostic (8.68e-2)" "unprognostic (9.68e-2)" "unprognostic (5.34e-2)" "unprognostic (1.56e-3)" "unprognostic (6.95e-2)" "unprognostic (1.35e-2)" "unprognostic (1.23e-1)" "unprognostic (1.49e-1)" "unprognostic (3.44e-3)" "unprognostic (1.76e-1)" 14.6 9.7 9.8 14.5 11.3 2.2 13.9 9.5 11.2 11.6 8.3 12.4 6.9 10.7 10.6 22.3 10.4 7.3 10.1 9.5 12.3 14.4 14.3 11.0 14.2 12.4 12.4 10.4 18.2 10.8 10.2 15.6 12.0 10.4 12.3 16.8 19.8 9.6 32.0 17.8 10.3 10.4 12.9 8.4 12.8 6.7 10.9 6.9 46.4 11.3 15.0 16.4 15.5 13.6 42.6 27.8 9.1 17.4 20.5 30.3 22.8 20.1 14.3 22.0 18.5 18.6 22.8 59.7 21.2 25.1 34.3 24.3 28.9 28.2 32.5 109.9 13.8 19.2 13.5 19.1 33.4 37.1 7.0 24.5 38.8 17.6 44.4 13.1 23.9 26.4 26.2 23.3 22.1 11.5 29.7 14.5 19.9 47.3 34.4 0.0 32.2 58.7 21.4 24.1 49.6 17.6 25.7 28.7 34.4 10.1 24.7 15.3 16.3 22.9 24.0 13.7 39.9 37.7 18.3 55.5 29.1 37.8 23.8 1.9 13.2 0.7 10.3 11.9 15.8 15.9 14.9 12.0 16.9 13.3 15.0 12.5 0.8 10.8 15.8 26.0 15.2 10.5 9.8 11.3 9.5 11.2 9.5 12.3 12.4 12.4 12.0 12.9 10.9 13.6 18.3 9.6 14.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 14.9 11.2 0.0 0.0 10.5 7.3 0.0 33.7 5.7 0.0 49.0 16.4 0.0 25.7 14.9 5.8 0.0 0.0 0.0 13.2 43.5 7.3 0.0 12.6 2.5 20.2 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.5 0.0 0.0 11.6 13.8 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 31.2 2.2 24.8 0.0 0.0 RLF "Zn-15L, ZNF292L" ENSG00000117000 "RLF zinc finger" Q13129 1 40161387-40240921 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054653, HPA057300" Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 42: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 43: THP-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA054653: AB_2682557, HPA057300: AB_2683404" "unprognostic (1.71e-1)" "unprognostic (2.24e-2)" "unprognostic (6.46e-2)" "unprognostic (1.88e-2)" "unprognostic (6.78e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.75e-4)" "unprognostic (5.84e-2)" "unprognostic (3.43e-2)" "unprognostic (2.18e-2)" "unprognostic (2.60e-2)" "unprognostic (9.38e-2)" "prognostic unfavorable (7.68e-6)" "unprognostic (1.86e-1)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (4.69e-2)" 8.7 4.9 5.5 6.2 6.0 32.8 8.3 12.0 7.9 8.4 2.5 7.6 5.1 7.9 4.7 7.3 7.0 6.6 7.5 6.0 5.6 4.9 7.7 8.2 7.7 4.1 4.3 8.3 5.6 6.5 5.1 7.3 4.2 6.6 5.2 15.4 5.7 5.4 8.5 12.2 6.2 6.1 4.3 6.2 5.7 10.3 5.2 10.2 5.8 7.1 8.5 7.8 8.4 8.2 18.3 6.9 13.3 13.9 11.6 9.4 15.8 6.7 9.9 11.3 14.9 14.0 9.4 18.1 8.6 8.6 8.4 16.8 16.9 11.8 20.4 8.5 11.4 14.9 8.0 8.7 9.2 12.5 8.7 9.3 12.1 12.0 13.5 13.5 7.8 9.8 23.0 10.8 10.4 5.8 10.6 7.5 17.8 6.7 7.9 8.2 21.8 10.6 7.2 18.2 9.4 13.1 12.5 16.5 12.0 20.5 7.8 44.6 6.7 13.2 14.1 11.0 12.6 9.8 9.8 16.6 11.5 11.4 8.4 6.9 1.5 3.0 1.8 2.0 2.4 2.3 1.8 1.9 1.9 2.1 2.3 2.0 3.2 2.4 2.4 0.8 1.8 1.3 5.5 6.0 12.0 7.9 6.0 5.6 4.1 4.3 4.2 4.3 5.2 8.2 36.7 32.1 15.1 52.2 55.8 65.6 50.3 12.7 30.7 17.8 25.5 18.4 16.9 2.8 23.9 3.7 16.7 8.9 40.6 10.4 5.9 13.8 41.3 43.8 41.6 24.9 20.2 11.3 87.1 6.7 10.6 34.9 29.6 56.0 26.6 23.0 16.1 9.0 9.7 26.9 84.7 8.8 14.2 13.8 45.2 8.7 9.0 39.9 17.8 60.9 17.5 14.1 9.2 71.9 89.0 10.1 15.5 7.9 44.6 28.7 8.9 5.5 26.0 17.2 13.1 52.8 36.1 32.2 20.8 29.3 61.1 17.2 45.8 17.0 10.8 33.0 RNF115 "CL469780, ZNF364" ENSG00000265491 "Ring finger protein 115" Q9Y4L5 1 145738868-145824095 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 6.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019130 Approved Approved Nucleoli,Mitochondria NA NA "Cluster 34: Basophils - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli, Mitochondria" "HPA019130: AB_1859220" "unprognostic (3.44e-2)" "unprognostic (2.47e-3)" "unprognostic (2.24e-1)" "unprognostic (1.09e-1)" "unprognostic (5.48e-2)" "unprognostic (1.90e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (2.29e-2)" "unprognostic (1.46e-2)" "unprognostic (1.35e-1)" "unprognostic (2.64e-2)" "unprognostic (7.29e-2)" "unprognostic (1.44e-2)" "unprognostic (3.23e-1)" "unprognostic (4.77e-2)" "unprognostic (2.46e-2)" "unprognostic (1.08e-1)" 8.9 5.0 7.7 4.6 7.3 7.5 7.5 16.1 9.0 7.1 6.1 9.0 3.4 12.2 4.1 5.7 7.9 4.7 24.9 7.7 6.8 5.6 5.1 5.9 5.0 6.3 6.8 5.5 5.3 6.8 5.3 3.5 6.6 7.3 3.7 13.9 5.9 5.2 32.1 6.1 5.5 11.1 5.7 5.0 5.8 3.9 7.5 5.0 6.1 25.3 4.7 7.9 5.6 7.1 11.0 4.5 5.4 3.9 9.6 12.5 4.2 8.1 15.1 5.9 7.1 4.9 3.8 7.7 9.0 11.7 5.7 7.5 6.0 5.5 6.3 7.7 3.9 6.1 5.9 4.6 6.1 9.7 13.7 7.3 4.8 6.0 7.1 6.7 7.7 5.9 6.1 12.2 10.8 8.3 7.1 6.0 6.8 7.0 9.4 6.7 5.4 6.4 11.6 3.6 5.3 7.4 6.6 8.0 6.3 6.6 8.9 9.1 9.4 8.4 6.6 5.1 8.7 10.2 10.3 8.0 4.2 6.4 5.4 6.4 1.0 1.6 1.4 0.8 1.2 1.5 1.0 1.4 0.8 1.2 1.0 1.4 0.7 1.6 0.8 1.1 1.0 0.7 7.7 7.3 16.1 9.0 7.7 6.8 6.3 6.8 6.6 5.7 7.5 7.1 168.4 16.0 29.2 61.7 43.5 20.6 32.6 24.4 23.9 101.3 35.9 29.1 152.5 38.6 27.0 18.4 114.7 26.8 155.6 13.2 33.2 44.8 68.5 52.9 45.4 72.3 27.1 60.6 91.2 80.3 28.7 60.8 28.1 55.8 31.7 39.1 71.7 33.1 37.2 82.4 77.6 23.5 28.5 41.5 36.2 25.3 39.4 38.9 39.2 84.3 71.0 64.4 90.6 81.4 83.9 52.4 18.8 80.9 90.5 76.0 22.5 46.6 29.6 111.1 59.2 60.2 53.5 76.5 63.7 23.7 18.0 19.8 75.7 65.2 23.6 40.2 RNF125 FLJ20456 ENSG00000101695 "Ring finger protein 125" Q96EQ8 18 32018825-32073219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 18.4" "Cell type enhanced" "Detected in many" "dendritic cells: 169.6;Early spermatids: 90.7;NK-cells: 160.6;Oligodendrocytes: 64.3;T-cells: 114.8" "Cancer enhanced" "Detected in all" "testis cancer: 8.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 51.5;SK-MEL-30: 13.2;U-937: 11.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041514 Uncertain Supported "Nucleoli,Golgi apparatus" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" Nucleoli "HPA041514: AB_10795596" "unprognostic (2.13e-2)" "unprognostic (2.05e-2)" "unprognostic (2.88e-1)" "unprognostic (3.93e-1)" "unprognostic (5.03e-1)" "unprognostic (4.50e-2)" "unprognostic (2.30e-3)" "unprognostic (6.15e-2)" "unprognostic (4.21e-2)" "unprognostic (3.24e-1)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.99e-1)" "unprognostic (4.12e-1)" "unprognostic (1.82e-1)" "unprognostic (7.07e-3)" 10.2 1.3 2.0 5.2 3.7 18.4 6.3 2.7 2.7 3.9 1.6 5.0 10.5 2.9 0.5 2.5 3.4 3.3 2.6 1.9 2.3 1.0 12.5 4.7 7.0 3.6 3.2 1.4 3.1 1.7 0.3 3.7 3.4 1.8 6.4 0.3 2.2 1.4 2.3 4.9 11.3 3.3 2.6 5.9 3.4 1.0 3.8 5.3 1.4 2.9 4.0 3.0 1.7 6.2 1.2 0.1 0.2 0.4 0.5 0.8 1.0 0.1 0.0 0.0 0.0 0.1 2.5 0.1 1.2 0.1 0.4 0.9 1.6 1.2 0.2 6.6 2.6 0.3 0.4 0.3 0.1 8.9 51.5 1.6 2.4 0.0 2.8 0.3 0.4 2.7 0.1 1.9 0.1 2.0 2.3 8.2 4.2 8.9 1.5 9.2 0.6 0.2 0.5 0.5 0.9 0.3 0.2 0.1 13.2 1.6 1.3 4.2 0.2 0.1 0.7 0.1 0.1 5.9 0.2 0.1 0.6 11.5 6.9 13.3 4.5 4.5 15.0 2.5 9.9 2.5 12.0 12.8 4.2 2.3 9.5 12.3 1.9 15.5 2.8 4.3 13.7 6.9 2.0 3.7 2.7 2.7 1.9 2.3 3.6 3.2 3.4 2.6 3.8 6.2 62.2 3.2 5.8 3.3 16.3 9.8 3.1 1.0 14.2 0.8 5.3 3.7 2.1 4.3 3.8 12.9 0.0 0.4 169.6 24.6 1.9 1.0 90.7 4.9 2.1 28.4 1.2 15.8 2.7 1.8 0.1 5.3 8.6 13.4 18.9 0.2 12.5 25.1 10.5 0.0 3.0 8.3 0.0 19.2 12.6 17.4 2.8 18.4 1.8 30.9 23.8 0.7 160.6 3.5 64.3 1.1 4.5 0.0 49.9 2.7 41.4 4.5 1.7 0.9 0.0 3.2 3.2 0.5 1.8 5.8 6.8 0.8 114.8 0.2 14.7 2.4 RNF144B "bA528A10.3, IBRDC2, P53RFP" ENSG00000137393 "Ring finger protein 144B" Q7Z419 6 18387350-18468870 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.9" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 71.9" "Group enriched" "Detected in many" 9 "dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9" "Cell line enhanced" "Detected in many" "Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046013, HPA054127, HPA072469" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 59: Non-specific - Translation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoli Mitochondria "CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: " "unprognostic (2.24e-2)" "unprognostic (1.16e-1)" "unprognostic (1.56e-1)" "unprognostic (4.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.48e-3)" "unprognostic (5.89e-2)" "unprognostic (1.18e-2)" "unprognostic (6.55e-2)" "unprognostic (2.87e-3)" "unprognostic (2.44e-2)" "unprognostic (2.60e-1)" "unprognostic (1.34e-1)" "unprognostic (2.39e-1)" "unprognostic (3.91e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" 9.4 2.0 7.4 15.6 7.4 24.0 29.1 7.9 9.0 9.5 9.1 4.2 1.8 5.7 4.7 8.4 11.8 6.2 8.1 6.4 7.7 14.0 15.5 19.4 11.3 11.8 11.9 1.6 3.2 2.9 1.7 15.1 9.4 13.1 2.8 5.0 16.9 7.3 56.9 21.1 3.3 6.2 8.9 13.1 5.7 2.3 10.5 5.1 40.9 14.1 12.9 9.4 7.1 8.7 4.6 1.0 0.4 0.0 0.3 2.0 9.8 5.3 5.7 11.0 11.8 0.1 0.4 192.8 50.7 2.3 0.6 16.3 0.1 16.0 15.5 0.9 1.4 0.2 0.2 4.2 0.2 0.2 0.2 2.7 59.1 4.3 13.2 4.9 55.6 4.3 0.1 0.0 2.7 2.0 1.5 0.0 1.6 0.6 1.1 0.7 1.7 11.8 33.2 10.6 1.9 0.2 1.2 23.9 18.5 1.5 28.2 0.5 56.1 8.6 1.9 0.8 1.2 0.0 0.1 160.6 1.0 0.4 0.7 0.4 20.7 12.9 0.5 38.9 1.6 4.6 0.8 0.6 13.3 3.6 1.6 1.0 36.7 0.6 71.9 18.4 0.5 7.1 7.4 7.4 7.9 9.0 6.4 7.7 11.8 11.9 9.4 8.9 10.5 8.7 28.8 44.8 15.0 34.9 21.7 634.4 48.8 86.0 14.8 0.9 35.7 26.3 12.8 17.2 48.3 38.6 2.1 14.1 9.8 2.2 19.6 8.6 2.1 49.0 5.8 34.6 1.2 3.8 2.3 8.9 3.7 7.8 10.7 58.5 3.8 0.1 47.2 21.9 15.0 0.0 99.0 1.8 14.2 109.4 296.9 1.8 1.2 171.7 60.5 92.8 54.1 17.9 1.0 3.5 2.5 5.2 3.6 3.0 3.4 112.3 0.9 20.6 36.7 1.2 0.0 9.0 7.8 2.2 3.2 30.0 1501.1 1.5 4.9 0.1 2.3 42.6 RNF215 ENSG00000099999 "Ring finger protein 215" Q9Y6U7 22 30368811-30421771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 12.9;Cone photoreceptor cells: 12.5;Rod photoreceptor cells: 13.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029427, HPA056498" Approved Approved Nucleoli,Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 5: Muller glia cells - Visual perception" Microtubules Nucleoli "HPA029427: AB_2732447, HPA056498: AB_2683154" "unprognostic (1.24e-2)" "unprognostic (3.20e-1)" "unprognostic (3.67e-4)" "unprognostic (8.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-2)" "unprognostic (1.97e-1)" "unprognostic (5.32e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (6.37e-10)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (3.17e-1)" "unprognostic (1.78e-2)" 8.4 8.7 19.2 5.6 19.0 7.0 9.3 18.7 22.5 17.6 17.9 11.8 7.8 15.2 9.2 6.7 13.3 6.8 9.5 19.2 20.4 12.1 11.1 8.7 4.7 20.2 18.7 13.7 13.2 10.7 10.0 6.9 18.3 13.1 3.9 8.5 6.5 8.3 8.0 6.1 7.7 7.9 16.9 11.6 8.9 10.5 20.0 2.8 12.2 2.9 3.9 12.3 10.8 17.4 6.8 14.0 14.4 23.4 13.8 14.3 14.2 11.4 10.1 11.3 6.8 3.8 7.4 2.7 20.1 9.3 21.1 8.4 8.9 13.1 9.0 15.8 10.8 4.5 17.8 5.1 18.9 3.6 18.5 19.4 15.8 19.3 10.3 36.7 13.3 7.0 4.0 12.6 13.6 11.0 2.6 8.5 4.5 9.7 15.4 12.2 8.4 10.8 14.9 10.3 6.3 16.2 11.6 8.3 8.9 13.1 7.6 3.9 18.6 30.2 13.3 8.8 6.7 13.3 3.4 3.7 17.7 2.6 11.9 0.4 0.9 1.5 0.9 0.7 1.0 1.0 1.0 0.8 0.5 1.9 1.8 1.7 0.5 2.5 0.8 1.4 0.5 0.4 19.2 19.0 18.7 22.5 19.2 20.4 20.2 18.7 18.3 16.9 20.0 17.4 7.1 3.2 3.9 8.8 1.4 0.3 1.2 1.6 2.8 12.9 3.2 3.9 2.2 1.5 2.7 0.0 12.5 1.9 3.7 1.0 0.0 1.5 0.8 3.7 6.4 3.5 0.0 0.4 5.0 1.4 1.5 5.4 6.1 6.6 0.0 8.2 4.6 2.3 1.8 8.4 4.6 0.5 2.0 1.2 0.5 0.4 0.9 1.9 1.8 1.0 2.3 11.7 1.0 2.5 1.1 1.9 0.2 1.2 1.8 1.3 0.7 1.0 0.6 13.7 6.6 4.8 4.8 2.1 0.9 0.6 0.1 1.6 2.0 5.3 0.7 1.2 RPAP2 "C1orf82, FLJ13150, Rtr1" ENSG00000122484 "RNA polymerase II associated protein 2" Q8IXW5 1 92299059-92402056 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046443 Approved Supported Nucleoli,Cytosol No No "Cluster 11: Basophils - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoli, Cytosol" "HPA046443: AB_2679669" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.71e-2)" "unprognostic (4.12e-2)" "unprognostic (4.96e-3)" "unprognostic (5.73e-2)" "unprognostic (1.23e-3)" "unprognostic (3.29e-2)" "unprognostic (8.01e-3)" "unprognostic (4.09e-2)" "unprognostic (2.59e-1)" "unprognostic (6.09e-2)" "unprognostic (7.02e-4)" "unprognostic (1.18e-2)" "unprognostic (1.69e-1)" "unprognostic (3.62e-3)" "unprognostic (4.10e-2)" 1.4 1.9 3.2 2.2 4.1 3.9 2.2 12.6 8.7 1.6 0.3 1.4 1.8 2.1 3.2 1.3 1.4 1.5 1.6 3.3 0.9 2.2 3.0 1.4 2.6 1.2 0.2 2.1 2.5 2.0 1.7 1.5 1.8 2.1 1.6 9.3 2.1 1.3 3.0 3.2 1.7 1.5 0.2 2.3 1.8 2.0 1.8 2.8 2.7 2.3 1.9 1.4 1.1 8.4 4.0 2.3 4.1 3.8 3.3 4.2 3.4 3.0 2.1 2.0 1.6 1.7 1.7 5.9 5.1 2.3 2.7 2.7 3.4 1.9 3.0 4.0 2.4 3.5 4.6 2.3 1.9 6.3 3.4 2.1 2.4 2.5 2.5 2.9 2.1 3.6 3.7 3.7 3.0 2.0 5.4 3.9 3.1 2.2 2.7 3.9 5.4 2.5 2.6 3.4 3.8 2.7 4.4 4.5 2.5 3.0 2.3 4.7 3.6 2.8 3.7 3.3 4.4 3.7 4.5 3.0 2.0 3.9 1.9 1.9 0.7 0.6 1.3 0.5 1.5 1.1 1.0 1.1 0.6 1.3 1.0 1.2 1.4 1.3 0.7 1.1 1.0 0.4 3.2 4.1 12.6 8.7 3.3 0.9 1.2 0.2 1.8 0.2 1.8 8.4 23.1 64.1 78.5 66.9 20.1 9.2 16.7 15.7 23.9 63.6 16.3 16.5 24.7 10.0 44.5 7.3 110.5 21.3 31.5 6.4 11.7 19.2 68.1 18.8 48.6 23.4 12.6 13.3 97.1 13.6 14.2 24.8 13.3 17.6 62.0 37.7 9.3 8.0 9.7 35.3 91.3 13.3 14.2 8.7 4.6 9.7 19.0 15.6 1.8 43.1 16.6 31.4 42.2 68.3 78.8 13.8 13.6 21.4 28.5 15.9 11.9 15.6 45.0 95.2 26.3 44.4 20.3 27.3 20.0 16.8 9.8 23.7 35.8 42.3 12.1 10.4 RPL13A "L13A, TSTA1" ENSG00000142541 "Ribosomal protein L13a" P40429 19 49487510-49493057 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA038751 Approved Approved Nucleoli,Cytosol NA NA 44000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA038751: AB_10962004" "unprognostic (2.35e-3)" "unprognostic (2.15e-1)" "unprognostic (4.08e-2)" "unprognostic (2.02e-1)" "unprognostic (2.95e-3)" "unprognostic (2.55e-1)" "prognostic unfavorable (9.97e-4)" "unprognostic (1.21e-1)" "unprognostic (3.86e-2)" "unprognostic (1.98e-1)" "unprognostic (1.05e-1)" "unprognostic (1.87e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.81e-2)" "unprognostic (7.85e-2)" "unprognostic (3.22e-1)" "unprognostic (1.87e-1)" 2188.0 2248.7 1092.3 1522.1 1122.8 3160.3 2279.6 1064.6 1616.8 2808.8 1147.7 1987.3 1681.3 1743.7 742.1 2699.3 2138.4 1061.8 1522.6 1034.5 1074.4 1532.8 1642.1 1467.3 2995.9 1117.3 1065.6 4462.0 4145.5 956.8 1244.7 1070.5 1119.3 2042.8 957.8 585.8 2381.8 963.3 2940.7 3275.0 1966.3 780.3 1131.1 2267.8 2148.1 451.9 1123.9 2070.4 1594.9 1484.8 1783.2 2092.3 2369.7 1115.7 2693.9 3191.9 1553.5 4384.1 2927.6 4606.7 1812.7 2265.3 2944.1 1696.6 1823.7 2817.9 2001.2 6730.4 1792.9 1804.0 687.0 1724.4 1978.2 3463.6 974.1 1895.7 4496.8 3377.7 1945.3 3984.3 3562.3 5127.9 2581.9 5363.6 5688.6 1203.5 4051.7 3536.9 2763.2 2430.9 2982.0 2472.0 1975.0 2322.6 3629.2 5266.7 2905.4 2535.0 2987.2 3504.5 3396.6 2968.4 2319.3 4481.3 2545.5 3362.0 1184.7 5205.9 5408.7 1180.0 2303.0 5907.2 3249.6 2026.5 2165.3 1276.1 3061.9 2474.5 3628.5 3102.4 1267.1 3505.6 1898.9 1499.6 2615.2 669.3 3673.1 2167.5 5384.1 8504.2 6249.9 5035.0 3741.0 7985.6 7293.6 5930.8 400.5 4696.2 1914.5 4364.8 5054.0 13490.7 1092.3 1122.8 1064.6 1616.8 1034.5 1074.4 1117.3 1065.6 1119.3 1131.1 1123.9 1115.7 759.0 1618.6 1998.3 5.9 5793.5 11583.3 12255.7 8593.4 1801.8 534.6 8903.0 5580.5 544.1 4340.8 4712.7 1590.9 214.8 7997.8 3602.5 2445.5 5433.2 4560.9 304.1 1462.1 3740.3 3725.7 3984.3 2696.0 5.1 12776.9 10340.4 3277.8 916.9 2114.2 2546.8 1496.7 5087.0 4397.2 5887.8 220.4 6.0 7002.5 2705.8 7291.2 8449.9 709.7 9127.2 3169.3 5695.4 9.4 7891.8 1658.7 5864.1 8.0 12.4 7364.8 6114.5 4432.7 1348.9 11217.2 5888.9 7303.9 2192.4 723.4 2655.9 5724.7 2897.9 456.9 817.2 2602.1 14282.8 8401.6 4958.9 2454.2 8198.9 13221.0 RPL18A L18A ENSG00000105640 "Ribosomal protein L18a" Q02543 19 17859910-17864153 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Cancer enhanced" "Detected in all" "ovarian cancer: 682.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055259 Approved Approved Nucleoli,Cytosol No No 44000 "Cluster 37: B-cells - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA055259: AB_2682764" "unprognostic (3.40e-2)" "unprognostic (1.18e-1)" "unprognostic (1.66e-1)" "unprognostic (7.78e-2)" "unprognostic (1.56e-2)" "unprognostic (1.09e-1)" "unprognostic (3.79e-3)" "unprognostic (6.46e-2)" "unprognostic (2.30e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (6.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (5.44e-2)" "unprognostic (1.05e-1)" "unprognostic (1.55e-2)" "unprognostic (1.36e-1)" 1984.9 1325.9 783.3 1207.3 801.9 2675.9 2006.4 765.1 966.5 2276.5 976.5 1896.2 1072.6 1684.5 414.2 2432.1 1900.0 848.3 1178.2 738.0 778.4 1205.8 1161.2 1350.6 2511.2 806.4 757.5 3627.6 3907.4 541.6 923.3 757.2 789.9 1596.6 718.5 205.8 2590.5 635.5 2533.1 3581.5 1721.9 686.3 819.5 2048.4 1928.7 350.6 801.3 1573.9 1398.1 1213.3 1488.2 1737.1 2164.1 808.5 2623.4 2001.4 1299.0 1847.0 1923.3 3152.4 3291.2 1559.5 1979.9 2038.9 1930.5 2789.2 2550.3 3921.7 3523.0 1365.1 805.3 1913.5 1555.9 3350.6 708.6 2020.7 4206.5 1833.5 1792.6 3238.9 3314.5 2660.3 1916.4 3952.5 4349.3 1127.8 2410.2 2094.2 2265.6 3157.8 2386.5 2462.6 1313.5 4085.3 3633.0 3514.7 3067.9 2909.3 3049.2 3210.9 1376.3 4708.0 1887.0 2464.1 1879.4 2817.6 554.3 3813.0 5042.2 637.7 1814.7 5079.9 1738.1 1244.6 1438.8 2512.2 2674.5 3251.9 3283.4 2639.9 1632.9 4270.0 1580.0 1247.5 4513.0 690.0 4974.8 4521.9 8679.3 14996.3 8499.1 6207.0 6569.7 15438.5 9988.2 7821.6 433.2 5415.3 3633.6 7634.4 8027.2 21239.5 783.3 801.9 765.1 966.5 738.0 778.4 806.4 757.5 789.9 819.5 801.3 808.5 1797.3 519.2 1033.4 1.3 6570.0 8683.5 6503.8 6346.6 5314.4 252.0 7203.4 8120.9 437.2 2077.4 2572.8 923.2 127.2 4676.6 3414.9 1440.2 2387.0 3503.1 57.0 1112.5 3101.7 2919.9 1842.7 2735.0 1.8 8949.1 8763.1 2652.7 2316.6 1639.3 1447.9 3627.9 2837.8 2144.2 3317.2 131.2 2.2 3965.3 1881.8 4748.0 8399.9 194.1 4165.1 3240.6 4747.4 1.9 6119.2 908.2 3084.5 1.5 2.5 5684.1 3130.7 1627.9 3619.6 6541.4 3169.3 3629.8 1019.5 499.6 1255.6 3061.1 4561.4 199.9 834.7 6806.4 11135.4 4659.3 4511.8 4057.7 4606.2 8094.9 RPL19 "DKFZp779D216, FLJ27452, L19, MGC71997" ENSG00000108298 "Ribosomal protein L19" P84098 17 39200283-39204840 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "SK-BR-3: 37509.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043014, HPA051987" Approved Enhanced Nucleoli,Cytosol NA NA 160000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA043014: AB_10965840, HPA051987: AB_2681682" "unprognostic (4.07e-3)" "unprognostic (1.33e-1)" "unprognostic (3.18e-1)" "unprognostic (4.46e-2)" "unprognostic (4.25e-2)" "unprognostic (6.40e-2)" "unprognostic (9.70e-3)" "unprognostic (1.50e-1)" "unprognostic (5.46e-1)" "unprognostic (1.16e-2)" "unprognostic (3.32e-1)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.87e-5)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.48e-2)" "unprognostic (8.60e-2)" 2108.0 1641.8 1232.8 1325.7 1302.0 3445.4 2213.5 1236.2 1473.8 2449.2 1230.5 1983.7 1161.3 1717.3 1256.1 2160.0 1997.7 1159.4 1539.0 1175.0 1252.5 1725.6 1485.2 1453.6 2835.1 1303.7 1237.8 3638.0 3006.2 1537.0 1362.5 1050.7 1304.9 1733.7 1231.5 383.6 2136.0 1214.5 2763.0 2809.4 1733.8 1104.6 1324.2 2003.5 1872.5 615.5 1268.5 2335.8 1462.6 1879.2 2543.6 1915.1 2121.1 1325.7 1943.7 2617.7 1849.0 2258.4 3300.1 4133.6 1894.3 1788.5 3631.1 3629.7 2895.6 2872.0 1801.2 4740.4 3047.1 2580.8 2122.7 3228.2 2807.4 3714.8 1852.4 1922.4 4931.8 1693.5 1876.5 3797.5 5133.2 4201.0 2240.4 4647.6 3995.5 2805.3 5031.4 3396.2 3177.6 3991.6 3007.3 2696.5 2544.2 1939.5 5610.7 5814.7 1891.0 2269.3 1912.1 3270.3 2620.6 4777.9 3324.4 2419.1 2225.5 2457.9 1084.0 37509.3 5867.6 1982.1 3626.8 5201.1 1883.8 1410.9 1894.7 2165.8 3336.2 3504.5 3756.7 3505.5 1906.0 3147.3 1854.1 1051.1 2648.2 975.0 2486.9 2147.2 3862.3 4698.0 3984.2 3158.7 3263.9 4349.1 4920.5 4086.9 380.6 2830.2 1793.7 3012.9 3456.9 9398.3 1232.8 1302.0 1236.2 1473.8 1175.0 1252.5 1303.7 1237.8 1304.9 1324.2 1268.5 1325.7 2477.2 884.6 1438.4 49.0 5591.4 5551.7 6227.1 4092.6 3998.1 241.7 5532.9 7926.2 556.3 2332.0 2100.3 1138.5 93.8 3720.2 4011.1 1443.7 3623.4 3025.0 1451.9 1129.0 2357.2 2714.5 1957.2 2708.2 30.8 6238.2 5441.3 2425.2 1705.4 1503.7 1586.0 3024.3 2836.8 2406.3 4189.9 132.9 33.6 3550.3 1464.8 4218.0 5326.1 4539.9 3920.2 3259.8 3272.8 46.9 4282.6 1495.1 3932.1 20.1 51.1 3972.8 3267.4 2040.2 3289.0 6219.8 3226.4 5182.0 1049.1 390.5 1531.7 3215.1 3875.5 962.9 981.4 5376.4 6619.2 3899.7 4615.5 3399.1 3895.2 7406.6 RPL22 "EAP, L22" ENSG00000116251 "Ribosomal protein L22" P35268 1 6185020-6209389 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA068294 Approved Nucleoplasm,Nucleoli NA NA 860000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Nucleoli Nucleoplasm "HPA068294: AB_2732781" "unprognostic (3.16e-3)" "unprognostic (1.28e-1)" "unprognostic (3.13e-1)" "unprognostic (3.62e-2)" "unprognostic (2.27e-2)" "unprognostic (1.09e-1)" "unprognostic (1.29e-3)" "unprognostic (4.40e-2)" "unprognostic (7.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.48e-1)" "unprognostic (4.24e-2)" "unprognostic (1.46e-3)" "unprognostic (3.83e-1)" "unprognostic (3.88e-2)" "unprognostic (2.46e-1)" "unprognostic (1.98e-1)" 579.0 489.0 252.3 511.9 262.0 1064.4 599.4 258.1 400.1 716.0 257.9 573.4 475.0 513.3 313.9 621.7 590.5 220.4 390.9 243.7 261.0 473.0 480.3 396.9 659.8 256.3 250.3 1096.7 690.5 312.2 331.9 308.3 259.9 487.3 320.3 316.6 589.4 218.3 912.3 686.8 461.4 247.4 263.7 501.7 500.7 137.8 255.5 484.9 400.4 398.8 509.7 551.5 600.5 274.7 1443.4 400.8 836.4 858.6 576.1 897.0 659.0 1224.2 488.1 440.4 372.9 802.5 1213.4 2217.7 981.3 458.1 304.2 810.7 636.9 638.2 576.9 1093.6 1033.3 2159.0 948.8 1016.3 569.4 2893.0 828.4 799.9 516.3 393.5 808.6 907.3 560.1 610.3 1817.3 1301.1 512.9 634.7 1274.0 2340.3 522.1 953.0 880.1 1207.4 1731.8 1731.8 656.1 490.4 1149.9 1051.9 996.9 2846.8 2387.4 721.1 918.2 2247.5 1380.1 623.1 689.2 833.9 1170.4 1037.2 1544.9 3289.7 413.0 2911.2 395.5 109.0 297.7 71.2 268.2 270.0 474.9 547.1 502.6 373.2 451.6 500.6 679.0 560.8 22.0 337.5 227.9 472.2 416.3 664.1 252.3 262.0 258.1 400.1 243.7 261.0 256.3 250.3 259.9 263.7 255.5 274.7 1090.2 445.5 731.5 5.9 2372.5 1821.1 2035.3 1455.3 2241.2 217.6 1764.0 2190.8 277.9 1225.3 883.4 584.9 131.3 1816.1 1450.8 669.0 1905.6 1332.1 442.9 736.9 1377.2 1104.5 912.5 1508.9 15.3 1823.0 2751.0 1022.5 940.9 944.1 921.5 1256.6 1457.4 1491.7 1504.9 141.3 14.2 2032.2 449.6 1997.8 2098.8 320.1 2027.4 1440.8 1076.1 14.0 2435.3 890.1 1442.9 8.0 10.7 1575.3 1413.5 1234.1 1218.7 1837.3 1182.5 2505.6 437.3 390.8 775.7 1773.9 1169.1 358.6 473.0 2759.8 1935.8 1851.9 1791.5 1289.9 2231.0 2084.3 RPL27 L27 ENSG00000131469 "Ribosomal protein L27" P61353 17 42998273-43002959 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes, Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA002649 Approved Enhanced Nucleoplasm,Nucleoli NA NA 170000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Nucleoli Nucleoplasm "HPA002649: AB_1079840" "unprognostic (8.53e-3)" "unprognostic (7.15e-2)" "unprognostic (3.97e-2)" "unprognostic (2.81e-2)" "unprognostic (4.99e-2)" "unprognostic (4.31e-2)" "unprognostic (1.91e-3)" "unprognostic (7.32e-2)" "unprognostic (9.17e-2)" "unprognostic (1.19e-1)" "unprognostic (5.12e-2)" "unprognostic (3.86e-1)" "prognostic unfavorable (7.80e-8)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" 1871.8 1549.8 1111.3 1009.9 1116.5 2929.2 1962.9 1098.5 1512.7 2052.8 1111.9 1884.1 802.3 1550.5 994.9 1984.2 1652.8 740.8 1495.4 1092.8 1126.1 1276.4 1316.9 1278.5 1999.4 1122.6 1109.6 2598.8 2232.2 850.4 894.8 951.0 1119.0 1483.8 894.1 394.5 1530.7 749.8 2544.6 2726.6 1467.8 854.4 1124.4 1802.0 1559.6 409.4 1127.1 1682.4 1067.7 1510.1 1378.5 1650.9 1820.8 1132.8 2288.0 2867.0 1701.7 2480.6 2983.9 4422.4 2741.5 2594.6 2162.4 2777.2 1979.1 4107.0 1751.0 4309.7 2143.3 2087.9 1477.4 1948.8 2000.9 3363.7 2670.5 1996.4 4741.8 1694.3 2147.4 4431.8 3669.4 4908.1 1698.9 4175.7 2847.4 1867.0 2381.3 2795.0 2356.9 2241.9 3237.8 2584.2 2618.6 2253.4 4127.7 4153.0 2577.8 2634.0 1821.4 2841.1 4775.1 4927.8 2374.2 3092.9 1909.6 2094.8 1016.8 1982.1 4341.5 2299.8 3341.2 5076.5 2617.1 2021.7 1988.7 2497.2 3885.7 2219.6 4004.7 4327.4 1816.5 3030.7 2107.7 1007.1 1762.8 553.5 1773.1 1633.6 2518.3 3055.1 2633.3 2095.8 2115.1 2792.7 2987.8 2673.6 358.7 2155.7 1284.9 2726.2 2059.6 4601.4 1111.3 1116.5 1098.5 1512.7 1092.8 1126.1 1122.6 1109.6 1119.0 1124.4 1127.1 1132.8 770.3 734.0 1103.9 11.1 2217.2 2530.2 2296.2 1759.2 941.8 138.9 1779.8 1725.0 725.8 1302.6 1175.0 518.6 89.6 2093.8 1873.8 948.5 1496.7 1822.6 435.6 524.0 1202.0 1245.7 912.0 1291.4 9.9 3028.9 3551.3 1025.1 510.7 660.9 991.3 983.7 1689.1 1859.0 2118.7 65.6 10.7 2016.4 671.4 2560.1 2977.0 1070.0 2434.3 1522.8 1426.5 22.5 3232.7 722.9 2669.4 7.5 16.3 2450.0 1585.4 1279.6 957.2 2462.7 1301.2 2383.0 574.6 230.6 867.8 1669.6 1874.7 384.8 476.4 1644.1 3371.3 2184.8 1833.0 1266.3 2175.4 2628.2 RPL3 L3 ENSG00000100316 "Ribosomal protein L3" P39023 22 39312882-39320389 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003365, HPA055361" Uncertain Supported Nucleoli,Cytosol NA NA 470000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoli, Cytosol" "HPA003365: AB_1079841, HPA055361: AB_2732594" "unprognostic (9.79e-3)" "unprognostic (2.06e-1)" "unprognostic (2.31e-1)" "unprognostic (1.68e-3)" "unprognostic (5.44e-3)" "unprognostic (1.72e-1)" "unprognostic (3.51e-2)" "unprognostic (1.22e-1)" "unprognostic (3.63e-1)" "unprognostic (5.81e-2)" "unprognostic (5.87e-2)" "unprognostic (7.09e-2)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (6.09e-2)" "unprognostic (2.72e-1)" "unprognostic (4.32e-2)" 2058.6 1934.3 965.6 1484.2 985.8 2965.1 2704.2 936.9 1071.1 2705.4 1023.2 2078.1 1515.1 2007.3 1653.7 2522.3 2423.9 1128.4 1326.4 894.6 951.2 1745.2 1894.1 1421.2 2460.9 984.1 951.1 4838.0 4514.8 1462.2 1861.5 1099.8 977.1 2180.0 1361.7 809.1 2210.1 1551.8 558.4 3337.9 1722.9 1388.1 1050.0 1824.1 1982.0 752.6 1002.9 2006.1 1709.0 417.1 2320.5 2012.9 2317.5 996.1 2010.5 1836.9 2035.9 2149.6 2535.3 5394.1 2745.1 1497.8 2703.5 1400.5 1249.7 2327.8 1425.1 8262.2 2062.9 1734.1 873.2 1246.8 2275.3 3060.5 923.2 1448.3 2207.4 2039.5 2153.8 3438.2 3887.7 2932.6 1619.9 5321.2 4063.7 1265.0 4504.5 3956.7 2765.5 2217.6 2407.8 2657.6 2135.0 2597.5 2974.5 4241.1 2054.6 2172.9 1273.8 2369.5 1924.0 4017.5 2609.2 2927.6 1823.4 2180.2 936.2 2925.4 5031.9 1242.2 2226.2 4761.3 2864.1 951.4 1534.4 1027.8 1788.2 2074.0 1741.6 3606.5 2111.3 2564.4 1093.9 638.7 1690.8 351.4 3488.7 1481.6 5383.7 5629.1 4993.5 4037.9 2821.8 5113.1 6376.7 5111.7 215.7 4472.3 1339.8 3182.6 3668.7 11623.3 965.6 985.8 936.9 1071.1 894.6 951.2 984.1 951.1 977.1 1050.0 1002.9 996.1 2118.4 984.0 2299.9 16.3 4551.5 10412.0 9836.0 9475.4 2792.1 1065.7 9967.6 10172.3 182.6 4213.6 3849.3 1441.9 425.4 5623.9 4123.0 1288.7 5893.0 2943.4 2097.6 1061.7 2644.4 3666.1 2726.6 2263.9 17.0 6539.7 7508.2 2678.8 1207.4 1390.0 1784.7 4203.6 3429.3 2085.8 3282.5 358.4 18.3 3696.8 2925.6 3062.8 6215.2 4622.8 5581.1 2203.8 5104.8 17.8 3733.3 2455.8 4243.1 9.5 25.1 3814.3 2946.3 3499.2 2308.1 8261.9 3481.6 5422.4 1350.6 1305.5 1577.7 4469.5 4329.1 1074.6 1014.8 3712.4 12290.3 5489.4 4201.1 4673.7 4830.3 9407.7 RPL7A "L7A, SURF3, TRUP" ENSG00000148303 "Ribosomal protein L7a" P62424 9 133348218-133351426 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046794 Approved Nucleoli,Vesicles NA NA 490000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Nucleoli Vesicles "HPA046794: AB_2732534" "unprognostic (5.01e-2)" "unprognostic (1.49e-1)" "unprognostic (8.83e-3)" "unprognostic (1.07e-3)" "unprognostic (4.17e-3)" "unprognostic (7.95e-2)" "prognostic unfavorable (8.99e-4)" "unprognostic (1.98e-1)" "unprognostic (8.88e-2)" "prognostic unfavorable (3.60e-5)" "unprognostic (4.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (4.09e-2)" "unprognostic (4.06e-2)" "unprognostic (1.92e-2)" "unprognostic (9.89e-2)" 1864.3 2099.0 555.5 499.0 565.3 1295.5 1857.6 551.6 615.8 2259.5 549.3 1694.1 544.2 1635.0 1065.1 2717.9 1828.7 498.1 1316.3 539.3 556.2 1385.9 1390.8 1257.4 1006.5 570.3 558.1 3860.4 4112.2 606.1 1325.3 534.3 570.5 1665.0 909.8 237.3 1758.0 610.4 1999.9 2751.6 1419.1 767.3 588.2 1542.6 1762.7 692.1 563.8 1108.8 1287.3 862.8 1354.0 1718.9 2072.4 577.6 738.0 1094.6 1223.6 1227.0 2101.3 3459.0 1165.5 904.3 1835.4 1592.3 882.0 1676.1 941.1 2286.8 542.9 1587.3 858.2 1754.6 1831.4 2172.0 1273.6 977.8 1036.3 807.6 1533.7 1656.6 1389.2 1932.4 915.0 3509.5 3187.7 1154.6 1984.2 2581.3 2055.4 1579.3 1573.5 1170.9 1855.9 2494.0 1509.9 2010.8 1336.2 3265.2 1067.1 1307.0 1533.0 2946.8 2077.6 925.6 1144.0 1009.2 739.8 1878.6 1209.1 1008.0 2050.7 2009.1 1133.2 1042.8 746.6 950.3 1094.7 453.3 975.5 1410.1 814.8 1328.8 830.2 115.2 309.8 65.6 395.1 280.0 583.3 624.2 535.6 488.8 452.9 544.4 591.3 560.4 43.6 433.2 255.0 449.1 453.7 959.4 555.5 565.3 551.6 615.8 539.3 556.2 570.3 558.1 570.5 588.2 563.8 577.6 2135.7 519.2 830.9 22.5 3484.9 3244.6 4561.0 2878.3 4056.7 324.7 4450.1 8182.0 389.0 1720.0 1397.0 597.7 143.9 3617.6 2668.7 1136.8 2122.9 2037.3 1992.4 1277.7 3110.1 1843.9 1503.3 2592.1 30.3 4412.9 5135.5 1931.5 1701.4 1613.2 851.9 3717.2 1779.5 1292.4 2514.0 131.2 28.5 2769.2 876.9 2202.6 2161.8 4012.3 3736.3 2023.9 1511.9 22.5 2569.6 1085.1 2398.6 22.6 34.9 2672.7 2176.1 1929.6 3366.8 4776.6 2603.2 2708.5 569.1 516.9 966.3 2340.4 2271.5 1087.3 793.2 6499.1 3980.6 3307.4 2539.1 5934.2 3443.7 5327.8 RPL7L1 dJ475N16.4 ENSG00000146223 "Ribosomal protein L7 like 1" Q6DKI1 6 42879616-42889925 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046049, HPA050478" Approved Nucleoli,Mitochondria NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 52: Non-specific - Transcription" "Nucleoli, Mitochondria" "HPA046049: AB_10964167, HPA050478: AB_2681138" "unprognostic (1.03e-3)" "unprognostic (4.37e-2)" "unprognostic (3.37e-1)" "unprognostic (7.97e-2)" "unprognostic (7.73e-3)" "unprognostic (4.26e-2)" "prognostic unfavorable (8.53e-5)" "unprognostic (2.56e-1)" "unprognostic (2.98e-2)" "unprognostic (3.78e-2)" "unprognostic (2.08e-1)" "unprognostic (1.39e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.06e-1)" "unprognostic (7.31e-3)" "unprognostic (4.58e-2)" 37.2 39.5 26.1 31.7 28.0 22.6 40.2 27.2 33.5 28.2 20.6 30.4 25.4 30.0 34.0 35.4 34.2 21.5 30.8 28.7 27.3 37.7 48.4 25.2 34.4 23.7 24.1 33.6 32.2 45.4 29.1 31.7 24.2 33.7 34.1 20.0 28.0 27.7 45.5 33.9 23.4 33.4 24.0 27.1 28.6 16.1 26.6 37.1 35.9 44.4 42.8 35.6 27.0 25.9 155.6 48.4 84.2 135.5 77.5 99.5 57.1 121.3 87.8 115.0 94.6 120.4 57.6 231.4 107.0 102.6 93.4 72.5 193.4 147.6 189.4 121.9 144.6 123.7 64.5 109.9 85.2 192.5 91.6 102.5 110.6 151.0 144.7 77.5 114.7 100.2 243.1 77.6 106.2 113.3 110.5 124.2 85.1 472.2 70.3 124.9 94.3 147.1 89.7 96.6 160.1 97.8 103.7 78.2 131.3 66.1 105.0 183.1 110.1 110.5 91.9 88.4 211.3 96.7 163.8 343.2 61.7 178.7 117.7 7.3 13.1 12.4 16.0 15.8 20.3 14.9 15.7 17.0 12.5 17.4 16.5 16.0 2.8 19.7 14.9 14.5 14.3 13.6 26.1 28.0 27.2 33.5 28.7 27.3 23.7 24.1 24.2 24.0 26.6 25.9 56.2 76.9 103.0 12.7 69.3 57.1 89.3 70.6 67.7 62.6 49.2 61.8 42.2 61.5 71.2 42.3 33.3 88.2 77.7 23.9 86.1 92.2 12.6 68.4 96.6 71.6 94.4 73.0 25.9 66.9 84.1 67.5 42.8 44.9 51.2 120.6 51.8 65.0 53.0 72.3 23.3 44.4 54.9 45.0 34.4 12.5 79.2 44.5 30.2 8.4 75.8 78.6 64.9 12.5 15.6 81.3 30.8 71.5 56.1 83.8 25.1 79.8 71.3 69.7 52.6 89.9 64.0 54.9 75.6 65.8 60.2 80.0 65.6 117.8 52.5 58.9 RRNAD1 "C1orf66, CGI-41, METTL25B" ENSG00000143303 "Ribosomal RNA adenine dimethylase domain containing 1" Q96FB5 1 156728442-156736960 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047426 Approved Approved Nucleoli,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 16: U-266 - Nucleosome" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli Cytosol "HPA047426: AB_2680041" "unprognostic (2.12e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (2.00e-1)" "unprognostic (1.86e-2)" "unprognostic (2.75e-1)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (1.98e-1)" "unprognostic (2.89e-3)" "unprognostic (2.24e-1)" "unprognostic (2.76e-1)" "unprognostic (2.14e-1)" "unprognostic (3.35e-2)" "unprognostic (1.49e-1)" "unprognostic (5.03e-3)" 17.1 21.3 16.5 14.1 20.0 11.9 21.9 18.8 18.1 22.4 20.6 21.0 27.4 22.0 26.0 21.8 28.2 17.7 14.9 15.9 17.1 18.6 28.4 17.7 19.5 20.7 18.7 26.5 27.6 25.4 20.5 14.8 18.8 25.0 17.4 17.9 27.2 22.9 30.2 29.1 24.0 14.8 18.2 20.4 23.8 24.4 18.6 14.2 29.4 22.8 17.0 22.5 20.9 22.9 14.6 28.3 20.6 20.3 54.2 24.7 31.3 10.8 32.8 18.3 13.7 15.3 65.7 24.8 31.6 17.1 25.7 60.7 28.9 25.4 7.3 49.5 24.3 15.0 27.5 11.6 34.1 22.4 39.2 38.4 47.5 18.3 34.3 21.5 15.5 21.8 36.3 54.1 9.9 35.3 11.6 26.0 23.9 63.2 8.7 18.7 13.6 58.1 21.8 15.6 26.7 38.2 19.2 38.7 24.0 31.2 51.5 47.2 15.0 11.3 13.8 17.7 14.7 62.7 67.7 31.8 12.7 24.9 13.9 4.1 1.8 2.7 3.5 1.3 3.6 1.7 3.3 2.5 3.2 2.3 2.7 3.0 4.0 4.0 2.3 1.2 5.1 1.7 16.5 20.0 18.8 18.1 15.9 17.1 20.7 18.7 18.8 18.2 18.6 22.9 9.5 6.4 15.1 11.4 15.8 10.1 21.5 13.5 22.2 11.2 20.0 19.9 7.1 31.5 13.9 3.7 12.5 24.9 8.9 16.4 9.8 12.7 60.2 12.3 6.4 9.7 9.6 14.3 4.6 13.1 17.2 11.2 18.3 10.9 5.1 8.7 12.5 19.5 10.9 8.4 6.3 16.9 14.2 11.1 4.9 14.7 11.1 9.6 8.8 4.7 10.1 20.5 5.2 5.5 15.9 9.3 12.8 9.4 14.8 21.4 36.5 12.8 13.9 13.6 13.1 9.6 9.6 20.6 23.2 18.9 11.5 32.4 8.1 8.2 16.2 18.0 RRP1 "D21S2056E, NNP-1, Nop52, RRP1A" ENSG00000160214 "Ribosomal RNA processing 1" P56182 21 43789513-43805293 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016818, HPA018166" Approved Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 30: Non-specific - Translation" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" "HPA016818: AB_1854561, HPA018166: AB_1854562" "unprognostic (5.38e-2)" "unprognostic (3.48e-1)" "unprognostic (3.43e-1)" "unprognostic (2.53e-2)" "unprognostic (9.44e-2)" "unprognostic (1.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.26e-1)" "unprognostic (7.63e-3)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (6.29e-5)" "unprognostic (1.13e-1)" "unprognostic (9.21e-3)" "unprognostic (2.64e-1)" "unprognostic (1.88e-1)" 8.0 8.2 8.0 6.5 8.7 5.3 7.3 7.4 10.2 6.9 4.8 6.4 5.0 7.1 3.3 16.0 6.4 4.0 7.0 9.2 7.2 7.6 13.0 5.3 8.1 8.9 8.1 8.0 9.7 4.8 5.5 4.9 8.0 7.2 3.0 1.7 8.1 4.2 12.9 11.9 5.9 3.4 6.6 8.2 7.5 7.9 7.6 5.0 6.0 5.3 6.1 7.3 7.9 10.8 37.6 19.6 13.5 22.6 7.3 8.2 25.6 18.5 10.9 25.7 18.1 52.1 21.6 35.5 14.9 10.4 23.8 18.8 25.2 18.5 11.7 17.7 47.9 50.4 18.8 32.1 14.9 32.6 17.5 11.0 17.0 26.0 20.6 6.7 13.7 32.9 67.3 26.9 12.2 43.2 28.7 44.7 44.8 26.1 28.7 52.0 10.7 66.4 13.4 20.5 31.6 18.8 19.3 21.0 25.3 3.8 21.5 22.1 15.6 17.2 19.1 18.2 33.0 32.1 29.8 37.1 25.7 53.7 22.6 0.1 5.0 1.7 10.7 4.8 13.4 11.0 11.0 11.1 10.2 13.0 11.9 8.0 1.1 13.1 2.3 8.8 6.8 7.0 8.0 8.7 7.4 10.2 9.2 7.2 8.9 8.1 8.0 6.6 7.6 10.8 12.9 16.0 19.4 9.4 17.3 72.3 40.2 55.9 23.3 18.7 14.4 12.7 6.1 18.6 45.3 7.3 20.9 31.4 12.7 18.6 7.9 40.0 4.2 14.9 15.5 18.8 20.9 19.0 6.2 33.1 39.0 24.5 18.8 16.1 20.3 20.1 9.3 16.0 32.7 8.4 6.3 19.3 32.6 8.4 35.0 2.7 19.3 13.6 42.7 2.8 15.3 12.3 13.4 2.5 11.6 41.4 9.1 20.7 19.2 59.4 10.5 21.0 24.3 17.6 32.9 23.8 20.6 21.4 30.0 32.2 70.2 30.4 15.0 21.4 29.5 46.1 RRP36 "C6orf153, dJ20C7.4" ENSG00000124541 "Ribosomal RNA processing 36" Q96EU6 6 43021623-43034156 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029904, HPA029905" Uncertain Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA029904: AB_10611817, HPA029905: AB_2673244" "unprognostic (1.76e-1)" "unprognostic (4.47e-1)" "unprognostic (3.78e-2)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (2.61e-1)" "unprognostic (6.83e-2)" "unprognostic (1.32e-3)" "unprognostic (1.39e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (3.53e-1)" "unprognostic (1.63e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-2)" 30.0 34.6 19.4 27.4 19.7 28.7 28.7 21.5 23.2 26.0 19.8 29.0 20.8 25.5 22.9 37.8 23.2 19.0 30.1 20.3 22.3 35.1 37.3 25.5 32.3 21.3 20.9 18.4 35.8 34.7 31.9 24.2 22.0 28.5 24.3 16.6 27.1 25.0 51.3 34.3 25.9 29.7 20.8 33.3 30.6 17.7 21.0 31.1 23.4 34.8 35.2 30.0 26.4 20.8 141.5 77.9 75.8 111.3 79.7 74.0 63.6 108.9 97.7 136.1 132.6 141.9 59.8 64.7 86.3 113.8 100.1 73.5 127.7 131.8 149.3 82.5 129.9 104.1 82.7 153.2 92.3 87.5 77.7 75.6 79.0 163.0 69.1 48.7 112.2 57.6 128.2 68.4 127.8 148.1 106.0 95.6 84.3 249.7 79.6 98.7 74.7 74.9 83.2 130.5 96.4 84.5 80.1 72.8 129.1 70.6 100.1 106.0 91.2 125.1 95.1 83.4 173.8 63.8 103.9 172.0 54.5 108.6 119.1 2.4 2.2 2.0 3.3 3.0 2.7 4.5 2.4 4.2 2.3 1.4 2.2 4.5 2.5 2.0 2.4 6.0 1.4 0.8 19.4 19.7 21.5 23.2 20.3 22.3 21.3 20.9 22.0 20.8 21.0 20.8 26.8 0.0 15.6 4.6 14.7 13.4 11.2 13.5 5.7 16.1 19.7 22.1 15.1 20.0 14.1 20.2 16.7 29.3 33.1 12.7 13.7 33.7 10.1 18.3 26.5 18.5 13.9 4.6 8.1 44.8 41.8 18.0 12.8 18.0 6.3 27.3 21.0 36.0 29.1 18.5 8.1 12.6 12.2 16.6 11.7 23.0 11.8 20.0 14.2 2.8 26.1 36.9 20.6 6.6 9.6 44.0 7.4 18.8 18.8 17.7 12.4 20.5 10.0 20.3 6.6 19.3 24.7 9.5 10.6 16.5 18.6 33.7 16.5 61.5 14.2 14.3 RTF2 "C20orf43, CDAO5, HSPC164, RTFDC1" ENSG00000022277 "Replication termination factor 2" Q9BY42 20 56468585-56519449 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 162.8;Distal tubular cells: 156.5;Proximal tubular cells: 149.9;Syncytiotrophoblasts: 182.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053986 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA053986: AB_2682333" "unprognostic (1.65e-1)" "unprognostic (1.94e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.54e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (1.31e-4)" "unprognostic (8.90e-2)" "unprognostic (4.02e-3)" "unprognostic (1.16e-1)" "unprognostic (8.98e-2)" "unprognostic (3.66e-2)" "unprognostic (1.55e-2)" "unprognostic (1.55e-1)" "unprognostic (1.96e-1)" "unprognostic (4.58e-1)" "unprognostic (8.48e-3)" 73.8 72.7 101.4 65.9 113.3 128.5 65.7 117.4 106.7 66.2 88.3 79.2 60.5 70.6 48.9 64.2 64.8 49.2 85.9 97.2 106.7 68.7 63.8 58.1 70.7 113.7 109.6 71.1 59.3 63.0 67.8 55.4 115.0 58.2 54.2 61.3 51.2 62.2 181.4 69.6 60.8 65.4 111.1 67.8 59.3 57.0 108.4 79.2 60.6 111.1 76.2 73.8 57.5 123.5 132.8 93.3 91.1 91.3 111.1 97.9 85.9 198.5 148.1 280.0 158.5 192.6 125.2 110.4 232.0 161.5 139.7 144.9 92.4 153.8 190.7 52.6 72.9 138.9 97.4 150.8 127.9 201.3 186.6 88.1 156.5 126.0 106.9 119.7 121.3 118.1 109.6 114.3 139.1 253.9 171.6 173.0 68.8 185.2 175.9 116.3 247.2 149.5 119.1 86.1 95.1 103.1 208.2 355.0 199.0 66.7 165.0 191.7 131.5 242.2 156.0 133.0 165.1 94.6 116.1 156.9 190.7 134.7 135.1 309.4 205.4 562.3 125.6 192.8 106.2 115.7 106.4 122.5 223.6 134.0 119.7 110.6 580.4 197.4 200.5 189.6 152.2 254.1 101.4 113.3 117.4 106.7 97.2 106.7 113.7 109.6 115.0 111.1 108.4 123.5 87.2 51.3 61.2 0.0 20.9 0.0 0.0 0.0 0.0 0.0 54.1 56.9 0.0 0.0 34.0 66.2 0.0 162.8 50.9 0.0 156.5 104.5 0.0 47.8 51.2 38.8 0.0 0.0 0.0 96.3 109.5 37.3 0.0 47.7 90.8 57.9 0.0 0.0 110.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.8 0.0 0.0 92.0 0.0 0.0 0.0 0.0 101.9 0.0 0.0 5.3 0.0 0.0 149.9 34.2 0.0 0.0 0.0 37.4 0.0 0.0 0.0 0.0 182.9 26.4 89.8 0.0 0.0 SCML2 ENSG00000102098 "Scm polycomb group protein like 2" Q9UQR0 X 18239313-18354688 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.6" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 15.3;Oligodendrocyte precursor cells: 17.1;Spermatocytes: 26.3;Spermatogonia: 27.5" "Cancer enhanced" "Detected in many" "testis cancer: 4.1" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 6 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "NTERA-2: 39.7;REH: 37.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001662, HPA064713" Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA001662: AB_1079879, HPA064713: AB_2685333" "unprognostic (5.15e-2)" "unprognostic (2.57e-2)" "unprognostic (7.93e-2)" "unprognostic (7.26e-5)" "unprognostic (1.24e-1)" "unprognostic (2.24e-2)" "unprognostic (4.95e-5)" "unprognostic (2.33e-1)" "unprognostic (1.06e-2)" "unprognostic (1.18e-1)" "unprognostic (6.15e-4)" "unprognostic (1.83e-1)" "unprognostic (2.35e-4)" "unprognostic (3.30e-1)" "unprognostic (2.54e-1)" "unprognostic (1.97e-2)" "unprognostic (3.31e-3)" 1.4 4.0 0.9 1.2 1.0 6.3 2.0 1.3 1.5 2.3 1.0 1.8 1.1 2.6 1.1 1.0 1.5 0.7 0.8 1.0 1.2 0.7 1.4 0.5 1.1 0.9 0.8 6.0 1.3 1.7 1.5 1.9 1.1 1.1 1.3 3.5 8.8 1.1 1.3 2.0 0.9 2.5 0.8 1.2 0.6 11.6 0.9 3.4 2.4 1.4 1.2 1.4 1.7 1.3 1.9 6.8 24.7 5.9 1.9 2.5 7.2 4.0 2.9 7.3 8.3 9.2 1.3 0.0 0.9 1.9 5.7 0.1 32.7 0.6 9.4 0.0 26.0 0.0 5.7 4.0 0.9 21.1 5.0 1.5 1.1 5.7 6.9 1.9 0.4 20.2 16.0 0.0 5.1 3.2 33.3 10.0 39.7 0.7 9.0 37.8 11.9 4.5 0.2 0.4 14.0 16.3 7.7 6.5 0.1 26.0 8.2 8.8 1.0 6.8 4.9 15.2 3.6 0.0 20.4 32.0 2.6 13.8 5.4 0.0 0.1 0.0 0.4 0.1 0.4 0.1 0.1 0.1 0.5 0.6 0.1 0.0 0.0 0.5 0.0 3.8 0.0 0.2 0.9 1.0 1.3 1.5 1.0 1.2 0.9 0.8 1.1 0.8 0.9 1.3 0.5 0.0 0.5 3.6 1.7 3.6 1.0 0.0 2.8 2.3 0.8 1.3 1.8 0.0 0.6 0.0 0.0 1.8 1.7 0.4 0.0 0.3 1.3 0.9 2.5 1.2 1.2 4.2 7.7 0.2 0.4 2.4 0.0 0.2 0.0 6.1 0.0 0.9 1.9 6.7 15.3 0.7 0.0 0.0 0.5 1.6 1.8 0.6 0.0 0.0 0.2 1.7 0.0 17.1 10.2 0.2 0.0 1.2 0.3 1.2 0.1 0.8 0.0 3.8 0.0 2.6 0.6 26.3 27.5 1.8 4.1 0.4 0.5 9.8 1.2 0.3 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Human disease related genes, Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 14.6 13.5 10.5 14.8 10.8 7.2 17.9 8.4 12.3 13.6 8.5 14.3 11.9 17.6 19.0 15.3 12.7 8.7 14.3 10.9 11.0 15.0 15.8 12.6 21.2 9.6 8.9 13.7 17.7 17.7 8.9 12.9 9.3 14.2 15.1 6.8 15.0 16.2 22.9 14.8 11.1 17.1 8.5 15.5 14.0 21.3 11.1 16.4 21.2 16.4 20.2 18.8 11.7 10.2 29.8 11.8 28.5 38.9 33.1 29.8 30.6 41.3 35.9 34.0 29.1 36.6 42.0 46.7 30.2 38.1 32.4 29.7 44.5 40.5 42.3 41.2 23.0 39.9 24.4 30.6 32.7 68.5 43.9 26.4 45.0 36.3 40.4 21.1 30.0 31.2 72.7 37.8 36.4 33.1 69.6 25.1 47.4 48.3 18.1 41.8 53.5 39.3 32.7 32.6 43.3 35.6 28.1 57.0 48.9 31.1 26.4 39.6 29.1 36.6 36.7 44.4 34.8 33.9 37.6 62.0 40.7 31.1 46.0 10.4 14.5 4.1 19.1 19.1 23.8 17.8 23.0 21.1 15.3 20.1 23.0 19.5 2.3 23.4 27.5 13.0 21.5 15.9 10.5 10.8 8.4 12.3 10.9 11.0 9.6 8.9 9.3 8.5 11.1 10.2 36.2 19.2 34.7 15.0 45.7 27.5 26.8 45.1 35.3 21.1 21.3 29.1 12.3 14.3 46.0 22.0 6.2 30.6 35.7 14.5 35.2 37.7 109.0 12.1 29.9 25.2 22.8 35.3 34.0 24.9 32.2 27.4 20.9 18.7 49.4 26.3 18.9 22.1 37.9 13.5 31.8 22.6 36.7 24.3 16.3 106.7 25.4 30.0 24.9 30.9 40.3 23.7 42.2 23.6 29.9 33.4 18.3 33.1 49.0 37.1 17.1 46.6 26.1 20.0 19.7 33.2 38.7 75.6 100.7 47.5 33.1 25.0 38.1 33.2 27.9 22.4 SDHA "FP, SDH2, SDHF" ENSG00000073578 "Succinate dehydrogenase complex flavoprotein subunit A" P31040 5 218241-257082 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Electron transport, Transport, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 601.0;skeletal muscle: 479.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034929, HPA041981, HPA064582" Enhanced Supported Nucleoli,Mitochondria No No 360000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoli "CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293" "prognostic unfavorable (6.00e-4)" "unprognostic (1.93e-1)" "unprognostic (5.97e-2)" "unprognostic (1.36e-1)" "unprognostic (1.89e-1)" "unprognostic (1.62e-1)" "unprognostic (2.80e-1)" "unprognostic (3.14e-2)" "unprognostic (2.88e-1)" "unprognostic (1.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "prognostic favorable (9.53e-8)" "unprognostic (1.11e-2)" "unprognostic (2.62e-1)" "unprognostic (3.57e-1)" "unprognostic (1.79e-1)" 70.6 148.0 60.5 29.6 62.7 38.4 65.8 78.7 71.3 50.2 63.2 131.9 148.9 53.2 27.3 67.1 50.3 33.9 601.0 60.8 73.4 139.1 276.8 54.3 43.1 74.1 62.7 65.8 71.5 122.9 44.8 28.8 75.7 46.3 82.1 42.7 66.8 35.6 479.0 58.9 116.8 36.1 61.7 66.4 115.6 56.4 71.7 41.8 49.6 224.8 36.5 63.2 56.3 63.7 88.4 154.2 54.8 95.0 96.9 68.5 154.1 63.3 81.8 107.2 108.4 163.9 115.9 108.3 218.6 70.2 92.1 111.8 102.4 129.7 66.3 241.9 98.9 50.1 390.8 224.1 60.0 69.5 70.7 70.6 84.3 83.6 33.7 93.6 123.9 83.5 84.6 83.1 48.7 155.8 93.9 206.9 19.3 101.4 193.5 119.0 84.6 223.2 245.4 122.7 62.3 35.4 332.5 205.5 90.7 36.1 115.0 93.2 91.1 80.3 82.1 48.2 52.5 93.0 40.9 79.8 81.6 99.9 52.5 66.6 70.8 88.1 95.2 85.7 86.8 79.5 92.5 94.5 93.3 73.3 89.2 85.0 14.1 85.5 74.7 59.5 149.3 111.3 60.5 62.7 78.7 71.3 60.8 73.4 74.1 62.7 75.7 61.7 71.7 63.7 29.4 35.3 71.1 20.2 50.9 61.2 81.4 105.8 31.3 51.0 24.6 17.0 272.6 64.3 78.5 75.4 102.2 109.6 39.3 169.7 142.8 94.7 58.7 39.1 30.1 39.1 47.5 56.8 34.4 44.9 102.8 49.4 47.9 48.5 43.7 64.8 47.5 167.0 67.5 101.0 39.9 96.3 105.8 41.0 55.0 28.8 68.3 38.8 90.7 12.2 60.2 50.7 52.5 19.1 37.9 54.2 100.1 55.7 67.5 37.0 274.4 190.7 75.2 87.2 78.9 33.2 51.7 96.9 54.3 40.9 35.9 154.7 56.7 85.0 160.1 88.2 SELENOF SEP15 ENSG00000183291 "Selenoprotein F" O60613 1 86862445-86914424 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 248.6;Ductal cells: 235.9;Extravillous trophoblasts: 338.3;Hofbauer cells: 241.2;Syncytiotrophoblasts: 315.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054937 Approved Nucleoli,Cytosol "Intracellular and membrane" No No 420000 "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" Nucleoli Cytosol "HPA054937: AB_2682642" "unprognostic (6.15e-2)" "unprognostic (6.98e-3)" "prognostic favorable (6.53e-4)" "unprognostic (6.20e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (8.17e-4)" "prognostic unfavorable (1.98e-5)" "unprognostic (1.65e-1)" "unprognostic (6.51e-3)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.79e-3)" "unprognostic (2.39e-2)" "unprognostic (1.09e-1)" "unprognostic (8.24e-3)" "unprognostic (1.34e-2)" 118.1 137.9 77.6 118.8 80.0 107.9 147.4 80.9 106.1 156.6 97.9 127.8 113.5 117.4 211.4 83.6 130.1 123.3 84.6 75.2 84.3 160.3 173.9 114.9 140.6 82.6 79.8 124.6 93.4 115.7 88.4 155.8 84.0 121.1 134.2 90.7 104.1 116.4 45.6 66.3 111.3 107.1 86.4 107.2 116.8 66.7 79.0 135.5 234.0 64.7 126.9 146.6 72.6 92.5 203.1 133.3 118.0 129.1 383.0 396.4 178.3 249.1 317.3 251.4 254.8 176.8 261.8 245.2 309.7 248.9 195.7 131.8 135.2 150.7 296.0 222.1 180.2 252.4 108.5 178.2 245.2 336.8 166.1 272.3 233.0 152.8 253.0 180.2 220.2 207.8 241.4 262.3 253.3 90.2 254.4 227.3 170.7 211.2 197.9 207.7 205.1 251.9 355.5 198.5 149.5 122.6 241.6 235.6 349.2 104.7 104.0 298.5 205.3 180.0 122.9 347.6 277.0 155.1 158.7 251.9 107.7 268.4 216.7 170.9 111.3 113.4 89.7 115.9 116.1 161.4 98.7 97.2 107.1 194.2 98.8 102.3 109.3 82.3 132.4 166.3 115.2 171.3 77.6 80.0 80.9 106.1 75.2 84.3 82.6 79.8 84.0 86.4 79.0 92.5 131.6 118.6 155.2 0.0 52.4 0.0 0.0 0.0 0.0 0.0 142.1 107.7 0.0 0.0 74.9 108.5 0.0 248.6 89.3 0.0 74.3 235.9 0.0 102.2 119.1 73.2 0.0 0.0 0.0 193.5 338.3 85.2 0.0 98.1 64.3 68.8 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.1 0.0 0.0 64.1 0.0 0.0 0.0 0.0 197.8 0.0 0.0 19.1 0.0 0.0 151.5 70.0 0.0 0.0 0.0 61.5 0.0 0.0 0.0 0.0 315.2 53.9 122.2 0.0 0.0 SELENOH "C11orf31, SELH" ENSG00000211450 "Selenoprotein H" Q8IZQ5 11 57741250-57743554 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 444.1;Exocrine glandular cells: 315.1;Hofbauer cells: 416.3;Proximal tubular cells: 588.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048362 Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA048362: AB_2680370" "unprognostic (1.12e-2)" "unprognostic (3.05e-2)" "unprognostic (6.14e-2)" "unprognostic (1.18e-1)" "unprognostic (2.39e-1)" "unprognostic (1.69e-2)" "prognostic unfavorable (4.30e-4)" "unprognostic (3.61e-2)" "unprognostic (1.23e-2)" "prognostic favorable (1.80e-4)" "unprognostic (1.58e-1)" "unprognostic (7.56e-2)" "unprognostic (4.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.01e-1)" "unprognostic (1.78e-1)" "unprognostic (2.60e-1)" 96.0 167.2 38.4 31.6 41.1 39.4 95.6 36.4 70.0 91.4 39.5 82.0 31.7 73.7 11.9 135.0 72.7 20.6 117.5 39.9 43.2 125.6 171.2 85.9 42.5 38.2 38.7 96.4 110.8 9.2 104.6 26.2 39.6 110.6 13.1 5.4 99.4 16.2 117.0 79.6 88.0 15.0 37.5 130.1 91.3 66.8 41.1 14.5 103.2 6.2 27.9 87.0 86.3 39.7 116.5 84.5 79.8 47.6 7.6 29.1 18.8 43.1 30.3 36.4 19.8 26.7 56.2 51.0 120.7 15.4 31.0 50.9 26.6 47.1 8.3 75.7 85.3 67.8 59.0 66.4 63.7 105.1 140.0 38.4 43.3 39.0 19.4 39.9 50.4 68.9 70.2 44.0 23.7 112.6 103.5 181.1 155.6 32.8 89.6 122.5 75.6 106.7 23.6 62.2 46.0 105.1 39.1 35.2 133.6 18.3 102.2 79.7 64.1 41.1 101.2 90.3 64.2 269.8 226.2 41.3 95.3 89.0 106.1 295.2 385.8 204.5 160.2 417.6 151.4 346.4 209.6 171.4 396.4 349.2 282.1 208.8 29.7 187.7 394.2 488.1 175.3 469.5 38.4 41.1 36.4 70.0 39.9 43.2 38.2 38.7 39.6 37.5 41.1 39.7 182.7 166.7 151.8 0.0 61.0 0.0 0.0 0.0 0.0 0.0 273.3 267.0 0.0 0.0 74.3 150.8 0.0 288.7 77.7 0.0 444.1 256.7 0.0 175.5 95.2 90.2 0.0 0.0 0.0 315.1 280.8 68.4 0.0 104.1 133.7 148.5 0.0 0.0 416.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 119.1 0.0 0.0 102.4 0.0 0.0 0.0 0.0 288.7 0.0 0.0 14.8 0.0 0.0 588.6 142.8 0.0 0.0 0.0 74.7 0.0 0.0 0.0 0.0 147.2 49.0 190.5 0.0 0.0 SENP3 "DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1" ENSG00000161956 "SUMO specific peptidase 3" Q9H4L4 17 7561919-7571969 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" HPA060290 Supported Supported Nucleoplasm,Nucleoli Yes No "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli" "HPA060290: AB_2684244" "unprognostic (5.68e-2)" "unprognostic (2.39e-1)" "unprognostic (1.65e-1)" "unprognostic (1.01e-1)" "unprognostic (3.34e-1)" "unprognostic (3.48e-1)" "unprognostic (1.30e-3)" "unprognostic (2.82e-1)" "unprognostic (7.37e-2)" "unprognostic (3.72e-2)" "prognostic favorable (6.22e-5)" "unprognostic (2.71e-2)" "unprognostic (1.96e-1)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (8.21e-2)" "unprognostic (2.56e-2)" 24.2 24.0 43.7 21.0 42.6 25.4 23.7 38.5 47.9 23.7 38.5 32.4 21.2 26.7 27.4 25.4 25.9 19.3 25.2 42.6 39.8 34.1 20.5 28.6 26.5 40.4 42.2 26.8 26.4 38.1 26.4 22.5 41.1 23.0 25.4 24.7 24.8 26.0 33.5 28.6 25.2 28.9 39.5 28.3 27.0 29.0 44.0 33.8 23.9 30.9 31.2 29.7 21.8 42.0 76.4 90.8 52.7 82.5 58.6 42.8 54.8 54.8 56.0 93.4 87.2 54.9 32.5 90.3 52.6 72.7 62.3 72.0 114.4 85.8 78.0 63.7 105.0 46.7 74.8 56.9 79.1 44.0 57.9 55.1 86.5 107.1 103.5 53.3 76.0 102.1 61.5 24.7 73.0 51.4 107.9 33.6 64.2 70.9 54.5 97.1 48.8 52.4 62.9 44.0 52.5 67.6 55.3 52.7 60.0 66.6 44.1 28.5 40.5 53.0 45.9 51.3 119.0 36.3 40.4 57.3 53.9 45.7 80.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 43.7 42.6 38.5 47.9 42.6 39.8 40.4 42.2 41.1 39.5 44.0 42.0 4.5 3.2 5.4 0.0 4.9 8.5 6.4 1.6 10.2 6.1 6.7 11.0 7.1 7.2 3.6 1.8 22.9 3.0 4.8 2.6 0.0 2.3 1.4 4.0 4.2 4.7 6.6 1.3 0.0 2.4 2.3 3.8 3.6 4.7 1.3 5.2 8.2 2.7 1.5 6.7 0.0 3.0 2.0 6.0 6.4 0.7 4.1 4.9 3.6 0.0 4.7 5.5 4.1 0.0 0.0 2.1 0.8 2.2 6.4 6.1 4.0 1.1 2.1 7.3 0.0 5.2 4.4 3.7 4.0 7.4 11.6 4.1 4.9 3.0 3.7 6.4 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 760.6 1067.4 704.4 446.7 726.4 944.9 619.4 750.2 906.3 650.8 1027.1 728.4 443.4 509.9 776.2 887.9 456.8 469.4 1187.9 698.1 712.2 1002.2 1328.7 700.8 686.4 737.1 725.3 474.3 795.1 490.9 569.3 484.2 734.7 794.5 631.9 72.8 823.7 312.8 636.9 631.1 593.2 507.4 739.4 745.3 784.3 400.2 759.4 450.7 706.6 723.6 628.9 595.0 634.1 758.8 497.5 770.8 573.8 792.9 1963.2 1431.3 438.9 844.8 1042.5 540.4 682.7 991.5 470.0 250.4 694.7 1429.2 698.7 641.1 454.6 623.8 271.1 699.6 526.2 610.9 1074.9 1936.8 934.7 581.8 1235.8 1349.9 810.5 425.8 452.1 836.1 783.5 680.7 630.2 1593.5 1067.4 1441.8 758.6 1337.2 501.5 1849.7 885.1 743.9 382.6 1147.2 1462.5 1695.7 450.6 481.1 458.9 1871.5 463.9 488.4 1574.7 2363.9 682.9 920.0 469.0 1409.4 669.3 593.3 886.2 1837.8 989.2 1032.8 980.4 4033.8 5391.9 5884.9 2716.6 5055.2 2481.3 3853.8 2938.5 2784.5 4649.4 3901.8 2713.3 2731.7 3154.6 2568.8 4495.9 6486.5 3793.5 12856.7 704.4 726.4 750.2 906.3 698.1 712.2 737.1 725.3 734.7 739.4 759.4 758.8 1269.2 506.4 789.0 0.0 1149.8 1151.3 1379.1 3393.0 861.6 53.9 2373.1 2483.2 2229.8 1338.2 2099.5 1736.1 54.2 2660.9 1475.6 2388.2 3897.3 1707.6 576.8 1243.6 1343.1 1283.3 1167.5 1310.8 0.5 2255.2 3410.2 1489.3 1403.7 1261.0 785.9 775.2 1532.4 2884.5 3545.2 47.1 0.5 2862.6 2278.6 2262.1 2298.5 319.2 1225.3 2102.8 1817.8 0.0 2626.4 544.5 1881.6 1.5 0.3 1804.7 2363.9 992.2 1546.7 2188.9 3013.2 5083.6 1950.6 148.4 604.8 680.1 1737.3 750.2 381.1 1725.5 1556.5 3275.8 1216.9 1446.6 2042.5 2819.5 SFRP1 "FRP, FRP-1, SARP2" ENSG00000104332 "Secreted frizzled related protein 1" Q8N474 8 41261962-41309473 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 299.3;choroid plexus: 509.2" "Cell type enhanced" "Detected in many" "Breast glandular cells: 710.9;Breast myoepithelial cells: 1158.6;Cardiomyocytes: 266.3;Leydig cells: 578.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "hTERT-RPE1: 3203.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008116, HPA064870" Approved Approved Nucleoli,Cytosol "Secreted in other tissues" Yes No 1300000 "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 35: Glandular cells - Unknown function" Nucleoli Cytosol "CAB008116: AB_2187070, HPA064870: AB_2685376" "unprognostic (1.23e-3)" "unprognostic (7.01e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-1)" "unprognostic (7.13e-2)" "prognostic favorable (1.55e-4)" "unprognostic (1.79e-1)" "unprognostic (2.69e-3)" "unprognostic (2.15e-2)" "unprognostic (4.67e-3)" "unprognostic (3.52e-3)" "unprognostic (4.74e-2)" "unprognostic (1.72e-2)" "unprognostic (1.75e-2)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (3.12e-4)" 88.4 12.9 9.2 10.5 12.7 1.4 299.3 18.2 15.0 203.7 509.2 24.5 12.2 132.5 1.8 26.1 98.5 61.3 124.8 29.4 8.5 115.3 6.1 4.7 4.0 29.9 10.5 46.8 6.2 1.4 1.2 19.5 29.7 42.6 30.1 2.2 236.9 102.3 2.6 55.4 18.9 82.9 7.7 21.4 24.4 28.4 10.8 3.1 12.7 32.8 3.2 44.9 95.6 24.7 0.1 29.0 75.9 1.9 67.5 3.9 14.5 132.9 694.5 197.9 187.2 0.0 17.8 0.0 0.6 0.7 15.8 0.9 10.8 53.7 277.6 0.0 2.3 0.0 0.0 0.0 6.4 0.0 0.7 11.8 255.9 19.9 19.3 3203.5 6.2 0.2 0.0 0.0 3.7 0.0 0.0 0.2 205.8 0.1 0.3 0.0 15.7 0.0 422.6 0.0 4.1 18.5 5.5 0.0 41.5 264.7 0.1 2.1 1.9 0.1 19.6 0.2 18.3 0.0 0.0 0.0 0.2 0.0 279.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 12.7 18.2 15.0 29.4 8.5 29.9 10.5 29.7 7.7 10.8 24.7 8.4 0.0 0.0 2.0 1.2 11.2 134.0 1.4 147.4 1.8 710.9 1158.6 266.3 0.0 0.7 62.5 2.1 2.2 9.1 0.0 80.3 4.4 5.0 3.0 131.6 21.0 0.0 0.0 0.2 0.0 82.0 229.5 16.8 3.4 0.0 19.3 53.6 0.3 2.0 1.7 12.1 0.0 0.0 0.3 4.0 25.7 578.4 4.0 99.6 0.0 0.0 76.2 0.0 7.5 20.6 0.1 0.0 130.1 2.1 29.7 0.0 3.2 0.0 1.8 0.0 34.9 18.0 2.3 16.8 53.7 5.5 0.8 7.3 72.6 0.0 9.3 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 222.2;Late spermatids: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 16.8 16.1 13.6 11.2 15.6 12.4 16.5 16.7 14.6 26.8 13.8 28.0 12.8 29.1 9.5 12.0 27.6 9.1 15.3 13.4 14.9 11.1 19.9 14.0 16.9 15.2 14.4 33.3 25.6 10.7 10.3 7.1 15.4 16.4 7.2 7.8 16.6 16.7 51.1 16.0 18.8 12.0 14.9 16.2 19.8 43.0 14.6 14.1 17.6 19.8 10.2 23.5 16.4 16.8 13.1 21.3 16.3 10.5 10.6 10.9 29.5 8.5 9.6 21.7 20.2 24.6 11.5 39.1 21.1 6.7 13.2 15.0 12.4 15.4 6.1 12.8 24.0 24.3 12.9 33.7 27.1 22.1 26.1 11.5 20.0 13.1 13.2 11.7 8.3 24.5 20.8 19.4 7.9 43.4 25.5 43.2 22.7 9.6 20.5 38.9 10.6 34.2 11.3 19.5 26.3 12.2 13.3 25.3 15.0 5.8 20.7 18.4 5.9 15.4 12.9 9.2 15.3 22.4 35.7 22.7 10.9 36.9 12.5 20.6 47.0 50.0 53.6 41.8 65.2 57.9 74.2 65.8 47.6 65.9 84.1 66.3 13.4 55.1 33.7 71.4 78.3 58.7 13.6 15.6 16.7 14.6 13.4 14.9 15.2 14.4 15.4 14.9 14.6 16.8 11.2 16.0 16.7 0.0 20.0 0.0 18.1 0.0 32.5 5.5 12.5 21.1 0.0 12.8 7.4 18.4 14.6 17.3 27.1 7.9 9.8 12.6 222.2 8.5 10.1 8.7 3.6 17.1 0.0 12.9 11.8 12.7 10.2 7.7 6.3 16.9 11.0 17.3 14.2 0.0 0.0 8.8 0.0 12.9 0.0 384.4 30.7 13.5 0.0 0.0 17.1 11.8 22.6 0.0 0.0 10.1 15.7 21.8 16.7 9.5 40.1 23.7 6.6 14.1 19.7 18.3 13.0 10.5 30.9 17.0 0.0 21.1 21.0 14.8 11.9 12.0 SHLD3 "AC008560.1, CTC-534A2.2, FLJ26957, RINN1" ENSG00000253251 "Shieldin complex subunit 3" Q6ZNX1 5 65625027-65630928 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 17.5" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 4.0;dendritic cells: 5.9;Distal tubular cells: 3.9;Pancreatic endocrine cells: 4.6;Proximal tubular cells: 5.3;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066071, HPA068764" Approved Supported Nucleoplasm,Nucleoli No No "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA066071: AB_2685609, HPA068764: AB_2686028" "unprognostic (7.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.34e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.38e-2)" "unprognostic (7.24e-3)" "unprognostic (5.09e-4)" "unprognostic (2.12e-2)" "unprognostic (1.68e-2)" "unprognostic (1.49e-1)" "unprognostic (1.37e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.17e-4)" 2.3 2.7 2.4 2.7 2.5 17.5 4.2 2.8 3.6 1.8 1.8 2.8 2.8 2.3 3.1 1.5 1.9 2.4 1.8 2.3 2.1 2.9 2.6 2.5 4.8 2.4 2.1 1.5 3.4 2.1 2.5 2.5 2.3 4.3 3.0 3.7 2.0 2.5 1.8 2.9 2.7 1.7 2.4 2.5 2.4 3.2 2.4 3.9 2.4 1.9 3.6 2.5 1.3 3.2 2.6 3.6 5.0 10.8 2.9 3.5 6.3 3.8 3.5 5.8 7.0 5.9 8.0 4.9 4.2 4.6 6.5 3.1 5.1 4.7 8.5 6.7 6.5 4.3 10.3 8.3 2.5 5.0 7.5 2.1 6.8 6.0 6.1 1.6 3.7 7.7 6.4 11.5 4.7 6.9 6.7 7.7 4.0 1.5 2.2 4.4 4.9 7.9 4.9 6.0 6.7 5.5 3.2 3.3 11.0 3.4 3.8 4.6 3.0 5.0 6.8 4.1 6.6 7.2 14.3 10.7 3.7 6.1 4.7 15.9 3.0 6.4 3.8 2.9 4.0 3.9 4.5 4.0 2.8 3.1 6.1 5.6 3.3 4.9 3.1 3.2 6.2 2.1 2.4 2.5 2.8 3.6 2.3 2.1 2.4 2.1 2.3 2.4 2.4 3.2 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.8 3.6 0.0 0.0 0.0 0.0 0.0 4.0 5.9 0.0 3.9 3.1 0.0 1.9 1.8 0.8 0.0 0.0 0.0 2.9 3.8 0.9 0.0 2.1 0.0 2.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.4 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.1 1.8 2.1 0.0 0.0 SIX1 DFNA23 ENSG00000126778 "SIX homeobox 1" Q15475 14 60643421-60658259 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 47.8;salivary gland: 51.1;skeletal muscle: 119.4;tongue: 46.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 30.7;Basal respiratory cells: 30.8;Club cells: 33.9;Ionocytes: 30.5;Prostatic glandular cells: 27.4;Respiratory ciliated cells: 67.1;Skeletal myocytes: 77.3;Spermatogonia: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.3;LHCN-M2: 142.2;RH-30: 71.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001893, CAB058690" Enhanced Supported Nucleoplasm,Nucleoli No No "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Nucleoli "CAB058690: AB_2665581, HPA001893: AB_1079991" "unprognostic (3.62e-1)" "unprognostic (5.44e-2)" "unprognostic (5.09e-2)" "prognostic unfavorable (8.92e-6)" "unprognostic (1.33e-2)" "unprognostic (1.44e-2)" "unprognostic (2.04e-3)" "prognostic favorable (3.94e-4)" "unprognostic (1.40e-1)" "unprognostic (9.15e-2)" "unprognostic (6.45e-2)" "unprognostic (1.89e-1)" "unprognostic (3.06e-8)" "unprognostic (8.61e-2)" "unprognostic (2.13e-1)" "unprognostic (1.94e-1)" "unprognostic (3.86e-1)" 5.5 0.4 0.3 0.0 0.5 0.0 1.9 0.5 1.2 15.2 1.0 0.0 0.0 0.0 0.4 1.1 0.8 0.5 0.0 0.3 0.3 0.0 0.0 1.5 0.5 0.3 0.4 0.2 0.3 47.8 19.8 0.0 0.4 13.2 0.0 0.0 51.1 0.2 119.4 0.3 0.0 0.0 0.3 0.0 0.4 1.7 0.5 9.7 1.9 46.3 0.2 1.6 0.8 0.4 15.2 3.5 0.6 28.1 17.0 20.6 0.4 4.1 10.6 4.9 4.0 0.0 8.2 0.0 2.2 0.6 2.1 4.4 10.3 6.4 2.1 0.0 17.1 2.0 1.9 6.8 0.0 0.0 0.2 15.6 4.9 2.3 0.7 36.3 0.3 1.6 5.8 0.0 142.2 2.8 0.0 0.5 0.0 0.0 8.9 0.0 71.9 0.0 5.9 16.3 2.5 0.3 5.0 0.3 6.1 0.5 3.3 0.4 13.9 6.7 5.4 7.9 6.5 0.5 0.1 0.0 1.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.5 1.2 0.3 0.3 0.3 0.4 0.4 0.3 0.5 0.4 0.8 3.2 1.5 0.0 0.0 0.1 30.7 30.8 0.6 0.0 1.0 0.8 0.9 0.0 33.9 1.8 0.0 0.2 0.0 0.1 1.9 0.0 0.2 1.1 0.1 1.6 0.0 0.0 0.0 0.8 0.4 5.7 0.5 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.5 0.0 0.0 0.6 0.0 0.3 0.0 1.9 0.0 0.8 0.0 1.0 0.1 0.2 0.0 1.2 0.0 27.4 0.0 0.1 67.1 0.2 0.0 77.3 5.1 0.0 25.0 0.1 0.1 0.3 0.1 0.1 0.0 18.3 SLC11A1 "LSH, NRAMP, NRAMP1" ENSG00000018280 "Solute carrier family 11 member 1" P49279 2 218382029-218396894 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 78.6;lymphoid tissue: 46.6" "Cell type enhanced" "Detected in many" "Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2" "Cancer enhanced" "Detected in many" "glioma: 7.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0" "Group enriched" "Detected in many" 11 "dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HEL: 1.2;HMC-1: 1.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA029590, HPA050378, HPA068540" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Mitochondria Nucleoli "HPA029590: AB_10794613, HPA050378: , HPA068540: " "unprognostic (2.64e-1)" "unprognostic (3.05e-2)" "unprognostic (1.46e-2)" "unprognostic (2.34e-2)" "unprognostic (1.99e-2)" "unprognostic (3.83e-2)" "unprognostic (1.04e-3)" "unprognostic (2.06e-1)" "unprognostic (1.14e-1)" "unprognostic (1.58e-2)" "unprognostic (7.29e-3)" "unprognostic (2.49e-1)" "prognostic unfavorable (2.58e-8)" "unprognostic (9.55e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-2)" "unprognostic (1.08e-2)" 14.1 8.5 3.5 7.1 4.3 6.7 4.9 3.9 11.1 2.7 4.7 3.5 0.2 2.2 0.1 1.6 7.4 1.0 8.0 3.3 5.0 3.4 5.1 78.6 0.2 7.4 5.2 1.7 3.2 0.3 3.1 2.7 6.9 3.2 0.0 0.6 3.2 0.1 1.7 1.5 2.2 1.9 5.2 46.6 3.0 0.9 17.3 0.3 2.7 1.3 0.0 7.2 2.4 7.4 0.1 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 1.2 0.2 0.2 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.4 0.0 0.9 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 6.1 0.6 0.3 4.5 0.2 0.1 0.2 0.1 1.9 0.2 0.3 0.2 4.1 0.2 6.0 0.2 0.2 2.0 3.5 4.3 3.9 11.1 3.3 5.0 7.4 5.2 6.9 5.2 17.3 7.4 1.5 22.4 38.5 1.6 4.1 0.9 4.3 1.9 1.2 3.1 4.5 4.6 8.6 2.8 13.8 9.2 0.0 1.8 3.1 1.8 9.8 1.3 1.8 6.1 2.3 17.0 1.2 1.7 1.3 2.1 7.8 5.8 2.0 2.8 25.3 0.9 6.8 7.3 108.0 1.7 0.9 4.0 6.1 166.8 6.3 0.5 2.1 209.4 1.8 4.7 101.2 12.9 10.3 0.5 1.4 0.4 1.6 0.7 5.6 3.9 2.5 11.7 11.0 3.3 19.7 2.9 4.2 0.8 1.8 2.1 1.0 8.1 6.7 3.3 2.9 3.3 SLC1A3 "EA6, EAAT1, GLAST" ENSG00000079215 "Solute carrier family 1 member 3" P43003 5 36596588-36688334 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "brain: 776.8;choroid plexus: 400.6;retina: 221.1" "Cell type enhanced" "Detected in many" "Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0" "Cancer enriched" "Detected in all" 21 "glioma: 168.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6" "Group enriched" "Detected in many" 16 "dendritic cells: 1.6;monocytes: 1.5" "Cell line enhanced" "Detected in many" "AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002573, HPA037467, HPA037468" Enhanced Supported Approved Nucleoli,Vesicles NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Vesicles" "CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371" "unprognostic (1.23e-1)" "unprognostic (2.15e-2)" "unprognostic (2.58e-3)" "unprognostic (1.74e-2)" "unprognostic (1.02e-1)" "unprognostic (7.70e-2)" "unprognostic (3.89e-3)" "unprognostic (2.36e-1)" "unprognostic (1.24e-1)" "unprognostic (2.84e-2)" "unprognostic (4.17e-3)" "unprognostic (3.28e-1)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" "unprognostic (4.17e-2)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" 30.7 16.4 500.4 7.4 544.2 3.3 17.7 549.4 776.8 8.7 400.6 3.0 0.5 1.6 1.1 10.5 6.0 8.0 45.4 514.6 502.5 2.2 3.8 10.2 17.4 477.6 510.1 12.6 5.0 2.2 18.1 20.3 502.4 3.2 1.1 221.1 4.7 4.7 14.1 6.0 3.2 4.1 495.4 9.3 2.2 1.2 532.8 3.6 3.4 9.2 5.4 7.0 5.3 494.9 1.3 0.2 50.0 5.3 5.9 14.3 37.7 0.3 0.0 2.4 4.9 112.6 5.6 0.0 27.8 2.3 1.0 71.4 16.9 9.1 2.2 1.8 33.0 0.0 0.5 0.0 2.5 1.3 0.6 26.9 34.5 14.4 5.3 1.8 0.0 1.1 0.0 0.2 8.7 0.2 0.1 0.1 6.0 0.1 5.9 0.0 0.5 0.0 0.1 3.1 4.7 0.0 5.1 14.6 2.1 24.4 0.2 3.1 0.0 6.2 10.3 0.1 20.7 0.0 0.0 0.3 21.7 37.7 12.6 0.0 1.5 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 500.4 544.2 549.4 776.8 514.6 502.5 477.6 510.1 502.4 495.4 532.8 494.9 1.1 3.2 0.5 1735.2 0.7 10.7 14.3 19.0 83.1 7.1 3.7 3.4 36.0 0.0 3.1 0.0 2.1 32.9 0.1 0.0 0.0 0.8 0.7 16.3 1.2 8.9 0.0 0.8 2.6 0.0 15.9 7.8 2.0 11.7 0.0 0.2 1.1 0.5 41.2 3.3 4.7 0.0 0.0 77.6 5.9 4.1 4.4 59.6 7.2 332.6 3.3 472.6 0.0 237.7 249.0 0.3 0.0 0.0 0.7 5.2 0.0 0.0 5.3 19.1 6.6 2.6 3.1 0.3 0.3 32.7 7.1 9.2 1.0 20.7 0.0 3.6 SLC35F3 FLJ37712 ENSG00000183780 "Solute carrier family 35 member F3" Q8IY50 1 233904676-234324511 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 17.7" "Group enriched" "Detected in some" 6 "Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 35 "plasmacytoid DC: 3.5" "Lineage enriched" "Detected in single" 35 "dendritic cells: 3.5" "Cell line enriched" "Detected in some" 7 "HDLM-2: 111.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA051327, HPA061582" Uncertain Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 44: HDLM-2 - Immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" Nucleoli "HPA051327: AB_2681443, HPA061582: AB_2684563" "unprognostic (1.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-1)" "unprognostic (1.26e-1)" "unprognostic (8.62e-2)" "unprognostic (2.69e-5)" "unprognostic (3.38e-2)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (3.86e-2)" "unprognostic (9.09e-2)" "unprognostic (1.57e-3)" "unprognostic (7.83e-2)" "unprognostic (2.11e-1)" "unprognostic (3.62e-1)" "unprognostic (3.58e-1)" 0.0 1.1 6.9 0.3 17.7 0.1 2.5 9.5 15.5 0.3 0.0 0.4 0.1 0.3 0.7 0.5 0.4 0.1 0.0 5.4 0.7 0.7 0.0 0.2 0.8 1.6 0.3 0.1 3.5 1.4 2.6 0.0 1.9 0.5 0.1 0.3 2.5 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.7 0.2 2.5 2.3 0.5 0.1 0.5 0.0 0.5 9.5 3.0 7.9 1.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.1 0.2 0.6 0.1 7.7 0.0 111.9 0.2 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 12.1 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 9.0 0.0 0.0 0.0 7.7 0.0 4.2 2.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.8 0.0 0.1 0.2 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.9 17.7 9.5 15.5 5.4 0.7 1.6 0.3 1.9 0.2 2.5 9.5 0.1 0.0 0.0 8.5 0.9 0.4 2.4 0.3 10.8 2.1 3.0 8.9 0.7 0.0 0.1 0.0 0.0 0.0 9.5 0.0 3.9 1.4 0.7 5.9 1.6 0.1 1.8 0.0 485.2 3.4 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 216.1 0.1 26.4 0.0 0.0 0.9 0.0 0.6 0.0 9.4 0.9 0.0 0.0 190.5 45.4 0.6 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.5 0.0 0.8 0.1 0.6 1.5 0.8 0.1 0.0 0.4 0.0 0.0 0.2 SLC6A15 "FLJ10316, hv7-3, NTT73, SBAT1, V7-3" ENSG00000072041 "Solute carrier family 6 member 15" Q9H2J7 12 84859491-84913629 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 21.9;retina: 15.7" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9" "Group enriched" "Detected in some" 4 "head and neck cancer: 2.2;melanoma: 7.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008609 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 77: Retina - Visual perception" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Vesicles "HPA008609: AB_1857190" "unprognostic (1.01e-4)" "unprognostic (9.02e-2)" "unprognostic (1.27e-1)" "unprognostic (6.65e-6)" "unprognostic (1.25e-2)" "unprognostic (2.92e-1)" "unprognostic (7.65e-3)" "unprognostic (1.13e-1)" "unprognostic (1.97e-1)" "unprognostic (1.51e-1)" "unprognostic (4.05e-2)" "unprognostic (7.69e-4)" "unprognostic (2.57e-2)" "unprognostic (3.80e-1)" "unprognostic (1.23e-2)" "unprognostic (2.63e-3)" 0.6 1.4 8.0 0.2 7.8 0.0 0.4 4.0 12.7 0.9 0.0 0.4 0.1 0.5 0.0 2.8 0.2 0.0 0.0 6.9 12.9 0.2 0.0 0.1 0.0 7.4 21.9 0.3 0.0 0.0 5.5 3.8 16.7 0.2 0.2 15.7 0.8 0.1 0.0 1.4 0.4 0.3 0.2 0.0 0.1 0.4 8.8 0.1 0.3 1.6 0.2 0.2 1.3 5.0 0.0 2.5 10.3 0.0 93.5 55.4 0.1 0.1 21.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 12.0 1.2 0.0 23.7 0.1 0.0 25.1 0.0 4.1 0.0 33.5 0.0 0.2 31.4 48.2 11.9 135.3 25.3 0.3 0.0 0.0 0.0 25.9 0.0 0.1 0.0 28.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 91.7 22.6 0.1 31.1 71.0 0.2 0.0 0.0 0.0 12.7 6.5 0.1 0.0 0.0 0.0 0.1 23.1 0.0 27.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 7.8 4.0 12.7 6.9 12.9 7.4 21.9 16.7 0.2 8.8 5.0 0.0 0.0 0.0 4.2 0.1 2.7 0.0 3.1 42.1 19.7 0.1 0.1 0.5 0.0 0.0 0.0 6.2 0.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 63.9 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.8 57.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 32.0 1.9 0.0 1.1 0.0 4.0 46.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 11.1 0.0 0.5 1.0 0.4 0.5 5.8 0.6 0.3 0.0 0.0 0.0 0.0 SLC7A10 asc-1 ENSG00000130876 "Solute carrier family 7 member 10" Q9NS82 19 33208664-33225850 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "adipose tissue: 31.8;brain: 12.7;breast: 12.7" "Cell type enriched" "Detected in some" 4 "Astrocytes: 40.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041884, HPA057036" Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 43: THP-1 - Innate immune response" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nucleoli" "HPA041884: AB_10794494, HPA057036: AB_2683317" "unprognostic (1.85e-2)" "unprognostic (1.69e-3)" "unprognostic (2.79e-2)" "unprognostic (1.79e-6)" "unprognostic (1.16e-1)" "unprognostic (2.08e-1)" "unprognostic (1.31e-1)" "unprognostic (4.98e-3)" "unprognostic (4.64e-2)" "unprognostic (1.96e-1)" "unprognostic (3.28e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-2)" "unprognostic (1.34e-3)" "unprognostic (8.91e-2)" "unprognostic (3.47e-1)" "unprognostic (2.18e-2)" 31.8 0.3 7.9 0.1 9.7 0.0 12.7 10.1 11.1 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.3 9.2 0.5 0.0 0.0 0.2 8.5 12.4 0.0 0.1 0.0 0.0 0.2 8.4 0.0 0.0 0.5 0.8 0.0 0.1 0.2 0.5 0.0 6.0 0.0 0.1 0.5 12.7 0.0 0.5 0.4 0.3 0.3 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 3.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 9.7 10.1 11.1 7.3 9.2 8.5 12.4 8.4 6.0 12.7 5.1 0.1 0.0 0.0 40.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.8 0.0 2.4 0.0 9.5 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 SMC2 "CAP-E, hCAP-E, SMC2L1" ENSG00000136824 "Structural maintenance of chromosomes 2" O95347 9 104094260-104141419 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 25.7" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071309 Approved Supported Nucleoplasm,Nucleoli Yes No 26000 "Cluster 44: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA071309: AB_2686385" "unprognostic (1.51e-1)" "unprognostic (2.01e-3)" "unprognostic (2.26e-2)" "unprognostic (2.23e-2)" "unprognostic (3.04e-1)" "unprognostic (1.05e-1)" "unprognostic (5.57e-3)" "unprognostic (2.59e-3)" "unprognostic (1.47e-2)" "unprognostic (4.35e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (5.56e-3)" "unprognostic (8.02e-3)" "unprognostic (1.65e-1)" "unprognostic (1.12e-1)" "unprognostic (1.32e-2)" 5.2 4.1 2.8 11.3 4.0 18.4 6.6 4.4 3.3 7.5 1.3 8.2 7.5 6.0 2.6 7.3 4.7 4.0 7.9 2.2 4.0 6.3 4.7 4.5 16.0 4.9 3.7 4.7 3.5 5.7 1.5 6.9 4.1 4.2 8.8 5.6 3.1 4.7 2.2 7.4 7.6 5.4 3.5 7.2 6.1 12.0 3.5 25.7 7.6 5.4 15.9 4.9 3.2 5.0 59.3 45.0 49.4 45.9 10.3 14.9 46.2 53.5 25.4 46.9 39.4 39.3 44.9 112.6 25.2 27.7 40.5 97.6 72.3 34.8 63.2 71.6 30.3 67.9 68.8 25.5 2.7 41.5 65.6 9.8 7.0 63.7 25.7 15.9 33.7 71.2 55.8 89.8 43.0 28.9 109.1 21.3 42.9 47.6 34.8 72.0 141.3 42.2 20.1 21.1 46.5 35.9 63.8 29.6 15.5 20.5 59.5 28.0 27.1 56.8 59.1 79.3 67.9 32.6 118.2 64.6 36.8 59.8 70.3 15.0 2.2 2.5 4.8 5.9 5.4 7.3 4.4 4.8 2.6 7.9 5.0 5.8 0.3 7.0 7.4 4.4 6.0 2.4 2.8 4.0 4.4 3.3 2.2 4.0 4.9 3.7 4.1 3.5 3.5 5.0 19.6 25.6 11.9 6.5 19.9 27.3 16.4 27.6 11.4 39.7 16.6 19.3 45.1 7.2 17.8 16.5 8.4 54.3 15.2 13.7 35.2 18.9 40.0 114.6 21.6 21.4 4.9 95.3 10.2 20.4 93.8 20.2 13.3 16.0 22.2 40.4 21.0 7.6 44.3 28.6 15.5 14.6 26.4 19.8 19.8 24.7 18.6 22.9 7.2 7.5 19.8 15.6 22.6 5.5 18.4 15.6 6.3 12.4 40.9 7.3 10.3 15.0 12.0 19.1 13.1 25.1 37.7 84.5 93.5 27.4 23.2 25.9 18.1 28.1 35.0 14.2 SMG6 "C17orf31, EST1A, KIAA0732, SMG-6" ENSG00000070366 "SMG6 nonsense mediated mRNA decay factor" Q86US8 17 2059839-2303785 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042932 Approved Supported Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 89: Fibroblasts - ECM organization" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA042932: AB_10964261" "unprognostic (5.22e-2)" "unprognostic (1.20e-1)" "unprognostic (5.30e-1)" "unprognostic (4.41e-2)" "unprognostic (1.33e-1)" "unprognostic (9.33e-3)" "unprognostic (1.62e-1)" "unprognostic (2.08e-1)" "unprognostic (4.75e-2)" "unprognostic (7.63e-2)" "unprognostic (4.78e-2)" "unprognostic (1.31e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.90e-2)" "unprognostic (2.67e-1)" "unprognostic (2.61e-1)" "unprognostic (3.08e-2)" 12.2 13.0 15.5 12.3 14.6 13.6 10.5 17.6 15.0 16.4 13.2 11.4 9.3 26.6 11.1 16.4 21.7 17.2 14.0 13.8 17.8 12.3 7.4 11.9 12.3 19.9 17.3 37.5 7.4 14.4 13.3 10.5 14.3 13.9 9.4 19.2 10.4 12.8 12.9 16.0 10.9 18.9 12.5 9.8 9.6 19.5 16.0 23.1 11.7 9.1 10.9 13.1 12.0 14.8 14.9 22.5 31.7 20.6 33.6 27.0 16.3 23.6 25.9 26.3 22.2 27.6 7.3 15.7 8.3 34.8 12.0 21.3 23.5 20.1 27.4 15.7 14.7 15.3 11.8 13.5 19.2 8.2 10.5 38.5 14.5 21.2 18.6 42.6 24.3 15.3 12.8 18.5 19.9 11.7 20.8 6.6 10.2 8.9 11.7 21.4 20.2 6.2 15.2 13.5 5.3 16.1 24.6 7.1 10.2 22.2 11.1 6.0 32.2 24.0 13.1 25.6 25.1 16.0 10.5 7.2 19.1 9.1 14.0 3.0 0.7 0.8 1.3 0.3 1.3 0.5 1.1 1.3 0.4 0.7 1.5 1.1 0.5 2.0 1.6 1.3 0.6 0.6 15.5 14.6 17.6 15.0 13.8 17.8 19.9 17.3 14.3 12.5 16.0 14.8 17.2 22.4 18.4 41.4 13.2 7.9 13.8 13.1 10.2 35.6 13.8 14.5 8.0 7.2 11.8 14.7 75.0 16.5 17.7 17.9 5.9 13.8 22.5 19.4 37.1 20.3 4.2 12.8 57.1 12.4 10.7 21.0 18.3 21.3 10.8 20.3 17.9 9.1 10.3 47.1 61.7 14.4 16.2 8.7 6.8 36.9 16.8 10.6 8.8 81.5 15.9 24.8 21.6 44.7 64.3 17.2 15.2 19.9 14.6 14.7 10.1 7.6 17.9 50.5 26.3 27.1 20.4 63.7 59.0 15.1 8.7 17.4 24.9 22.4 13.5 14.2 SNAPC1 "PTFgamma, SNAP43" ENSG00000023608 "Small nuclear RNA activating complex polypeptide 1" Q16533 14 61762420-61796428 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 171.9;Spermatocytes: 215.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 153.7;hTERT-HME1: 153.7;U-2 OS: 207.6;U-251 MG: 146.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067076, HPA072276" Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 17: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 9: U-2 OS - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli Nucleoplasm "HPA067076: AB_2732757, HPA072276: AB_2732199" "unprognostic (7.40e-2)" "unprognostic (5.04e-2)" "unprognostic (3.09e-2)" "unprognostic (1.11e-1)" "unprognostic (2.94e-1)" "unprognostic (8.55e-2)" "unprognostic (1.68e-3)" "unprognostic (1.88e-1)" "unprognostic (4.01e-2)" "unprognostic (5.18e-2)" "unprognostic (1.58e-1)" "unprognostic (1.99e-1)" "unprognostic (2.47e-3)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.10e-1)" "unprognostic (2.26e-1)" 6.2 9.0 2.7 6.4 3.6 6.0 5.9 4.9 3.4 10.1 4.1 3.5 3.6 7.0 4.9 6.0 6.4 7.7 8.3 2.7 2.9 7.0 5.2 4.8 8.1 4.3 5.7 6.1 3.6 7.9 5.8 8.7 4.5 6.8 3.0 6.6 5.2 6.9 4.4 5.2 3.2 4.8 3.0 6.8 3.2 20.0 3.0 7.1 7.2 4.7 6.9 10.0 5.2 4.6 57.6 11.0 10.7 22.8 11.7 13.6 12.7 47.4 31.4 53.3 31.4 3.9 11.5 11.9 61.5 20.3 153.7 17.7 10.6 14.3 87.3 13.0 7.6 7.1 5.7 8.1 30.8 7.5 15.2 13.1 9.5 45.0 153.7 20.7 20.7 16.2 8.0 10.6 51.4 7.4 18.3 12.0 10.3 6.4 35.9 13.9 28.3 4.4 43.9 8.8 7.6 18.3 31.3 5.5 39.0 13.2 11.0 11.7 31.8 58.4 207.6 38.2 146.6 7.0 7.8 10.5 39.7 9.5 35.3 7.7 5.0 4.5 4.4 4.3 5.7 8.4 5.4 3.8 5.2 8.8 8.8 5.7 4.9 7.0 3.8 6.9 6.5 3.6 2.7 3.6 4.9 3.4 2.7 2.9 4.3 5.7 4.5 3.0 3.0 4.6 22.6 35.3 18.3 10.1 28.0 95.3 56.2 171.9 43.3 10.2 11.5 18.0 24.6 11.5 53.6 29.5 2.1 16.8 31.2 3.4 7.9 28.6 70.7 70.1 28.7 29.3 4.2 10.7 12.8 15.9 31.5 31.1 4.1 47.6 41.8 20.2 26.7 6.9 17.3 8.4 13.3 4.0 42.7 11.7 32.6 17.1 22.1 31.6 17.8 10.3 12.4 40.4 4.1 10.6 14.6 20.3 1.9 20.3 7.9 28.8 5.6 13.3 83.9 12.6 19.7 38.3 34.7 215.0 67.7 23.5 64.5 5.6 29.0 20.6 6.8 20.8 SNAPIN "BLOC1S7, BORCS3, SNAPAP" ENSG00000143553 "SNAP associated protein" O95295 1 153658703-153661852 "Predicted intracellular proteins, Transporters" "Exocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046974 Approved Approved "Nucleoli,Golgi apparatus" NA NA 20000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus" Nucleoli "HPA046974: AB_10962506" "unprognostic (3.65e-1)" "unprognostic (1.67e-1)" "unprognostic (1.47e-1)" "unprognostic (5.66e-2)" "unprognostic (1.75e-1)" "unprognostic (2.06e-1)" "unprognostic (1.64e-3)" "unprognostic (1.54e-1)" "unprognostic (4.86e-2)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.31e-1)" "unprognostic (4.73e-1)" "unprognostic (1.31e-3)" "unprognostic (4.89e-2)" 34.6 50.8 41.5 18.5 42.9 13.1 30.3 44.3 43.0 23.9 38.7 35.7 12.8 30.7 34.1 35.1 27.5 21.7 63.7 39.9 43.5 37.8 32.1 21.0 27.4 43.1 42.3 24.0 17.5 41.2 16.4 19.0 42.9 24.4 20.2 25.1 22.1 29.4 91.5 27.9 23.2 30.4 44.5 30.9 26.3 19.2 43.0 30.6 25.5 77.0 31.9 31.1 23.5 45.1 50.8 60.6 51.5 31.0 63.2 42.7 32.4 41.7 46.1 57.8 43.9 43.9 39.3 35.8 82.6 42.9 29.0 65.6 42.5 54.4 40.9 49.3 57.4 39.6 41.3 21.1 65.4 39.3 24.4 50.5 41.1 43.6 49.0 61.0 54.8 41.7 34.7 27.8 59.5 82.7 46.0 23.9 27.5 78.6 64.7 42.9 44.1 96.8 65.0 47.6 38.9 67.8 48.0 55.0 57.8 50.3 84.0 43.5 48.4 27.2 40.5 54.4 40.0 65.6 77.4 56.0 51.4 24.9 36.1 106.2 146.9 139.7 86.8 154.1 100.6 130.1 88.2 88.9 153.5 119.6 96.9 87.9 30.4 118.1 126.8 115.6 136.3 146.6 41.5 42.9 44.3 43.0 39.9 43.5 43.1 42.3 42.9 44.5 43.0 45.1 41.7 19.2 16.6 7.2 31.6 20.6 35.1 88.7 35.9 14.2 39.1 44.4 39.8 40.0 45.3 29.5 8.4 64.4 35.9 18.0 74.3 71.4 9.6 31.5 24.2 34.9 13.8 33.6 5.9 65.2 49.5 31.2 16.3 25.6 30.4 31.9 40.7 35.1 90.2 21.9 6.5 20.0 40.7 48.3 21.8 26.6 30.7 34.7 26.6 4.7 76.5 84.8 59.8 8.0 14.4 53.5 25.5 49.7 23.8 34.7 26.6 76.7 40.9 21.7 46.0 25.3 39.7 29.3 42.6 45.5 23.4 73.7 26.9 44.2 24.6 36.2 SNORC "ASCL830, C2orf82, UNQ830" ENSG00000182600 "Secondary ossification center associated regulator of chondrocyte maturation" Q6UX34 2 232857270-232878708 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 55.0;breast: 14.2;skin 1: 32.2" "Group enriched" "Detected in some" 22 "Breast glandular cells: 367.0;Breast myoepithelial cells: 324.9" "Cancer enhanced" "Detected in many" "liver cancer: 7.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 20 "basophil: 2.8" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.8" "Cell line enriched" "Detected in some" 13 "Hep G2: 59.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA052824 Approved Approved Nucleoplasm,Nucleoli "Intracellular and membrane" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 35: Glandular cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA052824: AB_2681964" "unprognostic (4.58e-3)" "unprognostic (1.31e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (1.27e-1)" "unprognostic (2.11e-1)" "unprognostic (3.06e-1)" "unprognostic (4.71e-1)" "unprognostic (1.23e-3)" "unprognostic (3.52e-1)" "unprognostic (1.79e-1)" "unprognostic (2.00e-1)" "unprognostic (4.30e-7)" "unprognostic (1.83e-3)" "unprognostic (8.15e-2)" "unprognostic (1.58e-2)" "unprognostic (1.33e-2)" 1.3 0.9 6.7 0.2 14.1 0.5 14.2 21.2 8.5 0.7 0.2 3.3 0.9 0.7 0.5 1.0 1.2 0.0 0.8 11.9 23.5 1.3 7.4 0.8 0.6 37.8 14.8 0.7 1.7 0.3 1.6 0.2 28.3 1.5 0.3 0.6 4.7 0.1 1.0 32.2 1.7 0.1 38.2 1.1 0.8 8.1 14.2 0.1 0.6 0.0 0.0 0.9 0.8 55.0 0.9 0.0 0.3 1.4 1.0 1.6 2.4 0.3 0.0 0.3 0.7 0.0 0.2 0.0 0.7 0.1 0.5 0.5 0.0 0.0 0.0 0.6 2.1 0.5 0.4 59.6 0.8 0.1 1.7 0.0 1.3 0.4 0.8 0.7 1.6 0.6 0.1 0.2 0.2 0.2 0.2 0.5 0.0 0.0 2.2 0.4 0.6 0.4 0.1 0.9 0.2 0.8 0.4 0.0 2.2 1.0 0.1 2.6 0.9 0.2 0.8 0.8 0.8 3.8 4.7 0.2 0.1 1.4 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 14.1 21.2 8.5 11.9 23.5 37.8 14.8 28.3 38.2 14.2 55.0 3.1 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 367.0 324.9 0.0 0.0 0.0 1.8 0.0 0.1 10.1 0.0 5.9 0.5 0.0 3.8 0.4 6.3 0.0 0.0 0.0 0.8 0.1 2.9 0.0 2.3 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.0 2.3 0.9 0.0 0.0 SOGA1 "C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA" ENSG00000149639 "Suppressor of glucose, autophagy associated 1" O94964 20 36777447-36863538 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 63.9" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 54.8;Oligodendrocytes: 50.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043992 Approved Approved Nucleoli,Cytosol "Secreted to blood" NA Yes "Cluster 21: Non-specific - Transcription" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Nucleoli, Cytosol" "HPA043992: AB_2678762" "unprognostic (2.34e-2)" "unprognostic (1.35e-1)" "unprognostic (6.58e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.48e-1)" "unprognostic (2.27e-3)" "unprognostic (1.37e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (8.28e-5)" "unprognostic (1.09e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (4.49e-4)" "unprognostic (6.99e-2)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (4.45e-3)" 6.6 14.2 13.4 3.6 18.1 1.1 6.2 63.9 16.4 9.5 0.0 12.3 1.9 10.9 3.8 7.0 9.6 4.8 9.5 12.8 14.4 7.8 0.9 6.2 2.5 14.6 15.0 10.4 2.8 7.3 4.9 6.2 12.6 9.0 2.8 4.5 4.7 8.8 2.4 8.6 5.8 8.4 8.8 4.6 6.4 7.9 15.1 2.9 12.2 3.9 3.1 11.2 7.4 21.9 13.4 18.0 21.5 23.2 12.2 11.2 5.6 11.6 12.5 16.1 9.5 7.3 2.1 6.0 4.2 20.4 14.0 17.8 17.3 10.8 16.8 0.9 3.4 9.7 18.5 9.7 6.4 2.1 9.0 6.3 13.0 15.4 10.9 7.0 10.6 6.5 6.9 1.2 17.8 13.0 6.9 5.1 5.5 1.3 13.8 16.1 19.9 2.3 9.5 4.0 25.5 15.9 24.1 26.1 7.5 9.4 33.3 14.4 16.3 40.2 7.7 19.9 25.7 2.4 0.6 5.8 17.1 2.8 26.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.0 13.4 18.1 63.9 16.4 12.8 14.4 14.6 15.0 12.6 8.8 15.1 21.9 16.5 0.0 1.8 18.9 4.4 12.6 5.4 6.3 13.6 26.3 9.6 8.9 16.1 5.7 6.7 20.2 37.5 15.6 11.3 1.7 1.9 3.8 0.9 8.6 20.5 14.5 6.0 1.3 19.9 1.5 10.2 12.0 0.5 21.9 10.8 33.0 10.4 0.6 10.0 23.5 30.3 1.5 0.0 7.6 10.7 2.4 12.2 8.1 5.4 21.5 4.5 17.8 0.0 54.8 50.9 1.4 2.4 18.8 1.8 6.0 2.1 1.5 3.9 3.8 13.1 23.2 16.9 0.5 1.3 13.7 16.1 3.3 1.4 14.0 3.0 2.9 SP5 ENSG00000204335 "Sp5 transcription factor" Q6BEB4 2 170715337-170718078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 8.8" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 2.8;Cardiomyocytes: 3.1;Distal tubular cells: 3.9;Endometrial stromal cells: 7.1;Fibroblasts: 4.4;Intestinal goblet cells: 4.3;Spermatogonia: 3.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "Hep G2: 122.1" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Low region specificity" "Detected in some" HPA074123 Approved Nucleoplasm,Nucleoli NA NA "Cluster 31: Skin - Epidermis development" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Nucleoplasm "HPA074123: AB_2686664" "unprognostic (1.16e-2)" "unprognostic (6.99e-2)" "unprognostic (3.41e-2)" "unprognostic (2.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.52e-3)" "unprognostic (1.45e-1)" "unprognostic (4.60e-2)" "unprognostic (4.77e-1)" "unprognostic (8.97e-3)" "unprognostic (1.79e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-8)" "unprognostic (8.05e-3)" "unprognostic (2.49e-1)" "unprognostic (2.41e-2)" "unprognostic (2.17e-1)" 2.5 1.2 0.5 0.2 0.5 0.0 1.4 2.2 0.3 8.8 0.5 1.5 1.0 3.7 0.4 1.2 1.2 0.2 0.2 0.2 1.4 0.2 2.1 0.5 0.2 0.3 1.4 0.4 0.4 0.3 0.1 0.2 0.2 1.7 0.2 0.0 1.5 0.2 0.2 4.6 1.4 0.1 0.0 0.0 3.1 0.8 1.8 0.1 0.1 0.0 0.8 1.5 2.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 27.7 0.1 0.0 0.5 0.0 0.5 1.5 0.3 0.0 0.0 3.5 0.3 0.4 0.1 122.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 2.0 2.3 0.0 0.0 0.0 0.1 0.0 0.1 0.3 4.2 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 2.2 0.3 0.2 1.4 0.3 1.4 0.2 0.0 1.8 0.2 0.2 0.0 0.0 0.3 0.0 0.8 0.1 0.0 2.8 0.0 0.2 0.3 3.1 0.0 0.0 1.8 0.0 1.5 0.1 0.3 3.9 0.0 0.2 2.3 7.1 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.0 1.3 0.0 0.0 0.0 2.5 0.2 0.0 0.4 4.3 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.4 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 3.7 0.2 0.1 0.3 0.2 0.0 1.6 0.0 SPATA17 "CFAP305, FAP305, IQCH, MOT17" ENSG00000162814 "Spermatogenesis associated 17" Q96L03 1 217631324-217871696 "Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 10.3" "Cell type enhanced" "Detected in many" "Early spermatids: 770.1;Endometrial ciliated cells: 117.8;Late spermatids: 518.2;Respiratory ciliated cells: 150.1;Spermatocytes: 284.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA030099 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nucleoli" "HPA030099: AB_2270988" "unprognostic (4.72e-2)" "unprognostic (7.58e-3)" "unprognostic (4.30e-2)" "unprognostic (3.66e-2)" "unprognostic (3.69e-2)" "unprognostic (2.41e-2)" "unprognostic (3.31e-3)" "unprognostic (3.25e-2)" "unprognostic (1.39e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (2.80e-2)" "unprognostic (3.24e-4)" "unprognostic (2.07e-1)" "unprognostic (2.78e-2)" "unprognostic (2.77e-3)" "unprognostic (1.82e-1)" 0.1 0.2 0.5 0.2 0.5 1.6 0.5 0.9 0.6 0.4 2.0 0.2 0.4 0.4 3.4 0.3 4.1 0.3 0.2 0.7 0.5 0.8 0.1 0.5 0.2 1.4 1.3 0.3 0.3 2.6 0.4 0.2 1.5 0.3 0.2 1.7 0.3 0.3 2.1 0.6 0.4 0.1 0.7 0.2 0.3 10.3 0.7 0.1 0.7 0.1 0.1 0.1 0.0 0.9 0.1 0.3 0.4 0.3 0.1 0.5 0.3 0.1 0.2 0.1 0.0 0.2 0.9 0.1 0.3 0.1 0.1 0.8 0.2 0.3 0.1 0.1 0.3 0.1 0.5 0.2 0.1 0.1 0.1 0.1 0.6 0.3 0.3 0.4 0.0 0.2 0.2 0.3 0.1 0.7 0.1 0.3 0.6 0.4 0.3 0.1 0.1 0.1 0.6 0.3 1.4 0.6 0.2 0.2 0.2 0.5 0.4 0.1 0.1 0.2 0.2 0.3 0.1 0.3 0.2 0.1 0.6 0.1 0.3 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.5 0.5 0.9 0.6 0.7 0.5 1.4 1.3 1.5 0.7 0.7 0.9 0.2 3.2 0.0 10.7 0.1 0.6 0.9 6.6 0.0 0.4 2.1 1.9 2.1 0.0 18.4 3.7 20.9 0.9 0.0 0.4 5.9 2.4 770.1 117.8 3.4 0.6 1.8 0.0 5.1 0.7 0.6 1.6 0.5 3.2 0.0 2.0 0.0 0.0 0.2 0.0 3.3 1.3 12.2 0.0 0.3 518.2 8.7 0.5 1.8 2.8 0.0 4.4 0.0 5.0 1.3 0.3 0.2 6.8 0.3 1.0 0.2 10.6 150.1 18.5 0.0 2.0 2.3 284.7 8.4 0.4 1.0 0.3 0.3 2.8 0.9 0.4 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402336-45421415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 4.5 4.9 4.7 4.6 5.1 6.3 4.5 5.5 6.2 5.5 4.4 5.2 5.9 4.4 3.9 10.0 5.0 2.7 5.7 4.9 5.0 6.0 7.5 3.3 4.6 4.9 4.8 6.1 5.8 4.3 3.1 5.2 5.0 4.2 4.8 4.6 4.4 3.9 8.9 7.4 5.5 4.4 5.0 4.5 4.5 3.4 5.2 4.9 5.3 5.4 5.0 5.4 6.0 5.6 10.0 6.3 9.9 7.3 8.0 7.8 12.0 8.7 7.9 9.3 9.0 17.3 6.3 7.3 9.5 5.8 16.9 22.5 14.8 10.9 10.3 10.0 8.4 9.5 11.2 13.6 9.0 12.8 4.0 6.2 12.2 7.7 10.1 10.6 7.4 9.4 15.6 11.4 10.5 6.7 8.9 24.5 7.1 24.8 9.7 9.8 13.9 6.8 11.7 9.8 13.5 6.9 7.2 15.5 8.4 11.7 13.7 23.1 4.7 4.5 6.9 27.8 18.8 9.7 20.8 11.3 11.6 20.8 8.3 0.0 0.9 1.2 1.1 0.7 0.4 0.6 0.7 1.5 0.9 0.7 0.6 0.9 1.1 1.1 1.9 1.0 0.8 0.2 4.7 5.1 5.5 6.2 4.9 5.0 4.9 4.8 5.0 5.0 5.2 5.6 4.7 0.0 1.1 7.2 8.9 5.0 8.9 4.6 5.2 7.9 3.7 2.4 6.9 7.2 5.2 3.7 16.7 12.2 7.3 5.4 3.9 6.2 20.6 6.2 5.4 6.3 3.6 2.5 11.0 7.3 11.9 5.2 9.2 8.4 4.5 8.6 1.1 5.7 8.0 6.7 10.1 6.3 0.0 3.7 7.6 7.1 7.8 7.7 3.6 6.5 7.7 5.0 2.1 16.6 14.6 5.5 3.1 3.8 8.5 6.2 9.2 5.7 2.4 6.5 0.0 4.1 4.1 6.2 5.6 10.4 6.8 6.7 5.8 6.1 7.3 8.2 SPATS2L "DNAPTP6, SGNP" ENSG00000196141 "Spermatogenesis associated serine rich 2 like" Q9NUQ6 2 200305881-200482264 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 478.4;Paneth cells: 467.4;Proximal tubular cells: 568.2;Skeletal myocytes: 470.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 48.0" "Group enriched" "Detected in all" 5 "dendritic cells: 16.8;granulocytes: 48.0;T-cells: 31.6" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 475.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055427, HPA066310" Uncertain Enhanced Nucleoli,Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Cytosol" "HPA055427: AB_2682813, HPA066310: AB_2685655" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (9.35e-2)" "unprognostic (1.78e-2)" "unprognostic (4.39e-3)" "unprognostic (3.58e-2)" "unprognostic (2.17e-3)" "unprognostic (3.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (3.95e-1)" "unprognostic (7.84e-3)" "unprognostic (3.71e-2)" "unprognostic (5.67e-2)" "unprognostic (6.01e-2)" "unprognostic (2.99e-1)" 47.1 27.0 36.9 37.2 38.4 10.4 31.7 35.2 48.6 77.5 44.2 85.5 82.1 37.5 26.6 65.3 81.6 114.8 117.3 41.4 41.0 70.0 110.3 47.6 24.1 42.1 45.0 66.0 60.6 41.9 40.4 68.8 44.0 50.7 83.2 16.5 166.1 67.8 70.6 33.6 82.8 51.3 43.6 39.1 101.4 28.9 39.9 40.8 42.9 36.3 22.9 81.2 45.7 46.7 174.8 94.6 113.0 13.8 74.0 96.4 43.4 299.6 100.1 193.2 143.8 262.6 190.0 1.0 69.1 197.4 108.5 167.5 35.2 186.9 130.4 109.5 47.2 1.4 80.0 315.2 138.8 28.9 12.3 121.4 182.5 134.3 128.3 138.0 75.4 21.6 41.1 119.0 280.0 55.4 4.4 8.3 28.2 303.4 226.7 0.6 388.2 11.1 475.5 134.2 3.1 31.9 77.0 45.5 127.0 165.3 23.9 39.5 120.9 131.3 129.3 41.4 170.9 34.9 36.3 2.2 104.1 14.1 179.5 48.0 5.2 7.6 5.8 5.9 14.0 2.8 6.3 6.0 16.8 3.3 2.6 3.1 4.2 6.8 4.7 12.8 31.6 2.8 36.9 38.4 35.2 48.6 41.4 41.0 42.1 45.0 44.0 43.6 39.9 46.7 83.4 86.6 26.2 104.5 11.2 91.1 262.5 123.6 67.7 21.4 63.2 51.4 127.8 403.2 70.3 172.9 12.5 19.4 9.5 478.4 111.6 157.7 75.9 129.8 59.4 64.2 55.1 15.1 116.4 147.0 38.2 101.8 151.9 56.9 56.5 51.4 94.2 230.0 82.5 60.6 202.9 246.6 54.9 139.6 98.1 22.4 165.6 56.1 128.1 68.4 18.0 8.7 2.1 79.9 106.5 210.8 467.4 142.1 9.4 284.9 153.2 568.2 167.1 56.4 78.9 470.9 89.3 38.0 82.6 68.4 77.9 9.9 28.2 6.6 78.4 198.8 SPC24 "FLJ90806, SPBC24" ENSG00000161888 "SPC24 component of NDC80 kinetochore complex" Q8NBT2 19 11131520-11155808 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 26.0;lymphoid tissue: 14.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.0;Extravillous trophoblasts: 15.5;Hofbauer cells: 14.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA051234 Approved Supported Nucleoplasm,Nucleoli NA Yes "Cluster 40: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA051234: AB_2681397" "unprognostic (1.57e-1)" "prognostic favorable (3.59e-4)" "unprognostic (6.79e-2)" "unprognostic (1.07e-3)" "unprognostic (4.04e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (1.21e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (6.12e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.62e-2)" "unprognostic (3.52e-2)" "unprognostic (2.25e-1)" "unprognostic (8.82e-2)" 1.9 1.7 1.3 4.8 1.5 26.0 1.2 3.9 2.1 2.1 1.7 4.7 4.5 2.7 0.8 5.0 1.3 2.3 2.7 1.6 1.5 0.8 1.6 1.6 6.3 1.1 0.8 1.3 1.1 0.4 0.4 3.2 1.3 1.6 4.3 1.2 1.3 2.0 4.0 3.9 4.1 8.1 0.5 3.1 2.9 4.3 1.4 14.7 0.9 1.1 6.5 2.5 2.0 2.4 73.6 26.9 36.9 30.1 5.0 9.7 16.6 42.3 15.7 38.6 43.6 28.4 24.6 58.2 46.0 18.5 22.8 38.8 29.0 30.3 28.7 30.9 24.9 78.5 68.9 43.2 1.1 55.5 33.7 1.9 1.1 27.8 12.8 10.0 34.7 62.3 42.8 118.3 27.6 48.7 76.4 32.9 25.5 19.8 43.9 59.8 56.7 18.6 11.2 23.8 38.4 27.2 37.0 22.4 9.6 17.5 22.0 19.8 33.2 36.8 38.3 49.6 51.2 70.5 39.8 55.6 26.9 53.9 30.5 1.9 0.4 0.4 0.5 0.5 0.4 0.8 0.9 1.5 0.2 0.7 0.9 0.6 2.2 2.0 0.5 0.5 1.7 0.3 1.3 1.5 3.9 2.1 1.6 1.5 1.1 0.8 1.3 0.5 1.4 2.4 0.2 0.0 0.5 0.3 1.5 1.1 1.2 1.3 0.0 0.0 1.0 0.4 9.0 1.5 0.8 5.5 6.2 10.0 0.9 2.8 0.0 0.2 0.3 1.0 2.2 2.2 2.4 35.0 0.3 0.0 15.5 3.5 3.6 1.8 5.7 6.5 4.6 0.7 14.0 0.0 0.3 2.6 0.0 3.0 2.5 3.0 0.6 1.0 0.0 1.0 0.0 2.1 2.1 0.5 0.3 0.3 0.0 0.4 6.3 0.3 0.7 0.6 0.2 0.6 0.0 1.3 2.4 6.9 10.8 2.1 0.3 2.1 2.2 0.5 6.6 1.2 SPIN4 "FLJ44984, TDRD28" ENSG00000186767 "Spindlin family member 4" Q56A73 X 63347228-63351332 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" HPA044559 Uncertain Approved Nucleoli,Cytosol NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 27: Mucus-secreting cells - Mucin production" Cytosol Nucleoli "HPA044559: AB_10794171" "unprognostic (9.66e-2)" "unprognostic (2.00e-1)" "unprognostic (1.90e-1)" "unprognostic (2.21e-2)" "unprognostic (2.31e-1)" "unprognostic (3.12e-1)" "unprognostic (3.22e-4)" "unprognostic (3.30e-3)" "unprognostic (9.44e-3)" "unprognostic (8.62e-2)" "unprognostic (3.65e-3)" "unprognostic (9.39e-2)" "prognostic unfavorable (3.56e-6)" "unprognostic (1.74e-2)" "unprognostic (2.15e-1)" "unprognostic (2.57e-1)" "unprognostic (8.09e-2)" 1.8 1.7 1.4 2.7 1.3 10.2 3.3 0.9 1.7 2.4 1.7 3.6 2.2 3.4 2.3 5.9 2.7 2.1 1.3 1.3 3.1 1.5 1.3 3.1 3.5 1.6 2.0 2.9 1.7 1.7 2.3 4.4 1.6 3.3 4.1 2.0 7.2 1.7 0.5 2.0 2.2 3.5 1.2 2.8 2.2 0.7 2.5 3.1 2.5 0.5 5.6 2.1 2.7 1.8 31.7 8.0 18.2 14.9 3.9 5.5 13.1 15.6 6.5 8.9 10.6 5.4 30.7 0.0 6.7 7.3 10.2 10.3 23.7 11.2 16.2 13.7 7.5 40.5 10.3 4.9 1.7 35.5 30.3 2.6 3.9 14.9 8.0 4.3 9.9 7.0 12.5 38.2 20.4 10.7 11.9 19.0 18.8 5.2 11.5 16.4 39.2 8.7 6.5 8.3 0.1 10.0 27.9 8.1 3.0 37.4 17.4 16.9 4.3 17.9 19.9 29.8 9.8 8.4 10.4 20.5 9.5 28.8 10.7 0.7 0.8 1.6 0.5 0.9 0.2 0.4 0.3 0.3 0.6 0.4 0.1 0.4 0.0 2.6 0.8 0.0 0.2 0.4 1.4 1.3 0.9 1.7 1.3 3.1 1.6 2.0 1.6 1.2 2.5 1.8 3.0 0.0 2.0 2.3 2.9 3.3 1.4 3.5 6.2 5.7 6.0 4.3 1.5 1.5 5.8 3.7 2.1 6.1 3.9 3.6 1.9 0.6 0.0 3.4 3.2 5.1 6.7 11.1 2.4 1.4 6.8 3.4 2.0 2.1 9.5 3.5 8.6 1.3 2.6 1.7 3.3 6.7 4.1 1.0 2.1 0.4 3.1 2.2 5.4 1.9 1.1 1.3 5.2 3.0 4.5 1.3 6.3 3.4 0.7 2.3 0.6 1.3 5.7 2.8 0.0 2.5 2.6 0.1 0.5 9.8 6.3 3.3 3.1 4.3 5.7 5.7 SPRY3 HSPRY3 ENSG00000168939 "Sprouty RTK signaling antagonist 3" O43610 X 155612572-155782459 "Predicted membrane proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.3" "Group enriched" "Detected in some" 7 "Astrocytes: 42.7;Excitatory neurons: 40.9;Inhibitory neurons: 43.5;Microglial cells: 62.8;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 20.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.7" "Low region specificity" "Detected in many" CAB013505 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoli "CAB013505: " "unprognostic (3.70e-2)" "unprognostic (4.39e-1)" "unprognostic (5.24e-2)" "unprognostic (3.37e-2)" "unprognostic (3.65e-1)" "unprognostic (1.20e-1)" "unprognostic (7.88e-2)" "unprognostic (1.16e-1)" "unprognostic (3.68e-3)" "unprognostic (1.52e-4)" "unprognostic (1.21e-2)" "unprognostic (9.60e-2)" "unprognostic (5.26e-2)" "unprognostic (6.65e-2)" "unprognostic (1.86e-1)" "unprognostic (5.44e-2)" "unprognostic (3.49e-2)" 0.9 1.2 1.5 0.4 1.5 1.7 0.8 5.3 1.8 0.8 0.1 0.8 0.8 1.0 2.7 0.7 0.8 0.7 0.8 1.4 1.0 0.6 0.6 0.7 0.4 2.0 1.3 1.7 0.4 0.8 0.8 1.3 2.0 0.6 0.8 1.4 0.8 0.7 0.9 0.4 0.8 0.8 0.7 0.9 0.6 0.4 1.5 0.4 0.7 1.0 0.5 0.6 0.5 1.0 0.4 0.2 1.5 5.7 1.1 0.6 0.0 1.6 0.9 0.5 0.8 0.4 0.9 0.0 2.8 0.9 1.2 0.3 0.8 0.3 0.5 0.1 0.2 0.8 1.8 0.1 0.5 0.3 0.3 1.3 1.0 0.6 0.3 0.4 0.9 0.4 0.1 0.5 1.0 0.2 0.2 0.2 0.6 0.2 0.0 0.3 0.2 1.4 0.5 0.7 0.5 0.4 0.8 0.0 0.2 0.8 0.5 0.4 1.2 0.5 0.8 0.3 0.4 0.5 0.1 1.2 1.4 0.6 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.5 5.3 1.8 1.4 1.0 2.0 1.3 2.0 0.7 1.5 1.0 4.0 0.0 0.0 42.7 0.3 0.1 0.1 0.2 0.0 3.4 0.5 0.4 1.7 0.0 0.3 0.0 4.2 0.1 0.2 1.9 0.0 0.2 0.0 5.2 1.2 2.2 0.0 0.4 40.9 0.6 0.2 0.6 0.5 5.0 0.0 1.1 2.2 1.1 0.3 0.0 43.5 1.4 0.0 0.8 0.3 0.0 0.9 0.5 1.8 62.8 0.7 0.6 0.0 32.2 20.3 0.6 0.1 0.0 0.2 0.1 0.9 0.4 0.3 1.3 0.0 0.9 2.0 0.0 0.0 0.5 0.1 0.0 0.3 2.5 1.0 0.2 SPTBN4 "KIAA1642, SPTBN3" ENSG00000160460 "Spectrin beta, non-erythrocytic 4" Q9H254 19 40466241-40576464 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 20.1;pituitary gland: 7.8" "Cell type enhanced" "Detected in some" "Astrocytes: 48.6;Bipolar cells: 65.2;Cone photoreceptor cells: 56.3;Excitatory neurons: 209.5;Horizontal cells: 74.0;Inhibitory neurons: 194.8;Oligodendrocyte precursor cells: 46.3;Rod photoreceptor cells: 64.2" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebral cortex: 20.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.8;Karpas-707: 2.5;SCLC-21H: 3.9;SH-SY5Y: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054481 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli Nucleoplasm "HPA054481: AB_2682502" "unprognostic (1.97e-3)" "unprognostic (1.02e-1)" "unprognostic (5.65e-4)" "unprognostic (3.72e-4)" "unprognostic (7.79e-3)" "unprognostic (9.77e-2)" "unprognostic (2.62e-1)" "unprognostic (2.50e-2)" "unprognostic (3.19e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-4)" "unprognostic (4.54e-1)" "unprognostic (2.55e-2)" "unprognostic (6.79e-2)" "unprognostic (1.42e-1)" "unprognostic (1.85e-2)" "unprognostic (2.02e-1)" 1.1 2.1 4.8 0.1 5.9 0.1 0.7 6.4 20.1 1.1 0.0 1.6 0.3 1.5 0.1 0.4 1.3 0.4 2.1 4.8 0.0 0.8 0.3 0.3 0.0 4.0 0.0 2.6 0.9 1.4 7.8 0.0 2.2 1.5 0.0 3.4 0.6 0.4 2.1 0.5 0.5 0.3 0.0 0.2 1.2 2.0 0.7 0.1 0.7 0.9 0.0 1.1 0.7 6.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.2 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.8 2.5 0.0 0.6 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.5 0.0 0.0 3.9 2.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.4 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.9 6.4 20.1 4.8 0.0 4.0 0.0 2.2 0.0 0.7 6.0 0.2 0.0 0.0 48.6 0.1 0.1 0.2 0.1 0.6 65.2 0.7 0.6 4.9 0.0 0.2 0.0 56.3 0.0 2.7 0.1 0.0 0.2 3.4 0.3 0.8 0.5 16.3 0.0 209.5 0.0 0.0 1.0 0.0 0.8 0.0 0.7 0.4 0.8 0.2 74.0 194.8 0.5 0.0 0.6 0.2 1.3 8.1 0.6 1.8 10.3 0.6 6.1 0.0 46.3 13.4 0.1 0.0 7.2 0.1 0.4 0.3 1.7 0.2 64.2 0.0 1.6 0.7 3.5 6.0 0.3 0.4 0.0 0.4 0.4 0.3 0.2 SPTY2D1 "DKFZp686I068, FLJ39441, Spt2" ENSG00000179119 "SPT2 chromatin protein domain containing 1" Q68D10 11 18606403-18634791 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 34.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039372, HPA040177, HPA047957" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Nucleoli" "HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224" "unprognostic (8.43e-2)" "unprognostic (1.50e-1)" "unprognostic (8.62e-2)" "unprognostic (2.16e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-1)" "unprognostic (1.51e-2)" "unprognostic (5.42e-2)" "unprognostic (1.74e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (2.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (2.07e-4)" "unprognostic (1.33e-2)" "unprognostic (1.75e-1)" "unprognostic (1.21e-1)" "unprognostic (3.33e-1)" 7.5 8.7 2.3 8.6 2.4 34.3 10.0 3.6 5.9 10.6 4.3 7.8 7.0 7.6 5.6 8.1 6.6 10.1 4.9 3.0 2.7 8.9 10.3 7.3 8.2 2.3 2.9 9.7 7.8 8.1 4.0 8.7 2.4 8.7 8.2 4.5 9.4 5.6 7.9 7.4 6.5 7.8 2.4 7.3 7.5 4.2 2.7 8.5 10.0 7.5 9.6 9.4 5.3 3.1 11.8 11.2 9.0 12.7 14.3 15.1 13.5 17.3 18.9 14.2 16.8 10.4 5.2 27.0 9.3 16.3 11.0 12.1 15.3 13.4 20.5 14.1 14.0 10.6 6.4 9.5 14.1 22.6 20.4 12.7 13.6 9.3 17.8 10.1 15.3 15.8 15.3 41.7 15.9 12.2 15.5 9.3 8.5 22.8 12.6 14.2 25.1 11.4 14.9 16.9 8.8 12.3 15.1 17.8 12.3 11.7 11.0 9.6 13.7 13.7 11.7 27.1 10.8 14.3 19.0 21.0 16.4 12.6 11.8 4.7 1.9 2.9 2.7 2.9 4.1 1.2 2.6 2.8 1.7 1.1 2.4 2.6 2.2 3.7 2.8 1.4 3.1 1.8 2.3 2.4 3.6 5.9 3.0 2.7 2.3 2.9 2.4 2.4 2.7 3.1 42.3 25.6 47.7 5.2 38.0 55.8 19.6 17.1 32.5 13.7 55.0 39.5 21.6 18.6 29.9 27.6 10.4 14.3 75.3 31.7 17.6 25.3 2.4 47.4 53.8 29.1 44.3 15.4 9.9 24.9 26.5 35.3 40.2 74.1 57.7 20.5 22.9 28.5 16.3 11.8 9.6 39.4 24.4 33.4 49.6 3.2 19.0 44.3 16.0 15.0 24.4 12.4 49.4 9.0 8.9 27.7 29.8 13.9 83.6 28.0 21.0 17.4 47.5 11.4 32.9 42.9 28.2 14.2 17.3 41.6 66.3 27.5 69.7 27.1 24.4 29.2 SREK1IP1 "FLJ36754, P18SRP, SFRS12IP1" ENSG00000153006 "SREK1 interacting protein 1" Q8N9Q2 5 64718148-64768691 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 300.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045677, HPA062853" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Nucleoli" "HPA045677: AB_10964635, HPA062853: AB_2684881" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.17e-2)" "unprognostic (1.06e-1)" "unprognostic (1.51e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.51e-1)" "unprognostic (2.13e-1)" "unprognostic (8.60e-3)" "unprognostic (8.67e-2)" "unprognostic (1.20e-2)" "prognostic unfavorable (9.68e-4)" "unprognostic (2.67e-1)" "unprognostic (8.39e-2)" "unprognostic (3.85e-2)" "unprognostic (1.99e-1)" 6.2 5.5 5.1 4.2 5.3 4.6 6.4 6.0 7.2 5.0 5.3 4.9 4.1 5.0 5.6 6.9 4.6 4.3 4.0 5.0 5.4 5.7 5.8 5.6 5.7 5.4 5.2 6.6 4.3 5.8 2.8 8.6 5.6 5.6 4.8 6.4 5.1 5.3 3.6 9.0 4.4 5.5 5.3 5.5 5.2 3.2 5.3 6.9 5.9 4.7 6.0 5.3 4.3 5.8 8.3 4.2 10.5 7.9 9.2 15.1 6.2 12.3 9.9 8.3 11.0 7.8 8.9 8.6 12.4 9.9 7.9 5.3 9.6 18.7 14.5 10.3 11.6 9.4 7.6 7.0 9.5 10.2 9.1 9.9 17.3 11.5 14.8 8.8 12.4 10.6 8.4 5.2 9.9 3.0 18.2 10.3 5.4 2.2 5.6 8.6 8.5 13.8 14.3 6.6 4.5 6.7 7.8 5.5 12.1 7.3 7.0 19.5 12.5 6.0 3.6 7.3 13.0 7.5 13.8 7.7 11.5 15.7 8.3 2.0 1.6 0.7 1.8 1.2 1.8 1.6 1.7 1.7 1.4 1.5 1.7 1.7 0.6 1.5 0.8 3.3 1.6 0.9 5.1 5.3 6.0 7.2 5.0 5.4 5.4 5.2 5.6 5.3 5.3 5.8 69.3 48.1 44.1 20.2 43.8 81.8 62.5 117.8 43.3 51.8 49.0 59.2 31.2 75.8 63.2 86.5 31.3 72.6 54.8 87.3 90.1 72.2 300.6 69.3 66.0 63.1 61.0 79.8 30.8 75.2 84.6 55.8 35.2 86.6 53.8 33.9 91.1 100.3 64.5 97.6 23.4 71.4 89.5 79.7 62.4 179.2 95.7 54.8 39.2 15.9 65.1 59.2 71.1 19.1 25.4 196.8 136.3 72.6 39.1 76.2 66.8 114.8 58.4 43.5 65.7 57.7 56.9 44.3 46.2 47.0 104.0 48.7 50.4 30.5 54.2 83.2 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035690-40039181 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 440000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 309.1 307.5 330.1 118.1 327.1 252.7 300.4 323.8 426.0 301.7 320.4 272.5 121.5 311.2 282.1 257.7 270.7 155.8 390.1 317.9 349.3 391.5 229.5 220.8 168.0 357.0 402.7 323.5 192.4 324.3 306.8 143.8 339.7 264.4 158.9 212.8 237.8 158.9 354.7 201.2 215.7 163.4 321.1 219.7 247.6 165.6 326.2 276.9 275.6 338.5 172.9 266.7 253.9 355.1 131.8 163.7 399.5 301.4 300.0 275.5 189.4 232.4 265.0 213.4 223.3 297.8 113.7 107.9 245.0 305.1 319.5 216.6 322.8 260.9 207.0 257.5 230.3 258.3 530.2 364.0 231.4 238.2 211.8 276.0 298.3 177.8 213.3 391.0 360.6 297.7 280.2 204.2 356.3 204.5 370.2 291.4 217.6 520.1 301.3 247.6 176.8 192.6 477.5 401.7 287.2 255.0 231.2 243.2 171.2 243.7 332.8 448.6 290.9 240.4 160.3 229.4 171.1 161.8 494.7 291.0 234.7 255.4 229.7 729.8 525.0 875.7 484.5 485.8 473.9 600.9 547.9 549.0 562.5 509.0 522.0 510.2 452.7 525.9 459.5 1148.0 755.1 1262.6 330.1 327.1 323.8 426.0 317.9 349.3 357.0 402.7 339.7 321.1 326.2 355.1 1378.8 461.6 415.0 83.2 577.0 667.1 861.7 1395.7 427.4 432.9 617.7 914.5 880.3 649.1 906.9 995.0 125.1 867.3 812.5 742.7 2551.3 1366.9 353.1 1215.7 729.8 957.7 554.0 619.4 39.4 1087.2 1100.4 699.1 324.7 1513.6 564.0 669.5 654.7 819.4 1022.1 348.3 56.1 676.9 1226.8 631.1 882.8 377.3 1039.8 645.8 789.8 36.5 1174.3 1262.8 619.0 39.2 76.0 1240.7 894.4 986.9 610.9 826.3 874.5 2276.2 935.5 477.3 624.5 651.9 749.3 779.9 643.1 631.5 710.3 758.8 644.1 831.9 673.2 975.0 SRSF9 "SFRS9, SRp30c" ENSG00000111786 "Serine and arginine rich splicing factor 9" Q13242 12 120461672-120469748 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049849 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA049849: AB_2680911" "unprognostic (3.80e-1)" "unprognostic (3.84e-1)" "unprognostic (1.50e-1)" "unprognostic (1.75e-2)" "unprognostic (2.41e-1)" "unprognostic (2.50e-3)" "prognostic unfavorable (9.85e-7)" "unprognostic (9.65e-3)" "prognostic unfavorable (7.80e-4)" "unprognostic (2.31e-2)" "unprognostic (4.35e-1)" "unprognostic (1.19e-2)" "unprognostic (1.19e-3)" "unprognostic (9.57e-2)" "unprognostic (3.13e-1)" "unprognostic (2.57e-1)" "unprognostic (1.60e-1)" 68.2 112.1 71.2 75.5 74.3 95.0 72.0 73.9 75.2 70.3 81.0 88.7 73.0 57.5 85.5 126.6 76.1 48.7 38.8 70.6 75.1 94.7 92.0 62.1 99.3 72.7 77.2 71.2 113.8 94.2 78.2 85.2 74.0 76.9 84.2 21.8 77.1 57.4 30.0 80.6 63.5 58.9 74.4 86.7 82.6 93.3 77.6 110.2 80.6 27.5 129.1 82.9 75.6 72.1 334.7 229.2 344.3 222.7 153.6 153.7 365.3 224.3 200.7 281.5 240.2 276.9 153.1 323.6 254.7 189.4 152.7 194.9 312.0 318.9 308.5 244.7 321.9 276.3 152.8 273.5 197.7 344.7 241.8 163.4 201.8 244.6 211.0 301.2 260.4 207.0 353.6 95.3 245.9 466.8 339.7 668.7 429.6 224.8 198.2 374.2 144.1 312.9 246.4 420.4 303.9 217.3 262.5 137.3 276.2 222.4 415.9 299.4 229.1 207.8 247.0 157.8 246.3 288.6 234.5 404.9 218.8 255.7 221.5 28.7 16.9 49.3 22.5 19.8 17.5 41.2 17.4 19.9 22.5 36.7 17.3 19.1 19.7 26.5 27.7 30.7 20.1 8.7 71.2 74.3 73.9 75.2 70.6 75.1 72.7 77.2 74.0 74.4 77.6 72.1 172.6 25.6 37.2 17.3 190.1 264.9 269.7 81.2 140.0 74.5 235.6 174.4 1.7 157.3 60.4 161.8 29.2 339.2 204.5 119.5 489.1 200.6 68.5 179.1 149.9 143.8 144.7 141.9 24.1 155.1 469.4 148.9 105.5 143.9 33.7 321.3 132.8 150.0 202.9 72.3 23.6 160.5 63.1 136.3 322.0 28.5 124.5 171.3 200.9 11.2 192.7 134.4 129.8 14.1 24.1 152.4 102.2 155.0 317.8 336.8 89.8 404.3 63.6 55.3 52.6 128.1 165.5 288.5 248.8 218.2 313.4 475.4 158.1 433.1 160.6 392.2 SSX1 CT5.1 ENSG00000126752 "SSX family member 1" Q16384 X 48255392-48267444 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 6.8" "Group enriched" "Detected in some" 4 "Spermatocytes: 24.2;Spermatogonia: 30.2" "Cancer enhanced" "Detected in many" "liver cancer: 7.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "Daudi: 66.1;Karpas-707: 90.5;U-2197: 22.7" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (2.25e-1)" "unprognostic (3.51e-3)" "unprognostic (2.36e-1)" "unprognostic (4.32e-3)" "unprognostic (3.38e-1)" "unprognostic (5.41e-2)" "unprognostic (6.94e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.1 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 90.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.2 22.7 0.1 0.0 4.8 0.1 5.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 24.2 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2 "CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX" ENSG00000241476 "SSX family member 2" Q16385 X 52696896-52707189 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 59 "testis: 15.0" "Cell type enriched" "Detected in single" 4 "Spermatogonia: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045683, HPA071685" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX2B CT5.2b ENSG00000268447 "SSX family member 2B" Q16385 X 52751132-52790305 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 33 "testis: 29.9" "Cell type enriched" "Detected in single" 9 "Spermatogonia: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.7;PC-3: 2.5;T-47d: 1.0;U-2197: 1.5" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 29.9 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.5 0.0 0.2 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.2 0.7 0.9 0.2 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX3 CT5.3 ENSG00000165584 "SSX family member 3" Q99909 X 48346427-48356707 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 40 "testis: 13.5" "Group enriched" "Detected in some" 26 "Spermatocytes: 52.7;Spermatogonia: 118.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 4 "Karpas-707: 2.1" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.86e-1)" "unprognostic (2.13e-2)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.7 118.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4 CT5.4 ENSG00000268009 "SSX family member 4" O60224 X 48383516-48393347 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 2.2;Karpas-707: 5.4;U-266/70: 4.5;U-266/84: 3.3" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.4 0.0 0.0 0.0 0.0 0.4 0.2 0.3 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 4.5 3.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX4B OTTHUMT00000056510 ENSG00000269791 "SSX family member 4B" O60224 X 48402078-48411910 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 17 "testis: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.2;Karpas-707: 5.4;U-266/70: 1.9;U-266/84: 9.0" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX5 ENSG00000165583 "SSX family member 5" O60225 X 48186220-48196795 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "Spermatogonia: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 9 "BEWO: 4.7" "HPA045683, HPA071685" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 28: BEWO - Transcription regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.20e-1)" "unprognostic (2.96e-1)" "unprognostic (1.23e-1)" 0.0 0.0 0.6 0.0 0.4 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.7 0.6 0.3 0.5 0.4 0.6 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SSX7 ENSG00000187754 "SSX family member 7" Q7RTT5 X 52644061-52654900 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "brain: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 2.3;RT4: 1.7" "HPA045683, HPA071685" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "HPA045683: AB_2679418, HPA071685: " "unprognostic (1.29e-1)" 0.0 0.0 0.4 0.1 0.5 0.2 0.0 1.2 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.6 0.2 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.7 0.4 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.2 0.7 0.2 0.1 0.6 0.2 0.7 0.2 0.4 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STAG3 ENSG00000066923 "Stromal antigen 3" Q9UJ98 7 100177563-100221488 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Chromosome partition, Meiosis" "Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 66 "testis: 54.7" "Cell type enhanced" "Detected in many" "B-cells: 56.5;Spermatocytes: 152.6;Spermatogonia: 60.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 41.7;HMC-1: 54.4;U-698: 13.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA049106, HPA058330" Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 3: HMC-1 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli Nucleoplasm "HPA049106: AB_2680634, HPA058330: AB_2683681" "unprognostic (6.56e-4)" "prognostic favorable (8.45e-4)" "unprognostic (1.25e-2)" "unprognostic (7.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-3)" "unprognostic (3.59e-2)" "unprognostic (4.62e-2)" "unprognostic (1.12e-1)" "unprognostic (3.46e-1)" "unprognostic (3.31e-4)" "unprognostic (4.26e-4)" "unprognostic (7.48e-2)" "unprognostic (6.80e-2)" "unprognostic (2.72e-1)" "unprognostic (3.13e-2)" "unprognostic (5.07e-4)" 0.2 0.2 0.1 0.1 0.1 0.8 0.3 0.2 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 0.3 0.1 0.3 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.4 0.1 0.0 0.1 0.2 0.1 54.7 0.3 0.6 0.1 0.0 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.2 0.0 41.7 1.1 0.0 0.1 0.2 0.0 0.0 1.2 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 54.4 0.0 0.1 0.8 0.2 0.0 0.3 1.4 0.2 0.0 0.0 0.0 0.4 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 13.1 0.7 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.3 0.3 1.9 0.0 2.7 2.9 56.5 6.8 10.9 1.8 1.2 7.4 1.9 1.8 2.2 10.0 1.7 7.3 2.1 2.0 12.1 1.7 13.7 0.3 29.8 26.1 2.9 4.2 1.2 8.4 6.5 0.2 3.3 4.1 0.5 7.8 1.3 4.9 4.2 29.4 2.2 20.2 6.1 5.7 0.0 2.2 8.6 23.5 4.7 4.6 5.4 5.6 4.2 2.7 13.4 5.0 5.1 0.2 0.5 1.9 2.1 8.2 1.1 6.9 15.1 7.0 0.0 8.0 5.4 152.6 60.0 0.4 8.5 2.9 10.8 2.6 2.0 11.7 STEAP3 "dudlin-2, STMP3, TSAP6" ENSG00000115107 "STEAP3 metalloreductase" Q658P3 2 119223831-119265652 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Cell cycle, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 189.5;parathyroid gland: 78.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3" "Group enriched" "Detected in many" 6 "dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3" "Cell line enhanced" "Detected in many" "U-87 MG: 149.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA050510 Approved Approved Nucleoli,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 15: Hepatocytes - Hemostasis" Cytosol Nucleoli "HPA050510: AB_2681151" "unprognostic (6.51e-2)" "unprognostic (6.48e-2)" "unprognostic (4.89e-2)" "unprognostic (3.45e-2)" "unprognostic (1.94e-3)" "unprognostic (9.07e-2)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (9.75e-2)" "unprognostic (1.58e-3)" "unprognostic (5.08e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.82e-1)" "unprognostic (4.45e-1)" "unprognostic (9.37e-2)" "unprognostic (6.82e-2)" 9.1 6.3 4.3 3.9 3.7 16.9 14.5 7.1 4.6 16.7 10.6 9.5 22.1 3.6 5.3 15.8 7.7 2.3 9.5 7.0 7.5 6.9 189.5 9.1 0.9 14.4 9.4 4.4 27.1 78.9 13.8 11.3 12.8 11.8 6.9 0.7 34.3 7.5 29.9 9.0 10.9 3.1 7.6 1.8 22.5 1.9 7.2 2.2 5.4 12.5 3.1 7.0 7.2 12.7 21.8 25.6 0.0 8.7 12.1 112.9 22.1 6.8 7.4 13.1 11.8 19.5 29.0 0.1 49.9 38.5 94.1 35.9 11.1 22.4 14.9 0.1 35.9 42.1 22.2 38.8 30.0 10.5 7.7 67.3 38.7 78.0 27.7 89.8 11.4 0.0 20.9 4.2 37.6 20.6 0.1 6.2 34.2 33.3 52.7 0.2 14.7 18.5 16.2 54.1 41.9 7.7 18.8 64.1 4.9 4.9 12.7 13.7 49.6 81.2 46.8 17.4 37.4 0.1 0.1 0.2 149.1 26.2 17.2 0.0 2.4 0.4 0.1 2.7 0.0 0.4 0.0 0.0 4.1 0.1 0.0 0.0 0.0 1.3 0.4 0.2 0.0 1.0 4.3 3.7 7.1 4.6 7.0 7.5 14.4 9.4 12.8 7.6 7.2 12.7 9.1 0.0 7.9 2.3 1.0 2.0 7.4 11.9 8.0 0.6 15.5 10.7 6.2 2.8 16.2 0.0 0.0 33.3 0.2 12.2 0.0 8.1 0.2 8.1 1.9 6.2 1.8 29.5 1.3 36.2 4.1 3.6 23.4 5.7 3.8 3.5 1.4 91.6 10.9 0.0 1.0 6.0 8.2 5.9 3.8 0.7 1.8 6.1 0.0 1.9 1.4 0.1 0.0 0.5 0.0 20.8 7.7 7.5 0.1 8.3 11.8 1.5 36.1 0.1 6.6 4.1 3.3 0.6 0.2 19.5 1.4 23.7 0.4 13.1 11.6 8.9 STK24 "MST-3, MST3, MST3B, STE20, STK3" ENSG00000102572 "Serine/threonine kinase 24" Q9Y6E0 13 98445185-98577940 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 203.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026435, HPA026502" Enhanced Supported Nucleoli,Cytosol No No 1100000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Cytosol" "HPA026435: AB_1854151, HPA026502: AB_1854152" "unprognostic (3.49e-2)" "unprognostic (2.39e-2)" "unprognostic (1.78e-1)" "unprognostic (3.44e-2)" "unprognostic (2.86e-1)" "unprognostic (3.25e-2)" "unprognostic (9.67e-3)" "prognostic unfavorable (6.23e-6)" "unprognostic (5.45e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (5.81e-4)" "unprognostic (9.62e-2)" "prognostic favorable (6.91e-5)" "unprognostic (3.10e-2)" "unprognostic (4.49e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-2)" 71.4 32.4 30.9 49.0 32.6 58.0 60.9 34.3 34.4 99.1 49.4 75.1 83.0 53.9 58.4 167.9 50.7 55.8 49.1 34.2 29.0 77.0 32.4 54.1 67.0 29.0 35.5 44.2 48.0 42.4 31.1 57.5 27.2 49.6 72.3 31.7 70.4 51.2 47.1 154.4 94.4 48.2 28.5 51.5 78.3 36.9 41.3 68.2 55.0 38.8 74.1 86.6 113.9 29.2 161.8 49.4 85.6 79.8 128.6 76.4 121.3 73.8 103.0 100.9 97.7 145.7 212.6 114.1 36.6 92.8 63.1 142.1 80.2 162.3 95.5 286.3 41.2 122.0 59.8 84.2 181.0 124.4 82.8 49.8 253.7 79.3 231.6 106.2 88.2 88.0 45.2 76.6 67.0 70.3 93.5 51.1 76.9 217.3 36.6 116.5 52.5 62.3 98.1 143.2 49.8 71.4 46.7 74.2 103.0 129.7 89.6 119.1 120.0 63.8 46.3 52.8 86.5 74.1 41.7 42.5 99.3 74.0 107.4 5.7 12.7 6.3 5.5 10.9 6.6 6.1 10.2 8.0 10.9 7.9 6.9 5.6 10.9 1.5 13.5 7.1 13.7 6.7 30.9 32.6 34.3 34.4 34.2 29.0 29.0 35.5 27.2 28.5 41.3 29.2 36.2 12.8 27.4 27.7 37.4 70.9 83.6 51.2 20.5 20.3 41.5 33.5 3.0 55.8 55.8 68.0 56.3 39.2 36.9 203.8 25.4 35.8 3.5 74.2 48.7 32.5 42.6 41.4 39.2 55.0 45.9 43.2 65.7 99.6 18.4 49.1 25.0 26.6 28.0 10.1 34.2 86.0 24.4 82.2 57.9 5.9 26.8 58.4 56.9 49.6 47.6 25.5 20.6 35.7 11.1 84.4 96.5 30.5 25.5 60.4 111.8 39.2 51.6 11.0 39.5 47.7 41.0 2.9 21.2 61.9 82.1 20.0 45.5 20.4 59.1 153.3 STON2 "STN2, STNB2" ENSG00000140022 "Stonin 2" Q8WXE9 14 81260656-81436465 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 79.8" "Cell type enriched" "Detected in many" 4 "Astrocytes: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 4 "monocytes: 1.2" "Cell line enhanced" "Detected in many" "HEL: 113.4;HMC-1: 60.9;Karpas-707: 58.3;RT4: 46.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003086 Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 36: HEL - Hemostasis" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Cytosol" "HPA003086: AB_2302748" "unprognostic (5.28e-2)" "unprognostic (9.83e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.96e-4)" "unprognostic (2.50e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.55e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (3.30e-1)" "unprognostic (9.88e-2)" "unprognostic (9.19e-2)" "unprognostic (5.82e-3)" "unprognostic (1.37e-1)" "unprognostic (6.15e-2)" "unprognostic (1.44e-1)" 3.4 0.8 65.6 1.2 64.8 5.5 9.6 31.2 44.7 4.6 14.1 4.4 4.0 1.2 5.1 14.3 10.7 5.9 3.0 60.1 79.8 14.3 3.0 5.0 1.0 36.5 68.3 2.8 0.9 0.3 10.0 2.5 39.5 2.1 5.0 10.2 5.6 2.7 13.2 8.0 4.3 1.7 27.0 16.3 5.7 3.3 60.9 2.5 10.8 17.4 2.9 6.3 9.5 53.7 4.7 3.1 12.1 0.2 0.0 0.1 13.4 0.0 0.1 0.0 0.3 10.0 4.2 0.0 5.5 0.0 3.4 30.6 16.5 39.8 0.0 0.8 5.5 113.4 19.9 4.2 0.0 0.0 60.9 1.7 33.5 0.0 11.0 0.0 0.0 6.1 40.2 58.3 1.2 6.8 5.4 0.0 11.9 11.5 2.4 0.1 17.6 3.4 8.4 46.0 28.1 1.7 13.7 0.6 0.0 9.9 1.7 0.3 0.3 2.4 8.8 9.7 2.6 6.0 11.9 0.1 8.4 0.4 2.6 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.1 65.6 64.8 31.2 44.7 60.1 79.8 36.5 68.3 39.5 27.0 60.9 53.7 6.3 3.2 0.5 253.4 0.1 13.6 13.2 20.5 30.7 0.6 11.8 8.1 1.1 2.8 6.8 18.4 12.5 1.4 0.1 4.8 7.9 0.6 0.4 56.0 1.2 5.0 0.0 12.2 0.9 0.5 0.4 8.3 7.1 16.1 0.0 12.5 4.2 0.9 3.4 3.3 4.4 3.2 14.2 18.0 6.1 1.6 10.2 13.5 1.8 23.4 2.3 23.9 0.0 12.1 15.2 3.2 2.7 8.6 1.0 6.8 4.6 20.6 5.8 6.1 0.0 36.1 3.2 1.0 5.9 24.3 8.8 15.5 0.9 6.3 2.7 33.2 STPG2 "C4orf37, MGC46496" ENSG00000163116 "Sperm tail PG-rich repeat containing 2" Q8N412 4 97184093-98143476 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9;testis: 1.9" "Cell type enhanced" "Detected in some" "Astrocytes: 81.6;Excitatory neurons: 34.7;Inhibitory neurons: 38.2;Microglial cells: 36.5;Oligodendrocyte precursor cells: 21.1;Oligodendrocytes: 150.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059473 Approved Nucleoplasm,Nucleoli NA NA "Cluster 21: Non-specific - Transcription" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Nucleoli "HPA059473: " "unprognostic (3.05e-2)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (6.12e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-2)" "unprognostic (6.59e-3)" "unprognostic (8.87e-3)" "unprognostic (2.18e-1)" "unprognostic (2.05e-2)" "unprognostic (2.40e-2)" "unprognostic (1.32e-3)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" "unprognostic (7.55e-3)" "unprognostic (5.78e-2)" 0.0 0.1 0.5 0.0 1.3 0.0 0.2 0.7 0.5 0.1 0.2 0.0 0.1 0.0 0.4 0.0 0.2 0.1 0.0 0.3 1.0 0.6 0.2 0.1 0.1 1.1 0.9 0.1 0.2 0.2 0.4 0.2 1.2 0.1 0.1 0.9 0.1 0.1 0.0 0.2 0.1 0.0 0.9 0.1 0.1 1.9 0.7 0.1 0.4 0.0 0.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 1.3 0.7 0.5 0.3 1.0 1.1 0.9 1.2 0.9 0.7 1.9 0.2 0.0 0.0 81.6 0.7 0.0 0.4 0.0 0.0 0.9 0.4 0.1 0.4 0.0 0.1 0.0 6.2 0.1 0.0 0.0 3.9 0.0 1.8 0.6 0.1 0.0 0.0 0.0 34.7 0.0 0.0 0.0 0.5 0.3 0.0 0.4 0.7 0.1 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 36.5 0.0 0.8 0.0 21.1 150.4 0.2 0.0 0.0 0.1 0.1 0.3 0.8 0.0 1.8 0.0 0.0 0.0 3.2 1.0 0.0 0.0 0.1 0.1 0.4 0.0 0.2 STX17 FLJ20651 ENSG00000136874 "Syntaxin 17" P56962 9 99906654-99974534 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001204 Approved Uncertain Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 16: U-266 - Nucleosome" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoli, Cytosol" "HPA001204: AB_1080118" "unprognostic (1.16e-1)" "unprognostic (2.50e-1)" "unprognostic (8.67e-2)" "unprognostic (2.93e-1)" "unprognostic (6.71e-2)" "unprognostic (1.88e-1)" "unprognostic (2.36e-1)" "unprognostic (1.70e-2)" "unprognostic (9.75e-2)" "unprognostic (1.62e-1)" "unprognostic (1.04e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.62e-5)" "unprognostic (9.48e-2)" "unprognostic (4.32e-2)" "unprognostic (5.70e-2)" "unprognostic (1.28e-1)" 9.3 9.4 7.6 9.3 8.3 11.3 12.3 12.9 8.9 9.5 10.2 9.5 8.9 10.8 10.9 12.0 8.0 8.5 8.1 7.6 7.8 9.7 18.3 9.3 9.2 7.6 7.1 10.9 12.1 11.0 7.6 10.7 7.7 12.4 9.8 10.9 12.8 11.3 16.7 17.6 9.4 10.5 6.7 10.5 10.9 7.9 7.9 11.4 13.2 13.0 10.3 7.7 9.8 10.9 12.9 12.4 11.2 13.0 14.0 13.2 22.3 9.7 13.1 10.1 8.4 14.1 15.8 25.2 9.2 9.5 17.7 14.1 9.6 13.6 7.1 21.3 7.7 16.0 16.3 8.3 15.9 22.5 5.3 12.2 15.9 10.9 15.7 11.7 12.0 21.9 22.4 12.5 8.2 15.4 14.5 8.4 10.0 15.3 8.8 10.8 20.3 10.5 13.7 15.5 6.2 11.9 19.1 13.3 10.2 7.0 13.8 6.9 9.1 6.5 9.9 11.1 8.3 18.5 24.4 4.8 9.2 9.5 6.9 18.6 3.6 7.3 6.4 3.9 9.1 6.3 7.7 7.2 4.6 5.1 8.8 8.4 4.0 14.5 8.2 2.8 4.6 4.6 7.6 8.3 12.9 8.9 7.6 7.8 7.6 7.1 7.7 6.7 7.9 10.9 25.1 16.0 32.6 35.6 26.2 10.6 19.2 13.9 34.7 14.9 20.1 20.6 19.1 14.3 19.4 23.9 20.9 24.7 21.5 10.7 29.4 19.0 67.2 13.5 21.6 18.7 25.2 26.9 41.9 19.4 19.5 18.0 28.1 15.6 26.0 24.0 18.5 25.0 10.4 10.1 40.5 15.7 20.3 12.7 10.6 36.7 25.7 17.1 8.8 45.0 24.8 21.8 24.7 48.7 47.4 15.7 18.1 18.0 24.4 30.9 17.8 21.1 19.6 13.5 39.5 19.6 20.2 33.6 18.1 27.3 12.1 27.4 26.6 27.0 16.2 18.3 SUB1 "p14, p15, PC4" ENSG00000113387 "SUB1 regulator of transcription" P53999 5 32531633-32604079 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 1838.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 1427.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001311, CAB015351" Supported Supported Nucleoplasm,Nucleoli NA NA 120000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Nucleoplasm, Nucleoli" "CAB015351: AB_2197157, HPA001311: AB_1080123" "unprognostic (5.19e-2)" "unprognostic (1.58e-1)" "unprognostic (5.25e-2)" "unprognostic (1.71e-1)" "unprognostic (2.26e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.25e-6)" "unprognostic (8.31e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.46e-3)" "unprognostic (5.04e-2)" "unprognostic (1.95e-1)" "unprognostic (1.02e-3)" "unprognostic (2.12e-1)" "unprognostic (2.99e-1)" "unprognostic (2.43e-1)" "unprognostic (2.45e-1)" 142.0 98.7 88.7 130.4 100.7 251.7 122.1 72.7 152.6 109.7 69.4 110.0 88.7 85.4 83.3 108.9 66.0 74.1 113.3 104.3 98.7 129.2 135.3 91.2 159.8 80.7 87.2 68.3 62.0 107.3 88.4 103.2 94.7 73.2 107.1 83.6 76.6 65.4 105.2 69.6 83.7 79.4 86.0 144.9 97.3 71.1 92.6 204.2 69.2 108.9 137.3 124.0 73.2 85.3 199.9 161.8 315.3 295.8 187.5 329.1 197.7 340.3 245.4 300.8 275.4 236.9 307.3 101.2 231.0 236.5 307.3 132.4 266.9 278.9 402.9 420.2 244.1 337.8 365.8 450.5 264.4 594.6 441.4 233.3 235.6 321.0 228.0 166.0 228.9 378.5 399.4 1427.8 269.5 178.6 566.8 942.9 207.8 235.9 326.9 247.8 409.9 645.7 303.0 178.2 170.4 141.1 526.9 244.9 251.9 198.2 272.0 544.9 238.7 324.7 351.5 275.8 261.0 556.0 1035.0 180.5 297.7 634.9 202.4 650.7 135.8 326.2 164.7 142.3 151.4 330.4 215.9 219.8 265.1 214.8 168.2 195.2 163.7 155.2 133.4 390.1 344.6 326.1 88.7 100.7 72.7 152.6 104.3 98.7 80.7 87.2 94.7 86.0 92.6 85.3 298.9 144.2 163.4 27.1 638.2 584.9 588.7 709.9 324.4 118.1 459.2 383.9 196.7 244.5 320.1 310.8 43.8 493.0 613.5 342.1 1009.5 711.4 131.6 319.0 263.7 280.2 281.4 379.5 71.5 327.2 785.0 323.6 227.9 329.9 307.5 188.6 223.1 375.4 500.5 85.8 60.9 362.9 484.2 319.0 721.3 68.1 239.9 422.5 528.3 37.5 587.5 223.7 500.5 64.3 50.4 416.3 516.6 344.6 1838.8 536.0 342.4 921.2 291.9 79.7 203.8 224.0 468.5 447.2 439.9 411.8 565.4 836.8 575.5 357.7 394.6 645.5 TAF13 "TAF2K, TAFII18" ENSG00000197780 "TATA-box binding protein associated factor 13" Q15543 1 109062486-109076003 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044492 Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 17: WM-115 - Nervous system development" "Cluster 41: Macrophages - Immune response" Nucleoplasm Nucleoli "HPA044492: AB_10962871" "unprognostic (8.54e-2)" "unprognostic (2.02e-2)" "unprognostic (2.82e-2)" "unprognostic (1.15e-1)" "unprognostic (2.85e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.74e-6)" "unprognostic (1.73e-2)" "unprognostic (2.18e-1)" "prognostic favorable (2.42e-5)" "unprognostic (1.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.43e-1)" "unprognostic (2.11e-2)" "unprognostic (1.91e-1)" "unprognostic (7.61e-3)" "unprognostic (7.22e-3)" 37.0 17.5 22.5 23.3 24.2 49.7 22.4 23.8 26.3 25.5 14.8 26.4 16.1 21.1 21.9 33.9 12.2 27.3 30.5 19.9 24.7 34.4 32.0 18.3 15.0 25.0 24.5 7.0 17.0 25.7 8.7 33.4 25.7 25.2 27.7 9.2 15.1 17.2 66.9 18.9 17.0 34.9 28.9 12.8 20.9 17.0 27.8 12.9 28.0 48.4 24.3 34.7 9.2 25.6 74.5 19.3 28.7 42.0 80.7 75.2 47.6 172.3 72.5 68.7 69.0 30.6 16.4 28.1 64.2 115.6 40.8 30.7 50.9 62.2 102.8 48.6 11.5 28.5 43.0 31.9 63.8 50.7 41.5 67.5 73.0 115.4 62.3 36.8 59.6 25.8 55.5 26.7 93.9 42.8 26.7 13.6 57.6 34.4 39.2 20.7 51.7 11.5 80.0 63.6 29.8 37.2 84.6 54.2 63.7 50.8 18.5 35.5 78.5 112.7 43.1 80.3 95.5 32.4 88.5 36.9 119.8 26.2 171.2 2.0 2.3 2.0 0.8 1.7 0.7 0.7 0.5 0.8 0.8 0.6 0.5 0.8 4.0 0.2 1.6 1.5 1.3 0.5 22.5 24.2 23.8 26.3 19.9 24.7 25.0 24.5 25.7 28.9 27.8 25.6 46.4 19.2 24.6 1.0 10.3 70.2 10.7 12.3 8.6 5.5 14.7 10.2 63.6 10.0 20.3 7.3 0.0 16.7 21.2 35.6 13.7 16.2 55.2 29.4 24.0 21.4 31.8 9.3 4.5 20.9 30.1 20.9 11.7 48.8 14.5 5.1 25.7 37.9 18.2 6.7 3.8 30.2 18.3 28.3 37.6 6.6 9.3 26.5 14.2 1.9 14.5 13.8 5.2 3.0 3.6 31.8 21.7 12.8 9.8 21.9 25.4 31.1 16.8 7.5 6.6 23.6 20.1 10.8 18.2 10.7 82.3 54.9 13.8 6.8 17.9 29.0 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843443-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 7.2 7.6 4.1 8.4 4.1 7.1 8.7 5.3 4.2 6.9 6.4 5.9 5.1 9.7 6.6 9.6 9.6 7.2 4.8 3.8 5.1 13.3 6.3 8.7 11.4 3.9 5.4 5.7 4.4 14.7 3.7 13.0 3.7 9.0 5.7 9.0 8.1 9.0 2.8 8.6 4.2 8.1 3.8 7.1 6.1 11.0 5.4 11.4 10.5 3.4 12.7 7.9 6.0 4.7 25.1 20.4 29.2 9.6 14.1 21.2 52.7 29.9 23.3 25.3 23.3 19.1 18.1 27.1 13.6 21.3 26.7 15.0 26.9 31.7 27.3 31.3 35.9 31.5 8.9 28.3 19.5 22.1 32.4 17.0 16.5 21.4 28.5 20.8 37.4 14.8 19.8 27.2 25.0 15.3 16.6 20.1 37.7 15.6 17.5 10.2 27.2 8.0 24.9 24.3 12.3 33.6 23.5 28.9 21.9 18.9 10.4 17.4 20.4 31.9 39.8 31.1 35.7 14.9 19.9 39.7 18.4 24.8 26.7 3.6 9.1 6.2 12.1 15.5 12.1 11.1 10.2 14.3 13.4 11.7 6.3 10.0 0.5 10.2 12.4 10.6 11.1 5.2 4.1 4.1 5.3 4.2 3.8 5.1 3.9 5.4 3.7 3.8 5.4 4.7 12.5 19.2 22.0 22.2 13.1 16.2 29.9 17.9 19.9 24.5 8.0 6.1 4.0 2.8 26.0 12.9 27.1 25.0 12.6 2.4 13.7 19.5 11.6 26.8 21.0 15.4 1.8 10.5 38.8 18.9 37.4 18.4 13.7 17.3 8.8 12.7 6.8 4.7 12.7 15.2 27.1 3.3 8.2 12.0 11.5 3.8 19.0 14.6 0.0 15.0 15.5 25.5 15.5 32.6 23.5 15.7 3.8 13.2 16.6 9.5 1.7 26.5 29.7 21.0 19.7 15.9 16.2 47.6 33.9 19.7 13.2 23.7 15.1 24.8 4.4 18.7 TANK "I-TRAF, TRAF2" ENSG00000136560 "TRAF family member associated NFKB activator" Q92844 2 161136908-161236230 "Predicted intracellular proteins" "DNA damage, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010345, HPA037675, HPA037676" Approved Supported Nucleoli,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" Cytosol Nucleoli "CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601" "unprognostic (1.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.53e-1)" "unprognostic (5.27e-2)" "unprognostic (3.98e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (2.90e-4)" "unprognostic (1.71e-1)" "unprognostic (2.98e-2)" "unprognostic (4.16e-2)" "unprognostic (1.06e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (2.78e-6)" "unprognostic (2.13e-2)" "unprognostic (2.00e-1)" "unprognostic (5.69e-3)" "unprognostic (2.30e-2)" 42.9 36.2 20.9 46.2 23.6 84.2 57.7 22.1 24.7 30.5 25.3 32.4 28.0 30.7 27.0 29.8 35.0 43.0 27.1 20.1 24.1 29.1 66.5 39.7 52.8 24.0 25.5 30.8 22.9 27.8 19.7 36.9 23.5 24.6 35.8 32.1 26.6 24.7 52.3 26.7 29.1 32.5 21.4 43.2 30.2 22.3 21.9 42.1 36.4 43.3 51.4 49.0 25.0 25.1 39.2 24.5 31.7 36.3 91.3 124.9 45.2 58.0 86.4 39.3 57.7 30.8 50.5 53.1 38.7 67.6 28.2 27.5 19.2 43.4 59.5 126.6 20.5 29.8 22.5 79.1 72.4 51.1 32.2 98.3 66.6 59.6 46.6 73.5 101.7 32.0 30.5 68.7 77.7 29.3 31.4 50.7 18.2 40.9 21.5 17.9 45.5 35.2 86.3 62.1 26.4 30.7 37.4 40.6 60.4 43.2 17.5 64.9 108.2 50.4 29.3 25.7 34.0 46.6 46.1 80.9 66.9 40.3 40.8 122.2 71.4 97.1 36.0 78.5 55.9 63.8 58.8 53.1 66.5 66.7 39.9 39.6 189.4 42.4 94.0 43.4 100.7 55.0 20.9 23.6 22.1 24.7 20.1 24.1 24.0 25.5 23.5 21.4 21.9 25.1 34.7 57.7 79.6 82.3 108.9 59.9 106.3 82.7 21.6 32.7 73.0 71.5 27.3 42.9 69.2 46.0 12.5 43.1 54.8 50.4 60.7 58.8 18.0 47.2 42.3 46.7 47.4 63.8 49.9 40.5 82.9 67.8 28.5 52.4 59.5 17.0 28.2 58.1 45.6 21.9 60.9 29.3 71.2 71.5 194.0 10.0 52.8 106.8 72.9 120.9 177.7 33.5 40.2 63.3 87.4 56.0 43.9 26.4 57.1 81.8 34.4 46.5 66.2 37.4 26.3 52.1 40.3 54.3 33.9 29.3 60.9 134.9 109.3 33.0 32.2 158.4 TBCA ENSG00000171530 "Tubulin folding cofactor A" O75347 5 77691166-77868780 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036487 Approved Supported Nucleoli,Microtubules NA NA 1800000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 2: Hepatocytes - Metabolism" Microtubules Nucleoli "HPA036487: AB_10669794" "unprognostic (2.03e-2)" "unprognostic (2.12e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (2.06e-1)" "unprognostic (1.78e-2)" "unprognostic (4.95e-2)" "unprognostic (9.59e-2)" "unprognostic (1.73e-1)" "unprognostic (5.68e-2)" "unprognostic (4.67e-2)" "unprognostic (1.98e-1)" "unprognostic (2.78e-3)" "unprognostic (7.63e-2)" "unprognostic (2.66e-1)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" 152.9 255.7 134.2 112.1 136.7 156.5 146.4 137.9 177.2 149.1 137.7 152.0 105.3 131.3 246.2 170.6 142.3 89.0 153.9 134.8 152.7 189.9 286.7 114.4 146.2 144.7 151.8 194.1 131.7 162.1 150.7 122.9 150.4 127.7 106.2 108.8 124.4 100.0 147.1 98.1 104.6 104.7 138.3 108.7 153.0 79.3 145.4 155.0 130.2 108.1 140.7 133.1 136.9 140.9 427.1 286.2 526.4 515.1 227.5 322.7 285.1 352.9 303.2 377.9 432.6 389.5 456.0 654.1 627.0 200.5 562.2 258.0 328.1 453.9 372.7 306.6 524.8 310.9 286.4 426.5 331.7 271.8 248.1 326.4 350.4 270.0 401.0 372.1 329.6 532.2 331.9 396.4 346.7 367.4 575.7 650.3 320.5 122.1 265.0 383.6 434.5 703.6 373.7 358.0 501.1 324.3 339.3 236.6 668.0 455.3 337.2 679.0 307.2 192.2 214.2 341.5 563.3 323.0 339.3 580.9 438.0 463.3 391.1 73.3 138.4 77.5 135.4 153.6 153.5 218.6 160.9 162.4 172.5 196.0 150.8 194.9 82.2 132.7 168.3 253.7 241.6 156.8 134.2 136.7 137.9 177.2 134.8 152.7 144.7 151.8 150.4 138.3 145.4 140.9 177.5 153.8 141.9 53.2 234.6 210.9 264.5 447.5 140.0 167.4 310.9 371.0 88.5 275.9 217.0 303.5 58.4 453.9 195.5 231.4 718.1 377.4 46.5 458.4 263.1 185.2 253.5 189.1 71.2 388.5 374.1 216.1 151.4 238.8 159.0 394.1 297.0 1298.8 411.2 148.0 73.9 300.7 252.3 495.5 401.4 42.7 306.6 226.3 225.9 40.3 394.9 231.3 254.3 66.9 126.8 476.2 283.1 258.8 182.6 406.3 256.6 1037.0 360.8 133.3 236.7 214.8 223.0 236.5 119.0 261.6 226.0 563.8 203.7 505.0 303.6 303.3 TBL1X "EBI, TBL1" ENSG00000101849 "Transducin beta like 1 X-linked" O60907 X 9463295-9741037 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Activator "Congenital hypothyroidism, Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 103.8;Oligodendrocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "CAB005363, HPA067703" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Nucleoli "CAB005363: AB_2240272, HPA067703: AB_2685892" "prognostic unfavorable (8.50e-4)" "unprognostic (2.03e-1)" "unprognostic (2.12e-1)" "unprognostic (2.89e-2)" "unprognostic (2.44e-1)" "unprognostic (1.40e-2)" "unprognostic (2.21e-3)" "unprognostic (3.09e-1)" "unprognostic (2.70e-1)" "unprognostic (3.27e-1)" "prognostic favorable (1.32e-4)" "unprognostic (2.66e-1)" "prognostic favorable (4.58e-4)" "unprognostic (6.71e-2)" "unprognostic (6.38e-2)" "unprognostic (3.40e-3)" "unprognostic (1.53e-1)" 9.3 9.1 20.0 8.7 21.3 7.2 9.7 17.4 16.7 18.1 14.2 9.4 2.8 38.4 35.3 10.2 16.6 7.1 7.3 16.7 21.1 16.6 13.6 5.8 9.0 23.8 20.2 18.0 9.2 23.9 18.7 20.7 19.7 25.4 5.3 16.5 7.3 43.2 4.6 7.5 5.0 26.6 18.6 8.4 8.1 9.7 26.7 18.4 12.0 5.2 10.2 13.5 12.7 20.0 0.1 29.6 18.5 49.2 16.8 17.4 18.4 11.3 25.0 21.3 22.2 22.4 20.2 31.6 0.8 22.7 9.1 6.7 40.7 8.9 30.9 13.0 19.6 20.0 35.6 26.5 23.7 7.2 68.6 15.6 10.1 22.3 11.8 11.7 19.9 17.2 35.8 53.5 12.5 25.6 17.8 27.2 36.7 14.2 31.5 39.3 14.5 39.3 28.9 16.9 23.4 10.6 27.2 6.8 16.9 48.2 13.3 15.6 29.1 7.5 18.3 0.8 4.6 32.6 27.8 25.1 27.2 17.4 7.1 6.3 4.7 5.7 2.2 2.9 1.8 2.2 1.7 2.0 3.5 3.6 3.1 2.9 18.7 0.3 2.0 0.3 2.9 2.1 20.0 21.3 17.4 16.7 16.7 21.1 23.8 20.2 19.7 18.6 26.7 20.0 12.6 0.0 4.5 103.8 17.3 6.5 13.2 3.8 9.1 11.8 19.1 18.0 10.1 20.0 6.8 31.3 22.9 78.1 20.4 7.9 13.7 10.7 1.0 34.4 80.7 10.3 22.8 3.8 12.5 7.8 6.0 13.1 9.7 51.1 11.4 32.5 11.4 64.3 11.3 6.7 17.1 5.4 2.0 33.0 22.8 3.2 14.3 19.7 5.4 61.8 37.5 46.6 19.6 46.3 109.7 7.5 7.9 28.6 9.5 24.1 0.2 21.8 10.0 24.5 0.0 9.4 27.9 1.4 18.0 16.5 12.4 45.0 18.8 22.3 4.9 23.7 TBPL1 "STUD, TLF, TLP, TRF2" ENSG00000028839 "TATA-box binding protein like 1" P62380 6 133952170-133990432 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 126.7" "Group enriched" "Detected in all" 5 "Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071810, HPA071813" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA071810: AB_2686451, HPA071813: AB_2686452" "unprognostic (2.21e-3)" "unprognostic (1.95e-2)" "unprognostic (5.11e-2)" "unprognostic (6.67e-3)" "prognostic favorable (7.22e-4)" "unprognostic (5.16e-3)" "prognostic unfavorable (7.91e-5)" "unprognostic (1.19e-1)" "unprognostic (3.94e-2)" "unprognostic (4.66e-2)" "prognostic favorable (7.23e-4)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.14e-4)" "unprognostic (1.03e-1)" "unprognostic (1.07e-1)" "unprognostic (2.82e-1)" "unprognostic (8.16e-2)" 12.1 11.7 16.9 12.0 18.9 37.5 10.5 19.0 23.0 10.4 12.7 11.7 13.3 12.3 8.1 11.7 13.1 11.8 11.9 19.3 19.4 9.2 13.7 9.7 21.3 14.2 12.9 12.5 8.1 10.4 11.7 14.8 14.2 12.2 14.3 15.0 9.1 12.3 6.4 9.0 12.9 11.1 11.7 12.6 11.7 126.7 20.0 19.8 16.8 9.2 16.9 15.1 9.8 16.5 16.5 19.6 43.9 28.5 32.6 33.3 24.5 29.9 31.5 39.1 51.1 23.0 13.0 49.8 20.2 24.1 43.8 21.2 28.0 32.3 46.8 38.3 35.9 87.8 11.5 25.5 33.0 46.4 32.8 20.8 32.2 43.8 47.1 30.7 37.6 43.3 129.3 33.4 28.1 37.0 39.2 27.8 49.2 23.6 25.1 26.7 26.4 19.5 23.2 14.3 56.5 56.2 17.7 23.2 37.8 36.9 10.5 18.5 34.4 22.5 32.4 50.0 33.6 27.2 31.5 32.8 37.7 30.0 27.4 133.1 31.7 81.8 62.7 33.3 69.8 67.6 53.1 67.1 29.8 60.2 50.6 59.5 74.8 52.5 38.3 35.4 60.5 64.0 16.9 18.9 19.0 23.0 19.3 19.4 14.2 12.9 14.2 11.7 20.0 16.5 35.6 6.4 12.2 10.7 43.2 70.7 27.0 46.7 46.1 22.8 29.8 34.2 12.8 28.6 21.1 7.3 18.8 40.7 59.1 16.8 29.4 29.1 407.5 20.6 17.1 40.8 71.0 51.4 35.3 25.2 69.7 30.8 36.7 14.8 40.0 13.5 22.9 11.2 24.4 15.2 25.2 26.5 48.8 14.8 43.2 75.1 21.1 38.3 32.0 22.5 21.3 23.3 42.2 27.2 27.7 31.4 24.2 18.4 35.2 39.7 17.9 28.4 28.2 12.3 19.7 27.3 35.1 557.4 72.8 36.7 65.8 244.9 50.0 11.0 24.3 37.6 TCEA1 "GTF2S, SII, TCEA, TF2S, TFIIS" ENSG00000187735 "Transcription elongation factor A1" P23193 8 53966552-54022456 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043786 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA043786: AB_10959468" "unprognostic (5.35e-2)" "unprognostic (9.90e-2)" "unprognostic (2.39e-1)" "unprognostic (2.11e-3)" "unprognostic (3.34e-2)" "unprognostic (1.17e-1)" "unprognostic (3.72e-2)" "unprognostic (1.77e-1)" "unprognostic (4.14e-2)" "unprognostic (1.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.75e-5)" "unprognostic (3.80e-3)" "unprognostic (1.10e-1)" "unprognostic (1.13e-1)" "unprognostic (3.05e-2)" 52.7 46.0 44.1 56.5 47.5 81.2 62.2 44.7 58.3 55.3 42.5 49.7 47.1 55.6 45.8 53.9 52.4 42.6 35.9 42.0 46.0 59.8 90.4 46.7 98.3 47.2 44.6 61.9 68.4 80.0 28.2 49.3 47.0 59.0 50.7 49.0 56.5 54.2 42.0 49.8 46.9 52.4 47.5 49.5 52.2 36.8 44.2 72.4 124.2 41.7 112.6 54.6 41.4 55.1 161.3 157.9 138.1 145.7 99.3 121.8 100.9 122.1 147.3 143.5 160.2 91.4 131.0 392.5 136.9 147.0 152.5 120.9 182.3 116.6 212.9 225.0 88.5 293.6 71.5 139.5 309.7 116.8 122.7 88.5 308.1 137.4 606.2 121.3 128.2 132.9 191.1 334.0 135.5 75.6 245.8 83.3 229.1 265.0 47.1 185.1 48.2 72.5 204.0 107.0 129.9 95.5 101.9 91.0 356.3 132.2 129.6 132.6 110.6 106.1 96.3 120.6 114.5 201.1 134.4 260.9 184.9 133.2 152.1 82.3 64.1 78.7 103.9 63.1 98.3 213.8 107.0 96.7 81.8 174.1 93.9 99.3 23.1 97.5 60.6 116.7 153.0 73.5 44.1 47.5 44.7 58.3 42.0 46.0 47.2 44.6 47.0 47.5 44.2 55.1 94.7 89.8 106.2 24.2 253.2 135.5 128.3 98.9 257.2 77.0 129.2 124.3 23.9 82.9 109.4 99.3 89.6 115.5 143.8 61.0 168.3 121.0 86.4 126.9 145.4 92.5 87.2 330.7 17.7 109.9 125.1 118.8 111.6 124.4 98.7 75.7 66.4 160.7 87.7 57.2 20.1 96.6 118.0 89.5 134.2 191.0 134.8 124.2 117.4 17.8 132.5 166.0 170.0 22.1 29.7 121.1 71.6 132.8 341.1 146.0 72.2 207.6 110.6 104.5 78.9 102.6 130.4 94.9 103.1 237.2 150.6 112.1 154.8 108.5 88.1 148.6 TCF19 SC1 ENSG00000137310 "Transcription factor 19" Q9Y242 6 31158547-31167159 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 37.0;Glandular and luminal cells: 17.6;Plasma cells: 21.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 82.8;GAMG: 47.0;HEK 293: 43.3;JURKAT: 40.9;Karpas-707: 39.2;SCLC-21H: 48.5;U-138 MG: 49.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA065994 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 64: Macrophages - Immune response" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA065994: " "unprognostic (1.41e-2)" "unprognostic (4.92e-2)" "unprognostic (4.00e-2)" "unprognostic (5.16e-3)" "unprognostic (1.99e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (5.66e-4)" "unprognostic (7.04e-2)" "unprognostic (1.35e-2)" "unprognostic (5.92e-2)" "unprognostic (1.74e-3)" "unprognostic (1.56e-2)" "prognostic unfavorable (3.54e-10)" "unprognostic (3.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.36e-2)" "unprognostic (1.21e-1)" 4.6 1.7 0.3 2.6 0.4 1.0 4.3 0.7 0.4 6.9 0.2 5.8 4.4 4.2 2.1 12.5 3.8 0.4 3.7 0.3 0.3 4.1 2.0 4.4 10.0 0.5 0.4 4.8 3.2 0.0 1.3 0.3 0.5 5.1 1.7 0.6 4.7 0.8 2.7 8.9 7.2 1.1 0.3 9.5 5.5 1.9 0.7 0.0 2.4 0.1 1.7 5.2 8.1 0.3 82.8 0.7 0.7 0.1 5.4 7.0 0.7 0.5 0.0 0.1 0.1 5.3 0.1 0.1 17.7 20.1 47.0 0.1 0.0 30.3 0.0 0.5 43.3 7.3 5.1 2.0 0.0 0.2 21.1 2.9 0.0 2.3 0.0 4.4 17.9 40.9 0.1 39.2 8.1 0.3 1.2 13.2 0.1 0.0 0.0 1.1 4.8 0.7 7.1 0.3 48.5 0.5 0.4 0.1 0.5 6.5 0.1 6.0 0.0 49.0 0.2 0.4 0.4 12.5 15.0 24.8 0.1 0.3 0.3 0.0 0.1 0.0 0.2 0.0 1.3 0.5 0.6 1.1 0.3 0.5 0.8 0.2 0.1 0.4 0.0 0.0 1.0 0.5 0.3 0.4 0.7 0.4 0.3 0.3 0.5 0.4 0.5 0.3 0.7 0.3 2.8 3.2 0.6 0.7 6.7 5.1 3.1 2.5 8.6 3.0 2.8 2.9 1.2 0.0 2.5 3.7 0.0 2.9 3.9 1.8 7.9 1.3 0.3 4.7 2.0 4.7 1.2 37.0 0.1 1.8 9.6 5.6 5.6 17.6 1.3 7.0 1.8 0.6 8.9 1.7 0.2 3.9 2.0 2.9 5.4 0.7 5.0 4.8 12.4 0.0 6.0 4.2 8.2 0.0 0.2 1.1 0.9 6.4 21.1 1.3 1.6 0.4 0.2 0.5 0.0 3.5 5.3 0.7 11.1 9.6 3.8 0.4 7.6 2.0 8.8 2.9 TCHHL1 "S100A17, THHL1" ENSG00000182898 "Trichohyalin like 1" Q5QJ38 1 152084141-152089064 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 50 "SK-BR-3: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042579, HPA063483" Enhanced Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 8: SK-BR-3 - Unknown function" "Nuclear membrane, Nucleoli" "HPA042579: AB_10794283, HPA063483: AB_2685021" "unprognostic (8.21e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956687-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA "Cluster 83: Testis - Spermatogenesis" Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TEX264 "FLJ13935, ZSIG11" ENSG00000164081 "Testis expressed 264, ER-phagy receptor" Q9Y6I9 3 51662693-51704323 "Plasma proteins, Predicted intracellular proteins" "Autophagy, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 374.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005002, HPA017739" Enhanced Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoli, Cytosol" "CAB005002: AB_425976, HPA017739: AB_1857910" "unprognostic (2.80e-3)" "unprognostic (1.05e-2)" "unprognostic (2.69e-1)" "unprognostic (2.79e-3)" "unprognostic (8.11e-2)" "unprognostic (8.26e-3)" "unprognostic (2.05e-1)" "unprognostic (3.06e-3)" "unprognostic (2.30e-1)" "unprognostic (5.19e-2)" "prognostic favorable (5.67e-4)" "unprognostic (1.83e-1)" "prognostic favorable (7.95e-9)" "unprognostic (4.99e-2)" "unprognostic (3.65e-1)" "unprognostic (3.17e-1)" "unprognostic (4.67e-2)" 34.7 73.4 43.5 23.1 46.5 22.3 35.6 48.7 51.7 39.0 53.1 41.5 39.0 34.2 41.2 41.1 44.0 39.7 41.4 43.8 47.2 67.6 65.3 29.8 33.5 47.2 45.5 31.3 54.3 88.5 26.2 29.4 46.4 45.1 34.5 20.4 58.7 46.9 34.2 69.3 37.6 26.3 46.3 40.9 46.7 111.5 45.9 29.1 48.7 29.6 26.3 35.9 34.9 48.4 36.5 65.5 11.6 59.3 116.8 56.4 23.5 31.0 72.0 50.1 50.1 35.2 84.2 51.6 21.9 44.1 84.2 34.7 32.7 61.6 23.7 42.0 51.9 49.6 40.2 47.8 104.0 31.5 53.6 74.8 96.9 56.3 57.1 45.3 36.9 39.0 26.6 87.7 51.9 42.1 50.9 73.3 12.6 59.8 72.7 24.3 15.3 98.7 79.7 50.1 16.5 26.8 37.4 101.5 48.0 15.7 49.6 66.0 27.3 49.8 20.8 53.0 41.2 61.0 71.3 26.4 61.5 65.9 50.9 99.2 110.1 69.3 119.7 115.6 120.3 98.6 122.6 113.6 104.6 102.4 100.9 103.1 23.5 76.1 115.6 92.4 159.9 139.9 43.5 46.5 48.7 51.7 43.8 47.2 47.2 45.5 46.4 46.3 45.9 48.4 63.6 35.3 21.9 12.4 36.7 34.8 46.7 123.9 45.5 33.5 69.9 68.2 24.4 65.8 68.2 99.3 58.4 142.9 52.3 70.3 62.6 83.1 57.7 44.9 31.8 54.8 32.9 24.8 6.5 75.7 88.9 41.4 29.0 48.2 16.5 45.3 38.9 63.1 105.4 42.1 9.1 56.5 118.0 48.3 45.5 61.2 51.0 47.8 65.8 8.4 56.1 62.6 89.6 7.5 12.3 59.6 76.4 48.9 36.0 45.6 137.6 126.7 49.7 55.4 26.3 30.8 30.7 374.8 111.7 46.3 35.4 76.3 61.9 110.4 86.0 49.9 TFF3 "HITF, ITF" ENSG00000160180 "Trefoil factor 3" Q07654 21 42311667-42315651 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix: 305.8;intestine: 355.3;salivary gland: 340.2;thyroid gland: 416.7" "Cell type enriched" "Detected in many" 10 "Intestinal goblet cells: 33890.3" "Cancer enhanced" "Detected in all" "colorectal cancer: 765.0" "Region enriched" "Detected in single" 6 "midbrain: 1.9" "Immune cell enriched" "Detected in single" 9 "eosinophil: 1.8" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "MCF7: 58.7;OE19: 126.6;T-47d: 27.8;TIME: 105.0" "CAB020681, HPA035464" Enhanced Approved Nucleoplasm,Nucleoli "Secreted to blood" No NA 151000000 6500000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" Nucleoplasm Nucleoli "CAB020681: , HPA035464: AB_2674636" "unprognostic (2.84e-2)" "unprognostic (3.61e-3)" "unprognostic (1.07e-1)" "prognostic favorable (5.60e-6)" "unprognostic (1.28e-1)" "unprognostic (2.35e-2)" "unprognostic (2.13e-1)" "unprognostic (5.03e-2)" "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (3.71e-1)" "unprognostic (6.90e-2)" "unprognostic (4.31e-2)" "unprognostic (1.25e-1)" "unprognostic (2.04e-1)" "unprognostic (2.44e-2)" "unprognostic (3.86e-2)" 11.5 5.9 0.1 27.8 0.1 2.2 26.3 0.3 0.2 305.8 0.1 355.3 208.0 2.8 0.5 22.7 49.8 82.8 3.5 0.1 0.1 5.7 6.6 9.9 3.5 0.1 1.9 3.5 6.1 0.0 1.3 0.1 0.2 9.8 305.8 0.1 340.2 1.6 0.9 6.7 290.6 8.4 0.1 23.1 7.4 0.5 0.2 1.8 416.7 1.7 0.9 3.6 4.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.7 0.0 0.7 0.1 126.6 12.1 0.0 9.0 0.3 0.1 0.0 16.1 0.1 0.0 1.7 0.0 0.0 27.8 0.0 105.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.1 0.1 0.1 1.9 0.2 0.1 0.2 0.1 36.9 16.0 25.3 0.0 15.4 41.6 15.1 196.3 3.4 0.1 804.5 444.7 21.6 919.3 595.9 22.0 0.0 0.6 3.4 2188.7 0.0 9.4 0.5 29.3 1.4 322.8 770.9 0.0 0.0 67.8 0.7 21.5 71.4 11.4 59.2 2.0 170.3 5.8 2.1 5.0 0.0 33890.3 3263.2 3.4 42.4 9.0 2.5 2.8 96.0 0.0 0.0 0.0 0.0 0.0 0.0 45.2 1855.5 7.9 6.1 73.0 2788.7 0.1 453.2 0.1 0.0 1.1 28.2 1.0 0.3 4.3 38.6 0.8 14.9 0.6 1376.3 107.7 THTPA THTPASE ENSG00000259431 "Thiamine triphosphatase" Q9BU02 14 23555988-23560271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 54.8;Spermatocytes: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028876 Approved Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA028876: AB_10600731" "unprognostic (3.50e-3)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (7.11e-2)" "unprognostic (2.25e-1)" "unprognostic (2.12e-1)" "unprognostic (4.13e-1)" "unprognostic (1.58e-3)" "unprognostic (1.98e-1)" "unprognostic (1.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.70e-9)" "unprognostic (3.47e-2)" "unprognostic (2.32e-1)" "unprognostic (3.62e-2)" "unprognostic (5.40e-2)" 13.6 17.6 29.3 10.4 41.7 8.2 11.0 27.5 33.0 9.4 28.5 11.5 14.2 12.1 15.1 8.5 14.9 9.7 14.8 30.1 27.0 14.4 11.3 9.5 10.6 28.4 27.5 12.6 11.4 19.8 11.1 6.7 27.7 16.0 10.6 13.2 17.3 14.0 23.6 6.9 9.8 11.8 27.9 10.7 10.7 20.1 27.9 11.0 11.5 20.7 10.2 10.2 7.3 29.3 3.9 24.1 11.4 12.4 26.3 14.6 6.3 11.2 9.7 10.7 10.5 4.9 15.9 7.2 9.5 13.1 12.1 11.8 12.1 13.8 7.8 15.9 13.7 10.2 16.9 13.3 13.0 9.1 8.7 20.6 10.2 16.4 12.0 22.9 13.0 11.6 7.7 15.9 15.7 11.6 14.6 3.7 4.1 20.9 20.1 9.9 7.9 13.4 18.9 7.6 22.1 10.6 10.8 22.0 6.6 6.6 14.9 4.4 10.9 7.0 7.4 14.5 6.5 18.9 12.2 4.4 7.3 4.2 10.9 13.7 16.0 8.7 9.8 12.0 9.8 10.2 7.2 7.6 14.7 15.3 11.7 10.2 1.7 8.3 16.1 18.7 6.4 10.9 29.3 41.7 27.5 33.0 30.1 27.0 28.4 27.5 27.7 27.9 27.9 29.3 8.1 6.4 7.5 16.6 14.5 0.0 7.8 0.0 6.8 27.4 12.0 10.7 0.1 8.6 3.7 7.3 8.4 11.0 9.2 7.2 54.8 14.5 21.9 6.7 9.2 6.2 6.1 3.4 11.8 12.4 5.1 9.9 9.2 6.7 23.5 7.7 7.1 10.8 18.4 8.4 23.1 7.5 0.0 7.9 0.0 23.0 11.5 9.8 0.0 4.7 9.9 33.4 14.4 15.1 37.0 8.2 9.6 7.5 11.3 9.3 15.2 38.9 2.9 11.6 13.1 13.2 7.7 57.5 8.3 9.5 0.0 6.7 9.3 14.2 7.7 5.9 THUMPD3 DKFZP434F091 ENSG00000134077 "THUMP domain containing 3" Q9BV44 3 9362971-9386791 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 145.3;Spermatocytes: 183.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036170, HPA036171" Approved Enhanced Nucleoli,Cytosol No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol Nucleoli "HPA036170: AB_10671836, HPA036171: AB_2674985" "unprognostic (2.13e-2)" "unprognostic (8.30e-2)" "unprognostic (1.74e-3)" "unprognostic (4.25e-2)" "unprognostic (2.66e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (1.25e-7)" "unprognostic (6.54e-2)" "unprognostic (1.09e-1)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-1)" "unprognostic (4.53e-2)" "unprognostic (4.05e-2)" "unprognostic (1.59e-2)" 14.5 15.5 10.1 15.0 11.5 33.0 18.0 12.7 11.0 18.1 14.0 19.1 16.8 16.3 16.7 20.9 14.7 13.6 24.6 9.9 11.7 20.0 23.4 14.2 18.8 11.2 10.6 14.7 15.5 25.8 12.1 15.1 12.0 19.5 19.0 22.0 15.9 17.9 26.9 13.6 14.3 14.4 11.6 14.3 14.1 59.4 10.9 18.3 23.1 26.4 17.7 16.4 9.6 15.2 40.0 53.0 36.4 18.7 46.5 44.4 146.3 47.2 38.3 47.1 35.8 40.2 41.0 41.0 35.8 43.5 74.1 26.0 66.4 48.3 47.9 45.6 39.1 51.0 51.2 35.3 44.8 66.0 35.3 36.2 53.7 55.7 58.1 38.0 31.5 65.1 80.2 58.2 62.9 55.3 78.9 27.2 69.3 44.0 50.1 49.4 62.7 57.9 29.7 60.4 15.5 48.9 39.6 27.5 43.5 37.2 45.2 42.1 22.8 45.0 38.9 54.9 53.1 73.1 186.7 129.2 55.0 60.5 65.7 19.1 17.8 17.6 20.5 23.4 26.2 17.2 17.6 21.9 20.8 20.0 28.0 21.5 3.6 17.7 29.0 20.5 18.4 14.1 10.1 11.5 12.7 11.0 9.9 11.7 11.2 10.6 12.0 11.6 10.9 15.2 14.9 25.6 21.8 10.1 14.0 10.7 29.3 42.6 16.5 21.6 19.5 23.2 45.3 17.2 34.6 22.0 16.7 34.7 13.1 10.0 52.8 39.2 270.0 19.2 26.8 14.9 3.0 9.7 9.7 29.4 28.4 22.3 12.2 20.9 28.4 21.9 13.2 25.3 27.4 38.7 13.2 15.5 38.7 14.8 6.8 145.3 20.5 18.0 12.4 9.4 20.2 31.4 18.6 18.1 12.5 28.2 9.8 25.9 16.2 32.6 10.9 32.6 20.1 35.2 6.6 28.5 24.5 183.5 52.9 18.9 12.9 27.5 18.4 49.2 20.0 20.9 TLCD2 ENSG00000185561 "TLC domain containing 2" A6NGC4 17 1702816-1710377 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 129.3;Distal enterocytes: 112.4;Proximal enterocytes: 68.9;Skeletal myocytes: 124.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 3.4;neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 3.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 9.0;HaCaT: 8.4;SiHa: 11.2;T-47d: 9.4" "Not detected" "Not detected" "Region enhanced" "Detected in all" "spinal cord: 14.2" HPA046063 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 17: Basophils - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Vesicles Nucleoli "HPA046063: AB_2679520" "unprognostic (1.78e-1)" "unprognostic (6.71e-2)" "unprognostic (2.56e-2)" "unprognostic (1.20e-1)" "unprognostic (8.64e-3)" "unprognostic (1.64e-1)" "unprognostic (3.32e-1)" "unprognostic (4.04e-2)" "unprognostic (7.94e-2)" "unprognostic (7.74e-2)" "unprognostic (2.29e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.36e-5)" "unprognostic (3.77e-2)" "unprognostic (2.82e-1)" "unprognostic (7.79e-2)" "unprognostic (4.44e-2)" 10.3 9.4 0.6 1.8 0.7 2.1 4.7 1.6 0.9 3.0 2.3 7.3 6.0 1.8 1.2 4.7 2.7 1.8 2.1 0.6 0.5 1.8 7.0 3.9 0.7 1.0 0.7 2.5 1.2 1.0 1.1 1.5 1.0 1.9 5.3 10.5 2.9 0.9 1.7 2.4 6.9 1.2 0.7 1.3 4.7 0.6 1.0 0.1 1.6 0.8 0.8 3.1 3.5 1.6 1.0 1.1 1.1 3.5 8.1 9.0 0.3 1.9 1.8 1.0 0.7 6.9 3.1 0.1 1.9 3.1 1.0 8.4 1.5 0.9 0.7 0.2 0.7 0.9 2.4 0.3 2.3 0.1 2.4 7.6 3.2 1.2 2.2 2.9 0.7 0.1 0.8 0.4 0.9 1.9 0.1 0.4 0.1 3.4 0.6 0.1 5.3 0.2 0.7 2.7 0.2 0.4 11.2 1.0 1.6 1.5 9.4 0.8 2.6 0.5 2.3 2.1 0.5 0.1 0.1 0.1 0.6 0.3 1.0 3.4 0.2 0.4 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.4 0.2 0.2 1.6 0.3 0.1 0.2 0.1 0.1 0.6 0.7 1.6 0.9 0.6 0.5 1.0 0.7 1.0 0.7 1.0 1.6 19.0 51.3 55.5 0.3 1.6 0.0 8.2 0.0 4.0 7.9 5.8 9.5 2.7 17.2 18.0 11.0 129.3 4.9 2.0 112.4 0.0 7.3 1.1 12.9 10.4 14.1 9.0 11.2 0.5 9.6 2.6 14.9 20.9 13.3 15.8 3.9 18.9 24.2 5.5 0.0 0.4 24.6 0.0 6.5 0.0 1.8 13.4 10.7 0.0 3.7 1.4 11.7 0.0 0.0 0.1 13.5 40.1 5.7 3.3 6.3 68.9 1.1 19.9 57.8 6.6 124.2 17.8 0.6 0.8 9.1 0.3 4.0 5.1 5.4 35.7 13.0 TMA16 "C4orf43, FLJ11184" ENSG00000198498 "Translation machinery associated 16 homolog" Q96EY4 4 163494442-163520539 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.6;Late spermatids: 179.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041571, HPA052688" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli Nucleoplasm "HPA041571: AB_10794381, HPA052688: AB_2681916" "unprognostic (6.02e-2)" "unprognostic (1.19e-1)" "unprognostic (4.63e-2)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (2.92e-3)" "prognostic unfavorable (2.70e-5)" "prognostic unfavorable (4.40e-4)" "unprognostic (2.30e-3)" "unprognostic (1.33e-2)" "unprognostic (1.17e-3)" "unprognostic (2.69e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (6.98e-2)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (2.56e-2)" 16.4 11.9 4.4 17.9 4.6 12.5 18.0 5.4 6.7 10.8 5.1 13.0 11.0 15.8 6.9 14.3 11.4 9.9 9.2 4.4 5.1 12.1 13.5 8.9 22.0 4.8 4.7 16.8 14.8 9.5 5.3 14.0 5.0 11.8 11.8 5.7 14.4 9.9 9.6 14.4 10.1 13.0 4.9 16.1 12.8 26.7 4.5 19.1 11.6 7.6 20.0 13.9 10.8 6.2 49.1 24.1 43.0 37.3 20.1 32.6 41.3 56.3 29.8 34.2 28.5 23.4 65.4 108.1 22.7 34.0 27.0 25.2 54.6 43.0 43.0 58.1 42.6 154.3 23.3 41.3 39.6 120.2 46.7 22.6 40.0 27.1 36.4 29.5 34.5 39.4 55.1 79.9 39.7 47.2 74.9 68.4 45.6 28.4 43.0 67.7 38.3 68.9 26.2 23.8 22.5 35.2 36.8 46.3 43.4 25.7 30.3 51.3 59.3 23.5 46.0 22.9 61.2 55.8 75.8 124.7 47.3 64.0 72.3 11.7 37.0 3.5 18.4 58.8 26.1 55.6 32.4 23.5 42.3 51.7 29.8 26.1 1.3 35.3 48.4 74.8 31.3 19.4 4.4 4.6 5.4 6.7 4.4 5.1 4.8 4.7 5.0 4.9 4.5 6.2 25.7 22.4 31.2 3.3 51.2 32.9 36.3 52.0 29.6 15.4 42.9 40.5 37.6 47.1 31.7 33.1 4.2 53.8 25.6 16.4 64.6 53.2 165.6 19.0 61.4 30.0 30.5 28.8 8.8 71.0 92.3 37.9 15.3 17.9 29.1 41.6 36.0 55.6 36.4 15.2 7.3 37.5 20.3 43.3 23.4 179.2 55.6 25.4 26.6 6.5 44.4 15.8 16.5 11.6 11.0 54.9 30.6 32.0 30.0 57.8 11.9 71.7 19.0 14.3 39.5 30.4 33.7 103.9 42.1 28.5 39.6 30.5 24.1 43.7 44.0 28.9 TMEM151A "MGC33486, TMEM151" ENSG00000179292 "Transmembrane protein 151A" Q8N4L1 11 66291894-66296664 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 112.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocytes: 70.1" "Cancer enhanced" "Detected in some" "glioma: 4.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 15.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041035 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli Cytosol "HPA041035: AB_10794404" "unprognostic (1.20e-1)" "unprognostic (8.24e-3)" "unprognostic (4.80e-2)" "unprognostic (1.75e-2)" "unprognostic (3.44e-1)" "unprognostic (7.60e-2)" "unprognostic (9.48e-3)" "unprognostic (8.57e-2)" "unprognostic (8.73e-4)" "unprognostic (2.41e-3)" "unprognostic (2.02e-2)" "unprognostic (6.11e-3)" "unprognostic (1.69e-3)" "unprognostic (2.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.38e-2)" "unprognostic (2.67e-2)" 3.1 1.4 41.3 0.0 68.0 0.0 0.0 73.5 60.8 0.0 3.8 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.8 45.2 44.0 0.1 0.2 0.1 0.0 86.0 68.1 0.2 1.1 0.3 9.7 0.0 69.6 0.1 0.0 1.5 0.2 0.0 0.0 0.0 0.1 0.0 61.8 0.0 5.4 0.3 70.6 0.0 0.0 0.0 0.0 0.0 0.1 112.9 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.0 1.1 0.0 3.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 15.3 3.5 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 68.0 73.5 60.8 45.2 44.0 86.0 68.1 69.6 61.8 70.6 112.9 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.7 4.3 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.1 0.0 7.7 0.0 11.6 0.4 0.0 1.0 9.2 0.1 0.0 0.0 0.0 0.0 0.1 15.2 11.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.8 0.0 2.5 0.0 2.0 70.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.1 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 TMEM178B DKFZp547G036 ENSG00000261115 "Transmembrane protein 178B" H3BS89 7 141074064-141480380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.3;parathyroid gland: 11.9;tongue: 12.2" "Group enriched" "Detected in many" 5 "Astrocytes: 175.0;Excitatory neurons: 584.8;Inhibitory neurons: 566.2;Oligodendrocyte precursor cells: 306.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 6.0;HDLM-2: 5.7;NTERA-2: 5.1;RPTEC TERT1: 8.2;SCLC-21H: 6.4;WM-115: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048771 Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles Nucleoli "HPA048771: AB_2680517" "unprognostic (7.33e-3)" "unprognostic (2.02e-2)" "unprognostic (2.83e-2)" "unprognostic (7.79e-4)" "unprognostic (1.94e-1)" "unprognostic (1.49e-1)" "unprognostic (2.95e-1)" "unprognostic (1.69e-2)" "unprognostic (6.94e-2)" "unprognostic (2.21e-2)" "unprognostic (7.17e-4)" "unprognostic (1.05e-1)" "prognostic favorable (4.10e-4)" "unprognostic (2.02e-1)" "unprognostic (1.10e-1)" "unprognostic (5.35e-3)" "unprognostic (8.98e-2)" 0.3 1.4 3.7 0.6 5.4 0.0 0.5 0.2 7.4 0.3 0.0 0.8 0.0 0.8 0.4 0.7 0.3 0.3 11.3 7.0 5.0 1.3 0.0 0.3 1.4 1.5 5.9 0.1 0.9 11.9 4.2 0.0 5.6 2.3 0.3 5.5 1.2 0.5 4.6 0.2 0.4 1.0 0.6 0.7 0.3 0.5 5.2 1.4 8.5 12.2 3.1 0.5 0.2 1.9 0.0 0.1 0.0 0.0 0.5 0.2 1.5 0.1 2.3 0.7 0.8 0.0 0.0 1.9 2.0 0.1 0.5 0.0 6.0 0.0 1.9 5.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 5.1 0.0 0.0 0.4 0.9 2.6 8.2 2.4 6.4 3.9 0.1 0.2 0.9 1.2 0.8 0.0 0.0 0.1 0.9 2.7 0.0 0.0 0.0 0.0 0.4 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 5.4 0.2 7.4 7.0 5.0 1.5 5.9 5.6 0.6 5.2 1.9 1.3 0.0 0.0 175.0 0.0 0.5 0.7 0.9 0.6 25.5 1.4 0.5 48.7 0.0 1.3 1.8 2.1 0.0 0.0 0.0 1.9 0.1 1.3 0.2 0.1 1.2 0.0 0.0 584.8 0.4 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.1 30.3 566.2 0.0 2.0 0.0 0.0 1.6 0.0 0.1 1.8 24.4 0.0 4.2 0.0 306.1 81.3 0.8 0.0 0.7 0.0 2.2 0.0 3.4 0.2 1.8 0.0 3.9 0.8 1.4 0.7 2.9 0.1 0.3 0.3 0.2 0.1 2.0 TMEM187 "CXorf12, DXS9878E, ITBA1" ENSG00000177854 "Transmembrane protein 187" Q14656 X 153972754-153983194 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" HPA038134 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 22: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Cytosol" "HPA038134: AB_10669517" "unprognostic (1.51e-1)" "unprognostic (4.35e-2)" "unprognostic (1.41e-1)" "unprognostic (1.28e-1)" "unprognostic (3.08e-1)" "unprognostic (7.88e-2)" "unprognostic (8.94e-2)" "unprognostic (2.41e-1)" "unprognostic (3.09e-1)" "unprognostic (4.22e-2)" "unprognostic (5.33e-2)" "unprognostic (7.41e-2)" "prognostic favorable (9.14e-8)" "unprognostic (6.73e-2)" "unprognostic (1.57e-1)" "unprognostic (1.05e-1)" "unprognostic (7.04e-2)" 6.9 9.1 5.5 4.8 6.5 2.7 6.5 6.3 6.5 6.7 8.9 6.2 5.0 5.8 7.0 5.1 7.4 4.2 6.2 5.5 6.0 5.6 8.3 4.8 7.7 6.8 6.3 7.1 12.4 5.6 6.8 3.6 6.3 6.7 3.2 2.7 10.7 6.2 6.4 8.5 6.8 4.4 6.7 7.0 6.4 3.9 6.1 5.4 5.0 3.2 4.6 5.9 5.6 8.0 11.9 13.1 2.9 11.6 12.1 10.0 1.8 4.7 2.9 1.4 4.7 2.8 20.7 1.8 27.5 5.2 7.7 11.3 3.9 7.4 1.1 15.8 6.4 3.2 8.3 4.8 10.4 1.9 3.5 12.8 12.1 4.0 7.6 7.4 4.2 7.4 2.9 15.0 6.7 14.7 6.8 2.6 2.1 14.2 18.4 6.5 2.0 20.1 9.2 3.9 4.4 4.1 8.2 6.9 5.8 3.2 11.9 4.0 7.3 2.4 2.6 10.1 2.9 10.9 7.7 2.5 6.9 7.7 1.7 31.5 15.2 19.6 21.5 11.7 21.8 14.6 25.9 23.1 11.4 18.8 31.6 19.5 14.1 17.0 11.4 30.6 29.3 17.7 5.5 6.5 6.3 6.5 5.5 6.0 6.8 6.3 6.3 6.7 6.1 8.0 6.7 0.0 6.3 3.9 4.7 2.8 6.1 11.7 5.2 4.8 9.4 9.8 5.2 12.8 5.1 7.3 6.2 13.3 8.5 5.9 1.9 10.1 0.3 9.4 5.4 7.0 2.4 4.0 1.5 8.7 10.8 6.8 3.6 7.9 3.8 9.0 7.9 16.1 12.4 1.7 1.8 8.2 12.2 7.0 3.3 0.6 14.6 7.1 10.6 0.0 7.0 14.6 5.2 0.5 3.7 9.9 3.8 14.3 3.6 5.9 12.0 8.7 6.5 6.0 6.6 7.8 5.5 1.7 9.4 4.3 4.7 9.9 6.9 14.7 8.1 3.8 TMEM217 "C6orf128, dJ355M6.2" ENSG00000172738 "Transmembrane protein 217" Q8N7C4 6 37212178-37258155 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 9.1" "Cell type enhanced" "Detected in many" "Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045432, HPA071187" Approved Nucleoli,Cytosol NA NA "Cluster 43: Testis - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoli Cytosol "HPA045432: AB_2732519, HPA071187: AB_2732174" "unprognostic (7.78e-2)" "unprognostic (5.49e-2)" "unprognostic (2.22e-2)" "unprognostic (1.29e-2)" "unprognostic (7.79e-2)" "unprognostic (2.02e-1)" "unprognostic (6.77e-3)" "unprognostic (1.40e-2)" "unprognostic (3.51e-2)" "unprognostic (4.23e-4)" "unprognostic (8.22e-2)" "unprognostic (2.18e-1)" "unprognostic (5.62e-2)" "unprognostic (7.26e-2)" "unprognostic (1.33e-2)" "unprognostic (6.99e-2)" "unprognostic (1.59e-1)" 0.7 3.1 0.9 0.7 1.0 2.8 0.5 1.0 1.6 0.3 0.9 0.3 1.1 0.3 1.5 1.6 0.7 1.2 0.3 0.9 0.9 0.6 0.9 0.7 0.4 0.9 0.9 0.3 2.7 1.3 0.1 0.3 1.0 0.3 0.3 0.7 1.2 0.1 0.1 1.0 0.4 0.4 0.8 0.2 0.2 9.1 1.0 0.7 0.7 0.0 0.3 2.2 0.1 1.1 0.7 0.0 0.5 0.4 0.3 2.1 0.3 2.2 3.9 1.9 5.5 1.7 1.3 0.1 0.8 0.5 2.4 1.2 0.7 0.6 2.0 0.7 1.1 7.7 1.7 0.9 0.9 0.2 3.7 1.4 1.7 5.0 0.5 1.0 6.4 0.8 2.5 0.0 0.9 0.9 0.5 3.2 0.6 0.0 0.3 1.0 0.2 0.2 2.1 0.8 0.6 0.3 0.4 0.4 1.0 0.9 0.1 0.4 17.6 1.8 0.5 0.2 0.4 0.5 0.7 1.9 0.3 1.7 0.4 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.9 1.0 1.0 1.6 0.9 0.9 0.9 0.9 1.0 0.8 1.0 1.1 2.6 0.0 0.6 2.9 0.7 2.5 8.9 2.6 0.6 0.8 3.9 1.8 0.2 1.5 3.9 1.8 0.0 0.8 1.3 3.4 3.9 15.0 20.5 8.3 1.3 3.3 1.8 0.0 2.9 16.0 0.6 3.8 2.0 5.6 5.7 1.4 0.4 0.1 0.9 3.3 2.1 0.4 2.0 0.6 6.3 14.9 0.6 2.8 1.8 0.0 0.0 6.4 0.0 1.5 3.0 15.9 1.1 0.0 0.5 6.9 0.8 1.1 5.0 0.5 0.0 4.1 1.8 55.0 0.8 3.4 3.0 1.1 1.1 1.5 1.0 13.9 TMEM35B ZMYM6NB ENSG00000243749 "Transmembrane protein 35B" Q8NCS4 1 34981535-34985353 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 22.4;Alveolar cells type 2: 13.4;Club cells: 6.2;granulocytes: 8.8;Respiratory ciliated cells: 15.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 115.3;CAPAN-2: 113.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051024 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 5: Breast - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli" "HPA051024: AB_2681316" "unprognostic (3.34e-3)" "unprognostic (2.77e-3)" "unprognostic (4.25e-1)" "unprognostic (2.12e-2)" "unprognostic (5.52e-2)" "unprognostic (2.08e-2)" "unprognostic (2.06e-1)" "unprognostic (4.31e-2)" "unprognostic (1.06e-1)" "unprognostic (7.51e-3)" "unprognostic (2.32e-1)" "unprognostic (9.41e-2)" "unprognostic (2.03e-2)" "unprognostic (1.86e-1)" "unprognostic (5.49e-2)" "unprognostic (4.53e-3)" "unprognostic (1.07e-1)" 48.9 36.0 12.6 25.1 12.5 13.6 40.1 12.4 18.5 41.6 16.9 27.4 16.6 36.2 39.0 15.4 41.3 41.0 32.3 12.4 13.1 36.8 40.1 44.2 40.0 13.8 12.8 32.5 29.6 29.8 21.8 63.4 13.7 30.4 26.6 2.2 25.8 34.8 8.6 13.3 27.6 30.1 13.7 32.5 24.4 22.6 13.4 29.7 44.7 20.4 30.9 36.2 33.3 14.4 25.8 19.5 4.2 7.3 115.3 67.1 9.3 27.7 46.2 19.1 25.8 19.4 113.1 12.6 42.1 28.4 30.3 27.2 8.1 23.4 15.0 49.2 12.9 27.2 9.0 23.1 63.2 18.0 27.5 67.7 21.3 17.4 36.6 39.1 38.3 26.8 17.5 36.2 34.2 16.2 13.3 18.6 20.2 0.0 13.6 17.7 37.3 4.0 53.6 24.9 11.1 3.5 42.4 0.6 39.5 21.3 10.3 27.9 39.4 25.6 24.0 22.7 15.8 20.9 12.7 8.9 25.7 29.4 22.2 161.3 101.2 112.4 188.7 118.6 202.9 108.9 205.0 208.3 71.3 89.9 177.7 179.9 31.4 165.4 100.4 159.5 232.4 182.9 12.6 12.5 12.4 18.5 12.4 13.1 13.8 12.8 13.7 13.7 13.4 14.4 0.6 22.4 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 6.2 0.0 0.0 0.1 0.2 0.0 0.0 1.0 0.0 0.3 0.7 2.1 0.0 0.0 0.0 0.2 0.2 2.0 0.0 0.3 8.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 15.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 TMEM42 MGC29956 ENSG00000169964 "Transmembrane protein 42" Q69YG0 3 44861904-44865670 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 70.0;Late spermatids: 85.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052569 Uncertain Uncertain Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Nucleoli "HPA052569: AB_2681871" "prognostic favorable (5.23e-4)" "unprognostic (1.06e-1)" "unprognostic (1.91e-1)" "unprognostic (3.73e-2)" "unprognostic (2.32e-1)" "unprognostic (7.93e-2)" "unprognostic (6.99e-3)" "unprognostic (1.64e-2)" "unprognostic (9.16e-2)" "unprognostic (9.23e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-1)" "prognostic favorable (1.10e-5)" "unprognostic (1.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.19e-1)" 14.8 21.8 15.4 2.2 16.5 2.1 13.6 16.2 18.0 16.9 14.8 11.4 2.4 12.3 11.3 11.4 12.9 3.5 15.1 15.4 16.5 19.7 22.8 11.5 4.7 15.8 16.2 18.5 14.1 7.3 25.8 3.8 16.2 17.5 3.5 4.3 11.7 5.1 20.7 13.2 10.1 3.8 16.4 14.2 13.6 26.4 16.2 9.4 20.2 8.8 4.2 13.6 14.1 17.0 6.0 6.1 1.8 3.5 22.4 17.7 0.2 4.9 7.0 5.9 6.0 1.4 11.9 4.1 9.3 9.8 2.6 4.1 0.4 7.5 6.1 6.3 0.1 2.6 8.1 6.7 23.7 3.0 0.2 18.4 19.3 6.2 13.7 12.7 10.3 10.3 0.1 8.4 9.2 4.8 2.7 5.0 3.3 7.4 2.4 2.1 1.0 1.0 13.3 2.4 1.9 2.3 5.9 2.0 2.5 5.7 4.4 5.2 6.8 5.2 0.6 7.6 5.5 2.8 2.2 1.2 10.4 3.6 2.4 5.8 9.0 4.7 7.6 8.7 8.4 15.4 11.6 7.2 11.5 13.0 15.7 12.7 1.7 10.7 11.9 12.6 10.0 9.7 15.4 16.5 16.2 18.0 15.4 16.5 15.8 16.2 16.2 16.4 16.2 17.0 8.0 22.4 7.7 0.0 14.0 6.1 14.4 31.5 19.4 8.9 17.5 21.2 11.3 18.6 13.0 33.1 2.1 22.5 15.1 4.5 13.7 19.9 70.0 16.0 14.0 10.5 12.0 12.0 0.0 10.2 14.0 18.3 7.1 13.0 3.8 24.7 13.2 18.5 22.7 18.5 0.0 10.2 24.4 10.6 6.0 85.6 27.4 11.7 7.2 0.0 11.2 21.5 10.3 0.0 0.0 14.3 9.3 19.5 6.2 19.1 11.7 21.7 19.9 15.8 6.6 15.4 9.0 33.8 19.9 13.0 8.9 9.7 12.8 29.2 10.7 9.4 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.0 8.8 5.8 10.8 6.3 10.7 11.3 6.7 8.7 7.8 7.4 12.3 10.6 8.1 10.8 9.1 6.6 8.5 4.8 5.4 6.6 10.2 12.6 9.3 12.4 6.5 6.8 6.6 9.1 9.4 5.5 13.2 7.0 7.9 12.2 6.8 8.3 9.2 5.2 9.8 9.3 9.9 6.9 10.7 10.4 5.0 7.0 11.6 11.4 4.4 10.5 13.0 6.6 7.0 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 5.8 6.3 6.7 8.7 5.4 6.6 6.5 6.8 7.0 6.9 7.0 7.0 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915871-7943165 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "lymphoid tissue: 9.9" "Cell type enhanced" "Detected in some" "dendritic cells: 15.0;granulocytes: 63.4;Langerhans cells: 17.5;monocytes: 31.6;T-cells: 29.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 9.4;neutrophil: 7.8;NK-cell: 5.2;T-reg: 18.5" "Group enriched" "Detected in many" 5 "granulocytes: 7.8;NK-cells: 5.2;T-cells: 18.5" "Cell line enriched" "Detected in some" 9 "HDLM-2: 111.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 44: HDLM-2 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.5 0.2 0.4 3.9 0.4 2.2 0.2 1.1 0.5 0.2 0.3 0.5 0.5 0.3 0.2 0.6 0.1 1.6 0.2 0.4 0.1 0.2 0.7 0.8 9.0 0.3 0.1 0.2 0.7 0.0 0.0 0.2 0.3 0.3 1.1 0.5 0.3 0.2 0.2 0.5 0.8 0.2 0.0 4.1 0.8 0.2 0.3 3.7 0.2 0.2 9.9 1.9 0.0 1.1 2.5 0.9 0.2 0.2 0.0 0.1 0.1 0.1 0.4 0.5 0.5 3.1 0.5 0.1 1.2 0.1 1.8 0.4 0.0 0.4 1.9 111.5 0.2 0.6 0.5 0.1 1.8 0.0 0.9 0.3 0.7 0.5 0.2 0.4 0.1 0.1 0.4 0.3 0.1 0.2 0.0 0.3 0.1 0.1 0.2 0.1 0.7 0.2 0.3 0.1 0.2 0.2 0.4 0.2 0.0 1.3 0.1 0.3 0.3 0.3 3.2 0.1 0.5 0.2 0.2 0.2 13.0 0.8 0.1 1.5 1.9 0.2 1.7 0.6 0.3 0.3 1.1 9.4 1.4 0.4 0.2 1.7 7.8 5.2 0.1 0.3 18.5 1.4 0.4 0.4 1.1 0.5 0.4 0.1 0.3 0.1 0.3 0.0 0.3 1.1 0.6 0.0 1.7 0.0 1.6 0.3 0.9 0.3 0.6 0.0 0.3 0.5 0.4 0.0 1.9 0.0 0.0 0.0 15.0 0.1 0.0 1.3 0.0 0.6 1.0 0.8 0.0 0.0 0.2 1.1 0.0 1.0 3.6 1.4 63.4 0.0 0.0 0.0 0.8 0.0 0.3 0.2 0.0 0.3 17.5 0.0 0.0 3.6 5.4 0.0 31.6 0.0 1.0 0.0 0.1 2.0 0.1 0.0 9.4 0.5 0.0 0.1 0.0 0.0 0.0 7.7 1.0 0.4 0.1 0.1 0.4 0.0 29.2 0.0 0.5 0.3 TNNI1 ENSG00000159173 "Troponin I1, slow skeletal type" P19237 1 201403768-201429866 "Predicted intracellular proteins" "Actin-binding, Muscle protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 40 "skeletal muscle: 12562.8;tongue: 3158.3" "Group enriched" "Detected in some" 17 "Cardiomyocytes: 74.7;Skeletal myocytes: 176.2" "Group enriched" "Detected in many" 5 "head and neck cancer: 9.6;prostate cancer: 3.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 491.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028190 Approved Uncertain Nucleoplasm,Nucleoli NA NA 74000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm Nucleoli "HPA028190: AB_10600831" "unprognostic (2.82e-2)" "unprognostic (2.27e-1)" "unprognostic (2.91e-1)" "unprognostic (5.39e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (9.27e-4)" "unprognostic (1.93e-2)" "unprognostic (2.37e-1)" "unprognostic (4.25e-1)" "unprognostic (3.81e-2)" "unprognostic (1.75e-1)" "unprognostic (2.92e-2)" "unprognostic (1.05e-2)" "unprognostic (2.59e-2)" "unprognostic (3.52e-1)" "unprognostic (2.11e-1)" "unprognostic (1.71e-1)" 1.3 0.4 0.0 0.1 0.0 0.1 1.6 0.1 0.1 0.3 0.0 0.9 2.1 1.2 0.4 194.2 0.4 1.2 97.4 0.0 0.2 10.8 1.9 1.1 0.3 0.1 0.0 0.5 1.5 0.0 0.3 0.1 0.1 85.8 0.0 0.0 56.6 0.0 12562.8 2.1 2.5 0.1 0.0 0.3 1.3 0.5 0.1 1.6 1.4 3158.3 0.4 0.2 1.5 0.1 0.9 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.6 0.0 55.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.8 0.3 0.0 0.0 491.6 0.9 0.0 0.8 0.3 0.0 0.1 0.1 0.1 4.9 0.4 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.9 74.7 0.0 0.0 0.0 0.0 0.4 0.0 0.7 5.9 0.0 3.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 7.3 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.5 3.6 0.0 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 176.2 2.2 0.0 0.2 0.0 0.0 0.5 1.0 0.0 0.9 0.1 TNPO2 "FLJ12155, IPO3, KPNB2B, TRN2" ENSG00000105576 "Transportin 2" O14787 19 12699194-12724011 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 100.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046446, HPA071498" Approved Approved Nucleoplasm,Nucleoli Yes No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nucleoli" "CAB046446: AB_10603392, HPA071498: AB_2686405" "unprognostic (1.88e-1)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.16e-5)" "unprognostic (2.25e-1)" "unprognostic (3.64e-2)" "unprognostic (2.72e-2)" "unprognostic (6.75e-2)" "unprognostic (3.44e-1)" "unprognostic (1.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.63e-2)" "prognostic favorable (8.18e-4)" "unprognostic (2.76e-3)" "unprognostic (6.00e-2)" "unprognostic (3.50e-3)" "unprognostic (7.63e-2)" 28.3 33.0 50.3 21.7 54.4 26.8 24.8 36.7 57.3 30.9 28.2 28.4 17.3 33.3 25.5 31.3 30.3 20.5 26.6 54.6 44.1 22.5 18.4 23.0 23.4 51.3 45.4 40.3 20.6 32.3 33.6 20.9 50.9 26.6 19.8 33.0 22.2 23.9 25.7 48.1 23.4 28.1 39.5 26.3 23.5 32.7 51.5 27.8 26.8 20.1 23.9 28.6 27.6 51.2 54.4 40.5 61.0 78.3 36.3 47.6 39.5 61.0 40.1 86.5 60.6 55.9 28.5 36.6 46.5 51.7 24.1 70.5 109.2 60.3 47.9 45.6 87.6 56.5 72.1 68.4 40.9 100.6 52.0 42.9 46.8 57.5 60.4 55.8 41.0 72.7 89.4 33.9 48.5 93.4 84.8 68.8 71.0 39.8 120.8 80.7 47.6 67.0 51.2 38.9 148.6 73.8 49.6 62.2 30.7 41.2 43.5 35.2 41.5 131.5 34.9 71.3 91.2 66.8 70.4 62.3 39.2 89.9 47.9 0.2 0.2 0.1 0.6 0.3 0.9 0.4 0.4 0.5 0.4 0.4 0.8 1.0 0.8 0.1 0.4 1.5 0.2 0.2 50.3 54.4 36.7 57.3 54.6 44.1 51.3 45.4 50.9 39.5 51.5 51.2 13.2 6.4 17.9 24.2 10.7 31.0 8.9 10.6 14.8 42.4 22.8 17.1 17.6 11.5 10.0 22.0 100.1 10.9 11.0 14.1 5.9 9.7 12.2 16.2 20.6 17.0 22.9 14.9 22.3 8.5 6.6 18.0 10.2 12.9 3.8 20.7 19.2 17.8 10.5 57.2 26.6 17.7 8.2 13.0 14.9 19.5 31.1 8.7 8.8 22.5 11.1 24.6 6.2 19.6 24.7 15.2 9.1 32.4 8.7 19.3 11.9 16.7 11.3 33.6 6.6 23.8 15.3 23.8 11.3 21.9 41.5 14.5 9.5 16.5 16.6 9.3 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388525-40417896 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 127.8;testis: 65.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 4.2;white matter: 8.0" "Low region specificity" "Detected in some" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.2 2.5 0.2 20.0 0.2 42.0 5.4 0.1 0.7 5.0 1.1 17.8 18.1 3.9 0.3 29.0 1.5 2.6 1.2 0.2 0.2 1.2 2.8 4.1 40.3 0.2 0.8 1.0 0.9 0.3 0.3 15.9 0.5 1.4 19.8 0.1 4.3 0.5 0.3 15.3 17.0 7.6 0.2 9.9 8.9 65.7 1.1 127.8 1.9 0.2 42.5 6.0 9.6 0.4 212.6 275.6 343.1 158.0 16.8 33.9 76.3 283.3 151.5 255.0 224.2 130.5 157.6 339.4 140.1 96.7 152.7 326.5 266.8 113.5 339.5 182.7 177.8 224.8 167.9 216.7 1.6 318.4 228.6 7.4 9.2 179.8 181.4 55.1 136.3 216.5 247.5 225.8 279.2 72.6 372.3 209.6 143.0 152.4 108.3 310.7 531.9 141.3 61.6 133.3 201.6 144.6 229.3 281.4 89.4 198.2 236.9 143.2 90.3 167.0 233.2 195.5 276.7 128.4 154.9 290.7 94.3 214.9 285.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.1 0.1 0.0 0.0 0.1 1.4 0.1 0.0 2.4 0.4 0.2 0.2 0.1 0.7 0.2 0.2 0.2 0.8 0.5 0.2 1.1 0.4 1.0 0.0 2.0 0.3 17.4 11.7 3.7 15.0 2.2 0.0 18.7 17.1 1.3 2.8 5.8 0.0 0.0 72.9 6.1 19.8 0.0 0.8 20.3 12.7 15.8 9.3 0.0 216.8 0.2 0.0 92.4 23.3 23.0 10.0 0.0 117.5 20.7 5.4 83.5 0.0 0.1 34.2 18.3 33.9 13.2 19.1 4.7 14.1 1.8 0.0 2.6 0.0 3.1 0.0 0.1 0.3 3.5 1.9 31.3 3.1 3.4 0.1 1.8 0.0 72.3 0.5 19.5 621.2 269.6 45.1 6.1 8.9 14.8 4.3 61.0 6.9 TRAF6 RNF85 ENSG00000175104 "TNF receptor associated factor 6" Q9Y4K3 11 36483769-36510272 "Enzymes, Predicted intracellular proteins" "DNA damage, Immunity, Osteogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004605, HPA019805, HPA020599" Approved Uncertain Nucleoli,Mitochondria NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" Mitochondria Nucleoli "CAB004605: AB_628391, HPA019805: AB_1858231, HPA020599: AB_1858232" "unprognostic (2.48e-2)" "unprognostic (1.38e-1)" "unprognostic (2.83e-1)" "unprognostic (8.73e-2)" "unprognostic (1.71e-1)" "unprognostic (1.55e-1)" "unprognostic (2.43e-1)" "unprognostic (2.10e-1)" "unprognostic (1.40e-1)" "unprognostic (1.21e-1)" "unprognostic (1.16e-2)" "unprognostic (9.22e-2)" "prognostic favorable (1.36e-4)" "unprognostic (2.82e-2)" "unprognostic (1.20e-1)" "unprognostic (3.92e-2)" "unprognostic (1.07e-1)" 6.5 5.1 4.3 5.3 5.2 23.3 5.8 4.6 5.8 6.1 4.7 5.7 6.0 6.4 5.7 6.4 6.2 5.7 7.5 4.8 4.4 6.7 7.9 7.9 6.3 4.7 4.5 7.9 7.2 6.0 4.0 6.2 4.5 5.0 6.3 5.4 5.9 5.4 7.0 6.4 7.6 7.5 3.7 8.4 5.7 7.8 4.8 9.5 9.6 8.0 7.1 5.5 6.2 6.5 5.1 6.3 12.0 6.8 11.0 7.9 5.1 7.5 8.0 6.8 8.8 5.6 3.3 6.7 4.5 8.0 7.8 9.4 9.6 7.6 11.2 11.0 11.1 6.4 5.0 5.0 7.1 7.2 7.5 7.5 10.5 3.6 11.1 6.6 9.7 8.7 9.7 7.1 8.7 6.2 11.6 4.0 6.5 5.8 5.7 7.5 16.2 3.8 8.2 10.4 1.9 10.4 7.5 7.1 5.3 8.0 8.3 6.9 7.7 9.6 8.5 8.9 9.2 8.2 7.4 7.1 5.4 5.0 7.3 59.5 12.4 34.6 17.8 17.9 17.4 17.1 15.0 17.5 12.3 13.6 14.5 19.0 17.5 16.2 13.7 7.2 13.2 14.5 4.3 5.2 4.6 5.8 4.8 4.4 4.7 4.5 4.5 3.7 4.8 6.5 9.1 9.6 5.1 13.1 12.1 12.7 13.8 6.5 6.8 2.7 5.3 3.6 7.0 7.2 4.0 3.7 6.2 6.6 12.3 8.1 5.9 8.7 7.3 6.3 6.3 12.1 4.2 7.4 29.0 7.2 6.2 6.5 6.6 10.4 19.0 5.5 19.2 6.0 7.2 8.4 24.0 5.8 8.2 8.5 13.6 3.4 2.5 7.8 7.2 17.8 9.1 4.6 8.2 11.1 29.1 7.9 8.2 4.1 10.8 10.4 10.0 5.5 3.1 2.9 13.1 6.6 9.5 15.2 9.3 8.0 12.5 6.4 10.9 4.4 3.9 11.6 TRIM27 "RFP, RNF76" ENSG00000204713 "Tripartite motif containing 27" P14373 6 28903002-28923988 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Transport, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048684, HPA053408" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA048684: AB_2680493, HPA053408: AB_2682139" "unprognostic (1.57e-1)" "unprognostic (1.48e-2)" "unprognostic (2.36e-1)" "unprognostic (1.14e-2)" "unprognostic (1.70e-2)" "unprognostic (2.56e-1)" "unprognostic (2.00e-3)" "unprognostic (1.17e-2)" "unprognostic (1.01e-2)" "unprognostic (1.12e-3)" "unprognostic (4.76e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (3.50e-6)" "unprognostic (1.27e-1)" "unprognostic (1.41e-1)" "unprognostic (1.47e-1)" "prognostic favorable (2.71e-4)" 23.8 28.1 1.8 7.2 1.7 1.1 23.3 1.1 2.6 33.0 2.2 23.0 8.7 24.5 0.0 20.5 31.0 0.5 24.3 1.6 1.3 32.7 59.5 26.8 2.2 2.2 2.1 30.8 53.0 0.6 33.8 4.5 1.8 35.1 0.6 0.1 25.8 6.5 21.2 17.6 26.8 2.3 1.5 45.8 27.3 14.4 2.0 0.9 26.3 0.0 1.0 28.7 22.6 2.0 2.4 8.2 1.2 21.7 2.8 6.2 0.3 16.1 0.8 5.1 6.2 6.1 1.7 1.6 1.1 4.8 1.3 17.5 4.0 9.2 0.5 1.3 2.6 20.3 2.5 9.3 4.3 2.0 5.7 0.1 1.0 4.1 1.3 0.6 4.5 5.8 2.1 12.1 1.3 4.9 11.1 0.9 0.0 3.4 13.5 20.1 4.6 49.7 3.9 2.3 4.9 18.7 19.9 11.6 4.1 0.6 11.6 12.2 13.1 6.3 9.3 14.7 5.1 31.7 2.7 17.9 6.8 24.8 20.0 5.2 4.4 2.5 7.0 12.5 11.3 7.0 10.6 5.5 8.5 1.8 4.1 7.6 2.7 6.4 7.0 5.6 5.2 9.9 1.8 1.7 1.1 2.6 1.6 1.3 2.2 2.1 1.8 1.5 2.0 2.0 21.4 16.0 24.8 11.8 32.2 28.4 41.9 27.4 33.6 11.7 32.2 24.6 18.3 24.3 24.0 29.5 16.7 46.4 25.4 15.9 21.5 39.5 12.9 27.1 27.0 32.0 27.6 24.6 13.5 43.4 55.5 25.5 26.5 27.2 21.5 36.9 27.8 42.1 41.1 8.4 13.4 38.5 26.4 28.3 23.5 6.8 23.9 29.0 8.8 16.9 46.5 10.4 29.9 19.1 19.7 48.9 18.7 18.4 51.2 53.3 19.3 27.6 23.9 13.6 19.7 14.8 31.0 8.0 16.1 25.8 19.6 45.6 28.9 43.7 28.3 30.9 TRIM34 RNF21 ENSG00000258659 "Tripartite motif containing 34" Q9BYJ4 11 5619764-5644398 "Predicted intracellular proteins" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "B-cells: 6.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 4.6;Macrophages: 1.8;Squamous epithelial cells: 4.3;T-cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 22.9;SK-BR-3: 24.6" "Low region specificity" "Detected in all" HPA077996 Approved Nucleoli,Centrosome NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 59: Non-specific - Transcription" Centrosome Nucleoli "HPA077996: AB_2686873" "unprognostic (8.66e-3)" "unprognostic (9.94e-2)" "unprognostic (1.53e-3)" "unprognostic (1.25e-1)" "unprognostic (2.71e-1)" "unprognostic (5.88e-2)" "unprognostic (9.68e-2)" "unprognostic (1.37e-1)" "unprognostic (1.70e-1)" "unprognostic (2.74e-1)" "unprognostic (9.16e-3)" "unprognostic (8.16e-2)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (3.91e-2)" "unprognostic (3.40e-1)" "unprognostic (6.76e-2)" 5.2 8.7 1.3 9.2 1.4 2.1 6.3 1.2 1.8 5.5 1.6 6.9 7.4 5.2 6.7 4.6 5.6 6.3 2.9 1.3 1.8 5.0 5.1 8.4 12.1 2.1 1.7 8.1 3.1 3.2 2.3 9.6 1.7 4.9 7.3 0.5 7.4 4.7 1.0 6.0 7.6 6.3 1.9 13.6 6.9 2.5 1.6 6.2 4.4 2.2 12.2 6.1 4.9 2.1 3.3 1.7 0.7 0.1 7.3 11.3 22.9 5.0 14.5 12.7 12.3 1.5 11.6 11.8 2.2 6.8 9.5 5.3 0.4 10.8 6.4 15.7 0.5 6.3 0.5 0.7 3.3 7.0 4.3 11.9 9.1 6.4 2.1 9.9 16.6 10.3 0.3 0.8 6.1 1.4 6.3 3.9 0.0 4.7 1.0 9.3 0.4 0.7 7.7 9.1 0.0 0.0 0.1 24.6 3.7 2.1 4.3 3.3 13.4 3.3 0.5 1.3 1.8 1.2 1.5 4.5 9.4 0.9 1.6 11.7 18.7 4.7 6.6 20.5 7.3 15.0 6.3 8.3 20.2 16.0 7.7 6.8 19.0 8.0 18.1 10.1 12.2 10.5 1.3 1.4 1.2 1.8 1.3 1.8 2.1 1.7 1.7 1.9 1.6 2.1 0.2 0.0 0.5 0.0 6.2 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.3 0.2 1.0 0.0 1.3 0.0 0.0 0.5 1.3 4.6 0.1 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.2 0.0 0.0 4.3 0.0 0.4 2.1 0.2 0.3 0.1 TRIM41 "MGC1127, RINCK" ENSG00000146063 "Tripartite motif containing 41" Q8WV44 5 181222499-181235808 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 57.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HDLM-2: 77.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024204 Approved Supported "Nucleoli,Nuclear bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" "Nucleoli, Nuclear bodies" "HPA024204: AB_1858299" "unprognostic (1.13e-1)" "unprognostic (7.05e-2)" "unprognostic (1.23e-2)" "unprognostic (7.93e-2)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (9.56e-2)" "unprognostic (7.24e-2)" "unprognostic (8.66e-2)" "unprognostic (6.87e-2)" "unprognostic (2.21e-3)" "unprognostic (2.07e-1)" "unprognostic (5.17e-3)" "unprognostic (2.45e-3)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.22e-4)" "unprognostic (2.68e-2)" 7.9 9.6 52.7 7.5 57.8 8.1 5.8 48.3 50.8 6.9 31.3 6.6 8.4 7.6 5.8 10.1 6.4 3.2 9.4 42.2 44.1 9.5 12.2 6.2 4.9 57.3 57.3 6.0 9.9 11.7 10.9 4.1 53.2 6.8 2.7 7.0 7.6 5.6 26.1 9.8 7.2 3.5 54.5 8.2 8.8 13.2 53.8 10.1 11.7 12.7 5.2 6.8 6.7 54.7 9.3 24.0 8.7 14.6 10.1 10.0 20.6 13.3 7.2 9.6 9.0 20.4 13.8 16.0 21.4 9.1 18.0 17.3 9.1 31.9 5.2 77.8 29.2 17.8 24.9 11.7 9.7 13.3 11.8 8.8 16.1 12.0 4.2 9.3 5.6 23.8 22.7 18.8 5.3 33.8 20.0 14.7 8.3 7.0 11.3 18.7 13.2 20.9 5.5 14.7 13.5 12.7 12.3 14.3 18.7 3.8 28.7 14.8 11.7 13.1 8.9 8.0 10.3 41.2 28.1 21.9 13.7 15.3 11.3 0.2 0.3 0.6 0.6 0.3 0.9 0.5 0.6 1.1 0.4 0.6 0.6 0.8 1.0 0.6 0.7 0.7 0.9 0.4 52.7 57.8 48.3 50.8 42.2 44.1 57.3 57.3 53.2 54.5 53.8 54.7 9.1 3.2 12.4 11.4 10.1 8.0 9.5 7.5 8.0 19.1 10.5 8.9 13.2 12.8 10.0 11.0 18.8 14.6 13.6 12.3 11.7 8.5 8.0 15.8 12.9 10.4 12.7 5.9 5.2 12.1 10.0 7.5 16.8 12.4 2.5 12.3 10.4 21.0 8.8 28.6 5.3 13.1 12.2 15.1 7.3 4.0 5.3 10.1 8.8 5.6 11.8 15.0 14.4 1.5 5.8 9.9 12.3 11.7 11.1 9.5 16.0 8.0 24.1 30.4 0.0 24.4 10.7 33.2 23.7 12.3 11.2 13.0 13.6 10.2 12.6 8.3 TRIM51 "SPRYD5, TRIM51A" ENSG00000124900 "Tripartite motif-containing 51" Q9BSJ1 11 55883297-55891810 "Predicted intracellular proteins" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 50 "melanoma: 4.3" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 112 "basophil: 11.2" "Lineage enriched" "Detected in single" 112 "granulocytes: 11.2" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 61.3" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 40: Granulosa cells - Unknown function" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (9.60e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM51GP ENSG00000220948 "Tripartite motif-containing 51G, pseudogene" 11 48975324-48983826 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.1" "HPA044988, HPA077883" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 33: SK-MEL-30 - Melanocyte processes" Vesicles Nucleoli "HPA044988: AB_2679171, HPA077883: AB_2732362" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM52 RNF102 ENSG00000183718 "Tripartite motif containing 52" Q96A61 5 181254417-181261139 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "HPA054565, HPA056819" Approved Approved "Nucleoli,Intermediate filaments" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" Nucleoli "Intermediate filaments" "HPA054565: AB_2682525, HPA056819: AB_2683245" "unprognostic (1.21e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-2)" "unprognostic (5.23e-1)" "unprognostic (2.75e-1)" "unprognostic (1.10e-1)" "unprognostic (5.16e-2)" "unprognostic (3.98e-2)" "unprognostic (7.37e-2)" "unprognostic (2.71e-1)" "unprognostic (2.24e-3)" "unprognostic (7.48e-3)" "prognostic unfavorable (3.46e-4)" "unprognostic (2.96e-1)" "unprognostic (6.41e-2)" "unprognostic (1.33e-2)" "prognostic favorable (4.07e-4)" 9.3 10.0 10.8 8.6 10.9 8.7 9.0 14.0 14.4 14.2 11.0 12.2 8.1 10.1 9.1 7.0 12.3 5.5 11.0 10.9 10.8 13.7 11.6 12.1 14.2 11.4 10.5 16.0 15.6 9.2 18.9 5.9 11.6 15.2 6.6 21.5 11.5 7.0 6.7 10.0 13.1 5.3 9.6 18.7 11.0 11.6 11.4 10.8 17.3 3.9 9.7 12.0 10.8 11.7 4.3 4.9 7.8 10.0 13.8 8.7 6.9 4.6 4.1 4.4 3.8 7.1 7.7 9.3 4.9 5.0 12.0 7.8 4.2 6.2 5.1 16.0 8.9 3.6 21.4 6.0 3.3 11.0 7.9 8.7 5.1 4.7 2.7 7.2 5.3 13.5 3.8 21.3 4.6 8.1 6.1 10.0 2.7 4.8 6.3 7.1 4.2 6.4 3.7 5.6 8.8 7.1 6.6 4.7 4.4 6.8 8.8 7.4 6.5 8.8 4.6 4.2 4.4 15.5 8.1 6.3 10.0 9.5 3.5 5.8 2.2 5.2 7.1 1.9 7.9 4.9 7.5 7.8 1.8 3.5 9.2 7.5 2.3 5.1 1.9 2.4 5.5 3.3 10.8 10.9 14.0 14.4 10.9 10.8 11.4 10.5 11.6 9.6 11.4 11.7 11.9 19.2 23.6 6.5 20.5 8.8 6.5 3.1 8.0 27.8 6.7 6.7 9.4 8.6 15.0 7.3 39.6 3.7 28.1 7.2 3.9 3.5 27.2 10.3 14.4 14.0 9.0 8.6 9.5 2.5 1.1 12.6 6.6 11.8 17.7 21.2 7.9 3.5 4.2 28.6 10.5 8.3 2.0 6.0 9.7 5.4 12.8 10.3 5.4 9.4 12.5 17.3 35.0 6.6 8.1 2.3 8.1 9.4 24.9 4.5 8.1 3.4 11.6 42.9 0.0 20.3 13.3 25.2 11.0 5.5 6.1 4.2 25.9 19.0 7.8 4.1 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "A549: 4.8" HPA077996 Uncertain Nucleoli,Centrosome NA NA "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Nucleoli "HPA077996: AB_2686873" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRMT1L C1orf25 ENSG00000121486 "TRNA methyltransferase 1 like" Q7Z2T5 1 185118101-185157072 "Metabolic proteins, Predicted intracellular proteins" "Behavior, tRNA processing" "Methyltransferase, RNA-binding, Transferase, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 73.0;Spermatocytes: 103.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026728 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA026728: AB_1845641" "unprognostic (1.07e-2)" "unprognostic (1.31e-1)" "unprognostic (8.55e-3)" "unprognostic (2.96e-1)" "unprognostic (1.46e-2)" "unprognostic (8.95e-2)" "unprognostic (2.38e-1)" "unprognostic (4.41e-2)" "unprognostic (2.32e-1)" "unprognostic (2.46e-3)" "unprognostic (1.32e-1)" "unprognostic (8.75e-2)" "unprognostic (1.16e-2)" "unprognostic (7.44e-2)" "unprognostic (9.45e-2)" "unprognostic (7.87e-2)" "unprognostic (2.26e-1)" 6.8 8.6 7.8 8.4 9.1 5.7 7.6 9.7 9.7 7.9 9.1 7.7 8.5 7.3 9.4 6.9 10.6 7.0 12.1 7.6 8.4 13.1 14.5 7.4 10.8 8.7 8.2 11.4 5.0 12.1 7.0 8.2 8.9 7.6 7.2 8.9 5.6 8.1 20.8 4.8 7.0 6.9 9.1 10.6 7.2 27.7 8.2 10.2 10.4 18.7 11.9 7.0 5.5 12.3 12.4 22.3 15.1 11.3 21.8 20.0 21.5 11.7 10.5 15.7 16.4 20.4 23.1 13.5 28.5 8.1 24.0 15.6 25.7 15.3 15.4 16.1 11.2 13.0 15.9 20.9 15.2 19.3 20.6 9.6 20.3 16.1 16.1 16.6 17.5 17.9 34.5 18.0 18.9 10.5 14.7 11.2 24.9 25.3 4.6 17.1 21.7 21.6 15.2 13.5 13.4 12.0 22.8 22.0 16.2 34.2 22.4 10.7 16.9 14.3 11.4 9.9 15.8 28.7 41.5 21.3 9.4 16.8 14.0 24.0 10.6 21.9 7.5 14.7 8.1 12.3 9.9 9.3 13.3 18.1 12.3 9.7 12.3 12.8 19.2 5.5 14.2 9.2 7.8 9.1 9.7 9.7 7.6 8.4 8.7 8.2 8.9 9.1 8.2 12.3 8.2 12.8 15.6 24.2 18.0 2.7 8.1 11.6 7.4 8.7 6.9 6.5 29.5 11.5 15.1 16.5 8.4 16.3 10.0 8.9 27.4 12.2 73.0 22.4 8.9 11.7 6.1 29.0 19.8 6.0 9.9 12.0 10.7 8.2 8.8 14.5 11.0 25.0 13.0 3.3 19.6 9.2 12.2 17.5 6.2 25.0 12.5 13.7 1.8 20.6 16.3 9.6 6.2 18.6 36.8 7.6 10.9 12.0 10.7 5.9 9.6 23.9 44.2 8.6 0.0 11.0 9.6 103.8 32.0 9.7 2.4 11.4 10.7 13.6 8.3 5.3 TRMT5 "KIAA1393, TRM5" ENSG00000126814 "TRNA methyltransferase 5" Q32P41 14 60971441-60981170 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Early spermatids: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000943 Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA000943: AB_1080388" "unprognostic (1.58e-2)" "unprognostic (3.62e-2)" "unprognostic (6.63e-3)" "unprognostic (1.11e-2)" "unprognostic (7.70e-3)" "unprognostic (2.26e-2)" "unprognostic (7.82e-3)" "unprognostic (4.50e-2)" "unprognostic (3.95e-1)" "unprognostic (1.78e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (1.60e-3)" "unprognostic (1.82e-1)" "unprognostic (1.97e-2)" "unprognostic (2.10e-2)" "unprognostic (1.40e-1)" 7.3 5.5 3.5 4.4 3.8 4.8 9.8 6.0 4.1 6.5 3.1 6.7 5.7 7.0 7.8 7.6 7.4 5.1 4.2 3.4 4.6 6.9 6.8 5.0 6.0 2.5 3.4 9.9 6.7 10.5 3.5 7.0 2.8 6.9 6.0 5.2 7.6 4.8 7.5 6.7 4.5 7.0 3.1 4.7 5.8 17.3 4.0 6.1 7.2 7.2 5.8 6.7 3.9 3.8 49.7 12.5 17.9 25.0 15.5 23.6 19.4 18.2 14.0 19.1 15.2 9.8 28.7 25.2 19.9 13.3 14.3 22.3 22.9 26.4 25.0 25.3 11.5 18.6 8.1 10.2 25.1 33.2 9.9 18.3 25.1 17.4 25.4 17.0 17.0 21.6 24.5 8.8 28.3 18.7 17.1 16.8 16.4 19.4 20.3 5.4 41.5 21.4 16.3 16.7 22.1 21.6 20.2 20.1 16.6 15.4 33.5 19.7 16.1 22.1 26.7 15.7 17.5 5.3 10.8 11.6 15.6 7.2 21.0 0.1 3.2 0.7 2.4 5.5 3.3 4.9 3.4 3.5 3.0 4.1 3.8 3.4 0.3 1.4 5.9 5.2 4.5 2.5 3.5 3.8 6.0 4.1 3.4 4.6 2.5 3.4 2.8 3.1 4.0 3.8 7.0 6.4 10.9 3.9 4.5 6.4 19.5 15.9 9.6 5.7 6.3 10.0 8.0 1.5 19.6 11.0 4.2 12.8 5.7 3.2 1.9 7.7 221.8 8.2 17.4 9.2 5.4 10.7 5.4 7.5 12.4 12.4 9.7 8.1 6.3 12.1 8.6 7.0 10.9 3.3 6.7 8.3 8.2 6.2 7.6 50.2 11.1 6.0 7.2 3.7 4.1 12.2 1.0 9.0 6.3 8.2 4.8 7.5 4.7 8.2 3.9 11.1 14.9 5.4 13.1 14.7 9.5 23.3 12.6 11.1 4.3 19.2 5.2 14.4 7.6 10.6 TSEN15 C1orf19 ENSG00000198860 "TRNA splicing endonuclease subunit 15" Q8WW01 1 184051651-184123978 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029237 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 29: U-266 - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA029237: AB_10671361" "unprognostic (4.54e-1)" "unprognostic (2.29e-1)" "unprognostic (2.05e-1)" "unprognostic (1.04e-2)" "unprognostic (8.72e-3)" "unprognostic (8.04e-3)" "prognostic unfavorable (2.07e-5)" "unprognostic (1.82e-2)" "unprognostic (4.11e-2)" "prognostic favorable (4.59e-4)" "unprognostic (3.82e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.66e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (2.93e-2)" "unprognostic (2.20e-1)" 16.4 17.9 21.4 14.8 23.0 19.8 17.8 22.2 27.9 17.1 15.4 20.6 11.6 17.4 28.1 15.1 14.7 12.3 21.9 21.1 22.6 14.7 15.3 16.6 19.1 23.1 20.4 11.6 17.3 15.9 11.8 17.5 22.5 17.2 13.6 21.7 15.2 15.2 36.2 14.1 11.5 17.8 19.9 14.7 15.3 14.6 22.3 28.1 21.0 22.8 18.7 16.4 12.3 29.7 83.3 28.2 39.2 41.6 30.1 31.7 96.6 40.1 77.9 64.1 61.7 30.0 35.8 54.3 40.2 50.4 41.0 38.8 44.2 38.7 69.6 78.1 23.4 28.2 19.7 34.7 60.1 103.4 32.3 21.1 67.2 29.7 60.9 25.4 38.1 95.5 55.9 144.0 59.7 43.4 97.8 46.5 72.6 107.6 30.7 60.3 65.0 113.0 37.6 26.6 35.2 52.3 54.0 39.0 102.7 41.2 51.1 57.8 20.0 39.5 83.9 26.5 61.9 190.4 141.7 87.1 36.7 52.5 86.1 33.5 16.7 24.7 33.7 27.5 30.2 24.8 32.3 35.3 35.9 18.1 24.4 33.7 3.1 54.3 25.4 31.8 39.8 35.0 21.4 23.0 22.2 27.9 21.1 22.6 23.1 20.4 22.5 19.9 22.3 29.7 15.5 48.1 8.1 22.2 26.1 11.1 12.4 17.3 16.5 8.7 18.4 13.7 32.0 10.0 17.1 12.9 4.2 42.5 31.4 3.4 54.8 33.0 1.6 6.7 13.1 15.9 6.7 22.7 30.9 41.8 48.9 20.0 14.3 11.7 32.3 18.0 18.2 34.0 31.7 3.3 32.7 8.4 10.2 13.1 29.1 2.5 21.8 16.6 33.8 13.1 21.6 19.8 64.9 42.7 91.7 35.9 4.5 19.5 45.7 13.3 5.4 71.4 6.9 12.5 13.1 11.3 24.9 46.0 44.6 23.1 13.2 22.6 34.8 19.1 9.8 10.5 TSPYL1 TSPYL ENSG00000189241 "TSPY like 1" Q9H0U9 6 116267760-116279930 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031970 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 38: Basophils - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nucleoli" "HPA031970: AB_2674092" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.11e-2)" "unprognostic (9.99e-2)" "unprognostic (1.70e-1)" "unprognostic (3.54e-2)" "unprognostic (2.46e-1)" "unprognostic (1.04e-1)" "unprognostic (2.76e-1)" "unprognostic (9.18e-3)" "prognostic favorable (5.40e-4)" "unprognostic (5.12e-1)" "prognostic favorable (1.48e-13)" "unprognostic (1.61e-1)" "unprognostic (1.81e-1)" "unprognostic (2.34e-2)" "unprognostic (2.47e-1)" 26.5 73.8 51.1 17.1 56.4 34.4 23.4 35.2 78.2 22.5 25.5 30.8 24.4 28.4 33.0 34.0 31.4 20.5 43.3 64.9 38.1 50.4 40.9 21.4 21.4 25.9 22.2 34.9 33.3 63.9 40.1 16.0 26.0 42.0 17.7 26.1 30.2 33.9 114.9 29.4 30.0 24.3 17.1 29.5 35.5 28.9 34.6 22.3 39.6 91.9 25.6 31.4 22.7 44.5 22.2 21.5 27.3 50.3 47.2 30.9 22.7 35.2 34.7 31.3 35.8 27.7 15.9 47.3 43.0 40.8 28.2 38.5 21.6 59.8 33.2 19.4 56.0 19.1 29.9 50.8 29.8 31.9 11.2 36.2 46.0 32.5 31.2 32.9 30.3 20.7 34.3 36.1 44.2 48.9 21.5 18.9 13.6 21.3 19.8 19.1 23.5 26.3 54.9 42.9 23.7 23.6 29.2 38.8 18.0 30.6 51.0 39.1 37.3 21.2 18.7 17.2 38.7 19.8 22.7 25.2 35.1 20.3 14.1 121.0 30.1 51.5 40.5 51.0 61.4 46.4 52.4 45.4 26.1 52.2 51.1 50.0 24.1 33.2 57.7 44.9 44.8 34.0 51.1 56.4 35.2 78.2 64.9 38.1 25.9 22.2 26.0 17.1 34.6 44.5 29.4 35.3 45.9 15.7 65.2 166.1 100.6 37.6 70.6 81.0 91.7 47.5 100.0 61.5 40.5 104.8 27.1 54.8 54.2 49.3 154.6 40.8 33.0 40.5 42.0 40.4 74.6 49.7 65.4 43.9 25.5 63.1 41.3 34.9 31.7 67.5 73.9 81.3 42.4 38.7 50.5 59.3 46.8 82.1 116.0 20.2 75.5 40.2 87.2 22.5 38.3 82.6 42.2 15.6 20.2 48.8 52.5 95.5 24.1 77.0 60.3 218.9 41.4 58.1 131.5 87.6 63.5 61.9 39.8 55.5 162.0 59.7 69.1 101.3 70.2 75.8 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 7.9 8.2 3.4 8.1 4.4 7.5 12.2 3.9 4.1 7.7 3.6 7.3 5.7 9.1 8.9 9.2 9.6 5.4 8.6 3.2 6.2 7.3 7.9 6.3 9.4 3.8 3.3 11.7 8.3 10.8 4.4 8.3 4.1 6.9 8.6 5.2 8.9 5.6 9.9 8.4 5.9 9.3 3.4 8.6 6.7 12.5 4.6 7.5 9.9 8.4 11.3 9.5 7.1 8.2 43.0 20.6 13.9 10.5 11.5 23.1 6.7 17.5 14.2 26.3 22.9 31.6 25.3 37.3 15.2 26.3 27.3 21.2 22.4 27.4 38.1 17.9 27.4 42.0 10.3 43.7 21.9 40.7 21.3 15.3 24.5 32.0 34.5 12.9 24.4 9.2 59.5 10.7 23.6 17.0 32.4 14.0 25.3 18.9 21.3 21.2 29.9 32.1 20.2 24.8 11.4 16.6 14.3 13.1 16.7 16.1 16.2 9.6 20.6 16.4 18.2 19.8 30.3 15.0 4.1 41.8 17.8 31.2 17.9 0.0 4.7 0.0 9.1 10.0 10.1 9.9 10.1 9.1 10.5 9.7 12.6 9.8 0.2 9.3 7.1 4.9 9.6 5.9 3.4 4.4 3.9 4.1 3.2 6.2 3.8 3.3 4.1 3.4 4.6 8.2 6.8 9.6 10.4 19.9 10.1 5.6 9.2 7.2 8.0 5.1 6.3 4.3 8.2 4.3 8.8 0.0 4.2 13.4 4.8 2.2 7.9 10.1 18.2 5.6 6.7 8.0 7.3 6.3 27.6 9.5 12.7 8.8 7.7 5.2 12.0 12.0 3.9 4.9 7.6 3.3 33.7 4.5 2.0 8.1 4.6 2.7 8.4 4.0 5.4 27.2 6.5 5.5 1.0 32.2 66.7 5.1 4.7 7.2 6.5 7.0 2.2 4.8 12.4 6.0 6.6 9.7 6.4 28.3 11.3 7.4 5.7 6.4 8.2 9.9 7.9 6.8 TTF1 ENSG00000125482 "Transcription termination factor 1" Q15361 9 132375548-132406851 "Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "DNA replication inhibitor, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054837 Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Nucleoli" "HPA054837: AB_2682621" "unprognostic (7.07e-2)" "unprognostic (5.62e-3)" "unprognostic (9.12e-2)" "unprognostic (6.05e-2)" "unprognostic (1.66e-1)" "unprognostic (1.22e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-1)" "unprognostic (9.21e-3)" "unprognostic (3.08e-1)" "unprognostic (1.33e-1)" "unprognostic (6.95e-3)" "unprognostic (2.09e-2)" "unprognostic (5.93e-3)" "unprognostic (8.38e-2)" "unprognostic (3.44e-1)" "unprognostic (4.71e-2)" 8.0 5.0 7.0 6.2 7.7 16.7 9.6 9.0 8.3 7.4 6.7 9.6 4.7 8.5 9.0 6.4 7.3 5.3 13.3 6.9 7.3 6.6 4.2 7.0 10.5 7.0 7.1 8.6 6.6 7.0 5.0 6.5 7.1 7.9 6.6 8.6 6.1 7.4 13.6 7.1 6.5 7.1 6.8 7.9 6.5 9.6 7.1 18.9 10.4 10.3 10.0 7.9 6.9 8.3 12.5 11.5 16.4 14.8 9.0 11.5 14.7 14.1 10.7 16.2 12.0 11.8 13.2 20.9 11.5 10.6 18.3 29.7 18.5 10.8 17.1 13.9 12.6 9.6 17.2 9.5 9.1 25.6 14.9 7.1 12.0 13.8 10.5 13.1 14.0 34.1 19.3 17.5 12.7 19.0 59.8 15.5 30.0 22.3 16.8 37.1 22.8 24.9 13.1 10.1 14.4 24.8 19.8 14.4 10.7 15.3 17.9 13.7 13.2 25.0 15.8 21.8 16.8 8.2 24.8 25.0 14.7 20.6 25.1 17.0 5.8 12.0 6.6 6.0 8.6 13.6 8.4 7.8 3.6 12.2 9.3 7.0 20.9 8.2 7.4 11.2 9.6 3.3 7.0 7.7 9.0 8.3 6.9 7.3 7.0 7.1 7.1 6.8 7.1 8.3 26.8 25.6 21.6 12.7 35.4 9.8 21.9 26.9 7.4 27.2 11.8 15.5 40.1 25.8 18.3 18.4 60.5 23.8 33.2 14.8 19.6 28.5 22.9 26.2 21.4 29.5 12.1 68.0 12.4 21.2 22.8 17.5 15.3 16.8 22.8 28.8 27.5 8.3 18.7 30.3 10.6 15.4 20.3 22.0 12.1 6.8 23.6 17.4 1.8 14.0 30.1 20.3 41.2 9.5 19.2 25.3 18.6 25.9 14.3 22.8 16.5 19.3 29.2 55.0 26.3 21.9 24.1 47.4 61.8 7.5 8.5 25.2 28.2 16.8 19.7 24.5 TTK "CT96, MPH1, MPS1, MPS1L1" ENSG00000112742 "TTK protein kinase" P33981 6 80003887-80042527 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3" "Cell type enhanced" "Detected in many" "Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "T-reg: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB010166, CAB013229" Enhanced Approved Nucleoli,Cytosol NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "CAB010166: AB_632567, CAB013229: AB_2533230" "unprognostic (4.27e-2)" "unprognostic (8.71e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (1.44e-5)" "unprognostic (7.97e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (3.84e-10)" "unprognostic (1.56e-3)" "unprognostic (7.95e-2)" "unprognostic (2.02e-3)" "prognostic unfavorable (2.54e-4)" "unprognostic (1.54e-1)" "unprognostic (0.00e+0)" "unprognostic (3.51e-2)" "unprognostic (1.06e-1)" "unprognostic (1.46e-1)" "unprognostic (1.66e-1)" 0.7 0.8 0.0 4.2 0.1 25.3 2.2 0.1 0.3 0.7 0.0 4.8 4.0 1.0 0.1 4.8 0.6 0.5 0.1 0.1 0.1 0.2 0.5 0.8 8.1 0.2 0.1 0.2 0.2 0.3 0.0 3.9 0.2 0.8 5.9 1.8 0.7 0.1 0.0 3.6 4.1 1.7 0.1 1.4 3.3 34.3 0.2 46.6 0.4 0.1 9.0 1.2 1.4 0.2 39.9 23.4 68.2 56.4 3.1 9.5 38.5 44.9 27.4 64.2 77.8 32.1 29.6 58.5 34.1 19.5 66.9 50.0 60.7 27.6 88.6 53.4 49.3 54.1 29.4 26.5 0.2 64.4 33.9 1.2 2.8 45.0 28.6 9.6 36.9 80.6 60.2 58.5 55.2 29.5 37.0 46.4 40.4 35.4 27.9 32.7 124.4 24.4 16.3 25.2 46.8 27.4 26.6 28.3 16.3 36.6 26.6 48.3 15.4 28.8 28.5 18.8 72.9 13.1 47.1 32.4 10.3 58.9 25.1 0.0 0.0 0.3 0.1 0.0 0.1 0.2 0.2 0.4 0.0 0.7 0.0 0.1 0.0 0.3 0.0 0.0 1.2 0.2 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.3 3.2 1.1 0.0 1.4 1.3 0.6 2.6 0.0 0.2 0.9 0.5 0.6 0.0 2.3 0.0 2.1 9.8 0.8 2.2 3.9 0.4 43.3 3.1 1.6 1.1 1.8 23.1 0.2 0.2 15.0 2.1 2.6 2.3 1.3 13.9 0.7 0.2 6.5 0.0 0.2 3.0 4.1 2.6 1.2 21.4 0.9 1.9 0.0 0.0 5.2 0.2 1.0 0.0 0.1 0.6 0.2 0.7 5.1 0.4 0.3 0.1 3.0 1.6 6.6 0.1 1.7 130.5 33.0 8.5 0.3 3.7 1.1 0.5 5.6 1.6 TTLL1 C22orf7 ENSG00000100271 "Tubulin tyrosine ligase like 1" O95922 22 43039516-43089419 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 39.9;Spermatogonia: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048392 Approved Approved Nucleoli,Mitochondria No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli Mitochondria "HPA048392: AB_2680384" "unprognostic (1.02e-1)" "unprognostic (4.06e-3)" "unprognostic (1.51e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.18e-3)" "unprognostic (4.27e-3)" "prognostic unfavorable (2.34e-5)" "unprognostic (8.22e-2)" "unprognostic (2.16e-2)" "unprognostic (3.29e-1)" "unprognostic (4.47e-3)" "unprognostic (1.82e-1)" "prognostic favorable (1.68e-4)" "unprognostic (1.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.03e-1)" "unprognostic (3.38e-2)" 4.0 7.2 9.9 2.7 10.0 2.2 4.6 10.0 12.1 4.9 6.9 5.2 1.8 5.8 8.1 3.8 9.8 3.9 8.5 11.0 10.1 5.3 1.7 3.8 3.8 7.6 8.3 5.4 3.6 5.9 9.7 2.7 8.3 4.9 3.1 11.3 4.7 3.8 3.4 4.8 3.1 4.0 7.8 3.2 4.0 13.5 10.7 5.6 7.0 3.7 3.4 4.6 4.8 8.8 0.9 0.8 17.5 12.3 18.8 17.1 0.5 5.8 6.5 3.3 5.6 0.0 2.6 1.0 3.5 10.6 1.8 0.6 1.5 1.5 3.4 1.4 2.7 1.7 0.6 1.6 13.3 4.5 2.2 13.5 21.8 2.0 5.4 14.3 10.7 14.2 0.5 10.8 12.3 5.5 4.3 7.4 2.2 4.6 1.2 9.3 9.2 0.2 6.1 1.5 4.0 8.2 4.6 2.4 16.0 9.1 6.3 7.4 10.1 3.4 2.3 7.7 0.8 3.6 0.7 0.5 9.1 8.2 6.2 4.7 5.5 6.7 10.6 5.9 11.2 2.7 9.8 12.3 9.8 4.5 8.4 10.5 1.2 10.5 4.8 6.5 6.4 5.7 9.9 10.0 10.0 12.1 11.0 10.1 7.6 8.3 8.3 7.8 10.7 8.8 3.8 0.0 2.7 3.9 1.5 2.3 2.4 5.9 2.8 5.1 6.2 7.2 5.0 1.5 5.6 1.8 6.2 2.7 3.4 1.1 15.6 7.3 39.9 12.8 6.6 4.1 0.0 2.1 8.8 4.9 1.3 5.9 3.6 4.1 1.3 9.2 5.7 0.3 4.9 5.0 9.0 3.0 16.2 4.0 2.2 18.2 4.1 2.4 8.8 3.7 4.4 6.4 7.2 4.0 3.8 4.5 6.6 6.0 0.5 2.4 0.6 7.2 20.0 11.5 6.6 5.6 3.7 10.7 32.6 4.8 2.7 0.7 5.9 5.5 1.8 2.2 TTLL2 "C6orf104, dJ366N23.3, NYD-TSPG" ENSG00000120440 "Tubulin tyrosine ligase like 2" Q9BWV7 6 167325071-167359503 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 18.4" "Group enriched" "Detected in some" 184 "Early spermatids: 389.3;Late spermatids: 274.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "CACO-2: 1.9" "Not detected" "Not detected" HPA027985 Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 39: CACO-2 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Nuclear membrane, Nucleoli" "HPA027985: AB_2211832" "unprognostic (5.98e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-1)" "unprognostic (6.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.79e-1)" "unprognostic (5.29e-2)" "unprognostic (9.47e-4)" "unprognostic (7.57e-2)" "unprognostic (2.63e-4)" "unprognostic (3.50e-2)" "unprognostic (2.39e-1)" "unprognostic (8.14e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-2)" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 1.6 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 18.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 389.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 274.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TUB rd5 ENSG00000166402 "TUB bipartite transcription factor" P50607 11 8019244-8106243 "Disease related genes, Predicted intracellular proteins" "Phagocytosis, Sensory transduction" Obesity "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 79.1;retina: 82.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Excitatory neurons: 34.6;Horizontal cells: 30.3;Inhibitory neurons: 23.2;Oligodendrocyte precursor cells: 23.1;Rod photoreceptor cells: 55.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 26.8;HEK 293: 33.7;HeLa: 54.3;SCLC-21H: 51.0;SH-SY5Y: 38.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017997, HPA049019" Enhanced Approved "Nucleoli,Centriolar satellite" "Intracellular and membrane" NA NA "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" "Centriolar satellite" Nucleoli "HPA017997: AB_1858449, HPA049019: AB_2680601" "unprognostic (2.53e-1)" "unprognostic (7.23e-2)" "unprognostic (1.80e-2)" "unprognostic (4.06e-2)" "unprognostic (9.62e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-2)" "unprognostic (2.53e-1)" "unprognostic (9.71e-2)" "unprognostic (5.08e-2)" "prognostic favorable (2.85e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.35e-5)" "unprognostic (8.37e-3)" "unprognostic (1.61e-1)" "unprognostic (1.41e-1)" "unprognostic (1.39e-2)" 7.1 17.3 25.5 2.5 26.2 0.2 6.6 14.4 25.1 26.5 2.5 8.1 2.0 24.4 10.3 3.2 19.8 4.7 12.6 35.9 31.4 11.4 0.9 3.9 1.9 18.6 79.1 18.2 4.6 13.7 31.7 4.3 30.8 8.6 2.3 82.6 5.3 8.1 2.9 6.4 3.9 11.3 18.0 1.7 3.7 5.0 27.5 2.5 10.8 8.2 0.9 11.0 13.9 16.4 0.0 9.8 14.2 16.7 13.2 4.3 0.0 9.4 2.5 9.9 13.2 0.0 0.1 0.0 0.8 13.2 4.6 0.1 26.8 2.0 9.2 0.0 33.7 0.0 54.3 6.1 2.2 0.0 0.4 6.8 2.4 4.7 0.0 0.8 0.9 15.7 0.0 0.1 4.8 1.4 0.1 0.1 9.4 0.0 0.1 12.6 0.2 0.0 0.0 0.5 51.0 38.1 6.9 0.1 2.6 6.3 1.4 0.2 0.0 5.4 12.5 0.9 3.9 0.1 0.0 0.0 4.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 26.2 14.4 25.1 35.9 31.4 18.6 79.1 30.8 18.0 27.5 16.4 0.5 0.0 0.0 15.0 0.0 0.8 2.0 0.1 1.2 15.5 0.8 1.9 3.5 1.5 0.7 0.0 41.7 0.2 0.1 0.0 5.9 0.1 4.2 4.4 14.1 0.5 1.8 0.0 34.6 0.0 0.4 6.8 0.0 0.4 1.3 10.1 1.4 0.2 0.2 30.3 23.2 0.0 0.0 0.0 0.7 4.9 14.6 0.2 1.8 8.4 0.0 12.6 0.0 23.1 1.9 0.0 0.0 14.7 0.1 1.5 0.0 10.2 5.1 55.6 0.0 6.8 1.5 1.6 1.4 0.2 0.9 0.0 0.5 0.5 0.0 0.4 TUT4 "KIAA0191, PAPD3, TENT3A, ZCCHC11" ENSG00000134744 "Terminal uridylyl transferase 4" Q5TAX3 1 52408282-52553487 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "RNA-mediated gene silencing" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 52.2;Cytotrophoblasts: 53.6;dendritic cells: 64.9;Endometrial ciliated cells: 59.5;Endometrial stromal cells: 96.1;Granulosa cells: 70.7;Theca cells: 57.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027412, HPA027973" Supported Supported Nucleoli,Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoli "HPA027412: AB_1852281, HPA027973: AB_10603242" "unprognostic (2.74e-2)" "unprognostic (1.67e-2)" "unprognostic (1.19e-2)" "unprognostic (3.48e-2)" "unprognostic (1.36e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (9.00e-4)" "unprognostic (2.64e-1)" "unprognostic (5.05e-2)" "unprognostic (3.84e-1)" "unprognostic (6.57e-3)" "unprognostic (3.11e-2)" "unprognostic (5.35e-3)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (7.08e-2)" "unprognostic (2.33e-1)" 22.5 34.4 28.4 18.3 28.6 26.6 21.4 44.7 36.2 34.1 28.6 26.3 8.7 27.4 23.7 19.3 30.8 15.4 27.1 26.8 35.3 22.9 31.3 22.1 34.2 28.5 29.4 46.3 31.2 29.5 41.5 21.2 28.5 26.1 11.2 84.9 20.7 16.5 60.0 35.1 30.9 15.9 26.4 35.0 22.3 46.9 33.4 32.5 31.4 30.0 29.4 23.1 26.5 33.5 24.4 22.7 55.3 37.3 21.1 27.1 36.4 20.0 31.0 30.3 34.9 23.6 12.5 50.6 23.0 30.0 49.1 19.7 41.6 22.6 38.7 39.7 36.5 53.7 30.0 49.7 35.0 59.4 29.1 31.9 49.4 32.6 40.0 38.6 21.4 35.7 44.7 25.6 25.7 0.3 60.1 42.7 39.8 12.5 27.5 51.3 55.3 39.3 33.4 20.0 28.7 26.8 31.8 14.1 32.9 62.3 19.4 31.5 18.1 23.2 30.6 21.1 26.2 52.7 74.0 71.8 15.5 32.0 17.0 83.7 9.7 34.8 26.1 4.0 19.3 49.0 27.3 21.6 5.1 50.2 33.1 22.0 37.6 25.3 3.7 61.9 23.3 5.1 28.4 28.6 44.7 36.2 26.8 35.3 28.5 29.4 28.5 26.4 33.4 33.5 52.2 0.0 0.0 0.0 36.0 0.0 0.0 0.0 0.0 0.0 36.1 41.4 0.0 0.0 0.0 47.8 0.0 53.6 64.9 0.0 15.6 28.5 0.0 59.5 96.1 14.3 0.0 0.0 0.0 17.0 19.1 18.8 0.0 46.7 0.0 70.7 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 9.8 0.0 0.0 0.0 0.0 19.6 0.0 0.0 30.2 0.0 0.0 22.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 36.9 28.2 57.3 0.0 0.0 TWIST2 "bHLHa39, Dermo-1, DERMO1" ENSG00000233608 "Twist family bHLH transcription factor 2" Q8WVJ9 2 238848032-238910534 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 83.0" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 95.4;Fibroblasts: 58.9;Leydig cells: 48.1;Peritubular cells: 39.1;Theca cells: 23.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 24 "eosinophil: 4.6" "Lineage enriched" "Detected in single" 47 "granulocytes: 4.6" "Cell line enhanced" "Detected in many" "ASC diff: 80.0;ASC TERT1: 50.5;BJ: 69.3;BJ hTERT+: 212.4;fHDF/TERT166: 97.4;U-2197: 81.3" "Low region specificity" "Detected in single" HPA062870 Supported Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Nucleoplasm Nucleoli "HPA062870: AB_2684888" "unprognostic (1.62e-2)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.81e-2)" "unprognostic (2.53e-4)" "unprognostic (1.83e-2)" "unprognostic (4.06e-2)" "unprognostic (1.13e-2)" "unprognostic (2.75e-2)" "unprognostic (2.33e-1)" "unprognostic (2.24e-1)" "unprognostic (1.17e-1)" "unprognostic (2.40e-9)" "unprognostic (1.59e-2)" "unprognostic (2.06e-1)" "unprognostic (1.98e-2)" "unprognostic (4.48e-2)" 59.7 4.0 0.3 1.4 0.3 0.4 43.3 0.3 0.5 83.0 0.6 22.9 0.3 31.3 0.7 10.1 30.4 1.7 10.8 0.4 0.3 1.8 0.7 9.3 0.3 0.4 0.8 39.9 1.8 0.1 8.3 3.1 0.4 25.7 1.1 0.0 7.9 3.7 1.8 33.5 8.9 2.9 0.4 2.3 10.3 1.9 0.3 0.1 8.2 1.0 0.4 21.3 54.2 0.5 0.1 4.5 0.4 0.0 80.0 50.5 0.1 69.3 212.4 31.0 46.4 0.0 0.0 0.0 2.1 97.4 2.5 0.5 0.7 5.4 22.5 0.0 7.3 0.0 4.0 0.2 13.7 0.0 1.6 11.8 2.9 15.0 12.5 3.7 4.2 0.0 0.0 0.0 4.2 0.0 0.0 0.0 3.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.7 0.0 0.9 11.8 1.2 2.2 81.3 0.8 0.0 0.0 0.0 0.3 2.1 4.3 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.5 0.4 0.3 0.4 0.8 0.4 0.4 0.3 0.5 2.5 0.0 2.6 0.0 0.1 2.0 16.0 0.0 7.4 0.0 0.5 0.4 0.6 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.4 3.6 95.4 1.3 0.0 0.0 4.4 0.0 1.9 58.9 0.0 2.1 1.3 0.5 2.9 0.1 2.2 0.0 0.2 0.0 0.0 0.0 3.6 1.2 48.1 0.8 1.8 12.2 0.4 0.0 8.2 0.5 0.1 0.1 0.0 39.1 0.0 20.5 0.0 0.0 0.0 0.0 0.0 1.1 9.6 0.5 3.3 0.2 1.7 1.6 1.6 23.2 0.0 3.7 UBE2I UBC9 ENSG00000103275 "Ubiquitin conjugating enzyme E2 I" P63279 16 1308880-1327018 "Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003909, CAB009021, CAB079920" Approved Supported Nucleoplasm,Nucleoli NA NA 130000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 14: REH - Unknown function" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529" "unprognostic (2.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.55e-2)" "unprognostic (3.51e-1)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (2.88e-3)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (7.60e-3)" "unprognostic (3.56e-1)" "unprognostic (7.28e-2)" "unprognostic (9.30e-2)" "unprognostic (1.57e-1)" "prognostic favorable (5.68e-4)" "unprognostic (1.15e-3)" 62.5 76.3 42.5 60.3 44.0 81.6 62.0 46.1 49.3 64.7 37.1 63.8 45.1 72.7 48.7 74.2 67.3 34.3 68.2 45.2 45.2 63.4 40.8 53.1 76.0 39.3 42.3 93.1 49.1 72.0 61.6 58.1 40.2 53.4 47.3 31.7 56.4 46.7 58.0 68.0 61.1 53.8 42.2 71.9 52.9 47.6 47.1 110.3 53.2 57.0 89.3 66.6 63.1 42.1 121.3 161.1 269.0 157.7 112.7 135.8 114.4 170.0 121.7 154.3 152.9 191.8 190.1 208.2 137.7 148.1 140.7 142.4 193.2 159.2 197.9 151.2 133.4 130.6 136.6 188.4 178.6 194.9 148.0 127.1 100.7 152.1 180.0 149.0 170.0 169.9 190.3 124.3 148.0 254.4 349.6 193.0 219.0 136.0 118.5 434.0 170.9 238.4 145.7 106.6 150.3 159.8 149.3 164.1 177.7 152.8 167.5 234.4 139.4 149.2 172.6 134.0 155.5 132.1 170.4 423.4 85.3 142.9 164.7 278.7 214.3 327.1 165.9 256.6 200.9 297.8 167.8 170.3 214.7 241.1 148.2 149.6 149.5 202.6 249.5 186.3 196.5 260.9 42.5 44.0 46.1 49.3 45.2 45.2 39.3 42.3 40.2 42.2 47.1 42.1 109.5 51.3 67.0 16.3 172.8 178.6 186.4 275.6 97.3 64.6 101.9 105.7 89.1 84.4 140.9 62.5 50.1 312.8 153.9 77.4 105.7 211.9 64.4 66.6 100.6 118.3 102.3 127.4 17.2 148.2 293.1 134.4 55.5 104.6 109.5 149.7 94.2 43.7 213.5 47.1 16.8 97.1 162.8 104.8 182.1 37.8 129.8 124.8 128.1 15.9 220.2 104.7 209.1 16.6 26.7 212.3 91.8 107.6 144.1 294.8 90.4 117.7 65.7 63.1 78.9 82.1 185.4 139.6 145.7 158.4 206.7 418.1 144.7 134.9 134.7 304.5 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 2.3 3.7 6.6 10.4 6.5 28.7 4.5 5.8 13.7 4.1 5.0 13.1 8.7 4.5 4.4 10.6 3.3 2.5 11.3 6.8 7.4 3.5 3.2 3.0 19.0 6.5 6.6 1.0 0.7 4.4 3.0 10.1 6.9 2.1 15.5 2.5 2.7 3.1 17.2 5.3 8.2 9.4 6.0 6.2 4.7 19.3 6.7 47.1 2.9 13.0 18.6 6.3 5.0 6.1 123.3 111.6 167.1 79.8 15.4 27.9 94.2 130.2 72.8 146.0 102.6 79.9 147.1 140.4 50.0 47.0 108.4 98.6 154.1 76.7 131.2 128.1 87.2 85.6 54.0 93.8 6.9 105.2 102.0 9.8 18.1 114.0 47.2 34.3 85.8 157.4 111.0 114.0 116.4 113.3 190.8 135.1 65.4 126.9 57.4 145.0 176.2 122.9 57.1 58.1 131.3 132.8 90.2 112.1 44.8 49.8 117.1 64.6 41.8 65.7 104.6 116.1 159.6 57.8 120.1 182.9 64.5 107.0 139.1 0.0 0.7 1.7 3.3 2.3 2.5 8.5 4.5 3.3 1.7 6.6 6.4 7.1 0.0 1.2 8.9 3.4 10.8 2.4 6.6 6.5 5.8 13.7 6.8 7.4 6.5 6.6 6.9 6.0 6.7 6.1 1.9 0.0 2.2 1.3 13.3 14.3 10.4 29.9 2.8 6.4 6.3 8.6 12.8 0.0 12.1 5.5 0.0 74.5 5.4 10.1 5.9 10.9 24.4 15.7 7.6 5.3 1.2 134.3 8.3 7.5 103.4 11.8 10.7 6.7 8.8 32.2 3.9 2.4 27.7 10.1 6.1 14.4 32.6 1.9 5.4 8.2 3.1 5.8 3.6 1.9 2.6 1.6 0.0 1.0 1.4 10.3 2.9 4.1 32.1 5.2 3.3 12.2 16.2 1.2 6.6 0.8 11.3 114.1 113.1 15.5 10.9 22.4 9.3 12.1 30.5 11.3 UBFD1 "FLJ38870, FLJ42145, UBPH" ENSG00000103353 "Ubiquitin family domain containing 1" O14562 16 23557721-23574389 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Cell type enhanced" "Detected in many" "Late spermatids: 76.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051746 Approved Nucleoplasm,Nucleoli NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA051746: AB_2681587" "unprognostic (2.70e-2)" "unprognostic (1.84e-1)" "unprognostic (9.45e-3)" "unprognostic (2.31e-2)" "unprognostic (1.47e-1)" "unprognostic (4.91e-2)" "unprognostic (2.86e-3)" "unprognostic (1.63e-1)" "unprognostic (2.17e-1)" "unprognostic (3.86e-1)" "unprognostic (8.28e-2)" "unprognostic (8.06e-2)" "unprognostic (6.20e-3)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "unprognostic (3.13e-1)" "unprognostic (1.46e-1)" 12.8 20.7 18.8 11.9 18.3 10.8 12.7 16.6 19.0 13.7 25.0 13.6 7.4 17.1 18.3 13.1 17.3 12.0 20.7 18.4 24.3 15.5 17.0 9.9 12.4 20.1 21.2 17.4 13.5 25.2 19.6 18.0 26.2 15.4 11.7 10.7 12.4 15.2 81.2 10.6 9.6 18.8 16.5 11.1 10.7 26.0 21.9 21.0 17.7 39.0 15.7 13.4 11.1 16.7 17.1 40.0 55.0 40.0 62.3 76.9 48.8 45.8 44.2 42.3 39.1 29.9 30.1 39.3 68.5 66.9 28.5 23.6 88.4 36.1 53.9 57.1 47.3 20.8 34.0 66.3 33.2 21.9 34.7 55.1 26.5 41.3 38.4 64.9 41.4 31.1 47.6 20.7 47.1 37.4 30.9 39.5 118.0 29.2 17.2 53.6 33.7 33.0 39.5 14.9 53.5 47.6 17.6 34.3 31.8 52.7 47.1 31.6 43.1 23.3 26.1 25.7 27.2 25.0 29.8 23.6 43.0 25.3 36.6 0.0 0.5 0.5 1.4 0.7 0.7 0.6 0.9 1.3 1.1 1.3 0.5 0.8 0.0 1.2 0.3 1.5 0.8 0.4 18.8 18.3 16.6 19.0 18.4 24.3 20.1 21.2 26.2 16.5 21.9 16.7 10.0 6.4 2.6 10.1 6.8 8.8 10.2 10.3 13.1 11.6 16.5 13.8 35.1 8.6 6.6 20.2 22.9 19.2 14.9 8.1 15.6 13.0 49.3 20.7 29.4 11.6 7.2 10.3 14.6 11.5 27.2 17.2 7.1 20.6 0.0 26.4 5.3 19.0 13.4 6.7 12.3 10.2 2.0 6.6 5.1 76.1 18.6 6.6 10.6 7.5 10.7 11.0 6.2 5.0 9.8 8.8 8.9 9.8 9.8 20.4 4.8 18.3 8.8 14.9 26.3 17.1 19.2 21.3 21.7 14.0 14.2 36.0 8.3 22.2 9.3 14.8 UBR3 "DKFZp434P117, FLJ37422, KIAA2024, ZNF650" ENSG00000144357 "Ubiquitin protein ligase E3 component n-recognin 3" Q6ZT12 2 169827454-170084131 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 71.2;tongue: 87.1" "Cell type enhanced" "Detected in all" "Astrocytes: 162.6;Excitatory neurons: 305.1;Inhibitory neurons: 302.0;Oligodendrocyte precursor cells: 232.2;Oligodendrocytes: 288.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035390 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nucleoli" "HPA035390: AB_10670699" "unprognostic (1.35e-2)" "unprognostic (1.24e-1)" "unprognostic (1.59e-2)" "unprognostic (1.27e-1)" "unprognostic (2.07e-2)" "unprognostic (1.24e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.26e-1)" "unprognostic (3.19e-2)" "unprognostic (5.56e-2)" "unprognostic (2.01e-1)" "unprognostic (3.38e-1)" "unprognostic (2.18e-1)" 14.2 12.4 4.4 7.7 5.8 7.4 9.2 5.9 8.5 10.9 2.8 8.8 8.1 10.1 6.9 12.8 8.4 9.3 29.4 8.0 3.3 15.2 21.0 8.8 7.2 2.4 2.7 10.2 11.9 21.5 2.1 8.7 3.3 13.1 8.5 21.2 11.5 10.3 71.2 9.2 7.5 11.1 3.2 8.8 9.3 9.7 3.4 9.5 17.9 87.1 7.3 11.0 2.3 8.4 14.8 12.4 12.9 17.1 25.0 19.7 10.8 26.1 15.0 14.7 11.8 19.1 9.1 16.7 22.2 20.5 12.0 19.0 15.5 13.2 18.2 17.4 13.4 61.1 12.6 20.3 12.4 20.4 18.9 11.9 12.1 19.3 12.9 11.7 14.8 8.3 32.4 17.6 25.6 14.0 13.3 10.0 10.1 14.9 10.2 12.6 21.1 17.8 10.5 20.5 25.1 13.7 18.4 16.7 10.6 10.2 10.9 11.4 18.9 22.1 9.0 17.5 16.7 14.2 11.9 15.1 18.2 11.8 12.5 0.0 0.6 0.5 0.9 0.6 1.3 0.6 0.5 0.8 0.9 0.3 0.9 1.2 0.6 0.8 0.5 0.7 1.0 0.4 4.4 5.8 5.9 8.5 8.0 3.3 2.4 2.7 3.3 3.2 3.4 8.4 19.0 44.8 26.9 162.6 16.3 25.9 12.4 14.8 20.5 46.3 15.8 8.9 109.7 17.2 20.0 12.9 81.3 19.7 22.9 17.1 3.9 8.7 7.6 16.8 21.9 26.4 16.7 24.4 305.1 11.0 8.4 22.2 23.4 22.0 16.5 22.7 30.4 39.0 10.2 63.9 302.0 11.3 22.4 20.9 18.7 10.2 25.7 18.7 16.0 110.5 18.7 61.7 14.4 232.2 288.0 10.7 15.0 19.2 21.3 20.9 15.3 10.0 13.4 51.5 26.3 29.0 21.8 12.4 8.6 22.9 29.0 23.0 18.1 17.3 13.2 17.2 UBXN11 "SOC, SOCI, UBXD5" ENSG00000158062 "UBX domain protein 11" Q5T124 1 26281328-26318363 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 131.1;Late spermatids: 327.4;Respiratory ciliated cells: 121.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 93.2;intermediate monocyte: 82.6;myeloid DC: 48.4;non-classical monocyte: 72.2" "Group enriched" "Detected in all" 4 "dendritic cells: 48.4;monocytes: 93.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028600, HPA031357" Approved Approved Nucleoli,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoli, Cytosol" "HPA028600: AB_10604001, HPA031357: AB_2673840" "unprognostic (1.78e-3)" "prognostic favorable (2.54e-5)" "unprognostic (8.18e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.53e-1)" "prognostic favorable (4.90e-4)" "prognostic unfavorable (5.90e-6)" "unprognostic (8.41e-2)" "unprognostic (2.70e-1)" "unprognostic (4.41e-2)" "unprognostic (1.79e-3)" "unprognostic (1.89e-2)" "unprognostic (5.59e-3)" "unprognostic (5.00e-2)" "unprognostic (2.20e-1)" "unprognostic (3.25e-1)" "unprognostic (1.31e-2)" 10.5 10.8 23.2 9.5 25.2 19.3 10.6 17.8 35.1 11.6 45.1 8.4 3.4 9.5 14.7 6.2 31.2 5.1 11.0 26.8 23.9 19.1 7.8 17.7 8.0 25.3 27.9 13.4 11.1 8.0 31.3 4.3 22.0 11.5 2.7 15.0 9.4 6.5 5.6 7.6 8.0 4.1 24.3 21.8 8.8 48.4 25.0 6.8 25.1 3.4 3.9 8.5 7.5 20.1 26.4 11.7 5.7 11.6 4.1 3.1 19.7 5.7 8.8 15.6 11.3 4.6 22.8 15.3 8.5 3.6 10.3 14.0 3.5 9.3 3.9 7.7 13.6 2.6 18.1 11.5 7.2 11.2 5.0 4.7 9.9 26.3 6.7 4.9 4.3 11.1 10.2 10.3 5.4 11.8 6.4 5.4 11.5 7.4 8.8 13.1 4.2 13.8 8.7 3.8 26.9 6.3 14.1 13.1 10.2 2.9 10.3 10.7 4.2 8.9 13.4 13.4 8.7 9.7 29.8 17.7 11.0 15.4 7.5 2.2 93.2 4.6 9.0 82.6 11.4 12.7 13.6 10.8 48.4 16.2 15.2 9.7 6.8 6.1 72.2 7.5 12.5 41.7 23.2 25.2 17.8 35.1 26.8 23.9 25.3 27.9 22.0 24.3 25.0 20.1 4.3 0.0 1.1 5.5 18.8 21.4 15.7 23.4 5.2 11.9 13.2 15.5 1.3 5.7 16.2 23.9 22.9 9.9 10.0 5.5 13.7 14.7 131.1 78.6 9.2 5.1 9.0 6.7 7.0 8.7 20.8 10.0 17.9 8.3 10.2 11.9 6.1 3.0 20.9 23.5 5.1 5.9 18.3 62.4 35.3 327.4 12.8 59.9 10.6 2.8 41.9 24.2 12.3 2.0 1.6 7.6 2.5 10.1 9.5 9.8 1.2 26.7 121.2 54.9 19.7 6.6 11.5 26.1 24.0 5.1 13.4 7.3 23.7 8.7 8.3 12.1 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531264 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050969, HPA070526" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA050969: AB_2681294, HPA070526: " "unprognostic (2.20e-1)" "prognostic favorable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 21.5 25.3 40.3 10.2 41.2 16.4 20.4 40.5 45.2 21.2 37.0 26.0 11.8 20.2 18.7 21.2 19.9 12.2 28.1 38.1 39.2 29.3 52.7 17.2 15.1 41.6 41.4 22.2 29.8 22.6 24.2 14.3 40.0 26.9 9.3 13.5 25.6 17.3 43.9 19.1 18.0 11.2 40.7 20.9 24.9 20.4 42.1 17.5 23.4 26.8 11.5 20.9 17.2 40.9 13.9 30.0 33.9 43.8 23.6 16.7 28.9 22.0 32.1 37.0 28.0 30.1 12.4 15.0 12.9 26.4 28.9 26.3 31.9 28.0 15.8 27.7 29.8 14.0 46.3 19.2 33.6 23.2 19.9 18.8 25.8 29.9 21.6 22.4 23.0 36.3 17.9 11.2 27.6 55.2 31.9 11.8 40.4 27.0 29.6 30.1 52.5 25.1 24.1 13.0 45.7 28.9 31.8 23.9 34.3 15.4 46.6 13.5 17.1 40.9 20.7 25.7 21.7 22.7 31.3 19.4 20.3 16.0 29.1 2.1 5.5 9.0 7.3 7.2 9.8 7.4 8.5 6.4 5.2 8.0 11.3 5.6 3.6 7.0 2.6 5.9 12.0 5.6 40.3 41.2 40.5 45.2 38.1 39.2 41.6 41.4 40.0 40.7 42.1 40.9 13.6 16.0 5.0 7.8 12.4 14.3 10.3 9.9 12.5 18.0 16.2 20.1 14.0 4.3 6.2 14.7 8.4 33.8 12.0 20.4 29.4 22.7 21.9 9.0 10.2 14.3 12.1 3.0 4.7 26.2 17.5 15.7 6.6 9.2 2.5 16.2 13.2 20.5 26.4 26.9 6.1 11.6 16.2 10.0 13.4 33.3 17.7 14.0 16.0 4.7 20.4 22.0 9.2 2.0 6.0 18.6 12.3 19.9 8.0 14.3 21.1 31.6 3.1 13.1 19.7 12.4 17.2 32.8 33.4 11.8 12.5 25.7 10.0 14.9 14.8 8.5 USP37 KIAA1594 ENSG00000135913 "Ubiquitin specific peptidase 37" Q86T82 2 218450251-218568351 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 119.4;Late spermatids: 145.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045160 Approved Approved Nucleoplasm,Nucleoli NA Yes "Cluster 44: Non-specific - Transcription" "Cluster 6: Brain - Smell perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA045160: AB_10795620" "unprognostic (7.00e-2)" "unprognostic (2.29e-1)" "unprognostic (8.83e-2)" "unprognostic (9.19e-4)" "unprognostic (1.83e-1)" "prognostic favorable (2.85e-4)" "unprognostic (2.18e-2)" "unprognostic (1.14e-1)" "unprognostic (9.66e-3)" "unprognostic (1.17e-1)" "unprognostic (3.78e-3)" "unprognostic (1.11e-1)" "unprognostic (3.82e-2)" "unprognostic (3.26e-1)" "unprognostic (2.87e-1)" "unprognostic (6.69e-2)" "unprognostic (6.41e-3)" 2.7 4.1 3.5 4.4 4.7 11.8 4.7 8.5 4.9 3.6 1.9 3.0 2.9 4.2 7.5 3.9 3.3 3.5 2.3 3.3 4.0 2.9 3.8 3.0 6.0 3.8 4.0 5.9 3.0 4.0 1.4 4.0 4.0 3.6 3.5 9.1 3.9 3.0 2.9 3.9 3.3 3.2 2.5 3.8 3.4 12.7 3.4 6.3 5.0 4.2 4.9 3.6 2.2 8.3 9.6 6.9 14.2 11.0 3.6 4.4 12.1 7.1 5.1 12.2 13.6 13.1 7.4 8.7 7.5 5.6 9.3 8.9 15.7 8.0 13.4 12.0 8.3 23.5 13.6 8.7 4.1 15.6 11.3 2.4 4.7 12.9 9.2 4.5 5.3 15.0 17.3 16.2 7.8 7.2 20.1 10.6 12.2 6.2 5.9 16.0 21.3 8.0 4.2 11.2 15.5 8.4 11.5 5.6 7.2 13.6 6.4 10.8 6.8 13.7 12.0 7.7 9.5 11.0 10.4 17.6 7.4 11.2 9.5 4.2 2.0 3.8 3.1 2.3 3.2 2.5 2.6 2.7 2.1 3.2 4.0 2.6 1.6 3.2 2.2 2.9 3.6 1.2 3.5 4.7 8.5 4.9 3.3 4.0 3.8 4.0 4.0 2.5 3.4 8.3 12.8 0.0 11.0 34.3 16.5 19.5 7.0 7.1 22.2 14.7 14.4 10.2 4.9 4.3 9.6 7.3 27.1 8.4 13.4 5.5 0.0 5.8 119.4 13.3 11.8 14.2 10.3 16.6 47.4 2.3 6.6 13.2 9.2 16.4 5.1 16.2 12.5 11.0 7.8 15.2 40.0 8.9 4.1 8.5 22.9 145.5 9.9 17.2 21.4 27.2 10.2 9.1 10.3 35.2 60.5 4.9 7.4 9.8 14.6 12.1 7.1 4.2 11.1 19.9 6.6 12.7 21.6 60.8 31.4 13.6 20.6 7.3 19.7 10.9 7.6 7.1 USP42 FLJ12697 ENSG00000106346 "Ubiquitin specific peptidase 42" Q9H9J4 7 6104884-6161564 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.1;Spermatocytes: 72.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006939, HPA064800" Approved Nucleoplasm,Nucleoli NA NA "Cluster 10: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA006939: , HPA064800: AB_2685355" "unprognostic (1.48e-2)" "unprognostic (1.47e-1)" "unprognostic (2.59e-1)" "unprognostic (1.69e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (1.19e-2)" "unprognostic (3.32e-1)" "unprognostic (1.05e-1)" "unprognostic (2.82e-1)" "unprognostic (6.21e-3)" "unprognostic (2.47e-2)" "unprognostic (3.17e-3)" "unprognostic (3.14e-2)" "unprognostic (3.06e-2)" "unprognostic (2.19e-2)" "unprognostic (2.66e-1)" 3.8 3.0 3.1 3.2 3.0 13.4 3.9 5.8 4.4 4.3 2.4 4.5 4.5 4.9 3.6 3.7 4.3 3.4 3.2 3.0 3.0 3.9 4.0 4.1 3.8 2.8 3.1 4.9 3.8 4.7 3.8 3.3 2.7 3.8 3.4 5.8 3.5 3.1 4.3 5.4 4.3 4.1 2.9 4.4 3.6 15.2 3.2 5.7 4.0 3.4 3.2 4.0 3.8 3.2 10.2 7.4 13.1 12.9 7.4 5.5 9.0 5.4 6.9 6.2 6.1 5.3 5.2 12.0 3.4 6.7 9.2 9.3 11.1 5.9 6.7 2.9 8.6 5.6 6.1 5.5 6.3 13.0 6.1 6.4 6.8 6.7 8.5 5.7 7.7 10.0 21.7 7.9 4.1 9.1 7.9 14.6 14.8 5.2 5.6 14.9 10.2 8.2 5.9 5.3 10.0 17.7 6.9 14.0 4.3 12.0 6.5 6.6 6.5 5.5 20.5 7.0 6.5 7.0 6.3 10.3 4.6 7.8 11.0 0.6 0.3 0.9 0.5 0.6 0.7 0.4 0.6 0.3 0.3 0.2 0.4 1.0 0.3 0.5 0.3 0.6 0.5 0.2 3.1 3.0 5.8 4.4 3.0 3.0 2.8 3.1 2.7 2.9 3.2 3.2 13.7 12.8 7.0 19.6 16.1 40.5 18.2 5.2 26.7 18.7 17.4 10.8 10.5 8.6 6.8 1.8 22.9 8.3 16.4 20.7 0.0 10.4 89.1 27.1 15.3 14.4 10.7 10.8 26.1 10.4 8.4 13.4 15.3 25.6 9.5 13.4 12.8 9.8 8.2 21.9 26.2 18.1 8.2 9.1 19.9 42.5 14.3 12.4 10.6 18.7 7.7 10.1 12.3 18.6 26.2 12.0 7.7 12.8 21.7 22.3 12.4 5.7 10.6 18.7 13.1 16.2 14.9 72.4 37.0 23.1 41.5 26.8 19.2 6.4 14.4 15.3 USP46 FLJ12552 ENSG00000109189 "Ubiquitin specific peptidase 46" P62068 4 52590960-52659301 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Behavior, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Bipolar cells: 150.8;Early spermatids: 229.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007288, CAB076369, CAB076370" Uncertain Approved "Nucleoli,Nucleoli rim" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoli, Nucleoli rim" "CAB076369: AB_2665642, CAB076370: AB_2665643, HPA007288: AB_1080531" "unprognostic (1.15e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (1.31e-1)" "unprognostic (1.41e-1)" "unprognostic (1.53e-3)" "unprognostic (1.59e-1)" "unprognostic (2.45e-2)" "unprognostic (1.80e-2)" "unprognostic (2.89e-1)" "unprognostic (1.95e-1)" "unprognostic (1.05e-1)" "unprognostic (1.45e-1)" "unprognostic (3.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.28e-1)" 4.4 8.6 30.4 3.3 31.2 2.9 6.4 27.4 31.5 7.6 22.4 3.9 4.4 6.5 5.4 11.5 7.0 5.3 28.6 30.8 33.3 9.9 2.9 3.9 3.7 27.9 33.9 11.0 5.2 10.4 4.6 5.3 26.7 6.9 4.0 11.5 8.3 6.7 14.5 7.5 4.2 5.0 30.4 3.3 6.0 12.3 32.5 3.4 9.3 12.5 5.5 6.0 7.4 26.8 8.1 5.7 18.0 13.3 19.1 23.8 19.8 13.0 10.5 9.5 7.9 11.5 6.2 5.4 14.9 13.0 13.4 4.7 31.6 15.1 17.2 4.7 11.1 8.4 5.3 12.8 19.1 11.2 9.4 20.4 13.9 9.7 9.1 18.4 14.2 7.4 8.3 7.4 20.3 7.4 4.8 5.9 13.3 9.0 6.8 12.0 13.1 1.1 20.3 14.8 10.8 12.9 6.4 21.5 12.9 17.1 7.9 8.2 13.3 9.2 20.1 10.9 19.9 7.5 3.7 4.2 14.2 6.7 11.6 0.7 0.4 0.1 0.7 0.4 0.5 0.4 1.2 0.6 0.9 0.4 0.2 0.2 0.1 0.4 0.3 1.4 0.4 0.3 30.4 31.2 27.4 31.5 30.8 33.3 27.9 33.9 26.7 30.4 32.5 26.8 10.0 6.4 7.2 24.2 6.4 5.4 11.2 15.2 26.2 150.8 13.7 11.7 44.9 14.3 16.4 14.7 4.2 12.1 10.7 5.2 21.5 10.8 229.8 18.4 34.9 12.5 4.2 6.7 32.6 12.0 12.5 17.8 17.3 15.6 0.0 22.9 13.6 6.8 5.8 35.3 24.3 5.9 10.2 8.4 4.6 34.1 28.9 7.9 8.8 21.5 12.9 30.0 5.2 30.2 12.6 12.5 9.9 36.1 9.5 21.1 3.9 17.1 23.8 8.7 6.6 16.2 15.9 3.2 14.4 25.9 8.2 7.7 8.0 18.3 7.1 17.7 UTP14A "NY-CO-16, SDCCAG16, Utp14" ENSG00000156697 "UTP14A small subunit processome component" Q9BVJ6 X 129906121-129929761 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA047217, HPA054023, CAB079950" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Cytosol "CAB079950: , HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (6.75e-2)" "unprognostic (2.20e-1)" "unprognostic (1.10e-1)" "unprognostic (7.84e-3)" "unprognostic (2.95e-1)" "prognostic unfavorable (7.67e-4)" "unprognostic (3.00e-3)" "unprognostic (8.24e-2)" "unprognostic (4.09e-3)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (6.99e-3)" "prognostic unfavorable (8.12e-8)" "unprognostic (4.77e-2)" "unprognostic (1.13e-1)" "unprognostic (5.06e-2)" "unprognostic (9.99e-2)" 11.5 7.8 5.9 11.9 7.7 9.8 13.2 6.2 8.1 10.5 5.6 10.1 7.2 11.2 11.1 11.6 10.7 7.6 7.8 5.9 7.6 9.0 8.2 7.5 13.7 6.7 7.0 12.7 16.1 9.5 5.2 10.1 6.6 8.2 11.9 5.1 8.6 8.3 12.5 10.0 8.2 11.7 5.8 9.5 10.1 2.2 7.0 12.7 9.2 6.3 17.1 14.2 9.8 7.1 34.7 38.0 19.9 52.9 32.7 33.2 33.5 37.6 28.5 37.0 29.4 39.0 33.5 81.6 73.7 27.3 40.2 43.4 80.6 40.8 45.1 27.2 40.1 46.6 32.9 29.8 36.9 66.7 34.5 40.9 35.1 50.2 52.6 23.7 29.5 29.9 47.3 25.0 32.1 57.1 48.4 50.6 41.6 65.5 42.1 37.5 30.1 56.0 25.4 26.1 20.8 54.7 21.3 38.9 45.2 26.1 21.0 38.4 25.8 16.2 21.2 45.8 73.2 30.8 38.4 71.1 24.4 81.2 37.4 29.2 9.4 5.0 13.9 16.8 16.1 12.3 11.5 13.1 13.8 14.1 14.4 13.5 1.1 18.5 15.4 11.0 17.6 8.8 5.9 7.7 6.2 8.1 5.9 7.6 6.7 7.0 6.6 5.8 7.0 7.1 10.1 12.8 15.6 3.6 11.2 8.4 17.0 11.1 17.6 5.3 10.2 13.2 10.5 11.5 20.6 0.0 4.2 24.1 16.8 7.2 13.7 16.8 0.2 12.7 24.0 10.1 7.7 12.2 7.8 12.6 20.0 11.9 9.7 15.7 14.0 10.6 6.8 5.1 13.6 1.7 7.2 10.4 12.2 9.5 5.5 0.5 6.2 11.1 5.4 3.7 17.8 6.5 16.5 3.5 8.4 13.0 9.7 7.2 14.7 12.2 4.9 9.1 8.1 5.2 13.1 17.9 13.2 1.3 2.2 18.9 8.0 40.6 13.1 13.1 13.8 11.4 UTP14C "2700066J21Rik, KIAA0266" ENSG00000253797 "UTP14C small subunit processome component" Q5TAP6 13 52024691-52033600 "Predicted intracellular proteins" "Differentiation, Meiosis, Ribosome biogenesis, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.2;JURKAT: 2.2;MOLT-4: 1.3;NB-4: 5.7;RPTEC TERT1: 2.1;THP-1: 2.9" "HPA047217, HPA054023" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 24: NB-4 - Immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoli Cytosol "HPA047217: AB_2679987, HPA054023: AB_2682346" "unprognostic (7.89e-2)" "unprognostic (5.98e-2)" "unprognostic (4.47e-1)" "unprognostic (1.25e-1)" "unprognostic (2.33e-3)" "unprognostic (2.51e-1)" "unprognostic (2.02e-1)" "unprognostic (3.30e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (7.52e-4)" "unprognostic (7.35e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.46e-5)" "unprognostic (2.44e-2)" "unprognostic (3.43e-1)" "unprognostic (1.74e-1)" "unprognostic (3.04e-2)" 5.7 5.2 3.8 0.0 3.5 0.0 5.2 3.6 4.4 5.9 4.0 6.1 0.3 7.1 0.0 4.4 5.9 0.0 6.2 3.4 3.5 5.9 7.7 4.7 0.6 3.3 3.9 5.5 6.8 1.2 5.5 0.0 3.3 5.3 0.0 2.2 6.6 0.0 6.7 3.7 5.6 0.2 3.3 5.1 5.9 3.2 3.7 1.8 6.1 2.4 0.0 5.5 5.1 3.8 0.0 0.0 1.2 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.2 0.0 0.0 0.0 0.2 1.3 5.7 0.0 0.0 0.0 0.5 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 3.5 3.6 4.4 3.4 3.5 3.3 3.9 3.3 3.3 3.7 3.8 9.9 6.4 17.5 8.5 8.2 5.9 5.6 10.8 9.6 13.9 13.7 7.9 23.8 12.8 15.8 16.5 4.2 10.1 5.1 21.2 0.0 7.3 0.4 9.1 13.9 13.9 18.6 19.9 8.9 7.6 9.6 13.9 5.1 12.4 11.4 14.4 14.6 33.6 9.3 25.2 9.0 14.7 8.2 13.5 3.9 0.8 10.5 8.1 8.8 5.6 8.2 14.1 10.3 6.6 10.7 7.7 11.3 14.3 8.4 12.7 9.9 6.4 14.8 11.6 6.6 20.2 12.6 7.2 13.3 14.0 8.4 7.0 7.2 9.4 14.1 6.7 UTP15 "FLJ12787, FLJ23637, NET21" ENSG00000164338 "UTP15 small subunit processome component" Q8TED0 5 73565443-73583380 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044697 Approved "Nucleoli,Endoplasmic reticulum" No No "Cluster 32: T-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Endoplasmic reticulum" "HPA044697: AB_2679050" "unprognostic (8.96e-2)" "unprognostic (1.19e-1)" "unprognostic (1.87e-3)" "unprognostic (8.36e-2)" "unprognostic (1.78e-1)" "unprognostic (5.80e-2)" "unprognostic (1.39e-2)" "unprognostic (5.74e-2)" "unprognostic (2.12e-1)" "unprognostic (4.16e-3)" "unprognostic (1.02e-1)" "unprognostic (1.53e-2)" "unprognostic (2.27e-2)" "unprognostic (9.66e-2)" "unprognostic (7.10e-2)" "unprognostic (1.92e-1)" "unprognostic (1.22e-1)" 8.7 6.5 2.0 8.0 2.4 36.9 9.7 3.2 3.2 4.6 1.2 6.8 5.5 7.2 6.4 9.2 5.0 5.1 4.8 2.2 2.5 5.1 7.5 5.9 10.8 2.1 2.3 4.9 7.4 7.5 3.1 6.0 2.7 5.9 8.3 5.5 4.9 4.7 7.2 9.5 5.2 7.6 1.6 7.8 5.7 6.1 2.1 7.6 8.1 7.5 10.7 9.3 4.5 3.6 21.2 22.3 15.8 44.6 12.6 14.9 27.9 24.8 14.1 27.1 29.8 25.0 29.6 47.5 24.9 16.6 34.2 17.3 25.5 45.5 41.6 23.9 19.2 21.7 23.7 20.2 15.5 20.2 18.1 15.2 20.0 30.8 34.3 8.3 19.1 21.2 33.8 25.3 23.2 26.4 31.7 14.0 20.6 7.5 12.7 24.5 24.7 45.9 16.1 28.5 15.8 16.9 22.7 17.6 27.4 13.4 22.8 14.4 15.4 15.9 22.5 19.4 49.3 19.0 27.6 60.5 26.0 34.3 23.8 4.9 6.8 4.6 8.2 7.0 7.6 7.9 8.1 9.1 7.4 7.0 9.6 9.4 5.1 8.2 7.2 7.0 7.3 4.9 2.0 2.4 3.2 3.2 2.2 2.5 2.1 2.3 2.7 1.6 2.1 3.6 8.4 0.0 7.3 2.3 7.7 14.7 13.1 5.0 11.4 3.8 6.7 6.5 6.8 4.3 5.2 5.5 6.2 8.0 6.0 2.7 3.9 8.9 4.3 4.9 6.8 6.9 2.4 9.4 6.4 7.8 9.5 8.0 5.6 6.8 7.0 6.7 2.9 8.1 6.8 1.7 5.4 4.1 2.0 5.8 2.1 2.8 3.1 3.9 7.2 1.9 3.6 3.0 2.1 3.5 6.9 6.5 3.6 5.3 9.1 10.0 2.2 6.3 1.7 4.7 6.6 9.5 8.8 10.0 12.4 11.7 17.0 6.6 6.1 7.6 6.7 9.8 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20 small subunit processome component" O75691 12 101280105-101386618 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 4.3 4.2 2.2 5.0 3.7 4.2 5.7 2.9 2.7 5.7 2.5 3.2 2.1 4.6 2.6 4.0 3.8 2.4 3.0 2.3 2.5 3.3 3.0 3.0 5.0 2.8 2.8 6.4 4.8 5.3 2.2 4.3 2.9 3.5 4.2 3.5 5.6 3.3 5.2 4.6 3.1 4.0 2.4 3.6 3.2 5.6 3.3 4.3 4.2 3.9 4.8 5.1 3.5 5.0 8.1 19.9 14.8 6.9 13.0 15.1 18.2 13.8 10.8 21.5 11.8 23.1 5.7 21.6 7.1 15.4 16.2 16.6 33.0 14.2 27.8 9.8 13.4 22.8 10.0 17.3 7.3 38.4 10.2 9.9 7.3 29.9 10.3 8.2 15.0 10.9 36.7 4.3 15.8 10.6 16.8 10.9 38.9 11.3 20.6 18.8 24.2 16.8 9.1 24.4 17.0 11.5 25.8 16.1 15.7 12.2 17.0 8.5 17.1 25.3 12.5 17.8 27.1 7.8 12.6 35.1 13.8 17.2 39.6 0.0 0.2 0.0 0.5 0.3 0.5 0.9 0.5 0.7 0.4 0.6 0.6 0.7 0.0 0.6 0.2 0.8 0.5 0.2 2.2 3.7 2.9 2.7 2.3 2.5 2.8 2.8 2.9 2.4 3.3 5.0 14.3 9.6 9.9 16.0 16.7 10.1 9.7 7.7 11.4 9.9 8.7 8.4 10.3 7.2 13.6 3.7 10.4 7.8 4.4 3.4 5.9 7.6 1.5 11.4 24.5 12.6 6.6 14.9 17.0 11.6 8.8 13.0 7.7 10.1 13.3 18.6 7.1 7.6 5.8 21.9 17.0 6.3 4.1 6.3 3.5 1.2 9.6 8.6 3.6 8.4 3.3 3.3 4.1 16.1 34.2 5.9 1.9 8.2 13.2 14.5 1.1 3.0 9.0 9.4 6.6 24.9 11.0 22.6 22.3 17.3 11.1 2.9 10.0 23.7 9.8 7.2 UTP3 "CRLZ1, DKFZp761F222, FLJ23256, SAS10" ENSG00000132467 "UTP3 small subunit processome component" Q9NQZ2 4 70688532-70690551 "Predicted intracellular proteins" "Chromatin regulator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035655, HPA041453" Approved Supported Nucleoli,Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoli Vesicles "HPA035655: AB_10601832, HPA041453: AB_2677488" "unprognostic (2.44e-2)" "unprognostic (9.70e-2)" "unprognostic (7.36e-3)" "unprognostic (2.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.90e-2)" "unprognostic (6.79e-3)" "unprognostic (2.13e-1)" "unprognostic (3.50e-2)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (4.44e-3)" "prognostic favorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (7.95e-2)" "unprognostic (2.24e-1)" "unprognostic (2.24e-2)" 22.4 22.7 8.9 25.5 9.5 19.1 18.7 9.4 11.3 14.0 10.0 16.9 16.3 16.1 15.0 20.6 16.3 14.6 17.0 9.9 9.8 21.0 27.1 18.6 33.0 9.1 9.3 15.7 14.9 16.3 9.4 16.3 9.1 15.1 16.4 12.0 15.9 13.7 15.9 18.8 21.5 20.2 8.7 34.5 17.8 11.4 9.6 32.1 16.0 13.1 31.5 22.1 12.3 10.0 33.7 32.3 42.4 35.4 58.9 44.3 36.3 68.4 43.9 38.4 37.0 42.4 43.7 147.4 42.1 58.9 43.8 27.7 62.7 93.7 55.4 45.9 35.9 56.1 43.0 45.9 63.9 85.9 47.9 60.4 55.2 47.0 46.0 42.3 52.2 42.3 65.3 48.2 62.8 69.7 79.9 47.8 29.6 68.9 46.7 33.8 58.3 60.5 69.7 53.7 35.5 48.4 29.1 65.4 44.5 46.1 36.1 34.2 58.5 38.8 65.9 37.3 44.3 69.6 55.4 104.8 47.3 41.4 34.8 8.4 10.7 5.6 6.4 12.6 6.8 7.0 5.3 7.4 13.4 6.1 7.7 6.7 0.8 6.8 11.3 13.5 7.3 5.5 8.9 9.5 9.4 11.3 9.9 9.8 9.1 9.3 9.1 8.7 9.6 10.0 19.2 57.7 54.2 4.9 23.7 22.9 44.3 42.2 24.5 19.4 12.3 14.4 20.6 14.3 50.5 12.9 6.2 26.7 30.0 11.8 19.6 29.3 1.1 22.8 29.3 26.7 15.0 16.8 6.2 29.8 14.6 23.6 21.9 25.1 29.2 16.7 16.8 25.1 21.9 16.8 5.9 14.7 30.5 37.8 24.2 2.2 17.4 24.2 12.4 5.6 27.9 26.8 30.9 2.5 8.9 22.6 9.5 25.2 18.5 23.0 15.9 27.9 45.7 22.3 13.1 30.8 48.8 11.5 9.5 23.0 25.6 21.6 24.6 22.2 15.6 29.9 UTP6 "C17orf40, HCA66" ENSG00000108651 "UTP6 small subunit processome component" Q9NYH9 17 31860904-31901708 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 102.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025936, HPA055806" Supported Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 35: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli "Mitotic chromosome" "HPA025936: AB_1845588, HPA055806: AB_2682930" "unprognostic (1.55e-1)" "unprognostic (1.07e-1)" "unprognostic (5.61e-3)" "unprognostic (2.54e-1)" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (1.86e-5)" "unprognostic (5.68e-2)" "unprognostic (9.78e-3)" "unprognostic (5.50e-2)" "unprognostic (2.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (1.63e-1)" "unprognostic (2.87e-1)" "unprognostic (3.96e-2)" "unprognostic (4.76e-2)" 17.7 14.3 24.2 7.8 24.3 9.5 15.8 24.9 39.8 21.5 25.4 17.0 4.4 15.3 12.9 17.7 17.1 4.3 17.2 24.2 24.1 21.1 24.4 14.5 11.4 24.0 24.3 20.5 19.1 5.1 19.7 6.4 24.0 22.3 6.4 10.2 13.1 5.7 16.2 17.4 17.1 6.9 23.6 25.7 15.1 18.7 24.5 9.1 18.0 6.3 12.5 16.7 17.0 24.7 14.4 9.0 12.3 7.4 11.9 8.0 15.3 11.8 6.7 17.6 13.6 32.8 7.8 20.9 14.0 11.3 16.7 18.6 16.7 14.1 16.0 4.6 26.4 13.1 21.2 31.6 14.1 19.8 13.5 13.2 15.1 16.7 12.5 16.3 11.4 13.2 23.1 11.9 13.8 11.6 19.4 56.4 16.9 17.2 14.6 20.6 17.8 21.4 19.0 12.9 8.4 12.8 12.5 9.3 22.7 19.4 22.7 39.0 11.5 27.8 20.5 14.3 24.3 13.0 25.9 31.8 18.9 14.4 15.4 15.5 10.6 7.4 7.1 11.3 7.0 12.6 7.7 7.7 14.7 15.2 6.6 7.7 13.7 5.9 11.1 21.3 8.1 7.8 24.2 24.3 24.9 39.8 24.2 24.1 24.0 24.3 24.0 23.6 24.5 24.7 22.5 19.2 24.3 17.9 32.7 25.7 30.7 29.1 12.5 16.7 13.5 16.3 15.6 14.3 31.7 5.5 8.4 42.4 34.3 10.6 9.8 29.7 35.6 23.4 29.0 21.1 5.4 29.5 23.0 24.0 50.3 26.2 16.3 33.5 36.2 20.5 12.1 15.6 35.8 11.8 21.4 16.3 20.3 21.0 17.6 5.4 18.6 29.4 8.8 18.7 43.4 16.4 7.2 17.6 16.2 26.3 8.4 17.0 17.4 31.9 12.7 18.5 30.3 16.4 6.6 28.2 23.7 102.9 66.2 17.2 26.0 38.3 19.9 21.0 16.7 31.2 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991149 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.1" "Cell type enhanced" "Detected in many" "Early spermatids: 138.1;Extravillous trophoblasts: 178.1;Late spermatids: 71.8;Leydig cells: 132.3;Peritubular cells: 149.3;Skeletal myocytes: 65.9;Syncytiotrophoblasts: 80.7" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9;urothelial cancer: 6.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "U-2197: 518.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 21.0 1.5 5.7 3.3 1.8 0.4 7.4 0.5 2.1 5.4 6.8 6.7 1.1 8.0 1.4 3.0 5.4 9.6 4.3 1.9 6.9 1.5 0.6 15.9 2.3 0.9 2.3 14.2 4.0 1.2 0.3 40.1 1.0 11.0 2.2 1.1 1.6 4.1 1.7 4.1 2.2 9.0 0.6 2.0 2.6 3.4 2.7 0.5 3.0 1.5 0.8 9.3 4.0 0.5 8.1 13.1 69.5 0.2 90.5 112.2 1.1 48.6 34.0 40.8 50.8 15.2 3.1 0.0 0.1 76.9 4.6 6.9 4.8 4.6 55.9 28.4 0.1 3.6 4.8 0.3 41.3 0.5 0.2 86.6 7.6 60.1 26.9 21.8 6.1 0.1 0.0 0.1 51.5 0.1 0.5 0.4 1.4 0.1 0.3 0.1 91.7 0.4 0.0 8.3 0.2 0.1 20.8 0.7 0.1 2.4 0.2 0.3 2.8 90.3 13.4 518.3 1.6 0.2 0.2 0.0 16.8 0.0 3.8 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 5.7 1.8 0.5 2.1 1.9 6.9 0.9 2.3 1.0 0.6 2.7 0.5 2.5 3.2 2.2 0.0 0.0 8.0 11.1 2.1 4.0 0.0 0.9 4.6 1.2 1.5 3.3 11.0 0.0 35.6 0.1 0.0 0.0 13.4 138.1 1.3 31.0 1.7 0.0 0.0 0.4 2.6 178.1 33.4 1.1 1.2 0.0 0.1 2.5 0.0 7.5 0.0 2.0 0.0 2.0 0.0 10.3 71.8 132.3 0.7 3.6 6.5 0.0 17.1 0.0 0.0 1.4 13.2 0.0 149.3 0.0 17.7 0.0 0.1 3.2 0.3 13.1 65.9 21.8 1.1 1.4 1.8 5.3 80.7 0.5 23.1 0.0 4.5 VMP1 "EPG3, TANGO5, TMEM49" ENSG00000062716 "Vacuole membrane protein 1" Q96GC9 17 59707192-59842255 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autophagy, Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 984.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 4 "neutrophil: 3000.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 3000.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030773, HPA064780" Approved Approved "Nucleoli,Endoplasmic reticulum" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" "Endoplasmic reticulum" Nucleoli "HPA030773: AB_10602248, HPA064780: AB_2685348" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (3.14e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (1.39e-1)" "unprognostic (2.41e-1)" "unprognostic (2.98e-1)" "unprognostic (8.43e-2)" "unprognostic (4.21e-2)" "prognostic unfavorable (2.77e-8)" "unprognostic (1.88e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-3)" 36.7 47.2 23.1 56.2 29.1 22.8 36.6 15.9 32.7 30.3 5.4 58.6 56.0 32.4 23.2 33.0 16.0 59.8 22.0 17.1 23.7 36.6 58.5 29.6 31.4 29.1 24.9 22.9 30.8 38.4 10.4 39.2 27.3 34.0 59.8 30.2 23.5 23.1 19.9 19.5 60.4 33.9 24.5 52.5 47.6 22.3 35.8 22.3 32.5 28.9 20.7 47.9 16.4 38.0 65.8 128.2 43.8 82.2 88.3 54.8 77.3 87.4 87.4 64.3 98.0 85.1 166.1 42.2 143.9 70.6 81.5 79.8 62.4 59.5 80.5 102.7 80.9 55.5 89.2 97.3 89.6 68.5 51.4 77.4 46.7 87.3 76.2 93.2 67.6 41.3 69.8 70.2 68.7 177.9 66.7 21.9 63.0 146.6 75.3 41.8 79.8 101.1 92.5 72.1 36.4 89.1 57.5 62.4 83.8 62.6 124.4 49.0 89.8 81.3 75.0 68.8 83.6 105.4 145.0 66.8 84.4 37.6 92.8 131.6 570.4 76.0 62.8 393.0 69.2 56.6 59.3 65.4 174.3 49.5 53.9 60.5 3000.2 69.0 666.9 59.2 73.9 501.6 23.1 29.1 15.9 32.7 17.1 23.7 29.1 24.9 27.3 24.5 35.8 38.0 164.8 89.8 124.1 35.3 68.6 161.1 984.4 188.9 665.9 36.1 429.1 187.1 27.9 125.8 273.3 275.8 58.4 91.7 71.0 511.1 23.5 223.1 7.2 372.8 197.7 148.2 310.6 29.9 80.1 137.9 123.5 193.6 367.0 708.6 135.4 111.2 48.2 108.4 121.7 28.6 84.6 254.1 168.9 335.2 270.7 11.5 35.8 322.6 129.9 45.0 231.1 50.4 51.5 51.8 141.2 160.7 508.1 35.3 92.5 553.1 361.1 72.6 289.7 51.6 92.1 59.2 293.5 83.6 44.6 672.6 129.7 175.8 127.3 67.5 241.7 629.2 VWA5A "BCSC-1, LOH11CR2A" ENSG00000110002 "Von Willebrand factor A domain containing 5A" O00534 11 124115404-124147721 "Predicted intracellular proteins" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "granulocytes: 563.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 5 "basophil: 57.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 57.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 59.7;HEL: 44.1;HHSteC: 32.1;HUVEC TERT2: 39.5;RPTEC TERT1: 43.0" "Low region specificity" "Detected in all" "HPA037813, HPA037814, HPA061500" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 45: Intestine - Brush border" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 60: Granulocytes - Receptor signaling" Nucleoplasm Nucleoli "HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542" "unprognostic (2.69e-1)" "unprognostic (1.75e-1)" "unprognostic (5.58e-2)" "unprognostic (6.48e-2)" "unprognostic (8.49e-3)" "unprognostic (2.48e-1)" "unprognostic (8.18e-2)" "unprognostic (4.88e-2)" "unprognostic (1.18e-1)" "unprognostic (5.15e-2)" "unprognostic (4.53e-2)" "unprognostic (2.38e-2)" "prognostic favorable (1.55e-5)" "unprognostic (4.54e-2)" "unprognostic (7.21e-2)" "unprognostic (2.16e-1)" "unprognostic (4.65e-1)" 17.2 24.9 18.7 12.8 16.1 3.1 24.2 12.8 19.4 22.4 14.3 37.9 26.5 13.9 25.3 15.0 15.0 31.1 6.8 16.9 44.0 21.7 6.4 30.8 12.2 21.3 25.6 10.2 20.7 4.4 37.4 10.2 27.9 17.8 43.3 11.9 30.0 19.2 4.3 28.5 36.6 16.0 17.0 8.3 28.2 9.6 47.1 8.0 11.5 12.3 14.6 22.8 12.6 16.2 0.0 0.6 7.6 0.5 7.9 7.4 2.8 1.1 0.6 0.6 0.3 0.4 59.7 0.0 7.2 1.3 10.3 0.4 1.5 13.6 0.0 20.9 0.2 44.1 10.5 1.4 32.1 0.6 19.8 21.8 1.5 1.3 4.4 2.9 39.5 5.8 2.4 7.3 2.4 0.2 0.9 0.7 11.9 0.0 1.5 0.0 26.2 0.3 43.0 0.5 6.7 0.7 1.1 0.4 2.1 17.3 5.4 1.9 1.0 0.2 5.5 0.3 0.0 2.7 2.5 0.0 24.1 0.9 0.4 57.8 7.9 0.9 4.7 5.5 1.1 7.1 5.0 2.7 8.0 3.8 6.3 4.1 0.6 8.1 9.3 4.3 12.7 6.1 18.7 16.1 12.8 19.4 16.9 44.0 21.3 25.6 27.9 17.0 47.1 16.2 5.0 9.6 28.3 4.6 1.3 17.2 14.6 14.9 4.6 3.8 12.6 8.8 2.6 5.7 33.2 33.1 2.1 7.9 2.0 25.0 9.8 27.8 50.6 11.5 4.8 4.3 15.0 3.4 4.0 28.1 2.5 11.4 17.3 7.6 563.0 3.8 3.9 3.2 35.7 32.0 17.1 22.3 30.5 6.6 7.2 6.0 2.8 6.7 5.4 1.9 3.6 14.3 3.1 8.0 2.6 17.7 16.8 0.4 2.5 6.5 50.6 15.1 59.1 1.4 0.0 9.5 5.7 0.7 4.1 4.8 12.5 1.9 9.4 5.9 23.7 13.6 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "WASP like actin nucleation promoting factor" O00401 7 123681943-123749003 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 282.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 138.3;U-2197: 128.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favorable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 20.4 24.7 19.2 12.8 22.2 5.6 21.7 13.5 42.4 29.1 13.6 42.4 37.2 27.1 18.3 29.5 18.7 28.4 18.2 43.0 20.4 44.1 46.8 19.9 7.8 18.0 19.1 35.1 29.5 40.0 13.0 34.6 17.4 25.3 37.9 24.9 22.3 24.0 24.7 18.0 41.5 23.6 13.5 17.0 30.1 22.5 20.9 10.3 35.2 28.7 11.0 38.7 22.5 18.4 34.4 24.8 26.7 23.0 41.2 42.4 34.7 23.3 38.7 16.9 21.7 20.5 42.2 3.5 18.1 35.3 36.0 25.1 50.1 25.7 25.9 6.0 19.9 3.0 19.6 22.2 44.7 4.6 2.9 34.2 47.0 25.0 42.2 37.9 29.5 3.6 15.5 6.6 40.6 20.7 6.0 6.1 50.1 36.5 22.4 3.6 21.6 7.7 35.6 138.3 32.9 48.1 32.1 95.0 63.0 41.4 18.6 4.5 33.8 44.9 12.6 128.1 23.2 7.2 2.7 7.5 38.8 3.8 36.7 2.4 1.7 0.8 1.7 1.7 1.4 2.0 1.1 1.0 1.5 1.3 1.4 1.5 0.7 2.5 3.0 1.9 0.6 0.6 19.2 22.2 13.5 42.4 43.0 20.4 18.0 19.1 17.4 13.5 20.9 18.4 71.2 86.6 61.1 36.9 11.5 60.4 48.9 44.4 46.1 32.9 67.6 57.1 69.8 52.9 53.7 53.3 20.9 41.6 12.6 200.2 52.8 52.6 26.2 58.0 53.1 43.9 67.9 5.9 55.9 54.1 52.4 62.6 50.0 68.8 3.8 35.0 56.4 61.9 12.7 26.9 51.2 105.1 40.7 13.8 25.1 9.3 48.1 15.6 30.2 34.7 14.0 60.9 6.2 42.7 48.7 70.6 113.4 64.7 14.0 104.4 108.0 96.0 49.5 32.4 19.7 54.1 75.3 17.2 21.3 54.9 68.3 81.3 13.1 76.0 74.8 282.3 WDCP "C2orf44, FLJ21945, MMAP" ENSG00000163026 "WD repeat and coiled coil containing" Q9H6R7 2 24029347-24049575 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 9.2;Distal tubular cells: 7.9;Granulosa cells: 4.3;Theca cells: 4.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041054 Approved Approved Nucleoli,Cytosol NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoli Cytosol "HPA041054: AB_10796566" "unprognostic (1.07e-1)" "unprognostic (3.19e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.32e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (5.14e-8)" "unprognostic (7.69e-2)" "unprognostic (9.01e-3)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (5.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (7.76e-2)" "unprognostic (3.00e-1)" 2.6 3.7 3.9 3.8 4.1 1.4 4.4 4.7 4.0 3.5 4.6 4.2 2.5 4.2 3.7 3.2 3.2 2.7 3.4 3.8 4.0 3.5 4.1 2.6 6.6 3.9 4.1 5.4 2.6 5.0 2.3 4.2 4.0 3.6 2.9 6.3 2.9 4.5 6.1 2.9 3.3 3.5 3.9 4.2 3.0 4.9 4.3 7.7 3.1 8.7 7.0 3.6 2.7 4.6 12.3 18.8 20.1 14.0 13.6 10.7 7.2 14.6 7.8 15.1 14.1 17.2 5.6 32.0 6.2 7.5 12.6 8.8 28.7 10.0 15.6 19.4 16.4 19.7 8.5 17.8 9.3 18.0 13.0 6.5 7.6 15.6 7.7 7.8 14.3 18.4 27.5 8.7 15.9 5.6 23.8 10.8 24.3 12.2 14.3 25.7 33.8 12.9 7.1 6.1 15.4 21.3 7.2 7.0 9.1 14.0 5.4 7.9 13.9 12.0 13.1 7.2 13.6 14.4 19.2 45.2 7.7 19.0 9.5 0.0 1.8 1.1 5.2 2.7 5.3 3.3 3.3 3.8 3.1 2.9 4.6 5.0 0.4 3.9 2.0 1.1 5.4 3.3 3.9 4.1 4.7 4.0 3.8 4.0 3.9 4.1 4.0 3.9 4.3 4.6 3.1 3.2 3.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 1.7 2.7 0.0 0.0 0.6 9.2 0.0 2.9 1.8 0.0 7.9 2.3 0.0 1.5 3.2 1.6 0.0 0.0 0.0 2.0 2.5 1.4 0.0 1.0 0.0 4.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 1.4 0.7 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.1 1.0 4.5 0.0 0.0 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 9.1 6.3 2.2 8.4 2.8 2.9 9.3 2.8 2.6 7.3 7.4 5.9 5.4 6.7 4.2 6.6 7.4 3.1 4.4 2.6 3.1 5.9 11.2 4.5 7.1 2.2 2.7 7.6 5.1 9.2 3.0 6.2 2.2 5.8 7.7 4.3 4.4 4.9 10.3 5.0 4.9 8.0 2.3 6.2 6.6 11.7 2.7 8.5 6.0 7.4 11.8 9.4 4.3 2.7 35.6 22.2 21.7 33.5 23.0 18.8 24.9 24.1 15.9 27.8 24.3 23.8 11.6 42.4 32.4 18.2 17.7 23.1 55.0 28.4 44.4 34.3 28.1 39.7 22.7 19.0 19.1 74.8 20.0 18.5 19.8 35.4 53.3 16.3 27.2 29.1 49.7 20.2 24.2 20.4 35.9 15.5 78.7 30.7 34.7 33.9 75.5 32.5 13.8 23.4 33.4 30.1 27.8 33.6 39.6 29.6 13.5 29.9 24.0 20.9 33.1 38.4 54.9 29.3 36.8 64.5 30.5 47.2 55.0 0.1 6.8 0.6 9.3 7.1 12.0 9.3 8.4 11.0 13.5 8.6 12.9 11.9 0.6 9.6 8.1 7.4 12.4 7.4 2.2 2.8 2.8 2.6 2.6 3.1 2.2 2.7 2.2 2.3 2.7 2.7 11.4 9.6 14.3 5.9 13.1 20.9 21.9 13.1 15.4 11.3 11.2 9.7 14.9 8.6 23.4 7.3 6.2 10.7 8.6 4.6 9.8 12.8 33.2 11.7 20.4 13.2 3.6 10.7 12.4 13.8 9.9 14.9 8.2 7.5 16.4 11.9 8.9 27.4 7.9 15.2 12.5 6.4 14.2 7.3 5.7 43.6 12.5 7.1 10.6 5.6 8.2 7.4 10.3 13.0 7.5 12.3 4.1 11.7 10.9 31.4 3.0 7.4 17.6 7.3 13.1 23.0 13.8 52.3 50.8 21.7 22.4 5.1 10.6 31.1 9.8 15.4 WDR55 "FLJ20195, FLJ21702" ENSG00000120314 "WD repeat domain 55" Q9H6Y2 5 140664676-140674124 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043470, HPA048143, HPA075133" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Nucleoli "HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: " "prognostic unfavorable (1.51e-4)" "unprognostic (1.35e-1)" "unprognostic (7.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.88e-6)" "unprognostic (9.96e-2)" "unprognostic (2.78e-1)" "unprognostic (3.05e-1)" "unprognostic (4.00e-2)" "unprognostic (1.02e-2)" "unprognostic (1.19e-3)" "unprognostic (1.37e-1)" "unprognostic (2.14e-1)" "unprognostic (3.70e-1)" "unprognostic (2.51e-2)" 9.9 9.2 5.2 9.5 5.4 12.9 9.2 6.2 5.6 7.6 6.8 10.6 9.3 7.8 4.3 13.4 7.4 6.1 7.7 5.4 5.8 9.4 12.3 8.8 10.1 6.4 5.6 7.5 11.1 6.1 9.0 7.6 6.0 8.8 10.3 4.0 10.5 5.4 9.1 11.0 11.0 6.4 5.4 12.6 10.5 4.9 5.7 7.8 7.4 6.0 10.6 8.9 7.9 5.9 13.2 18.0 8.5 34.4 12.8 10.1 23.7 12.9 15.5 13.3 15.2 31.1 17.7 12.3 16.8 16.6 24.3 16.1 11.5 22.4 10.2 11.6 9.6 14.1 15.9 12.7 12.2 14.8 25.5 12.2 12.7 18.3 9.6 9.2 14.4 13.7 9.9 9.3 14.9 19.2 14.0 13.3 8.9 18.9 15.2 11.6 12.2 11.6 15.9 19.7 8.3 11.1 17.7 51.3 20.2 10.4 36.3 15.8 13.0 17.5 9.0 20.3 17.6 15.6 12.9 9.6 22.7 19.5 10.6 6.4 10.2 7.8 11.3 16.6 11.7 8.5 10.5 9.8 9.9 7.3 8.3 8.5 9.0 10.3 14.2 7.2 12.6 10.0 5.2 5.4 6.2 5.6 5.4 5.8 6.4 5.6 6.0 5.4 5.7 5.9 17.1 9.6 16.7 5.9 16.9 14.5 10.9 9.1 9.6 13.5 15.5 10.3 5.3 5.7 16.2 18.4 12.5 21.6 28.9 31.9 21.5 20.2 29.3 20.6 13.1 12.9 14.9 13.9 7.2 28.2 42.8 12.6 25.0 13.9 19.7 16.4 12.5 14.9 20.8 23.5 7.0 22.6 8.2 16.1 13.9 9.7 9.6 18.3 8.8 1.0 20.5 5.7 23.7 4.5 6.5 27.2 39.3 7.5 23.0 15.6 24.9 20.8 17.2 8.3 13.1 13.0 14.1 7.9 9.8 15.1 13.4 23.3 21.0 14.2 26.0 16.4 WDR74 "FLJ10439, Nsa1" ENSG00000133316 "WD repeat domain 74" Q6RFH5 11 62832342-62841809 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 565.6;choroid plexus: 711.0" "Cell type enriched" "Detected in all" 5 "Early spermatids: 616.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037795, HPA038419" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA037795: AB_10671380, HPA038419: AB_2676006" "unprognostic (5.52e-2)" "unprognostic (3.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (4.35e-2)" "unprognostic (3.47e-2)" "unprognostic (3.97e-3)" "unprognostic (6.58e-2)" "unprognostic (1.67e-2)" "unprognostic (1.62e-2)" "unprognostic (2.46e-2)" "unprognostic (8.20e-3)" "unprognostic (1.29e-3)" "unprognostic (2.77e-2)" "unprognostic (6.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.35e-1)" 21.3 21.8 352.4 20.5 274.3 127.1 21.2 485.9 291.6 19.5 711.0 19.6 17.1 20.8 14.6 25.8 22.3 11.4 23.1 251.8 208.5 21.5 28.5 14.9 30.6 220.8 221.4 25.6 30.9 15.1 11.4 18.3 292.3 19.5 16.4 33.7 25.0 13.7 59.3 31.2 17.7 17.0 305.3 30.1 22.0 15.4 244.7 62.3 28.4 25.3 23.9 24.8 18.9 565.6 64.2 76.2 28.8 49.4 22.9 31.4 85.9 35.8 37.5 73.6 49.1 108.8 77.0 111.6 97.6 28.5 59.0 84.1 88.8 69.0 56.8 72.7 64.2 55.5 84.1 97.5 65.9 112.3 36.0 30.9 75.7 47.8 153.9 24.8 36.1 80.5 126.1 32.5 33.7 120.6 106.7 178.7 117.1 70.9 96.7 108.9 49.9 193.6 52.7 35.6 65.7 72.1 40.8 84.1 115.4 27.8 58.8 83.1 28.0 44.4 52.4 98.3 88.2 81.0 120.3 137.1 47.5 68.3 57.2 40.1 140.9 11.7 40.2 61.4 49.7 66.0 42.1 38.6 105.0 121.5 56.8 52.0 51.0 93.2 44.9 154.3 52.4 47.8 352.4 274.3 485.9 291.6 251.8 208.5 220.8 221.4 292.3 305.3 244.7 565.6 36.8 38.5 67.9 1.6 112.5 104.5 47.2 45.7 60.9 15.2 37.6 57.0 2.0 40.0 108.7 16.5 16.7 55.2 57.9 32.0 43.0 42.8 616.0 22.4 34.0 41.7 41.0 26.5 3.6 40.5 53.8 39.1 65.2 32.4 43.6 23.5 20.7 34.0 37.9 3.3 3.0 32.1 20.3 33.1 69.2 97.1 32.9 45.0 30.2 1.0 22.4 15.4 45.3 2.0 2.8 39.8 24.2 21.4 74.3 50.3 44.8 54.0 32.0 11.4 19.7 53.0 89.3 19.4 31.4 50.3 109.3 34.8 66.3 30.4 41.5 39.8 XDH "XO, XOR" ENSG00000158125 "Xanthine dehydrogenase" P47989 2 31334321-31414742 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "breast: 42.2;intestine: 49.5;liver: 68.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 262.1;Distal enterocytes: 143.5;Hepatocytes: 46.9;Paneth cells: 48.8;Proximal enterocytes: 96.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 8.2;HBEC3-KT: 20.0;hTERT-HME1: 31.0;U-251 MG: 8.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA062641, HPA069323" Supported Uncertain Nucleoplasm,Nucleoli "Intracellular and membrane" No No 77000 "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Nucleoli "HPA062641: AB_2684816, HPA069323: AB_2686121" "unprognostic (8.58e-2)" "unprognostic (4.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-2)" "unprognostic (7.06e-2)" "unprognostic (4.38e-3)" "unprognostic (7.48e-3)" "unprognostic (3.55e-1)" "unprognostic (3.60e-2)" "unprognostic (3.95e-3)" "unprognostic (3.51e-2)" "unprognostic (1.24e-6)" "unprognostic (2.25e-1)" "unprognostic (5.25e-2)" "unprognostic (2.54e-1)" "prognostic favorable (8.73e-6)" 0.2 0.0 0.0 4.8 0.0 0.1 42.2 0.3 0.0 0.3 0.4 11.1 44.9 0.9 2.3 9.8 0.1 4.5 0.0 0.0 0.0 0.2 68.5 0.3 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.1 1.3 9.5 0.1 3.6 0.1 0.5 1.1 49.5 0.7 0.0 0.0 3.2 0.1 0.0 0.2 0.3 0.0 2.3 2.7 2.0 0.1 2.0 0.4 0.0 0.0 0.0 0.1 0.1 8.2 4.7 1.0 1.4 0.3 2.3 0.1 1.6 0.3 0.8 4.2 0.0 20.0 1.0 1.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 1.8 1.1 31.0 0.4 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.4 1.2 0.2 0.0 1.4 4.5 5.7 5.2 0.0 0.1 0.1 0.3 0.0 1.7 0.0 0.0 0.0 3.8 2.4 0.2 8.9 2.5 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.6 0.0 2.4 0.0 0.2 0.5 6.0 5.5 2.8 0.3 262.1 6.5 0.4 2.8 3.6 0.0 0.0 0.3 1.1 143.5 0.0 3.9 0.3 7.9 2.8 0.3 11.9 0.0 0.2 8.2 0.6 0.2 2.0 37.0 0.0 0.0 1.4 46.9 0.0 0.0 0.2 8.4 2.0 1.9 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 48.8 0.0 0.0 2.2 96.8 0.0 1.0 0.7 0.0 0.3 0.7 0.0 0.2 1.2 0.1 0.4 0.7 0.2 22.2 16.9 XRN2 ENSG00000088930 "5'-3' exoribonuclease 2" Q9H0D6 20 21303331-21389825 "Predicted intracellular proteins" "mRNA processing, Transcription, Transcription regulation, Transcription termination" "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047118, HPA050485" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA047118: AB_2679941, HPA050485: AB_2681141" "unprognostic (9.38e-2)" "unprognostic (4.70e-2)" "unprognostic (2.07e-2)" "unprognostic (3.09e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.54e-5)" "unprognostic (7.26e-2)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-2)" "unprognostic (1.40e-1)" "unprognostic (1.99e-3)" "unprognostic (1.22e-1)" "unprognostic (1.97e-1)" "unprognostic (1.63e-2)" "unprognostic (1.31e-1)" 36.1 36.1 14.7 42.6 17.2 73.3 42.9 18.5 15.8 33.4 21.1 29.9 24.3 37.0 31.3 25.9 33.2 35.8 24.8 13.6 16.5 34.8 42.7 34.4 43.2 16.5 15.5 36.7 32.8 45.2 18.7 37.4 17.0 28.4 32.4 24.8 27.0 33.6 38.2 24.3 24.8 39.4 16.1 36.1 24.9 29.9 16.1 46.8 41.2 26.5 45.8 46.5 23.1 18.3 91.9 106.7 115.1 88.7 84.1 102.7 113.7 82.3 107.1 107.2 124.1 71.8 102.2 89.7 47.8 86.8 146.1 106.0 131.0 138.7 136.6 40.8 66.0 116.0 37.7 136.5 73.9 105.7 96.8 98.0 68.7 118.5 103.1 95.3 93.6 84.5 94.9 74.7 101.0 71.7 156.5 69.6 89.8 88.8 71.1 113.1 195.4 76.9 91.0 95.6 88.9 115.2 96.0 116.6 89.9 88.6 65.5 123.9 87.0 107.0 79.8 24.8 105.4 65.3 90.0 95.0 41.5 48.5 82.5 36.0 68.6 49.2 34.6 54.8 46.4 30.5 37.7 38.1 61.1 30.9 39.8 38.7 69.2 43.9 71.8 26.2 49.2 54.3 14.7 17.2 18.5 15.8 13.6 16.5 16.5 15.5 17.0 16.1 16.1 18.3 118.6 60.9 112.2 29.7 72.4 63.6 90.8 81.2 64.9 44.9 85.0 75.2 58.7 52.9 94.4 40.5 41.7 106.2 99.1 36.6 27.4 123.8 157.6 119.5 128.5 99.9 59.5 62.6 45.7 120.9 96.8 80.1 39.8 113.7 83.5 92.0 41.0 70.4 105.4 50.5 48.9 52.6 67.1 129.6 57.9 26.8 57.8 111.2 60.5 49.6 165.9 55.1 85.5 46.8 67.6 96.1 53.7 55.7 77.1 91.6 45.1 80.6 102.7 49.7 59.2 120.1 108.1 104.1 116.6 65.6 67.2 105.2 83.5 99.4 68.1 89.7 ZBTB43 "FLJ22470, KIAA0414, ZBTB22B, ZNF-X, ZNF297B" ENSG00000169155 "Zinc finger and BTB domain containing 43" O43298 9 126805006-126838210 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 60.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016825 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Cluster 34: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "HPA016825: AB_1858959" "unprognostic (1.18e-1)" "unprognostic (2.66e-1)" "unprognostic (7.02e-2)" "unprognostic (9.11e-2)" "unprognostic (5.69e-2)" "unprognostic (3.41e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" "unprognostic (6.87e-2)" "unprognostic (3.72e-2)" "unprognostic (5.14e-1)" "unprognostic (5.41e-3)" "prognostic favorable (8.73e-4)" "unprognostic (6.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" "unprognostic (7.13e-2)" 5.3 5.4 4.5 4.7 5.3 60.6 5.9 6.3 6.8 5.0 9.0 4.6 5.2 5.7 4.4 9.5 4.1 5.3 10.6 4.7 4.9 3.9 7.9 8.3 5.6 4.1 5.1 6.1 4.9 9.5 4.6 5.2 4.5 4.4 5.8 9.3 6.0 3.5 32.8 14.4 4.8 5.0 3.5 5.0 7.0 16.2 5.0 5.9 5.3 20.2 6.4 5.1 6.4 6.3 6.3 4.7 8.5 7.8 7.0 9.9 8.7 8.0 8.0 6.3 5.6 11.0 4.3 8.7 3.9 8.4 12.4 18.4 7.5 8.0 7.8 7.6 5.0 6.0 14.6 4.9 9.6 8.6 11.0 12.1 20.2 10.2 25.0 6.0 4.9 7.1 10.6 19.8 9.4 6.8 7.5 5.4 7.8 6.7 8.0 6.3 27.4 7.1 6.8 7.2 7.5 6.9 8.5 8.5 7.8 7.6 7.6 5.4 4.7 7.6 7.1 8.4 7.0 21.0 16.4 3.3 9.4 7.0 6.3 12.0 4.5 3.9 7.0 4.3 6.8 4.2 3.8 4.1 3.7 3.3 4.1 4.8 2.5 6.7 3.5 2.0 6.1 3.3 4.5 5.3 6.3 6.8 4.7 4.9 4.1 5.1 4.5 3.5 5.0 6.3 16.5 35.3 44.7 34.0 23.4 84.9 68.2 37.5 30.7 42.2 36.0 19.9 42.7 27.1 46.1 27.6 108.4 18.2 30.6 80.2 1.9 31.1 91.2 51.7 35.0 25.1 11.4 21.4 44.2 18.5 12.3 27.7 78.5 133.6 31.0 23.7 17.5 25.3 14.7 26.9 40.5 21.6 40.7 21.7 74.1 45.3 17.7 46.4 24.9 12.2 18.3 29.3 21.6 25.6 37.3 43.4 51.5 14.3 27.2 54.9 33.5 7.9 27.7 55.7 13.1 39.4 29.3 49.7 73.1 70.8 117.3 52.0 31.8 22.4 25.6 141.7 ZCCHC7 "AIR1, FLJ22611" ENSG00000147905 "Zinc finger CCHC-type containing 7" Q8N3Z6 9 37120574-37358149 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 225.6;Inhibitory neurons: 229.6;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 250.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 124.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020600, HPA021088, HPA029522" Uncertain Enhanced Nucleoli,Cytosol NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 57: B-cells - Immune response" "Nucleoli, Cytosol" "HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029" "unprognostic (1.19e-3)" "unprognostic (1.21e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (7.21e-3)" "unprognostic (2.78e-1)" "unprognostic (4.27e-3)" "unprognostic (3.18e-2)" "unprognostic (8.00e-3)" "unprognostic (1.29e-2)" "unprognostic (7.87e-2)" "unprognostic (1.83e-1)" "unprognostic (4.58e-2)" "unprognostic (8.23e-2)" "unprognostic (2.33e-1)" "unprognostic (1.04e-2)" "unprognostic (5.49e-2)" 8.3 7.4 5.8 12.7 5.5 13.7 13.2 18.7 8.8 9.3 5.1 8.2 7.9 11.6 11.3 7.5 9.6 7.9 6.4 5.3 5.4 7.4 8.1 6.5 23.2 5.6 6.2 16.6 11.2 7.1 9.4 7.9 6.6 7.0 10.9 9.9 7.8 7.1 5.9 8.2 8.2 9.5 4.4 10.6 7.7 12.1 7.4 12.9 12.3 6.0 24.8 9.5 7.5 9.2 17.2 9.4 17.5 18.4 17.4 27.0 15.5 17.4 21.3 14.0 19.2 11.8 8.6 54.8 8.1 14.0 15.9 7.2 16.6 17.1 19.9 26.3 8.8 19.1 19.3 10.7 27.3 32.5 17.5 18.6 26.3 14.2 56.7 26.0 16.0 24.4 53.3 21.8 12.7 8.2 24.9 18.2 18.3 20.3 17.3 124.7 11.0 16.2 17.6 7.1 17.5 12.9 12.6 15.3 17.1 16.9 10.2 21.4 12.7 9.9 11.8 14.1 10.3 5.0 13.2 76.4 14.9 20.8 18.7 8.4 7.6 20.6 12.9 9.0 12.8 32.6 14.9 15.0 7.2 48.9 18.6 17.3 15.3 18.4 17.2 13.2 13.4 9.3 5.8 5.5 18.7 8.8 5.3 5.4 5.6 6.2 6.6 4.4 7.4 9.2 27.7 35.3 18.5 126.3 110.3 28.3 29.5 28.2 32.5 15.5 21.7 23.7 10.7 15.7 21.7 5.5 10.4 15.3 32.8 7.7 27.4 16.3 52.2 17.6 37.6 18.7 19.1 38.5 225.6 15.8 25.4 31.0 30.1 24.2 23.5 18.0 16.4 11.6 15.2 11.8 229.6 22.5 40.7 17.9 22.8 20.8 27.1 20.3 16.0 121.8 19.8 18.2 28.8 196.1 250.0 12.8 13.6 19.5 44.7 34.9 17.7 22.5 19.1 24.9 6.6 33.9 25.4 60.1 44.8 29.3 32.7 18.6 42.2 32.4 20.3 26.0 ZCCHC9 "DKFZp761J139, PPP1R41" ENSG00000131732 "Zinc finger CCHC-type containing 9" Q8N567 5 81301587-81313297 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038404 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Nucleoli "HPA038404: AB_10672744" "unprognostic (1.55e-1)" "unprognostic (2.27e-1)" "unprognostic (1.31e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-2)" "unprognostic (1.71e-2)" "unprognostic (6.29e-2)" "unprognostic (4.91e-2)" "unprognostic (1.10e-1)" "unprognostic (3.31e-1)" "unprognostic (3.58e-2)" "unprognostic (2.68e-2)" "unprognostic (5.20e-3)" "unprognostic (1.60e-1)" "unprognostic (2.05e-1)" "unprognostic (1.29e-1)" "unprognostic (1.06e-1)" 13.4 12.3 8.7 15.9 8.6 10.8 13.5 9.7 13.4 15.5 9.8 15.2 14.9 15.5 16.3 14.6 12.6 14.3 11.2 8.6 9.2 17.9 33.3 11.2 19.0 8.9 9.0 17.2 11.8 13.0 13.8 19.1 9.0 15.5 14.9 14.0 10.5 11.0 14.9 16.3 18.7 14.6 8.5 13.3 12.9 14.9 9.4 17.7 12.6 11.6 18.2 16.3 13.5 9.1 26.6 18.5 44.5 23.7 37.5 35.3 59.7 39.2 46.3 29.5 40.8 41.0 35.8 24.6 15.8 19.8 51.1 19.4 35.6 35.8 46.9 55.3 33.5 25.4 21.0 48.4 44.2 32.6 20.3 27.6 30.7 25.3 62.7 22.9 25.3 26.5 43.1 23.4 30.8 36.3 54.0 48.7 32.4 14.9 23.7 31.9 57.0 36.4 23.4 26.5 21.6 20.5 31.1 18.4 146.5 32.1 23.0 51.7 17.6 18.5 22.6 33.2 43.4 33.2 36.5 37.7 32.7 46.7 40.3 12.6 10.8 11.3 10.5 14.9 13.2 12.8 14.0 12.8 13.3 11.1 13.3 13.8 10.6 10.8 13.6 15.1 17.4 6.5 8.7 8.6 9.7 13.4 8.6 9.2 8.9 9.0 9.0 8.5 9.4 9.1 15.9 9.6 18.6 10.4 18.2 9.1 12.5 25.8 14.2 18.0 14.5 17.1 12.3 37.1 19.3 31.3 14.6 28.0 17.3 15.0 31.3 22.4 68.4 22.6 31.5 17.9 7.8 12.8 15.0 20.4 53.8 23.9 14.8 18.8 13.3 13.3 29.6 61.7 36.7 26.9 19.3 23.3 16.2 14.2 16.5 19.1 32.6 19.9 3.6 13.1 33.2 22.0 35.0 12.1 14.2 30.2 27.4 29.0 17.6 13.8 44.8 67.1 28.1 28.2 19.7 16.2 18.8 75.6 38.2 14.0 9.2 23.0 19.8 22.3 21.6 12.6 ZEB1 "AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a" ENSG00000148516 "Zinc finger E-box binding homeobox 1" P37275 10 31318495-31529814 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Corneal dystrophy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 287.8;Excitatory neurons: 276.1;Inhibitory neurons: 261.9;Microglial cells: 479.7;Oligodendrocyte precursor cells: 968.6" "Cancer enhanced" "Detected in all" "glioma: 15.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 113.1;TIME: 87.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027524, CAB058686, CAB079943" Enhanced Supported Nucleoplasm,Nucleoli NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Nucleoli "CAB058686: AB_2665569, CAB079943: , HPA027524: AB_1844977" "unprognostic (1.54e-1)" "unprognostic (3.08e-1)" "unprognostic (3.42e-2)" "unprognostic (1.04e-1)" "unprognostic (4.85e-2)" "unprognostic (7.40e-2)" "unprognostic (1.34e-2)" "unprognostic (5.59e-2)" "unprognostic (1.30e-1)" "unprognostic (2.96e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (5.59e-3)" "unprognostic (1.19e-1)" "unprognostic (1.62e-2)" "unprognostic (1.66e-2)" 26.6 8.6 16.4 12.9 16.2 8.6 16.8 14.0 20.1 33.2 9.9 49.2 6.0 38.7 13.4 11.7 18.6 20.0 34.8 15.2 22.8 7.5 10.4 16.0 9.6 21.1 19.2 9.3 3.8 3.4 7.9 17.5 21.2 14.5 12.3 14.8 8.0 26.9 54.4 7.0 11.8 39.9 16.8 8.1 18.1 10.1 18.2 29.9 11.2 60.5 9.7 24.4 16.4 18.5 0.1 11.1 35.1 43.9 58.4 113.1 0.0 32.7 44.9 6.6 9.3 0.2 0.1 11.3 15.6 39.6 9.3 0.0 14.9 0.0 11.8 19.1 7.9 0.0 7.0 6.3 44.4 9.8 0.3 53.4 0.1 19.6 17.6 21.4 54.9 9.5 7.5 14.4 42.7 0.1 33.7 6.2 2.3 0.0 6.6 11.6 66.0 5.1 12.9 0.0 0.9 15.6 11.1 0.0 0.0 7.2 0.0 6.7 87.7 40.8 9.4 10.0 16.7 9.1 6.3 12.8 10.9 0.0 4.2 4.9 0.0 5.4 2.4 0.0 3.2 4.1 3.2 1.7 1.3 3.1 6.8 3.5 8.5 6.6 0.0 3.1 5.0 1.6 16.4 16.2 14.0 20.1 15.2 22.8 21.1 19.2 21.2 16.8 18.2 18.5 104.4 0.0 7.7 212.9 34.6 11.2 3.0 2.0 0.6 42.7 1.4 2.8 106.3 1.5 3.6 1.8 45.9 0.3 22.0 0.0 0.0 2.1 110.1 7.2 287.8 110.6 0.0 12.2 276.1 2.7 0.5 66.1 2.0 6.5 1.3 17.0 49.6 13.4 1.2 10.1 261.9 0.0 0.0 3.8 25.6 141.8 30.7 6.3 26.6 479.7 10.7 7.2 7.2 968.6 7.3 2.5 0.0 102.0 33.2 3.7 0.0 1.6 1.5 43.4 78.9 99.2 74.2 17.4 15.7 1.1 8.7 0.7 36.2 12.0 0.0 3.8 ZFP91 "PZF, ZNF757" ENSG00000186660 "ZFP91 zinc finger protein, atypical E3 ubiquitin ligase" Q96JP5 11 58579063-58621550 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 243.7;Late spermatids: 179.3;Spermatocytes: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA024037, CAB025417, HPA065325" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "CAB025417: , HPA024037: AB_1859051, HPA065325: AB_2685468" "unprognostic (6.10e-2)" "unprognostic (5.01e-2)" "unprognostic (3.33e-3)" "unprognostic (9.19e-2)" "unprognostic (1.24e-1)" "unprognostic (2.33e-1)" "unprognostic (2.33e-2)" "unprognostic (3.37e-2)" "unprognostic (1.06e-1)" "unprognostic (2.36e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (3.16e-1)" "unprognostic (1.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.61e-1)" "unprognostic (2.23e-1)" "unprognostic (2.00e-3)" 25.0 22.0 27.8 23.0 32.3 59.2 21.9 28.0 33.4 22.0 16.0 28.9 25.9 22.4 17.6 24.4 19.9 21.5 29.8 22.9 26.9 25.1 30.7 21.3 24.8 26.5 28.8 20.2 22.8 29.8 15.3 20.3 27.1 19.3 33.5 29.8 20.2 22.6 53.2 25.7 29.0 24.4 28.8 24.3 21.1 86.4 28.4 36.7 25.9 45.3 26.2 27.5 20.4 32.8 65.4 36.3 42.0 43.3 39.6 47.5 23.1 52.3 98.3 59.6 50.7 19.9 67.1 77.5 50.6 66.9 59.4 56.7 43.2 56.0 77.9 41.3 24.3 51.2 36.5 21.9 44.9 65.3 80.9 41.8 53.8 83.9 97.3 49.4 60.0 51.5 51.4 71.4 77.7 21.7 56.8 36.1 22.2 37.6 35.4 43.4 71.0 51.8 43.8 60.9 45.1 35.9 67.2 61.0 86.8 22.7 68.2 48.5 67.8 74.8 51.4 114.0 59.3 41.0 32.3 62.9 66.2 36.1 78.1 1.3 1.4 1.0 1.5 1.2 0.8 1.3 0.9 0.9 1.4 1.1 0.9 1.2 1.5 1.0 1.3 2.0 0.8 0.8 27.8 32.3 28.0 33.4 22.9 26.9 26.5 28.8 27.1 28.8 28.4 32.8 24.6 25.6 33.6 0.0 29.1 60.2 26.1 20.6 44.3 31.9 25.4 17.9 45.7 38.6 20.6 18.4 16.7 12.1 31.7 46.2 13.7 23.7 243.7 30.1 33.7 28.8 25.2 46.7 0.0 31.2 11.4 31.3 23.9 40.9 50.6 32.5 27.5 51.3 16.6 35.3 0.0 27.6 12.2 45.3 55.9 179.3 30.7 36.5 23.2 0.0 36.4 21.1 25.7 0.0 0.0 29.5 18.6 27.1 26.2 35.0 34.6 26.7 24.2 22.4 19.7 34.7 27.6 140.9 41.1 53.7 66.5 13.8 24.2 17.9 39.1 43.4 ZFX ZNF926 ENSG00000005889 "Zinc finger protein X-linked" P17010 X 24149173-24216255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001748, HPA003877, HPA071863" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 42: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA003877: AB_1080648, HPA071863: AB_2686463" "unprognostic (2.60e-1)" "unprognostic (1.09e-1)" "unprognostic (7.99e-2)" "unprognostic (4.64e-2)" "unprognostic (1.66e-1)" "unprognostic (2.78e-1)" "unprognostic (1.81e-2)" "unprognostic (1.56e-1)" "unprognostic (2.77e-2)" "unprognostic (1.90e-1)" "unprognostic (6.84e-2)" "unprognostic (1.47e-1)" "unprognostic (9.22e-3)" "unprognostic (2.39e-1)" "unprognostic (4.27e-2)" "unprognostic (1.93e-1)" "unprognostic (5.95e-2)" 13.2 6.8 9.8 8.8 13.4 29.5 10.5 21.2 10.8 12.6 8.4 9.9 6.8 15.6 9.7 7.3 12.5 6.9 8.8 7.1 12.9 8.0 10.2 8.6 11.6 10.7 13.4 17.3 9.9 15.4 6.0 13.7 9.4 14.8 6.1 10.3 7.4 11.3 15.1 8.0 8.1 14.5 9.8 12.3 8.0 4.7 12.4 17.3 10.7 12.5 10.0 9.1 11.3 14.3 13.8 17.6 19.3 20.9 23.4 16.4 9.2 12.9 11.9 13.5 14.6 11.4 9.4 15.0 17.1 19.5 31.3 17.5 19.4 23.3 18.1 15.4 26.9 14.4 63.3 6.2 9.8 18.2 24.4 14.3 7.4 27.1 34.1 15.3 17.2 9.4 16.5 16.9 9.7 6.6 14.2 12.5 10.3 6.0 13.7 18.8 15.4 13.9 8.8 21.4 9.6 14.4 37.9 14.5 11.8 11.7 9.6 10.0 18.3 12.6 7.4 18.3 8.9 9.5 13.7 15.3 9.3 7.7 14.4 9.6 6.5 10.2 6.9 7.6 7.2 5.9 6.5 7.1 7.1 9.4 6.5 6.1 11.8 6.8 7.0 4.8 4.1 5.5 9.8 13.4 21.2 10.8 7.1 12.9 10.7 13.4 9.4 9.8 12.4 14.3 35.4 19.2 12.0 38.2 37.7 22.0 18.1 14.5 19.4 19.1 29.6 17.5 16.6 30.0 19.9 7.3 20.9 56.6 60.7 21.0 5.9 14.4 2.0 29.2 48.1 26.2 20.4 16.4 32.4 16.1 13.6 29.2 16.3 30.6 27.9 39.9 24.7 26.6 17.1 15.2 33.6 16.6 4.1 24.3 26.2 5.7 35.8 31.2 30.2 47.8 28.8 15.7 22.6 49.8 52.6 14.8 17.1 35.7 34.1 21.6 14.8 11.5 15.4 22.7 32.9 47.3 36.2 18.2 27.1 15.1 20.9 20.7 34.0 29.8 14.5 20.5 ZFY ZNF911 ENSG00000067646 "Zinc finger protein Y-linked" P08048 Y 2935281-2982506 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 35.7;Late spermatids: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001748, HPA071863" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA001748: AB_1080650, HPA071863: AB_2686463" "unprognostic (1.07e-1)" "unprognostic (7.43e-2)" "prognostic favorable (3.58e-5)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (2.75e-2)" "unprognostic (2.94e-2)" "unprognostic (1.04e-1)" "unprognostic (8.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.91e-1)" "unprognostic (2.54e-2)" 2.6 1.7 0.6 2.5 0.8 8.0 2.1 3.3 2.1 0.0 1.0 2.3 2.7 0.0 3.0 4.6 0.0 3.1 1.9 0.6 1.0 1.7 4.4 1.7 1.3 0.8 0.9 0.0 2.6 1.9 1.6 3.8 0.9 5.0 5.0 2.3 2.7 4.0 3.4 1.8 4.2 0.0 0.7 2.2 2.5 7.2 0.6 0.0 2.8 7.4 3.7 3.2 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 9.3 13.6 13.5 11.5 10.7 0.0 0.0 10.0 0.0 14.6 0.0 0.0 0.0 0.0 14.7 15.5 0.0 19.2 0.2 7.6 9.6 0.0 0.0 10.6 9.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 12.8 0.0 8.5 0.0 4.9 0.0 0.0 0.0 8.1 5.2 7.6 17.7 9.8 0.0 0.0 0.0 13.4 6.4 0.0 6.5 11.7 11.3 0.0 0.1 7.3 6.7 0.0 17.5 1.8 0.0 0.0 0.0 2.7 2.2 2.3 1.8 3.1 2.0 2.5 1.3 2.8 2.4 2.7 1.4 1.5 2.9 1.5 2.0 1.6 1.8 0.6 0.8 3.3 2.1 0.6 1.0 0.8 0.9 0.9 0.7 0.6 1.2 0.0 9.6 10.5 7.2 14.7 11.1 10.6 6.8 10.2 12.4 0.0 0.0 7.6 7.2 10.3 1.8 8.4 5.0 8.0 1.0 0.0 4.4 35.7 0.0 0.0 5.8 1.8 11.1 14.1 0.0 2.8 7.8 11.7 0.0 7.0 0.0 10.0 3.7 3.4 13.5 11.3 1.9 2.0 11.3 12.6 88.9 9.9 10.5 3.6 6.5 8.0 12.1 18.6 7.5 6.7 1.3 0.0 10.9 12.2 11.7 1.9 3.3 7.5 8.6 13.1 6.5 5.9 20.3 7.7 12.8 9.5 3.7 12.7 0.1 2.4 12.0 ZMAT4 FLJ13842 ENSG00000165061 "Zinc finger matrin-type 4" Q9H898 8 40530590-40897833 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 15.5;retina: 4.4;thyroid gland: 16.3" "Group enriched" "Detected in some" 6 "Excitatory neurons: 220.9;Inhibitory neurons: 507.5" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 86 "NK-cell: 8.6" "Lineage enriched" "Detected in single" 86 "NK-cells: 8.6" "Group enriched" "Detected in some" 5 "AF22: 22.5;U-2197: 14.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA069813, HPA071585" Enhanced Approved Nucleoplasm,Nucleoli No NA "Cluster 48: NK-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nucleoli" "HPA069813: AB_2686206, HPA071585: AB_2686423" "unprognostic (1.25e-2)" "unprognostic (9.29e-2)" "unprognostic (2.80e-1)" "unprognostic (2.83e-3)" "unprognostic (1.00e-1)" "unprognostic (1.42e-1)" "unprognostic (1.07e-1)" "unprognostic (9.73e-2)" "unprognostic (1.24e-1)" "unprognostic (2.02e-2)" "unprognostic (4.46e-4)" "unprognostic (5.44e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.79e-3)" 0.0 0.7 3.2 0.1 7.5 0.0 0.1 1.6 15.0 1.4 0.0 0.7 0.0 0.3 0.1 0.0 0.1 0.1 0.4 6.2 2.7 0.3 0.0 0.0 0.1 15.5 4.5 0.4 0.1 0.0 1.8 0.1 15.4 0.6 0.2 4.4 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.3 0.1 1.4 11.1 0.3 16.3 0.0 0.1 0.0 0.0 4.1 0.0 1.3 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.3 0.0 0.0 0.3 0.0 0.0 1.1 0.3 0.0 0.0 0.0 1.7 3.6 0.0 0.0 0.0 0.6 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.1 3.2 7.5 1.6 15.0 6.2 2.7 15.5 4.5 15.4 0.3 11.1 4.1 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.0 0.0 8.5 0.1 0.0 0.9 2.8 0.0 0.0 6.2 0.0 1.0 0.0 1.9 0.0 19.7 0.0 0.1 0.0 1.8 0.0 220.9 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 507.5 0.0 0.0 0.0 0.0 55.2 2.8 0.0 0.0 7.5 0.0 1.3 42.2 13.0 4.0 0.0 0.0 2.2 0.0 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.1 0.3 0.6 0.1 0.1 ZNF16 KOX9 ENSG00000170631 "Zinc finger protein 16" P17020 8 144930358-144950888 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Cell division, Transcription, Transcription regulation" "Activator, DNA-binding, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035782, HPA061835" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 15: NK-cells - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA035782: AB_10603243, HPA061835: AB_2684621" "unprognostic (4.11e-2)" "unprognostic (1.51e-2)" "unprognostic (6.87e-2)" "unprognostic (2.45e-1)" "unprognostic (2.69e-1)" "prognostic favorable (2.39e-4)" "unprognostic (7.53e-3)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (8.50e-2)" "unprognostic (1.45e-1)" "unprognostic (2.21e-1)" "unprognostic (8.59e-2)" "unprognostic (1.70e-2)" "unprognostic (2.96e-1)" "unprognostic (9.75e-2)" "unprognostic (4.17e-3)" 4.6 3.6 4.6 2.4 4.7 2.6 6.3 4.4 5.0 6.0 5.9 6.5 4.7 6.2 6.9 5.9 7.1 5.7 4.4 4.5 4.4 5.3 3.9 3.7 3.2 4.2 4.2 11.0 7.5 8.6 4.0 3.9 4.3 5.4 4.7 5.1 4.6 5.6 8.3 9.3 4.8 5.5 4.5 3.4 5.0 7.5 4.8 4.4 7.0 8.3 3.9 5.7 6.0 4.6 4.5 3.9 7.7 4.2 6.4 9.0 5.5 4.0 8.9 8.0 7.2 3.1 4.5 7.1 5.2 5.2 4.3 3.5 5.4 8.9 7.2 3.1 4.5 8.2 4.4 4.5 10.7 3.0 4.6 10.9 8.8 5.1 13.2 7.9 4.4 5.3 5.7 4.7 6.4 6.2 6.1 3.0 4.7 6.9 8.8 7.5 4.5 4.5 6.8 6.7 6.4 4.7 8.5 5.1 6.9 5.8 9.5 5.6 4.7 3.6 7.5 4.3 4.5 3.4 3.1 6.4 4.1 4.0 5.8 2.6 3.0 2.2 4.9 2.9 5.6 2.8 3.8 4.5 4.8 4.4 3.8 3.5 0.4 9.2 3.0 2.5 5.8 3.2 4.6 4.7 4.4 5.0 4.5 4.4 4.2 4.2 4.3 4.5 4.8 4.6 3.6 3.2 4.4 4.9 3.4 2.7 6.9 6.8 5.2 11.4 4.3 2.9 3.7 5.7 3.1 9.2 12.5 5.9 7.0 3.2 1.9 7.3 10.3 2.0 3.5 3.7 4.2 3.0 6.8 4.4 3.6 3.8 5.1 3.9 7.0 9.4 5.0 4.5 3.6 6.7 6.3 5.6 6.1 3.5 2.4 3.7 6.2 2.1 1.8 6.5 5.4 6.2 7.2 6.6 7.2 3.6 4.9 6.4 3.2 4.2 10.6 4.8 3.4 25.1 0.0 3.4 4.0 13.6 18.1 4.5 4.5 5.5 5.1 6.6 5.4 5.5 ZNF175 OTK18 ENSG00000105497 "Zinc finger protein 175" Q9Y473 19 51571283-51592510 "Predicted intracellular proteins, Transcription factors" "Antiviral defense, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HEL: 50.6;RT4: 45.4;TIME: 45.7" "Low region specificity" "Detected in all" "HPA002717, HPA074615" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoli Cytosol "HPA002717: AB_1080681, HPA074615: " "unprognostic (9.41e-2)" "unprognostic (1.43e-1)" "unprognostic (2.44e-1)" "unprognostic (1.59e-1)" "unprognostic (1.46e-1)" "unprognostic (9.50e-3)" "unprognostic (2.44e-1)" "unprognostic (1.84e-1)" "unprognostic (7.33e-3)" "unprognostic (9.94e-2)" "unprognostic (6.33e-3)" "unprognostic (6.20e-2)" "unprognostic (1.35e-3)" "unprognostic (1.50e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (6.64e-4)" "unprognostic (3.50e-3)" 3.1 3.9 4.6 4.3 5.0 3.5 5.4 11.2 6.2 3.9 6.7 3.9 5.5 5.9 5.2 3.1 4.7 3.1 4.4 3.9 4.8 4.4 3.1 4.9 6.0 4.7 4.4 8.9 3.3 10.0 6.2 8.0 4.5 4.0 3.8 11.3 6.0 4.9 4.6 3.6 4.3 5.1 3.9 6.0 4.5 10.3 5.9 5.2 6.9 3.6 6.1 3.8 3.2 6.7 3.6 6.3 6.2 6.6 6.5 9.0 0.1 8.1 10.3 7.4 8.9 6.4 5.5 6.6 4.6 8.2 4.6 5.9 6.8 5.6 13.2 0.0 10.0 50.6 10.5 2.2 5.7 8.5 31.1 3.5 5.1 15.1 7.3 37.2 12.1 6.3 17.3 6.7 8.1 0.0 9.2 6.3 3.5 4.4 6.4 0.0 8.1 3.2 4.0 45.4 7.9 5.7 7.6 2.5 4.7 5.0 1.8 6.9 45.7 11.3 5.1 2.6 7.9 8.8 17.6 6.8 31.4 5.0 5.8 0.0 0.4 0.0 0.4 0.1 0.5 0.5 0.4 0.4 0.4 0.5 0.6 0.5 0.2 0.2 0.1 1.4 0.1 0.2 4.6 5.0 11.2 6.2 3.9 4.8 4.7 4.4 4.5 3.9 5.9 6.7 3.6 6.4 5.4 12.1 3.4 1.1 1.5 1.7 1.8 8.0 2.7 2.5 3.5 1.5 5.3 5.5 2.1 7.9 4.1 1.5 1.9 1.9 11.6 1.4 2.9 3.9 1.8 16.2 11.6 1.6 1.5 3.4 2.6 1.5 14.0 5.5 6.4 2.4 3.2 16.8 12.8 1.3 2.0 5.9 2.1 10.6 3.4 2.4 3.6 10.3 3.1 2.6 5.2 12.5 17.5 6.9 0.6 2.6 1.6 1.8 4.4 2.0 4.4 7.8 0.0 4.3 2.6 6.3 4.3 2.1 1.4 12.0 2.4 3.2 2.0 0.8 ZNF324B FLJ45850 ENSG00000249471 "Zinc finger protein 324B" Q6AW86 19 58451611-58457833 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 22.9;Inhibitory neurons: 10.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 6 "NK-cell: 4.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 4.0" "Cell line enhanced" "Detected in all" "HEK 293: 38.7" HPA023400 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoli Cytosol "HPA023400: AB_1859195" "unprognostic (2.75e-1)" "unprognostic (2.36e-2)" "unprognostic (2.27e-1)" "unprognostic (1.35e-1)" "unprognostic (2.19e-1)" "unprognostic (5.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.47e-3)" "unprognostic (2.65e-1)" "unprognostic (3.21e-1)" "prognostic favorable (2.83e-4)" "unprognostic (5.58e-2)" "unprognostic (2.43e-1)" "unprognostic (9.50e-2)" "unprognostic (1.40e-1)" "unprognostic (1.56e-3)" "unprognostic (2.94e-2)" 2.4 2.2 1.0 2.8 1.1 1.7 2.7 2.3 2.3 3.4 0.4 2.3 1.8 2.9 1.4 3.0 3.0 2.1 1.8 1.3 0.4 2.3 2.4 2.2 2.3 0.8 0.2 3.0 3.6 2.6 3.0 1.4 0.4 2.7 1.8 1.9 2.7 2.4 3.1 3.8 2.3 2.2 0.0 3.4 2.6 3.0 0.3 2.5 2.8 1.7 2.0 3.0 2.6 0.8 5.9 9.6 5.2 8.6 3.6 3.1 3.8 5.2 3.8 4.2 3.0 3.4 2.5 8.0 3.2 3.1 4.3 4.8 6.9 4.8 3.2 8.1 38.7 6.9 8.5 1.3 3.7 11.3 9.8 3.1 4.8 4.7 4.0 2.7 3.0 7.0 10.1 4.7 4.3 3.9 8.4 2.7 2.8 6.9 5.4 7.9 6.8 4.8 2.7 11.4 12.2 7.0 4.9 7.9 1.3 3.5 2.9 3.2 3.5 9.9 2.5 5.3 8.5 10.2 9.9 5.7 3.9 4.8 3.9 0.0 0.6 0.0 0.6 0.3 0.4 0.2 0.3 0.4 0.3 0.5 0.6 0.4 0.7 4.0 0.2 0.3 0.2 0.5 1.0 1.1 2.3 2.3 1.3 0.4 0.8 0.2 0.4 0.0 0.3 0.8 1.8 0.0 0.5 9.1 2.9 0.8 1.0 0.6 1.8 3.1 1.6 1.3 0.9 1.5 2.2 1.8 22.9 0.9 2.4 2.2 0.0 1.8 1.0 1.9 3.1 1.5 0.0 2.1 9.5 1.6 0.9 1.5 1.5 1.2 0.0 1.8 1.4 1.3 0.9 5.0 10.6 1.0 0.0 2.2 0.4 1.8 3.1 1.2 0.0 0.0 2.0 2.0 3.1 7.5 9.5 1.4 0.6 2.6 1.5 1.0 1.2 1.2 2.7 6.6 6.6 2.3 1.6 6.6 4.8 1.2 1.0 0.7 2.0 4.2 1.3 1.0 ZNF330 "HSA6591, NOA36" ENSG00000109445 "Zinc finger protein 330" Q9Y3S2 4 141220887-141234697 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 154.0;Early spermatids: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015705, HPA056325" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 38: Heart - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoli Nucleoplasm "HPA015705: AB_1859199, HPA056325: AB_2683101" "unprognostic (1.90e-1)" "unprognostic (4.65e-2)" "unprognostic (3.66e-1)" "unprognostic (1.35e-2)" "unprognostic (4.12e-1)" "unprognostic (5.93e-2)" "unprognostic (2.37e-1)" "unprognostic (2.32e-3)" "unprognostic (4.49e-3)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (3.66e-6)" "prognostic favorable (7.27e-6)" "unprognostic (3.24e-1)" "unprognostic (4.60e-2)" "unprognostic (2.02e-2)" "unprognostic (1.30e-2)" 29.1 26.8 11.9 20.3 12.6 35.5 22.8 14.3 15.7 23.1 15.0 30.9 18.5 26.0 17.6 25.2 25.6 19.8 100.3 11.0 12.8 26.0 51.7 25.1 28.6 13.3 12.6 25.1 26.9 23.9 15.5 20.2 13.2 21.0 22.7 25.0 48.1 20.1 67.1 19.0 21.2 32.1 12.9 23.2 22.8 26.3 13.1 21.5 37.4 43.4 26.7 23.4 18.7 14.6 20.7 24.8 29.5 23.4 51.7 46.1 41.3 54.0 31.1 34.1 32.1 33.5 38.6 87.6 32.4 34.3 19.3 16.1 52.6 35.0 51.7 40.8 34.4 40.7 39.2 47.6 55.2 103.8 31.6 46.6 40.3 32.0 46.4 41.4 36.1 53.1 84.3 57.9 43.8 46.4 80.9 48.6 26.3 63.2 46.7 65.0 42.2 55.9 36.7 22.6 51.1 23.8 19.0 42.9 55.7 33.0 21.5 28.1 38.7 43.3 29.4 26.3 39.1 96.1 74.7 83.2 36.2 63.8 31.6 16.3 27.4 16.7 15.9 22.7 22.3 21.6 20.1 20.7 28.9 17.7 21.6 20.0 4.1 20.1 18.8 19.6 25.9 16.3 11.9 12.6 14.3 15.7 11.0 12.8 13.3 12.6 13.2 12.9 13.1 14.6 32.5 54.5 32.4 8.1 31.9 49.2 53.9 22.3 35.3 63.0 21.5 29.1 154.0 27.1 26.2 9.2 14.6 38.2 29.8 21.2 58.7 32.7 197.7 34.9 58.2 31.5 16.8 29.6 13.0 51.0 37.9 35.3 18.8 26.9 22.9 25.7 32.5 70.6 73.5 16.8 13.4 25.7 20.3 56.2 36.0 50.5 39.1 48.2 46.2 20.6 38.1 38.4 14.4 11.6 17.3 43.5 27.8 28.6 27.4 43.6 26.0 78.3 20.3 26.1 13.1 42.4 34.9 46.2 17.7 33.6 51.6 34.3 29.7 38.4 26.9 56.6 ZNF362 "FLJ25476, lin-29, RN" ENSG00000160094 "Zinc finger protein 362" Q5T0B9 1 33256492-33300719 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059239 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA059239: AB_2683955" "unprognostic (8.31e-3)" "unprognostic (2.61e-1)" "unprognostic (2.23e-2)" "unprognostic (6.90e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (4.02e-3)" "unprognostic (2.02e-2)" "unprognostic (7.74e-2)" "unprognostic (1.82e-1)" "unprognostic (9.25e-2)" "unprognostic (1.52e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (2.67e-1)" "unprognostic (5.83e-2)" "unprognostic (2.66e-1)" 15.7 12.0 18.4 8.5 17.2 6.7 15.5 17.2 23.1 19.5 8.5 18.9 7.3 22.0 10.2 12.6 16.3 9.1 20.2 16.9 15.6 15.4 8.9 12.6 9.4 18.3 15.4 17.0 13.5 11.9 17.7 11.3 14.3 20.1 5.5 6.3 16.4 13.3 19.7 17.7 11.6 11.7 12.7 16.2 13.7 7.6 18.0 12.2 16.3 11.3 6.7 18.6 15.0 15.8 6.3 10.3 43.7 17.4 11.3 7.9 27.8 8.6 10.3 10.7 11.3 10.6 21.2 3.0 17.1 11.2 3.3 20.6 10.2 5.0 4.5 18.0 7.5 16.1 6.1 13.2 10.1 7.3 12.3 16.9 12.2 4.7 4.1 10.8 14.8 21.2 1.6 5.5 8.3 15.7 23.9 12.9 23.9 3.9 8.4 39.4 10.4 1.5 8.6 10.2 15.4 46.4 24.8 7.8 39.9 18.5 7.7 19.9 21.0 6.5 8.2 15.2 5.6 15.8 15.3 3.4 5.1 6.7 19.4 1.9 1.9 2.6 1.8 1.7 1.3 1.1 1.3 1.6 1.4 2.9 1.2 1.2 1.4 1.7 2.0 3.5 1.1 1.3 18.4 17.2 17.2 23.1 16.9 15.6 18.3 15.4 14.3 12.7 18.0 15.8 15.6 9.6 12.4 13.1 9.2 10.1 4.7 6.2 20.5 12.8 11.0 11.2 25.5 5.7 7.9 11.0 0.0 11.7 16.6 2.6 1.9 6.6 2.5 5.2 12.0 13.9 1.8 3.4 14.3 7.3 5.9 11.8 3.6 7.6 10.1 15.3 18.2 6.9 10.2 8.4 17.7 4.4 6.1 13.9 5.0 8.0 13.7 11.2 8.8 19.7 9.9 9.2 10.3 26.7 14.3 4.3 10.7 21.4 7.5 1.9 7.3 11.4 2.4 4.9 6.6 12.4 16.7 1.2 5.0 11.4 9.5 3.6 10.6 7.7 6.1 2.9 ZNF428 "C19orf37, MGC51082, Zfp428" ENSG00000131116 "Zinc finger protein 428" Q96B54 19 43607224-43619629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042596, HPA048072" Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoli "HPA042596: AB_2678070, HPA048072: AB_2680249" "unprognostic (2.45e-3)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "unprognostic (6.31e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (3.22e-2)" "unprognostic (2.32e-2)" "unprognostic (2.53e-1)" "unprognostic (6.67e-2)" "prognostic favorable (3.60e-5)" "unprognostic (3.85e-1)" "unprognostic (5.59e-2)" "unprognostic (1.85e-1)" "unprognostic (2.30e-2)" "unprognostic (4.00e-1)" "unprognostic (2.74e-2)" 26.4 43.4 47.5 17.3 45.6 24.0 26.7 39.3 59.8 38.5 28.9 48.8 17.3 43.4 8.9 22.3 34.7 10.7 45.7 46.9 44.9 44.4 39.2 25.2 17.6 44.7 43.9 43.3 30.7 18.1 55.2 13.5 39.0 41.7 6.3 15.6 28.2 14.0 44.1 18.8 25.0 10.7 40.3 30.9 30.1 57.1 52.2 22.0 37.5 14.3 10.0 34.1 26.7 44.6 38.2 33.8 53.2 79.6 20.8 15.5 21.6 28.6 15.6 23.0 24.5 19.8 25.6 66.3 62.7 26.1 13.8 9.4 21.7 6.1 7.8 54.1 87.2 73.4 34.1 34.7 39.0 57.3 55.8 27.8 12.7 19.9 10.3 23.3 32.5 48.3 76.9 40.1 24.6 42.3 140.0 97.9 30.8 17.9 22.8 135.6 23.3 49.1 27.3 25.4 90.2 102.0 44.2 25.5 66.6 14.2 15.3 79.6 55.2 24.1 66.7 22.7 44.5 43.2 56.8 117.1 34.2 56.9 53.4 1.4 2.1 9.3 6.2 1.4 3.1 4.8 5.5 6.1 2.5 6.2 5.9 2.7 0.8 2.6 2.6 5.6 3.9 1.0 47.5 45.6 39.3 59.8 46.9 44.9 44.7 43.9 39.0 40.3 52.2 44.6 67.8 0.0 3.9 26.1 44.5 32.1 80.3 173.5 55.8 101.7 68.6 74.7 19.7 61.5 76.4 66.2 14.6 142.1 78.8 43.1 148.7 89.1 153.3 81.7 79.1 69.3 162.2 66.0 17.6 79.6 46.7 79.3 38.7 59.4 36.3 214.9 76.4 51.4 104.4 57.2 19.7 62.3 156.6 38.6 60.8 63.5 88.9 42.3 113.8 14.0 45.4 191.7 99.9 18.1 26.7 74.5 52.0 90.7 45.5 41.0 30.0 216.8 48.1 72.5 72.3 59.0 102.9 29.6 173.1 44.2 25.9 55.1 71.3 174.1 52.8 53.7 ZNF444 "EZF2, FLJ11137, ZSCAN17" ENSG00000167685 "Zinc finger protein 444" Q8N0Y2 19 56132599-56160893 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 118.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056895, HPA065203" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 22: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Nucleoli "HPA056895: AB_2683267, HPA065203: AB_2685431" "unprognostic (1.58e-1)" "unprognostic (3.34e-1)" "unprognostic (5.00e-2)" "unprognostic (1.23e-2)" "unprognostic (1.26e-1)" "unprognostic (4.57e-2)" "unprognostic (1.32e-2)" "unprognostic (2.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.29e-2)" "unprognostic (1.35e-3)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.61e-4)" "unprognostic (4.70e-2)" "unprognostic (1.32e-1)" "unprognostic (1.32e-1)" "prognostic favorable (1.87e-4)" 13.2 23.4 33.8 6.3 31.4 3.2 15.8 28.3 36.3 24.1 31.3 32.5 11.4 24.9 7.7 16.5 26.1 9.3 23.9 30.5 30.2 23.7 64.3 18.1 5.7 38.6 32.4 26.0 46.4 7.8 29.3 4.8 31.4 35.2 4.2 5.7 21.6 19.6 18.6 14.6 19.0 5.9 29.1 17.7 32.0 21.3 32.6 16.0 28.8 7.0 4.4 25.8 17.7 32.1 11.3 21.1 19.0 16.7 8.0 8.1 12.5 14.0 9.2 11.7 12.6 23.1 12.4 19.7 12.2 8.1 5.9 10.3 11.8 9.5 4.9 17.3 118.4 19.6 15.3 42.4 13.0 8.7 17.4 9.5 8.5 9.5 7.3 17.6 10.6 24.1 25.7 8.6 8.3 14.6 28.4 24.4 20.5 22.3 38.2 32.7 12.3 10.7 13.0 10.2 20.4 28.0 7.1 23.2 11.2 10.3 23.2 15.7 14.4 20.8 18.2 4.6 15.6 20.5 18.9 15.1 13.1 11.8 13.9 1.9 1.1 2.4 2.3 0.9 2.5 1.2 4.0 4.0 1.2 2.3 4.0 2.7 0.1 2.2 0.6 2.1 2.9 1.4 33.8 31.4 28.3 36.3 30.5 30.2 38.6 32.4 31.4 29.1 32.6 32.1 12.2 3.2 18.1 26.1 11.0 3.1 17.4 15.3 5.2 17.9 13.9 11.8 13.9 28.6 17.6 11.0 8.4 18.8 5.6 15.6 9.8 26.4 28.6 16.2 8.9 15.1 29.3 6.1 10.0 21.9 9.7 10.0 20.9 9.2 10.2 16.8 18.5 38.9 10.7 20.2 10.0 28.0 20.3 7.2 6.1 39.2 12.2 5.5 16.0 5.6 13.6 17.7 12.3 14.6 19.0 18.3 9.9 12.0 8.6 13.5 18.7 26.9 18.3 13.4 26.3 8.5 12.6 13.6 25.6 3.4 5.3 12.4 11.2 43.4 22.9 11.0 ZNF507 "KIAA1084, Zfp507" ENSG00000168813 "Zinc finger protein 507" Q8TCN5 19 32345594-32387667 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030964, HPA049728" Uncertain Supported Nucleoli,Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoli Cytosol "HPA030964: AB_10670562, HPA049728: AB_2680864" "unprognostic (3.39e-1)" "unprognostic (3.78e-2)" "unprognostic (6.84e-2)" "unprognostic (2.61e-2)" "unprognostic (2.21e-2)" "unprognostic (1.74e-2)" "unprognostic (1.41e-3)" "unprognostic (1.20e-1)" "unprognostic (3.24e-2)" "unprognostic (4.28e-3)" "unprognostic (7.24e-2)" "unprognostic (7.44e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-1)" "unprognostic (1.89e-1)" "unprognostic (2.97e-2)" "unprognostic (1.46e-2)" 5.1 4.2 4.3 4.6 5.7 6.8 6.8 6.4 5.6 5.9 3.4 4.9 5.7 6.8 4.3 5.1 5.9 4.3 5.6 4.4 4.8 4.7 6.3 4.4 6.7 4.7 5.3 9.5 5.3 6.2 3.7 7.0 5.0 5.9 5.3 8.1 6.4 4.7 9.2 4.7 5.9 6.0 4.8 5.2 5.2 13.1 4.7 8.6 10.7 8.7 5.8 4.3 4.1 7.3 10.0 16.2 13.5 8.2 9.3 14.6 11.4 8.5 8.1 7.3 8.1 9.8 7.6 15.1 10.5 7.8 8.3 5.9 19.4 10.5 14.8 10.6 15.3 14.8 8.7 7.7 11.0 12.8 8.0 9.5 8.9 9.0 15.4 8.6 10.9 11.9 21.0 10.7 8.6 5.8 13.5 5.2 14.9 15.0 5.8 14.0 16.1 6.4 5.5 9.9 11.9 10.5 11.2 7.8 10.2 10.7 5.9 9.5 10.4 12.6 13.3 8.0 11.9 10.4 12.9 14.1 8.7 9.3 11.5 0.2 0.0 0.5 1.0 0.0 1.1 0.7 0.8 0.8 0.0 1.0 1.1 0.9 0.5 0.6 0.0 0.1 0.6 0.4 4.3 5.7 6.4 5.6 4.4 4.8 4.7 5.3 5.0 4.8 4.7 7.3 13.3 9.6 17.7 22.5 13.2 2.8 8.8 5.3 13.6 22.2 9.3 7.6 16.1 5.7 9.0 0.0 14.6 10.9 7.7 7.6 1.9 5.6 22.1 10.0 22.7 11.0 9.0 12.4 31.3 5.5 5.3 11.9 12.2 11.4 3.8 17.1 13.6 12.1 3.7 58.9 36.0 11.5 4.1 0.3 1.8 11.0 9.3 0.8 1.8 16.9 0.4 17.2 10.3 31.2 46.6 4.9 8.0 7.2 6.4 12.0 15.6 4.2 16.1 23.5 0.0 16.1 13.9 25.8 18.9 10.9 2.7 8.8 11.3 12.6 11.2 7.6 ZNF554 FLJ34817 ENSG00000172006 "Zinc finger protein 554" Q86TJ5 19 2819868-2836735 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "HPA060247, HPA063358" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm Nucleoli "HPA060247: AB_2684230, HPA063358: AB_2684995" "unprognostic (3.81e-1)" "unprognostic (1.89e-3)" "unprognostic (1.84e-1)" "unprognostic (3.58e-3)" "unprognostic (5.05e-2)" "unprognostic (7.36e-5)" "unprognostic (1.65e-1)" "prognostic favorable (9.31e-4)" "unprognostic (1.82e-1)" "unprognostic (3.37e-3)" "prognostic favorable (4.69e-4)" "unprognostic (1.57e-1)" "prognostic favorable (1.99e-5)" "unprognostic (1.75e-1)" "unprognostic (9.91e-3)" "unprognostic (1.79e-2)" "prognostic favorable (5.00e-4)" 2.0 2.0 2.9 0.6 2.8 0.5 2.5 2.7 4.0 3.0 1.5 2.6 1.3 2.6 1.2 2.5 2.3 0.6 3.3 2.7 2.8 2.9 3.1 1.4 0.6 2.9 2.4 3.7 3.1 1.5 2.9 1.1 2.9 2.7 0.8 2.5 2.7 0.9 5.2 3.5 2.3 0.6 1.8 1.9 2.5 2.5 3.5 0.9 2.6 2.1 0.7 2.7 2.6 2.4 1.2 0.2 0.9 1.3 0.7 0.9 1.3 0.7 0.6 1.0 0.7 0.1 0.3 1.5 0.6 0.4 1.1 0.7 0.2 0.7 0.8 0.0 0.5 0.5 0.8 0.4 0.6 0.2 0.5 0.7 1.0 0.4 0.7 0.9 0.3 1.1 1.1 0.8 0.5 0.6 1.1 0.3 0.7 0.2 0.1 1.3 0.6 0.3 0.5 1.1 1.5 1.8 0.5 0.3 1.1 0.9 0.4 0.8 0.2 0.4 0.4 0.6 0.4 2.3 2.8 0.4 0.6 0.7 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 0.0 0.6 0.3 0.1 0.1 0.2 0.2 0.9 0.1 0.2 2.9 2.8 2.7 4.0 2.7 2.8 2.9 2.4 2.9 1.8 3.5 2.4 2.2 12.8 12.5 2.9 3.5 1.3 2.8 1.0 4.0 4.9 2.3 2.2 4.6 1.5 4.6 0.0 8.4 2.8 1.5 3.4 3.9 2.6 0.8 2.1 1.9 3.1 3.6 3.4 4.0 1.4 1.3 3.4 1.5 2.7 0.0 4.4 3.3 2.9 1.5 3.3 4.8 2.0 2.0 2.4 2.5 0.7 3.1 1.6 0.0 1.0 1.4 4.7 5.2 3.5 2.7 1.7 1.0 2.6 3.3 3.3 5.9 3.0 5.5 4.9 0.0 3.8 2.3 7.0 12.2 2.7 1.4 8.8 2.7 3.7 2.2 2.1 ZNF577 MGC4400 ENSG00000161551 "Zinc finger protein 577" Q9BSK1 19 51804816-51890950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 39.2;Early spermatids: 56.3;Late spermatids: 60.6;Oligodendrocytes: 50.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041499, HPA046761" Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 36: HEL - Hemostasis" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Nucleoli" "HPA041499: AB_2677516, HPA046761: AB_2679791" "unprognostic (1.17e-1)" "unprognostic (2.71e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-1)" "unprognostic (8.21e-2)" "unprognostic (1.45e-3)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (3.01e-3)" "unprognostic (1.18e-1)" "unprognostic (1.04e-1)" "unprognostic (6.51e-3)" "unprognostic (2.81e-3)" "unprognostic (2.72e-2)" "unprognostic (2.70e-1)" "unprognostic (7.02e-2)" "prognostic favorable (2.03e-4)" 9.4 7.2 11.9 5.4 15.0 4.2 12.2 14.2 13.2 14.3 8.0 14.5 4.6 11.7 7.1 6.8 12.7 8.0 12.2 11.5 16.1 13.6 6.8 7.9 5.5 14.0 12.3 27.1 8.8 14.9 8.4 9.3 13.3 18.4 6.6 16.9 12.0 11.3 7.2 20.6 9.0 7.2 10.2 12.7 8.9 18.8 13.5 7.7 18.7 9.1 5.7 11.1 9.3 21.0 1.6 0.1 7.8 9.5 13.1 14.1 0.0 9.3 3.4 3.5 7.1 1.0 1.3 1.6 0.9 4.3 5.2 2.5 3.1 1.9 1.9 0.0 9.0 15.6 0.2 1.4 10.2 3.4 5.1 11.1 5.8 5.2 1.5 10.9 1.8 0.0 3.5 0.1 4.5 0.0 9.7 4.4 9.0 0.0 0.2 4.2 3.9 2.9 5.8 3.4 3.2 1.6 2.3 1.1 8.0 7.9 1.6 3.7 1.2 6.4 8.8 1.8 3.4 6.3 0.0 2.0 1.7 0.6 10.6 4.4 1.6 3.7 0.9 2.5 2.7 7.2 1.8 2.2 1.8 3.5 2.2 1.4 0.6 3.3 2.0 2.0 0.9 1.1 11.9 15.0 14.2 13.2 11.5 16.1 14.0 12.3 13.3 10.2 13.5 21.0 8.8 0.0 2.6 14.4 4.0 4.5 3.7 4.0 2.2 12.2 8.1 7.9 8.5 4.3 3.0 18.4 10.4 7.2 4.8 2.7 39.2 4.3 56.3 7.2 7.4 6.6 3.0 2.1 20.1 1.1 5.4 6.3 4.1 5.6 5.1 9.8 7.1 1.8 5.7 6.7 19.3 4.7 2.0 2.2 3.7 60.6 8.1 6.7 0.0 9.4 4.0 15.2 1.0 26.2 50.1 1.2 1.9 12.8 0.9 5.9 5.1 4.9 3.0 9.9 0.0 6.9 7.6 12.3 14.0 4.2 5.3 4.5 2.5 4.2 4.4 3.0 ZNF583 FLJ31030 ENSG00000198440 "Zinc finger protein 583" Q96ND8 19 56397966-56436035 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 60.5;Late spermatids: 43.0;Spermatocytes: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023805, HPA023957" Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli Cytosol "HPA023805: AB_2671318, HPA023957: AB_2671383" "unprognostic (9.89e-3)" "unprognostic (5.52e-3)" "unprognostic (8.14e-2)" "unprognostic (2.89e-2)" "unprognostic (1.15e-1)" "unprognostic (6.69e-3)" "unprognostic (1.49e-1)" "unprognostic (1.85e-1)" "unprognostic (2.31e-2)" "unprognostic (1.79e-2)" "unprognostic (8.43e-3)" "unprognostic (5.00e-2)" "unprognostic (9.54e-5)" "unprognostic (2.30e-2)" "unprognostic (1.16e-1)" "unprognostic (2.37e-2)" "unprognostic (2.54e-2)" 3.2 2.4 3.9 1.7 4.0 1.0 1.9 5.6 4.2 2.2 1.3 2.1 1.3 2.6 2.2 1.5 2.4 2.3 2.1 3.7 4.9 2.8 2.6 2.8 1.8 4.0 3.9 4.6 2.6 4.0 2.7 2.0 3.8 2.4 1.4 4.0 0.9 1.9 2.1 0.8 1.3 2.6 4.2 2.4 1.6 7.4 3.9 2.7 3.4 3.3 1.8 2.1 1.3 4.3 0.0 2.1 4.9 0.0 3.4 2.7 0.0 6.2 6.2 2.8 2.3 0.3 0.7 4.7 3.0 5.7 5.1 0.3 2.0 1.9 3.0 2.2 10.8 6.2 0.0 1.1 3.9 5.2 5.4 3.8 3.0 4.0 2.0 4.1 2.8 4.8 2.3 1.7 9.3 0.0 6.5 1.7 1.2 0.0 2.0 3.2 9.3 3.5 2.2 4.5 2.8 4.2 0.0 0.6 1.6 2.5 3.1 6.6 1.9 14.5 4.0 2.8 12.4 6.2 12.3 7.4 0.3 1.4 5.2 9.7 1.5 3.3 3.1 2.2 4.6 4.5 2.5 2.9 1.7 3.5 4.6 2.8 0.6 6.1 3.7 2.4 3.6 1.9 3.9 4.0 5.6 4.2 3.7 4.9 4.0 3.9 3.8 4.2 3.9 4.3 7.7 3.2 1.5 4.6 7.9 1.8 3.2 2.8 0.6 17.5 3.5 1.8 5.3 0.0 1.9 1.8 6.2 1.8 4.9 0.6 9.8 5.7 60.5 2.1 6.2 6.6 0.0 9.1 14.6 2.7 0.5 6.5 1.1 2.9 10.8 10.5 7.5 2.4 3.9 10.1 12.1 1.6 0.0 3.3 4.3 43.0 6.8 3.3 3.6 4.7 3.8 12.2 16.5 15.1 12.0 2.5 1.8 13.5 1.6 3.0 1.2 5.2 1.7 15.1 6.6 13.8 7.1 30.6 17.2 0.6 1.7 1.1 6.8 6.9 1.4 2.4 ZNF593 ZT86 ENSG00000142684 "Zinc finger protein 593" O00488 1 26169908-26170873 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054363, HPA059387" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA054363: AB_2682462, HPA059387: AB_2684001" "unprognostic (1.23e-2)" "unprognostic (8.97e-2)" "unprognostic (7.13e-2)" "unprognostic (7.42e-2)" "unprognostic (9.37e-2)" "unprognostic (5.92e-2)" "unprognostic (1.63e-2)" "unprognostic (8.96e-2)" "unprognostic (5.06e-1)" "unprognostic (1.76e-2)" "unprognostic (1.78e-1)" "unprognostic (1.08e-1)" "unprognostic (4.46e-2)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.66e-1)" "unprognostic (4.79e-2)" 35.8 31.8 20.0 12.6 21.0 20.3 30.7 21.4 25.6 18.1 20.6 23.6 13.0 22.7 6.6 32.5 23.0 6.1 37.9 20.3 23.0 40.2 63.9 21.8 10.1 21.1 22.3 32.1 61.5 16.4 25.7 9.3 22.7 31.3 6.2 2.5 24.3 7.6 101.3 32.4 21.1 7.0 20.6 28.2 39.0 16.3 20.8 4.6 28.0 21.9 8.3 25.5 20.7 21.5 76.0 41.3 13.1 48.4 13.3 17.3 72.2 32.8 16.5 37.3 36.3 62.8 44.4 87.2 58.9 21.0 29.7 48.3 47.2 43.5 13.5 53.1 150.6 59.6 33.6 98.3 56.6 82.5 50.0 31.4 41.8 41.8 43.7 15.5 32.3 20.6 91.4 32.7 23.1 58.1 34.1 154.7 53.0 72.7 143.0 42.0 23.6 89.8 27.7 32.8 35.7 39.4 39.8 98.4 132.1 10.7 41.0 46.3 33.6 35.7 42.0 75.8 62.4 64.1 71.3 97.2 42.2 171.1 46.9 0.5 41.3 0.6 35.6 69.1 33.0 64.2 48.7 34.9 57.5 63.3 36.1 34.6 1.9 44.6 70.9 70.4 58.4 39.3 20.0 21.0 21.4 25.6 20.3 23.0 21.1 22.3 22.7 20.6 20.8 21.5 38.9 12.8 57.9 2.6 56.8 171.3 180.9 67.7 128.1 18.0 116.1 142.0 6.0 88.6 50.6 60.7 2.1 114.5 29.8 86.1 103.7 102.2 6.7 70.7 62.6 45.1 109.8 26.5 2.5 147.0 158.5 49.7 75.4 83.4 50.9 62.2 40.7 201.5 79.4 3.3 3.2 156.7 36.7 59.9 52.3 14.3 32.3 37.3 49.8 0.0 47.2 20.9 21.6 2.0 2.1 130.8 61.6 23.3 94.9 197.2 71.7 218.0 27.8 16.7 13.1 65.1 57.7 39.0 52.2 111.6 168.4 222.6 28.8 68.0 128.4 185.3 ZNF596 ENSG00000172748 "Zinc finger protein 596" Q8TC21 8 232137-264703 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.1;Late spermatids: 20.4;Oligodendrocytes: 20.7;Spermatocytes: 63.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 11.4" "Low region specificity" "Detected in all" HPA055463 Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 42: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Mitochondria" "HPA055463: AB_2682821" "unprognostic (3.30e-1)" "unprognostic (1.47e-1)" "unprognostic (3.01e-2)" "unprognostic (2.41e-1)" "unprognostic (2.90e-1)" "unprognostic (9.07e-3)" "unprognostic (9.68e-3)" "unprognostic (2.10e-3)" "unprognostic (1.74e-1)" "unprognostic (4.84e-1)" "unprognostic (1.70e-5)" "unprognostic (6.37e-2)" "unprognostic (1.20e-1)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "unprognostic (3.51e-1)" "unprognostic (4.53e-1)" 2.6 3.5 4.2 2.0 4.5 1.8 5.2 8.3 5.0 3.8 4.6 2.7 2.7 7.1 7.0 2.3 4.1 2.1 3.4 4.0 5.5 4.2 3.0 3.1 3.8 4.4 4.1 5.0 3.4 4.9 4.6 3.6 4.3 3.9 3.2 18.7 2.3 4.0 2.9 4.5 2.6 3.2 3.2 5.0 3.7 15.5 5.1 3.4 5.7 1.8 2.8 2.7 2.5 6.8 1.6 1.1 4.5 11.4 2.1 2.3 3.6 3.6 1.5 1.3 2.4 1.1 2.0 1.6 1.3 2.7 1.9 3.3 1.2 2.6 1.7 1.2 1.9 3.3 3.3 1.3 2.4 1.4 1.8 4.8 0.4 1.5 2.4 2.2 1.0 5.7 2.4 5.4 7.8 5.6 4.0 1.8 2.4 3.0 1.1 1.6 1.0 2.7 4.4 2.7 2.7 6.7 2.3 1.2 1.8 2.3 3.6 4.1 2.6 3.3 0.9 0.3 1.8 1.7 5.1 2.2 4.1 1.4 2.4 4.6 1.5 2.3 2.4 1.2 3.1 3.2 2.5 2.2 1.7 3.6 2.9 3.4 1.4 1.5 2.9 2.3 2.9 1.3 4.2 4.5 8.3 5.0 4.0 5.5 4.4 4.1 4.3 3.2 5.1 6.8 2.3 3.2 2.7 10.1 2.2 0.4 0.7 2.6 2.2 8.3 1.3 1.8 2.9 1.5 2.4 1.8 2.1 2.1 0.8 1.6 3.9 2.1 60.1 1.5 2.7 2.5 0.0 1.7 14.1 1.7 1.4 2.1 5.1 1.3 5.1 2.9 2.2 0.9 1.1 11.8 15.7 1.5 4.1 0.8 0.3 20.4 4.1 0.9 0.0 9.4 0.5 5.4 1.0 15.6 20.7 1.3 0.5 1.2 2.9 0.7 1.6 1.9 3.8 9.0 0.0 2.6 1.8 63.7 4.5 3.1 0.4 1.5 1.8 2.9 1.5 0.5 ZNF597 "FLJ33071, HIT-4" ENSG00000167981 "Zinc finger protein 597" Q96LX8 16 3432414-3443504 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 25.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 8.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001556 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nucleoli" "HPA001556: AB_1080740" "unprognostic (1.98e-1)" "unprognostic (8.07e-2)" "unprognostic (1.03e-1)" "unprognostic (9.15e-3)" "unprognostic (2.88e-1)" "unprognostic (6.16e-2)" "unprognostic (1.84e-2)" "unprognostic (5.56e-2)" "unprognostic (3.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.34e-1)" "unprognostic (8.75e-3)" "unprognostic (4.73e-2)" "unprognostic (7.26e-2)" "unprognostic (4.58e-1)" "unprognostic (2.89e-1)" "unprognostic (5.99e-3)" 1.6 1.9 1.1 1.5 1.1 1.9 1.7 1.0 1.3 1.4 0.8 1.1 1.2 1.5 2.1 1.1 1.4 1.9 1.3 1.0 1.5 1.3 1.7 2.4 2.1 0.9 1.1 2.0 1.6 1.4 1.3 2.3 1.0 1.4 1.0 2.3 1.1 1.2 0.7 1.3 1.3 1.2 1.0 1.8 1.2 3.9 1.4 1.5 2.0 1.1 1.8 1.6 0.9 1.2 0.0 1.2 1.5 3.7 1.1 1.7 5.9 1.8 2.2 1.7 2.1 0.0 2.3 3.1 1.7 2.0 1.3 1.0 3.5 1.6 2.2 1.9 1.4 5.3 3.6 2.2 1.6 3.2 3.1 2.2 2.5 1.9 2.1 1.7 4.7 1.6 1.1 2.0 2.0 1.0 2.3 3.3 5.0 1.4 0.0 1.4 4.5 2.1 1.4 4.9 2.0 2.8 3.5 1.8 1.4 4.1 1.5 4.7 3.1 2.8 1.4 0.0 1.7 2.6 2.9 0.4 0.0 1.8 1.7 3.1 0.8 8.8 0.9 1.7 1.5 0.9 0.7 0.8 0.8 0.7 1.2 0.9 0.2 0.7 0.8 0.4 1.2 0.6 1.1 1.1 1.0 1.3 1.0 1.5 0.9 1.1 1.0 1.0 1.4 1.2 8.3 25.6 2.6 0.0 4.3 0.1 1.8 0.3 2.8 2.1 4.3 3.8 1.9 1.5 5.2 1.8 0.0 1.2 3.6 1.4 0.0 1.1 8.1 3.8 2.1 4.2 2.4 0.4 2.9 1.0 1.8 2.6 1.5 4.5 3.8 3.0 2.5 1.4 1.2 0.0 1.9 2.1 0.0 1.0 0.7 4.1 1.2 2.7 0.0 4.7 3.0 1.8 0.0 1.0 2.0 1.8 1.0 2.2 2.1 2.4 0.7 1.3 0.9 3.1 6.6 2.7 2.6 5.3 8.0 1.9 0.4 1.5 3.3 1.1 2.4 2.3 ZNF615 FLJ33710 ENSG00000197619 "Zinc finger protein 615" Q8N8J6 19 51991332-52008230 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Cancer enriched" "Detected in all" 4 "prostate cancer: 11.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA052422 Uncertain Approved Nucleoli,Mitochondria NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Mitochondria Nucleoli "HPA052422: AB_2681825" "unprognostic (2.20e-1)" "unprognostic (4.66e-2)" "unprognostic (4.56e-1)" "unprognostic (2.64e-1)" "unprognostic (4.08e-3)" "unprognostic (7.28e-2)" "unprognostic (5.23e-2)" "unprognostic (3.68e-1)" "unprognostic (4.44e-3)" "unprognostic (2.44e-2)" "unprognostic (4.41e-2)" "unprognostic (4.80e-2)" "unprognostic (1.77e-1)" "unprognostic (8.16e-3)" "unprognostic (3.03e-1)" "unprognostic (1.82e-1)" "prognostic favorable (2.98e-4)" 5.2 3.7 4.1 2.9 6.5 5.7 6.6 9.4 5.6 4.9 3.4 4.8 3.5 7.8 4.7 4.2 6.4 5.0 5.9 4.5 6.0 6.0 3.9 5.1 4.4 3.7 4.6 10.2 3.8 10.1 4.6 5.6 3.7 17.5 3.6 9.8 5.5 6.3 3.7 4.7 3.1 6.5 1.8 5.3 4.1 3.7 4.6 4.7 7.6 6.8 4.3 4.2 3.5 8.6 1.5 6.2 5.8 12.4 11.2 8.1 4.7 4.5 6.9 6.4 5.7 1.2 1.7 2.2 2.4 5.0 3.9 1.5 4.7 3.1 5.2 0.3 10.0 7.5 5.6 4.3 8.6 0.0 4.1 6.8 3.7 10.2 10.2 10.6 3.0 2.7 0.0 0.0 4.3 0.5 0.0 3.8 6.1 0.2 9.6 4.7 10.2 4.0 3.9 10.3 5.4 4.7 5.4 4.7 3.2 6.3 7.1 3.4 5.9 5.4 6.2 3.3 3.3 4.3 12.3 2.8 3.0 0.0 8.7 5.8 2.2 4.2 2.5 3.2 5.3 2.8 4.5 3.6 3.3 2.9 4.3 3.1 2.5 8.2 2.0 2.0 4.2 2.9 4.1 6.5 9.4 5.6 4.5 6.0 3.7 4.6 3.7 1.8 4.6 8.6 5.1 6.4 7.2 7.5 4.5 2.8 2.1 1.0 1.8 6.4 4.4 3.4 6.9 5.7 1.4 3.7 6.2 4.1 5.9 2.4 3.9 2.2 2.6 2.3 4.4 3.5 9.0 2.1 10.2 1.2 2.9 5.3 2.0 2.4 0.0 6.2 4.2 2.1 3.0 3.3 7.8 2.7 2.0 3.5 3.6 1.0 2.5 4.1 7.2 5.6 3.8 3.2 7.2 8.0 12.0 1.2 3.9 4.1 3.4 4.3 2.2 3.1 3.1 7.0 6.6 5.2 6.7 3.8 2.2 2.6 4.0 5.1 3.9 2.8 2.8 2.0 ZNF627 FLJ90365 ENSG00000198551 "Zinc finger protein 627" Q7L945 19 11559374-11619161 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA049770, HPA073463" Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 10: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 57: B-cells - Immune response" Nucleoplasm Nucleoli "HPA049770: AB_2680871, HPA073463: AB_2686606" "unprognostic (1.81e-1)" "unprognostic (9.89e-2)" "unprognostic (1.64e-2)" "unprognostic (3.14e-2)" "unprognostic (7.89e-3)" "prognostic favorable (8.12e-4)" "unprognostic (2.81e-1)" "unprognostic (1.00e-1)" "unprognostic (1.83e-3)" "unprognostic (3.17e-2)" "unprognostic (2.03e-1)" "unprognostic (1.67e-2)" "prognostic favorable (6.93e-7)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (3.91e-1)" "unprognostic (6.39e-3)" 5.6 4.1 5.7 4.3 5.9 7.6 11.1 7.4 6.8 8.3 6.0 5.9 5.7 10.6 8.7 4.6 12.2 5.0 5.2 5.6 5.9 9.6 7.1 6.1 6.8 6.1 6.0 13.1 7.5 8.9 5.8 6.3 5.9 8.0 6.8 8.3 5.9 6.5 4.0 5.5 5.0 6.2 6.2 6.6 6.0 8.0 6.3 9.3 13.1 5.6 5.6 6.4 5.6 7.9 6.0 5.2 15.0 18.8 6.7 6.9 8.5 8.4 10.0 9.5 9.5 3.9 4.0 4.6 8.4 6.6 4.8 5.1 6.0 8.2 10.5 8.3 2.8 12.8 2.8 7.6 12.5 6.9 6.9 8.4 11.6 6.2 14.3 14.5 10.6 10.9 11.9 6.0 12.5 12.3 11.3 6.9 11.3 4.0 10.4 12.6 11.3 6.3 10.8 9.2 20.8 15.5 11.5 6.1 12.6 12.7 11.1 19.6 9.2 10.0 4.8 6.2 5.9 8.6 9.0 4.8 4.6 11.3 8.4 14.2 4.5 7.4 4.6 4.9 5.3 9.0 5.6 5.8 7.2 5.8 7.4 6.7 2.4 7.3 4.8 2.7 3.2 4.2 5.7 5.9 7.4 6.8 5.6 5.9 6.1 6.0 5.9 6.2 6.3 7.9 2.9 12.8 5.9 6.2 11.2 1.3 3.4 4.0 6.2 4.5 6.2 5.8 15.0 7.2 3.1 9.2 4.2 5.2 5.4 3.7 17.6 5.4 7.9 7.0 4.9 4.3 5.3 8.0 4.5 2.6 4.3 4.3 10.2 3.7 1.3 6.1 6.1 6.1 3.2 6.7 4.8 3.2 10.2 4.4 4.4 4.0 5.3 3.1 0.0 3.7 3.2 4.9 3.1 6.6 7.3 4.1 3.1 5.3 6.7 4.9 3.5 7.3 11.6 5.8 0.0 3.1 4.7 15.5 4.4 3.6 2.7 4.7 4.8 3.1 4.3 3.3 ZNF692 "AREBP, FLJ20531, Zfp692" ENSG00000171163 "Zinc finger protein 692" Q9BU19 1 248850006-248859144 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 52.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059337, HPA062792" Uncertain Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059337: AB_2683984, HPA062792: AB_2684869" "unprognostic (4.86e-2)" "unprognostic (9.51e-2)" "unprognostic (1.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.90e-1)" "unprognostic (6.72e-3)" "unprognostic (2.85e-3)" "unprognostic (5.66e-3)" "unprognostic (1.25e-1)" "unprognostic (4.50e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.65e-3)" "prognostic unfavorable (7.72e-9)" "unprognostic (5.32e-2)" "unprognostic (2.07e-2)" "unprognostic (1.59e-1)" "prognostic favorable (8.35e-5)" 13.0 16.5 35.1 4.7 36.3 7.5 16.3 36.3 48.5 26.6 34.1 20.1 5.1 17.1 8.2 23.2 25.3 4.9 18.0 35.0 34.7 27.0 21.7 12.5 6.2 36.5 35.5 27.6 28.2 7.4 29.1 4.2 37.7 34.9 3.6 8.5 17.8 5.3 17.7 18.7 16.6 3.8 34.1 23.5 19.7 38.9 35.7 7.0 24.7 4.7 4.4 21.3 20.8 36.8 7.1 6.4 6.1 14.7 4.7 2.5 26.4 6.1 1.9 6.2 4.0 8.2 9.8 8.8 11.7 2.3 2.5 9.5 9.1 8.8 3.9 12.6 5.7 9.9 17.8 2.2 3.5 11.4 8.3 3.2 10.2 6.8 17.5 5.8 5.9 11.1 21.1 6.2 2.9 3.8 5.9 23.7 12.2 17.1 13.1 19.3 3.6 16.9 11.9 4.5 11.7 8.8 6.3 10.1 12.2 2.3 13.1 18.5 4.5 2.7 5.0 2.7 8.0 17.0 11.3 5.8 6.2 14.9 4.7 0.0 1.5 1.4 3.6 1.1 3.3 3.0 2.9 4.0 3.1 2.3 4.1 3.0 3.3 8.1 1.0 2.5 3.5 2.0 35.1 36.3 36.3 48.5 35.0 34.7 36.5 35.5 37.7 34.1 35.7 36.8 7.8 9.6 8.6 27.1 10.7 9.6 12.5 19.0 11.4 15.3 16.8 18.7 5.4 7.2 10.8 11.0 22.9 12.8 10.3 10.0 5.9 7.6 14.3 6.1 7.0 6.7 8.3 22.7 20.6 4.0 10.4 8.1 15.8 6.8 5.7 15.9 2.9 6.2 6.5 11.8 19.7 12.3 12.2 6.0 5.5 7.8 10.2 5.4 16.0 10.3 6.1 8.3 9.2 8.5 23.5 5.7 5.2 7.2 6.6 17.3 11.6 4.1 10.8 13.6 0.0 8.4 8.0 52.7 15.4 11.0 8.0 6.2 11.3 9.5 14.3 10.0 ZNF696 FLJ14129 ENSG00000185730 "Zinc finger protein 696" Q9H7X3 8 143289676-143299952 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057855, HPA072473" Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 48: NK-cells - Unknown function" "Cluster 6: Brain - Smell perception" "Cluster 9: U-2 OS - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA057855: AB_2683545, HPA072473: AB_2686524" "unprognostic (3.23e-2)" "prognostic unfavorable (6.63e-5)" "unprognostic (3.62e-2)" "prognostic unfavorable (3.52e-5)" "unprognostic (2.58e-1)" "unprognostic (7.86e-2)" "unprognostic (2.76e-3)" "unprognostic (8.82e-2)" "unprognostic (3.16e-1)" "unprognostic (3.02e-1)" "prognostic favorable (1.41e-4)" "unprognostic (6.57e-2)" "unprognostic (8.22e-2)" "unprognostic (7.99e-2)" "unprognostic (2.86e-1)" "unprognostic (3.42e-3)" "unprognostic (8.09e-3)" 4.0 3.3 3.9 3.3 3.7 3.5 3.2 5.9 6.1 3.4 0.0 3.3 6.0 4.5 2.5 2.6 3.4 2.1 2.8 4.2 2.5 3.3 4.6 2.8 3.8 5.6 3.0 4.7 5.0 4.3 3.2 2.7 5.0 3.1 1.9 3.6 5.7 2.3 3.9 6.6 3.7 2.3 0.9 4.0 3.3 3.5 3.4 2.1 3.7 2.4 3.0 3.7 2.8 4.9 8.2 7.4 7.8 8.8 3.2 2.5 14.9 6.3 2.4 4.4 2.7 4.3 6.3 0.7 8.2 2.5 2.5 5.8 8.5 3.8 4.5 9.1 17.9 10.8 8.8 6.7 3.4 4.5 13.5 2.4 6.1 3.0 6.8 3.3 2.2 6.4 22.2 5.3 3.1 17.3 4.6 8.8 10.2 9.7 17.1 9.8 4.4 8.1 3.0 6.3 11.6 16.1 9.3 6.7 8.2 5.3 10.3 8.1 4.5 6.2 13.4 5.5 10.9 9.7 7.3 10.0 4.2 9.2 7.5 1.2 2.0 1.7 2.9 1.1 3.0 2.4 2.1 3.1 2.1 3.2 3.9 3.5 1.2 3.5 2.0 3.8 0.7 1.9 3.9 3.7 5.9 6.1 4.2 2.5 5.6 3.0 5.0 0.9 3.4 4.9 2.2 0.0 0.0 3.6 3.0 2.9 2.3 0.6 0.0 5.3 1.5 1.3 2.8 2.8 0.3 3.7 6.2 1.7 1.8 2.1 3.9 2.4 1.2 0.8 2.3 2.5 0.0 1.3 3.4 2.0 1.8 1.9 2.0 1.0 0.0 2.9 2.2 2.2 1.2 3.3 3.9 1.0 2.0 0.9 0.7 2.4 4.1 0.7 1.8 1.0 0.9 1.8 6.2 4.5 3.1 1.5 0.3 1.2 2.3 1.7 2.7 1.9 0.3 4.5 6.6 1.7 2.2 3.0 5.7 1.1 2.0 0.4 2.5 2.7 2.0 0.6 ZNF71 "Cos26, EZFIT" ENSG00000197951 "Zinc finger protein 71" Q9NQZ8 19 56595300-56626481 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 20.6" HPA018124 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoli Nucleoplasm "HPA018124: AB_1848339" "unprognostic (1.93e-2)" "unprognostic (7.95e-2)" "unprognostic (1.32e-1)" "unprognostic (1.96e-2)" "unprognostic (7.72e-2)" "unprognostic (5.03e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.09e-1)" "unprognostic (1.39e-1)" "unprognostic (1.12e-3)" "unprognostic (1.90e-3)" "unprognostic (3.91e-2)" "unprognostic (4.34e-2)" "unprognostic (1.08e-1)" "unprognostic (2.05e-1)" "unprognostic (6.97e-3)" 3.3 2.1 3.1 2.0 2.9 1.1 3.1 2.4 4.8 3.3 0.0 3.9 1.3 4.3 1.3 2.5 3.1 1.9 3.9 4.9 2.0 2.4 0.9 2.4 3.0 1.9 2.5 3.6 2.5 2.4 2.9 2.1 1.7 3.1 1.1 3.3 2.5 2.7 3.5 2.8 2.2 2.5 1.0 2.7 2.5 3.2 2.0 3.2 2.3 2.7 1.5 3.5 2.7 2.3 3.1 7.9 9.1 8.7 3.1 3.3 5.7 3.2 3.9 3.6 4.0 1.5 1.4 3.3 3.2 3.5 3.3 1.1 2.0 3.5 2.1 0.0 20.6 5.4 0.9 3.0 3.7 6.4 4.3 4.7 3.4 3.1 2.6 4.0 4.6 7.2 2.3 0.0 3.4 0.0 12.5 2.3 9.0 0.0 7.9 4.8 6.9 3.0 2.1 5.8 9.0 10.5 2.9 4.5 4.4 3.7 3.4 6.3 5.3 10.5 5.1 2.6 6.4 2.2 3.0 5.0 3.0 3.8 3.1 2.9 1.7 3.5 4.3 1.4 4.5 3.2 3.3 3.6 2.8 3.5 3.4 3.6 0.6 6.1 2.6 2.3 3.7 2.6 3.1 2.9 2.4 4.8 4.9 2.0 1.9 2.5 1.7 1.0 2.0 2.3 8.9 3.2 1.7 3.9 4.5 2.9 2.8 3.8 2.8 9.3 4.8 4.3 3.9 4.3 2.0 7.3 4.2 4.9 5.5 0.6 3.9 10.1 2.7 2.5 3.5 9.8 2.4 2.5 7.4 4.9 6.8 4.6 1.5 2.1 0.0 7.8 3.6 1.0 5.7 11.8 6.6 2.1 4.1 2.4 5.2 3.6 6.2 3.5 3.6 1.9 4.2 3.4 12.3 5.0 4.8 6.3 1.9 5.7 1.4 2.4 1.0 5.8 0.9 8.1 0.0 5.1 6.3 7.4 10.7 2.3 4.3 1.5 5.5 5.5 2.3 1.4 ZNF77 pT1 ENSG00000175691 "Zinc finger protein 77" Q15935 19 2933218-2944971 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023397 Uncertain Approved Nucleoplasm,Nucleoli No No "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoli Nucleoplasm "HPA023397: AB_1859447" "unprognostic (1.17e-2)" "prognostic favorable (8.49e-4)" "unprognostic (2.18e-1)" "prognostic favorable (6.65e-5)" "unprognostic (2.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.21e-1)" "prognostic favorable (6.79e-6)" "unprognostic (2.06e-1)" "unprognostic (5.03e-2)" "unprognostic (3.93e-3)" "unprognostic (2.65e-3)" "unprognostic (3.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.84e-2)" "unprognostic (1.79e-3)" 2.7 2.7 2.3 1.2 2.3 2.2 4.6 4.6 2.6 3.5 2.0 2.5 1.4 3.0 2.8 3.1 2.9 1.4 2.6 2.1 2.2 3.4 2.7 2.8 2.5 2.2 2.2 3.4 3.0 3.3 3.1 2.9 2.3 2.8 2.1 4.0 2.6 2.1 2.6 3.2 2.1 2.9 2.1 2.6 3.2 3.6 2.2 3.4 3.0 4.1 3.4 2.6 2.9 2.7 4.3 2.1 9.4 5.5 1.9 2.5 4.2 2.5 3.8 5.0 5.9 6.5 1.7 4.8 2.1 2.8 2.7 3.4 6.1 4.1 8.3 0.7 4.7 5.9 3.4 7.3 4.8 0.2 4.6 3.9 5.6 3.9 5.7 6.2 7.0 9.2 7.7 0.0 3.4 4.7 7.2 4.2 2.1 3.7 2.8 8.1 7.3 3.3 4.1 6.5 3.8 7.2 3.9 3.6 4.6 4.5 3.5 10.0 3.5 2.1 2.7 6.0 4.7 4.8 4.9 2.2 5.4 0.1 3.9 0.0 1.6 0.8 3.0 1.7 3.5 3.7 3.1 3.2 2.2 3.5 2.3 3.4 0.1 2.4 1.8 1.7 1.6 1.9 2.3 2.3 4.6 2.6 2.1 2.2 2.2 2.2 2.3 2.1 2.2 2.7 4.2 3.2 3.9 3.6 2.2 11.6 4.7 3.3 14.2 2.8 4.6 5.3 2.2 1.5 3.4 1.8 2.1 3.6 5.7 1.9 0.0 2.1 2.1 3.3 3.6 3.7 7.2 1.3 2.9 1.8 3.0 2.9 4.6 4.0 2.5 4.0 4.2 2.2 1.7 0.0 3.2 2.5 2.0 1.6 2.8 0.3 2.8 1.7 1.8 0.0 0.7 3.3 4.1 1.0 2.6 2.4 1.9 1.5 2.0 2.8 1.5 1.4 2.0 5.6 0.0 2.5 2.3 9.7 8.1 6.8 10.9 6.2 3.3 5.4 3.4 1.8 ZNF771 DSC43 ENSG00000179965 "Zinc finger protein 771" Q7L3S4 16 30407414-30431108 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 33.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 35.6;REH: 23.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030730, HPA046672, HPA059398" Uncertain Enhanced Nucleoplasm,Nucleoli No No "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002" "unprognostic (8.21e-2)" "unprognostic (1.61e-1)" "unprognostic (9.21e-2)" "unprognostic (2.41e-1)" "unprognostic (1.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.45e-1)" "unprognostic (2.16e-1)" "unprognostic (1.94e-1)" "unprognostic (1.95e-2)" "unprognostic (3.12e-5)" "unprognostic (3.53e-2)" "unprognostic (3.44e-2)" "unprognostic (1.63e-1)" "unprognostic (2.38e-1)" "unprognostic (2.57e-1)" "unprognostic (9.99e-3)" 4.6 7.2 9.4 1.5 9.9 1.2 4.8 8.6 15.7 7.8 1.9 10.6 1.3 13.3 2.0 4.4 9.9 1.4 6.9 10.7 8.7 7.8 13.2 3.2 0.9 8.4 6.8 10.8 4.9 2.9 8.1 0.5 6.6 9.5 1.4 1.8 4.0 3.7 12.6 3.8 4.7 2.9 4.7 2.5 6.2 3.7 8.4 1.0 5.2 1.5 1.1 10.2 5.4 8.9 4.5 5.2 6.7 5.6 9.3 4.0 5.2 6.3 3.1 3.9 4.1 2.1 2.2 5.2 10.4 3.1 4.8 3.2 6.9 2.8 4.0 1.9 35.6 4.4 3.6 6.8 4.8 2.3 4.9 6.0 2.2 4.9 3.0 4.2 4.0 5.4 10.9 3.1 3.3 8.1 5.4 7.0 5.3 2.7 3.9 23.7 5.1 3.4 2.3 1.8 10.6 6.7 3.4 3.1 4.8 3.4 3.8 2.6 3.8 6.7 8.0 3.9 4.6 4.6 5.4 2.8 4.5 4.9 4.4 0.8 0.7 0.5 1.8 1.4 2.6 1.4 2.2 2.2 1.7 3.3 3.1 2.0 1.0 1.2 0.3 2.3 2.6 1.6 9.4 9.9 8.6 15.7 10.7 8.7 8.4 6.8 6.6 4.7 8.4 8.9 5.4 3.2 0.5 6.2 3.7 5.1 11.5 1.8 22.2 12.0 9.1 15.7 7.1 20.0 1.5 5.5 10.4 5.5 7.2 7.8 33.2 6.2 1.6 4.5 12.3 7.6 4.2 4.4 8.6 4.4 3.3 12.4 5.6 9.0 1.3 12.6 13.2 19.1 3.5 11.8 9.4 10.0 0.0 1.6 2.4 2.2 25.1 3.2 5.4 5.6 1.3 15.9 2.1 5.5 5.4 2.5 5.1 29.7 4.4 15.5 8.6 29.4 0.7 8.0 13.1 15.2 12.0 1.2 1.8 8.5 6.7 3.6 5.1 9.5 10.0 4.3 ZNF865 ENSG00000261221 "Zinc finger protein 865" P0CJ78 19 55605647-55617269 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 34.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068079 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoli Nucleoplasm "HPA068079: AB_2685947" "unprognostic (3.98e-3)" "unprognostic (2.46e-1)" "unprognostic (4.72e-3)" "unprognostic (8.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.20e-2)" "unprognostic (3.22e-3)" "unprognostic (1.23e-1)" "unprognostic (1.16e-1)" "unprognostic (2.30e-2)" "unprognostic (1.05e-2)" "unprognostic (8.85e-2)" "unprognostic (1.40e-2)" "unprognostic (3.62e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "unprognostic (9.41e-3)" 8.9 7.8 5.4 2.9 4.8 4.2 8.4 5.7 6.4 10.4 0.2 12.9 3.7 12.4 0.9 7.4 10.1 0.7 15.5 5.2 2.1 8.5 8.1 8.6 2.4 5.5 4.2 11.0 9.9 3.7 10.5 1.6 3.8 11.5 1.0 1.6 8.5 2.1 34.9 11.4 9.4 1.3 2.1 13.0 9.3 4.1 5.2 3.0 10.6 6.2 1.3 10.7 8.1 5.2 7.4 5.9 2.5 4.1 2.7 2.1 6.9 5.2 2.9 2.8 2.7 1.9 4.7 8.5 5.8 3.8 1.4 6.1 1.6 3.2 1.1 8.5 19.4 4.9 3.8 2.6 4.3 5.7 9.3 3.1 4.9 3.4 2.0 2.5 1.9 5.2 9.6 5.7 1.8 3.5 8.9 6.1 5.7 4.3 10.3 13.8 4.0 5.4 3.3 5.0 6.0 9.7 7.2 4.3 4.6 1.3 3.4 8.8 5.6 4.2 10.1 3.9 6.6 11.9 11.0 4.4 5.2 4.3 6.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.4 4.8 5.7 6.4 5.2 2.1 5.5 4.2 3.8 2.1 5.2 5.2 7.2 0.0 0.0 3.9 6.3 4.1 1.3 3.1 8.0 5.3 5.4 3.7 20.5 4.3 1.3 14.7 0.0 2.6 3.4 8.3 5.9 3.7 2.3 3.0 3.5 5.4 6.0 3.0 3.2 4.5 3.2 5.2 8.6 3.6 0.0 6.9 7.1 6.7 4.7 10.1 3.0 5.6 4.1 5.3 5.8 5.2 5.3 5.1 5.4 1.0 4.0 4.5 3.1 4.0 2.7 6.1 1.8 10.1 4.5 1.4 5.8 4.0 1.6 3.3 6.6 4.3 6.4 1.3 1.2 4.5 4.3 2.6 5.7 5.6 6.1 1.1 ZNF878 ENSG00000257446 "Zinc finger protein 878" C9JN71 19 12043805-12052961 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.0;Cytotrophoblasts: 1.2;Spermatogonia: 1.2;Syncytiotrophoblasts: 1.2" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.2" HPA052735 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm Nucleoli "HPA052735: AB_2681932" "unprognostic (3.27e-2)" "unprognostic (1.76e-1)" "unprognostic (2.62e-2)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (1.56e-2)" "unprognostic (3.00e-4)" "unprognostic (1.42e-1)" "unprognostic (7.43e-3)" "unprognostic (2.80e-1)" "unprognostic (6.67e-2)" "unprognostic (8.75e-2)" "unprognostic (3.02e-1)" "unprognostic (7.65e-3)" "unprognostic (6.82e-2)" "unprognostic (4.04e-1)" "unprognostic (3.62e-2)" 0.3 0.3 0.1 0.2 0.0 1.3 0.2 0.7 0.4 0.4 0.1 0.3 0.1 0.3 0.2 0.3 0.3 0.2 0.2 0.1 0.1 1.1 0.2 0.4 0.2 0.2 0.2 0.5 0.5 0.1 0.2 0.7 0.2 0.3 0.2 0.4 0.3 0.0 0.1 0.1 0.3 0.2 0.2 0.3 0.3 1.0 0.3 0.2 0.3 0.1 0.1 0.3 0.2 0.0 1.5 0.0 0.8 3.2 0.0 0.0 2.0 0.5 0.2 0.6 0.8 1.3 0.2 0.7 0.7 0.2 0.9 0.4 0.3 0.5 0.5 0.0 0.5 0.9 0.0 1.7 0.0 0.6 1.6 0.0 0.0 0.3 0.0 0.0 0.0 2.0 0.0 0.0 0.7 0.0 1.6 0.9 1.8 0.0 0.2 1.2 1.6 0.0 1.1 1.2 0.8 0.1 0.0 0.0 0.1 1.7 1.7 2.1 0.0 0.9 0.7 0.7 0.9 0.6 2.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.4 0.1 0.1 0.2 0.2 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.0 0.8 0.0 0.0 0.0 0.0 1.2 0.3 0.1 0.0 0.3 0.1 0.2 0.2 0.4 0.0 0.0 0.2 0.2 0.9 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.3 0.4 1.2 0.0 0.0 1.2 0.1 0.0 0.0 0.0 ZSCAN26 "SRE-ZBP, ZNF187" ENSG00000197062 "Zinc finger and SCAN domain containing 26" Q16670 6 28267058-28278224 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027521 Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 44: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nucleoli" "HPA027521: AB_2672314" "unprognostic (1.07e-1)" "unprognostic (4.10e-1)" "unprognostic (1.95e-1)" "unprognostic (3.31e-2)" "unprognostic (1.38e-3)" "unprognostic (4.60e-3)" "prognostic unfavorable (7.81e-5)" "unprognostic (1.00e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-2)" "unprognostic (2.49e-3)" "unprognostic (9.01e-2)" "prognostic unfavorable (6.79e-5)" "unprognostic (4.45e-2)" "unprognostic (1.44e-1)" "unprognostic (3.10e-1)" "prognostic favorable (1.68e-4)" 9.9 11.1 18.5 10.3 19.1 6.8 15.1 24.3 23.0 20.2 14.4 16.2 8.9 18.9 13.5 9.6 14.3 12.7 13.0 19.5 20.4 12.1 9.9 10.3 11.0 19.0 17.9 30.2 11.9 14.0 16.4 9.3 18.6 17.1 10.0 26.6 10.2 18.1 11.9 9.9 11.6 16.3 17.3 17.5 10.9 7.8 18.7 11.4 14.4 10.4 12.2 13.6 12.2 22.4 8.1 6.6 18.8 16.2 19.0 18.5 4.2 16.2 15.0 19.9 19.8 4.9 5.7 4.6 22.9 10.1 15.1 5.7 8.6 11.3 21.5 9.8 9.6 12.2 10.6 9.9 13.2 10.1 7.1 15.5 10.7 15.4 14.0 25.8 20.5 7.0 10.2 9.2 16.0 6.7 10.9 13.3 5.6 4.3 10.5 10.7 16.1 7.8 17.2 7.9 13.6 10.3 9.6 4.0 13.2 15.2 6.5 6.9 13.7 16.3 11.7 5.8 19.2 9.9 14.5 8.7 5.8 11.0 14.3 17.9 7.9 14.0 16.1 6.4 19.0 16.3 16.0 17.6 12.5 19.9 19.4 16.0 5.8 22.5 5.5 6.0 15.6 12.5 18.5 19.1 24.3 23.0 19.5 20.4 19.0 17.9 18.6 17.3 18.7 22.4 8.8 0.0 5.6 15.3 9.2 0.0 2.7 0.0 4.0 8.9 4.7 8.3 10.4 2.8 6.2 0.0 4.2 4.9 9.2 1.8 3.9 5.6 5.9 3.8 7.8 7.0 6.7 7.8 23.5 5.0 2.8 8.1 2.0 3.1 6.3 11.1 4.6 1.8 5.9 1.7 26.1 2.6 0.0 5.1 0.0 2.5 9.0 4.3 0.0 8.4 2.3 12.8 14.4 30.7 28.8 3.6 4.0 13.2 3.5 2.2 4.9 4.6 1.5 9.6 19.7 7.7 7.5 7.5 8.7 2.9 0.0 1.4 7.2 8.1 3.4 0.8